data_2joz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2joz _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.96 115.72 4.38 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.378 2.052 . . . . 0.0 111.717 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.07 -14.94 63.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.121 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -94.4 -18.63 21.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.75 0.309 . . . . 0.0 111.417 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.28 139.84 39.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.765 0.317 . . . . 0.0 110.62 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.32 -152.62 21.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.307 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 m -126.8 128.25 46.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 55.5 m95 -118.51 143.75 46.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.849 0.357 . . . . 0.0 111.563 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.602 ' HB2' HD13 ' A' ' 112' ' ' ILE . 19.4 t70 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.326 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.744 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 1.3 tp10 -106.53 36.44 2.62 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 123.39 1.567 . . . . 0.0 107.781 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.19 70.66 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.656 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -95.54 -168.0 1.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.156 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.86 144.49 76.37 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 111.499 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 34' ' ' LYS . 10.0 Cg_exo -71.73 -178.93 3.36 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.414 2.742 . . . . 0.0 113.17 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -141.28 -151.46 5.56 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.495 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 28.5 Cg_endo -61.16 -163.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.561 2.841 . . . . 0.0 112.588 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -52.81 -34.43 53.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.889 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -101.82 17.14 23.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.664 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 77.57 0.23 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 49' ' ' GLU . 99.0 t -54.76 144.67 5.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 123.554 0.742 . . . . 0.0 112.079 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 8.9 mtpm? -55.63 -40.68 72.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.398 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -154.69 163.39 40.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.802 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . . . -143.23 150.32 39.15 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.834 0.35 . . . . 0.0 110.573 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.436 ' HG1' ' HB ' ' A' ' 48' ' ' THR . 19.3 p -134.0 140.56 46.79 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 21' ' ' TRP . 7.2 p -112.4 129.68 67.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 m -108.4 125.93 52.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.978 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -100.59 117.21 34.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.476 . . . . 0.0 110.076 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.604 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 1.1 m -102.35 -179.64 4.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.71 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' HG23 ' A' ' 41' ' ' THR . 37.0 tt0 -44.33 -70.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.128 0.971 . . . . 0.0 113.057 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.21 9.84 8.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.226 0.536 . . . . 0.0 110.78 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.604 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 1.5 pm0 -133.69 150.61 51.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.358 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.51 133.89 56.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 61' ' ' PHE . 22.1 t -116.89 122.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.535 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.83 139.84 30.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.436 ' HB ' ' HG1' ' A' ' 37' ' ' THR . 0.6 OUTLIER -127.51 133.39 49.84 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.41 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HB3' HG13 ' A' ' 33' ' ' VAL . 49.4 mt-10 -125.27 134.4 52.3 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 56' ' ' GLU . 21.3 t -91.11 108.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.336 0.588 . . . . 0.0 109.938 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.438 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 66.8 mtt -99.3 138.43 36.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.546 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 34.6 tt0 -64.53 115.21 4.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.781 0.324 . . . . 0.0 110.472 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.91 -13.69 63.43 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.433 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.438 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 0.1 OUTLIER -113.43 -37.51 4.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.352 0.596 . . . . 0.0 110.436 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.8 -159.83 29.5 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.55 ' HG3' HG23 ' A' ' 50' ' ' VAL . 2.2 mp0 -62.33 126.53 27.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.21 121.39 60.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.843 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -88.2 131.25 34.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.016 0.436 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.499 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 42.8 mt -88.0 165.04 31.38 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.493 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 51.6 Cg_exo -49.79 120.31 5.8 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.87 2.38 . . . . 0.0 111.499 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.535 ' HB3' HG23 ' A' ' 46' ' ' VAL . 11.0 p90 -64.3 134.14 54.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 111.653 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.5 mmm -102.07 129.91 48.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.48 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . . . -77.13 148.94 35.73 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.338 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -140.14 153.83 46.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' A' ' 80' ' ' LEU . 92.6 mttt -126.27 149.47 49.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.229 0.537 . . . . 0.0 110.362 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -93.79 116.11 34.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.281 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 78' ' ' GLN . 21.6 mt -84.81 -52.45 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.428 0.632 . . . . 0.0 109.549 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -133.93 150.36 51.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.093 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.13 155.54 40.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.89 0.376 . . . . 0.0 111.019 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -125.02 158.81 32.79 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 t -67.9 -33.0 73.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -169.95 90.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.873 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.1 -78.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.703 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -139.86 155.77 47.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.088 0.47 . . . . 0.0 110.184 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 mt -135.11 137.19 50.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.669 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.64 121.67 42.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 75' ' ' ILE . 35.3 pt -132.92 151.43 34.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.313 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.47 ' HB2' HD11 ' A' ' 67' ' ' ILE . 18.1 tt0 -124.54 136.73 54.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.391 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -79.91 170.1 16.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.727 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 88.5 mt -131.39 146.8 52.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . 0.44 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . 121.21 -153.71 16.6 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.95 -13.09 37.35 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.632 2.221 . . . . 0.0 112.601 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -125.83 46.32 2.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.993 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 32.9 p90 -84.5 -36.55 0.61 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 61.0 Cg_endo -75.32 -4.41 15.29 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 CA-C-N 121.097 1.427 . . . . 0.0 113.431 -170.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.26 109.52 21.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -86.95 166.47 15.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -131.38 163.16 28.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.996 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -121.25 141.74 50.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.036 0.446 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.7 mt -128.59 137.9 51.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.874 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 79.1 mttt -141.58 156.65 45.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -78.89 144.18 35.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.59 -171.4 15.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.891 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.44 155.63 29.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 71.81 -55.44 0.66 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.757 0.823 . . . . 0.0 111.049 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.08 40.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.502 HG23 ' HA ' ' A' ' 110' ' ' THR . 28.5 p -108.11 171.9 7.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.14 0.495 . . . . 0.0 111.591 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 52.3 tp -118.61 132.67 56.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.323 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 73.0 mt -97.72 110.05 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.405 ' CZ3' HG21 ' A' ' 38' ' ' VAL . 4.2 t90 -103.98 115.02 29.68 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.171 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.39 131.54 55.49 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.884 0.85 . . . . 0.0 111.205 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -151.76 131.32 13.05 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.046 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.57 12.12 8.72 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.347 0.404 . . . . 0.0 111.13 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.89 70.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.274 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -92.61 135.18 34.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.792 0.33 . . . . 0.0 110.458 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -102.31 116.81 33.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.488 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -118.09 128.36 54.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 111.571 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.3 m -95.01 119.21 33.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.104 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.608 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 20.7 mmt -107.19 135.26 49.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.502 ' HA ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.61 146.74 24.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 26.6 ttp180 -93.27 128.91 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.931 0.396 . . . . 0.0 110.783 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 22' ' ' ASP . 19.2 mm -84.39 150.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.317 -0.848 0 CA-C-O 121.505 0.669 . . . . 0.0 110.138 -179.1 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.34 110.59 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.831 2.354 . . . . 0.0 112.424 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -62.71 -26.86 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.698 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB2' HD12 ' A' ' 90' ' ' LEU . 21.8 p90 -88.44 -13.22 40.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.71 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -86.57 142.01 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.622 0.249 . . . . 0.0 110.387 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.79 -159.66 24.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.502 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 m -116.49 122.27 44.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.579 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 69.4 m95 -116.25 136.54 52.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.134 0.493 . . . . 0.0 111.543 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB2' HG12 ' A' ' 112' ' ' ILE . 26.3 t70 -110.26 151.51 27.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.219 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 56.3 mt-10 -63.05 -23.36 67.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.581 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.05 -59.05 0.38 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.262 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -170.27 170.86 7.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 75.42 148.75 0.12 Allowed Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.892 0.877 . . . . 0.0 111.655 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 60.8 Cg_endo -73.09 176.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 0.0 113.152 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.84 -152.74 10.85 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.324 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HG2' HG23 ' A' ' 33' ' ' VAL . 3.2 Cg_endo -48.19 154.32 2.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.759 2.972 . . . . 0.0 113.471 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 t -69.08 -4.73 18.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.229 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.99 -22.78 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.58 22.07 1.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 29' ' ' PRO . 20.1 t -89.16 132.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.0 110.187 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 58.6 mtmt -99.7 -14.96 18.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.107 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p 176.9 159.57 0.36 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.732 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -122.44 136.8 54.97 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.125 0.488 . . . . 0.0 110.331 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 p -118.39 130.74 56.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.664 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.78 134.51 55.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.298 0.571 . . . . 0.0 110.225 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 12.0 m -120.19 126.27 50.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.207 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -101.3 118.29 36.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.244 0.545 . . . . 0.0 110.206 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -96.77 175.86 6.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 41' ' ' THR . 23.1 tt0 -60.96 -35.63 77.29 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.84 -8.63 4.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.464 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 2.2 mp0 -126.68 153.51 45.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 112.219 -169.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.4 t -107.2 120.31 58.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.581 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 61' ' ' PHE . 52.2 t -107.06 125.06 63.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -112.01 127.3 55.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.058 0.456 . . . . 0.0 110.305 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.96 128.03 54.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.763 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 37.7 mt-10 -99.92 129.43 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' A' ' 56' ' ' GLU . 44.8 t -90.24 110.11 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.9 ttm -122.56 145.2 48.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.89 135.07 57.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.839 0.352 . . . . 0.0 110.217 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.56 -56.65 1.97 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.288 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -95.7 -33.7 12.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.76 -149.39 19.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.952 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 45.1 mt-10 -72.92 115.25 12.0 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.6 t -108.75 122.52 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.408 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 48' ' ' THR . 85.7 mt-30 -85.86 119.17 25.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.495 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.1 154.67 67.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.73 122.98 8.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.992 2.461 . . . . 0.0 112.3 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 37.0 p90 -64.64 139.91 58.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtm -112.09 133.49 54.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.776 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.28 134.73 36.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.341 . . . . 0.0 110.68 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.43 ' CD1' HG23 ' A' ' 45' ' ' VAL . 37.1 p90 -130.98 157.12 43.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.089 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.584 ' HE3' HD13 ' A' ' 80' ' ' LEU . 96.7 mttt -127.05 158.99 35.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.51 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.1 t -97.16 119.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.959 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 ' HB2' ' A' ' 78' ' ' GLN . 17.7 mt -82.58 -56.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.404 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -127.68 153.83 46.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.501 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -148.28 148.02 29.99 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.178 -172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -145.23 147.28 32.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.4 p -77.15 -26.81 53.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.469 . . . . 0.0 110.131 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.98 70.06 0.92 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.214 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.06 -88.75 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.882 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 t -152.43 157.78 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.175 0.512 . . . . 0.0 110.574 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.51 135.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.057 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -117.56 128.54 55.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 pt -124.39 157.06 32.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.26 0.553 . . . . 0.0 111.416 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.719 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 34.8 tt0 -134.41 144.63 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.102 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.86 151.1 20.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' HE3' ' A' ' 65' ' ' LYS . 94.8 mt -99.86 163.72 12.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.562 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -152.5 21.71 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.956 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.84 -6.68 13.07 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.368 2.045 . . . . 0.0 111.956 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.51 10.11 29.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.708 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.8 OUTLIER -61.28 170.17 1.82 Allowed Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.747 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.719 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 9.4 Cg_exo 9.42 -1.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.15 1 C-N-CA 128.173 5.915 . . . . 0.0 120.681 -148.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 84' ' ' TYR . 34.6 tp -74.3 103.84 4.84 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -113.33 173.47 6.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -138.52 149.29 45.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.524 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.3 m -122.18 143.35 49.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.94 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 17' ' ' TYR . 94.9 mt -121.65 131.8 54.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -134.57 155.88 49.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.636 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -74.13 144.65 44.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.025 0.44 . . . . 0.0 110.632 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 145.38 18.34 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -70.41 158.6 35.71 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.568 0.223 . . . . 0.0 110.797 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 67.83 12.86 9.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.345 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.72 56.11 2.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.791 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 p -130.58 173.0 11.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.774 -0.251 . . . . 0.0 110.795 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.9 tp -129.27 133.25 47.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 0.0 110.359 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.37 114.22 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -103.83 113.43 26.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.5 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 28.7 mt-10 -103.29 139.03 39.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.421 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -145.99 122.27 10.9 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.446 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER 67.32 8.9 6.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.249 179.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.1 -14.77 25.98 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.649 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 32.5 mt-30 -93.33 133.39 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 30.6 ptt180 -102.41 124.33 47.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.4 0.619 . . . . 0.0 112.223 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -112.35 130.45 55.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 m -93.14 119.27 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.579 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 24.2 mmt -108.73 148.17 30.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.851 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -116.08 157.3 24.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.477 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -76.49 133.2 39.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mt -71.23 152.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.087 -178.711 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.488 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 t . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 121.43 0.633 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 2.4 Cg_endo -81.13 97.57 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.743 2.296 . . . . 0.0 112.271 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -77.84 -11.51 59.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 110.149 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -93.94 -4.31 50.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.121 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 83.4 t80 -75.63 135.74 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.648 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.95 -166.75 19.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.37 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 m -108.67 128.21 54.65 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -111.1 146.74 36.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.292 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -108.98 139.24 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.199 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 7.2 mm-40 -45.43 -61.91 1.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.124 0.89 . . . . 0.0 112.251 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.17 21.34 59.35 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.252 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.17 -167.23 1.24 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.016 0.527 . . . . 0.0 110.989 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.22 146.99 59.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.34 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.08 152.61 36.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.245 2.63 . . . . 0.0 113.104 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.55 -153.91 30.13 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.545 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.38 114.84 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.43 2.753 . . . . 0.0 112.415 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -82.19 70.45 9.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 123.143 1.449 . . . . 0.0 111.129 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -128.94 -63.34 0.97 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.269 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.94 -49.02 0.2 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.098 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG21 ' HG2' ' A' ' 51' ' ' MET . 6.2 t -91.65 133.27 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -108.8 -19.33 13.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.148 0.499 . . . . 0.0 110.982 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 m -161.91 165.41 27.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.746 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -137.66 145.07 42.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.867 0.365 . . . . 0.0 110.838 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -122.77 132.25 54.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.43 129.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.225 0.536 . . . . 0.0 110.795 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.5 m -118.29 128.32 54.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.056 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.2 m -101.86 176.87 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.428 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 41' ' ' THR . 41.5 tt0 -50.47 -54.54 21.42 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.81 -21.28 9.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.457 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.56 156.88 42.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.342 0.591 . . . . 0.0 111.646 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.27 127.34 63.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.73 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.0 124.14 72.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -106.09 135.9 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.37 126.2 53.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.904 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -98.23 126.56 43.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 56' ' ' GLU . 45.8 t -86.3 111.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.382 0.61 . . . . 0.0 109.419 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.43 ' HG2' HG21 ' A' ' 33' ' ' VAL . 88.1 mtp -113.92 130.72 56.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.959 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.3 117.17 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.578 0.549 . . . . 0.0 111.026 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.09 -24.18 33.33 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.236 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -97.08 -58.09 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.715 0.769 . . . . 0.0 110.253 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.71 -152.0 17.26 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.611 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 50' ' ' VAL . 49.0 mt-10 -84.14 117.28 23.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.252 0.526 . . . . 0.0 110.101 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.0 t -105.47 123.86 60.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.9 126.79 31.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.32 159.39 64.82 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.043 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.84 141.93 34.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.036 2.491 . . . . 0.0 111.68 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -67.43 128.33 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.454 0.645 . . . . 0.0 111.062 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.0 mtm -103.89 119.49 39.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.932 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -74.41 134.85 42.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.472 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -127.52 147.41 50.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 0.0 110.489 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.529 ' HD2' HD21 ' A' ' 80' ' ' LEU . 21.2 ptmt -122.9 159.08 28.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.17 122.59 54.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.052 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.1 mt -90.11 -48.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.502 0.667 . . . . 0.0 109.248 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 m -144.12 156.23 44.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.57 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -149.43 130.56 14.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.363 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.2 t -173.24 160.67 4.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.804 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -84.95 -35.55 21.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.182 0.515 . . . . 0.0 109.992 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -100.27 -39.81 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.341 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.41 -3.04 88.52 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.683 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t 67.24 168.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.454 0.645 . . . . 0.0 111.374 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 26.7 mt -107.21 137.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.783 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.497 ' HG2' HD13 ' A' ' 67' ' ' ILE . 30.7 tt0 -122.83 128.54 50.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 88' ' ' SER . 36.1 pt -122.3 158.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.506 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.614 ' CD ' ' HA ' ' A' ' 85' ' ' PRO . 33.0 tt0 -133.39 137.07 45.66 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 72.9 m-85 -80.42 150.45 29.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.457 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 97.2 mt -110.48 -173.09 2.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.892 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.75 -151.76 43.29 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.75 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 -17.03 39.38 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.212 1.942 . . . . 0.0 111.809 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.11 18.96 9.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.715 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 5.5 p90 -59.06 170.07 0.99 Allowed Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.249 0.343 . . . . 0.0 110.443 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 11.96 -0.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 1 C-N-CA 128.082 5.855 . . . . 0.0 121.405 -149.334 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.9 tp -66.97 115.98 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 119.631 1.105 . . . . 0.0 108.272 166.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 59.0 pttt -108.14 179.98 4.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.395 0.617 . . . . 0.0 112.31 -170.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.402 ' HB3' HG13 ' A' ' 77' ' ' ILE . 45.8 t -152.02 165.31 35.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.582 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.5 m -127.03 142.41 51.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.066 0.46 . . . . 0.0 111.215 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.9 mt -124.1 122.53 38.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.274 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 26.3 ttmt -133.35 158.49 42.87 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -173.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -89.42 153.17 21.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.17 0.509 . . . . 0.0 111.768 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.62 162.03 12.68 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.75 -10.39 53.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -130.47 51.12 2.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.765 0.317 . . . . 0.0 111.175 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.35 27.69 73.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.55 160.19 16.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.154 0.502 . . . . 0.0 112.071 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' HE1' ' A' ' 109' ' ' MET . 19.6 tp -128.47 134.78 48.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 91' ' ' LYS . 72.8 mt -104.68 111.91 36.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.037 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.5 t90 -104.13 111.77 24.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.956 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 27.1 mt-10 -100.74 131.5 46.6 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.467 0.651 . . . . 0.0 110.369 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.563 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 16.9 tm0? -152.56 121.17 6.42 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.271 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.563 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 2.6 t-20 75.8 -53.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.95 0.781 . . . . 0.0 112.665 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.14 -25.07 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.207 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -120.19 152.76 37.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.857 0.829 . . . . 0.0 111.176 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 20.5 ptt180 -95.53 126.29 40.71 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 21.8 mmtp -88.25 127.21 35.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.911 0.386 . . . . 0.0 110.243 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.2 m -109.11 111.6 23.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.464 ' HE1' HD22 ' A' ' 98' ' ' LEU . 22.1 ptt? -134.99 156.36 49.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.483 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 m -112.53 155.32 24.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.028 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 111' ' ' ARG . 12.9 ttp85 -78.29 130.25 36.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.957 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.95 146.16 9.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.0 110.168 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.894 -179.689 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.7 Cg_exo -75.79 110.88 3.17 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.939 2.426 . . . . 0.0 111.305 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -63.68 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.058 -174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -84.3 -13.22 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.779 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 17.2 t80 -78.5 138.16 38.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.67 -163.04 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.173 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 84.8 m -110.01 121.96 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.035 0.445 . . . . 0.0 110.511 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 80.8 m95 -106.41 144.41 33.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.577 ' HB2' HD11 ' A' ' 112' ' ' ILE . 22.6 t70 -104.34 120.34 40.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.51 48.44 1.55 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.783 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.49 47.13 2.65 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.568 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -162.5 144.24 10.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.92 164.16 0.13 Allowed Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 124.083 0.864 . . . . 0.0 111.328 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.56 135.54 49.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.681 2.254 . . . . 0.0 113.163 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.19 -154.12 8.69 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.525 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.49 124.49 9.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.617 2.878 . . . . 0.0 112.432 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -82.05 -7.86 59.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.786 -167.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.06 -32.58 62.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.093 0.473 . . . . 0.0 111.535 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.25 39.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.25 136.38 25.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.434 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.0 mmpt? -73.22 -41.01 64.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -161.69 160.4 28.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.162 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.99 135.4 54.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.458 ' HG1' ' HB ' ' A' ' 48' ' ' THR . 35.9 p -117.29 125.91 51.86 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.95 127.72 75.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.2 m -105.82 124.69 49.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.49 118.84 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.36 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -100.38 179.56 4.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 167.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -68.52 -36.66 79.18 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.294 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -111.99 -11.67 13.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -135.01 145.81 48.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.491 0.662 . . . . 0.0 112.344 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 64' ' ' TYR . 97.9 t -111.93 118.38 57.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.526 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.69 122.67 63.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.959 0.409 . . . . 0.0 109.977 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -107.26 133.02 52.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.808 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.458 ' HB ' ' HG1' ' A' ' 37' ' ' THR . 1.3 m -124.31 134.27 53.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 30.1 mt-10 -100.22 125.24 46.36 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -88.01 110.1 20.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.21 121.64 43.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -170.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.88 115.94 4.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.52 10.14 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.098 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -111.44 -59.04 2.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.515 0.674 . . . . 0.0 109.972 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.93 -164.24 19.57 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.68 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' HG21 ' A' ' 50' ' ' VAL . 2.4 mp0 -69.65 126.64 30.34 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.589 0.709 . . . . 0.0 111.628 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.78 122.56 70.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.659 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.96 128.66 33.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.2 0.524 . . . . 0.0 111.993 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 75.6 mt -90.47 165.05 24.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.993 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.5 Cg_endo -57.54 130.47 39.1 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.724 2.283 . . . . 0.0 112.097 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -63.83 147.02 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.971 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -123.88 118.26 26.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.074 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.27 138.33 31.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.809 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.482 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.0 p90 -137.66 171.72 14.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.914 0.388 . . . . 0.0 110.388 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.711 ' HG3' HD11 ' A' ' 80' ' ' LEU . 80.7 mttt -130.01 154.44 47.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.266 0.555 . . . . 0.0 111.08 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.18 124.22 46.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.306 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 78' ' ' GLN . 15.9 mt -88.55 -47.71 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 109.58 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -143.61 156.67 44.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.631 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -149.2 150.92 33.41 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -140.36 145.08 36.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.987 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -73.64 -25.94 60.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.494 0.664 . . . . 0.0 109.506 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -152.35 76.31 1.15 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.582 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.39 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.392 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 m -150.7 154.17 36.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.134 0.492 . . . . 0.0 110.683 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 14.3 mt -118.52 137.62 51.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -117.42 121.68 41.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.83 156.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.672 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 67' ' ' ILE . 15.6 tt0 -130.26 138.35 50.47 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -80.05 -0.93 37.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -165.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.711 HD11 ' HG3' ' A' ' 65' ' ' LYS . 97.6 mt 50.74 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.363 0.415 . . . . 0.0 111.586 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.79 -151.35 49.32 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.716 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.02 -11.1 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.767 2.311 . . . . 0.0 111.987 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.18 30.57 6.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.002 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 15.4 p90 -80.67 -15.71 0.23 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.181 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 87.3 Cg_endo -92.19 -3.82 3.83 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 CA-C-N 120.867 1.345 . . . . 0.0 112.929 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.47 113.73 25.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.0 0.428 . . . . 0.0 110.021 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -111.57 164.41 13.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.458 ' HB2' ' HG3' ' A' ' 102' ' ' GLN . 21.8 t -134.01 155.67 49.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.812 -175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.8 m -112.74 140.81 47.21 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.084 0.469 . . . . 0.0 110.508 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 98.3 mt -124.44 124.59 42.65 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.698 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 39.2 mtpt -135.53 155.19 50.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.2 ptt85 -86.72 161.09 18.6 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.38 39.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -90.69 -10.94 41.26 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -155.65 93.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 111.544 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.71 40.93 42.01 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.657 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.92 159.88 40.82 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.469 0.176 . . . . 0.0 110.859 -175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -123.89 135.21 53.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 25.8 mm -103.84 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.432 ' HB3' ' HE1' ' A' ' 109' ' ' MET . 7.5 t90 -108.46 113.78 27.1 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 31.9 mt-10 -106.19 129.29 54.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.263 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 88' ' ' SER . 7.0 tt0 -153.35 134.08 13.79 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.115 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 59.46 18.16 6.64 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.307 0.38 . . . . 0.0 111.834 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.01 -13.07 60.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.49 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 41.2 mt-30 -92.81 134.99 34.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.055 0.455 . . . . 0.0 111.133 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -101.44 115.8 31.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.09 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -111.16 141.01 45.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.598 0.237 . . . . 0.0 111.299 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -119.06 115.34 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.432 ' HE1' ' HB3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -114.83 165.32 12.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.349 0.595 . . . . 0.0 111.553 -177.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -102.21 163.07 12.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.162 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 42.4 ttp180 -106.36 134.86 48.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.4 mm -81.87 155.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.668 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 110.564 -179.167 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.93 122.24 11.28 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.919 2.413 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.34 -26.71 68.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -92.76 -10.43 37.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.055 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.5 -164.59 23.47 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.325 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.4 m -112.41 127.75 56.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.925 0.393 . . . . 0.0 110.145 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -117.42 151.41 37.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 112' ' ' ILE . 13.8 t70 -89.52 130.92 35.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 4.2 mm-40 -52.85 -53.55 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.726 0.641 . . . . 0.0 112.376 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.04 35.17 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.51 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.5 tpp180 -99.41 149.33 23.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.58 79.07 21.73 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.3 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 25' ' ' ARG . 96.7 Cg_endo -99.91 -164.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.741 2.96 . . . . 0.0 110.927 174.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.35 173.79 33.08 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.912 171.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.1 132.51 16.79 Favored 'Trans proline' 0 C--N 1.324 -0.721 0 C-N-CA 122.989 2.459 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 p -86.03 6.74 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 t0 69.2 84.03 0.15 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.566 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.68 -38.02 2.07 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.63 138.54 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.676 0.274 . . . . 0.0 110.431 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.697 ' HE3' ' HB2' ' A' ' 52' ' ' GLU . 95.8 mttt -91.17 -38.89 12.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.486 0.66 . . . . 0.0 110.201 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -167.75 171.8 9.74 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.65 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -135.55 164.5 27.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.079 0.466 . . . . 0.0 111.647 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 p -127.95 157.18 41.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.2 125.7 74.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.288 0.565 . . . . 0.0 111.02 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -108.33 122.4 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -101.14 117.67 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -101.61 176.32 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 41' ' ' THR . 44.7 mt-10 -62.56 -39.66 94.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.69 -3.35 5.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.849 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.99 157.5 45.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.224 0.535 . . . . 0.0 111.646 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.09 133.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.69 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.76 124.33 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.495 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 59' ' ' LEU . 17.8 mt-10 -98.79 137.41 37.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.264 0.554 . . . . 0.0 110.947 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.09 120.26 35.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.808 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.87 131.9 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.369 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.515 HG23 ' HG2' ' A' ' 56' ' ' GLU . 39.9 t -89.48 113.6 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.297 0.57 . . . . 0.0 110.665 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.0 mtt -116.07 135.53 53.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.697 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 34.4 tt0 -70.66 128.91 37.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.99 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 -27.32 7.36 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.343 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -93.21 -62.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.665 0.745 . . . . 0.0 109.997 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.14 -155.26 19.78 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.299 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HG2' HG23 ' A' ' 50' ' ' VAL . 50.3 mt-10 -87.71 129.09 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.374 0.607 . . . . 0.0 110.162 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.8 t -104.38 122.61 57.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.94 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.87 130.4 37.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.019 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 47' ' ' GLU . 94.8 mt -85.31 154.66 60.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -50.23 143.08 26.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.109 2.539 . . . . 0.0 112.524 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -59.87 119.02 6.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.7 mtm -109.79 121.78 46.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.218 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 149.36 39.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.531 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.21 159.91 36.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.84 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.539 ' HD2' HD22 ' A' ' 80' ' ' LEU . 20.4 ptmt -121.69 144.31 48.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.029 0.442 . . . . 0.0 109.846 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.78 115.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.806 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.5 mt -93.6 -51.86 10.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.898 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -124.92 154.61 40.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.717 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -149.19 147.74 28.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -148.74 146.27 28.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.3 p -73.48 -24.19 60.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.375 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -161.29 78.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.91 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.87 -84.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.978 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 m -145.41 148.89 33.83 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.096 0.474 . . . . 0.0 110.644 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.23 132.35 66.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -114.76 124.17 51.09 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.72 149.21 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 32.4 tt0 -124.36 136.76 54.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -77.11 157.45 31.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.281 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.539 HD22 ' HD2' ' A' ' 65' ' ' LYS . 90.6 mt -121.11 166.48 13.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.977 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.41 -152.19 17.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.977 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.69 -9.85 15.04 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -122.98 57.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 37.3 p90 -85.21 -27.68 0.39 Allowed Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.071 -171.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 10.3 Cg_endo -89.31 -3.57 5.95 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 CA-C-N 121.089 1.425 . . . . 0.0 112.701 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.9 tp -89.21 117.25 28.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 64.1 pttt -113.76 162.43 16.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.942 0.401 . . . . 0.0 110.955 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.77 160.26 34.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.9 m -115.7 139.24 50.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 98' ' ' LEU . 96.1 mt -124.1 124.33 42.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -132.33 152.86 51.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.496 . . . . 0.0 111.018 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -69.46 151.18 46.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.807 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.45 152.2 18.28 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.89 145.16 56.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.688 0.28 . . . . 0.0 111.259 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 66.47 20.48 10.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.553 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.47 4.21 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.072 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 p -117.16 173.8 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 90' ' ' LEU . 49.4 tp -127.7 135.94 50.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.251 0.548 . . . . 0.0 111.345 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.4 mt -108.8 111.06 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.5 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.712 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 20.2 t90 -105.41 117.97 35.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.322 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.4 mt-10 -102.48 132.75 48.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.528 0.68 . . . . 0.0 110.113 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -151.24 123.94 8.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.128 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 62.02 22.44 13.08 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.729 0.643 . . . . 0.0 111.26 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.39 -8.35 69.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.98 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -93.1 134.06 35.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.992 0.396 . . . . 0.0 110.064 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -101.18 127.66 47.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.103 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 5.0 mmpt? -127.51 139.58 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.169 0.509 . . . . 0.0 111.657 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 m -106.58 114.11 28.02 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.995 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.712 ' HE2' ' HE3' ' A' ' 100' ' ' TRP . 12.4 ptp -119.37 148.4 43.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.644 -172.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -98.15 152.78 18.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -84.67 123.89 30.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -74.13 154.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.128 0.49 . . . . 0.0 109.98 179.282 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 8.1 m . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 39.2 Cg_exo -56.85 121.26 9.75 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.629 2.219 . . . . 0.0 111.684 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -69.86 -15.25 63.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.993 -172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -98.15 -5.67 33.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 28.0 t80 -85.53 136.37 33.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 0.0 111.036 -171.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.18 -143.25 14.82 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.029 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m -127.88 126.39 41.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 87.2 m95 -117.92 138.81 51.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.139 0.495 . . . . 0.0 111.486 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 4.4 t70 -83.55 126.47 32.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.498 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 109' ' ' MET . 44.2 mt-10 -90.71 72.72 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.65 -15.94 60.86 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.257 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -100.45 142.75 31.49 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 70.71 145.24 0.11 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.562 1.164 . . . . 0.0 111.3 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.69 148.78 66.28 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.702 2.268 . . . . 0.0 112.501 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.4 -160.9 36.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.048 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.525 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.9 Cg_endo -62.98 152.58 78.62 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.711 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 p -78.67 3.76 15.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.736 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.39 -11.22 60.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.287 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 111.69 47.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.718 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.525 HG21 ' HG2' ' A' ' 29' ' ' PRO . 17.1 t -105.84 135.12 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.672 0.272 . . . . 0.0 110.28 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.08 -42.44 47.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.624 . . . . 0.0 111.024 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -166.14 163.17 18.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.534 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.12 36.98 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.78 141.14 51.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.54 129.76 70.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.333 0.587 . . . . 0.0 110.578 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 35.1 m -111.95 119.48 38.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.305 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -102.17 121.19 41.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.799 0.333 . . . . 0.0 111.225 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 1.7 m -101.83 173.9 6.19 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.4 ' H ' HG21 ' A' ' 41' ' ' THR . 1.5 mp0 -53.04 -46.56 68.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -129.8 8.09 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 45.0 mt-10 -121.77 135.4 54.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.562 -175.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 64' ' ' TYR . 87.2 t -107.97 118.07 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.561 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 52.8 t -109.96 123.12 65.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 15.6 mt-10 -97.27 132.47 42.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.53 0.681 . . . . 0.0 111.066 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -127.85 118.25 23.33 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.1 177.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.455 ' OE2' ' HG3' ' A' ' 29' ' ' PRO . 27.6 mt-10 -109.0 126.66 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.302 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.88 111.65 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.247 0.546 . . . . 0.0 110.043 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 32' ' ' GLY . 39.1 ttm -118.92 125.95 50.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.515 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.03 127.17 30.5 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.012 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.6 -28.79 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.655 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -125.77 -34.73 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.178 0.513 . . . . 0.0 111.289 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.42 -140.73 15.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.251 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.63 138.56 50.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.23 0.538 . . . . 0.0 111.209 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' THR . 80.0 t -128.72 121.38 54.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.097 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -82.16 130.52 35.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 76.3 mt -95.84 159.69 31.82 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.651 171.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.08 117.39 3.85 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.79 2.327 . . . . 0.0 111.601 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -61.62 127.29 30.75 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.529 0.681 . . . . 0.0 111.475 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 42.5 ttm -95.2 144.36 25.87 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.556 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.97 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 110.471 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.409 ' CD1' HG21 ' A' ' 45' ' ' VAL . 15.7 p90 -138.08 163.07 32.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.067 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HE3' HG12 ' A' ' 67' ' ' ILE . 49.7 pttt -122.61 152.82 40.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.962 0.41 . . . . 0.0 110.117 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.63 112.95 37.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.032 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.568 HG12 ' HE3' ' A' ' 65' ' ' LYS . 11.5 mt -83.95 -53.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.287 0.565 . . . . 0.0 109.871 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 m -127.1 151.58 48.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.11 146.86 27.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -137.2 153.8 50.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.1 m -79.37 -30.02 42.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -152.76 80.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.131 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.32 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.671 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 p -148.68 154.71 40.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.173 0.511 . . . . 0.0 110.994 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 31.9 mt -128.35 130.99 69.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.001 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.81 124.13 51.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.32 157.68 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.689 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 47.4 tt0 -132.69 135.93 46.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -74.72 144.37 43.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 -179.7 3.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.759 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.67 -151.53 34.24 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.582 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 -10.15 21.35 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.718 2.278 . . . . 0.0 112.313 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -99.5 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.693 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.827 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 1.6 p90 -60.1 -179.31 0.17 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.371 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER 12.76 -0.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.258 1 C-N-CA 127.75 5.633 . . . . 0.0 121.343 -149.375 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 84' ' ' TYR . 63.0 tp -71.66 113.52 8.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 119.905 1.229 . . . . 0.0 109.759 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 94.7 mttt -91.44 170.82 9.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.418 0.628 . . . . 0.0 111.643 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -151.75 152.45 32.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.35 171.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.2 m -118.07 141.78 48.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.32 0.581 . . . . 0.0 111.31 -173.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 80.9 mt -121.12 124.65 45.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.641 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 51.9 mtpt -132.59 156.91 46.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 111.669 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -65.59 144.2 57.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.598 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.81 -168.53 25.3 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.926 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.7 -41.43 13.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.336 0.589 . . . . 0.0 111.674 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.84 18.37 21.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.191 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.66 26.36 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 p -106.0 175.67 5.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.341 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 90' ' ' LEU . 59.5 tp -105.55 128.4 53.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 34.0 mm -96.97 109.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.477 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 16.6 t90 -103.25 112.76 25.78 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.703 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.3 mt-10 -104.47 131.19 52.12 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.69 0.757 . . . . 0.0 109.853 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -151.15 120.29 6.74 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.314 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 61.56 23.2 13.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -8.79 70.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.748 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.2 142.23 27.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -93.68 115.76 28.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 71.3 mttt -106.33 115.56 30.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.444 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.0 m -92.93 118.05 30.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.775 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 10.3 mmt -99.42 139.09 35.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -95.12 143.51 26.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.107 0.479 . . . . 0.0 110.286 -177.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -79.24 128.94 33.94 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.461 HD13 ' HB2' ' A' ' 22' ' ' ASP . 26.8 mm -75.99 142.85 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.337 0.589 . . . . 0.0 109.486 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.059 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.773 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.694 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.2 Cg_exo -67.45 104.13 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.816 2.344 . . . . 0.0 111.656 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.446 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 40.6 p90 -57.65 -34.27 69.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.987 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.564 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 50.1 p90 -78.93 -9.62 59.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.694 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 2.1 t80 -80.82 23.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.331 0.586 . . . . 0.0 111.364 -172.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 17' ' ' TYR . . . -115.61 -177.78 18.49 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.095 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 m -99.23 116.86 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.446 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 50.6 m95 -114.05 132.32 56.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.465 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.28 129.99 45.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.25 -55.63 26.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.43 27.55 73.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.107 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.7 144.68 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.6 160.71 0.13 Allowed Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 124.388 1.055 . . . . 0.0 112.086 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.85 153.6 72.54 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.686 2.258 . . . . 0.0 111.516 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.03 -169.66 46.07 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.964 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 64.2 Cg_exo -50.66 162.89 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 124.466 3.444 . . . . 0.0 113.879 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 p -69.34 -9.42 53.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.59 -10.13 59.18 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.012 -0.43 . . . . 0.0 111.106 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.7 27.67 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.547 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.614 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 21.4 t -74.06 134.67 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.262 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -81.14 -32.67 33.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 m -158.73 160.34 36.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.506 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.01 137.01 46.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.142 0.496 . . . . 0.0 111.092 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.445 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 24.6 p -118.39 136.86 53.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.259 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.78 134.14 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.179 0.514 . . . . 0.0 110.671 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -123.3 128.31 49.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.701 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 97.0 m-85 -102.06 116.79 33.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.128 0.489 . . . . 0.0 110.546 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.52 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -103.04 -178.16 3.58 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.78 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -46.01 -64.2 0.8 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.17 10.29 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.772 0.796 . . . . 0.0 110.16 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.52 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -137.98 145.83 42.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.181 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 64' ' ' TYR . 90.0 t -101.36 132.3 47.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.19 123.16 67.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.828 0.347 . . . . 0.0 110.159 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -103.78 138.31 40.56 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.435 0.636 . . . . 0.0 110.279 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.445 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -124.23 122.13 36.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.182 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.59 120.03 39.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.797 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 56' ' ' GLU . 33.2 t -87.98 112.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.6 127.57 55.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.16 132.12 49.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.67 0.606 . . . . 0.0 111.517 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.4 3.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.07 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -93.9 -63.96 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.14 -157.02 21.05 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.376 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.8 mp0 -74.98 129.61 37.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.38 0.61 . . . . 0.0 110.843 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.84 122.58 66.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.708 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -84.76 131.63 34.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.872 0.368 . . . . 0.0 111.917 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.69 164.89 30.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.543 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.83 152.33 36.1 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.876 2.384 . . . . 0.0 112.44 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.77 114.66 10.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 110.693 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.428 ' HE1' ' CE2' ' A' ' 83' ' ' TYR . 70.7 mtp -96.62 118.38 32.99 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.544 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -75.98 140.85 42.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.969 0.414 . . . . 0.0 111.66 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CD1' HG21 ' A' ' 45' ' ' VAL . 8.9 p90 -145.94 150.11 35.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -132.93 151.56 52.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.486 0.66 . . . . 0.0 111.243 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.87 128.94 38.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.846 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 78' ' ' GLN . 36.7 mt -90.94 -52.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.177 175.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.6 m -138.48 156.95 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.196 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -147.54 152.85 38.67 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -157.89 135.48 10.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 120.819 0.343 . . . . 0.0 111.156 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -11.94 59.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.1 -39.15 89.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.067 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.08 36.78 0.15 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.21 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 m -149.84 136.49 19.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 117.573 0.686 . . . . 0.0 110.736 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 18.6 mt -136.24 137.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.98 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -114.09 129.06 56.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 32.7 pt -131.45 157.43 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.858 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.745 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 6.2 tp-100 -124.28 147.05 48.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -96.48 151.05 19.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 63' ' ' ALA . 38.1 mt -107.74 156.13 19.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.154 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -154.42 21.75 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.24 -4.76 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.765 2.31 . . . . 0.0 112.618 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.428 ' CE2' ' HE1' ' A' ' 62' ' ' MET . 71.0 m-85 -97.67 11.45 37.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.966 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -65.35 176.71 0.79 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.948 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.966 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 20.0 Cg_exo 5.06 -1.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 1 C-N-CA 128.425 6.084 . . . . 0.0 121.872 -148.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.2 tp -90.19 102.94 15.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 120.299 1.409 . . . . 0.0 108.057 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 20.4 pttp -115.39 178.66 4.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 0.0 112.352 -166.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 m -133.27 165.6 24.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.096 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -123.86 142.16 51.38 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.443 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 93.7 mt -117.92 124.6 48.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.365 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -137.51 154.98 49.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.955 0.407 . . . . 0.0 110.991 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -65.12 143.72 57.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.253 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.01 132.97 10.14 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 42.3 mt-10 -68.59 158.43 34.0 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.899 -0.177 . . . . 0.0 110.568 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 12.9 m120 75.51 -7.42 1.79 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.74 0.816 . . . . 0.0 110.784 -174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.53 0.9 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.873 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.4 p -131.16 174.24 10.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.748 0.309 . . . . 0.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.82 133.18 54.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.884 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.16 110.2 30.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.231 0.539 . . . . 0.0 109.87 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -104.97 114.13 28.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.788 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.9 134.71 43.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.266 0.555 . . . . 0.0 109.687 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -148.79 111.77 4.87 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.748 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.59 31.71 20.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.82 0.819 . . . . 0.0 110.698 166.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.44 -17.17 55.85 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.941 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -92.04 136.29 33.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.968 0.384 . . . . 0.0 110.839 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 106' ' ' ARG . 23.2 ttt180 -99.94 114.97 28.6 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -109.7 136.25 49.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.595 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -120.93 114.13 21.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.856 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.416 ' HE1' ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -118.22 151.49 37.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -109.36 151.72 26.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -87.92 135.74 33.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.298 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.78 147.58 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.616 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.557 -174.774 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.41 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 14.7 m . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.231 0.538 . . . . 0.0 111.856 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 14' ' ' THR . 6.1 Cg_endo -49.45 120.13 5.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.725 2.95 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -69.53 -14.24 62.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.468 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -98.03 -11.54 22.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.498 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -86.05 135.71 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.93 -168.24 22.5 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.984 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.7 m -104.08 129.93 51.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -120.44 135.8 54.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.016 0.436 . . . . 0.0 111.039 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.74 139.09 31.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.027 174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 37.5 mt-10 -50.31 -43.83 53.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.21 -56.81 2.8 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.187 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 -105.7 141.24 37.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 65.81 142.77 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.637 1.211 . . . . 0.0 112.054 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.1 Cg_exo -81.44 171.09 13.96 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.251 2.634 . . . . 0.0 112.571 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.91 -154.97 30.34 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.313 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -61.89 -31.06 84.72 Favored 'Trans proline' 0 C--O 1.23 0.098 0 C-N-CA 123.315 2.676 . . . . 0.0 113.597 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 83.2 m 75.6 -21.14 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.748 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' PRO . 11.9 m-20 -51.13 -54.7 22.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.398 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.36 -43.07 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.002 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.35 134.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.72 -32.47 14.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 m -167.88 165.41 13.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.943 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -121.97 148.06 45.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.096 0.474 . . . . 0.0 111.055 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 p -118.11 139.48 51.18 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.54 137.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.162 0.506 . . . . 0.0 111.19 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -119.41 127.84 53.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.901 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -101.69 125.64 48.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 111.425 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -101.36 178.97 4.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.415 ' H ' HG21 ' A' ' 41' ' ' THR . 36.5 mt-10 -55.03 -42.1 72.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -141.29 19.55 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 110.821 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.8 mt-10 -129.06 145.16 51.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 62' ' ' MET . 92.5 t -117.14 121.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.07 124.02 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -111.8 128.78 56.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -111.62 125.18 53.67 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.485 177.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.19 128.08 45.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' A' ' 56' ' ' GLU . 43.6 t -92.31 112.61 26.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 0.0 110.359 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -112.3 161.56 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.433 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.0 123.96 26.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 110.759 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 -10.93 44.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.592 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -98.71 -68.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 50' ' ' VAL . . . 125.66 -142.59 13.86 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.613 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HG2' HG23 ' A' ' 50' ' ' VAL . 53.1 mt-10 -95.65 120.61 36.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.291 0.567 . . . . 0.0 110.644 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 48' ' ' THR . 73.9 t -104.68 124.89 59.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.694 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -88.13 119.57 28.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.629 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.6 mt -81.09 163.64 54.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.806 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.4 Cg_endo -62.25 146.4 95.89 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.792 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -64.04 131.01 46.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 111.075 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.54 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 50.8 mtt -97.43 118.19 33.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.838 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.83 127.71 32.83 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CD1' HG23 ' A' ' 45' ' ' VAL . 45.6 p90 -129.18 171.81 12.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.959 0.409 . . . . 0.0 111.332 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.544 ' HE3' HD22 ' A' ' 80' ' ' LEU . 99.0 mttt -120.71 159.73 24.77 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.253 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -103.72 120.97 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.781 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 78' ' ' GLN . 19.9 mt -87.55 -54.0 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.233 0.539 . . . . 0.0 109.813 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -136.46 153.19 51.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.144 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.74 124.39 11.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.455 0.645 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 72' ' ' ASP . 35.5 t -108.85 -22.55 12.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.124 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 m 73.77 -38.71 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.851 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 70' ' ' SER . 23.9 t70 -98.53 -59.41 1.75 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.756 0.312 . . . . 0.0 111.435 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.64 -60.52 2.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.176 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 30.5 t -154.0 164.84 37.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.407 0.622 . . . . 0.0 111.598 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.55 136.4 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.456 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HG2' HD13 ' A' ' 67' ' ' ILE . 27.2 tt0 -115.09 131.01 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.739 0.304 . . . . 0.0 110.37 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.64 158.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.136 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.582 ' HB2' HD11 ' A' ' 67' ' ' ILE . 61.8 tt0 -131.84 140.85 49.26 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 58.4 m-85 -86.41 179.42 6.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' HE3' ' A' ' 65' ' ' LYS . 90.0 mt -134.87 -176.21 4.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.324 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.65 -152.98 30.98 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HG2' ' CE2' ' A' ' 83' ' ' TYR . 28.0 Cg_endo -65.44 -7.35 15.75 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.215 1.944 . . . . 0.0 112.047 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.515 ' CE2' ' HG2' ' A' ' 82' ' ' PRO . 24.8 m-85 -114.16 34.78 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.1 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 19.6 p90 -85.33 -27.35 0.38 Allowed Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 84.2 Cg_endo -83.32 -4.44 11.0 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.439 1.55 . . . . 0.0 112.922 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.88 133.22 44.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.333 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -111.49 168.72 9.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.117 0.484 . . . . 0.0 111.181 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 156.47 46.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.315 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -124.58 142.13 51.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.83 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 98' ' ' LEU . 97.6 mt -120.39 124.19 44.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.567 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 32.8 mtmm -124.26 161.56 25.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.39 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.39 144.91 33.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.011 0.434 . . . . 0.0 110.396 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.64 171.09 23.65 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.507 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.18 -19.9 60.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.097 -0.551 . . . . 0.0 111.944 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -121.41 29.66 7.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 -173.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.05 39.7 62.92 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -116.63 174.91 5.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.451 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 90' ' ' LEU . 39.1 tp -113.23 131.78 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.89 111.44 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.866 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.487 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 12.0 t90 -97.0 112.89 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.827 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -110.81 132.63 54.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -150.69 128.25 11.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.092 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.66 17.12 9.47 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.6 64.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.82 134.3 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.427 ' NH2' ' HE3' ' A' ' 91' ' ' LYS . 96.4 mtt180 -101.39 123.92 46.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.595 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 19.3 mmtp -106.99 125.7 51.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.953 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -97.66 113.2 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.487 ' HE1' ' HB2' ' A' ' 100' ' ' TRP . 65.6 mtm -100.38 155.46 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.856 -169.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.11 150.42 20.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.835 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 3.0 ptt180 -95.78 139.82 31.46 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mm -95.87 155.48 3.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.864 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.902 0.858 . . . . 0.0 109.769 177.811 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.822 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 29.3 m . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.822 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 16.1 Cg_exo -68.82 90.47 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.192 1.928 . . . . 0.0 112.169 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -75.7 -9.15 58.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.01 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -84.41 -11.68 55.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 15' ' ' PRO . 10.5 m-85 -72.68 151.08 42.43 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.71 -167.07 12.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.388 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.3 m -110.55 128.07 55.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 110.501 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 111' ' ' ARG . 64.1 m95 -113.36 128.6 56.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 37' ' ' THR . 15.0 t70 -88.21 120.69 29.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.16 76.1 2.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.348 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.23 40.4 2.47 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -128.04 144.49 51.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.43 156.75 0.16 Allowed Pre-proline 0 N--CA 1.465 0.311 0 O-C-N 124.213 0.946 . . . . 0.0 111.756 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.74 134.51 50.94 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.455 2.104 . . . . 0.0 111.857 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.9 -174.85 34.98 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.229 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 18.2 Cg_endo -59.76 128.4 26.78 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.159 2.573 . . . . 0.0 112.75 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -67.86 -10.38 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.347 0.594 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.88 -33.17 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.561 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.57 -27.96 0.54 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.221 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.57 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 5.8 t -82.59 133.35 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -91.48 -31.08 16.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.092 0.473 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 m -160.2 165.09 32.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.613 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.78 154.85 51.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.012 0.434 . . . . 0.0 111.292 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 22' ' ' ASP . 5.7 p -123.18 130.44 52.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.407 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.39 130.39 66.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.058 0.456 . . . . 0.0 110.572 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.2 m -114.78 127.09 55.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.774 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.83 117.64 35.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.17 0.51 . . . . 0.0 110.2 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -101.11 179.18 4.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.543 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.43 ' H ' HG22 ' A' ' 41' ' ' THR . 29.9 mt-10 -52.84 -64.13 0.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -119.18 14.49 13.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 111.698 -174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.49 148.62 34.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.91 0.386 . . . . 0.0 111.019 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 64' ' ' TYR . 98.0 t -110.19 119.45 59.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.526 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.8 123.35 53.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.991 0.424 . . . . 0.0 110.426 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.22 137.24 38.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.368 0.604 . . . . 0.0 110.75 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.03 122.26 31.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.867 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -99.67 135.89 40.41 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.53 112.08 23.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.6 mmm -110.47 124.94 52.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.043 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.56 113.88 2.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.976 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 -26.83 23.15 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.4 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -96.23 -55.03 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.598 0.713 . . . . 0.0 109.813 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.19 -156.64 15.64 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.496 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.99 126.74 30.52 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.279 0.561 . . . . 0.0 110.564 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.88 122.59 68.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -81.81 128.45 34.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.574 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.2 mt -93.75 165.45 17.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.489 173.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.0 Cg_endo -58.45 128.4 28.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.297 1.998 . . . . 0.0 111.432 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -66.89 122.9 18.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.75 0.786 . . . . 0.0 111.231 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 40.2 ttm -80.39 127.87 32.9 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.18 135.76 41.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.426 ' CD1' HG22 ' A' ' 45' ' ' VAL . 6.2 p90 -147.09 157.93 43.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -123.68 136.64 54.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.169 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.448 ' HA ' HG23 ' A' ' 77' ' ' ILE . 78.9 t -75.7 122.94 30.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.882 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 78' ' ' GLN . 27.4 mt -83.9 -54.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.4 m -140.78 156.47 46.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.7 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.67 126.39 11.81 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.161 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -161.94 156.26 22.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.056 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 m -82.17 -26.87 33.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.125 0.488 . . . . 0.0 110.107 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.7 -29.89 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.76 0.81 89.23 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p 60.96 -178.54 0.11 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.97 1.308 . . . . 0.0 112.222 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 11.3 mt -108.13 130.59 60.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.134 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -126.38 128.49 47.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 66' ' ' VAL . 29.4 pt -131.01 155.86 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.996 0.426 . . . . 0.0 111.198 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.661 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 5.6 tp-100 -123.68 146.22 48.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.205 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 41.4 m-85 -98.45 151.05 21.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.873 0.368 . . . . 0.0 110.365 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.4 mt -113.82 164.51 13.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.7 -151.28 23.05 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.513 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.68 -6.91 11.54 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.974 2.449 . . . . 0.0 112.627 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 13.07 30.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.867 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -60.45 174.22 0.53 Allowed Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.106 -173.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 44.5 Cg_exo 5.18 -0.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 128.847 6.365 . . . . 0.0 121.944 -148.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 84' ' ' TYR . 49.0 tp -78.12 103.04 7.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 120.086 1.312 . . . . 0.0 108.095 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -95.7 -176.8 3.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -166.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.402 ' HB3' HG13 ' A' ' 77' ' ' ILE . 40.6 t -141.69 159.32 42.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.235 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.8 m -137.17 144.71 43.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.507 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 87.2 mt -126.59 124.65 40.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.546 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 98' ' ' LEU . 62.3 mttp -123.17 167.0 14.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -79.82 149.52 31.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.952 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.51 ' HA3' ' HB ' ' A' ' 97' ' ' THR . . . -116.24 137.66 13.85 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -41.41 74.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.32 25.78 2.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.453 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.04 39.02 13.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.27 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.51 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -107.63 171.91 7.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.362 -0.419 . . . . 0.0 109.886 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.613 HD21 ' HE3' ' A' ' 109' ' ' MET . 34.3 tp -128.8 131.08 47.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.78 112.81 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.614 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 20.7 t90 -96.54 112.65 24.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 36.3 mt-10 -104.64 130.04 52.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.458 0.647 . . . . 0.0 110.031 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.434 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 19.7 tm0? -153.78 134.74 13.87 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.798 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.9 OUTLIER 66.55 13.33 9.25 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.323 0.39 . . . . 0.0 111.525 173.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.28 71.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.073 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.31 142.69 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 58.7 mtt180 -99.51 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.168 0.508 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 29.7 mmmt -101.7 141.4 34.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.556 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 m -119.24 112.68 19.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.614 ' HE1' ' HB2' ' A' ' 100' ' ' TRP . 23.6 ptt? -126.37 141.57 51.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.755 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.7 m -98.94 154.46 18.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.435 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 21' ' ' TRP . 20.3 ptt180 -88.11 157.72 18.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.054 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 22' ' ' ASP . 19.7 mm -95.76 147.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--N 1.312 -1.036 0 CA-C-O 121.268 0.556 . . . . 0.0 111.435 -172.114 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.2 124.63 14.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.277 2.651 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -64.78 -27.88 69.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.139 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -83.8 -6.45 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.249 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -71.75 137.11 47.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 109.996 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.03 -149.73 17.42 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.931 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.8 m -127.09 132.37 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.545 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -120.69 150.87 40.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.237 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.546 ' HB2' HD13 ' A' ' 112' ' ' ILE . 7.0 t0 -107.23 127.85 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.13 -18.89 41.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.848 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 -56.02 1.07 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 40.0 ttm180 -170.44 149.8 3.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.29 155.86 50.12 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.732 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.23 134.35 33.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.609 2.206 . . . . 0.0 111.019 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.25 -153.22 7.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.667 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.21 138.68 72.29 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.059 2.506 . . . . 0.0 112.05 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -80.3 16.16 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.494 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.72 -31.1 41.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.036 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.99 95.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.987 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.487 HG21 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -103.62 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -87.01 -37.04 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.153 0.501 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' ARG . 51.6 m -159.92 163.69 34.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.923 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.24 130.99 50.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 p -123.8 130.79 53.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.7 127.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.252 0.549 . . . . 0.0 110.484 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.542 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 88.8 m -108.41 129.46 55.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.43 117.48 35.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.144 0.497 . . . . 0.0 110.508 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 42' ' ' GLU . 2.5 m -102.29 -179.62 4.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.814 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.422 ' H ' HG23 ' A' ' 41' ' ' THR . 29.1 mm-40 -44.3 -66.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.502 0.721 . . . . 0.0 112.609 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -126.08 9.52 7.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 111.205 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -133.3 143.26 48.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.408 0.623 . . . . 0.0 111.411 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.92 128.31 48.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.809 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 45.7 t -104.29 123.46 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.157 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.3 mt-10 -95.2 129.13 42.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.446 0.641 . . . . 0.0 110.655 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.16 116.42 19.9 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.019 176.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.33 135.82 44.25 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.66 110.77 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.575 ' HE3' ' HG3' ' A' ' 54' ' ' ARG . 91.4 mtp -116.92 134.86 54.23 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.872 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.6 116.58 10.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.857 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -11.71 66.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.49 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.575 ' HG3' ' HE3' ' A' ' 51' ' ' MET . 4.5 mmp_? -106.86 -59.41 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.183 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.84 -165.03 12.16 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.543 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -75.73 127.59 33.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.433 0.635 . . . . 0.0 110.523 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' THR . 79.4 t -115.91 121.84 68.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.158 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.58 122.43 32.03 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.844 0.354 . . . . 0.0 110.209 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 74.4 mt -91.13 164.85 23.54 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.554 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 11.7 Cg_endo -57.45 134.48 63.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.589 2.193 . . . . 0.0 111.655 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 46' ' ' VAL . 55.9 m-85 -58.86 132.14 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.346 -174.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.838 ' HA ' ' HE2' ' A' ' 62' ' ' MET . 7.1 mmt -98.94 119.89 38.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 133.55 41.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.431 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -130.24 159.41 36.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 110.912 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.477 ' HD2' HD23 ' A' ' 80' ' ' LEU . 50.1 mttm -122.82 158.2 30.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.614 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.59 112.86 38.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.131 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 78' ' ' GLN . 16.4 mt -83.05 -54.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.594 0.711 . . . . 0.0 109.702 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -142.36 150.74 41.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.585 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG2' ' N ' ' A' ' 71' ' ' THR . 8.9 tt0 -150.28 132.55 15.47 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.612 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 72' ' ' ASP . 17.4 t -93.72 -21.24 19.46 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.477 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 26.6 m 75.15 -35.4 0.28 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.782 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 70' ' ' SER . 4.0 p-10 -101.83 -7.0 22.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.663 ' HA3' HH11 ' A' ' 92' ' ' ARG . . . -158.87 -51.76 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.145 -1.502 . . . . 0.0 114.219 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p -118.73 143.03 47.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.261 0.553 . . . . 0.0 112.466 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 69' ' ' GLN . 22.4 mt -136.64 137.6 47.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.432 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -118.91 124.58 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 30.2 pt -126.82 155.2 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.384 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.598 ' HB2' HD12 ' A' ' 67' ' ' ILE . 36.1 tt0 -124.45 146.93 48.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 21.1 m-85 -86.35 152.99 22.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.726 0.298 . . . . 0.0 110.487 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 ' HD2' ' A' ' 65' ' ' LYS . 98.1 mt -114.26 163.72 14.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.31 -152.27 21.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.503 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.34 -8.57 12.87 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.965 2.444 . . . . 0.0 112.665 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 49.0 m-85 -104.75 18.67 21.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.853 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 2.2 p90 -55.71 169.63 0.49 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -176.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 9.28 -0.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 1 C-N-CA 128.734 6.289 . . . . 0.0 121.418 -150.983 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 87' ' ' LYS . 2.7 tm? -73.66 146.3 44.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.563 ' N ' HD12 ' A' ' 86' ' ' LEU . 65.9 pttt -144.17 173.1 12.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.644 0.735 . . . . 0.0 112.793 -167.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 m -132.69 159.42 39.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.029 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.3 m -130.26 142.82 50.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.5 mt -121.74 124.73 44.91 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 46.5 mmtm -114.59 170.03 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.663 HH11 ' HA3' ' A' ' 73' ' ' GLY . 27.7 ptt-85 -92.71 145.02 24.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.416 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -104.75 138.69 14.29 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.78 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.11 -35.91 76.28 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.091 0.556 . . . . 0.0 112.077 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -95.89 24.74 5.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.312 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.24 42.24 24.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.383 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.416 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 18.0 p -121.0 173.94 6.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.649 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 tp -120.39 131.33 54.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 63.8 mt -99.12 112.98 32.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.728 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 10.0 t90 -99.98 115.56 29.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.381 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 26.0 mt-10 -97.67 129.64 44.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -152.8 124.26 7.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.317 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 67.26 -7.46 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.44 0.463 . . . . 0.0 112.172 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.45 9.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.773 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.54 136.97 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.568 0.223 . . . . 0.0 110.413 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 76.1 mtt180 -100.41 116.32 32.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.898 0.38 . . . . 0.0 110.424 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -119.41 141.28 49.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.183 0.516 . . . . 0.0 111.332 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -94.41 122.69 37.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.952 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 100' ' ' TRP . 66.1 mtp -102.55 133.44 47.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.38 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -97.77 143.87 27.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.714 0.292 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -88.44 123.9 33.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.27 0.557 . . . . 0.0 110.992 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -79.02 155.84 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.461 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.357 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.675 0.274 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.5 Cg_exo -68.1 125.51 13.13 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.947 2.431 . . . . 0.0 111.161 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -67.49 -19.65 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -90.38 -13.06 35.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.349 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 18.0 t80 -78.61 134.0 37.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.86 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.93 -155.43 21.24 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.057 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.6 m -121.16 131.44 54.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.823 0.344 . . . . 0.0 110.35 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -116.26 141.41 48.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.574 ' HA ' HG22 ' A' ' 37' ' ' THR . 4.1 t70 -106.11 133.49 50.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.052 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 51.5 mt-10 -94.87 71.46 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.652 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.21 41.6 3.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.832 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -167.32 147.79 5.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 74.74 144.71 0.11 Allowed Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.163 0.914 . . . . 0.0 111.464 -178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 6.2 Cg_exo -79.77 160.81 24.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.122 2.548 . . . . 0.0 112.986 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.95 8.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -38.35 128.11 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 124.261 3.308 . . . . 0.0 113.602 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -64.65 -13.24 53.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.96 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.12 -33.75 76.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.16 -10.0 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.852 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -81.71 132.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -94.87 -25.76 16.46 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.818 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 4.4 m 175.67 -178.95 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.23 0.956 . . . . 0.0 108.679 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.95 167.42 18.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.995 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 22' ' ' ASP . 15.9 p -117.89 137.23 52.94 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . 0.668 HG11 ' HE1' ' A' ' 109' ' ' MET . 10.6 p -112.09 124.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.377 0.608 . . . . 0.0 111.098 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.408 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 82.1 m -106.31 125.85 51.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.722 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.52 118.77 37.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 110.813 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 42' ' ' GLU . 1.2 m -89.72 179.84 5.92 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.421 ' H ' HG23 ' A' ' 41' ' ' THR . 0.3 OUTLIER -47.37 -46.65 25.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -148.42 27.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.362 0.601 . . . . 0.0 110.539 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.82 159.53 41.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.347 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 64' ' ' TYR . 92.3 t -117.82 129.87 73.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.447 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 97.2 t -111.38 123.93 67.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -100.61 137.28 39.23 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.277 0.56 . . . . 0.0 111.514 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -123.27 117.4 25.19 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.214 172.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.57 133.44 43.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.522 HG21 ' HG2' ' A' ' 56' ' ' GLU . 36.0 t -96.6 113.51 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.871 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 ttt -133.78 141.77 47.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.694 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.43 132.64 48.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.187 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.3 -14.61 61.97 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.281 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.41 -56.71 2.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 110.191 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.07 -143.52 15.74 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.358 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HG2' HG21 ' A' ' 50' ' ' VAL . 50.9 mt-10 -96.33 115.61 27.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.46 0.648 . . . . 0.0 110.43 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.5 t -104.57 126.89 59.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.289 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.448 ' HG2' HG21 ' A' ' 48' ' ' THR . 34.4 mt-30 -83.76 130.54 34.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.851 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 93.9 mt -93.73 160.15 33.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.757 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.7 Cg_endo -61.91 121.82 10.06 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.539 2.159 . . . . 0.0 111.545 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -45.9 128.79 9.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.216 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.5 mmm -110.48 129.67 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.518 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.33 148.51 29.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.746 0.307 . . . . 0.0 110.674 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 45' ' ' VAL . 28.7 p90 -144.28 164.91 29.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.72 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -123.05 155.63 36.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 109.992 178.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -101.72 112.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.734 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 78' ' ' GLN . 12.0 mt -73.83 -51.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.431 0.634 . . . . 0.0 109.629 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.08 146.26 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.48 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -149.07 136.88 20.52 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.264 0.554 . . . . 0.0 110.894 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t -107.38 149.08 28.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.557 171.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -61.35 -32.96 72.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.281 0.562 . . . . 0.0 109.678 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -157.51 91.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.802 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.81 -94.61 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.231 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 91' ' ' LYS . 65.4 m -136.66 157.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -110.07 118.84 37.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.29 158.14 36.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.55 ' HB2' HD12 ' A' ' 67' ' ' ILE . 45.8 tt0 -135.99 127.81 29.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.429 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 67.3 m-85 -85.17 129.34 34.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 84' ' ' TYR . 69.7 mt -86.53 162.22 18.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.921 0.391 . . . . 0.0 110.576 -176.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.4 -152.21 17.4 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.426 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.57 -18.71 65.05 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.803 2.335 . . . . 0.0 112.485 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -111.41 31.63 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.489 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.68 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 2.5 p90 -90.62 -1.14 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -169.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 94.6 Cg_endo -92.01 -3.49 4.01 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 CA-C-N 121.719 1.65 . . . . 0.0 112.764 166.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.79 134.27 50.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.197 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -113.72 174.27 6.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.24 0.543 . . . . 0.0 112.104 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -143.7 165.89 26.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.507 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -134.14 142.87 47.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 111.267 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.56 135.17 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.83 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.554 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 66.0 mttm -132.41 162.6 30.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.763 0.316 . . . . 0.0 110.324 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 92' ' ' ARG . 15.8 ptt-85 -84.67 144.92 28.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.31 152.46 20.65 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.09 -10.85 60.23 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.69 77.48 1.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.727 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.39 48.09 21.74 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.886 0.741 . . . . 0.0 113.535 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.5 169.77 16.98 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.748 -0.266 . . . . 0.0 110.942 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -124.07 135.26 53.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 82.1 mt -102.78 117.34 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.79 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -109.9 113.73 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -108.97 134.88 51.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.349 0.595 . . . . 0.0 111.078 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -150.55 119.0 6.43 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 68.38 -68.12 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.067 0.854 . . . . 0.0 112.018 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.04 1.65 0.07 OUTLIER Glycine 0 C--N 1.316 -0.58 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.822 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -113.42 135.42 53.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.724 0.762 . . . . 0.0 110.355 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -102.46 115.57 30.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.374 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -94.89 136.59 35.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.041 0.448 . . . . 0.0 110.858 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 m -109.12 113.69 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.668 ' HE1' HG11 ' A' ' 38' ' ' VAL . 64.3 mtp -110.76 144.92 38.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.494 -174.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -95.33 153.36 17.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.203 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -90.13 142.63 27.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 22' ' ' ASP . 22.7 mm -92.99 148.98 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.173 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.544 179.844 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.9 t . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.6 Cg_exo -74.91 84.35 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.503 2.135 . . . . 0.0 111.486 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.561 ' HE1' ' HA ' ' A' ' 71' ' ' THR . 44.2 p90 -65.36 -24.39 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.54 -176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -82.35 -19.52 39.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -80.09 138.57 36.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.983 0.421 . . . . 0.0 110.764 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.54 -153.42 20.43 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.133 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -119.68 128.43 53.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.451 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 63.0 m95 -121.67 139.69 53.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.638 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.542 ' HB2' HD11 ' A' ' 112' ' ' ILE . 9.9 t0 -107.94 135.6 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 55.7 mt-10 -54.12 -45.5 71.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.87 22.03 25.48 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.848 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -170.89 149.72 3.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 69.39 144.76 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.75 0.657 . . . . 0.0 111.479 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.7 Cg_exo -78.44 151.16 25.69 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.908 2.405 . . . . 0.0 112.582 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.45 -166.63 25.53 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.571 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.6 150.62 1.4 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.224 3.283 . . . . 0.0 113.949 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -72.31 -7.71 50.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.41 -12.41 51.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.962 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.84 41.98 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.866 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 t -105.12 133.28 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.58 -30.31 20.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.392 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 22.7 p -176.37 174.43 1.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.437 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.04 157.73 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.493 0.663 . . . . 0.0 111.0 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.53 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 1.5 p -117.39 129.51 55.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.662 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -112.54 129.41 68.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.225 0.536 . . . . 0.0 109.904 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 m -114.14 130.07 56.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.172 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.26 116.2 32.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.542 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -103.23 -178.28 3.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -47.96 -51.19 24.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -138.01 10.63 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.544 0.212 . . . . 0.0 111.389 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.542 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -138.76 149.1 44.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 111.785 -177.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 64' ' ' TYR . 78.4 t -111.71 124.96 68.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.26 124.37 64.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.13 134.21 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.53 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 1.7 m -124.9 135.38 52.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.078 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.0 127.96 47.26 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -97.02 112.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.268 0.556 . . . . 0.0 110.702 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -119.21 107.18 13.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.905 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.96 117.1 5.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.77 -36.01 3.62 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -99.52 -62.3 1.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.697 0.76 . . . . 0.0 109.547 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 -164.42 24.21 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.052 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 50' ' ' VAL . 11.2 mp0 -80.16 127.01 31.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 117.637 0.719 . . . . 0.0 110.177 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.54 121.54 63.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.604 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -80.36 130.52 35.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 111.622 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.7 mt -91.76 163.89 26.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.714 174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 73.6 Cg_exo -49.37 125.22 13.29 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.712 2.275 . . . . 0.0 112.114 176.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.74 137.57 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtm -108.09 121.99 45.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.33 148.15 41.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.557 ' CD1' HG23 ' A' ' 45' ' ' VAL . 9.9 p90 -146.85 151.43 37.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.33 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 158.94 29.79 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.69 112.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 78' ' ' GLN . 20.1 mt -76.83 -54.08 13.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.52 151.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.584 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -155.27 111.56 3.18 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.98 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.561 ' HA ' ' HE1' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -69.92 -11.0 60.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.105 174.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.24 -56.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.633 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.4 -47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.993 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 26.8 t -161.25 155.56 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.614 0.721 . . . . 0.0 112.721 -169.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.3 mt -126.21 137.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.342 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.528 ' HG2' HD13 ' A' ' 67' ' ' ILE . 37.7 tt0 -117.45 124.59 49.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 pt -129.98 157.47 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.402 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.755 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 32.9 tt0 -131.65 135.53 46.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.618 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -82.89 3.58 29.19 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -169.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.7 mt 52.29 -162.52 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.607 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.42 -151.86 42.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.816 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.22 -8.7 23.64 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.687 2.258 . . . . 0.0 111.579 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.88 15.24 22.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.447 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -65.7 178.07 0.62 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.755 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 11.2 Cg_exo 10.91 -1.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.274 1 C-N-CA 126.985 5.124 . . . . 0.0 120.263 -142.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.575 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.7 tp -78.12 103.83 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -103.9 172.08 7.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.379 0.609 . . . . 0.0 111.814 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 t -132.39 148.33 52.41 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.084 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.3 m -123.92 143.63 50.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.561 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 85.8 mt -128.0 123.93 35.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.117 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 30.3 mtmm -123.67 160.32 27.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.709 0.29 . . . . 0.0 110.505 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -80.36 144.71 32.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -99.21 -175.53 31.64 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.465 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -91.43 -30.15 16.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.972 0.415 . . . . 0.0 111.935 -171.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 48.5 m-80 -102.59 25.76 8.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.637 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.93 37.65 50.1 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.613 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' THR . . . . . 0.469 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 15.9 p -105.17 174.58 5.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.901 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 90' ' ' LEU . 29.8 tp -122.95 133.74 54.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 63.4 mt -96.96 110.25 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -98.34 113.21 25.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.867 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 11.9 mt-10 -110.85 132.01 54.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.73 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 103' ' ' ASN . 23.2 tm0? -152.21 118.2 5.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.456 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 54.8 t30 63.97 24.04 13.49 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.657 0.742 . . . . 0.0 111.288 164.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.48 34.47 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.124 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -92.48 132.91 36.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.542 0.671 . . . . 0.0 111.346 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -103.58 116.36 32.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.919 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -127.08 117.8 23.15 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.4 m -93.16 114.15 26.58 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -112.28 159.73 18.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.116 -173.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -104.39 153.75 20.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.24 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -88.27 161.19 17.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 22' ' ' ASP . 21.7 mm -94.86 151.86 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.049 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.316 -0.856 0 CA-C-O 121.037 0.446 . . . . 0.0 109.817 -179.391 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.516 0.198 . . . . 0.0 111.176 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.98 122.25 11.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.889 2.392 . . . . 0.0 111.713 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -67.98 -14.91 63.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -98.99 -8.48 25.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.373 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -81.93 140.2 34.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.96 -171.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.1 -149.83 17.3 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.252 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 m -119.51 134.24 55.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.7 0.285 . . . . 0.0 110.254 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 82.3 m95 -126.08 142.64 51.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.606 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.437 ' HB2' HD12 ' A' ' 112' ' ' ILE . 1.5 t70 -96.08 120.05 35.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.54 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 109' ' ' MET . 12.6 pt-20 -98.5 79.17 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.993 0.902 . . . . 0.0 109.795 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.83 -8.05 56.61 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.881 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.689 HH11 ' HB1' ' A' ' 26' ' ' ALA . 1.1 tmt_? -101.04 140.3 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB1' HH11 ' A' ' 25' ' ' ARG . . . 65.01 143.67 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.354 1.034 . . . . 0.0 111.274 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -93.04 172.62 2.02 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.546 2.164 . . . . 0.0 112.242 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.9 -155.13 20.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.488 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' HG22 ' A' ' 33' ' ' VAL . 10.3 Cg_endo -56.2 163.74 5.93 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.8 2.333 . . . . 0.0 112.804 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 m -74.72 2.52 9.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.566 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.84 -43.2 96.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.81 59.39 0.02 OUTLIER Glycine 0 CA--C 1.513 -0.065 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.56 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' HD2' ' A' ' 29' ' ' PRO . 8.3 t -100.24 134.61 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.853 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 8.7 mmpt? -81.71 -40.79 22.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -166.45 165.86 16.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.058 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.61 148.73 52.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.431 . . . . 0.0 111.266 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -133.5 131.49 39.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.155 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.85 139.56 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.925 0.393 . . . . 0.0 110.93 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.5 m -119.39 129.34 54.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.06 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -101.89 117.64 35.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.1 p -101.9 -177.35 3.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.184 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -45.03 -56.13 4.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.466 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.22 -4.13 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.719 -173.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.39 157.15 28.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.542 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.63 117.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.56 124.21 64.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.78 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.76 136.48 42.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.654 0.74 . . . . 0.0 110.737 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.83 116.98 21.71 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.476 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -108.29 128.55 54.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.12 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.43 113.65 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.522 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.3 mtm -123.08 130.64 53.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.467 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.45 131.51 47.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.705 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.97 -29.44 11.24 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.284 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -122.57 -33.85 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 111.311 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.2 -151.24 19.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.564 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.09 133.45 46.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.228 0.537 . . . . 0.0 110.165 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.4 t -123.87 123.85 67.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.229 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -85.63 118.63 25.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.905 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.57 159.54 55.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 114.37 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.077 1.852 . . . . 0.0 110.62 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -69.9 146.69 51.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.534 -172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.28 148.76 22.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.53 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.72 131.6 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -114.57 142.48 46.37 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.374 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -122.17 151.11 41.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.728 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.23 125.19 41.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.077 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 78' ' ' GLN . 12.9 mt -96.26 -55.62 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -131.61 153.86 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.805 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.13 152.7 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 111.48 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -139.71 167.33 22.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -80.33 -38.8 29.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.34 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 6.4 p-10 -147.96 9.57 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.408 -172.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.19 -81.11 1.47 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.318 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 5.1 p -145.52 152.01 39.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 111.677 -174.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -125.98 138.49 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.5 tt0 -117.54 127.38 53.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -125.66 157.08 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.581 ' HB2' HD13 ' A' ' 67' ' ' ILE . 44.1 tt0 -126.58 144.19 50.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -83.23 149.29 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.225 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -105.1 167.79 9.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.22 -152.1 21.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.23 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.04 -5.17 15.75 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.579 2.186 . . . . 0.0 111.795 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -98.6 15.58 24.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.724 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.739 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -63.0 -177.3 0.19 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.132 175.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.739 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 12.32 -0.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.252 1 C-N-CA 127.35 5.367 . . . . 0.0 120.561 -148.098 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.8 tp -85.31 121.26 27.78 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -120.65 168.48 11.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.386 0.612 . . . . 0.0 111.603 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.27 154.9 47.13 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.635 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 10.4 m -113.82 141.82 46.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.476 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.14 124.78 43.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.287 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 33.3 mtmm -133.4 157.43 45.58 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.934 0.397 . . . . 0.0 110.467 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 24.1 ptt180 -66.16 147.26 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.058 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -73.25 -170.23 18.38 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.159 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -86.96 -39.34 15.81 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.191 0.519 . . . . 0.0 110.013 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -148.64 102.2 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.925 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 53.82 44.92 70.8 Favored Glycine 0 C--N 1.333 0.385 0 O-C-N 123.349 0.406 . . . . 0.0 113.183 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.03 174.0 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.413 0.149 . . . . 0.0 111.149 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 tp -129.31 136.17 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.462 HG13 ' HA2' ' A' ' 93' ' ' GLY . 67.5 mt -111.55 110.59 32.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.877 0.37 . . . . 0.0 110.33 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.683 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 10.0 t90 -105.14 113.07 26.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.786 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 70.2 mt-10 -96.49 130.3 43.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.423 0.63 . . . . 0.0 110.089 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.467 ' CD ' ' HB2' ' A' ' 103' ' ' ASN . 25.8 tm0? -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.684 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.467 ' HB2' ' CD ' ' A' ' 102' ' ' GLN . 5.8 t-20 67.75 9.89 7.4 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.409 0.443 . . . . 0.0 111.252 172.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.5 -10.85 53.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.255 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -108.62 143.5 37.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.854 -0.203 . . . . 0.0 110.547 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.587 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 24.6 ptt180 -99.4 126.26 45.26 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -88.66 126.52 35.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.529 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 m -94.78 113.76 25.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.683 ' HE2' ' HE3' ' A' ' 100' ' ' TRP . 59.9 mtt -114.62 142.33 46.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 112.273 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.02 151.01 19.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.104 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -86.09 123.99 32.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 22' ' ' ASP . 37.3 mm -72.76 147.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.429 0.633 . . . . 0.0 111.518 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.656 -179.076 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 19.6 m . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.175 0.512 . . . . 0.0 112.165 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.44 104.17 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.985 2.457 . . . . 0.0 111.879 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.82 -15.17 63.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.382 -174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -101.85 6.79 41.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.01 125.99 44.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.158 0.504 . . . . 0.0 111.072 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.21 -168.95 24.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.236 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.1 m -102.07 131.44 48.54 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 109' ' ' MET . 62.6 m95 -116.09 137.14 52.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.816 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.9 t70 -99.79 127.01 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 112.185 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 35' ' ' SER . 44.4 mt-10 -101.64 78.04 1.8 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.997 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.11 -0.46 35.73 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.324 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 25' ' ' ARG . 6.9 tpp180 -114.9 144.11 44.08 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.65 146.83 0.12 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 0.0 111.179 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.54 171.91 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.497 2.132 . . . . 0.0 112.721 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.86 -155.18 25.03 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.887 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -38.38 145.54 0.16 Allowed 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 124.28 3.32 . . . . 0.0 113.665 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.21 -5.67 14.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -171.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.75 -36.09 81.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.09 53.61 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.597 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 49' ' ' GLU . 18.8 t -100.94 134.37 41.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -79.03 -39.68 33.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 38.5 m -159.77 166.17 30.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.085 -171.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.49 152.33 40.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 22' ' ' ASP . 12.9 p -131.87 127.04 35.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.33 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.89 136.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.106 0.479 . . . . 0.0 111.233 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 m -121.77 125.64 47.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.653 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.77 116.43 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.876 0.37 . . . . 0.0 110.375 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.541 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -104.58 170.13 8.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.22 -45.86 92.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.877 0.37 . . . . 0.0 111.934 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.85 -9.2 23.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 3.7 pt-20 -156.74 148.08 22.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -166.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 64' ' ' TYR . 96.7 t -101.77 118.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.843 170.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.34 124.46 55.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.7 0.286 . . . . 0.0 110.457 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.04 136.7 37.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.608 0.718 . . . . 0.0 111.518 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.491 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 2.3 m -128.47 131.4 48.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.526 171.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HB3' HG11 ' A' ' 33' ' ' VAL . 32.9 mt-10 -120.53 135.93 54.93 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.522 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 56' ' ' GLU . 45.8 t -96.41 113.6 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -119.74 126.88 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.384 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 106.88 6.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.325 0.583 . . . . 0.0 110.477 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.05 6.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.26 -60.01 1.65 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.921 0.867 . . . . 0.0 109.747 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.04 -166.32 14.04 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.003 -172.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 50' ' ' VAL . 1.6 mp0 -71.89 127.15 31.66 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.502 0.668 . . . . 0.0 111.433 174.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.0 t -118.39 122.69 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.928 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG2' HG23 ' A' ' 48' ' ' THR . 82.1 mt-30 -93.74 126.76 39.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.916 0.389 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.48 161.76 26.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.316 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 137.03 40.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.887 2.391 . . . . 0.0 112.059 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.602 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 44.2 p90 -72.09 152.49 42.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.8 mtp -111.87 140.45 46.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.663 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.96 28.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.502 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 45' ' ' VAL . 7.7 p90 -147.28 166.52 26.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.812 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -128.19 159.3 35.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.55 126.3 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.123 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 78' ' ' GLN . 12.2 mt -85.43 -51.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.1 m -145.03 161.31 39.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.462 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -148.97 132.99 17.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.08 0.466 . . . . 0.0 110.777 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.6 t -151.01 121.88 7.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -78.11 -15.74 58.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.527 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -104.27 -21.45 13.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.726 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 -67.06 0.47 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.838 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 47.3 t -177.52 157.09 1.23 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 0.0 110.993 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -116.85 132.71 65.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.212 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.479 ' HG2' HD11 ' A' ' 67' ' ' ILE . 30.0 tt0 -111.09 123.73 50.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 pt -124.96 157.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.032 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.662 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 36.1 tt0 -138.42 139.94 39.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 98.0 m-85 -88.17 153.97 20.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 0.0 110.896 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.4 mt -110.77 -176.82 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.029 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.54 -152.52 35.76 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.68 -16.91 51.59 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.396 2.064 . . . . 0.0 111.926 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -92.31 20.41 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.96 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.865 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 26.3 p90 -61.17 172.27 0.97 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.707 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.865 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 11.5 -0.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.084 1 C-N-CA 128.153 5.902 . . . . 0.0 121.065 -150.08 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.0 tp -69.22 104.21 2.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 119.556 1.071 . . . . 0.0 108.289 167.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 61.1 pttt -103.63 174.71 5.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.414 0.626 . . . . 0.0 111.94 -171.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 t -144.66 161.36 39.36 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.157 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -124.28 142.97 50.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.8 0.334 . . . . 0.0 110.578 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.48 122.72 38.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 53.4 mttp -118.83 160.58 21.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.2 0.524 . . . . 0.0 111.188 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -70.61 143.0 51.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.57 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.9 143.77 22.45 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.888 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.82 -44.5 73.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.908 -0.646 . . . . 0.0 111.172 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.51 81.34 2.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.81 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 55.3 55.1 30.06 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.711 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.52 175.24 10.09 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.832 -0.216 . . . . 0.0 111.112 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.57 135.26 54.52 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.553 HG21 ' HG3' ' A' ' 106' ' ' ARG . 82.7 mt -104.9 111.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.245 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 15.7 t90 -97.87 112.77 24.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.811 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 28.8 mt-10 -102.12 131.66 48.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -151.64 123.58 8.09 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.701 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.28 19.77 10.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.314 0.384 . . . . 0.0 111.827 173.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.07 -21.86 34.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.533 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 10.6 pt20 -92.61 145.65 24.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.013 0.406 . . . . 0.0 110.947 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.553 ' HG3' HG21 ' A' ' 99' ' ' ILE . 15.6 ttm180 -94.04 117.98 30.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.452 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 28.1 mmtm -95.04 117.99 31.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.096 0.475 . . . . 0.0 109.809 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -100.13 114.59 28.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.615 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.534 ' HB2' ' HB3' ' A' ' 21' ' ' TRP . 12.3 ptp -127.65 137.92 52.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.338 0.589 . . . . 0.0 111.729 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -101.05 146.43 27.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.582 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -80.52 127.73 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.158 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.547 HD11 ' HB2' ' A' ' 22' ' ' ASP . 31.4 mm -73.57 145.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.535 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.311 -1.108 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 -176.447 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.247 0.546 . . . . 0.0 111.355 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 37.9 Cg_exo -62.9 103.91 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.864 2.376 . . . . 0.0 111.949 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.78 -10.98 60.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.284 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 44.5 p90 -89.57 -6.62 56.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -71.35 138.99 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.136 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.42 -163.5 21.18 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.033 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.6 m -115.23 122.64 46.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.022 0.439 . . . . 0.0 110.432 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.436 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 50.1 m95 -116.3 133.64 55.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.139 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.571 ' CB ' HD13 ' A' ' 112' ' ' ILE . 11.7 t70 -109.68 132.43 54.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.952 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 109' ' ' MET . 6.2 mm-40 -74.04 -58.15 3.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.603 173.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.94 32.16 55.9 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 9.0 ttm180 -158.08 167.68 29.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -167.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 107' ' ' LYS . . . 67.43 165.36 0.12 Allowed Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.928 0.768 . . . . 0.0 112.211 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 134.5 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.355 2.037 . . . . 0.0 111.356 171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 -166.31 21.28 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.977 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -48.62 125.15 12.07 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.067 2.511 . . . . 0.0 111.868 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -80.1 -1.44 40.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.26 -33.92 74.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.559 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 146.57 37.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.977 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.63 138.91 28.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 29.3 mtpp -86.58 -28.09 23.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.994 0.425 . . . . 0.0 111.108 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 p -177.31 167.47 2.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.981 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.43 144.23 49.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -117.87 133.58 55.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.111 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.03 136.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 111.161 -175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.6 m -123.02 130.94 53.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.555 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -100.61 120.61 40.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.097 0.475 . . . . 0.0 110.317 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.442 HG21 ' H ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -95.7 179.1 5.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.374 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' HG21 ' A' ' 41' ' ' THR . 29.6 mt-10 -51.53 -38.68 55.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.306 0.642 . . . . 0.0 111.801 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -151.37 19.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 111.447 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -131.1 147.73 52.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 64' ' ' TYR . 66.5 t -101.84 118.51 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.459 HG22 ' CD1' ' A' ' 61' ' ' PHE . 70.6 t -108.21 124.42 64.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.34 137.5 52.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.342 0.591 . . . . 0.0 110.453 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.26 138.1 51.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.141 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -97.98 125.4 42.9 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HG2' ' A' ' 56' ' ' GLU . 48.6 t -90.11 110.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.488 ' SD ' ' HG3' ' A' ' 54' ' ' ARG . 43.0 ttm -112.07 135.21 53.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.151 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 28.4 tt0 -63.77 113.35 3.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.934 -175.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.57 -18.4 56.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.752 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 9.6 mmt180 -101.36 -74.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.816 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.41 -156.1 26.64 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.506 ' HG2' HG23 ' A' ' 50' ' ' VAL . 44.8 mt-10 -92.92 120.69 33.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.415 0.626 . . . . 0.0 111.179 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -112.57 128.12 69.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.892 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HG2' HG23 ' A' ' 48' ' ' THR . 79.8 mt-30 -80.07 131.55 35.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.143 0.497 . . . . 0.0 111.601 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -87.86 163.7 36.98 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.494 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.25 123.58 12.27 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.648 2.232 . . . . 0.0 111.749 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.459 ' CD1' HG22 ' A' ' 46' ' ' VAL . 17.8 m-85 -68.42 142.15 55.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.143 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.4 mtm -109.86 123.74 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.801 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.57 140.09 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CD1' HG22 ' A' ' 45' ' ' VAL . 42.1 p90 -132.82 170.9 14.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.885 0.374 . . . . 0.0 110.63 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HD2' HD23 ' A' ' 80' ' ' LEU . 10.0 ptmm? -144.1 143.0 30.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.66 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -83.33 124.3 39.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.727 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 78' ' ' GLN . 11.5 mt -85.62 -54.41 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.595 0.712 . . . . 0.0 109.661 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 m -139.56 163.44 32.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.818 -174.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -144.51 149.27 35.65 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.5 t -125.33 121.02 32.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.6 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.89 -6.39 32.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 111.366 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.89 -48.17 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.558 ' HA3' ' HD3' ' A' ' 92' ' ' ARG . . . 146.33 46.49 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.64 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.6 m -147.27 151.97 37.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.224 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.49 138.44 48.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.231 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -110.46 126.8 54.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.934 0.397 . . . . 0.0 109.973 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.76 157.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.454 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.611 ' HB2' HD12 ' A' ' 67' ' ' ILE . 34.7 tt0 -132.34 144.85 50.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.614 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -92.86 156.98 16.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.02 0.438 . . . . 0.0 110.76 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.485 HD23 ' HD2' ' A' ' 65' ' ' LYS . 83.1 mt -112.08 -177.08 3.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.415 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.85 -151.93 41.65 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.238 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.86 -5.27 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.551 2.168 . . . . 0.0 112.154 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -102.75 20.54 17.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.142 0.496 . . . . 0.0 109.805 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.951 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.1 p90 -58.47 170.81 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.298 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.951 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 1.2 Cg_exo 9.34 0.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.162 1 C-N-CA 128.711 6.274 . . . . 0.0 121.659 -152.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' A' ' 84' ' ' TYR . 66.8 tp -66.57 109.81 2.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 119.986 1.266 . . . . 0.0 109.062 170.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.96 166.77 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 111.874 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 t -140.22 156.2 46.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.527 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -112.72 141.3 46.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.134 0.492 . . . . 0.0 110.89 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.93 126.75 49.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.805 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 94.0 mttt -124.95 154.96 40.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.945 0.402 . . . . 0.0 110.257 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.558 ' HD3' ' HA3' ' A' ' 73' ' ' GLY . 36.4 ptt-85 -79.42 144.26 34.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.051 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.7 26.54 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.14 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.12 134.36 38.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.021 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 71.89 -66.14 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.639 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.29 59.59 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.47 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 p -134.74 170.07 16.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.122 0.169 . . . . 0.0 110.581 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.3 tp -129.53 135.42 48.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.604 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 75.2 mt -105.65 126.26 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 17.7 t90 -117.3 115.75 25.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.079 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -110.99 134.87 52.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 111.432 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.68 121.35 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.937 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.85 9.74 5.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.635 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.95 -8.05 29.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.716 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.05 134.65 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -102.02 116.13 32.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.104 0.478 . . . . 0.0 111.237 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 2.0 mmpt? -98.55 139.49 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.547 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.9 m -121.74 112.24 18.15 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.553 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 52.2 mtm -116.8 141.4 48.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -173.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -98.63 151.77 20.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.539 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 57.1 ttp85 -83.5 127.4 33.69 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.571 HD13 ' CB ' ' A' ' 22' ' ' ASP . 30.0 mm -85.4 144.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.47 0.652 . . . . 0.0 110.598 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.31 -1.12 0 CA-C-N 114.605 -1.18 . . . . 0.0 107.898 174.962 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.687 0.28 . . . . 0.0 110.799 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.42 109.37 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -68.45 -18.99 64.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.194 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -95.02 -10.18 31.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.795 0.331 . . . . 0.0 111.305 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -80.64 130.29 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 0.0 110.969 -172.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.86 -164.24 25.51 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.263 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -105.39 130.69 53.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 98' ' ' LEU . 71.7 m95 -119.54 144.56 46.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.262 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB2' HD12 ' A' ' 112' ' ' ILE . 15.7 t70 -96.76 141.37 30.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 6.1 mm-40 -48.14 -49.97 30.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.12 -54.52 3.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.637 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -135.95 164.19 28.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.32 161.45 0.16 Allowed Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 124.039 0.837 . . . . 0.0 111.395 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.29 175.4 9.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.628 2.218 . . . . 0.0 112.154 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.21 -153.69 7.64 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.399 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.757 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 4.5 Cg_endo -47.68 148.62 5.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 124.355 3.37 . . . . 0.0 113.433 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.3 p -81.26 -2.17 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.923 -172.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.72 -1.04 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.251 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.62 35.23 29.36 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.897 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.757 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 24.6 t -76.4 133.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.748 ' HE3' ' HB3' ' A' ' 52' ' ' GLU . 49.5 mtmt -91.47 -13.58 31.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.788 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 18.5 m -148.7 157.51 43.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.877 0.37 . . . . 0.0 110.609 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -159.79 145.87 15.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.084 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 139.53 44.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.092 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.31 133.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 110.121 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -121.26 124.57 44.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.839 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -101.97 117.81 35.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.123 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.498 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -102.33 179.43 4.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.327 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 41' ' ' THR . 33.1 mt-10 -54.93 -42.92 72.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -128.21 -16.25 4.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.921 0.391 . . . . 0.0 111.808 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 6.9 pt-20 -125.76 142.17 51.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.166 0.508 . . . . 0.0 111.803 -173.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.61 125.56 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 61' ' ' PHE . 66.9 t -115.92 123.82 71.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 137.92 34.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 110.736 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.526 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -125.63 118.85 26.57 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.647 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -105.63 125.61 51.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.198 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 42.5 t -98.86 111.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.258 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -99.48 109.11 21.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.748 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 41.5 tt0 -65.39 106.63 1.43 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.045 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.95 -29.68 2.19 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.116 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 55' ' ' GLY . 17.0 ptp180 -125.01 -51.77 1.67 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.515 0.197 . . . . 0.0 111.04 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 54' ' ' ARG . . . 142.45 -156.36 26.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.017 -176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -79.8 146.34 32.33 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 111.818 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.21 122.05 59.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.412 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.526 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.0 mt-30 -95.68 131.5 41.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.806 0.336 . . . . 0.0 111.052 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.17 157.25 39.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.245 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.02 118.61 4.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.815 2.343 . . . . 0.0 111.577 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB3' HG21 ' A' ' 46' ' ' VAL . 52.6 p90 -60.44 145.35 48.55 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.214 0.53 . . . . 0.0 111.481 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.11 125.83 50.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.809 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.7 136.42 34.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -127.12 161.11 29.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.723 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -122.18 144.46 48.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.3 t -89.4 114.02 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.828 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 78' ' ' GLN . 10.1 mt -81.15 -56.69 5.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.741 0.781 . . . . 0.0 109.188 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -124.77 149.39 47.4 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.626 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -147.65 136.45 21.97 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.372 0.606 . . . . 0.0 111.774 -170.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' SER . 37.0 t -141.3 150.54 42.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.811 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -9.57 55.37 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -146.41 -27.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.73 -76.21 0.95 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.562 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 3.4 p -159.28 164.41 34.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 mt -132.92 135.53 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.43 131.72 55.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 pt -130.76 156.81 42.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.552 ' HB2' HD13 ' A' ' 67' ' ' ILE . 53.1 tt0 -124.98 131.74 53.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.658 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -85.62 152.96 22.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 111.034 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.72 -178.0 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.603 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.82 -152.27 34.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.175 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.59 -10.73 17.45 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.722 2.281 . . . . 0.0 112.589 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.59 25.96 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 1.005 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 34.9 p90 -55.24 166.51 0.86 Allowed Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.616 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 1.005 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 8.13 -0.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.031 1 C-N-CA 128.988 6.459 . . . . 0.0 121.487 -153.397 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.822 ' HG ' HE22 ' A' ' 102' ' ' GLN . 35.4 tp -70.77 103.29 2.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 119.936 1.244 . . . . 0.0 107.928 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -98.45 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.415 0.626 . . . . 0.0 112.155 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -141.81 158.87 43.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.891 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 m -123.83 141.07 52.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.479 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.39 122.94 41.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.91 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 40.3 mtpt -137.96 149.45 46.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.533 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -90.2 147.08 23.78 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.16 -160.72 18.14 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.265 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.12 137.23 57.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 66.22 -157.96 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.924 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.5 57.18 3.47 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.561 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 42.1 p -121.13 148.88 43.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 20.9 tp -112.01 132.73 54.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -97.69 113.35 31.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -96.64 114.25 25.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.834 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 106' ' ' ARG . 26.2 mt-10 -105.89 133.32 50.79 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.621 0.724 . . . . 0.0 110.405 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.822 HE22 ' HG ' ' A' ' 86' ' ' LEU . 5.7 tm0? -150.55 133.21 15.78 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.775 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.99 -43.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.794 0.684 . . . . 0.0 111.38 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 102' ' ' GLN . . . 164.26 -19.3 0.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.22 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -103.0 141.19 36.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.817 0.342 . . . . 0.0 110.99 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . 0.406 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 15.3 ptp180 -101.33 138.51 38.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.496 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 17.0 mmtm -127.15 133.94 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.273 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 t -94.91 128.75 41.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.113 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.431 ' HE2' HD21 ' A' ' 98' ' ' LEU . 22.1 ptt? -123.6 149.05 45.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.332 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.81 150.07 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.512 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -85.03 154.81 21.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 22' ' ' ASP . 16.9 mm -96.86 150.57 4.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.995 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 47.4 Cg_exo -56.53 117.05 3.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.606 2.204 . . . . 0.0 112.152 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -63.78 -28.49 69.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.729 0.3 . . . . 0.0 111.52 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 12.2 p90 -85.27 -1.28 56.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.837 0.351 . . . . 0.0 111.313 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.639 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 55.3 t80 -75.49 125.64 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 109.999 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.98 -158.11 22.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.314 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 m -110.34 132.48 54.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.639 0.257 . . . . 0.0 110.8 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 61.5 m95 -123.15 137.8 54.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.552 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.551 ' HB2' HD13 ' A' ' 112' ' ' ILE . 17.0 t70 -103.73 128.16 51.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' HE3' ' A' ' 109' ' ' MET . 60.3 mt-10 -95.25 75.84 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 39.72 2.33 Favored Glycine 0 C--N 1.317 -0.478 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.624 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -164.52 160.69 20.65 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 73.19 144.59 0.11 Allowed Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 124.022 0.826 . . . . 0.0 111.079 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 16.7 Cg_exo -67.45 140.66 53.2 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.836 2.357 . . . . 0.0 112.451 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.12 -167.84 43.02 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.432 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 32.9 Cg_exo -53.41 163.55 2.49 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.612 2.875 . . . . 0.0 113.376 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -71.37 -25.07 62.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.405 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.18 13.47 0.31 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.4 28.04 13.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 22.1 t -89.05 134.39 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -68.55 -44.31 74.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.542 0.686 . . . . 0.0 110.183 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.6 p -175.74 175.11 2.09 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.148 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.35 154.08 38.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.308 0.575 . . . . 0.0 111.332 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 22' ' ' ASP . 23.0 p -119.34 142.21 48.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.146 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.26 131.63 63.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.365 0.602 . . . . 0.0 110.615 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.2 m -116.71 120.03 37.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.127 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -101.4 117.01 34.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -101.72 -177.8 3.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -54.42 -45.37 72.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -126.58 -13.56 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -126.16 154.81 42.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 111.731 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' CD1' ' A' ' 64' ' ' TYR . 96.3 t -110.4 130.64 63.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.82 123.53 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.744 0.307 . . . . 0.0 110.176 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.85 137.74 34.48 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.426 0.631 . . . . 0.0 110.502 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -122.01 119.91 32.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.184 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -100.63 128.48 46.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.84 112.75 33.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.985 0.421 . . . . 0.0 109.876 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.7 ttp -116.63 138.17 51.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.72 126.1 22.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.818 0.699 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.39 -28.15 11.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.579 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HE ' ' HB3' ' A' ' 54' ' ' ARG . 9.4 mmm180 -92.81 -75.61 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.625 0.726 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.0 -145.35 16.84 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.025 -171.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.9 131.36 35.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.762 0.791 . . . . 0.0 111.261 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.32 120.64 64.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.975 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . 0.476 ' HG2' HG23 ' A' ' 48' ' ' THR . 78.7 mt-30 -92.58 126.69 37.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.81 158.46 47.65 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.495 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 132.34 28.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.92 2.414 . . . . 0.0 112.105 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -60.41 128.41 36.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.609 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -103.35 120.41 40.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.15 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.0 127.98 34.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.369 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.477 ' CD1' HG22 ' A' ' 45' ' ' VAL . 34.2 p90 -114.66 154.99 27.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.113 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.78 147.52 49.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.381 0.61 . . . . 0.0 110.331 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.8 114.67 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.679 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.521 HD12 ' HB2' ' A' ' 78' ' ' GLN . 15.8 mt -81.49 -53.96 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.5 m -133.17 153.26 51.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.301 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.64 145.27 27.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 145.7 50.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -71.86 -23.56 61.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -165.63 89.87 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.867 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.47 -84.92 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.078 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -146.89 156.09 42.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 9.1 mt -133.31 136.15 55.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.56 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.09 119.6 35.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.29 157.35 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.699 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 33.9 tt0 -130.75 144.4 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -94.68 154.91 17.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.578 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.32 -177.38 3.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.26 -153.52 29.22 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.258 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.66 -16.03 52.26 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.514 2.143 . . . . 0.0 112.122 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.88 31.18 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.224 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.906 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 52.9 p90 -59.7 173.48 0.52 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.251 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 11.65 -0.84 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.128 1 C-N-CA 128.243 5.962 . . . . 0.0 121.415 -152.267 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.6 tp -68.47 104.27 1.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 119.575 1.08 . . . . 0.0 108.24 167.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -105.74 173.29 6.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 111.927 -172.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.8 t -139.54 158.42 44.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.204 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.4 m -119.61 142.87 48.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.826 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 97.7 mt -130.72 130.77 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.846 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -144.93 164.74 30.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.895 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -98.44 154.9 17.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.857 0.36 . . . . 0.0 110.034 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.08 -153.73 29.58 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.306 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -75.73 -46.76 29.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.565 0.698 . . . . 0.0 110.104 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -97.02 -160.46 0.8 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.79 51.28 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 p -117.05 141.32 48.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.781 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.473 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 28.9 tp -102.69 135.66 43.93 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.8 108.97 22.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.639 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 16.2 t90 -107.62 111.95 24.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 23.0 mt-10 -107.23 131.66 53.94 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.387 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -150.59 118.31 6.17 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.4 t30 69.63 -5.09 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.604 0.565 . . . . 0.0 112.229 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.13 -14.6 4.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.432 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -108.46 135.5 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.326 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -101.7 127.0 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.255 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -117.98 124.82 49.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.665 0.269 . . . . 0.0 111.655 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 113.91 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.639 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 21.1 ptp -125.14 151.4 45.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.914 0.388 . . . . 0.0 110.965 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 m -100.17 156.07 17.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.143 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 41.9 ttt85 -87.45 141.42 28.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.927 0.394 . . . . 0.0 110.375 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 22' ' ' ASP . 30.6 mm -72.72 147.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 pm0 . . . . . 0 C--N 1.316 -0.853 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.8 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.601 0.715 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.3 Cg_exo -79.15 97.87 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.073 2.515 . . . . 0.0 110.831 172.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -63.17 -25.7 68.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.359 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -82.95 -18.32 40.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.666 0.27 . . . . 0.0 111.678 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -74.04 136.61 43.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.677 0.275 . . . . 0.0 110.709 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.15 -158.21 22.27 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.224 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.5 m -117.82 129.03 55.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.619 0.247 . . . . 0.0 110.605 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -113.7 141.36 47.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.182 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.613 ' HB2' HD11 ' A' ' 112' ' ' ILE . 20.1 t70 -109.02 134.98 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.778 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 109' ' ' MET . 33.8 mt-10 -96.1 40.8 1.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.602 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.06 78.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.319 -0.944 . . . . 0.0 110.945 172.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -91.66 142.82 27.2 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.71 155.49 0.14 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.594 1.184 . . . . 0.0 111.401 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.48 135.13 48.0 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.384 2.056 . . . . 0.0 111.862 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.78 -154.76 22.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.436 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 171.63 5.01 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.28 2.654 . . . . 0.0 113.037 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -129.66 -6.59 4.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.462 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.94 -41.2 70.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.692 0.758 . . . . 0.0 111.681 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.677 ' HA3' ' HE2' ' A' ' 51' ' ' MET . . . 164.37 -37.01 0.3 Allowed Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 50' ' ' VAL . 17.8 t -67.34 134.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -111.26 -15.24 13.68 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.982 0.42 . . . . 0.0 110.786 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m -157.31 158.25 35.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.968 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 23' ' ' GLU . . . -136.12 164.73 27.37 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.193 0.521 . . . . 0.0 110.933 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.599 ' HG1' ' HB ' ' A' ' 48' ' ' THR . 20.0 p -131.06 131.29 44.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.086 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.85 129.52 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.255 0.55 . . . . 0.0 110.702 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.6 m -114.53 125.65 54.03 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -101.4 117.14 34.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 p -101.75 -178.0 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.567 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -49.36 -52.82 25.77 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.478 0.486 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -134.87 9.23 3.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.228 0.537 . . . . 0.0 110.969 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 163.9 27.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.0 111.334 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.2 t -115.88 122.28 69.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.29 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.34 122.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.32 136.92 45.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.379 0.609 . . . . 0.0 110.817 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.599 ' HB ' ' HG1' ' A' ' 37' ' ' THR . 0.6 OUTLIER -125.9 130.72 51.86 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 178.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' HB3' HG12 ' A' ' 33' ' ' VAL . 43.3 mt-10 -110.33 136.53 49.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.246 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.5 t -94.34 111.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.677 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -116.7 115.39 25.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.44 113.89 7.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.606 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.12 -20.83 11.26 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -111.65 -61.06 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.815 0.817 . . . . 0.0 110.021 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.36 -158.83 22.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.287 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.24 131.08 36.96 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.376 0.608 . . . . 0.0 110.558 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' THR . 93.2 t -113.23 121.14 64.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.019 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -91.41 128.68 37.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.624 0.25 . . . . 0.0 110.926 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.9 mt -86.94 159.91 50.66 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 20.1 Cg_endo -62.74 132.05 35.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.063 1.842 . . . . 0.0 111.128 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -57.02 127.23 30.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.58 0.705 . . . . 0.0 111.191 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtm -104.19 130.05 51.95 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.6 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.83 132.09 41.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -124.39 146.74 48.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HG2' HD12 ' A' ' 80' ' ' LEU . 73.5 mmtt -121.69 155.45 35.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.699 0.761 . . . . 0.0 110.663 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.5 115.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.522 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 78' ' ' GLN . 15.2 mt -81.99 -54.0 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -136.39 153.11 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.77 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -148.25 150.9 34.52 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.9 t -143.57 139.09 29.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.617 0.246 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -68.98 -17.72 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.669 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.24 -44.92 86.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.413 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.59 30.54 0.22 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.802 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 p -135.0 131.25 36.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 mt -135.32 137.59 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.328 -177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -117.5 123.62 46.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.7 pt -132.59 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.154 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.545 ' HB2' HD12 ' A' ' 67' ' ' ILE . 34.0 tt0 -139.38 142.21 37.55 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -71.83 174.19 7.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.077 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 65' ' ' LYS . 76.5 mt -127.85 174.58 9.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.99 -152.76 31.8 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 -9.49 20.08 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.381 2.054 . . . . 0.0 111.952 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -102.34 20.5 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -95.43 2.64 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -172.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 77.1 Cg_endo -93.87 -4.58 2.76 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 CA-C-N 121.393 1.533 . . . . 0.0 112.368 162.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.85 112.02 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.679 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -99.81 170.26 8.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.56 . . . . 0.0 110.995 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -130.35 158.3 40.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.089 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.7 m -128.98 142.01 51.07 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.014 0.435 . . . . 0.0 111.069 -177.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.8 mt -121.1 123.62 42.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.097 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.492 ' HE3' HG23 ' A' ' 89' ' ' THR . 93.3 mttt -132.0 155.37 48.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.107 0.479 . . . . 0.0 111.371 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -84.63 152.36 23.86 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.428 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.59 -156.79 32.36 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.344 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -83.34 -28.7 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -109.16 -165.15 0.99 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.266 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.88 54.01 4.64 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -117.34 154.61 30.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.611 0.243 . . . . 0.0 110.647 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 91' ' ' LYS . 61.5 tp -106.93 127.88 53.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.126 0.489 . . . . 0.0 110.749 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 66.7 mt -99.33 110.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.29 173.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -102.41 115.99 31.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 25.6 mt-10 -98.71 130.36 45.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.416 0.626 . . . . 0.0 110.119 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.494 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 1.2 tm0? -153.76 132.11 12.0 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 1.6 t-20 66.68 10.99 7.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.504 0.502 . . . . 0.0 111.865 172.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.93 1.77 55.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.964 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 58.7 mt-30 -96.0 136.76 36.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -99.13 114.03 26.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -119.98 137.92 53.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 0.0 111.882 -172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 t -119.92 124.48 46.11 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.613 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.496 ' HE2' ' HG2' ' A' ' 23' ' ' GLU . 65.0 mtt -125.73 160.66 29.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.21 0.529 . . . . 0.0 111.854 -170.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.37 141.09 30.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.993 175.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -81.48 125.06 30.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mm -77.99 147.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--N 1.312 -1.055 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.333 -174.315 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.0 m . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 87.3 Cg_endo -97.97 133.18 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.036 2.491 . . . . 0.0 114.005 -167.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . 0.419 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 54.4 p90 -105.9 -13.25 15.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.053 173.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 13.4 p90 -106.31 -0.27 24.48 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -80.48 26.38 0.38 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.88 -165.39 12.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.932 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.1 m -109.8 125.97 53.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 90.2 m95 -111.92 135.45 52.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.277 0.56 . . . . 0.0 111.394 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 112' ' ' ILE . 2.8 t70 -87.64 123.31 32.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.739 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.48 76.18 3.32 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.03 3.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.675 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -153.45 141.83 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.23 158.94 0.12 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 123.904 0.752 . . . . 0.0 112.206 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.04 177.67 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.971 2.447 . . . . 0.0 112.056 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.65 -162.67 11.71 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 33' ' ' VAL . 99.3 Cg_exo -42.41 157.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.446 3.431 . . . . 0.0 114.332 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -68.71 -18.66 64.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.901 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.89 -55.43 29.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.297 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.94 50.27 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.351 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -99.38 132.77 44.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 44.9 mtpt -111.62 -18.16 12.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.923 0.392 . . . . 0.0 110.878 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 19.0 m -155.38 167.05 31.65 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.239 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.33 150.21 49.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.855 0.359 . . . . 0.0 110.471 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 132.29 39.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.904 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -112.39 131.55 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.109 0.48 . . . . 0.0 110.648 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -113.45 125.25 54.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.145 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 98.8 m-85 -101.25 118.09 36.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.129 0.49 . . . . 0.0 109.684 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -100.65 -179.09 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.385 -177.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' HG23 ' A' ' 41' ' ' THR . 9.2 tp10 -50.58 -58.37 5.98 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.116 0.26 . . . . 0.0 111.53 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.53 -5.8 9.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 0.0 110.691 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -115.74 155.01 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.141 0.495 . . . . 0.0 111.307 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.2 118.14 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.64 124.66 60.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.71 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -95.28 133.59 39.01 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.679 0.752 . . . . 0.0 111.126 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 118.48 23.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.615 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -104.39 131.82 51.31 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.738 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 47.4 t -86.8 112.42 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.745 0.784 . . . . 0.0 110.144 -174.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.523 ' HG2' HG22 ' A' ' 33' ' ' VAL . 66.8 mtt -113.29 120.02 39.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.34 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.88 129.63 43.06 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.011 0.434 . . . . 0.0 110.284 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.53 -20.38 48.66 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.278 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -107.01 -51.36 2.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.635 0.731 . . . . 0.0 109.553 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.48 -151.62 17.81 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.374 -172.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HG2' HG21 ' A' ' 50' ' ' VAL . 45.4 mt-10 -81.68 121.64 26.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.241 0.521 . . . . 0.0 110.063 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -104.84 122.4 57.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.78 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -83.86 118.76 24.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 90.8 mt -95.44 163.63 21.07 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 88.4 Cg_exo -44.72 120.29 2.73 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.054 2.503 . . . . 0.0 112.773 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -71.84 141.44 49.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.104 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' MET . . . . . 0.764 ' HE1' ' HA ' ' A' ' 62' ' ' MET . 24.7 mmt -103.88 149.81 24.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.49 141.42 28.54 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.47 162.31 29.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.126 0.488 . . . . 0.0 111.256 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -135.88 159.18 42.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.456 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.9 t -103.67 118.46 50.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.538 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 78' ' ' GLN . 14.2 mt -85.91 -50.72 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -138.74 160.11 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.214 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -147.33 135.16 21.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.74 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 t -137.51 116.67 12.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -64.86 -20.94 66.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 0.0 109.949 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -42.76 78.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.826 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.36 35.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.347 -1.406 . . . . 0.0 115.004 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -154.58 140.85 18.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.652 0.726 . . . . 0.0 111.895 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 mt -130.05 137.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.9 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 67' ' ' ILE . 60.0 tt0 -110.3 123.42 49.78 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 158.35 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HB2' HD13 ' A' ' 67' ' ' ILE . 46.8 tt0 -132.59 147.72 52.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.411 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 96.4 m-85 -99.17 157.43 16.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.173 0.511 . . . . 0.0 110.599 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.436 HD22 ' CE1' ' A' ' 84' ' ' TYR . 26.2 mt -112.22 179.51 3.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.073 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -150.43 41.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.921 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.09 -12.32 15.34 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.849 2.366 . . . . 0.0 112.833 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.19 20.49 18.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.377 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -66.23 -176.19 0.22 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.583 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 59.4 Cg_exo 2.98 -3.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.484 1 C-N-CA 126.613 4.876 . . . . 0.0 120.823 -138.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 84' ' ' TYR . 56.8 tp -72.3 116.71 13.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 120.116 1.325 . . . . 0.0 110.763 176.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.62 167.35 15.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.646 0.736 . . . . 0.0 111.883 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 t -150.58 145.08 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.334 169.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 141.57 51.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.886 0.374 . . . . 0.0 110.995 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.7 mt -115.86 124.03 49.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -129.7 165.88 20.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.119 0.485 . . . . 0.0 111.607 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -77.13 147.91 36.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.135 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.43 173.11 22.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.707 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.65 -2.43 48.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.72 28.49 5.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.535 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.07 49.15 42.62 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.138 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 p -130.98 173.79 10.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.809 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -119.06 134.0 55.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.76 116.74 41.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.124 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . 0.539 ' HB2' ' HE2' ' A' ' 109' ' ' MET . 12.4 t90 -96.73 112.43 24.19 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.0 133.37 49.89 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -149.74 129.15 12.97 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.91 22.67 13.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.089 0.471 . . . . 0.0 110.85 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.26 -8.9 68.87 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.548 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -92.48 145.65 24.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.65 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -100.54 117.01 33.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.084 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -104.06 132.81 49.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.473 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 t -100.92 126.64 47.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.539 ' HE2' ' HB2' ' A' ' 100' ' ' TRP . 59.4 mtm -117.61 144.46 45.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 1.1 m -96.92 158.69 15.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.997 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.316 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 22' ' ' ASP . 24.1 mm -71.59 146.6 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--N 1.314 -0.969 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.43 -171.651 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.422 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.6 Cg_endo -83.58 123.73 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.199 2.599 . . . . 0.0 111.578 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -69.45 -9.36 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.12 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -113.24 -0.72 14.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.688 0.28 . . . . 0.0 111.619 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 58.2 t80 -97.99 126.64 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.141 0.496 . . . . 0.0 111.501 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -160.64 24.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.261 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' THR . . . . . 0.423 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 29.1 m -101.39 123.72 45.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.803 0.335 . . . . 0.0 110.403 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -104.85 139.63 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 111.851 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.495 ' HB2' ' CD1' ' A' ' 112' ' ' ILE . 8.7 t70 -79.02 123.66 27.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.822 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 4.3 mm-40 -88.76 85.53 6.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.394 172.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -38.13 5.24 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.622 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -137.54 141.78 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 165.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -131.11 140.98 40.29 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.705 -171.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 27.6 Cg_endo -97.93 143.89 0.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.957 3.105 . . . . 0.0 111.293 168.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.49 -157.92 25.8 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.498 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 50.9 Cg_exo -49.05 161.62 0.53 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 125.006 3.804 . . . . 0.0 114.069 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.06 13.7 16.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.492 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.01 -28.1 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.87 59.55 0.59 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.45 133.31 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -96.03 -23.24 16.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 111.556 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -157.98 163.21 38.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -148.7 165.89 30.01 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.467 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 3.3 p -133.35 132.9 41.8 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.743 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 120.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.444 0.64 . . . . 0.0 109.596 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -108.93 126.11 52.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -100.66 117.64 35.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -100.16 173.61 6.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.347 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 41' ' ' THR . 37.5 tt0 -50.38 -40.18 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -136.24 -0.59 2.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.099 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -126.05 151.66 46.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.942 -0.473 . . . . 0.0 111.759 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.84 118.89 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.85 124.06 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -98.07 139.15 34.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.315 0.578 . . . . 0.0 110.778 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.467 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -123.58 136.63 54.63 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.536 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 32.7 mt-10 -97.48 130.28 44.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.02 107.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' MET . . . . . 0.566 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -133.85 133.16 41.22 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.3 -169.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -80.38 88.8 5.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.091 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.65 -52.78 0.47 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.499 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ARG . . . . . 0.566 ' HG2' ' HB3' ' A' ' 51' ' ' MET . 10.0 ptp180 -94.62 -33.11 13.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.52 -173.18 29.55 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.0 mp0 -67.33 117.22 9.03 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.774 0.797 . . . . 0.0 110.803 174.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -124.73 128.29 73.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.627 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 131.72 36.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.976 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.0 mt -89.86 162.25 36.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.735 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 76.5 Cg_exo -47.2 121.37 5.2 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.795 2.33 . . . . 0.0 112.307 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -70.62 141.16 51.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.295 0.569 . . . . 0.0 110.954 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -107.96 147.68 30.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.79 148.08 26.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.791 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -145.04 154.72 42.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.489 ' HG3' HD12 ' A' ' 80' ' ' LEU . 55.4 mtpt -128.46 156.19 43.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.41 124.22 49.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.843 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.58 HD11 ' HG2' ' A' ' 76' ' ' GLU . 18.3 mt -87.49 -50.25 13.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -144.92 155.74 43.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.348 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.43 128.65 12.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.415 0.626 . . . . 0.0 111.108 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.406 ' HB3' ' H ' ' A' ' 74' ' ' SER . 38.4 t -136.56 147.14 46.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.3 p -80.85 -23.21 39.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.698 0.285 . . . . 0.0 111.593 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -143.16 -10.07 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.5 -83.22 1.06 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.337 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 70' ' ' SER . 4.1 p -164.37 153.67 13.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 122.84 0.456 . . . . 0.0 110.532 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 25.2 mt -114.09 138.01 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HG2' HD11 ' A' ' 67' ' ' ILE . 30.2 tt0 -120.49 124.93 46.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.0 110.181 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -128.44 157.73 40.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.342 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.58 ' HB2' HD12 ' A' ' 67' ' ' ILE . 57.3 tt0 -130.03 144.14 51.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -82.63 167.38 18.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 65' ' ' LYS . 95.8 mt -129.22 166.48 19.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.334 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.53 -153.78 17.51 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.38 -21.9 46.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.038 1.825 . . . . 0.0 111.6 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -105.64 40.72 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.083 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' TYR . . . . . 0.477 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 45.8 p90 -78.15 -33.16 0.94 Allowed Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 85.9 Cg_endo -74.04 -3.6 14.05 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 CA-C-N 121.222 1.472 . . . . 0.0 113.068 -170.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 tp -88.1 124.83 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.156 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -111.66 168.97 9.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -138.29 153.45 49.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.63 -173.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -120.08 142.26 49.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.0 mt -125.95 124.41 40.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.74 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 85.9 mttt -130.52 163.35 27.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.039 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -86.79 143.67 27.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.72 -146.26 17.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.28 125.93 35.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.06 -153.09 0.28 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.79 53.19 4.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.124 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 p -115.68 144.01 44.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LEU . . . . . 0.472 HD22 HD22 ' A' ' 90' ' ' LEU . 29.9 tp -109.57 133.68 52.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 70.9 mt -98.48 110.28 25.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 175.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -105.94 114.8 29.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 32.8 mt-10 -106.2 131.72 53.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.651 0.738 . . . . 0.0 110.321 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 1.2 tm0? -151.75 135.18 16.07 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.016 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . 0.472 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.7 OUTLIER 65.09 9.12 5.25 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.796 0.331 . . . . 0.0 111.621 176.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.98 13.42 57.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.654 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 3.5 pt20 -120.93 149.0 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -96.07 125.85 40.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.325 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 3.1 mmpt? -111.71 139.75 46.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.544 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.3 m -105.25 114.66 28.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.722 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 64.2 mmm -101.85 133.15 47.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.62 142.87 33.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 111' ' ' ARG . 8.9 ttp180 -82.63 130.56 35.14 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.147 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.4 mm -62.83 144.58 14.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 121.422 0.63 . . . . 0.0 110.868 -171.602 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.468 ' H ' HD12 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -135.33 164.55 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 0.0 111.333 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.7 ttp -106.98 116.03 31.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.72 110.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.983 0.421 . . . . 0.0 110.687 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -75.44 160.47 30.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.368 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.49 137.95 2.3 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -140.96 -59.35 0.5 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.527 0.164 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 64.08 -167.07 0.22 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.457 0.473 . . . . 0.0 110.548 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -143.65 150.14 38.31 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.98 123.28 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.163 0.506 . . . . 0.0 110.807 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 71.1 mmtt -81.35 -22.41 38.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.495 0.664 . . . . 0.0 109.225 174.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.404 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 pm0 -75.59 135.33 40.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.019 171.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.85 145.5 56.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.725 0.774 . . . . 0.0 111.627 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -144.7 80.66 11.46 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.007 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.96 115.72 4.38 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.378 2.052 . . . . 0.0 111.717 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.07 -14.94 63.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.121 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -94.4 -18.63 21.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.75 0.309 . . . . 0.0 111.417 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.28 139.84 39.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.765 0.317 . . . . 0.0 110.62 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.32 -152.62 21.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.307 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 m -126.8 128.25 46.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.608 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 55.5 m95 -118.51 143.75 46.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.849 0.357 . . . . 0.0 111.563 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.602 ' HB2' HD13 ' A' ' 112' ' ' ILE . 19.4 t70 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.326 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.744 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 1.3 tp10 -106.53 36.44 2.62 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 123.39 1.567 . . . . 0.0 107.781 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.19 70.66 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.656 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -95.54 -168.0 1.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.156 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -75.86 144.49 76.37 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 111.499 -176.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.513 ' HB3' ' HA ' ' A' ' 34' ' ' LYS . 10.0 Cg_exo -71.73 -178.93 3.36 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.414 2.742 . . . . 0.0 113.17 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -141.28 -151.46 5.56 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.495 -177.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 28.5 Cg_endo -61.16 -163.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.561 2.841 . . . . 0.0 112.588 175.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -52.81 -34.43 53.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.889 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.615 ' HB3' ' HA ' ' A' ' 131' ' ' HIS . 10.1 m-20 -101.82 17.14 23.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.664 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 77.57 0.23 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.537 HG13 ' HB3' ' A' ' 49' ' ' GLU . 99.0 t -54.76 144.67 5.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 123.554 0.742 . . . . 0.0 112.079 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.631 ' HB3' ' HZ2' ' A' ' 34' ' ' LYS . 8.9 mtpm? -55.63 -40.68 72.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.398 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -154.69 163.39 40.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.802 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.472 ' HB3' ' CG ' ' A' ' 23' ' ' GLU . . . -143.23 150.32 39.15 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.834 0.35 . . . . 0.0 110.573 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.436 ' HG1' ' HB ' ' A' ' 48' ' ' THR . 19.3 p -134.0 140.56 46.79 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.422 ' CG1' ' HB2' ' A' ' 21' ' ' TRP . 7.2 p -112.4 129.68 67.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 m -108.4 125.93 52.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.978 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -100.59 117.21 34.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.476 . . . . 0.0 110.076 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.604 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 1.1 m -102.35 -179.64 4.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.71 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.445 ' H ' HG23 ' A' ' 41' ' ' THR . 37.0 tt0 -44.33 -70.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.128 0.971 . . . . 0.0 113.057 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.21 9.84 8.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.226 0.536 . . . . 0.0 110.78 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.604 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 1.5 pm0 -133.69 150.61 51.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.358 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.51 133.89 56.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 61' ' ' PHE . 22.1 t -116.89 122.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.535 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.83 139.84 30.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.436 ' HB ' ' HG1' ' A' ' 37' ' ' THR . 0.6 OUTLIER -127.51 133.39 49.84 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.41 178.445 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.537 ' HB3' HG13 ' A' ' 33' ' ' VAL . 49.4 mt-10 -125.27 134.4 52.3 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.55 HG23 ' HG3' ' A' ' 56' ' ' GLU . 21.3 t -91.11 108.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.336 0.588 . . . . 0.0 109.938 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.438 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 66.8 mtt -99.3 138.43 36.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.546 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 34.6 tt0 -64.53 115.21 4.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.781 0.324 . . . . 0.0 110.472 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.91 -13.69 63.43 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.433 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.438 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 0.1 OUTLIER -113.43 -37.51 4.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.352 0.596 . . . . 0.0 110.436 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.8 -159.83 29.5 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.55 ' HG3' HG23 ' A' ' 50' ' ' VAL . 2.2 mp0 -62.33 126.53 27.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.21 121.39 60.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.843 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.656 HE22 ' HB3' ' A' ' 122' ' ' ASP . 7.7 mt-30 -88.2 131.25 34.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.016 0.436 . . . . 0.0 110.804 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.518 HD22 ' OE2' ' A' ' 129' ' ' GLU . 42.8 mt -88.0 165.04 31.38 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.493 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.499 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 51.6 Cg_exo -49.79 120.31 5.8 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.87 2.38 . . . . 0.0 111.499 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.535 ' HB3' HG23 ' A' ' 46' ' ' VAL . 11.0 p90 -64.3 134.14 54.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 111.653 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.5 mmm -102.07 129.91 48.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.48 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.568 ' HB2' ' HB2' ' A' ' 80' ' ' LEU . . . -77.13 148.94 35.73 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.338 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -140.14 153.83 46.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' A' ' 80' ' ' LEU . 92.6 mttt -126.27 149.47 49.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.229 0.537 . . . . 0.0 110.362 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.5 t -93.79 116.11 34.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.281 -178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.47 HD11 ' HB2' ' A' ' 78' ' ' GLN . 21.6 mt -84.81 -52.45 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.428 0.632 . . . . 0.0 109.549 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -133.93 150.36 51.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.093 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.13 155.54 40.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.89 0.376 . . . . 0.0 111.019 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -125.02 158.81 32.79 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 t -67.9 -33.0 73.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -169.95 90.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.873 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.1 -78.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.703 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -139.86 155.77 47.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.088 0.47 . . . . 0.0 110.184 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.466 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 mt -135.11 137.19 50.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.669 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.64 121.67 42.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.42 HG22 HG22 ' A' ' 75' ' ' ILE . 35.3 pt -132.92 151.43 34.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.313 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.47 ' HB2' HD11 ' A' ' 67' ' ' ILE . 18.1 tt0 -124.54 136.73 54.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.391 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -79.91 170.1 16.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.727 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.568 ' HB2' ' HB2' ' A' ' 63' ' ' ALA . 88.5 mt -131.39 146.8 52.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . 0.44 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . 121.21 -153.71 16.6 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.95 -13.09 37.35 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.632 2.221 . . . . 0.0 112.601 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -125.83 46.32 2.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.993 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 32.9 p90 -84.5 -36.55 0.61 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -172.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 61.0 Cg_endo -75.32 -4.41 15.29 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 CA-C-N 121.097 1.427 . . . . 0.0 113.431 -170.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.26 109.52 21.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -86.95 166.47 15.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -131.38 163.16 28.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.996 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -121.25 141.74 50.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.036 0.446 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.466 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.7 mt -128.59 137.9 51.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.874 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.491 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 79.1 mttt -141.58 156.65 45.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -78.89 144.18 35.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.59 -171.4 15.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.891 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.44 155.63 29.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 71.81 -55.44 0.66 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.757 0.823 . . . . 0.0 111.049 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.08 40.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.502 HG23 ' HA ' ' A' ' 110' ' ' THR . 28.5 p -108.11 171.9 7.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.14 0.495 . . . . 0.0 111.591 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.411 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 52.3 tp -118.61 132.67 56.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.323 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 73.0 mt -97.72 110.05 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.405 ' CZ3' HG21 ' A' ' 38' ' ' VAL . 4.2 t90 -103.98 115.02 29.68 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.171 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -112.39 131.54 55.49 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.884 0.85 . . . . 0.0 111.205 178.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -151.76 131.32 13.05 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.046 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.57 12.12 8.72 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.347 0.404 . . . . 0.0 111.13 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.89 70.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.274 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -92.61 135.18 34.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.792 0.33 . . . . 0.0 110.458 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 22.5 ttt180 -102.31 116.81 33.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.488 -179.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -118.09 128.36 54.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 111.571 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.3 m -95.01 119.21 33.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.104 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.608 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 20.7 mmt -107.19 135.26 49.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.502 ' HA ' HG23 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.61 146.74 24.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.877 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.529 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 26.6 ttp180 -93.27 128.91 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.931 0.396 . . . . 0.0 110.783 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.602 HD13 ' HB2' ' A' ' 22' ' ' ASP . 19.2 mm -84.39 150.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -94.15 99.32 11.62 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.505 0.669 . . . . 0.0 110.138 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 t -154.75 168.57 26.41 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.159 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.477 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 99.1 mttt 57.91 31.12 20.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.267 0.556 . . . . 0.0 110.716 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -77.32 46.45 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.88 25.64 6.73 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.214 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.89 130.09 22.18 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.035 0.445 . . . . 0.0 110.02 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -57.65 123.42 15.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.057 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.477 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 41.0 tt0 -129.29 110.61 12.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -82.93 147.14 28.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.256 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.656 ' HB3' HE22 ' A' ' 58' ' ' GLN . 1.3 m-20 -73.48 160.58 31.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.977 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.501 ' H ' ' NE2' ' A' ' 58' ' ' GLN . 7.4 tp10 -110.39 148.6 31.67 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.82 118.33 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.238 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.0 m -138.8 128.45 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.063 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -98.33 105.38 17.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 109.779 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 t -109.55 128.93 55.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.417 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.2 99.13 10.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.518 ' OE2' HD22 ' A' ' 59' ' ' LEU . 7.6 pt-20 -144.11 159.14 43.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 112.385 -166.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -140.91 23.69 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.947 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.615 ' HA ' ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -53.33 138.18 33.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.87 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -143.18 91.46 2.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.878 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -74.5 125.35 28.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -143.8 173.44 11.68 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.917 0.389 . . . . 0.0 111.266 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.901 176.504 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 120.871 0.367 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 pt -139.92 164.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.374 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.2 mtp -129.68 104.53 7.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.5 135.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.117 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 m -132.16 133.74 44.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.916 0.389 . . . . 0.0 110.708 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.39 -153.54 17.66 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.076 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m 62.98 19.77 11.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.789 0.435 . . . . 0.0 111.464 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.9 151.5 48.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.294 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 65.17 23.2 12.3 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.866 0.729 . . . . 0.0 111.51 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -90.58 121.92 32.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.54 122.49 40.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.59 0.234 . . . . 0.0 110.399 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.98 117.13 27.97 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -80.17 5.93 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 111.662 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -59.09 119.6 39.82 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.267 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.34 110.59 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.831 2.354 . . . . 0.0 112.424 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -62.71 -26.86 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.698 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.489 ' HB2' HD12 ' A' ' 90' ' ' LEU . 21.8 p90 -88.44 -13.22 40.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.71 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -86.57 142.01 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.622 0.249 . . . . 0.0 110.387 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.79 -159.66 24.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.502 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 m -116.49 122.27 44.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.579 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 69.4 m95 -116.25 136.54 52.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.134 0.493 . . . . 0.0 111.543 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.552 ' HB2' HG12 ' A' ' 112' ' ' ILE . 26.3 t70 -110.26 151.51 27.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.219 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 56.3 mt-10 -63.05 -23.36 67.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.581 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.05 -59.05 0.38 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.262 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -170.27 170.86 7.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 75.42 148.75 0.12 Allowed Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.892 0.877 . . . . 0.0 111.655 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.522 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 60.8 Cg_endo -73.09 176.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 0.0 113.152 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -113.84 -152.74 10.85 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.324 -177.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HG2' HG23 ' A' ' 33' ' ' VAL . 3.2 Cg_endo -48.19 154.32 2.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.759 2.972 . . . . 0.0 113.471 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 t -69.08 -4.73 18.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.229 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.99 -22.78 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.58 22.07 1.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.413 HG23 ' HG2' ' A' ' 29' ' ' PRO . 20.1 t -89.16 132.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.0 110.187 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.522 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 58.6 mtmt -99.7 -14.96 18.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.107 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p 176.9 159.57 0.36 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.732 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.506 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -122.44 136.8 54.97 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.125 0.488 . . . . 0.0 110.331 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 p -118.39 130.74 56.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.664 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.78 134.51 55.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.298 0.571 . . . . 0.0 110.225 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.447 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 12.0 m -120.19 126.27 50.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.207 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -101.3 118.29 36.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.244 0.545 . . . . 0.0 110.206 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -96.77 175.86 6.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' H ' HG23 ' A' ' 41' ' ' THR . 23.1 tt0 -60.96 -35.63 77.29 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.84 -8.63 4.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.464 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 2.2 mp0 -126.68 153.51 45.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 112.219 -169.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.43 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.4 t -107.2 120.31 58.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.581 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.525 HG22 ' HB3' ' A' ' 61' ' ' PHE . 52.2 t -107.06 125.06 63.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -112.01 127.3 55.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.058 0.456 . . . . 0.0 110.305 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.401 HG21 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.96 128.03 54.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.763 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 37.7 mt-10 -99.92 129.43 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.439 HG22 ' HG2' ' A' ' 56' ' ' GLU . 44.8 t -90.24 110.11 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.9 ttm -122.56 145.2 48.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.89 135.07 57.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.839 0.352 . . . . 0.0 110.217 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.56 -56.65 1.97 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.288 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -95.7 -33.7 12.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.76 -149.39 19.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.952 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 45.1 mt-10 -72.92 115.25 12.0 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.6 t -108.75 122.52 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.408 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.401 ' HG2' HG21 ' A' ' 48' ' ' THR . 85.7 mt-30 -85.86 119.17 25.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.495 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.1 154.67 67.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.73 122.98 8.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.992 2.461 . . . . 0.0 112.3 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.532 ' HB2' ' HB3' ' A' ' 44' ' ' GLU . 37.0 p90 -64.64 139.91 58.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtm -112.09 133.49 54.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.776 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.28 134.73 36.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.341 . . . . 0.0 110.68 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.43 ' CD1' HG23 ' A' ' 45' ' ' VAL . 37.1 p90 -130.98 157.12 43.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.089 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.584 ' HE3' HD13 ' A' ' 80' ' ' LEU . 96.7 mttt -127.05 158.99 35.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.51 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.1 t -97.16 119.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.959 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.586 HD13 ' HB2' ' A' ' 78' ' ' GLN . 17.7 mt -82.58 -56.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.404 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -127.68 153.83 46.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.501 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -148.28 148.02 29.99 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.178 -172.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -145.23 147.28 32.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.4 p -77.15 -26.81 53.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.469 . . . . 0.0 110.131 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.98 70.06 0.92 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.214 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.06 -88.75 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.882 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 t -152.43 157.78 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.175 0.512 . . . . 0.0 110.574 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.51 135.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.057 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -117.56 128.54 55.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 pt -124.39 157.06 32.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.26 0.553 . . . . 0.0 111.416 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.719 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 34.8 tt0 -134.41 144.63 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.102 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.86 151.1 20.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.584 HD13 ' HE3' ' A' ' 65' ' ' LYS . 94.8 mt -99.86 163.72 12.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.562 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -152.5 21.71 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.956 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.84 -6.68 13.07 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.368 2.045 . . . . 0.0 111.956 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.51 10.11 29.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.708 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.8 OUTLIER -61.28 170.17 1.82 Allowed Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.747 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.719 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 9.4 Cg_exo 9.42 -1.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.15 1 C-N-CA 128.173 5.915 . . . . 0.0 120.681 -148.344 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.546 ' H ' ' C ' ' A' ' 84' ' ' TYR . 34.6 tp -74.3 103.84 4.84 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.117 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -113.33 173.47 6.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -138.52 149.29 45.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.524 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.472 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.3 m -122.18 143.35 49.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.94 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.489 HD12 ' HB2' ' A' ' 17' ' ' TYR . 94.9 mt -121.65 131.8 54.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -134.57 155.88 49.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.636 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -74.13 144.65 44.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.025 0.44 . . . . 0.0 110.632 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 145.38 18.34 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -70.41 158.6 35.71 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.568 0.223 . . . . 0.0 110.797 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 67.83 12.86 9.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.345 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.72 56.11 2.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.791 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 p -130.58 173.0 11.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.774 -0.251 . . . . 0.0 110.795 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.9 tp -129.27 133.25 47.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 0.0 110.359 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.37 114.22 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -103.83 113.43 26.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.5 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 105' ' ' GLN . 28.7 mt-10 -103.29 139.03 39.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.421 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -145.99 122.27 10.9 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.446 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.439 ' N ' HD21 ' A' ' 103' ' ' ASN . 0.9 OUTLIER 67.32 8.9 6.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.249 179.008 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.1 -14.77 25.98 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.649 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.495 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 32.5 mt-30 -93.33 133.39 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.48 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 30.6 ptt180 -102.41 124.33 47.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.4 0.619 . . . . 0.0 112.223 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -112.35 130.45 55.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 m -93.14 119.27 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.579 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 24.2 mmt -108.73 148.17 30.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.851 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -116.08 157.3 24.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.477 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -76.49 133.2 39.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.552 HG12 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mt -71.23 152.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 152.67 39.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.087 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.6 m -86.92 106.47 17.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -102.22 142.09 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.538 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -137.76 82.89 1.95 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.226 171.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.38 121.43 6.66 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.481 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -96.69 96.25 8.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -153.83 103.78 2.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.45 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.58 154.45 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -48.43 119.14 2.83 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.755 0.66 . . . . 0.0 112.389 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.45 134.13 46.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.479 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.24 114.09 23.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 0.0 111.527 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -141.38 107.91 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.9 p -98.7 103.09 15.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.862 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.86 147.29 24.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.239 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -59.08 138.1 57.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.1 mt -86.17 37.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 111.391 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -122.21 139.88 53.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.32 64.11 2.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.863 0.839 . . . . 0.0 110.658 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -81.2 105.54 12.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.192 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -137.81 113.05 9.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.384 0.611 . . . . 0.0 111.169 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -135.66 131.8 36.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.752 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -131.76 167.33 19.71 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.7 m170 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.945 177.92 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.33 113.72 13.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.6 mtm -91.65 94.22 9.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.639 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.5 p -102.44 147.14 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.411 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -136.84 132.34 34.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.2 -165.65 34.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.782 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.8 p -170.57 143.21 2.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -122.72 142.19 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.261 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -116.11 89.49 3.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.022 0.439 . . . . 0.0 110.846 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -125.34 -169.53 2.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.444 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -80.07 149.39 30.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.154 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.03 136.89 58.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -92.72 -173.88 3.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.488 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 t -66.48 119.62 64.16 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.43 0.633 . . . . 0.0 110.119 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 2.4 Cg_endo -81.13 97.57 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.743 2.296 . . . . 0.0 112.271 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -77.84 -11.51 59.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 110.149 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -93.94 -4.31 50.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.121 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.432 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 83.4 t80 -75.63 135.74 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.648 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.95 -166.75 19.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.37 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 m -108.67 128.21 54.65 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 61.6 m95 -111.1 146.74 36.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.292 -178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -108.98 139.24 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.199 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.473 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 7.2 mm-40 -45.43 -61.91 1.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.124 0.89 . . . . 0.0 112.251 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.17 21.34 59.35 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.252 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.17 -167.23 1.24 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.016 0.527 . . . . 0.0 110.989 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.22 146.99 59.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.34 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.08 152.61 36.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.245 2.63 . . . . 0.0 113.104 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.55 -153.91 30.13 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.545 -178.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_endo -51.38 114.84 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.43 2.753 . . . . 0.0 112.415 179.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -82.19 70.45 9.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 123.143 1.449 . . . . 0.0 111.129 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -128.94 -63.34 0.97 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.269 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.94 -49.02 0.2 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.098 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG21 ' HG2' ' A' ' 51' ' ' MET . 6.2 t -91.65 133.27 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -108.8 -19.33 13.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.148 0.499 . . . . 0.0 110.982 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 m -161.91 165.41 27.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.746 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -137.66 145.07 42.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.867 0.365 . . . . 0.0 110.838 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -122.77 132.25 54.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.43 129.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.225 0.536 . . . . 0.0 110.795 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.5 m -118.29 128.32 54.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.056 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.405 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.2 m -101.86 176.87 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.428 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' HG22 ' A' ' 41' ' ' THR . 41.5 tt0 -50.47 -54.54 21.42 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.81 -21.28 9.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.457 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.56 156.88 42.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.342 0.591 . . . . 0.0 111.646 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.27 127.34 63.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.73 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.0 124.14 72.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -106.09 135.9 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.37 126.2 53.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.904 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -98.23 126.56 43.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.479 HG22 ' HG2' ' A' ' 56' ' ' GLU . 45.8 t -86.3 111.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.382 0.61 . . . . 0.0 109.419 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.43 ' HG2' HG21 ' A' ' 33' ' ' VAL . 88.1 mtp -113.92 130.72 56.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.959 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.3 117.17 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.578 0.549 . . . . 0.0 111.026 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.09 -24.18 33.33 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.236 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 2.8 mmp_? -97.08 -58.09 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.715 0.769 . . . . 0.0 110.253 -178.521 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.71 -152.0 17.26 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.611 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.479 ' HG2' HG22 ' A' ' 50' ' ' VAL . 49.0 mt-10 -84.14 117.28 23.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.252 0.526 . . . . 0.0 110.101 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.0 t -105.47 123.86 60.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.9 126.79 31.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.32 159.39 64.82 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.043 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.84 141.93 34.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.036 2.491 . . . . 0.0 111.68 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -67.43 128.33 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.454 0.645 . . . . 0.0 111.062 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.0 mtm -103.89 119.49 39.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.932 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.54 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -74.41 134.85 42.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.472 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -127.52 147.41 50.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 0.0 110.489 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.529 ' HD2' HD21 ' A' ' 80' ' ' LEU . 21.2 ptmt -122.9 159.08 28.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.434 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.17 122.59 54.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.052 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.1 mt -90.11 -48.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.502 0.667 . . . . 0.0 109.248 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 m -144.12 156.23 44.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.57 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -149.43 130.56 14.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.363 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.2 t -173.24 160.67 4.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.804 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -84.95 -35.55 21.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.182 0.515 . . . . 0.0 109.992 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -100.27 -39.81 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.341 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.41 -3.04 88.52 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.683 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t 67.24 168.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.454 0.645 . . . . 0.0 111.374 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 26.7 mt -107.21 137.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.783 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.497 ' HG2' HD13 ' A' ' 67' ' ' ILE . 30.7 tt0 -122.83 128.54 50.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.402 HG13 ' HB3' ' A' ' 88' ' ' SER . 36.1 pt -122.3 158.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.506 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.614 ' CD ' ' HA ' ' A' ' 85' ' ' PRO . 33.0 tt0 -133.39 137.07 45.66 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 72.9 m-85 -80.42 150.45 29.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.457 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.54 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 97.2 mt -110.48 -173.09 2.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.892 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.75 -151.76 43.29 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.75 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 -17.03 39.38 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.212 1.942 . . . . 0.0 111.809 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.11 18.96 9.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.715 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 5.5 p90 -59.06 170.07 0.99 Allowed Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.249 0.343 . . . . 0.0 110.443 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.715 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 11.96 -0.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 1 C-N-CA 128.082 5.855 . . . . 0.0 121.405 -149.334 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.514 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.9 tp -66.97 115.98 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 119.631 1.105 . . . . 0.0 108.272 166.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 59.0 pttt -108.14 179.98 4.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.395 0.617 . . . . 0.0 112.31 -170.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.402 ' HB3' HG13 ' A' ' 77' ' ' ILE . 45.8 t -152.02 165.31 35.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.582 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.593 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.5 m -127.03 142.41 51.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.066 0.46 . . . . 0.0 111.215 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.9 mt -124.1 122.53 38.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.274 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.561 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 26.3 ttmt -133.35 158.49 42.87 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -173.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -89.42 153.17 21.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.17 0.509 . . . . 0.0 111.768 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.62 162.03 12.68 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.75 -10.39 53.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -130.47 51.12 2.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.765 0.317 . . . . 0.0 111.175 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.35 27.69 73.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.55 160.19 16.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.154 0.502 . . . . 0.0 112.071 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 ' HE1' ' A' ' 109' ' ' MET . 19.6 tp -128.47 134.78 48.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.561 ' HB ' ' HB3' ' A' ' 91' ' ' LYS . 72.8 mt -104.68 111.91 36.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.037 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.418 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.5 t90 -104.13 111.77 24.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.956 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 27.1 mt-10 -100.74 131.5 46.6 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.467 0.651 . . . . 0.0 110.369 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.563 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 16.9 tm0? -152.56 121.17 6.42 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.271 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.563 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 2.6 t-20 75.8 -53.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.95 0.781 . . . . 0.0 112.665 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.14 -25.07 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.207 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -120.19 152.76 37.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.857 0.829 . . . . 0.0 111.176 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.418 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 20.5 ptt180 -95.53 126.29 40.71 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 21.8 mmtp -88.25 127.21 35.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.911 0.386 . . . . 0.0 110.243 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.2 m -109.11 111.6 23.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.464 ' HE1' HD22 ' A' ' 98' ' ' LEU . 22.1 ptt? -134.99 156.36 49.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.483 -172.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 m -112.53 155.32 24.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.028 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.433 HH11 ' HD2' ' A' ' 111' ' ' ARG . 12.9 ttp85 -78.29 130.25 36.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.957 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.95 146.16 9.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.0 110.168 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -140.79 118.9 11.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.894 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -74.34 109.11 7.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.665 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 64.38 84.15 0.15 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.647 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -91.46 151.98 20.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.926 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.11 -133.82 4.62 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.883 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -130.02 155.18 46.55 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.202 0.525 . . . . 0.0 109.633 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.05 150.43 27.25 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.942 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.45 -82.18 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.405 -0.118 . . . . 0.0 111.025 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.4 tttt 69.06 131.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.91 0.756 . . . . 0.0 111.475 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.62 164.0 15.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.259 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -119.67 101.13 7.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.978 0.418 . . . . 0.0 110.716 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -91.71 101.9 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.8 p -141.46 160.3 40.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.486 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -146.58 146.26 30.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.113 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 m -127.51 110.14 12.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.667 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.49 97.97 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.067 0.461 . . . . 0.0 111.123 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.34 93.27 4.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -131.57 89.55 2.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -136.32 149.35 48.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.036 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -157.62 150.26 22.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.96 0.409 . . . . 0.0 110.986 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -153.58 105.21 2.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.63 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -82.48 89.43 6.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.555 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.9 t60 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.171 -0.919 . . . . 0.0 109.485 174.138 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.514 0.197 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.18 124.29 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -132.45 135.94 46.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.168 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.05 111.86 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.022 0.439 . . . . 0.0 111.023 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 p -153.32 144.85 23.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.828 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.1 -62.72 4.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.3 m -79.72 69.9 6.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.184 0.516 . . . . 0.0 109.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.17 78.95 1.76 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.697 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -92.39 11.64 25.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.11 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -81.82 100.77 9.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.161 0.505 . . . . 0.0 110.034 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.5 -27.76 64.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -70.27 103.31 2.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.774 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.12 175.84 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.8 m -63.33 118.15 40.84 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.086 -176.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.42 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.7 Cg_exo -75.79 110.88 3.17 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.939 2.426 . . . . 0.0 111.305 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -63.68 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.058 -174.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -84.3 -13.22 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.779 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.42 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 17.2 t80 -78.5 138.16 38.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.67 -163.04 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.173 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 84.8 m -110.01 121.96 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.035 0.445 . . . . 0.0 110.511 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.428 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 80.8 m95 -106.41 144.41 33.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.577 ' HB2' HD11 ' A' ' 112' ' ' ILE . 22.6 t70 -104.34 120.34 40.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.51 48.44 1.55 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.783 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.49 47.13 2.65 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.568 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -162.5 144.24 10.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.92 164.16 0.13 Allowed Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 124.083 0.864 . . . . 0.0 111.328 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.56 135.54 49.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.681 2.254 . . . . 0.0 113.163 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.19 -154.12 8.69 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.525 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.49 124.49 9.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.617 2.878 . . . . 0.0 112.432 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -82.05 -7.86 59.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.786 -167.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.06 -32.58 62.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.093 0.473 . . . . 0.0 111.535 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.25 39.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.25 136.38 25.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.434 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.638 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.0 mmpt? -73.22 -41.01 64.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -161.69 160.4 28.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.162 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.99 135.4 54.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.458 ' HG1' ' HB ' ' A' ' 48' ' ' THR . 35.9 p -117.29 125.91 51.86 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.95 127.72 75.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.2 m -105.82 124.69 49.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.49 118.84 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.36 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -100.38 179.56 4.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 167.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -68.52 -36.66 79.18 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.294 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -111.99 -11.67 13.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -135.01 145.81 48.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.491 0.662 . . . . 0.0 112.344 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.482 HG23 ' CD1' ' A' ' 64' ' ' TYR . 97.9 t -111.93 118.38 57.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.526 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.69 122.67 63.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.959 0.409 . . . . 0.0 109.977 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -107.26 133.02 52.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.808 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.458 ' HB ' ' HG1' ' A' ' 37' ' ' THR . 1.3 m -124.31 134.27 53.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 -179.022 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 30.1 mt-10 -100.22 125.24 46.36 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.491 HG21 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -88.01 110.1 20.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.21 121.64 43.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -170.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.88 115.94 4.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.52 10.14 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.098 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -111.44 -59.04 2.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.515 0.674 . . . . 0.0 109.972 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.93 -164.24 19.57 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.68 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.491 ' HG3' HG21 ' A' ' 50' ' ' VAL . 2.4 mp0 -69.65 126.64 30.34 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.589 0.709 . . . . 0.0 111.628 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.78 122.56 70.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.659 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.96 128.66 33.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.2 0.524 . . . . 0.0 111.993 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.593 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 75.6 mt -90.47 165.05 24.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.993 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.593 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.5 Cg_endo -57.54 130.47 39.1 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.724 2.283 . . . . 0.0 112.097 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -63.83 147.02 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.971 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -123.88 118.26 26.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.074 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.27 138.33 31.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.809 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.482 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.0 p90 -137.66 171.72 14.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.914 0.388 . . . . 0.0 110.388 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.711 ' HG3' HD11 ' A' ' 80' ' ' LEU . 80.7 mttt -130.01 154.44 47.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.266 0.555 . . . . 0.0 111.08 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.18 124.22 46.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.306 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.553 HD12 ' HB2' ' A' ' 78' ' ' GLN . 15.9 mt -88.55 -47.71 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 109.58 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -143.61 156.67 44.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.631 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -149.2 150.92 33.41 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -140.36 145.08 36.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.987 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -73.64 -25.94 60.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.494 0.664 . . . . 0.0 109.506 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -152.35 76.31 1.15 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.582 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.39 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.392 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 m -150.7 154.17 36.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.134 0.492 . . . . 0.0 110.683 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.593 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 14.3 mt -118.52 137.62 51.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -117.42 121.68 41.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.83 156.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.672 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.553 ' HB2' HD12 ' A' ' 67' ' ' ILE . 15.6 tt0 -130.26 138.35 50.47 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -80.05 -0.93 37.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -165.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.711 HD11 ' HG3' ' A' ' 65' ' ' LYS . 97.6 mt 50.74 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.363 0.415 . . . . 0.0 111.586 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.79 -151.35 49.32 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.716 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.02 -11.1 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.767 2.311 . . . . 0.0 111.987 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.18 30.57 6.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.002 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 15.4 p90 -80.67 -15.71 0.23 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.181 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 87.3 Cg_endo -92.19 -3.82 3.83 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 CA-C-N 120.867 1.345 . . . . 0.0 112.929 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.47 113.73 25.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.0 0.428 . . . . 0.0 110.021 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.2 pttt -111.57 164.41 13.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.458 ' HB2' ' HG3' ' A' ' 102' ' ' GLN . 21.8 t -134.01 155.67 49.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.812 -175.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.8 m -112.74 140.81 47.21 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.084 0.469 . . . . 0.0 110.508 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 98.3 mt -124.44 124.59 42.65 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.698 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.481 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 39.2 mtpt -135.53 155.19 50.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.2 ptt85 -86.72 161.09 18.6 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.38 39.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -90.69 -10.94 41.26 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -155.65 93.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 111.544 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.71 40.93 42.01 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.657 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.92 159.88 40.82 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.469 0.176 . . . . 0.0 110.859 -175.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -123.89 135.21 53.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.481 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 25.8 mm -103.84 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.432 ' HB3' ' HE1' ' A' ' 109' ' ' MET . 7.5 t90 -108.46 113.78 27.1 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 31.9 mt-10 -106.19 129.29 54.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.263 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.458 ' HG3' ' HB2' ' A' ' 88' ' ' SER . 7.0 tt0 -153.35 134.08 13.79 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.115 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 59.46 18.16 6.64 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.307 0.38 . . . . 0.0 111.834 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.01 -13.07 60.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.49 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 41.2 mt-30 -92.81 134.99 34.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.055 0.455 . . . . 0.0 111.133 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -101.44 115.8 31.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.09 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -111.16 141.01 45.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.598 0.237 . . . . 0.0 111.299 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -119.06 115.34 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.432 ' HE1' ' HB3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -114.83 165.32 12.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.349 0.595 . . . . 0.0 111.553 -177.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -102.21 163.07 12.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.162 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.428 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 42.4 ttp180 -106.36 134.86 48.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.577 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.4 mm -81.87 155.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.668 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -75.77 84.49 2.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 110.564 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.9 m -78.82 92.92 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.061 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -101.7 7.2 42.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.261 0.553 . . . . 0.0 110.085 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.8 p -79.32 -10.14 59.74 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.287 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.01 -147.85 50.51 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.407 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -142.07 117.06 9.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.285 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.5 134.55 33.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.101 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -78.19 -67.95 0.68 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 59.08 17.84 5.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.586 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -151.95 172.95 15.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -105.78 179.34 4.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.377 . . . . 0.0 111.362 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -135.9 -165.6 1.73 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m 61.51 38.73 15.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.738 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -84.38 90.38 7.57 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.251 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.8 p -143.84 131.29 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.427 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.0 tp -140.42 142.65 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.566 ' HB3' ' HD2' ' A' ' 131' ' ' HIS . 48.4 mt-10 -117.84 146.56 43.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -141.2 73.25 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.256 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.566 ' HD2' ' HB3' ' A' ' 129' ' ' GLU . 7.7 p80 -147.17 156.35 42.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.01 -10.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.5 t60 69.84 -80.1 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.351 0.66 . . . . 0.0 110.25 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -169.02 -51.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.937 0.495 . . . . 0.0 109.832 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.82 177.776 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.36 107.93 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.6 mtm 64.89 85.74 0.14 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.62 -24.7 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.1 m 64.73 -175.96 0.17 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.121 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.53 139.96 15.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.612 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.403 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.8 p -90.61 13.91 14.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.562 0.22 . . . . 0.0 111.024 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 7' ' ' CYS . 2.3 mp0 68.14 168.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.881 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 66.59 12.73 8.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.24 137.05 44.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.898 0.38 . . . . 0.0 110.985 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.42 69.02 7.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.83 -88.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.476 ' O ' ' HB ' ' A' ' 14' ' ' THR . 0.8 OUTLIER -173.6 178.2 2.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.737 -170.241 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.476 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 18.4 m 73.53 129.33 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.926 0.891 . . . . 0.0 113.328 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.93 122.24 11.28 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.919 2.413 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.34 -26.71 68.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -92.76 -10.43 37.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.055 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.5 -164.59 23.47 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.325 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.4 m -112.41 127.75 56.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.925 0.393 . . . . 0.0 110.145 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -117.42 151.41 37.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB2' HD11 ' A' ' 112' ' ' ILE . 13.8 t70 -89.52 130.92 35.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 4.2 mm-40 -52.85 -53.55 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.726 0.641 . . . . 0.0 112.376 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.04 35.17 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.51 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.401 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.5 tpp180 -99.41 149.33 23.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.58 79.07 21.73 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.3 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.401 ' HD3' ' C ' ' A' ' 25' ' ' ARG . 96.7 Cg_endo -99.91 -164.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.741 2.96 . . . . 0.0 110.927 174.149 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.35 173.79 33.08 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.912 171.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.1 132.51 16.79 Favored 'Trans proline' 0 C--N 1.324 -0.721 0 C-N-CA 122.989 2.459 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 p -86.03 6.74 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 t0 69.2 84.03 0.15 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.566 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.68 -38.02 2.07 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.63 138.54 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.676 0.274 . . . . 0.0 110.431 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.697 ' HE3' ' HB2' ' A' ' 52' ' ' GLU . 95.8 mttt -91.17 -38.89 12.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.486 0.66 . . . . 0.0 110.201 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -167.75 171.8 9.74 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.65 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -135.55 164.5 27.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.079 0.466 . . . . 0.0 111.647 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 p -127.95 157.18 41.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.2 125.7 74.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.288 0.565 . . . . 0.0 111.02 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -108.33 122.4 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -101.14 117.67 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.432 HG23 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -101.61 176.32 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.432 ' H ' HG23 ' A' ' 41' ' ' THR . 44.7 mt-10 -62.56 -39.66 94.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.69 -3.35 5.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.849 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.99 157.5 45.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.224 0.535 . . . . 0.0 111.646 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.09 133.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.69 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.76 124.33 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.495 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.429 ' HB2' HD13 ' A' ' 59' ' ' LEU . 17.8 mt-10 -98.79 137.41 37.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.264 0.554 . . . . 0.0 110.947 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.44 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.09 120.26 35.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.808 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.87 131.9 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.369 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.515 HG23 ' HG2' ' A' ' 56' ' ' GLU . 39.9 t -89.48 113.6 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.297 0.57 . . . . 0.0 110.665 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.0 mtt -116.07 135.53 53.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.697 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 34.4 tt0 -70.66 128.91 37.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.99 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 -27.32 7.36 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.343 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -93.21 -62.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.665 0.745 . . . . 0.0 109.997 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.14 -155.26 19.78 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.299 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.515 ' HG2' HG23 ' A' ' 50' ' ' VAL . 50.3 mt-10 -87.71 129.09 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.374 0.607 . . . . 0.0 110.162 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.44 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.8 t -104.38 122.61 57.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.94 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.624 ' OE1' ' HA ' ' A' ' 119' ' ' GLU . 69.7 mt-30 -91.87 130.4 37.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.019 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.429 HD13 ' HB2' ' A' ' 47' ' ' GLU . 94.8 mt -85.31 154.66 60.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -50.23 143.08 26.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.109 2.539 . . . . 0.0 112.524 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -59.87 119.02 6.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.7 mtm -109.79 121.78 46.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.218 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 149.36 39.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.531 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.21 159.91 36.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.84 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' HD2' HD22 ' A' ' 80' ' ' LEU . 20.4 ptmt -121.69 144.31 48.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.029 0.442 . . . . 0.0 109.846 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.78 115.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.806 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.5 mt -93.6 -51.86 10.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.898 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -124.92 154.61 40.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.717 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -149.19 147.74 28.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -148.74 146.27 28.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.3 p -73.48 -24.19 60.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.375 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -161.29 78.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.91 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.87 -84.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.978 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 m -145.41 148.89 33.83 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.096 0.474 . . . . 0.0 110.644 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.23 132.35 66.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -114.76 124.17 51.09 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.72 149.21 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 32.4 tt0 -124.36 136.76 54.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -77.11 157.45 31.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.281 -178.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 HD22 ' HD2' ' A' ' 65' ' ' LYS . 90.6 mt -121.11 166.48 13.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.977 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.41 -152.19 17.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.977 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.69 -9.85 15.04 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -122.98 57.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 37.3 p90 -85.21 -27.68 0.39 Allowed Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.071 -171.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 10.3 Cg_endo -89.31 -3.57 5.95 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 CA-C-N 121.089 1.425 . . . . 0.0 112.701 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.9 tp -89.21 117.25 28.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 64.1 pttt -113.76 162.43 16.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.942 0.401 . . . . 0.0 110.955 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.77 160.26 34.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.54 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.9 m -115.7 139.24 50.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 HD21 HD22 ' A' ' 98' ' ' LEU . 96.1 mt -124.1 124.33 42.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -132.33 152.86 51.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.496 . . . . 0.0 111.018 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -69.46 151.18 46.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.807 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.45 152.2 18.28 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.89 145.16 56.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.688 0.28 . . . . 0.0 111.259 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 66.47 20.48 10.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.553 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.47 4.21 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.072 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 p -117.16 173.8 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.464 HD22 HD21 ' A' ' 90' ' ' LEU . 49.4 tp -127.7 135.94 50.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.251 0.548 . . . . 0.0 111.345 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.4 mt -108.8 111.06 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.5 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.712 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 20.2 t90 -105.41 117.97 35.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.322 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.54 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.4 mt-10 -102.48 132.75 48.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.528 0.68 . . . . 0.0 110.113 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -151.24 123.94 8.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.128 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 24.9 m-80 62.02 22.44 13.08 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.729 0.643 . . . . 0.0 111.26 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.39 -8.35 69.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.98 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -93.1 134.06 35.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.992 0.396 . . . . 0.0 110.064 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -101.18 127.66 47.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.103 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 5.0 mmpt? -127.51 139.58 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.169 0.509 . . . . 0.0 111.657 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 m -106.58 114.11 28.02 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.995 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.712 ' HE2' ' HE3' ' A' ' 100' ' ' TRP . 12.4 ptp -119.37 148.4 43.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.644 -172.146 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -98.15 152.78 18.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -84.67 123.89 30.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.525 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -74.13 154.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -72.28 90.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.128 0.49 . . . . 0.0 109.98 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 68.86 172.55 0.29 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.255 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -92.93 112.0 23.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.641 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.1 m -87.38 132.44 33.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.629 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 114.33 -161.07 12.85 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.048 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -151.08 124.59 8.97 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.624 ' HA ' ' OE1' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -74.42 112.99 11.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.223 0.535 . . . . 0.0 110.213 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -152.67 -71.5 0.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.371 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 61.21 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.999 0.812 . . . . 0.0 110.802 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -93.0 135.16 34.42 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.082 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 72.31 122.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.395 1.059 . . . . 0.0 111.832 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.7 123.14 20.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.7 m -112.58 98.11 7.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.768 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -108.7 72.17 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.566 . . . . 0.0 110.618 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -173.4 100.03 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.789 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.74 128.56 54.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -76.54 78.7 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.173 0.511 . . . . 0.0 110.215 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -67.75 102.62 1.25 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -123.99 161.92 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.682 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -169.82 122.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.098 0.249 . . . . 0.0 110.35 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.56 103.9 1.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.974 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -112.53 119.81 39.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.394 -177.305 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.981 ' HE3' ' HB2' ' A' ' 132' ' ' HIS . 53.7 mtt . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.52 164.93 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.183 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -99.55 119.63 38.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.759 HG12 ' HA ' ' A' ' 127' ' ' SER . 7.2 p -71.68 140.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.899 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.5 m -64.5 113.18 3.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.84 166.55 22.59 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.355 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -70.21 96.32 1.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -159.81 156.71 27.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.153 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.494 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 19.9 tp60 -129.82 -95.96 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 29.8 tt0 165.22 120.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.622 0.769 . . . . 0.0 108.987 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.53 ' O ' ' HG2' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -124.04 99.93 6.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.921 0.867 . . . . 0.0 110.88 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -141.92 8.95 1.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' THR . 9.0 tp10 -147.2 161.7 40.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 8.1 m 70.63 130.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 123.915 0.759 . . . . 0.0 112.29 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 39.2 Cg_exo -56.85 121.26 9.75 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.629 2.219 . . . . 0.0 111.684 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -69.86 -15.25 63.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.993 -172.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -98.15 -5.67 33.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.531 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 28.0 t80 -85.53 136.37 33.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 0.0 111.036 -171.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.18 -143.25 14.82 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.029 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m -127.88 126.39 41.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.567 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 87.2 m95 -117.92 138.81 51.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.139 0.495 . . . . 0.0 111.486 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.474 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 4.4 t70 -83.55 126.47 32.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.498 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.412 ' HA ' ' HE3' ' A' ' 109' ' ' MET . 44.2 mt-10 -90.71 72.72 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.65 -15.94 60.86 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.257 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -100.45 142.75 31.49 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 70.71 145.24 0.11 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.562 1.164 . . . . 0.0 111.3 -178.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_exo -69.69 148.78 66.28 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.702 2.268 . . . . 0.0 112.501 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.4 -160.9 36.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.048 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.525 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.9 Cg_endo -62.98 152.58 78.62 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.711 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 p -78.67 3.76 15.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.736 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.39 -11.22 60.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.287 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 111.69 47.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.718 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.525 HG21 ' HG2' ' A' ' 29' ' ' PRO . 17.1 t -105.84 135.12 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.672 0.272 . . . . 0.0 110.28 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.08 -42.44 47.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.624 . . . . 0.0 111.024 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -166.14 163.17 18.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.534 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.12 36.98 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.78 141.14 51.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.54 129.76 70.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.333 0.587 . . . . 0.0 110.578 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.561 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 35.1 m -111.95 119.48 38.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.305 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -102.17 121.19 41.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.799 0.333 . . . . 0.0 111.225 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.622 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 1.7 m -101.83 173.9 6.19 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.4 ' H ' HG21 ' A' ' 41' ' ' THR . 1.5 mp0 -53.04 -46.56 68.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -129.8 8.09 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.622 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 45.0 mt-10 -121.77 135.4 54.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.562 -175.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.409 HG21 ' CD1' ' A' ' 64' ' ' TYR . 87.2 t -107.97 118.07 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.561 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 52.8 t -109.96 123.12 65.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 15.6 mt-10 -97.27 132.47 42.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.53 0.681 . . . . 0.0 111.066 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -127.85 118.25 23.33 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.1 177.023 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.455 ' OE2' ' HG3' ' A' ' 29' ' ' PRO . 27.6 mt-10 -109.0 126.66 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.302 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.88 111.65 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.247 0.546 . . . . 0.0 110.043 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.436 ' HG3' ' O ' ' A' ' 32' ' ' GLY . 39.1 ttm -118.92 125.95 50.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.515 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.03 127.17 30.5 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.012 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.6 -28.79 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.655 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -125.77 -34.73 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.178 0.513 . . . . 0.0 111.289 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.42 -140.73 15.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.251 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.63 138.56 50.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.23 0.538 . . . . 0.0 111.209 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.435 ' O ' ' HA ' ' A' ' 48' ' ' THR . 80.0 t -128.72 121.38 54.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.097 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -82.16 130.52 35.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.508 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 76.3 mt -95.84 159.69 31.82 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.651 171.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.08 117.39 3.85 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.79 2.327 . . . . 0.0 111.601 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -61.62 127.29 30.75 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.529 0.681 . . . . 0.0 111.475 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 42.5 ttm -95.2 144.36 25.87 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.556 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.97 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 110.471 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.409 ' CD1' HG21 ' A' ' 45' ' ' VAL . 15.7 p90 -138.08 163.07 32.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.067 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HE3' HG12 ' A' ' 67' ' ' ILE . 49.7 pttt -122.61 152.82 40.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.962 0.41 . . . . 0.0 110.117 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.63 112.95 37.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.032 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.568 HG12 ' HE3' ' A' ' 65' ' ' LYS . 11.5 mt -83.95 -53.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.287 0.565 . . . . 0.0 109.871 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 m -127.1 151.58 48.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.11 146.86 27.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -137.2 153.8 50.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.1 m -79.37 -30.02 42.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -152.76 80.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.131 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.32 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.671 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 p -148.68 154.71 40.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.173 0.511 . . . . 0.0 110.994 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.544 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 31.9 mt -128.35 130.99 69.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.001 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.81 124.13 51.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.32 157.68 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.689 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 47.4 tt0 -132.69 135.93 46.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -74.72 144.37 43.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 -179.7 3.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.759 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.67 -151.53 34.24 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.582 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 -10.15 21.35 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.718 2.278 . . . . 0.0 112.313 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -99.5 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.693 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.827 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 1.6 p90 -60.1 -179.31 0.17 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.371 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.827 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER 12.76 -0.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.258 1 C-N-CA 127.75 5.633 . . . . 0.0 121.343 -149.375 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 84' ' ' TYR . 63.0 tp -71.66 113.52 8.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 119.905 1.229 . . . . 0.0 109.759 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 94.7 mttt -91.44 170.82 9.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.418 0.628 . . . . 0.0 111.643 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -151.75 152.45 32.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.35 171.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.451 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.2 m -118.07 141.78 48.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.32 0.581 . . . . 0.0 111.31 -173.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.544 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 80.9 mt -121.12 124.65 45.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.641 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.532 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 51.9 mtpt -132.59 156.91 46.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 111.669 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -65.59 144.2 57.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.598 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.81 -168.53 25.3 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.926 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.7 -41.43 13.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.336 0.589 . . . . 0.0 111.674 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.84 18.37 21.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.191 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.66 26.36 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 p -106.0 175.67 5.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.341 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.517 HD23 HD23 ' A' ' 90' ' ' LEU . 59.5 tp -105.55 128.4 53.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 34.0 mm -96.97 109.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.477 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 16.6 t90 -103.25 112.76 25.78 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.703 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.451 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.3 mt-10 -104.47 131.19 52.12 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.69 0.757 . . . . 0.0 109.853 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -151.15 120.29 6.74 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.314 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 61.56 23.2 13.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -8.79 70.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.748 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.2 142.23 27.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -93.68 115.76 28.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 71.3 mttt -106.33 115.56 30.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.444 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.0 m -92.93 118.05 30.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.775 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 10.3 mmt -99.42 139.09 35.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.474 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -95.12 143.51 26.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.107 0.479 . . . . 0.0 110.286 -177.931 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -79.24 128.94 33.94 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.461 HD13 ' HB2' ' A' ' 22' ' ' ASP . 26.8 mm -75.99 142.85 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.337 0.589 . . . . 0.0 109.486 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -150.21 127.55 11.4 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 m 60.48 -159.17 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.651 0.594 . . . . 0.0 109.925 -174.081 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.636 ' HZ2' ' HB3' ' A' ' 115' ' ' LYS . 0.3 OUTLIER -100.07 22.28 11.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.01 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' THR . . . . . 0.534 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER 64.67 165.13 0.15 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.555 0.742 . . . . 0.0 111.463 -178.565 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.06 -112.5 2.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -138.23 108.47 6.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 111.459 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -133.46 125.65 29.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.578 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.25 121.17 15.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.053 0.454 . . . . 0.0 110.539 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -129.95 139.45 51.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.408 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.856 0.36 . . . . 0.0 111.332 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -95.51 107.34 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.408 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -100.04 95.81 7.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.942 0.401 . . . . 0.0 110.893 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.3 m -124.68 118.49 26.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -135.18 148.06 49.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' SER . . . . . 0.759 ' HA ' HG12 ' A' ' 4' ' ' VAL . 50.8 m -144.49 128.22 17.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.047 0.451 . . . . 0.0 111.771 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.64 141.15 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.626 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.85 123.45 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -139.94 100.32 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.406 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 33.8 m170 -78.45 178.7 7.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.216 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . 0.981 ' HB2' ' HE3' ' A' ' 1' ' ' MET . 12.5 t60 -105.12 125.85 51.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.768 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -90.15 -172.62 3.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.54 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.412 ' O ' ' HB3' ' A' ' 135' ' ' HIS . 24.4 m80 -76.46 73.55 3.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.412 ' HB3' ' O ' ' A' ' 134' ' ' HIS . 5.5 p80 . . . . . 0 C--O 1.243 0.721 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.75 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' HG2' HG12 ' A' ' 2' ' ' ILE . 21.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.489 HG12 ' HG2' ' A' ' 1' ' ' MET . 45.1 mm 65.78 82.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 O-C-N 123.622 0.576 . . . . 0.0 111.388 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.92 139.02 31.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.13 98.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.884 0.373 . . . . 0.0 110.57 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -76.76 109.28 10.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.778 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.39 167.94 30.48 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.771 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 42.8 t -119.3 82.34 1.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.165 0.507 . . . . 0.0 110.058 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.12 82.41 7.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.669 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.594 ' HG2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -93.73 67.78 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.957 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -178.32 68.49 0.02 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -159.9 164.64 33.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -130.76 94.13 3.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.774 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -132.32 172.07 12.91 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 15.0 m -54.71 116.88 12.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 0.0 111.773 -176.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.694 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.2 Cg_exo -67.45 104.13 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.816 2.344 . . . . 0.0 111.656 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.446 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 40.6 p90 -57.65 -34.27 69.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.987 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.564 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 50.1 p90 -78.93 -9.62 59.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.694 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 2.1 t80 -80.82 23.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.331 0.586 . . . . 0.0 111.364 -172.155 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 17' ' ' TYR . . . -115.61 -177.78 18.49 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.095 -178.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 m -99.23 116.86 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.446 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 50.6 m95 -114.05 132.32 56.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.465 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.28 129.99 45.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -62.25 -55.63 26.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.43 27.55 73.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.107 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.7 144.68 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.6 160.71 0.13 Allowed Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 124.388 1.055 . . . . 0.0 112.086 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.85 153.6 72.54 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.686 2.258 . . . . 0.0 111.516 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.03 -169.66 46.07 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.964 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 64.2 Cg_exo -50.66 162.89 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 124.466 3.444 . . . . 0.0 113.879 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 p -69.34 -9.42 53.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.884 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.59 -10.13 59.18 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.012 -0.43 . . . . 0.0 111.106 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.7 27.67 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.547 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.614 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 21.4 t -74.06 134.67 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.262 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -81.14 -32.67 33.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 m -158.73 160.34 36.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.506 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.01 137.01 46.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.142 0.496 . . . . 0.0 111.092 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 24.6 p -118.39 136.86 53.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.259 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.78 134.14 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.179 0.514 . . . . 0.0 110.671 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -123.3 128.31 49.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.701 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.564 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 97.0 m-85 -102.06 116.79 33.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.128 0.489 . . . . 0.0 110.546 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.52 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -103.04 -178.16 3.58 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.78 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -46.01 -64.2 0.8 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.17 10.29 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.772 0.796 . . . . 0.0 110.16 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.52 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -137.98 145.83 42.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.181 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.489 HG21 ' CD1' ' A' ' 64' ' ' TYR . 90.0 t -101.36 132.3 47.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.19 123.16 67.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.828 0.347 . . . . 0.0 110.159 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -103.78 138.31 40.56 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.435 0.636 . . . . 0.0 110.279 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.445 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -124.23 122.13 36.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.182 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.59 120.03 39.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.797 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.469 HG22 ' HG3' ' A' ' 56' ' ' GLU . 33.2 t -87.98 112.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.6 127.57 55.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.16 132.12 49.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.67 0.606 . . . . 0.0 111.517 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.4 3.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.07 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -93.9 -63.96 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.14 -157.02 21.05 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.376 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.8 mp0 -74.98 129.61 37.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.38 0.61 . . . . 0.0 110.843 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.84 122.58 66.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.708 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -84.76 131.63 34.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.872 0.368 . . . . 0.0 111.917 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.69 164.89 30.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.543 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.83 152.33 36.1 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.876 2.384 . . . . 0.0 112.44 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.77 114.66 10.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 110.693 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.428 ' HE1' ' CE2' ' A' ' 83' ' ' TYR . 70.7 mtp -96.62 118.38 32.99 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.544 -179.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.467 ' HB1' HD11 ' A' ' 80' ' ' LEU . . . -75.98 140.85 42.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.969 0.414 . . . . 0.0 111.66 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.489 ' CD1' HG21 ' A' ' 45' ' ' VAL . 8.9 p90 -145.94 150.11 35.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -132.93 151.56 52.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.486 0.66 . . . . 0.0 111.243 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.87 128.94 38.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.846 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 78' ' ' GLN . 36.7 mt -90.94 -52.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.177 175.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.6 m -138.48 156.95 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.196 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.594 ' HB3' ' HG2' ' A' ' 9' ' ' GLN . 34.9 tt0 -147.54 152.85 38.67 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -174.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.771 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 33.2 t -157.89 135.48 10.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 120.819 0.343 . . . . 0.0 111.156 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -11.94 59.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.1 -39.15 89.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.067 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.08 36.78 0.15 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.21 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 m -149.84 136.49 19.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 117.573 0.686 . . . . 0.0 110.736 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.464 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 18.6 mt -136.24 137.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.98 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -114.09 129.06 56.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.408 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 32.7 pt -131.45 157.43 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.858 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.745 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 6.2 tp-100 -124.28 147.05 48.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.272 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -96.48 151.05 19.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.467 HD11 ' HB1' ' A' ' 63' ' ' ALA . 38.1 mt -107.74 156.13 19.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.154 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -154.42 21.75 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.24 -4.76 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.765 2.31 . . . . 0.0 112.618 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.428 ' CE2' ' HE1' ' A' ' 62' ' ' MET . 71.0 m-85 -97.67 11.45 37.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.966 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -65.35 176.71 0.79 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.948 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.966 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 20.0 Cg_exo 5.06 -1.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 1 C-N-CA 128.425 6.084 . . . . 0.0 121.872 -148.478 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.2 tp -90.19 102.94 15.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 120.299 1.409 . . . . 0.0 108.057 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 20.4 pttp -115.39 178.66 4.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 0.0 112.352 -166.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 2.6 m -133.27 165.6 24.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.096 -176.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -123.86 142.16 51.38 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.443 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.464 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 93.7 mt -117.92 124.6 48.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.365 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -137.51 154.98 49.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.955 0.407 . . . . 0.0 110.991 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -65.12 143.72 57.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.253 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.01 132.97 10.14 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 42.3 mt-10 -68.59 158.43 34.0 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.899 -0.177 . . . . 0.0 110.568 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.415 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 12.9 m120 75.51 -7.42 1.79 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.74 0.816 . . . . 0.0 110.784 -174.29 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.53 0.9 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.873 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.4 p -131.16 174.24 10.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.748 0.309 . . . . 0.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.82 133.18 54.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.884 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.16 110.2 30.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.231 0.539 . . . . 0.0 109.87 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.9 t90 -104.97 114.13 28.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.788 -178.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.9 134.71 43.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.266 0.555 . . . . 0.0 109.687 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -148.79 111.77 4.87 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.748 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.59 31.71 20.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.82 0.819 . . . . 0.0 110.698 166.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.44 -17.17 55.85 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.941 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -92.04 136.29 33.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.968 0.384 . . . . 0.0 110.839 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 106' ' ' ARG . 23.2 ttt180 -99.94 114.97 28.6 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -109.7 136.25 49.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.595 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -120.93 114.13 21.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.856 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.416 ' HE1' ' HB3' ' A' ' 109' ' ' MET . 0.1 OUTLIER -118.22 151.49 37.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -109.36 151.72 26.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -87.92 135.74 33.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.298 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.78 147.58 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.616 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.39 152.4 21.93 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.557 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.2 m -77.0 76.23 3.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -112.25 63.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -79.23 102.56 8.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.266 -172.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.0 66.6 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -98.49 83.48 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.632 0.73 . . . . 0.0 110.845 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -132.79 160.82 35.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.681 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -74.61 103.0 4.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.07 138.84 32.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.18 159.45 16.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.89 132.22 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.016 0.436 . . . . 0.0 111.204 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -64.17 104.41 0.74 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.667 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 t -87.87 104.56 16.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.243 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 70.15 -74.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.792 0.682 . . . . 0.0 111.488 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.0 t -164.44 133.24 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -113.27 107.32 15.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 110.449 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.46 152.0 8.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.73 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -62.71 107.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.192 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -116.9 130.98 57.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.785 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -104.79 117.3 33.71 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -82.56 -5.83 58.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.442 -171.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.0 t60 . . . . . 0 C--O 1.241 0.658 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.086 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.5 mtp . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt 68.15 96.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 O-C-N 123.924 0.765 . . . . 0.0 111.4 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtp -131.4 120.57 23.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.094 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.27 143.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -102.42 0.64 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.613 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.97 64.84 3.64 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.6 m -85.03 151.5 24.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.313 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.97 -138.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.676 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 70.07 35.81 2.09 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.458 0.474 . . . . 0.0 111.274 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -64.09 122.76 17.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -83.34 -32.61 26.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.43 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.59 61.65 3.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.976 0.893 . . . . 0.0 109.961 -170.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.556 ' O ' ' HB ' ' A' ' 14' ' ' THR . 10.0 tp10 -131.72 172.54 12.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.027 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.556 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 14.7 m 72.71 124.33 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 123.147 0.579 . . . . 0.0 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.41 ' HD2' ' HA ' ' A' ' 14' ' ' THR . 6.1 Cg_endo -49.45 120.13 5.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.725 2.95 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -69.53 -14.24 62.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.468 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -98.03 -11.54 22.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.498 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -86.05 135.71 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.93 -168.24 22.5 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.984 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.7 m -104.08 129.93 51.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -120.44 135.8 54.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.016 0.436 . . . . 0.0 111.039 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.74 139.09 31.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.027 174.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 37.5 mt-10 -50.31 -43.83 53.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.21 -56.81 2.8 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.187 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 -105.7 141.24 37.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.595 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 65.81 142.77 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.637 1.211 . . . . 0.0 112.054 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.1 Cg_exo -81.44 171.09 13.96 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.251 2.634 . . . . 0.0 112.571 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.91 -154.97 30.34 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.313 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.505 ' O ' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -61.89 -31.06 84.72 Favored 'Trans proline' 0 C--O 1.23 0.098 0 C-N-CA 123.315 2.676 . . . . 0.0 113.597 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.505 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 83.2 m 75.6 -21.14 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.748 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.422 ' H ' ' C ' ' A' ' 29' ' ' PRO . 11.9 m-20 -51.13 -54.7 22.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.398 176.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.36 -43.07 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.002 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.35 134.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.72 -32.47 14.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 m -167.88 165.41 13.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.943 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -121.97 148.06 45.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.096 0.474 . . . . 0.0 111.055 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 p -118.11 139.48 51.18 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.54 137.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.162 0.506 . . . . 0.0 111.19 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -119.41 127.84 53.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.901 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -101.69 125.64 48.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 111.425 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 0.9 OUTLIER -101.36 178.97 4.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.439 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.415 ' H ' HG21 ' A' ' 41' ' ' THR . 36.5 mt-10 -55.03 -42.1 72.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -141.29 19.55 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 110.821 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.8 mt-10 -129.06 145.16 51.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.54 ' HB ' ' HB2' ' A' ' 62' ' ' MET . 92.5 t -117.14 121.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.07 124.02 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -111.8 128.78 56.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.457 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -111.62 125.18 53.67 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.485 177.227 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.19 128.08 45.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.512 HG23 ' HG2' ' A' ' 56' ' ' GLU . 43.6 t -92.31 112.61 26.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 0.0 110.359 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -112.3 161.56 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.433 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.0 123.96 26.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 110.759 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 -10.93 44.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.592 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -98.71 -68.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.453 ' O ' ' HA ' ' A' ' 50' ' ' VAL . . . 125.66 -142.59 13.86 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.613 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HG2' HG23 ' A' ' 50' ' ' VAL . 53.1 mt-10 -95.65 120.61 36.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.291 0.567 . . . . 0.0 110.644 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 48' ' ' THR . 73.9 t -104.68 124.89 59.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.694 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -88.13 119.57 28.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.629 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.55 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.6 mt -81.09 163.64 54.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.806 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.55 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.4 Cg_endo -62.25 146.4 95.89 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.792 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -64.04 131.01 46.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 111.075 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.54 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 50.8 mtt -97.43 118.19 33.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.838 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.83 127.71 32.83 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' CD1' HG23 ' A' ' 45' ' ' VAL . 45.6 p90 -129.18 171.81 12.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.959 0.409 . . . . 0.0 111.332 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.544 ' HE3' HD22 ' A' ' 80' ' ' LEU . 99.0 mttt -120.71 159.73 24.77 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.253 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -103.72 120.97 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.781 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 78' ' ' GLN . 19.9 mt -87.55 -54.0 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.233 0.539 . . . . 0.0 109.813 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -136.46 153.19 51.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.144 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.74 124.39 11.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.455 0.645 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 72' ' ' ASP . 35.5 t -108.85 -22.55 12.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.124 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 m 73.77 -38.71 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.851 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.415 ' H ' ' C ' ' A' ' 70' ' ' SER . 23.9 t70 -98.53 -59.41 1.75 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.756 0.312 . . . . 0.0 111.435 -177.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.64 -60.52 2.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.176 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.482 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 30.5 t -154.0 164.84 37.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.407 0.622 . . . . 0.0 111.598 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.55 136.4 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.456 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.444 ' HG2' HD13 ' A' ' 67' ' ' ILE . 27.2 tt0 -115.09 131.01 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.739 0.304 . . . . 0.0 110.37 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.64 158.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.136 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.582 ' HB2' HD11 ' A' ' 67' ' ' ILE . 61.8 tt0 -131.84 140.85 49.26 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.411 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 58.4 m-85 -86.41 179.42 6.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD22 ' HE3' ' A' ' 65' ' ' LYS . 90.0 mt -134.87 -176.21 4.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.324 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.65 -152.98 30.98 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.515 ' HG2' ' CE2' ' A' ' 83' ' ' TYR . 28.0 Cg_endo -65.44 -7.35 15.75 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.215 1.944 . . . . 0.0 112.047 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.515 ' CE2' ' HG2' ' A' ' 82' ' ' PRO . 24.8 m-85 -114.16 34.78 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.1 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.561 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 19.6 p90 -85.33 -27.35 0.38 Allowed Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.561 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 84.2 Cg_endo -83.32 -4.44 11.0 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.439 1.55 . . . . 0.0 112.922 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.88 133.22 44.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.333 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -111.49 168.72 9.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.117 0.484 . . . . 0.0 111.181 -178.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 156.47 46.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.315 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -124.58 142.13 51.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.83 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' A' ' 98' ' ' LEU . 97.6 mt -120.39 124.19 44.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.567 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.482 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 32.8 mtmm -124.26 161.56 25.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.39 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.39 144.91 33.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.011 0.434 . . . . 0.0 110.396 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.64 171.09 23.65 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.507 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.18 -19.9 60.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.097 -0.551 . . . . 0.0 111.944 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -121.41 29.66 7.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 -173.667 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.05 39.7 62.92 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -116.63 174.91 5.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.451 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.476 HD11 ' HB3' ' A' ' 90' ' ' LEU . 39.1 tp -113.23 131.78 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.89 111.44 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.866 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.487 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 12.0 t90 -97.0 112.89 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.827 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -110.81 132.63 54.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -150.69 128.25 11.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.092 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.66 17.12 9.47 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.6 64.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.82 134.3 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.427 ' NH2' ' HE3' ' A' ' 91' ' ' LYS . 96.4 mtt180 -101.39 123.92 46.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.595 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 19.3 mmtp -106.99 125.7 51.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.953 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -97.66 113.2 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.487 ' HE1' ' HB2' ' A' ' 100' ' ' TRP . 65.6 mtm -100.38 155.46 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.856 -169.126 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.11 150.42 20.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.835 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.411 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 3.0 ptt180 -95.78 139.82 31.46 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mm -95.87 155.48 3.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.864 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.22 85.3 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.902 0.858 . . . . 0.0 109.769 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -99.68 57.7 1.02 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.332 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.83 86.39 4.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.117 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 t -154.62 179.13 9.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.315 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.55 161.22 14.12 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -89.06 97.26 11.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 0.0 110.314 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.13 153.18 30.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.956 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -113.91 118.28 33.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.227 -172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -89.88 107.99 19.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.86 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.07 99.4 8.99 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.852 0.834 . . . . 0.0 109.917 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -159.26 153.9 24.42 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.194 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -133.63 76.76 1.68 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.38 112.3 20.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.511 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -113.17 103.88 11.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.977 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -90.83 82.02 5.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 0.0 110.356 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.97 93.46 6.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.912 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.416 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 1.5 mm-40 -97.49 116.74 30.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.402 0.62 . . . . 0.0 111.009 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -127.43 30.06 5.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.885 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -90.72 146.51 23.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.4 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -83.68 114.83 21.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.629 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -69.11 116.57 9.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.805 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -137.18 118.02 14.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.726 178.428 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.974 0.416 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.56 91.16 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.01 118.72 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.028 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.17 151.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.098 0.475 . . . . 0.0 111.333 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 p -146.59 151.0 36.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -154.78 7.52 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.581 -175.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 t -131.85 7.59 4.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.168 0.509 . . . . 0.0 110.307 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . 0.531 ' HG3' ' H ' ' A' ' 9' ' ' GLN . 5.9 tp60 -96.92 -175.06 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . 0.531 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 54.2 tt0 -120.93 115.6 23.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -76.76 91.39 3.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.828 ' HG3' ' HG2' ' A' ' 12' ' ' GLU . 17.2 ptpt -95.19 -43.05 8.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.565 -169.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.828 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 4.5 pt-20 -158.62 103.88 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.0 111.028 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.482 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -101.92 -179.35 3.98 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.095 -177.125 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.822 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 29.3 m -80.35 -58.9 0.55 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.822 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 16.1 Cg_exo -68.82 90.47 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.192 1.928 . . . . 0.0 112.169 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -75.7 -9.15 58.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.01 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -84.41 -11.68 55.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.466 ' CD2' ' HB2' ' A' ' 15' ' ' PRO . 10.5 m-85 -72.68 151.08 42.43 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.71 -167.07 12.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.388 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.3 m -110.55 128.07 55.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 110.501 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.421 ' CZ3' ' HB3' ' A' ' 111' ' ' ARG . 64.1 m95 -113.36 128.6 56.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.536 ' HA ' HG22 ' A' ' 37' ' ' THR . 15.0 t70 -88.21 120.69 29.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.16 76.1 2.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.348 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.23 40.4 2.47 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -128.04 144.49 51.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.43 156.75 0.16 Allowed Pre-proline 0 N--CA 1.465 0.311 0 O-C-N 124.213 0.946 . . . . 0.0 111.756 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.74 134.51 50.94 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.455 2.104 . . . . 0.0 111.857 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.9 -174.85 34.98 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.229 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.57 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 18.2 Cg_endo -59.76 128.4 26.78 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.159 2.573 . . . . 0.0 112.75 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -67.86 -10.38 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.347 0.594 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.88 -33.17 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.561 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.57 -27.96 0.54 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.221 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 5.8 t -82.59 133.35 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -91.48 -31.08 16.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.092 0.473 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 m -160.2 165.09 32.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.613 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.78 154.85 51.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.012 0.434 . . . . 0.0 111.292 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.536 HG22 ' HA ' ' A' ' 22' ' ' ASP . 5.7 p -123.18 130.44 52.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.407 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.39 130.39 66.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.058 0.456 . . . . 0.0 110.572 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.2 m -114.78 127.09 55.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.774 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.83 117.64 35.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.17 0.51 . . . . 0.0 110.2 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.43 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -101.11 179.18 4.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.543 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.43 ' H ' HG22 ' A' ' 41' ' ' THR . 29.9 mt-10 -52.84 -64.13 0.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -119.18 14.49 13.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 111.698 -174.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.49 148.62 34.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.91 0.386 . . . . 0.0 111.019 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.426 HG22 ' CD1' ' A' ' 64' ' ' TYR . 98.0 t -110.19 119.45 59.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.526 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.8 123.35 53.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.991 0.424 . . . . 0.0 110.426 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.22 137.24 38.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.368 0.604 . . . . 0.0 110.75 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.03 122.26 31.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.867 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -99.67 135.89 40.41 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.53 112.08 23.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.6 mmm -110.47 124.94 52.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.043 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.56 113.88 2.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.976 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 -26.83 23.15 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.4 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -96.23 -55.03 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.598 0.713 . . . . 0.0 109.813 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.19 -156.64 15.64 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.496 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.99 126.74 30.52 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.279 0.561 . . . . 0.0 110.564 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.88 122.59 68.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -81.81 128.45 34.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.574 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.2 mt -93.75 165.45 17.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.489 173.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.574 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.0 Cg_endo -58.45 128.4 28.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.297 1.998 . . . . 0.0 111.432 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -66.89 122.9 18.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.75 0.786 . . . . 0.0 111.231 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 40.2 ttm -80.39 127.87 32.9 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.18 135.76 41.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.426 ' CD1' HG22 ' A' ' 45' ' ' VAL . 6.2 p90 -147.09 157.93 43.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -123.68 136.64 54.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.169 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.448 ' HA ' HG23 ' A' ' 77' ' ' ILE . 78.9 t -75.7 122.94 30.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.882 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.555 HD11 ' HB2' ' A' ' 78' ' ' GLN . 27.4 mt -83.9 -54.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.4 m -140.78 156.47 46.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.7 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.67 126.39 11.81 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.161 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -161.94 156.26 22.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.056 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 m -82.17 -26.87 33.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.125 0.488 . . . . 0.0 110.107 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.7 -29.89 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.76 0.81 89.23 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p 60.96 -178.54 0.11 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.97 1.308 . . . . 0.0 112.222 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.558 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 11.3 mt -108.13 130.59 60.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.134 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -126.38 128.49 47.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.448 HG23 ' HA ' ' A' ' 66' ' ' VAL . 29.4 pt -131.01 155.86 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.996 0.426 . . . . 0.0 111.198 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.661 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 5.6 tp-100 -123.68 146.22 48.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.205 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.489 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 41.4 m-85 -98.45 151.05 21.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.873 0.368 . . . . 0.0 110.365 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.4 mt -113.82 164.51 13.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.7 -151.28 23.05 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.513 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.68 -6.91 11.54 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.974 2.449 . . . . 0.0 112.627 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 13.07 30.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.867 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -60.45 174.22 0.53 Allowed Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.106 -173.697 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.867 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 44.5 Cg_exo 5.18 -0.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 128.847 6.365 . . . . 0.0 121.944 -148.432 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 84' ' ' TYR . 49.0 tp -78.12 103.04 7.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 120.086 1.312 . . . . 0.0 108.095 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 61.4 pttt -95.7 -176.8 3.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -166.38 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.402 ' HB3' HG13 ' A' ' 77' ' ' ILE . 40.6 t -141.69 159.32 42.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.235 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.539 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.8 m -137.17 144.71 43.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.507 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.558 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 87.2 mt -126.59 124.65 40.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.546 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.483 ' O ' HD12 ' A' ' 98' ' ' LEU . 62.3 mttp -123.17 167.0 14.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -79.82 149.52 31.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.952 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.51 ' HA3' ' HB ' ' A' ' 97' ' ' THR . . . -116.24 137.66 13.85 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -41.41 74.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.32 25.78 2.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.453 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.04 39.02 13.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.27 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.51 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -107.63 171.91 7.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.362 -0.419 . . . . 0.0 109.886 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.613 HD21 ' HE3' ' A' ' 109' ' ' MET . 34.3 tp -128.8 131.08 47.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.78 112.81 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.614 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 20.7 t90 -96.54 112.65 24.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.539 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 36.3 mt-10 -104.64 130.04 52.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.458 0.647 . . . . 0.0 110.031 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.434 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 19.7 tm0? -153.78 134.74 13.87 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.798 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.9 OUTLIER 66.55 13.33 9.25 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.323 0.39 . . . . 0.0 111.525 173.739 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.28 71.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.073 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.31 142.69 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.498 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 58.7 mtt180 -99.51 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.168 0.508 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 29.7 mmmt -101.7 141.4 34.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.556 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 m -119.24 112.68 19.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.614 ' HE1' ' HB2' ' A' ' 100' ' ' TRP . 23.6 ptt? -126.37 141.57 51.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.755 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.7 m -98.94 154.46 18.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.435 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.421 ' HB3' ' CZ3' ' A' ' 21' ' ' TRP . 20.3 ptt180 -88.11 157.72 18.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.054 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.528 HD12 ' HB2' ' A' ' 22' ' ' ASP . 19.7 mm -95.76 147.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.85 121.39 29.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.268 0.556 . . . . 0.0 111.435 -172.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 m -99.74 117.81 34.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.299 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -100.09 4.92 44.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.19 150.68 35.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.445 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.4 64.65 0.23 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.511 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 25.9 ttp-105 -97.1 84.8 3.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.973 0.416 . . . . 0.0 110.349 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -142.67 131.79 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.783 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 65.8 172.84 0.23 Allowed 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.922 0.764 . . . . 0.0 111.326 -174.051 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.502 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 46.2 tttp -173.37 130.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -118.97 -150.5 0.46 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 69.9 88.19 0.11 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.404 0.621 . . . . 0.0 111.251 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 118.13 11.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.319 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.6 m -153.58 109.01 3.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -121.03 18.32 11.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.395 0.617 . . . . 0.0 110.18 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m -91.79 101.02 13.62 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.4 tp -126.08 87.74 2.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.99 0.424 . . . . 0.0 110.15 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.69 131.03 44.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.304 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -175.42 117.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.964 0.411 . . . . 0.0 111.495 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -130.46 131.66 45.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.605 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -141.49 -80.79 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.14 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.1 m80 66.16 -60.91 0.3 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.685 0.616 . . . . 0.0 110.767 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.618 -0.705 . . . . 0.0 109.333 177.441 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.3 pt -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.588 0.709 . . . . 0.0 111.995 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -174.27 174.47 2.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.554 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 m -100.52 87.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 0.0 110.782 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.416 ' HB2' ' HA ' ' A' ' 70' ' ' SER . 4.0 m -81.24 34.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.964 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.45 110.24 0.46 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.092 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . 0.61 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 41.8 t -143.46 131.68 21.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -75.83 -5.86 47.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 111.744 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.34 -18.5 24.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.717 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.61 ' HG3' ' HB3' ' A' ' 7' ' ' CYS . 55.5 mt-30 -70.33 -45.59 65.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.222 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 69.89 -70.26 0.15 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.04 0.837 . . . . 0.0 110.545 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 67.19 -71.43 0.1 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.737 0.648 . . . . 0.0 112.415 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.41 ' HG3' ' H ' ' A' ' 14' ' ' THR . 4.3 tp10 -154.9 173.63 16.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -174.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.41 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 11.2 t -75.91 136.83 69.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.069 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.2 124.63 14.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.277 2.651 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -64.78 -27.88 69.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.139 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -83.8 -6.45 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.249 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -71.75 137.11 47.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 109.996 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.03 -149.73 17.42 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.931 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.8 m -127.09 132.37 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.545 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -120.69 150.87 40.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.237 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.546 ' HB2' HD13 ' A' ' 112' ' ' ILE . 7.0 t0 -107.23 127.85 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.13 -18.89 41.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.848 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 -56.02 1.07 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 40.0 ttm180 -170.44 149.8 3.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.29 155.86 50.12 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.732 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.23 134.35 33.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.609 2.206 . . . . 0.0 111.019 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.25 -153.22 7.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.667 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.21 138.68 72.29 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.059 2.506 . . . . 0.0 112.05 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -80.3 16.16 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.494 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.72 -31.1 41.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.036 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.99 95.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.987 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.487 HG21 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -103.62 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -87.01 -37.04 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.153 0.501 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.481 ' HA ' ' HA ' ' A' ' 25' ' ' ARG . 51.6 m -159.92 163.69 34.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.923 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.24 130.99 50.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 p -123.8 130.79 53.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.7 127.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.252 0.549 . . . . 0.0 110.484 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.542 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 88.8 m -108.41 129.46 55.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.43 117.48 35.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.144 0.497 . . . . 0.0 110.508 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.422 HG23 ' H ' ' A' ' 42' ' ' GLU . 2.5 m -102.29 -179.62 4.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.814 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.422 ' H ' HG23 ' A' ' 41' ' ' THR . 29.1 mm-40 -44.3 -66.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.502 0.721 . . . . 0.0 112.609 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -126.08 9.52 7.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 111.205 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -133.3 143.26 48.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.408 0.623 . . . . 0.0 111.411 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.92 128.31 48.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.809 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.542 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 45.7 t -104.29 123.46 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.157 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.3 mt-10 -95.2 129.13 42.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.446 0.641 . . . . 0.0 110.655 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.16 116.42 19.9 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.019 176.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.33 135.82 44.25 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.66 110.77 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.575 ' HE3' ' HG3' ' A' ' 54' ' ' ARG . 91.4 mtp -116.92 134.86 54.23 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.872 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.6 116.58 10.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.857 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -11.71 66.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.49 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.575 ' HG3' ' HE3' ' A' ' 51' ' ' MET . 4.5 mmp_? -106.86 -59.41 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.183 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.84 -165.03 12.16 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.543 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -75.73 127.59 33.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.433 0.635 . . . . 0.0 110.523 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' THR . 79.4 t -115.91 121.84 68.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.158 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.58 122.43 32.03 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.844 0.354 . . . . 0.0 110.209 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.581 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 74.4 mt -91.13 164.85 23.54 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.554 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.556 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 11.7 Cg_endo -57.45 134.48 63.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.589 2.193 . . . . 0.0 111.655 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.421 ' CD2' HG21 ' A' ' 46' ' ' VAL . 55.9 m-85 -58.86 132.14 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.346 -174.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.838 ' HA ' ' HE2' ' A' ' 62' ' ' MET . 7.1 mmt -98.94 119.89 38.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 133.55 41.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.431 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -130.24 159.41 36.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 110.912 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.477 ' HD2' HD23 ' A' ' 80' ' ' LEU . 50.1 mttm -122.82 158.2 30.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.614 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.59 112.86 38.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.131 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.598 HD12 ' HB2' ' A' ' 78' ' ' GLN . 16.4 mt -83.05 -54.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.594 0.711 . . . . 0.0 109.702 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -142.36 150.74 41.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.585 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . 0.477 ' HG2' ' N ' ' A' ' 71' ' ' THR . 8.9 tt0 -150.28 132.55 15.47 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.612 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.416 ' HA ' ' HB2' ' A' ' 5' ' ' SER . 17.4 t -93.72 -21.24 19.46 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.477 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 26.6 m 75.15 -35.4 0.28 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.782 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.407 ' H ' ' C ' ' A' ' 70' ' ' SER . 4.0 p-10 -101.83 -7.0 22.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.663 ' HA3' HH11 ' A' ' 92' ' ' ARG . . . -158.87 -51.76 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.145 -1.502 . . . . 0.0 114.219 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 2.8 p -118.73 143.03 47.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.261 0.553 . . . . 0.0 112.466 -173.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.446 HG12 ' HG3' ' A' ' 69' ' ' GLN . 22.4 mt -136.64 137.6 47.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.432 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -118.91 124.58 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . 0.554 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 30.2 pt -126.82 155.2 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.384 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.598 ' HB2' HD12 ' A' ' 67' ' ' ILE . 36.1 tt0 -124.45 146.93 48.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.462 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 21.1 m-85 -86.35 152.99 22.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.726 0.298 . . . . 0.0 110.487 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.477 HD23 ' HD2' ' A' ' 65' ' ' LYS . 98.1 mt -114.26 163.72 14.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.31 -152.27 21.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.503 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.34 -8.57 12.87 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.965 2.444 . . . . 0.0 112.665 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . 0.462 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 49.0 m-85 -104.75 18.67 21.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.853 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 2.2 p90 -55.71 169.63 0.49 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -176.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.853 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 9.28 -0.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 1 C-N-CA 128.734 6.289 . . . . 0.0 121.418 -150.983 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.563 HD12 ' N ' ' A' ' 87' ' ' LYS . 2.7 tm? -73.66 146.3 44.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.563 ' N ' HD12 ' A' ' 86' ' ' LEU . 65.9 pttt -144.17 173.1 12.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.644 0.735 . . . . 0.0 112.793 -167.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 m -132.69 159.42 39.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.029 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.524 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.3 m -130.26 142.82 50.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.5 mt -121.74 124.73 44.91 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 46.5 mmtm -114.59 170.03 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.663 HH11 ' HA3' ' A' ' 73' ' ' GLY . 27.7 ptt-85 -92.71 145.02 24.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.416 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -104.75 138.69 14.29 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.78 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.11 -35.91 76.28 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.091 0.556 . . . . 0.0 112.077 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -95.89 24.74 5.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.312 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.24 42.24 24.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.383 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.416 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 18.0 p -121.0 173.94 6.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.649 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 tp -120.39 131.33 54.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.569 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 63.8 mt -99.12 112.98 32.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.728 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 10.0 t90 -99.98 115.56 29.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.381 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.532 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 26.0 mt-10 -97.67 129.64 44.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -152.8 124.26 7.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.317 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 67.26 -7.46 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.44 0.463 . . . . 0.0 112.172 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.45 9.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.773 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.54 136.97 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.568 0.223 . . . . 0.0 110.413 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.532 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 76.1 mtt180 -100.41 116.32 32.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.898 0.38 . . . . 0.0 110.424 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -119.41 141.28 49.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.183 0.516 . . . . 0.0 111.332 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -94.41 122.69 37.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.952 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.728 ' SD ' ' HB2' ' A' ' 100' ' ' TRP . 66.1 mtp -102.55 133.44 47.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.38 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -97.77 143.87 27.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.714 0.292 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -88.44 123.9 33.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.27 0.557 . . . . 0.0 110.992 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.546 HD13 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -79.02 155.84 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.461 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -68.65 93.65 0.53 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -98.4 105.52 17.67 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.558 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -122.53 138.9 54.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.3 p -75.24 125.01 28.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.321 0.581 . . . . 0.0 112.001 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -93.66 2.09 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -123.74 119.73 30.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.01 156.87 30.04 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.267 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 67.83 100.63 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.111 0.882 . . . . 0.0 109.874 -174.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.426 ' HE3' ' HB2' ' A' ' 121' ' ' LYS . 35.7 ttmt -125.04 141.15 52.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.847 -173.049 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.54 155.73 16.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.724 0.297 . . . . 0.0 110.608 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.33 -7.7 17.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.991 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.91 106.38 0.69 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.437 0.637 . . . . 0.0 110.827 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.3 p -140.14 154.55 47.02 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.797 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -134.01 123.4 24.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.006 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.2 m -88.2 115.34 25.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.428 ' HB3' ' H ' ' A' ' 129' ' ' GLU . 9.6 mp -92.65 -162.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . 0.428 ' H ' ' HB3' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -135.37 164.66 27.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.577 179.565 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -161.13 134.74 6.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -90.63 84.82 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -120.24 137.54 54.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -168.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -160.75 154.75 22.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.838 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -133.56 94.29 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.071 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.2 t60 . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.127 176.203 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.5 mtm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.972 0.415 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.92 103.23 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -115.72 121.99 44.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.1 143.08 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 m -142.74 88.67 2.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.66 103.33 0.39 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.61 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.8 m -100.31 151.7 21.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.261 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -110.22 61.76 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.313 0.577 . . . . 0.0 110.002 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 -98.18 8.18 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.278 0.561 . . . . 0.0 109.917 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.66 158.82 31.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.05 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -92.13 9.77 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.51 137.31 34.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.2 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.87 149.92 29.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.628 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -132.87 109.6 13.02 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.506 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.406 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.5 Cg_exo -68.1 125.51 13.13 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.947 2.431 . . . . 0.0 111.161 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -67.49 -19.65 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -90.38 -13.06 35.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.349 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.406 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 18.0 t80 -78.61 134.0 37.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.86 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.93 -155.43 21.24 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.057 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.542 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.6 m -121.16 131.44 54.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.823 0.344 . . . . 0.0 110.35 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 74.0 m95 -116.26 141.41 48.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -177.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.574 ' HA ' HG22 ' A' ' 37' ' ' THR . 4.1 t70 -106.11 133.49 50.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.052 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.636 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 51.5 mt-10 -94.87 71.46 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.652 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.21 41.6 3.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.832 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -167.32 147.79 5.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 74.74 144.71 0.11 Allowed Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.163 0.914 . . . . 0.0 111.464 -178.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 6.2 Cg_exo -79.77 160.81 24.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.122 2.548 . . . . 0.0 112.986 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.95 8.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -38.35 128.11 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 124.261 3.308 . . . . 0.0 113.602 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -64.65 -13.24 53.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.96 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.12 -33.75 76.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.16 -10.0 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.852 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -81.71 132.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -94.87 -25.76 16.46 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.818 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.636 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 4.4 m 175.67 -178.95 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.23 0.956 . . . . 0.0 108.679 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.95 167.42 18.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.995 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.574 HG22 ' HA ' ' A' ' 22' ' ' ASP . 15.9 p -117.89 137.23 52.94 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . 0.668 HG11 ' HE1' ' A' ' 109' ' ' MET . 10.6 p -112.09 124.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.377 0.608 . . . . 0.0 111.098 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.408 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 82.1 m -106.31 125.85 51.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.722 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.52 118.77 37.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 110.813 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.421 HG23 ' H ' ' A' ' 42' ' ' GLU . 1.2 m -89.72 179.84 5.92 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.421 ' H ' HG23 ' A' ' 41' ' ' THR . 0.3 OUTLIER -47.37 -46.65 25.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.642 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -148.42 27.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.362 0.601 . . . . 0.0 110.539 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.82 159.53 41.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.347 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.471 HG21 ' CD1' ' A' ' 64' ' ' TYR . 92.3 t -117.82 129.87 73.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.447 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.408 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 97.2 t -111.38 123.93 67.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -100.61 137.28 39.23 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.277 0.56 . . . . 0.0 111.514 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.468 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -123.27 117.4 25.19 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.214 172.117 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.57 133.44 43.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.522 HG21 ' HG2' ' A' ' 56' ' ' GLU . 36.0 t -96.6 113.51 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.871 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 ttt -133.78 141.77 47.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.694 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.43 132.64 48.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.187 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.3 -14.61 61.97 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.281 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.41 -56.71 2.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 110.191 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.07 -143.52 15.74 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.358 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.522 ' HG2' HG21 ' A' ' 50' ' ' VAL . 50.9 mt-10 -96.33 115.61 27.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.46 0.648 . . . . 0.0 110.43 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.5 t -104.57 126.89 59.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.289 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.448 ' HG2' HG21 ' A' ' 48' ' ' THR . 34.4 mt-30 -83.76 130.54 34.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.851 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.537 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 93.9 mt -93.73 160.15 33.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.757 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.537 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.7 Cg_endo -61.91 121.82 10.06 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.539 2.159 . . . . 0.0 111.545 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -45.9 128.79 9.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.216 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.5 mmm -110.48 129.67 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.518 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.33 148.51 29.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.746 0.307 . . . . 0.0 110.674 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.471 ' CD1' HG21 ' A' ' 45' ' ' VAL . 28.7 p90 -144.28 164.91 29.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.72 ' HZ3' ' HB2' ' A' ' 65' ' ' LYS . 0.1 OUTLIER -123.05 155.63 36.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 109.992 178.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.6 t -101.72 112.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.734 179.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.55 HD12 ' HB2' ' A' ' 78' ' ' GLN . 12.0 mt -73.83 -51.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.431 0.634 . . . . 0.0 109.629 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.08 146.26 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.48 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -149.07 136.88 20.52 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.264 0.554 . . . . 0.0 110.894 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t -107.38 149.08 28.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.557 171.708 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -61.35 -32.96 72.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.281 0.562 . . . . 0.0 109.678 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -157.51 91.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.802 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.81 -94.61 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.231 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.435 ' OG ' ' HG2' ' A' ' 91' ' ' LYS . 65.4 m -136.66 157.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -110.07 118.84 37.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 33.8 pt -126.29 158.14 36.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.779 -174.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.55 ' HB2' HD12 ' A' ' 67' ' ' ILE . 45.8 tt0 -135.99 127.81 29.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.429 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.68 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 67.3 m-85 -85.17 129.34 34.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 84' ' ' TYR . 69.7 mt -86.53 162.22 18.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.921 0.391 . . . . 0.0 110.576 -176.074 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.4 -152.21 17.4 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.426 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.57 -18.71 65.05 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.803 2.335 . . . . 0.0 112.485 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -111.41 31.63 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.489 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.68 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 2.5 p90 -90.62 -1.14 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -169.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 94.6 Cg_endo -92.01 -3.49 4.01 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 CA-C-N 121.719 1.65 . . . . 0.0 112.764 166.665 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.79 134.27 50.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.197 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -113.72 174.27 6.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.24 0.543 . . . . 0.0 112.104 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -143.7 165.89 26.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.507 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -134.14 142.87 47.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 111.267 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.56 135.17 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.83 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.554 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 66.0 mttm -132.41 162.6 30.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.763 0.316 . . . . 0.0 110.324 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 92' ' ' ARG . 15.8 ptt-85 -84.67 144.92 28.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.31 152.46 20.65 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.09 -10.85 60.23 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.69 77.48 1.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.727 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.39 48.09 21.74 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.886 0.741 . . . . 0.0 113.535 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.5 169.77 16.98 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.748 -0.266 . . . . 0.0 110.942 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -124.07 135.26 53.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 82.1 mt -102.78 117.34 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.79 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 13.0 t90 -109.9 113.73 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 -177.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -108.97 134.88 51.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.349 0.595 . . . . 0.0 111.078 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 14.3 tm0? -150.55 119.0 6.43 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.222 179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 68.38 -68.12 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.067 0.854 . . . . 0.0 112.018 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.04 1.65 0.07 OUTLIER Glycine 0 C--N 1.316 -0.58 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.822 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -113.42 135.42 53.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.724 0.762 . . . . 0.0 110.355 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -102.46 115.57 30.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.374 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 21.5 mmtp -94.89 136.59 35.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.041 0.448 . . . . 0.0 110.858 177.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 m -109.12 113.69 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.668 ' HE1' HG11 ' A' ' 38' ' ' VAL . 64.3 mtp -110.76 144.92 38.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.494 -174.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -95.33 153.36 17.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.203 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -90.13 142.63 27.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.572 HD13 ' HB2' ' A' ' 22' ' ' ASP . 22.7 mm -92.99 148.98 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.173 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -93.73 95.1 8.94 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.544 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.8 m -145.87 115.64 7.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.92 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -85.5 24.5 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.57 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -104.98 147.31 27.93 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.43 170.2 40.23 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.445 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 36.4 ttp-105 64.91 19.6 11.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.997 0.903 . . . . 0.0 110.046 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -91.24 104.66 17.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.97 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.87 135.74 35.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.799 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -148.46 94.36 2.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.269 0.557 . . . . 0.0 110.045 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.67 124.32 38.63 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.779 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.31 80.06 1.51 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.156 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 13.7 ptpt -75.88 84.24 2.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.059 -176.891 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.8 p -78.18 177.04 8.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.39 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -137.32 38.74 2.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.775 0.798 . . . . 0.0 109.878 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.3 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 pp -109.15 30.75 6.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -80.19 116.8 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.719 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -150.29 140.23 21.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.778 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -132.29 164.59 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.736 0.303 . . . . 0.0 110.484 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -94.04 139.79 30.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -132.93 111.92 11.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.336 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -76.39 165.37 24.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.302 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.5 p80 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.848 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.426 ' O ' HG13 ' A' ' 2' ' ' ILE . 35.0 pt -83.0 110.22 17.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.731 0.777 . . . . 0.0 112.315 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.0 mtt -133.71 -49.37 0.83 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.099 169.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 t 52.55 58.2 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.757 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -83.89 71.45 10.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.4 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.19 123.02 16.77 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.08 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.0 m -60.84 -54.12 49.06 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.563 0.214 . . . . 0.0 110.498 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 70.02 132.92 0.03 OUTLIER 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.89 0.744 . . . . 0.0 111.684 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.84 96.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.099 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.468 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 22.1 tp60 -105.04 -64.88 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 10' ' ' GLN . 47.6 mttp -155.8 109.29 2.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.408 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.71 29.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.267 -168.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.32 97.98 2.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.028 0.442 . . . . 0.0 110.363 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.426 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.9 t -168.33 138.58 2.08 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.175 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.6 Cg_exo -74.91 84.35 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.503 2.135 . . . . 0.0 111.486 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.561 ' HE1' ' HA ' ' A' ' 71' ' ' THR . 44.2 p90 -65.36 -24.39 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.54 -176.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -82.35 -19.52 39.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -80.09 138.57 36.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.983 0.421 . . . . 0.0 110.764 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.54 -153.42 20.43 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.133 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -119.68 128.43 53.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.451 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 63.0 m95 -121.67 139.69 53.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.638 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.542 ' HB2' HD11 ' A' ' 112' ' ' ILE . 9.9 t0 -107.94 135.6 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.472 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 55.7 mt-10 -54.12 -45.5 71.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.87 22.03 25.48 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.848 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -170.89 149.72 3.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 69.39 144.76 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.75 0.657 . . . . 0.0 111.479 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.7 Cg_exo -78.44 151.16 25.69 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.908 2.405 . . . . 0.0 112.582 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.45 -166.63 25.53 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.571 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.6 150.62 1.4 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.224 3.283 . . . . 0.0 113.949 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -72.31 -7.71 50.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.41 -12.41 51.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.962 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.84 41.98 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.866 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 t -105.12 133.28 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.58 -30.31 20.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.392 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.472 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 22.7 p -176.37 174.43 1.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.437 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.04 157.73 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.493 0.663 . . . . 0.0 111.0 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.53 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 1.5 p -117.39 129.51 55.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.662 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -112.54 129.41 68.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.225 0.536 . . . . 0.0 109.904 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 m -114.14 130.07 56.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.172 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.26 116.2 32.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.542 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -103.23 -178.28 3.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -47.96 -51.19 24.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -138.01 10.63 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.544 0.212 . . . . 0.0 111.389 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.542 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -138.76 149.1 44.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 111.785 -177.014 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.557 HG23 ' CD1' ' A' ' 64' ' ' TYR . 78.4 t -111.71 124.96 68.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.26 124.37 64.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.13 134.21 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.53 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 1.7 m -124.9 135.38 52.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.078 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.0 127.96 47.26 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.484 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -97.02 112.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.268 0.556 . . . . 0.0 110.702 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -119.21 107.18 13.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.905 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.96 117.1 5.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.77 -36.01 3.62 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -99.52 -62.3 1.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.697 0.76 . . . . 0.0 109.547 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 -164.42 24.21 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.052 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.484 ' HG3' HG22 ' A' ' 50' ' ' VAL . 11.2 mp0 -80.16 127.01 31.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 117.637 0.719 . . . . 0.0 110.177 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.54 121.54 63.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.604 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -80.36 130.52 35.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 111.622 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.411 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.7 mt -91.76 163.89 26.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.714 174.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 73.6 Cg_exo -49.37 125.22 13.29 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.712 2.275 . . . . 0.0 112.114 176.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.74 137.57 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtm -108.09 121.99 45.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.33 148.15 41.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.557 ' CD1' HG23 ' A' ' 45' ' ' VAL . 9.9 p90 -146.85 151.43 37.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.33 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 158.94 29.79 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.69 112.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.565 HD11 ' HB2' ' A' ' 78' ' ' GLN . 20.1 mt -76.83 -54.08 13.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.52 151.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.584 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -155.27 111.56 3.18 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.98 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.561 ' HA ' ' HE1' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -69.92 -11.0 60.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.105 174.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.24 -56.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.633 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.4 -47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.993 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 26.8 t -161.25 155.56 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.614 0.721 . . . . 0.0 112.721 -169.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.3 mt -126.21 137.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.342 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.528 ' HG2' HD13 ' A' ' 67' ' ' ILE . 37.7 tt0 -117.45 124.59 49.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 pt -129.98 157.47 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.402 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.755 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 32.9 tt0 -131.65 135.53 46.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.618 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -82.89 3.58 29.19 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -169.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.7 mt 52.29 -162.52 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.607 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.42 -151.86 42.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.816 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.22 -8.7 23.64 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.687 2.258 . . . . 0.0 111.579 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.88 15.24 22.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.447 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.575 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.1 OUTLIER -65.7 178.07 0.62 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.755 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 11.2 Cg_exo 10.91 -1.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.274 1 C-N-CA 126.985 5.124 . . . . 0.0 120.263 -142.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.575 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.7 tp -78.12 103.83 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.688 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -103.9 172.08 7.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.379 0.609 . . . . 0.0 111.814 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 t -132.39 148.33 52.41 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.084 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.519 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.3 m -123.92 143.63 50.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.561 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.429 ' HA ' ' O ' ' A' ' 99' ' ' ILE . 85.8 mt -128.0 123.93 35.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.117 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 30.3 mtmm -123.67 160.32 27.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.709 0.29 . . . . 0.0 110.505 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -80.36 144.71 32.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.469 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -99.21 -175.53 31.64 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.465 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.482 ' HG2' ' ND2' ' A' ' 95' ' ' ASN . 0.0 OUTLIER -91.43 -30.15 16.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.972 0.415 . . . . 0.0 111.935 -171.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . 0.482 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 48.5 m-80 -102.59 25.76 8.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.637 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.93 37.65 50.1 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.613 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.469 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 15.9 p -105.17 174.58 5.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.901 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.42 HD11 ' HB3' ' A' ' 90' ' ' LEU . 29.8 tp -122.95 133.74 54.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.429 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 63.4 mt -96.96 110.25 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -98.34 113.21 25.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.867 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.519 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 11.9 mt-10 -110.85 132.01 54.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.73 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.434 ' NE2' ' HB2' ' A' ' 103' ' ' ASN . 23.2 tm0? -152.21 118.2 5.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.456 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.434 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 54.8 t30 63.97 24.04 13.49 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.657 0.742 . . . . 0.0 111.288 164.117 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.48 34.47 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.124 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -92.48 132.91 36.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.542 0.671 . . . . 0.0 111.346 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -103.58 116.36 32.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.919 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -127.08 117.8 23.15 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.4 m -93.16 114.15 26.58 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -112.28 159.73 18.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.116 -173.467 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -104.39 153.75 20.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.24 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -88.27 161.19 17.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.542 HD11 ' HB2' ' A' ' 22' ' ' ASP . 21.7 mm -94.86 151.86 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.049 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.83 105.08 4.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.037 0.446 . . . . 0.0 109.817 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -141.97 132.36 25.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -134.52 73.94 1.51 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.308 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.4 m -153.93 128.49 9.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.024 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.55 68.46 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -115.19 28.1 8.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.423 0.63 . . . . 0.0 109.707 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -78.25 103.43 8.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.772 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -117.24 126.74 53.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.491 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -125.16 162.38 24.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.293 0.568 . . . . 0.0 112.2 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -87.98 146.97 25.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.667 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.24 145.52 43.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.185 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.425 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.8 mtpt -114.1 88.16 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -93.42 97.3 10.47 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -83.0 129.09 35.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.181 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.5 t -152.65 113.42 4.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.5 tp -104.07 98.18 8.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.18 172.22 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.043 -167.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 68.52 96.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.034 172.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.92 129.01 38.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -116.91 132.76 56.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.027 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -122.85 100.67 7.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.477 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -96.89 142.1 29.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.303 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.232 177.578 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.708 0.29 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 64.77 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.417 -174.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 tpt -88.54 -13.92 38.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.63 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.7 t 61.89 72.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.901 0.857 . . . . 0.0 108.788 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -80.38 106.38 12.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.065 -170.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.38 150.38 18.51 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -131.3 122.39 26.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.621 0.71 . . . . 0.0 111.327 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -108.98 -167.56 1.23 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 56.5 48.57 16.47 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.51 111.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.845 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -72.81 130.46 40.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.83 127.99 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.089 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.05 161.88 35.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.467 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 23.2 m -71.93 124.7 91.26 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -177.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.98 122.25 11.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.889 2.392 . . . . 0.0 111.713 177.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -67.98 -14.91 63.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -98.99 -8.48 25.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.373 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 36.9 t80 -81.93 140.2 34.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.96 -171.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.1 -149.83 17.3 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.252 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 m -119.51 134.24 55.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.7 0.285 . . . . 0.0 110.254 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.442 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 82.3 m95 -126.08 142.64 51.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.606 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.437 ' HB2' HD12 ' A' ' 112' ' ' ILE . 1.5 t70 -96.08 120.05 35.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.54 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.548 ' HB3' ' HE1' ' A' ' 109' ' ' MET . 12.6 pt-20 -98.5 79.17 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.993 0.902 . . . . 0.0 109.795 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.83 -8.05 56.61 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.881 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.689 HH11 ' HB1' ' A' ' 26' ' ' ALA . 1.1 tmt_? -101.04 140.3 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.689 ' HB1' HH11 ' A' ' 25' ' ' ARG . . . 65.01 143.67 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.354 1.034 . . . . 0.0 111.274 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -93.04 172.62 2.02 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.546 2.164 . . . . 0.0 112.242 177.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.9 -155.13 20.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.488 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.614 ' HD2' HG22 ' A' ' 33' ' ' VAL . 10.3 Cg_endo -56.2 163.74 5.93 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.8 2.333 . . . . 0.0 112.804 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 m -74.72 2.52 9.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.566 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.84 -43.2 96.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.81 59.39 0.02 OUTLIER Glycine 0 CA--C 1.513 -0.065 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.56 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.614 HG22 ' HD2' ' A' ' 29' ' ' PRO . 8.3 t -100.24 134.61 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -177.346 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.853 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 8.7 mmpt? -81.71 -40.79 22.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -166.45 165.86 16.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.058 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.61 148.73 52.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.431 . . . . 0.0 111.266 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -133.5 131.49 39.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.155 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.85 139.56 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.925 0.393 . . . . 0.0 110.93 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.5 m -119.39 129.34 54.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.06 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -101.89 117.64 35.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.1 p -101.9 -177.35 3.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.184 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -45.03 -56.13 4.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.466 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.22 -4.13 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.719 -173.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.39 157.15 28.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.542 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.63 117.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 33.3 t -108.56 124.21 64.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.78 -177.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.76 136.48 42.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.654 0.74 . . . . 0.0 110.737 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.83 116.98 21.71 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.476 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -108.29 128.55 54.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.12 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.43 113.65 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.522 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.3 mtm -123.08 130.64 53.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.467 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.45 131.51 47.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.705 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.97 -29.44 11.24 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.284 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -122.57 -33.85 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 111.311 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.2 -151.24 19.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.564 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.09 133.45 46.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.228 0.537 . . . . 0.0 110.165 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.4 t -123.87 123.85 67.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.229 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -85.63 118.63 25.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.905 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.57 159.54 55.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 114.37 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.077 1.852 . . . . 0.0 110.62 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -69.9 146.69 51.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.534 -172.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.28 148.76 22.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.53 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.72 131.6 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -114.57 142.48 46.37 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.374 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -122.17 151.11 41.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.728 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.23 125.19 41.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.077 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.581 HD13 ' HB2' ' A' ' 78' ' ' GLN . 12.9 mt -96.26 -55.62 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -131.61 153.86 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.805 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.13 152.7 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 111.48 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.1 t -139.71 167.33 22.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -80.33 -38.8 29.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.34 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . 0.427 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 6.4 p-10 -147.96 9.57 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.408 -172.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.19 -81.11 1.47 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.318 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.514 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 5.1 p -145.52 152.01 39.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 111.677 -174.486 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -125.98 138.49 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.51 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.5 tt0 -117.54 127.38 53.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -125.66 157.08 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.581 ' HB2' HD13 ' A' ' 67' ' ' ILE . 44.1 tt0 -126.58 144.19 50.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -83.23 149.29 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.225 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -105.1 167.79 9.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.22 -152.1 21.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.23 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.04 -5.17 15.75 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.579 2.186 . . . . 0.0 111.795 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -98.6 15.58 24.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.724 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.739 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -63.0 -177.3 0.19 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.132 175.622 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.739 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 12.32 -0.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.252 1 C-N-CA 127.35 5.367 . . . . 0.0 120.561 -148.098 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.561 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.8 tp -85.31 121.26 27.78 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -120.65 168.48 11.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.386 0.612 . . . . 0.0 111.603 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.27 154.9 47.13 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.635 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.51 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 10.4 m -113.82 141.82 46.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.476 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.6 mt -124.14 124.78 43.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.287 178.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.514 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 33.3 mtmm -133.4 157.43 45.58 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.934 0.397 . . . . 0.0 110.467 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.427 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 24.1 ptt180 -66.16 147.26 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.058 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . 0.462 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -73.25 -170.23 18.38 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.159 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -86.96 -39.34 15.81 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.191 0.519 . . . . 0.0 110.013 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -148.64 102.2 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.925 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 53.82 44.92 70.8 Favored Glycine 0 C--N 1.333 0.385 0 O-C-N 123.349 0.406 . . . . 0.0 113.183 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.03 174.0 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.413 0.149 . . . . 0.0 111.149 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 tp -129.31 136.17 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.462 HG13 ' HA2' ' A' ' 93' ' ' GLY . 67.5 mt -111.55 110.59 32.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.877 0.37 . . . . 0.0 110.33 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.683 ' HE3' ' HE2' ' A' ' 109' ' ' MET . 10.0 t90 -105.14 113.07 26.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.786 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.587 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 70.2 mt-10 -96.49 130.3 43.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.423 0.63 . . . . 0.0 110.089 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.467 ' CD ' ' HB2' ' A' ' 103' ' ' ASN . 25.8 tm0? -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.684 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.467 ' HB2' ' CD ' ' A' ' 102' ' ' GLN . 5.8 t-20 67.75 9.89 7.4 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.409 0.443 . . . . 0.0 111.252 172.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.5 -10.85 53.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.255 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -108.62 143.5 37.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.854 -0.203 . . . . 0.0 110.547 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.587 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 24.6 ptt180 -99.4 126.26 45.26 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 1.5 mptm? -88.66 126.52 35.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.529 177.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 m -94.78 113.76 25.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.683 ' HE2' ' HE3' ' A' ' 100' ' ' TRP . 59.9 mtt -114.62 142.33 46.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 112.273 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.02 151.01 19.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.104 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -86.09 123.99 32.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.437 HD12 ' HB2' ' A' ' 22' ' ' ASP . 37.3 mm -72.76 147.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.429 0.633 . . . . 0.0 111.518 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -127.67 138.72 52.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.656 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.3 m 59.99 41.85 16.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.091 0.472 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -68.7 130.77 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.2 m -68.08 129.95 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -128.0 151.77 18.8 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.23 87.03 7.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 110.893 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . 0.429 ' HG2' ' H ' ' A' ' 120' ' ' GLU . 10.2 tt0 64.76 -169.55 0.2 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.028 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.429 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 42.2 mt-10 67.92 101.46 0.05 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.363 0.601 . . . . 0.0 111.398 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -165.9 171.03 13.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.234 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.75 144.91 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.27 -63.96 1.01 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.383 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' HB3' ' HZ2' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -157.65 94.36 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.545 0.688 . . . . 0.0 110.789 -177.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.0 m -87.87 52.21 2.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.559 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.62 162.01 41.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.695 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.7 t -152.71 113.83 4.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.48 99.62 11.34 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.879 0.371 . . . . 0.0 110.477 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -150.12 133.2 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.709 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -97.09 143.74 27.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 110.372 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -147.91 114.81 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -117.57 150.35 39.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -128.85 145.55 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.104 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 67.37 157.6 0.13 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.871 0.732 . . . . 0.0 111.103 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.836 172.368 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -97.42 154.15 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -130.59 129.54 42.89 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.2 p -132.13 128.5 59.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.03 0.443 . . . . 0.0 111.083 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.8 t -143.45 118.95 10.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.159 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.66 116.37 0.8 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.673 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 t -69.91 152.05 44.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.373 . . . . 0.0 110.474 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -82.43 103.95 12.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.591 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -77.24 96.06 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.945 0.403 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.16 127.43 32.32 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -85.49 112.88 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 0.0 111.244 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.2 -156.67 0.55 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.561 ' O ' ' HB ' ' A' ' 14' ' ' THR . 7.2 tt0 -143.63 -156.75 0.72 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.19 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.561 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 19.6 m 72.12 123.42 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 123.326 0.65 . . . . 0.0 112.165 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -63.44 104.17 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.985 2.457 . . . . 0.0 111.879 177.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.82 -15.17 63.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.382 -174.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -101.85 6.79 41.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.01 125.99 44.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.158 0.504 . . . . 0.0 111.072 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.21 -168.95 24.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.236 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.1 m -102.07 131.44 48.54 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.534 ' HB3' ' HB2' ' A' ' 109' ' ' MET . 62.6 m95 -116.09 137.14 52.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.816 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.9 t70 -99.79 127.01 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 112.185 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.408 ' O ' ' HB3' ' A' ' 35' ' ' SER . 44.4 mt-10 -101.64 78.04 1.8 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.997 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.11 -0.46 35.73 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.324 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.403 HH11 ' HD3' ' A' ' 25' ' ' ARG . 6.9 tpp180 -114.9 144.11 44.08 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.65 146.83 0.12 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 0.0 111.179 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.54 171.91 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.497 2.132 . . . . 0.0 112.721 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.86 -155.18 25.03 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.887 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -38.38 145.54 0.16 Allowed 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 124.28 3.32 . . . . 0.0 113.665 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.21 -5.67 14.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -171.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.75 -36.09 81.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.09 53.61 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.597 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.437 HG11 ' HB3' ' A' ' 49' ' ' GLU . 18.8 t -100.94 134.37 41.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -79.03 -39.68 33.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.408 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 38.5 m -159.77 166.17 30.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.085 -171.37 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.49 152.33 40.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.522 HG22 ' HA ' ' A' ' 22' ' ' ASP . 12.9 p -131.87 127.04 35.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.33 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.89 136.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.106 0.479 . . . . 0.0 111.233 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 m -121.77 125.64 47.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.653 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.77 116.43 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.876 0.37 . . . . 0.0 110.375 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.541 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -104.58 170.13 8.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.92 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -61.22 -45.86 92.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.877 0.37 . . . . 0.0 111.934 -176.268 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.85 -9.2 23.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.602 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 3.7 pt-20 -156.74 148.08 22.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -166.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.497 HG22 ' CD1' ' A' ' 64' ' ' TYR . 96.7 t -101.77 118.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.843 170.002 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.34 124.46 55.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.7 0.286 . . . . 0.0 110.457 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.04 136.7 37.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.608 0.718 . . . . 0.0 111.518 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.491 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 2.3 m -128.47 131.4 48.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.526 171.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.437 ' HB3' HG11 ' A' ' 33' ' ' VAL . 32.9 mt-10 -120.53 135.93 54.93 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.522 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.423 HG23 ' HG3' ' A' ' 56' ' ' GLU . 45.8 t -96.41 113.6 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -119.74 126.88 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.384 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 106.88 6.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.325 0.583 . . . . 0.0 110.477 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.05 6.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.26 -60.01 1.65 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.921 0.867 . . . . 0.0 109.747 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.04 -166.32 14.04 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.003 -172.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.423 ' HG3' HG23 ' A' ' 50' ' ' VAL . 1.6 mp0 -71.89 127.15 31.66 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.502 0.668 . . . . 0.0 111.433 174.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.0 t -118.39 122.69 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.928 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.46 ' HG2' HG23 ' A' ' 48' ' ' THR . 82.1 mt-30 -93.74 126.76 39.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.916 0.389 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.48 161.76 26.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.316 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 137.03 40.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.887 2.391 . . . . 0.0 112.059 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.602 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 44.2 p90 -72.09 152.49 42.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.8 mtp -111.87 140.45 46.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.663 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.96 28.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.502 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' CD1' HG22 ' A' ' 45' ' ' VAL . 7.7 p90 -147.28 166.52 26.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.812 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -128.19 159.3 35.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.55 126.3 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.123 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.536 HD12 ' HB2' ' A' ' 78' ' ' GLN . 12.2 mt -85.43 -51.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.1 m -145.03 161.31 39.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.462 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -148.97 132.99 17.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.08 0.466 . . . . 0.0 110.777 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.6 t -151.01 121.88 7.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 178.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -78.11 -15.74 58.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.527 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -104.27 -21.45 13.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.726 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 -67.06 0.47 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.838 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 47.3 t -177.52 157.09 1.23 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 0.0 110.993 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -116.85 132.71 65.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.212 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.479 ' HG2' HD11 ' A' ' 67' ' ' ILE . 30.0 tt0 -111.09 123.73 50.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 pt -124.96 157.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.032 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.662 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 36.1 tt0 -138.42 139.94 39.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.463 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 98.0 m-85 -88.17 153.97 20.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 0.0 110.896 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.4 mt -110.77 -176.82 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.029 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.54 -152.52 35.76 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.68 -16.91 51.59 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.396 2.064 . . . . 0.0 111.926 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -92.31 20.41 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.96 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.865 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 26.3 p90 -61.17 172.27 0.97 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.707 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.865 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 11.5 -0.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.084 1 C-N-CA 128.153 5.902 . . . . 0.0 121.065 -150.08 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.524 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.0 tp -69.22 104.21 2.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 119.556 1.071 . . . . 0.0 108.289 167.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 61.1 pttt -103.63 174.71 5.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.414 0.626 . . . . 0.0 111.94 -171.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 t -144.66 161.36 39.36 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.157 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -124.28 142.97 50.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.8 0.334 . . . . 0.0 110.578 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.48 122.72 38.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.456 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 53.4 mttp -118.83 160.58 21.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.2 0.524 . . . . 0.0 111.188 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -70.61 143.0 51.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.57 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.9 143.77 22.45 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.888 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.82 -44.5 73.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.908 -0.646 . . . . 0.0 111.172 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.51 81.34 2.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.81 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 55.3 55.1 30.06 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.711 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.52 175.24 10.09 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.832 -0.216 . . . . 0.0 111.112 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.57 135.26 54.52 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.553 HG21 ' HG3' ' A' ' 106' ' ' ARG . 82.7 mt -104.9 111.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.245 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.439 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 15.7 t90 -97.87 112.77 24.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.811 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 28.8 mt-10 -102.12 131.66 48.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.483 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -151.64 123.58 8.09 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.701 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.28 19.77 10.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.314 0.384 . . . . 0.0 111.827 173.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.07 -21.86 34.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.533 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.483 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 10.6 pt20 -92.61 145.65 24.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.013 0.406 . . . . 0.0 110.947 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.553 ' HG3' HG21 ' A' ' 99' ' ' ILE . 15.6 ttm180 -94.04 117.98 30.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.452 ' HD3' ' HA ' ' A' ' 107' ' ' LYS . 28.1 mmtm -95.04 117.99 31.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.096 0.475 . . . . 0.0 109.809 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -100.13 114.59 28.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.615 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.534 ' HB2' ' HB3' ' A' ' 21' ' ' TRP . 12.3 ptp -127.65 137.92 52.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.338 0.589 . . . . 0.0 111.729 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -101.05 146.43 27.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.582 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -80.52 127.73 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.158 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.547 HD11 ' HB2' ' A' ' 22' ' ' ASP . 31.4 mm -73.57 145.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.535 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -121.32 111.71 17.68 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.3 m -91.91 93.14 8.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.136 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.23 19.61 19.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.231 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 t -139.66 152.26 46.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.562 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.04 -67.18 0.34 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 56.96 84.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.721 0.772 . . . . 0.0 111.448 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -92.43 133.14 36.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.366 177.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -96.86 157.02 16.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.98 -177.48 4.51 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 9.2 t70 -91.02 149.28 21.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.9 102.98 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 122' ' ' ASP . 66.8 mmtt -120.16 124.89 46.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.527 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.5 t -130.36 150.7 51.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.666 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.03 107.18 10.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 110.768 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.0 t -113.45 103.85 11.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.875 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -106.18 99.99 9.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.364 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.13 157.72 22.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -102.18 115.26 30.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -67.94 123.62 21.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.263 0.554 . . . . 0.0 111.763 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -125.15 114.66 19.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.323 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -134.03 128.82 35.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.249 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -83.62 138.02 33.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.361 177.089 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.255 0.55 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.44 118.1 48.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.868 0.366 . . . . 0.0 110.528 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.73 124.61 43.68 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.3 t -85.01 -72.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.866 0.365 . . . . 0.0 111.245 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.6 p -136.86 111.58 8.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.1 76.04 2.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.916 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.0 m -76.95 103.16 6.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -109.01 134.89 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.14 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -101.27 116.12 32.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . 0.913 ' HB2' HG22 ' A' ' 71' ' ' THR . 75.9 mm-40 -116.52 -74.68 0.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.044 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.44 ' HE3' ' HB2' ' A' ' 11' ' ' LYS . 33.4 ttmt -169.75 163.88 9.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -60.91 114.8 3.27 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -105.81 166.98 10.09 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 10.1 t -55.03 120.63 30.64 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.247 0.546 . . . . 0.0 111.355 -178.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.463 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 37.9 Cg_exo -62.9 103.91 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.864 2.376 . . . . 0.0 111.949 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.78 -10.98 60.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.284 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.463 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 44.5 p90 -89.57 -6.62 56.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -71.35 138.99 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.136 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.42 -163.5 21.18 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.033 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.6 m -115.23 122.64 46.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.022 0.439 . . . . 0.0 110.432 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.436 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 50.1 m95 -116.3 133.64 55.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.139 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.571 ' CB ' HD13 ' A' ' 112' ' ' ILE . 11.7 t70 -109.68 132.43 54.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.952 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.553 ' HG2' ' HG2' ' A' ' 109' ' ' MET . 6.2 mm-40 -74.04 -58.15 3.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.603 173.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.94 32.16 55.9 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . 0.465 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 9.0 ttm180 -158.08 167.68 29.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -167.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.468 ' HB3' ' NZ ' ' A' ' 107' ' ' LYS . . . 67.43 165.36 0.12 Allowed Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.928 0.768 . . . . 0.0 112.211 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 134.5 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.355 2.037 . . . . 0.0 111.356 171.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 -166.31 21.28 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.977 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -48.62 125.15 12.07 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.067 2.511 . . . . 0.0 111.868 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -80.1 -1.44 40.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.26 -33.92 74.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.559 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 146.57 37.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.977 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.63 138.91 28.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.408 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 29.3 mtpp -86.58 -28.09 23.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.994 0.425 . . . . 0.0 111.108 -176.15 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 p -177.31 167.47 2.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.981 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.43 144.23 49.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -117.87 133.58 55.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.111 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.03 136.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 111.161 -175.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.6 m -123.02 130.94 53.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.555 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -100.61 120.61 40.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.097 0.475 . . . . 0.0 110.317 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.442 HG21 ' H ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -95.7 179.1 5.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.374 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.442 ' H ' HG21 ' A' ' 41' ' ' THR . 29.6 mt-10 -51.53 -38.68 55.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.306 0.642 . . . . 0.0 111.801 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -151.37 19.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 111.447 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -131.1 147.73 52.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG22 ' CD1' ' A' ' 64' ' ' TYR . 66.5 t -101.84 118.51 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.459 HG22 ' CD1' ' A' ' 61' ' ' PHE . 70.6 t -108.21 124.42 64.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.34 137.5 52.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.342 0.591 . . . . 0.0 110.453 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.459 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.26 138.1 51.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.141 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -97.98 125.4 42.9 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.506 HG23 ' HG2' ' A' ' 56' ' ' GLU . 48.6 t -90.11 110.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.488 ' SD ' ' HG3' ' A' ' 54' ' ' ARG . 43.0 ttm -112.07 135.21 53.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.151 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.408 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 28.4 tt0 -63.77 113.35 3.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.934 -175.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.57 -18.4 56.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.752 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.488 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 9.6 mmt180 -101.36 -74.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.816 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.41 -156.1 26.64 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.506 ' HG2' HG23 ' A' ' 50' ' ' VAL . 44.8 mt-10 -92.92 120.69 33.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.415 0.626 . . . . 0.0 111.179 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -112.57 128.12 69.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.892 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.459 ' HG2' HG23 ' A' ' 48' ' ' THR . 79.8 mt-30 -80.07 131.55 35.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.143 0.497 . . . . 0.0 111.601 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -87.86 163.7 36.98 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.494 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.25 123.58 12.27 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.648 2.232 . . . . 0.0 111.749 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.459 ' CD1' HG22 ' A' ' 46' ' ' VAL . 17.8 m-85 -68.42 142.15 55.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.143 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.4 mtm -109.86 123.74 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.801 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.57 140.09 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.416 ' CD1' HG22 ' A' ' 45' ' ' VAL . 42.1 p90 -132.82 170.9 14.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.885 0.374 . . . . 0.0 110.63 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.485 ' HD2' HD23 ' A' ' 80' ' ' LEU . 10.0 ptmm? -144.1 143.0 30.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.66 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -83.33 124.3 39.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.727 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.611 HD12 ' HB2' ' A' ' 78' ' ' GLN . 11.5 mt -85.62 -54.41 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.595 0.712 . . . . 0.0 109.661 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 m -139.56 163.44 32.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.818 -174.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -144.51 149.27 35.65 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.5 t -125.33 121.02 32.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.6 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.913 HG22 ' HB2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -69.89 -6.39 32.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 111.366 177.139 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.89 -48.17 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.558 ' HA3' ' HD3' ' A' ' 92' ' ' ARG . . . 146.33 46.49 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.64 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.6 m -147.27 151.97 37.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.224 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.49 138.44 48.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.231 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -110.46 126.8 54.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.934 0.397 . . . . 0.0 109.973 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.76 157.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.454 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.611 ' HB2' HD12 ' A' ' 67' ' ' ILE . 34.7 tt0 -132.34 144.85 50.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.614 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -92.86 156.98 16.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.02 0.438 . . . . 0.0 110.76 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.485 HD23 ' HD2' ' A' ' 65' ' ' LYS . 83.1 mt -112.08 -177.08 3.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.415 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.85 -151.93 41.65 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.238 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.86 -5.27 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.551 2.168 . . . . 0.0 112.154 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -102.75 20.54 17.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.142 0.496 . . . . 0.0 109.805 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.951 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.1 p90 -58.47 170.81 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.298 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.951 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 1.2 Cg_exo 9.34 0.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.162 1 C-N-CA 128.711 6.274 . . . . 0.0 121.659 -152.699 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.468 ' H ' ' C ' ' A' ' 84' ' ' TYR . 66.8 tp -66.57 109.81 2.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 119.986 1.266 . . . . 0.0 109.062 170.082 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.96 166.77 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 111.874 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 t -140.22 156.2 46.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.527 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -112.72 141.3 46.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.134 0.492 . . . . 0.0 110.89 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.93 126.75 49.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.805 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.536 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 94.0 mttt -124.95 154.96 40.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.945 0.402 . . . . 0.0 110.257 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.558 ' HD3' ' HA3' ' A' ' 73' ' ' GLY . 36.4 ptt-85 -79.42 144.26 34.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.051 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.7 26.54 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.14 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.12 134.36 38.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.021 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 71.89 -66.14 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.639 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.29 59.59 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.47 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 p -134.74 170.07 16.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.122 0.169 . . . . 0.0 110.581 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.3 tp -129.53 135.42 48.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.604 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.536 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 75.2 mt -105.65 126.26 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.486 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 17.7 t90 -117.3 115.75 25.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.079 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -110.99 134.87 52.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 111.432 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.68 121.35 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.937 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.85 9.74 5.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.635 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.95 -8.05 29.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.716 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.05 134.65 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -102.02 116.13 32.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.104 0.478 . . . . 0.0 111.237 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.542 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 2.0 mmpt? -98.55 139.49 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.547 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.9 m -121.74 112.24 18.15 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.553 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 52.2 mtm -116.8 141.4 48.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -173.507 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -98.63 151.77 20.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.539 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.436 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 57.1 ttp85 -83.5 127.4 33.69 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.571 HD13 ' CB ' ' A' ' 22' ' ' ASP . 30.0 mm -85.4 144.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.47 0.652 . . . . 0.0 110.598 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -131.27 110.66 11.26 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.605 -1.18 . . . . 0.0 107.898 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.9 p -114.02 122.42 46.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.654 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.55 36.44 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.965 0.888 . . . . 0.0 108.953 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.1 t -156.64 160.46 39.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.091 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.97 91.7 0.19 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.556 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.821 HH11 ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -119.45 109.2 15.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.83 99.56 0.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.821 ' HG2' HH11 ' A' ' 118' ' ' ARG . 37.4 mt-10 -103.3 94.12 5.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.079 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -87.59 133.65 33.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -172.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -113.18 141.67 46.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.468 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.08 103.63 14.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.11 0.481 . . . . 0.0 110.517 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -125.58 124.26 40.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.132 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.5 t -102.5 141.05 35.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.949 0.404 . . . . 0.0 110.842 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -101.02 85.93 2.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.0 m -91.18 75.65 6.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.081 0.467 . . . . 0.0 111.606 -173.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.1 134.09 29.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.729 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.8 136.08 34.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.309 0.576 . . . . 0.0 111.605 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -90.98 120.99 32.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.323 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -109.15 135.53 50.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.81 0.338 . . . . 0.0 110.37 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -68.88 103.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.956 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -116.32 97.12 5.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.435 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 170.37 -82.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.02 0.825 . . . . 0.0 109.566 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.337 178.204 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.483 0.183 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 mp -110.81 109.02 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 110.029 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.7 mtp -104.74 104.57 14.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.83 135.68 45.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.9 m -144.33 117.29 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.318 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.8 106.41 1.91 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.537 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.7 m -128.62 145.39 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.681 -0.305 . . . . 0.0 110.837 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.14 81.83 8.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -88.91 -39.33 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 5.1 tp60 -141.38 131.22 24.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.793 0.33 . . . . 0.0 110.563 -178.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -89.5 -33.31 16.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -75.5 127.01 32.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.924 -174.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.77 -171.55 3.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.887 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 9.0 t -82.46 140.17 44.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -177.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -61.42 109.37 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 178.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -68.45 -18.99 64.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.194 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -95.02 -10.18 31.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.795 0.331 . . . . 0.0 111.305 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -80.64 130.29 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 0.0 110.969 -172.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.86 -164.24 25.51 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.263 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -105.39 130.69 53.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.441 ' CH2' ' HB2' ' A' ' 98' ' ' LEU . 71.7 m95 -119.54 144.56 46.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.262 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.569 ' HB2' HD12 ' A' ' 112' ' ' ILE . 15.7 t70 -96.76 141.37 30.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.428 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 6.1 mm-40 -48.14 -49.97 30.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.12 -54.52 3.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.637 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -135.95 164.19 28.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.32 161.45 0.16 Allowed Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 124.039 0.837 . . . . 0.0 111.395 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.29 175.4 9.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.628 2.218 . . . . 0.0 112.154 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.21 -153.69 7.64 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.399 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.757 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 4.5 Cg_endo -47.68 148.62 5.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 124.355 3.37 . . . . 0.0 113.433 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.3 p -81.26 -2.17 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.923 -172.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.72 -1.04 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.251 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.62 35.23 29.36 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.897 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.757 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 24.6 t -76.4 133.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.748 ' HE3' ' HB3' ' A' ' 52' ' ' GLU . 49.5 mtmt -91.47 -13.58 31.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.788 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 18.5 m -148.7 157.51 43.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.877 0.37 . . . . 0.0 110.609 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.428 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -159.79 145.87 15.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.084 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 139.53 44.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.092 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.31 133.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 110.121 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -121.26 124.57 44.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.839 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -101.97 117.81 35.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.123 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.498 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -102.33 179.43 4.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.327 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.425 ' H ' HG23 ' A' ' 41' ' ' THR . 33.1 mt-10 -54.93 -42.92 72.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -128.21 -16.25 4.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.921 0.391 . . . . 0.0 111.808 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 6.9 pt-20 -125.76 142.17 51.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.166 0.508 . . . . 0.0 111.803 -173.494 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.61 125.56 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . 0.463 HG21 ' HB3' ' A' ' 61' ' ' PHE . 66.9 t -115.92 123.82 71.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 137.92 34.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 110.736 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.526 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -125.63 118.85 26.57 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.647 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -105.63 125.61 51.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.198 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.788 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 42.5 t -98.86 111.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.258 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -99.48 109.11 21.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.748 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 41.5 tt0 -65.39 106.63 1.43 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.045 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.95 -29.68 2.19 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.116 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.469 ' HG3' ' N ' ' A' ' 55' ' ' GLY . 17.0 ptp180 -125.01 -51.77 1.67 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.515 0.197 . . . . 0.0 111.04 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.469 ' N ' ' HG3' ' A' ' 54' ' ' ARG . . . 142.45 -156.36 26.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.017 -176.01 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -79.8 146.34 32.33 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 111.818 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.21 122.05 59.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.412 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.526 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.0 mt-30 -95.68 131.5 41.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.806 0.336 . . . . 0.0 111.052 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.17 157.25 39.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.245 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.02 118.61 4.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.815 2.343 . . . . 0.0 111.577 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.463 ' HB3' HG21 ' A' ' 46' ' ' VAL . 52.6 p90 -60.44 145.35 48.55 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.214 0.53 . . . . 0.0 111.481 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.11 125.83 50.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.809 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.7 136.42 34.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -127.12 161.11 29.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.723 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -122.18 144.46 48.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.3 t -89.4 114.02 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.828 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.552 HD13 ' HB2' ' A' ' 78' ' ' GLN . 10.1 mt -81.15 -56.69 5.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.741 0.781 . . . . 0.0 109.188 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -124.77 149.39 47.4 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.626 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -147.65 136.45 21.97 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.372 0.606 . . . . 0.0 111.774 -170.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 74' ' ' SER . 37.0 t -141.3 150.54 42.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.811 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -9.57 55.37 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -146.41 -27.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.73 -76.21 0.95 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.562 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 3.4 p -159.28 164.41 34.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 mt -132.92 135.53 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.43 131.72 55.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 pt -130.76 156.81 42.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.552 ' HB2' HD13 ' A' ' 67' ' ' ILE . 53.1 tt0 -124.98 131.74 53.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.658 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -85.62 152.96 22.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 111.034 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.72 -178.0 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.603 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.82 -152.27 34.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.175 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.59 -10.73 17.45 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.722 2.281 . . . . 0.0 112.589 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.59 25.96 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 1.005 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 34.9 p90 -55.24 166.51 0.86 Allowed Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.616 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 1.005 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 8.13 -0.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.031 1 C-N-CA 128.988 6.459 . . . . 0.0 121.487 -153.397 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.822 ' HG ' HE22 ' A' ' 102' ' ' GLN . 35.4 tp -70.77 103.29 2.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 119.936 1.244 . . . . 0.0 107.928 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -98.45 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.415 0.626 . . . . 0.0 112.155 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -141.81 158.87 43.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.891 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.2 m -123.83 141.07 52.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.479 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.39 122.94 41.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.91 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 40.3 mtpt -137.96 149.45 46.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.533 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -90.2 147.08 23.78 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.16 -160.72 18.14 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.265 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.12 137.23 57.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 66.22 -157.96 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.924 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -90.5 57.18 3.47 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.561 -178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 42.1 p -121.13 148.88 43.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.441 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 20.9 tp -112.01 132.73 54.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -97.69 113.35 31.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -96.64 114.25 25.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.834 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' CG ' ' HB3' ' A' ' 106' ' ' ARG . 26.2 mt-10 -105.89 133.32 50.79 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.621 0.724 . . . . 0.0 110.405 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.822 HE22 ' HG ' ' A' ' 86' ' ' LEU . 5.7 tm0? -150.55 133.21 15.78 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.775 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.99 -43.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.794 0.684 . . . . 0.0 111.38 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.439 ' H ' ' C ' ' A' ' 102' ' ' GLN . . . 164.26 -19.3 0.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.22 -179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -103.0 141.19 36.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.817 0.342 . . . . 0.0 110.99 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . 0.406 ' HB3' ' CG ' ' A' ' 101' ' ' GLU . 15.3 ptp180 -101.33 138.51 38.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.496 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 17.0 mmtm -127.15 133.94 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.273 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 t -94.91 128.75 41.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.113 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.431 ' HE2' HD21 ' A' ' 98' ' ' LEU . 22.1 ptt? -123.6 149.05 45.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.332 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.81 150.07 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.512 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.8 ptt180 -85.03 154.81 21.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 -177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.569 HD12 ' HB2' ' A' ' 22' ' ' ASP . 16.9 mm -96.86 150.57 4.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.37 83.42 7.34 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.0 m -83.04 133.29 35.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.468 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.26 88.99 3.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.343 0.592 . . . . 0.0 110.015 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.1 m -151.98 135.67 16.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.396 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.33 -38.11 0.78 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.675 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.584 ' O ' ' HD2' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -93.48 93.08 7.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.613 0.72 . . . . 0.0 109.743 177.336 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -146.52 120.69 9.5 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.026 -0.421 . . . . 0.0 112.045 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 72.1 149.33 0.09 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.138 0.899 . . . . 0.0 113.034 165.015 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -132.34 139.64 48.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.035 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -121.21 134.2 55.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.67 11.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.436 0.636 . . . . 0.0 111.364 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -116.41 111.1 19.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.15 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.0 p -146.22 134.02 21.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.36 . . . . 0.0 111.581 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -144.61 131.78 20.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.463 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.4 p -145.12 105.97 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.508 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.1 tp -168.41 125.1 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.243 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.84 179.32 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -147.12 154.48 41.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.621 0.248 . . . . 0.0 111.258 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -130.3 140.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.536 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.11 111.61 5.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.639 0.733 . . . . 0.0 110.718 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -85.09 123.58 30.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.62 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -70.41 120.02 15.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.994 0.426 . . . . 0.0 110.311 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.807 179.516 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.662 0.268 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.74 148.45 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.3 mtp -77.44 93.02 4.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.021 0.439 . . . . 0.0 110.848 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.69 111.8 37.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.618 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 m -81.31 106.71 13.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.539 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.89 167.87 32.25 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m -80.68 87.92 5.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -131.96 117.24 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.421 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.64 128.31 16.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.701 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -85.0 111.15 19.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.148 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.15 -78.18 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.741 0.651 . . . . 0.0 111.261 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -172.1 143.44 1.53 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -104.62 -170.19 1.73 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.205 0.526 . . . . 0.0 111.22 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t -86.86 151.81 52.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.281 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.639 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 47.4 Cg_exo -56.53 117.05 3.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.606 2.204 . . . . 0.0 112.152 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -63.78 -28.49 69.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.729 0.3 . . . . 0.0 111.52 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.407 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 12.2 p90 -85.27 -1.28 56.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.837 0.351 . . . . 0.0 111.313 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.639 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 55.3 t80 -75.49 125.64 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 109.999 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.98 -158.11 22.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.314 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 m -110.34 132.48 54.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.639 0.257 . . . . 0.0 110.8 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.564 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 61.5 m95 -123.15 137.8 54.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.552 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.551 ' HB2' HD13 ' A' ' 112' ' ' ILE . 17.0 t70 -103.73 128.16 51.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.52 ' HG2' ' HE3' ' A' ' 109' ' ' MET . 60.3 mt-10 -95.25 75.84 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.296 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 39.72 2.33 Favored Glycine 0 C--N 1.317 -0.478 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.624 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -164.52 160.69 20.65 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 73.19 144.59 0.11 Allowed Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 124.022 0.826 . . . . 0.0 111.079 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 16.7 Cg_exo -67.45 140.66 53.2 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.836 2.357 . . . . 0.0 112.451 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.12 -167.84 43.02 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.432 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 32.9 Cg_exo -53.41 163.55 2.49 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.612 2.875 . . . . 0.0 113.376 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -71.37 -25.07 62.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.405 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.18 13.47 0.31 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.4 28.04 13.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 22.1 t -89.05 134.39 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -68.55 -44.31 74.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.542 0.686 . . . . 0.0 110.183 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.6 p -175.74 175.11 2.09 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.148 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.35 154.08 38.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.308 0.575 . . . . 0.0 111.332 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.542 HG22 ' HA ' ' A' ' 22' ' ' ASP . 23.0 p -119.34 142.21 48.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.146 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.26 131.63 63.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.365 0.602 . . . . 0.0 110.615 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.2 m -116.71 120.03 37.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.127 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -101.4 117.01 34.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -101.72 -177.8 3.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -54.42 -45.37 72.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -126.58 -13.56 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -126.16 154.81 42.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 111.731 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.477 HG22 ' CD1' ' A' ' 64' ' ' TYR . 96.3 t -110.4 130.64 63.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.82 123.53 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.744 0.307 . . . . 0.0 110.176 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.85 137.74 34.48 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.426 0.631 . . . . 0.0 110.502 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.476 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -122.01 119.91 32.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.184 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -100.63 128.48 46.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.84 112.75 33.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.985 0.421 . . . . 0.0 109.876 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.7 ttp -116.63 138.17 51.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.72 126.1 22.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.818 0.699 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.39 -28.15 11.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.579 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HE ' ' HB3' ' A' ' 54' ' ' ARG . 9.4 mmm180 -92.81 -75.61 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.625 0.726 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.0 -145.35 16.84 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.025 -171.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.9 131.36 35.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.762 0.791 . . . . 0.0 111.261 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.32 120.64 64.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.975 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . 0.476 ' HG2' HG23 ' A' ' 48' ' ' THR . 78.7 mt-30 -92.58 126.69 37.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.81 158.46 47.65 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.495 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 132.34 28.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.92 2.414 . . . . 0.0 112.105 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -60.41 128.41 36.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.609 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -103.35 120.41 40.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.15 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.0 127.98 34.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.369 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.477 ' CD1' HG22 ' A' ' 45' ' ' VAL . 34.2 p90 -114.66 154.99 27.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.113 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.78 147.52 49.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.381 0.61 . . . . 0.0 110.331 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.8 114.67 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.679 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.521 HD12 ' HB2' ' A' ' 78' ' ' GLN . 15.8 mt -81.49 -53.96 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.5 m -133.17 153.26 51.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.301 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.64 145.27 27.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 145.7 50.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -71.86 -23.56 61.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -165.63 89.87 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.867 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.47 -84.92 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.078 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -146.89 156.09 42.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.523 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 9.1 mt -133.31 136.15 55.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.56 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.09 119.6 35.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.29 157.35 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.699 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 33.9 tt0 -130.75 144.4 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -94.68 154.91 17.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.578 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.32 -177.38 3.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.26 -153.52 29.22 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.258 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.66 -16.03 52.26 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.514 2.143 . . . . 0.0 112.122 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.88 31.18 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.224 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.906 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 52.9 p90 -59.7 173.48 0.52 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.251 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.906 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 11.65 -0.84 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.128 1 C-N-CA 128.243 5.962 . . . . 0.0 121.415 -152.267 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.503 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.6 tp -68.47 104.27 1.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 119.575 1.08 . . . . 0.0 108.24 167.463 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -105.74 173.29 6.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 111.927 -172.145 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.8 t -139.54 158.42 44.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.204 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.529 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.4 m -119.61 142.87 48.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.826 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 97.7 mt -130.72 130.77 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.846 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -144.93 164.74 30.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.895 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -98.44 154.9 17.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.857 0.36 . . . . 0.0 110.034 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.08 -153.73 29.58 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.306 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -75.73 -46.76 29.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.565 0.698 . . . . 0.0 110.104 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -97.02 -160.46 0.8 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.79 51.28 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 p -117.05 141.32 48.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.781 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.473 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 28.9 tp -102.69 135.66 43.93 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.8 108.97 22.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.639 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 16.2 t90 -107.62 111.95 24.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 -178.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.529 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 23.0 mt-10 -107.23 131.66 53.94 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.387 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -150.59 118.31 6.17 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.4 t30 69.63 -5.09 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.604 0.565 . . . . 0.0 112.229 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.13 -14.6 4.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.432 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -108.46 135.5 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.326 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -101.7 127.0 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.255 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 5.5 mtmt -117.98 124.82 49.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.665 0.269 . . . . 0.0 111.655 177.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 113.91 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.639 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 21.1 ptp -125.14 151.4 45.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.914 0.388 . . . . 0.0 110.965 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 m -100.17 156.07 17.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.143 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.564 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 41.9 ttt85 -87.45 141.42 28.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.927 0.394 . . . . 0.0 110.375 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.551 HD13 ' HB2' ' A' ' 22' ' ' ASP . 30.6 mm -72.72 147.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.41 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 pm0 -74.29 107.18 6.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 -175.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -100.12 16.54 23.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.059 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -137.55 19.48 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -175.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p -104.12 100.31 10.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.628 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.66 16.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.613 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.513 ' HD3' ' OE2' ' A' ' 120' ' ' GLU . 43.4 ttt180 -157.94 153.65 26.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -76.75 63.49 2.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 179.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . 0.513 ' OE2' ' HD3' ' A' ' 118' ' ' ARG . 74.7 mm-40 -66.99 149.33 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.349 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.99 104.74 16.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.368 0.604 . . . . 0.0 111.757 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.582 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 14.3 t70 -90.42 141.39 28.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.297 173.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.91 102.43 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.582 ' HE3' ' HB3' ' A' ' 122' ' ' ASP . 96.4 mttt -123.73 85.85 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.721 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.0 m -86.68 106.96 17.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.373 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -89.04 152.56 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -135.03 92.76 2.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.352 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.26 105.95 17.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.58 92.89 7.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.285 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.69 98.02 1.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.75 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -87.96 -42.15 12.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.435 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 68.06 104.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.198 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -70.34 134.02 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.472 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.9 121.41 42.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.621 0.248 . . . . 0.0 110.784 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.0 t60 . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 174.877 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -79.44 89.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.08 0.943 . . . . 0.0 111.198 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.765 ' HG2' HG23 ' A' ' 4' ' ' VAL . 46.1 ttm -156.91 132.94 9.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.189 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.765 HG23 ' HG2' ' A' ' 3' ' ' MET . 92.5 t 68.89 111.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 O-C-N 123.919 0.762 . . . . 0.0 112.216 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 m -87.66 -36.25 17.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.794 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.36 113.23 0.43 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.589 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.9 m -64.51 -34.57 78.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.697 0.248 . . . . 0.0 111.523 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.87 109.44 19.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 0.0 110.672 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -90.89 34.5 0.91 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.103 178.131 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -69.36 -32.76 72.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.256 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . 0.531 ' HZ1' ' HB3' ' A' ' 11' ' ' LYS . 8.6 mtpm? -103.02 118.78 37.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.201 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.88 88.5 2.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.803 0.335 . . . . 0.0 110.564 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -107.24 -1.0 22.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.526 0.679 . . . . 0.0 111.132 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.45 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.8 t -59.56 121.66 58.8 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.546 -172.154 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.3 Cg_exo -79.15 97.87 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.073 2.515 . . . . 0.0 110.831 172.778 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -63.17 -25.7 68.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.359 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -82.95 -18.32 40.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.666 0.27 . . . . 0.0 111.678 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -74.04 136.61 43.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.677 0.275 . . . . 0.0 110.709 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.15 -158.21 22.27 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.224 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.5 m -117.82 129.03 55.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.619 0.247 . . . . 0.0 110.605 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -113.7 141.36 47.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.182 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.613 ' HB2' HD11 ' A' ' 112' ' ' ILE . 20.1 t70 -109.02 134.98 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.778 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HG2' ' HE2' ' A' ' 109' ' ' MET . 33.8 mt-10 -96.1 40.8 1.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.602 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.06 78.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.319 -0.944 . . . . 0.0 110.945 172.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -91.66 142.82 27.2 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.71 155.49 0.14 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.594 1.184 . . . . 0.0 111.401 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.48 135.13 48.0 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.384 2.056 . . . . 0.0 111.862 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.78 -154.76 22.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.436 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 171.63 5.01 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.28 2.654 . . . . 0.0 113.037 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -129.66 -6.59 4.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.462 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.94 -41.2 70.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.692 0.758 . . . . 0.0 111.681 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.677 ' HA3' ' HE2' ' A' ' 51' ' ' MET . . . 164.37 -37.01 0.3 Allowed Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -174.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.43 HG13 ' O ' ' A' ' 50' ' ' VAL . 17.8 t -67.34 134.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -111.26 -15.24 13.68 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.982 0.42 . . . . 0.0 110.786 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m -157.31 158.25 35.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.968 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.403 ' H ' ' HB2' ' A' ' 23' ' ' GLU . . . -136.12 164.73 27.37 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.193 0.521 . . . . 0.0 110.933 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.599 ' HG1' ' HB ' ' A' ' 48' ' ' THR . 20.0 p -131.06 131.29 44.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.086 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.85 129.52 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.255 0.55 . . . . 0.0 110.702 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.6 m -114.53 125.65 54.03 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -101.4 117.14 34.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 p -101.75 -178.0 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.567 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -49.36 -52.82 25.77 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.478 0.486 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -134.87 9.23 3.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.228 0.537 . . . . 0.0 110.969 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 163.9 27.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.0 111.334 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.2 t -115.88 122.28 69.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.29 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.34 122.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.32 136.92 45.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.379 0.609 . . . . 0.0 110.817 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.599 ' HB ' ' HG1' ' A' ' 37' ' ' THR . 0.6 OUTLIER -125.9 130.72 51.86 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 178.537 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' HB3' HG12 ' A' ' 33' ' ' VAL . 43.3 mt-10 -110.33 136.53 49.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.246 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.43 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.5 t -94.34 111.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.677 ' HE2' ' HA3' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -116.7 115.39 25.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.871 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.44 113.89 7.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.606 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.12 -20.83 11.26 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -111.65 -61.06 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.815 0.817 . . . . 0.0 110.021 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.36 -158.83 22.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.287 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.24 131.08 36.96 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.376 0.608 . . . . 0.0 110.558 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' THR . 93.2 t -113.23 121.14 64.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.019 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -91.41 128.68 37.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.624 0.25 . . . . 0.0 110.926 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.486 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.9 mt -86.94 159.91 50.66 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 20.1 Cg_endo -62.74 132.05 35.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.063 1.842 . . . . 0.0 111.128 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -57.02 127.23 30.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.58 0.705 . . . . 0.0 111.191 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtm -104.19 130.05 51.95 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.6 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.83 132.09 41.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -124.39 146.74 48.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.496 ' HG2' HD12 ' A' ' 80' ' ' LEU . 73.5 mmtt -121.69 155.45 35.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.699 0.761 . . . . 0.0 110.663 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.5 115.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.522 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.545 HD12 ' HB2' ' A' ' 78' ' ' GLN . 15.2 mt -81.99 -54.0 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -136.39 153.11 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.77 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -148.25 150.9 34.52 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.9 t -143.57 139.09 29.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.617 0.246 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -68.98 -17.72 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.669 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.24 -44.92 86.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.413 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.59 30.54 0.22 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.802 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 p -135.0 131.25 36.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.545 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 mt -135.32 137.59 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.328 -177.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -117.5 123.62 46.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.7 pt -132.59 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.154 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.545 ' HB2' HD12 ' A' ' 67' ' ' ILE . 34.0 tt0 -139.38 142.21 37.55 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -71.83 174.19 7.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.077 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.496 HD12 ' HG2' ' A' ' 65' ' ' LYS . 76.5 mt -127.85 174.58 9.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.99 -152.76 31.8 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 -9.49 20.08 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.381 2.054 . . . . 0.0 111.952 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -102.34 20.5 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -95.43 2.64 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -172.925 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 77.1 Cg_endo -93.87 -4.58 2.76 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 CA-C-N 121.393 1.533 . . . . 0.0 112.368 162.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.85 112.02 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.679 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -99.81 170.26 8.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.56 . . . . 0.0 110.995 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -130.35 158.3 40.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.089 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.543 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.7 m -128.98 142.01 51.07 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.014 0.435 . . . . 0.0 111.069 -177.505 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.8 mt -121.1 123.62 42.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.097 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.492 ' HE3' HG23 ' A' ' 89' ' ' THR . 93.3 mttt -132.0 155.37 48.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.107 0.479 . . . . 0.0 111.371 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -84.63 152.36 23.86 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.428 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.59 -156.79 32.36 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.344 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -83.34 -28.7 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -109.16 -165.15 0.99 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.266 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.88 54.01 4.64 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -117.34 154.61 30.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.611 0.243 . . . . 0.0 110.647 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.41 HD13 ' O ' ' A' ' 91' ' ' LYS . 61.5 tp -106.93 127.88 53.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.126 0.489 . . . . 0.0 110.749 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.403 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 66.7 mt -99.33 110.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.29 173.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -102.41 115.99 31.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.543 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 25.6 mt-10 -98.71 130.36 45.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.416 0.626 . . . . 0.0 110.119 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.494 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 1.2 tm0? -153.76 132.11 12.0 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.494 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 1.6 t-20 66.68 10.99 7.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.504 0.502 . . . . 0.0 111.865 172.126 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.93 1.77 55.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.964 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 58.7 mt-30 -96.0 136.76 36.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -99.13 114.03 26.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -119.98 137.92 53.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 0.0 111.882 -172.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 t -119.92 124.48 46.11 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.613 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.496 ' HE2' ' HG2' ' A' ' 23' ' ' GLU . 65.0 mtt -125.73 160.66 29.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.21 0.529 . . . . 0.0 111.854 -170.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.37 141.09 30.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.993 175.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -81.48 125.06 30.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mm -77.99 147.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -100.74 125.74 47.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.333 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.1 m -106.11 101.44 10.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -91.71 113.96 26.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -103.65 155.27 18.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.426 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.08 130.61 2.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.939 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 84.33 1.32 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.65 87.53 2.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.845 0.355 . . . . 0.0 110.246 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 66.06 150.38 0.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.203 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -166.56 138.67 3.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.021 174.08 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.64 167.91 14.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -80.99 -74.42 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -112.98 113.16 25.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.781 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -140.65 102.71 4.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.114 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -82.96 -21.85 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.556 -176.239 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.4 t -75.95 74.37 2.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.405 0.621 . . . . 0.0 110.373 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.41 38.43 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.64 0.733 . . . . 0.0 109.365 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -76.8 101.34 5.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.557 -179.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -115.56 137.14 52.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.823 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -89.65 179.39 6.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.394 0.616 . . . . 0.0 111.727 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -144.2 153.03 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.166 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -150.37 122.46 8.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 0.0 110.806 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.39 117.94 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.276 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.881 176.295 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HE3' ' HG3' ' A' ' 82' ' ' PRO . 26.4 mmt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.574 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mm -86.96 85.63 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptm -88.44 -11.84 44.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.8 t 55.76 57.64 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.923 0.868 . . . . 0.0 110.225 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 m -152.56 100.07 2.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.305 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.06 -172.78 26.62 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.601 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.76 175.86 12.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 111.184 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -153.54 80.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 168.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -106.78 106.81 17.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.9 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.79 109.36 2.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.701 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -70.74 -25.56 62.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.583 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 37.49 21.31 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.242 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 tt0 -92.55 157.8 16.33 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.639 -1.619 . . . . 0.0 108.851 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.0 m -77.06 100.61 0.47 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 13' ' ' GLU . 87.3 Cg_endo -97.97 133.18 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.036 2.491 . . . . 0.0 114.005 -167.741 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.419 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 54.4 p90 -105.9 -13.25 15.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.053 173.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.52 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 13.4 p90 -106.31 -0.27 24.48 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -80.48 26.38 0.38 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.88 -165.39 12.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.932 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.557 ' OG1' ' HD2' ' A' ' 115' ' ' LYS . 22.1 m -109.8 125.97 53.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . 0.519 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 90.2 m95 -111.92 135.45 52.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.277 0.56 . . . . 0.0 111.394 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.521 ' HB2' HD13 ' A' ' 112' ' ' ILE . 2.8 t70 -87.64 123.31 32.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.739 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.48 76.18 3.32 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.03 3.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.675 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -153.45 141.83 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.23 158.94 0.12 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 123.904 0.752 . . . . 0.0 112.206 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.04 177.67 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.971 2.447 . . . . 0.0 112.056 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.65 -162.67 11.71 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' HG23 ' A' ' 33' ' ' VAL . 99.3 Cg_exo -42.41 157.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.446 3.431 . . . . 0.0 114.332 175.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -68.71 -18.66 64.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.901 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.89 -55.43 29.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.297 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.94 50.27 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.351 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.523 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -99.38 132.77 44.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . 0.421 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 44.9 mtpt -111.62 -18.16 12.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.923 0.392 . . . . 0.0 110.878 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.448 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 19.0 m -155.38 167.05 31.65 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.239 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.33 150.21 49.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.855 0.359 . . . . 0.0 110.471 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 132.29 39.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.904 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -112.39 131.55 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.109 0.48 . . . . 0.0 110.648 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -113.45 125.25 54.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.145 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . 0.52 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 98.8 m-85 -101.25 118.09 36.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.129 0.49 . . . . 0.0 109.684 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.405 HG23 ' H ' ' A' ' 42' ' ' GLU . 0.2 OUTLIER -100.65 -179.09 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.385 -177.655 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.405 ' H ' HG23 ' A' ' 41' ' ' THR . 9.2 tp10 -50.58 -58.37 5.98 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.116 0.26 . . . . 0.0 111.53 -176.461 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.53 -5.8 9.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 0.0 110.691 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -115.74 155.01 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.141 0.495 . . . . 0.0 111.307 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.2 118.14 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.64 124.66 60.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.71 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -95.28 133.59 39.01 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.679 0.752 . . . . 0.0 111.126 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 118.48 23.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.615 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -104.39 131.82 51.31 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.738 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.448 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 47.4 t -86.8 112.42 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.745 0.784 . . . . 0.0 110.144 -174.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.523 ' HG2' HG22 ' A' ' 33' ' ' VAL . 66.8 mtt -113.29 120.02 39.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.34 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.88 129.63 43.06 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.011 0.434 . . . . 0.0 110.284 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.53 -20.38 48.66 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.278 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 7.1 mmt180 -107.01 -51.36 2.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.635 0.731 . . . . 0.0 109.553 178.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.48 -151.62 17.81 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.374 -172.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HG2' HG21 ' A' ' 50' ' ' VAL . 45.4 mt-10 -81.68 121.64 26.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.241 0.521 . . . . 0.0 110.063 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -104.84 122.4 57.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.78 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -83.86 118.76 24.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.478 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 90.8 mt -95.44 163.63 21.07 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.478 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 88.4 Cg_exo -44.72 120.29 2.73 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.054 2.503 . . . . 0.0 112.773 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -71.84 141.44 49.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.104 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' MET . . . . . 0.764 ' HE1' ' HA ' ' A' ' 62' ' ' MET . 24.7 mmt -103.88 149.81 24.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.49 141.42 28.54 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.47 162.31 29.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.126 0.488 . . . . 0.0 111.256 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -135.88 159.18 42.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.456 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.9 t -103.67 118.46 50.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.538 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.594 HD13 ' HB2' ' A' ' 78' ' ' GLN . 14.2 mt -85.91 -50.72 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -138.74 160.11 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.214 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -147.33 135.16 21.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.74 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 t -137.51 116.67 12.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -64.86 -20.94 66.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 0.0 109.949 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -42.76 78.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.826 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.36 35.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.347 -1.406 . . . . 0.0 115.004 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -154.58 140.85 18.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.652 0.726 . . . . 0.0 111.895 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 mt -130.05 137.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.9 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.419 ' HG2' HD12 ' A' ' 67' ' ' ILE . 60.0 tt0 -110.3 123.42 49.78 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 158.35 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HB2' HD13 ' A' ' 67' ' ' ILE . 46.8 tt0 -132.59 147.72 52.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.411 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.449 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 96.4 m-85 -99.17 157.43 16.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.173 0.511 . . . . 0.0 110.599 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.436 HD22 ' CE1' ' A' ' 84' ' ' TYR . 26.2 mt -112.22 179.51 3.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.073 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -150.43 41.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.921 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . 0.458 ' HG3' ' HE3' ' A' ' 1' ' ' MET . 33.9 Cg_exo -59.09 -12.32 15.34 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.849 2.366 . . . . 0.0 112.833 177.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.19 20.49 18.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.377 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.571 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -66.23 -176.19 0.22 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.583 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 59.4 Cg_exo 2.98 -3.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.484 1 C-N-CA 126.613 4.876 . . . . 0.0 120.823 -138.232 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.571 ' H ' ' C ' ' A' ' 84' ' ' TYR . 56.8 tp -72.3 116.71 13.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 120.116 1.325 . . . . 0.0 110.763 176.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.62 167.35 15.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.646 0.736 . . . . 0.0 111.883 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 t -150.58 145.08 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.334 169.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 141.57 51.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.886 0.374 . . . . 0.0 110.995 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.7 mt -115.86 124.03 49.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -129.7 165.88 20.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.119 0.485 . . . . 0.0 111.607 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -77.13 147.91 36.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.135 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.43 173.11 22.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.707 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.65 -2.43 48.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.72 28.49 5.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.535 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.07 49.15 42.62 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.138 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 p -130.98 173.79 10.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.809 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -119.06 134.0 55.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.76 116.74 41.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.124 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . 0.539 ' HB2' ' HE2' ' A' ' 109' ' ' MET . 12.4 t90 -96.73 112.43 24.19 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.0 133.37 49.89 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -149.74 129.15 12.97 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.91 22.67 13.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.089 0.471 . . . . 0.0 110.85 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.26 -8.9 68.87 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.548 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -92.48 145.65 24.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.65 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -100.54 117.01 33.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.084 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -104.06 132.81 49.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.473 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 t -100.92 126.64 47.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.539 ' HE2' ' HB2' ' A' ' 100' ' ' TRP . 59.4 mtm -117.61 144.46 45.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.513 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 1.1 m -96.92 158.69 15.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.997 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.316 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.521 HD13 ' HB2' ' A' ' 22' ' ' ASP . 24.1 mm -71.59 146.6 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.13 85.59 5.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.43 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t 65.93 105.28 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.793 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.557 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 83.5 tttt -79.89 72.6 6.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 92.15 8.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.674 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 173.4 53.28 0.05 OUTLIER Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.604 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -98.55 98.92 10.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -160.58 84.53 0.7 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.479 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -134.18 123.26 24.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.223 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -72.13 134.79 45.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.26 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -82.66 130.31 35.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -161.49 104.55 1.25 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.746 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -136.94 130.93 32.31 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.518 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.2 t -104.5 179.68 4.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.372 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -145.13 121.0 10.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.744 0.307 . . . . 0.0 110.328 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 p -89.33 136.63 32.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.85 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -150.35 127.75 11.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.903 0.383 . . . . 0.0 110.176 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.06 94.91 2.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.893 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -115.85 89.14 3.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.552 0.691 . . . . 0.0 110.832 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -134.55 129.57 35.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.816 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -129.68 147.73 51.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -103.35 137.7 41.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.809 0.338 . . . . 0.0 111.662 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . 0.404 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 3.0 t-80 62.82 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.964 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . 0.404 ' H ' ' HB3' ' A' ' 134' ' ' HIS . 20.7 p-80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.099 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.749 0.309 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . 0.74 HD11 ' H ' ' A' ' 2' ' ' ILE . 0.2 OUTLIER -94.35 173.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.291 177.402 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -89.87 109.66 20.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.152 0.501 . . . . 0.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.04 170.07 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.095 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 p -106.38 125.34 50.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.445 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.1 -17.48 69.5 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -80.12 75.76 6.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.675 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -138.89 129.45 25.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.674 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 57.96 38.19 26.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.5 0.667 . . . . 0.0 110.003 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 2.5 pt20 -68.66 150.97 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.377 -176.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -84.46 -3.39 58.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 111.004 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -128.14 118.66 23.8 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 8.9 mm-40 -68.59 146.49 53.02 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.257 0.551 . . . . 0.0 110.6 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -107.19 93.18 8.97 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.927 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 13' ' ' GLU . 2.6 Cg_endo -83.58 123.73 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.199 2.599 . . . . 0.0 111.578 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -69.45 -9.36 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.12 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -113.24 -0.72 14.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.688 0.28 . . . . 0.0 111.619 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.422 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 58.2 t80 -97.99 126.64 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.141 0.496 . . . . 0.0 111.501 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -160.64 24.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.261 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' THR . . . . . 0.423 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 29.1 m -101.39 123.72 45.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.803 0.335 . . . . 0.0 110.403 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -104.85 139.63 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 111.851 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.495 ' HB2' ' CD1' ' A' ' 112' ' ' ILE . 8.7 t70 -79.02 123.66 27.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.822 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 26' ' ' ALA . 4.3 mm-40 -88.76 85.53 6.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.394 172.907 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -38.13 5.24 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.622 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -137.54 141.78 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 165.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.503 ' HB3' ' HB3' ' A' ' 23' ' ' GLU . . . -131.11 140.98 40.29 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.705 -171.708 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 27.6 Cg_endo -97.93 143.89 0.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.957 3.105 . . . . 0.0 111.293 168.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.49 -157.92 25.8 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.498 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 50.9 Cg_exo -49.05 161.62 0.53 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 125.006 3.804 . . . . 0.0 114.069 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.06 13.7 16.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.492 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.01 -28.1 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.87 59.55 0.59 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.45 133.31 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -96.03 -23.24 16.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 111.556 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -157.98 163.21 38.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.452 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -148.7 165.89 30.01 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.467 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 3.3 p -133.35 132.9 41.8 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.743 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 120.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.444 0.64 . . . . 0.0 109.596 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -108.93 126.11 52.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -100.66 117.64 35.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . 0.414 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -100.16 173.61 6.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.347 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 41' ' ' THR . 37.5 tt0 -50.38 -40.18 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -136.24 -0.59 2.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.099 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -126.05 151.66 46.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.942 -0.473 . . . . 0.0 111.759 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.84 118.89 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.85 124.06 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -98.07 139.15 34.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.315 0.578 . . . . 0.0 110.778 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.467 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -123.58 136.63 54.63 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.536 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.605 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 32.7 mt-10 -97.48 130.28 44.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.02 107.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' MET . . . . . 0.566 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -133.85 133.16 41.22 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.3 -169.243 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -80.38 88.8 5.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.091 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.65 -52.78 0.47 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.499 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ARG . . . . . 0.566 ' HG2' ' HB3' ' A' ' 51' ' ' MET . 10.0 ptp180 -94.62 -33.11 13.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.52 -173.18 29.55 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.605 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.0 mp0 -67.33 117.22 9.03 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.774 0.797 . . . . 0.0 110.803 174.356 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -124.73 128.29 73.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.627 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 131.72 36.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.976 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.409 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.0 mt -89.86 162.25 36.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.735 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.409 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 76.5 Cg_exo -47.2 121.37 5.2 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.795 2.33 . . . . 0.0 112.307 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -70.62 141.16 51.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.295 0.569 . . . . 0.0 110.954 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -107.96 147.68 30.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.79 148.08 26.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.791 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -145.04 154.72 42.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.489 ' HG3' HD12 ' A' ' 80' ' ' LEU . 55.4 mtpt -128.46 156.19 43.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.41 124.22 49.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.843 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.58 HD11 ' HG2' ' A' ' 76' ' ' GLU . 18.3 mt -87.49 -50.25 13.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -144.92 155.74 43.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.348 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.43 128.65 12.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.415 0.626 . . . . 0.0 111.108 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.406 ' HB3' ' H ' ' A' ' 74' ' ' SER . 38.4 t -136.56 147.14 46.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.3 p -80.85 -23.21 39.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.698 0.285 . . . . 0.0 111.593 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -143.16 -10.07 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.5 -83.22 1.06 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.337 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.406 ' H ' ' HB3' ' A' ' 70' ' ' SER . 4.1 p -164.37 153.67 13.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 122.84 0.456 . . . . 0.0 110.532 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 25.2 mt -114.09 138.01 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HG2' HD11 ' A' ' 67' ' ' ILE . 30.2 tt0 -120.49 124.93 46.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.0 110.181 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -128.44 157.73 40.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.342 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.58 ' HB2' HD12 ' A' ' 67' ' ' ILE . 57.3 tt0 -130.03 144.14 51.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -82.63 167.38 18.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD12 ' HG3' ' A' ' 65' ' ' LYS . 95.8 mt -129.22 166.48 19.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.334 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.53 -153.78 17.51 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.38 -21.9 46.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.038 1.825 . . . . 0.0 111.6 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -105.64 40.72 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.083 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' TYR . . . . . 0.477 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 45.8 p90 -78.15 -33.16 0.94 Allowed Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 85.9 Cg_endo -74.04 -3.6 14.05 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 CA-C-N 121.222 1.472 . . . . 0.0 113.068 -170.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 tp -88.1 124.83 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.156 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -111.66 168.97 9.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -138.29 153.45 49.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.63 -173.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.55 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -120.08 142.26 49.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.0 mt -125.95 124.41 40.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.74 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.537 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 85.9 mttt -130.52 163.35 27.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.039 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -86.79 143.67 27.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.72 -146.26 17.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.28 125.93 35.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.06 -153.09 0.28 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.79 53.19 4.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.124 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 p -115.68 144.01 44.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LEU . . . . . 0.472 HD22 HD22 ' A' ' 90' ' ' LEU . 29.9 tp -109.57 133.68 52.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ILE . . . . . 0.537 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 70.9 mt -98.48 110.28 25.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 175.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -105.94 114.8 29.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 32.8 mt-10 -106.2 131.72 53.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.651 0.738 . . . . 0.0 110.321 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLN . . . . . 0.496 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 1.2 tm0? -151.75 135.18 16.07 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.016 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . 0.472 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.7 OUTLIER 65.09 9.12 5.25 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.796 0.331 . . . . 0.0 111.621 176.435 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.98 13.42 57.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.654 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLN . . . . . 0.496 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 3.5 pt20 -120.93 149.0 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -96.07 125.85 40.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.325 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.555 ' HE2' ' HA ' ' A' ' 107' ' ' LYS . 3.1 mmpt? -111.71 139.75 46.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.544 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.3 m -105.25 114.66 28.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.722 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' MET . . . . . 0.405 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 64.2 mmm -101.85 133.15 47.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.62 142.87 33.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.424 HH11 ' HD2' ' A' ' 111' ' ' ARG . 8.9 ttp180 -82.63 130.56 35.14 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.147 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ILE . . . . . 0.495 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.4 mm -62.83 144.58 14.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -115.71 109.96 18.46 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.422 0.63 . . . . 0.0 110.868 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 t -171.26 107.04 0.25 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.607 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -88.23 128.02 35.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m 71.41 129.01 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.954 0.784 . . . . 0.0 109.575 -168.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.05 -102.88 0.5 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.612 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -125.35 155.17 40.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 -175.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.36 27.89 7.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.628 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.0 84.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.019 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.95 105.82 13.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.603 -172.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -169.04 132.99 1.4 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 175.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -150.99 130.87 13.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.084 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.48 92.13 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -70.91 95.97 1.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 110.758 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -77.87 112.94 15.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 p -121.48 126.17 48.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.4 tp -111.43 109.13 18.94 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.968 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -121.31 130.72 53.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -131.7 106.9 8.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -149.03 100.61 3.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -146.17 96.77 2.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.286 0.565 . . . . 0.0 110.593 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -95.75 116.05 28.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.282 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.4 p80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.274 177.514 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.96 115.72 4.38 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.378 2.052 . . . . 0.0 111.717 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.07 -14.94 63.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.121 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -94.4 -18.63 21.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.75 0.309 . . . . 0.0 111.417 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.28 139.84 39.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.765 0.317 . . . . 0.0 110.62 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.32 -152.62 21.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.307 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 m -126.8 128.25 46.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 55.5 m95 -118.51 143.75 46.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.849 0.357 . . . . 0.0 111.563 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' ILE . 19.4 t70 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.326 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.735 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 1.3 tp10 -106.53 36.44 2.62 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 123.39 1.567 . . . . 0.0 107.781 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.19 70.66 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.656 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -95.54 -168.0 1.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.156 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . -75.86 144.49 76.37 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 111.499 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' LYS . 10.0 Cg_exo -71.73 -178.93 3.36 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.414 2.742 . . . . 0.0 113.17 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.28 -151.46 5.56 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.495 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.16 -163.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.561 2.841 . . . . 0.0 112.588 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -52.81 -34.43 53.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.889 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -101.82 17.14 23.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.664 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 77.57 0.23 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 49' ' ' GLU . 99.0 t -54.76 144.67 5.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 123.554 0.742 . . . . 0.0 112.079 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 8.9 mtpm? -55.63 -40.68 72.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.398 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -154.69 163.39 40.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.802 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . . . -143.23 150.32 39.15 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.834 0.35 . . . . 0.0 110.573 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 p -134.0 140.56 46.79 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 21' ' ' TRP . 7.2 p -112.4 129.68 67.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 m -108.4 125.93 52.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.978 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -100.59 117.21 34.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.476 . . . . 0.0 110.076 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -102.35 -179.64 4.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.71 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 41' ' ' THR . 37.0 tt0 -44.33 -70.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.128 0.971 . . . . 0.0 113.057 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.21 9.84 8.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.226 0.536 . . . . 0.0 110.78 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.589 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 1.5 pm0 -133.69 150.61 51.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.358 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.51 133.89 56.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 61' ' ' PHE . 22.1 t -116.89 122.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.535 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.83 139.84 30.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.51 133.39 49.84 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.41 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.723 ' HB3' HG11 ' A' ' 33' ' ' VAL . 49.4 mt-10 -125.27 134.4 52.3 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 56' ' ' GLU . 21.3 t -91.11 108.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.336 0.588 . . . . 0.0 109.938 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 66.8 mtt -99.3 138.43 36.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 34.6 tt0 -64.53 115.21 4.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.781 0.324 . . . . 0.0 110.472 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.91 -13.69 63.43 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.433 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 0.1 OUTLIER -113.43 -37.51 4.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.352 0.596 . . . . 0.0 110.436 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.8 -159.83 29.5 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.2 mp0 -62.33 126.53 27.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.21 121.39 60.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.843 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -88.2 131.25 34.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.016 0.436 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 42.8 mt -88.0 165.04 31.38 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.493 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 51.6 Cg_exo -49.79 120.31 5.8 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.87 2.38 . . . . 0.0 111.499 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' HB3' HG22 ' A' ' 46' ' ' VAL . 11.0 p90 -64.3 134.14 54.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 111.653 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.5 mmm -102.07 129.91 48.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.48 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -77.13 148.94 35.73 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.338 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -140.14 153.83 46.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 80' ' ' LEU . 92.6 mttt -126.27 149.47 49.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.229 0.537 . . . . 0.0 110.362 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 77' ' ' ILE . 94.5 t -93.79 116.11 34.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.281 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 78' ' ' GLN . 21.6 mt -84.81 -52.45 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.428 0.632 . . . . 0.0 109.549 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -133.93 150.36 51.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.093 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -149.13 155.54 40.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.89 0.376 . . . . 0.0 111.019 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -125.02 158.81 32.79 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 t -67.9 -33.0 73.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -169.95 90.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.873 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.1 -78.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.703 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -139.86 155.77 47.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.088 0.47 . . . . 0.0 110.184 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 mt -135.11 137.19 50.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.669 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.64 121.67 42.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 75' ' ' ILE . 35.3 pt -132.92 151.43 34.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.313 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 67' ' ' ILE . 18.1 tt0 -124.54 136.73 54.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.391 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -79.91 170.1 16.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.727 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 88.5 mt -131.39 146.8 52.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . 0.439 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . 121.21 -153.71 16.6 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.95 -13.09 37.35 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.632 2.221 . . . . 0.0 112.601 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -125.83 46.32 2.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.993 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 32.9 p90 -84.5 -36.55 0.61 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 61.0 Cg_endo -75.32 -4.41 15.29 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 CA-C-N 121.097 1.427 . . . . 0.0 113.431 -170.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.26 109.52 21.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -86.95 166.47 15.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -131.38 163.16 28.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.996 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -121.25 141.74 50.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.036 0.446 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.7 mt -128.59 137.9 51.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.874 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 79.1 mttt -141.58 156.65 45.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -78.89 144.18 35.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.59 -171.4 15.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.891 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.44 155.63 29.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 71.81 -55.44 0.66 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.757 0.823 . . . . 0.0 111.049 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.08 40.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 110' ' ' THR . 28.5 p -108.11 171.9 7.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.14 0.495 . . . . 0.0 111.591 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 52.3 tp -118.61 132.67 56.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.323 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 73.0 mt -97.72 110.05 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CZ3' HG21 ' A' ' 38' ' ' VAL . 4.2 t90 -103.98 115.02 29.68 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.171 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 106' ' ' ARG . 35.5 mt-10 -112.39 131.54 55.49 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.884 0.85 . . . . 0.0 111.205 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -151.76 131.32 13.05 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.046 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.57 12.12 8.72 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.347 0.404 . . . . 0.0 111.13 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.89 70.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.274 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -92.61 135.18 34.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.792 0.33 . . . . 0.0 110.458 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 101' ' ' GLU . 22.5 ttt180 -102.31 116.81 33.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.488 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -118.09 128.36 54.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 111.571 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.3 m -95.01 119.21 33.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.104 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 20.7 mmt -107.19 135.26 49.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.61 146.74 24.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.877 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.533 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 26.6 ttp180 -93.27 128.91 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.931 0.396 . . . . 0.0 110.783 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.2 mm -84.39 150.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.317 -0.848 0 CA-C-O 121.505 0.669 . . . . 0.0 110.138 -179.1 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.34 110.59 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.831 2.354 . . . . 0.0 112.424 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -62.71 -26.86 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.698 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 90' ' ' LEU . 21.8 p90 -88.44 -13.22 40.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.71 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -86.57 142.01 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.622 0.249 . . . . 0.0 110.387 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.79 -159.66 24.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.502 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 m -116.49 122.27 44.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 69.4 m95 -116.25 136.54 52.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.134 0.493 . . . . 0.0 111.543 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.582 ' HB2' HG12 ' A' ' 112' ' ' ILE . 26.3 t70 -110.26 151.51 27.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.219 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 56.3 mt-10 -63.05 -23.36 67.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.581 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.05 -59.05 0.38 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.262 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -170.27 170.86 7.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 75.42 148.75 0.12 Allowed Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.892 0.877 . . . . 0.0 111.655 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 60.8 Cg_endo -73.09 176.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 0.0 113.152 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -113.84 -152.74 10.85 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.324 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 3.2 Cg_endo -48.19 154.32 2.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.759 2.972 . . . . 0.0 113.471 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 t -69.08 -4.73 18.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.229 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.99 -22.78 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.58 22.07 1.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG21 ' HG2' ' A' ' 29' ' ' PRO . 20.1 t -89.16 132.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.0 110.187 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 58.6 mtmt -99.7 -14.96 18.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.107 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p 176.9 159.57 0.36 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.732 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -122.44 136.8 54.97 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.125 0.488 . . . . 0.0 110.331 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 p -118.39 130.74 56.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.664 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.78 134.51 55.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.298 0.571 . . . . 0.0 110.225 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 12.0 m -120.19 126.27 50.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.207 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -101.3 118.29 36.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.244 0.545 . . . . 0.0 110.206 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -96.77 175.86 6.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 41' ' ' THR . 23.1 tt0 -60.96 -35.63 77.29 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.84 -8.63 4.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.464 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 2.2 mp0 -126.68 153.51 45.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 112.219 -169.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.4 t -107.2 120.31 58.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.581 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 61' ' ' PHE . 52.2 t -107.06 125.06 63.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -112.01 127.3 55.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.058 0.456 . . . . 0.0 110.305 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.96 128.03 54.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.763 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 37.7 mt-10 -99.92 129.43 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 56' ' ' GLU . 44.8 t -90.24 110.11 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.9 ttm -122.56 145.2 48.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.89 135.07 57.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.839 0.352 . . . . 0.0 110.217 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.56 -56.65 1.97 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.288 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -95.7 -33.7 12.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.76 -149.39 19.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.952 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 45.1 mt-10 -72.92 115.25 12.0 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.6 t -108.75 122.52 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.408 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HG2' HG23 ' A' ' 48' ' ' THR . 85.7 mt-30 -85.86 119.17 25.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.495 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.1 154.67 67.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.73 122.98 8.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.992 2.461 . . . . 0.0 112.3 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' HB3' HG22 ' A' ' 46' ' ' VAL . 37.0 p90 -64.64 139.91 58.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtm -112.09 133.49 54.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.776 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.28 134.73 36.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.341 . . . . 0.0 110.68 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.454 ' CD1' HG23 ' A' ' 45' ' ' VAL . 37.1 p90 -130.98 157.12 43.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.089 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HE3' HD11 ' A' ' 80' ' ' LEU . 96.7 mttt -127.05 158.99 35.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.51 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.1 t -97.16 119.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.959 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 78' ' ' GLN . 17.7 mt -82.58 -56.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.404 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -127.68 153.83 46.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.501 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -148.28 148.02 29.99 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.178 -172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -145.23 147.28 32.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.4 p -77.15 -26.81 53.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.469 . . . . 0.0 110.131 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.98 70.06 0.92 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.214 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.06 -88.75 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.882 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 t -152.43 157.78 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.175 0.512 . . . . 0.0 110.574 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.51 135.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.057 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -117.56 128.54 55.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 pt -124.39 157.06 32.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.26 0.553 . . . . 0.0 111.416 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.613 ' HB2' HD11 ' A' ' 67' ' ' ILE . 30.9 tt0 -134.41 144.63 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.102 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.86 151.1 20.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD11 ' HE3' ' A' ' 65' ' ' LYS . 94.8 mt -99.86 163.72 12.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.562 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -152.5 21.71 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.956 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.84 -6.68 13.07 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.368 2.045 . . . . 0.0 111.956 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.51 10.11 29.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.8 OUTLIER -61.28 170.17 1.82 Allowed Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.747 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 9.4 Cg_exo 9.42 -1.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.15 1 C-N-CA 128.173 5.915 . . . . 0.0 120.681 -148.344 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 84' ' ' TYR . 34.6 tp -74.3 103.84 4.84 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.117 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -113.33 173.47 6.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -138.52 149.29 45.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.524 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.3 m -122.18 143.35 49.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.94 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 17' ' ' TYR . 94.9 mt -121.65 131.8 54.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -134.57 155.88 49.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.636 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -74.13 144.65 44.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.025 0.44 . . . . 0.0 110.632 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 145.38 18.34 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -70.41 158.6 35.71 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.568 0.223 . . . . 0.0 110.797 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 67.83 12.86 9.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.345 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.72 56.11 2.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.791 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 p -130.58 173.0 11.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.774 -0.251 . . . . 0.0 110.795 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.9 tp -129.27 133.25 47.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 0.0 110.359 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.37 114.22 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -103.83 113.43 26.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.5 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 28.7 mt-10 -103.29 139.03 39.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.421 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -145.99 122.27 10.9 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.446 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.32 8.9 6.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.249 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.1 -14.77 25.98 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.649 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 32.5 mt-30 -93.33 133.39 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 30.6 ptt180 -102.41 124.33 47.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.4 0.619 . . . . 0.0 112.223 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -112.35 130.45 55.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 m -93.14 119.27 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 24.2 mmt -108.73 148.17 30.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.851 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -116.08 157.3 24.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.477 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 13.8 ttp180 -76.49 133.2 39.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mt -71.23 152.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.087 -178.711 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 t . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 121.43 0.633 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 2.4 Cg_endo -81.13 97.57 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.743 2.296 . . . . 0.0 112.271 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -77.84 -11.51 59.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 110.149 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -93.94 -4.31 50.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.121 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 83.4 t80 -75.63 135.74 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.648 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.95 -166.75 19.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.37 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 m -108.67 128.21 54.65 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 98' ' ' LEU . 61.6 m95 -111.1 146.74 36.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.292 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -108.98 139.24 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.199 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 7.2 mm-40 -45.43 -61.91 1.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.124 0.89 . . . . 0.0 112.251 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.17 21.34 59.35 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.252 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.17 -167.23 1.24 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.016 0.527 . . . . 0.0 110.989 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.22 146.99 59.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.34 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.08 152.61 36.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.245 2.63 . . . . 0.0 113.104 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -91.55 -153.91 30.13 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.545 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 6.1 Cg_endo -51.38 114.84 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.43 2.753 . . . . 0.0 112.415 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -82.19 70.45 9.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 123.143 1.449 . . . . 0.0 111.129 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -128.94 -63.34 0.97 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.269 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.94 -49.02 0.2 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.098 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 51' ' ' MET . 6.2 t -91.65 133.27 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -108.8 -19.33 13.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.148 0.499 . . . . 0.0 110.982 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 m -161.91 165.41 27.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.746 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -137.66 145.07 42.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.867 0.365 . . . . 0.0 110.838 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -122.77 132.25 54.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.43 129.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.225 0.536 . . . . 0.0 110.795 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.5 m -118.29 128.32 54.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.056 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.2 m -101.86 176.87 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.428 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 41' ' ' THR . 41.5 tt0 -50.47 -54.54 21.42 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.81 -21.28 9.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.457 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.56 156.88 42.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.342 0.591 . . . . 0.0 111.646 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.27 127.34 63.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.73 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.0 124.14 72.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -106.09 135.9 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.37 126.2 53.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.904 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -98.23 126.56 43.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 56' ' ' GLU . 45.8 t -86.3 111.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.382 0.61 . . . . 0.0 109.419 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.449 ' HG2' HG22 ' A' ' 33' ' ' VAL . 88.1 mtp -113.92 130.72 56.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.959 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.3 117.17 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.578 0.549 . . . . 0.0 111.026 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.09 -24.18 33.33 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.236 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 2.8 mmp_? -97.08 -58.09 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.715 0.769 . . . . 0.0 110.253 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.71 -152.0 17.26 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.611 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 50' ' ' VAL . 49.0 mt-10 -84.14 117.28 23.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.252 0.526 . . . . 0.0 110.101 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.0 t -105.47 123.86 60.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.9 126.79 31.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.32 159.39 64.82 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.043 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.84 141.93 34.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.036 2.491 . . . . 0.0 111.68 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -67.43 128.33 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.454 0.645 . . . . 0.0 111.062 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.0 mtm -103.89 119.49 39.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.932 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -74.41 134.85 42.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.472 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -127.52 147.41 50.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 0.0 110.489 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HD2' HD21 ' A' ' 80' ' ' LEU . 21.2 ptmt -122.9 159.08 28.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.17 122.59 54.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.052 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.1 mt -90.11 -48.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.502 0.667 . . . . 0.0 109.248 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 m -144.12 156.23 44.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.57 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -149.43 130.56 14.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.363 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.2 t -173.24 160.67 4.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.804 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -84.95 -35.55 21.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.182 0.515 . . . . 0.0 109.992 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -100.27 -39.81 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.341 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.41 -3.04 88.52 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.683 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t 67.24 168.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.454 0.645 . . . . 0.0 111.374 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 26.7 mt -107.21 137.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.783 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.7 tt0 -122.83 128.54 50.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.409 HG13 ' HB3' ' A' ' 88' ' ' SER . 36.1 pt -122.3 158.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.506 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.641 ' CD ' ' HA ' ' A' ' 85' ' ' PRO . 33.0 tt0 -133.39 137.07 45.66 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 72.9 m-85 -80.42 150.45 29.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.457 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.569 HD21 ' HD2' ' A' ' 65' ' ' LYS . 97.2 mt -110.48 -173.09 2.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.892 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.75 -151.76 43.29 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.75 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 -17.03 39.38 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.212 1.942 . . . . 0.0 111.809 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.11 18.96 9.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.727 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 5.5 p90 -59.06 170.07 0.99 Allowed Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.249 0.343 . . . . 0.0 110.443 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 11.96 -0.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 1 C-N-CA 128.082 5.855 . . . . 0.0 121.405 -149.334 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.9 tp -66.97 115.98 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 119.631 1.105 . . . . 0.0 108.272 166.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 59.0 pttt -108.14 179.98 4.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.395 0.617 . . . . 0.0 112.31 -170.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB3' HG13 ' A' ' 77' ' ' ILE . 45.8 t -152.02 165.31 35.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.582 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.5 m -127.03 142.41 51.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.066 0.46 . . . . 0.0 111.215 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.9 mt -124.1 122.53 38.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.274 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 26.3 ttmt -133.35 158.49 42.87 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -173.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -89.42 153.17 21.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.17 0.509 . . . . 0.0 111.768 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.62 162.03 12.68 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.75 -10.39 53.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -130.47 51.12 2.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.765 0.317 . . . . 0.0 111.175 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.35 27.69 73.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.55 160.19 16.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.154 0.502 . . . . 0.0 112.071 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 19.6 tp -128.47 134.78 48.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 91' ' ' LYS . 72.8 mt -104.68 111.91 36.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.037 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.5 t90 -104.13 111.77 24.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.956 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 27.1 mt-10 -100.74 131.5 46.6 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.467 0.651 . . . . 0.0 110.369 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 16.9 tm0? -152.56 121.17 6.42 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.271 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 2.6 t-20 75.8 -53.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.95 0.781 . . . . 0.0 112.665 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.14 -25.07 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.207 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -120.19 152.76 37.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.857 0.829 . . . . 0.0 111.176 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 20.5 ptt180 -95.53 126.29 40.71 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 21.8 mmtp -88.25 127.21 35.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.911 0.386 . . . . 0.0 110.243 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.2 m -109.11 111.6 23.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -134.99 156.36 49.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.483 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 m -112.53 155.32 24.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.028 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.29 130.25 36.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.957 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.95 146.16 9.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.0 110.168 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.894 -179.689 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.7 Cg_exo -75.79 110.88 3.17 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.939 2.426 . . . . 0.0 111.305 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -63.68 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.058 -174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -84.3 -13.22 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.779 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 17.2 t80 -78.5 138.16 38.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.67 -163.04 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.173 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 84.8 m -110.01 121.96 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.035 0.445 . . . . 0.0 110.511 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 80.8 m95 -106.41 144.41 33.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB2' HD11 ' A' ' 112' ' ' ILE . 22.6 t70 -104.34 120.34 40.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.51 48.44 1.55 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.783 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.49 47.13 2.65 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.568 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -162.5 144.24 10.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.92 164.16 0.13 Allowed Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 124.083 0.864 . . . . 0.0 111.328 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.56 135.54 49.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.681 2.254 . . . . 0.0 113.163 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.19 -154.12 8.69 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.525 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.49 124.49 9.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.617 2.878 . . . . 0.0 112.432 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -82.05 -7.86 59.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.786 -167.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.06 -32.58 62.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.093 0.473 . . . . 0.0 111.535 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.25 39.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.25 136.38 25.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.434 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.0 mmpt? -73.22 -41.01 64.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -161.69 160.4 28.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.162 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.99 135.4 54.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.9 p -117.29 125.91 51.86 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.95 127.72 75.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.2 m -105.82 124.69 49.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.49 118.84 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.36 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -100.38 179.56 4.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 167.966 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -68.52 -36.66 79.18 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.294 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -111.99 -11.67 13.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -135.01 145.81 48.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.491 0.662 . . . . 0.0 112.344 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' CD1' ' A' ' 64' ' ' TYR . 97.9 t -111.93 118.38 57.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.526 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.69 122.67 63.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.959 0.409 . . . . 0.0 109.977 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -107.26 133.02 52.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.808 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -124.31 134.27 53.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 30.1 mt-10 -100.22 125.24 46.36 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -88.01 110.1 20.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.21 121.64 43.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -170.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.88 115.94 4.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.52 10.14 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.098 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -111.44 -59.04 2.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.515 0.674 . . . . 0.0 109.972 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.93 -164.24 19.57 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.68 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.519 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.4 mp0 -69.65 126.64 30.34 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.589 0.709 . . . . 0.0 111.628 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.78 122.56 70.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.659 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -79.96 128.66 33.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.2 0.524 . . . . 0.0 111.993 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 75.6 mt -90.47 165.05 24.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.993 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.5 Cg_endo -57.54 130.47 39.1 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.724 2.283 . . . . 0.0 112.097 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -63.83 147.02 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.971 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -123.88 118.26 26.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.074 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.27 138.33 31.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.809 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.492 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.0 p90 -137.66 171.72 14.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.914 0.388 . . . . 0.0 110.388 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.702 ' HG3' HD11 ' A' ' 80' ' ' LEU . 80.7 mttt -130.01 154.44 47.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.266 0.555 . . . . 0.0 111.08 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.18 124.22 46.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.306 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.9 mt -88.55 -47.71 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 109.58 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -143.61 156.67 44.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.631 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -149.2 150.92 33.41 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -140.36 145.08 36.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.987 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -73.64 -25.94 60.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.494 0.664 . . . . 0.0 109.506 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -152.35 76.31 1.15 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.582 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.39 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.392 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 m -150.7 154.17 36.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.134 0.492 . . . . 0.0 110.683 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 14.3 mt -118.52 137.62 51.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -117.42 121.68 41.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.83 156.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.672 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 67' ' ' ILE . 4.5 tt0 -130.26 138.35 50.47 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -80.05 -0.93 37.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -165.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 65' ' ' LYS . 97.6 mt 50.74 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.363 0.415 . . . . 0.0 111.586 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.79 -151.35 49.32 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.716 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.02 -11.1 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.767 2.311 . . . . 0.0 111.987 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.18 30.57 6.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.002 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 15.4 p90 -80.67 -15.71 0.23 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.181 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 87.3 Cg_endo -92.19 -3.82 3.83 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 CA-C-N 120.867 1.345 . . . . 0.0 112.929 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.47 113.73 25.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.0 0.428 . . . . 0.0 110.021 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 62.2 pttt -111.57 164.41 13.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 102' ' ' GLN . 21.8 t -134.01 155.67 49.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.812 -175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.8 m -112.74 140.81 47.21 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.084 0.469 . . . . 0.0 110.508 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 98.3 mt -124.44 124.59 42.65 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.698 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 39.2 mtpt -135.53 155.19 50.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.2 ptt85 -86.72 161.09 18.6 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.38 39.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -90.69 -10.94 41.26 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -155.65 93.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 111.544 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.71 40.93 42.01 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.657 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.92 159.88 40.82 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.469 0.176 . . . . 0.0 110.859 -175.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -123.89 135.21 53.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 25.8 mm -103.84 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.585 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 7.5 t90 -108.46 113.78 27.1 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 31.9 mt-10 -106.19 129.29 54.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.263 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.467 ' HG3' ' HB2' ' A' ' 88' ' ' SER . 2.8 tt0 -153.35 134.08 13.79 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.115 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.4 m120 59.46 18.16 6.64 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.307 0.38 . . . . 0.0 111.834 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.01 -13.07 60.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.49 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 41.2 mt-30 -92.81 134.99 34.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.055 0.455 . . . . 0.0 111.133 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -101.44 115.8 31.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.09 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -111.16 141.01 45.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.598 0.237 . . . . 0.0 111.299 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -119.06 115.34 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.585 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -114.83 165.32 12.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.349 0.595 . . . . 0.0 111.553 -177.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -102.21 163.07 12.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.162 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 42.4 ttp180 -106.36 134.86 48.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.4 mm -81.87 155.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.668 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 110.564 -179.167 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.93 122.24 11.28 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.919 2.413 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.34 -26.71 68.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -92.76 -10.43 37.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.055 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.5 -164.59 23.47 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.325 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.4 m -112.41 127.75 56.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.925 0.393 . . . . 0.0 110.145 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -117.42 151.41 37.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' HD11 ' A' ' 112' ' ' ILE . 13.8 t70 -89.52 130.92 35.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 4.2 mm-40 -52.85 -53.55 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.726 0.641 . . . . 0.0 112.376 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.04 35.17 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.51 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.5 tpp180 -99.41 149.33 23.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.58 79.07 21.73 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.3 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 25' ' ' ARG . 96.7 Cg_endo -99.91 -164.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.741 2.96 . . . . 0.0 110.927 174.149 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.35 173.79 33.08 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.912 171.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.1 132.51 16.79 Favored 'Trans proline' 0 C--N 1.324 -0.721 0 C-N-CA 122.989 2.459 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 p -86.03 6.74 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 t0 69.2 84.03 0.15 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.566 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.68 -38.02 2.07 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.63 138.54 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.676 0.274 . . . . 0.0 110.431 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HE3' ' HB2' ' A' ' 52' ' ' GLU . 95.8 mttt -91.17 -38.89 12.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.486 0.66 . . . . 0.0 110.201 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -167.75 171.8 9.74 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.65 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -135.55 164.5 27.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.079 0.466 . . . . 0.0 111.647 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 p -127.95 157.18 41.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.2 125.7 74.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.288 0.565 . . . . 0.0 111.02 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -108.33 122.4 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -101.14 117.67 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -101.61 176.32 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' H ' HG22 ' A' ' 41' ' ' THR . 44.7 mt-10 -62.56 -39.66 94.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.086 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.69 -3.35 5.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.849 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.99 157.5 45.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.224 0.535 . . . . 0.0 111.646 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.09 133.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.69 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.76 124.33 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.495 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HB2' HD12 ' A' ' 59' ' ' LEU . 17.8 mt-10 -98.79 137.41 37.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.264 0.554 . . . . 0.0 110.947 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.09 120.26 35.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.808 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.87 131.9 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.369 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 56' ' ' GLU . 39.9 t -89.48 113.6 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.297 0.57 . . . . 0.0 110.665 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.0 mtt -116.07 135.53 53.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.723 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 34.4 tt0 -70.66 128.91 37.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.99 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 -27.32 7.36 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.343 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -93.21 -62.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.665 0.745 . . . . 0.0 109.997 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.14 -155.26 19.78 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.299 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.3 mt-10 -87.71 129.09 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.374 0.607 . . . . 0.0 110.162 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.8 t -104.38 122.61 57.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.94 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.87 130.4 37.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.019 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 47' ' ' GLU . 94.8 mt -85.31 154.66 60.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -50.23 143.08 26.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.109 2.539 . . . . 0.0 112.524 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -59.87 119.02 6.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.7 mtm -109.79 121.78 46.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.218 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 149.36 39.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.531 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.21 159.91 36.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.84 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HD2' HD21 ' A' ' 80' ' ' LEU . 20.4 ptmt -121.69 144.31 48.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.029 0.442 . . . . 0.0 109.846 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.78 115.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.806 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.5 mt -93.6 -51.86 10.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.898 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -124.92 154.61 40.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.717 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -149.19 147.74 28.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -148.74 146.27 28.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.3 p -73.48 -24.19 60.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.375 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -161.29 78.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.91 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.87 -84.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.978 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 m -145.41 148.89 33.83 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.096 0.474 . . . . 0.0 110.644 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.23 132.35 66.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -114.76 124.17 51.09 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.72 149.21 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 32.4 tt0 -124.36 136.76 54.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 70.0 m-85 -77.11 157.45 31.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.281 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.572 HD21 ' HD2' ' A' ' 65' ' ' LYS . 90.6 mt -121.11 166.48 13.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.977 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.41 -152.19 17.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.977 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.69 -9.85 15.04 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -122.98 57.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 37.3 p90 -85.21 -27.68 0.39 Allowed Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.071 -171.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 10.3 Cg_endo -89.31 -3.57 5.95 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 CA-C-N 121.089 1.425 . . . . 0.0 112.701 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.9 tp -89.21 117.25 28.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 64.1 pttt -113.76 162.43 16.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.942 0.401 . . . . 0.0 110.955 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.77 160.26 34.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.9 m -115.7 139.24 50.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 98' ' ' LEU . 96.1 mt -124.1 124.33 42.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -132.33 152.86 51.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.496 . . . . 0.0 111.018 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -69.46 151.18 46.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.807 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.45 152.2 18.28 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.89 145.16 56.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.688 0.28 . . . . 0.0 111.259 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 66.47 20.48 10.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.553 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.47 4.21 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.072 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 p -117.16 173.8 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 90' ' ' LEU . 49.4 tp -127.7 135.94 50.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.251 0.548 . . . . 0.0 111.345 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.4 mt -108.8 111.06 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.5 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.78 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.2 t90 -105.41 117.97 35.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.322 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.4 mt-10 -102.48 132.75 48.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.528 0.68 . . . . 0.0 110.113 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -151.24 123.94 8.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.128 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.02 22.44 13.08 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.729 0.643 . . . . 0.0 111.26 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.39 -8.35 69.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.98 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -93.1 134.06 35.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.992 0.396 . . . . 0.0 110.064 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -101.18 127.66 47.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.103 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 5.0 mmpt? -127.51 139.58 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.169 0.509 . . . . 0.0 111.657 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 m -106.58 114.11 28.02 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.995 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.78 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 12.4 ptp -119.37 148.4 43.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.644 -172.146 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -98.15 152.78 18.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -84.67 123.89 30.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -74.13 154.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.128 0.49 . . . . 0.0 109.98 179.282 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.1 m . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 39.2 Cg_exo -56.85 121.26 9.75 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.629 2.219 . . . . 0.0 111.684 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -69.86 -15.25 63.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.993 -172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -98.15 -5.67 33.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 28.0 t80 -85.53 136.37 33.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 0.0 111.036 -171.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.18 -143.25 14.82 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.029 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m -127.88 126.39 41.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 87.2 m95 -117.92 138.81 51.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.139 0.495 . . . . 0.0 111.486 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 4.4 t70 -83.55 126.47 32.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.498 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.446 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 44.2 mt-10 -90.71 72.72 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.65 -15.94 60.86 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.257 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -100.45 142.75 31.49 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 70.71 145.24 0.11 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.562 1.164 . . . . 0.0 111.3 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 14.5 Cg_exo -69.69 148.78 66.28 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.702 2.268 . . . . 0.0 112.501 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.4 -160.9 36.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.048 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.552 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.9 Cg_endo -62.98 152.58 78.62 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.711 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 p -78.67 3.76 15.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.736 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.39 -11.22 60.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.287 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 111.69 47.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.718 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' HG2' ' A' ' 29' ' ' PRO . 17.1 t -105.84 135.12 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.672 0.272 . . . . 0.0 110.28 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.08 -42.44 47.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.624 . . . . 0.0 111.024 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -166.14 163.17 18.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.534 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.12 36.98 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.78 141.14 51.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.54 129.76 70.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.333 0.587 . . . . 0.0 110.578 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 35.1 m -111.95 119.48 38.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.305 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -102.17 121.19 41.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.799 0.333 . . . . 0.0 111.225 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 1.7 m -101.83 173.9 6.19 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 mp0 -53.04 -46.56 68.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -129.8 8.09 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 45.0 mt-10 -121.77 135.4 54.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.562 -175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 64' ' ' TYR . 87.2 t -107.97 118.07 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 52.8 t -109.96 123.12 65.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 15.6 mt-10 -97.27 132.47 42.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.53 0.681 . . . . 0.0 111.066 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -127.85 118.25 23.33 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.1 177.023 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' OE2' ' HG3' ' A' ' 29' ' ' PRO . 27.6 mt-10 -109.0 126.66 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.302 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.88 111.65 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.247 0.546 . . . . 0.0 110.043 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 32' ' ' GLY . 39.1 ttm -118.92 125.95 50.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.515 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.03 127.17 30.5 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.012 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.6 -28.79 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.655 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -125.77 -34.73 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.178 0.513 . . . . 0.0 111.289 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.42 -140.73 15.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.251 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.63 138.56 50.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.23 0.538 . . . . 0.0 111.209 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 48' ' ' THR . 80.0 t -128.72 121.38 54.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.097 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -82.16 130.52 35.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 76.3 mt -95.84 159.69 31.82 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.651 171.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.08 117.39 3.85 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.79 2.327 . . . . 0.0 111.601 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -61.62 127.29 30.75 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.529 0.681 . . . . 0.0 111.475 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 42.5 ttm -95.2 144.36 25.87 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.556 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.97 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 110.471 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 45' ' ' VAL . 15.7 p90 -138.08 163.07 32.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.067 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.585 ' HE3' HG12 ' A' ' 67' ' ' ILE . 49.7 pttt -122.61 152.82 40.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.962 0.41 . . . . 0.0 110.117 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.63 112.95 37.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.032 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.585 HG12 ' HE3' ' A' ' 65' ' ' LYS . 11.5 mt -83.95 -53.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.287 0.565 . . . . 0.0 109.871 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 m -127.1 151.58 48.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.11 146.86 27.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -137.2 153.8 50.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.1 m -79.37 -30.02 42.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -152.76 80.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.131 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.32 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.671 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 p -148.68 154.71 40.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.173 0.511 . . . . 0.0 110.994 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 31.9 mt -128.35 130.99 69.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.001 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.81 124.13 51.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.32 157.68 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.765 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 47.4 tt0 -132.69 135.93 46.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -74.72 144.37 43.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 -179.7 3.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.759 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.67 -151.53 34.24 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.582 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 -10.15 21.35 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.718 2.278 . . . . 0.0 112.313 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -99.5 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.693 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.839 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 1.6 p90 -60.1 -179.31 0.17 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.371 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.839 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER 12.76 -0.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.258 1 C-N-CA 127.75 5.633 . . . . 0.0 121.343 -149.375 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' TYR . 63.0 tp -71.66 113.52 8.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 119.905 1.229 . . . . 0.0 109.759 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 94.7 mttt -91.44 170.82 9.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.418 0.628 . . . . 0.0 111.643 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -151.75 152.45 32.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.35 171.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.2 m -118.07 141.78 48.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.32 0.581 . . . . 0.0 111.31 -173.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 80.9 mt -121.12 124.65 45.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.641 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 51.9 mtpt -132.59 156.91 46.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 111.669 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -65.59 144.2 57.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.598 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.81 -168.53 25.3 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.926 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.7 -41.43 13.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.336 0.589 . . . . 0.0 111.674 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -102.84 18.37 21.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.191 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.66 26.36 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 p -106.0 175.67 5.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.341 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 90' ' ' LEU . 59.5 tp -105.55 128.4 53.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 34.0 mm -96.97 109.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 16.6 t90 -103.25 112.76 25.78 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.703 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.3 mt-10 -104.47 131.19 52.12 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.69 0.757 . . . . 0.0 109.853 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -151.15 120.29 6.74 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.314 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 61.56 23.2 13.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -8.79 70.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.748 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.2 142.23 27.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -93.68 115.76 28.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 71.3 mttt -106.33 115.56 30.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.444 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.0 m -92.93 118.05 30.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.599 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 10.3 mmt -99.42 139.09 35.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -95.12 143.51 26.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.107 0.479 . . . . 0.0 110.286 -177.931 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -79.24 128.94 33.94 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 22' ' ' ASP . 26.8 mm -75.99 142.85 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.337 0.589 . . . . 0.0 109.486 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.059 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 15.0 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.723 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.2 Cg_exo -67.45 104.13 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.816 2.344 . . . . 0.0 111.656 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 40.6 p90 -57.65 -34.27 69.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.987 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 50.1 p90 -78.93 -9.62 59.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 2.1 t80 -80.82 23.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.331 0.586 . . . . 0.0 111.364 -172.155 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.61 -177.78 18.49 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.095 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 m -99.23 116.86 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.45 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 50.6 m95 -114.05 132.32 56.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.465 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.28 129.99 45.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 36.6 mt-10 -62.25 -55.63 26.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.43 27.55 73.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.107 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.7 144.68 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.6 160.71 0.13 Allowed Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 124.388 1.055 . . . . 0.0 112.086 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.85 153.6 72.54 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.686 2.258 . . . . 0.0 111.516 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.03 -169.66 46.07 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.964 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 64.2 Cg_exo -50.66 162.89 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 124.466 3.444 . . . . 0.0 113.879 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 p -69.34 -9.42 53.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.884 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.59 -10.13 59.18 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.012 -0.43 . . . . 0.0 111.106 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.7 27.67 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.547 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.616 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 21.4 t -74.06 134.67 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.262 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -81.14 -32.67 33.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 m -158.73 160.34 36.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.506 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.01 137.01 46.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.142 0.496 . . . . 0.0 111.092 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 24.6 p -118.39 136.86 53.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.259 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.78 134.14 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.179 0.514 . . . . 0.0 110.671 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -123.3 128.31 49.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.701 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 97.0 m-85 -102.06 116.79 33.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.128 0.489 . . . . 0.0 110.546 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.524 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -103.04 -178.16 3.58 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.78 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -46.01 -64.2 0.8 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.17 10.29 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.772 0.796 . . . . 0.0 110.16 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.524 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -137.98 145.83 42.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.181 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' A' ' 64' ' ' TYR . 90.0 t -101.36 132.3 47.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.19 123.16 67.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.828 0.347 . . . . 0.0 110.159 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -103.78 138.31 40.56 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.435 0.636 . . . . 0.0 110.279 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.45 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -124.23 122.13 36.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.182 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.59 120.03 39.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.797 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 56' ' ' GLU . 33.2 t -87.98 112.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.6 127.57 55.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.16 132.12 49.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.67 0.606 . . . . 0.0 111.517 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.4 3.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.07 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -93.9 -63.96 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.14 -157.02 21.05 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.376 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.8 mp0 -74.98 129.61 37.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.38 0.61 . . . . 0.0 110.843 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.84 122.58 66.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.708 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -84.76 131.63 34.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.872 0.368 . . . . 0.0 111.917 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.69 164.89 30.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.543 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.83 152.33 36.1 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.876 2.384 . . . . 0.0 112.44 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.77 114.66 10.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 110.693 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.7 mtp -96.62 118.38 32.99 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.544 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -75.98 140.85 42.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.969 0.414 . . . . 0.0 111.66 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CD1' HG23 ' A' ' 45' ' ' VAL . 8.9 p90 -145.94 150.11 35.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -132.93 151.56 52.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.486 0.66 . . . . 0.0 111.243 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.87 128.94 38.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.846 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 36.7 mt -90.94 -52.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.177 175.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.6 m -138.48 156.95 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.196 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -147.54 152.85 38.67 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -157.89 135.48 10.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 120.819 0.343 . . . . 0.0 111.156 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -11.94 59.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.1 -39.15 89.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.067 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.08 36.78 0.15 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.21 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 m -149.84 136.49 19.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 117.573 0.686 . . . . 0.0 110.736 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 18.6 mt -136.24 137.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.98 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -114.09 129.06 56.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 32.7 pt -131.45 157.43 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.858 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.896 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 6.2 tp-100 -124.28 147.05 48.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -96.48 151.05 19.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 63' ' ' ALA . 38.1 mt -107.74 156.13 19.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.154 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -154.42 21.75 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.24 -4.76 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.765 2.31 . . . . 0.0 112.618 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -97.67 11.45 37.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.988 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -65.35 176.71 0.79 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.948 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.988 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 20.0 Cg_exo 5.06 -1.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 1 C-N-CA 128.425 6.084 . . . . 0.0 121.872 -148.478 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' TYR . 51.2 tp -90.19 102.94 15.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 120.299 1.409 . . . . 0.0 108.057 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 20.4 pttp -115.39 178.66 4.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 0.0 112.352 -166.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.425 ' CB ' ' HE1' ' A' ' 100' ' ' TRP . 2.6 m -133.27 165.6 24.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -123.86 142.16 51.38 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.443 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 93.7 mt -117.92 124.6 48.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.365 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -137.51 154.98 49.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.955 0.407 . . . . 0.0 110.991 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -65.12 143.72 57.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.253 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.01 132.97 10.14 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 42.3 mt-10 -68.59 158.43 34.0 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.899 -0.177 . . . . 0.0 110.568 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 83.3 m-20 75.51 -7.42 1.79 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.74 0.816 . . . . 0.0 110.784 -174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.53 0.9 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.873 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.4 p -131.16 174.24 10.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.748 0.309 . . . . 0.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.82 133.18 54.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.884 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.16 110.2 30.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.231 0.539 . . . . 0.0 109.87 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.453 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.9 t90 -104.97 114.13 28.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.788 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.9 134.71 43.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.266 0.555 . . . . 0.0 109.687 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -148.79 111.77 4.87 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.748 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.59 31.71 20.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.82 0.819 . . . . 0.0 110.698 166.829 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.44 -17.17 55.85 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.941 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -92.04 136.29 33.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.968 0.384 . . . . 0.0 110.839 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 106' ' ' ARG . 23.2 ttt180 -99.94 114.97 28.6 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -109.7 136.25 49.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.595 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -120.93 114.13 21.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.856 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.453 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -118.22 151.49 37.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -109.36 151.72 26.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -87.92 135.74 33.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.298 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.78 147.58 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.616 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.557 -174.774 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 14.7 m . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.231 0.538 . . . . 0.0 111.856 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 14' ' ' THR . 6.1 Cg_endo -49.45 120.13 5.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.725 2.95 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -69.53 -14.24 62.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.468 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -98.03 -11.54 22.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.498 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -86.05 135.71 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.93 -168.24 22.5 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.984 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.7 m -104.08 129.93 51.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -120.44 135.8 54.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.016 0.436 . . . . 0.0 111.039 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.74 139.09 31.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.027 174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 37.5 mt-10 -50.31 -43.83 53.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.21 -56.81 2.8 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.187 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 -105.7 141.24 37.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 65.81 142.77 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.637 1.211 . . . . 0.0 112.054 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.1 Cg_exo -81.44 171.09 13.96 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.251 2.634 . . . . 0.0 112.571 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.91 -154.97 30.34 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.313 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' O ' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -61.89 -31.06 84.72 Favored 'Trans proline' 0 C--O 1.23 0.098 0 C-N-CA 123.315 2.676 . . . . 0.0 113.597 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 83.2 m 75.6 -21.14 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.748 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -51.13 -54.7 22.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.398 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.36 -43.07 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.002 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.35 134.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.72 -32.47 14.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 m -167.88 165.41 13.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.943 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -121.97 148.06 45.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.096 0.474 . . . . 0.0 111.055 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 p -118.11 139.48 51.18 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.54 137.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.162 0.506 . . . . 0.0 111.19 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -119.41 127.84 53.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.901 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -101.69 125.64 48.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 111.425 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -101.36 178.97 4.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.439 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 41' ' ' THR . 36.5 mt-10 -55.03 -42.1 72.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -141.29 19.55 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 110.821 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.8 mt-10 -129.06 145.16 51.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 62' ' ' MET . 92.5 t -117.14 121.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.07 124.02 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -111.8 128.78 56.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -111.62 125.18 53.67 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.485 177.227 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.19 128.08 45.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 56' ' ' GLU . 43.6 t -92.31 112.61 26.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 0.0 110.359 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -112.3 161.56 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.433 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.0 123.96 26.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 110.759 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 -10.93 44.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.592 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -98.71 -68.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 50' ' ' VAL . . . 125.66 -142.59 13.86 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.613 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HG2' HG22 ' A' ' 50' ' ' VAL . 53.1 mt-10 -95.65 120.61 36.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.291 0.567 . . . . 0.0 110.644 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' THR . 73.9 t -104.68 124.89 59.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.694 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -88.13 119.57 28.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.629 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.6 mt -81.09 163.64 54.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.806 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.4 Cg_endo -62.25 146.4 95.89 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.792 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -64.04 131.01 46.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 111.075 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 50.8 mtt -97.43 118.19 33.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.838 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.83 127.71 32.83 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 45' ' ' VAL . 45.6 p90 -129.18 171.81 12.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.959 0.409 . . . . 0.0 111.332 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HE3' HD21 ' A' ' 80' ' ' LEU . 99.0 mttt -120.71 159.73 24.77 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.253 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -103.72 120.97 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.781 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 78' ' ' GLN . 19.9 mt -87.55 -54.0 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.233 0.539 . . . . 0.0 109.813 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -136.46 153.19 51.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.144 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.74 124.39 11.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.455 0.645 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 74' ' ' SER . 35.5 t -108.85 -22.55 12.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.124 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 m 73.77 -38.71 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.851 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.53 -59.41 1.75 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.756 0.312 . . . . 0.0 111.435 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.64 -60.52 2.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.176 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.498 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 30.5 t -154.0 164.84 37.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.407 0.622 . . . . 0.0 111.598 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.55 136.4 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.456 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 67' ' ' ILE . 27.2 tt0 -115.09 131.01 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.739 0.304 . . . . 0.0 110.37 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.64 158.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.136 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.606 ' HB2' HD11 ' A' ' 67' ' ' ILE . 61.8 tt0 -131.84 140.85 49.26 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 58.4 m-85 -86.41 179.42 6.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD21 ' HE3' ' A' ' 65' ' ' LYS . 90.0 mt -134.87 -176.21 4.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.324 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.65 -152.98 30.98 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HG2' ' CE2' ' A' ' 83' ' ' TYR . 28.0 Cg_endo -65.44 -7.35 15.75 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.215 1.944 . . . . 0.0 112.047 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.529 ' CE2' ' HG2' ' A' ' 82' ' ' PRO . 24.8 m-85 -114.16 34.78 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.1 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 19.6 p90 -85.33 -27.35 0.38 Allowed Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 84.2 Cg_endo -83.32 -4.44 11.0 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.439 1.55 . . . . 0.0 112.922 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.88 133.22 44.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.333 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 22.9 pttp -111.49 168.72 9.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.117 0.484 . . . . 0.0 111.181 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 156.47 46.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.315 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -124.58 142.13 51.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.83 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 98' ' ' LEU . 97.6 mt -120.39 124.19 44.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.567 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 32.8 mtmm -124.26 161.56 25.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.39 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.39 144.91 33.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.011 0.434 . . . . 0.0 110.396 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.64 171.09 23.65 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.507 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.18 -19.9 60.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.097 -0.551 . . . . 0.0 111.944 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -121.41 29.66 7.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 -173.667 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.05 39.7 62.92 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -116.63 174.91 5.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.451 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 90' ' ' LEU . 39.1 tp -113.23 131.78 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.89 111.44 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.866 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -97.0 112.89 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.827 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -110.81 132.63 54.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -150.69 128.25 11.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.092 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.66 17.12 9.47 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.6 64.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.82 134.3 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' NH2' ' HE3' ' A' ' 91' ' ' LYS . 96.4 mtt180 -101.39 123.92 46.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 19.3 mmtp -106.99 125.7 51.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.953 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -97.66 113.2 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.38 155.46 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.856 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.11 150.42 20.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.835 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 3.0 ptt180 -95.78 139.82 31.46 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mm -95.87 155.48 3.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.864 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.902 0.858 . . . . 0.0 109.769 177.811 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.818 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 29.3 m . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 16.1 Cg_exo -68.82 90.47 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.192 1.928 . . . . 0.0 112.169 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -75.7 -9.15 58.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.01 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -84.41 -11.68 55.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 15' ' ' PRO . 10.5 m-85 -72.68 151.08 42.43 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.71 -167.07 12.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.388 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.3 m -110.55 128.07 55.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 110.501 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.439 ' CZ3' ' HB3' ' A' ' 111' ' ' ARG . 64.1 m95 -113.36 128.6 56.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.0 t70 -88.21 120.69 29.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.16 76.1 2.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.348 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.23 40.4 2.47 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -128.04 144.49 51.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.43 156.75 0.16 Allowed Pre-proline 0 N--CA 1.465 0.311 0 O-C-N 124.213 0.946 . . . . 0.0 111.756 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.74 134.51 50.94 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.455 2.104 . . . . 0.0 111.857 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.9 -174.85 34.98 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.229 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.607 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 18.2 Cg_endo -59.76 128.4 26.78 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.159 2.573 . . . . 0.0 112.75 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -67.86 -10.38 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.347 0.594 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.88 -33.17 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.561 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.57 -27.96 0.54 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.221 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.607 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 5.8 t -82.59 133.35 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -91.48 -31.08 16.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.092 0.473 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 m -160.2 165.09 32.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.613 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.78 154.85 51.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.012 0.434 . . . . 0.0 111.292 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 22' ' ' ASP . 5.7 p -123.18 130.44 52.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.407 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.39 130.39 66.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.058 0.456 . . . . 0.0 110.572 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.2 m -114.78 127.09 55.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.774 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.83 117.64 35.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.17 0.51 . . . . 0.0 110.2 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -101.11 179.18 4.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.543 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' H ' HG22 ' A' ' 41' ' ' THR . 29.9 mt-10 -52.84 -64.13 0.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -119.18 14.49 13.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 111.698 -174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.49 148.62 34.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.91 0.386 . . . . 0.0 111.019 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 64' ' ' TYR . 98.0 t -110.19 119.45 59.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.526 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.8 123.35 53.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.991 0.424 . . . . 0.0 110.426 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.22 137.24 38.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.368 0.604 . . . . 0.0 110.75 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.03 122.26 31.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.867 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -99.67 135.89 40.41 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.53 112.08 23.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.6 mmm -110.47 124.94 52.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.043 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.56 113.88 2.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.976 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 -26.83 23.15 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.4 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -96.23 -55.03 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.598 0.713 . . . . 0.0 109.813 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.19 -156.64 15.64 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.496 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.99 126.74 30.52 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.279 0.561 . . . . 0.0 110.564 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.88 122.59 68.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.81 128.45 34.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.2 mt -93.75 165.45 17.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.489 173.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.0 Cg_endo -58.45 128.4 28.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.297 1.998 . . . . 0.0 111.432 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -66.89 122.9 18.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.75 0.786 . . . . 0.0 111.231 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 40.2 ttm -80.39 127.87 32.9 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.18 135.76 41.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CD1' HG23 ' A' ' 45' ' ' VAL . 6.2 p90 -147.09 157.93 43.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -123.68 136.64 54.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.169 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 77' ' ' ILE . 78.9 t -75.7 122.94 30.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.882 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 78' ' ' GLN . 27.4 mt -83.9 -54.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.4 m -140.78 156.47 46.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.7 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.67 126.39 11.81 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.161 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -161.94 156.26 22.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.056 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 m -82.17 -26.87 33.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.125 0.488 . . . . 0.0 110.107 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.7 -29.89 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.76 0.81 89.23 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p 60.96 -178.54 0.11 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.97 1.308 . . . . 0.0 112.222 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 11.3 mt -108.13 130.59 60.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.134 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -126.38 128.49 47.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' VAL . 29.4 pt -131.01 155.86 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.996 0.426 . . . . 0.0 111.198 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.758 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 5.6 tp-100 -123.68 146.22 48.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.205 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 41.4 m-85 -98.45 151.05 21.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.873 0.368 . . . . 0.0 110.365 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.4 mt -113.82 164.51 13.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.7 -151.28 23.05 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.513 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.68 -6.91 11.54 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.974 2.449 . . . . 0.0 112.627 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 13.07 30.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -60.45 174.22 0.53 Allowed Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.106 -173.697 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 44.5 Cg_exo 5.18 -0.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 128.847 6.365 . . . . 0.0 121.944 -148.432 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 84' ' ' TYR . 49.0 tp -78.12 103.04 7.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 120.086 1.312 . . . . 0.0 108.095 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 61.4 pttt -95.7 -176.8 3.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -166.38 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 77' ' ' ILE . 40.6 t -141.69 159.32 42.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.235 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.8 m -137.17 144.71 43.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.507 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 87.2 mt -126.59 124.65 40.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.546 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 98' ' ' LEU . 62.3 mttp -123.17 167.0 14.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -79.82 149.52 31.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.952 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.518 ' HA3' ' HB ' ' A' ' 97' ' ' THR . . . -116.24 137.66 13.85 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -41.41 74.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.32 25.78 2.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.453 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.04 39.02 13.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.27 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -107.63 171.91 7.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.362 -0.419 . . . . 0.0 109.886 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 91' ' ' LYS . 34.3 tp -128.8 131.08 47.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.78 112.81 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.446 ' HA ' HD23 ' A' ' 90' ' ' LEU . 20.7 t90 -96.54 112.65 24.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 36.3 mt-10 -104.64 130.04 52.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.458 0.647 . . . . 0.0 110.031 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 19.7 tm0? -153.78 134.74 13.87 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.798 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.9 OUTLIER 66.55 13.33 9.25 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.323 0.39 . . . . 0.0 111.525 173.739 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.28 71.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.073 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.31 142.69 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.554 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 58.7 mtt180 -99.51 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.168 0.508 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 29.7 mmmt -101.7 141.4 34.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.556 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 m -119.24 112.68 19.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HE3' HD23 ' A' ' 98' ' ' LEU . 23.6 ptt? -126.37 141.57 51.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.755 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.7 m -98.94 154.46 18.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.435 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 21' ' ' TRP . 20.3 ptt180 -88.11 157.72 18.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.054 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.7 mm -95.76 147.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--N 1.312 -1.036 0 CA-C-O 121.268 0.556 . . . . 0.0 111.435 -172.114 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.2 124.63 14.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.277 2.651 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -64.78 -27.88 69.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.139 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -83.8 -6.45 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.249 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -71.75 137.11 47.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 109.996 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.03 -149.73 17.42 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.931 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.8 m -127.09 132.37 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.545 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -120.69 150.87 40.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.237 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 112' ' ' ILE . 7.0 t0 -107.23 127.85 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.13 -18.89 41.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.848 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 -56.02 1.07 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 40.0 ttm180 -170.44 149.8 3.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.29 155.86 50.12 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.732 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.23 134.35 33.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.609 2.206 . . . . 0.0 111.019 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.25 -153.22 7.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.667 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.21 138.68 72.29 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.059 2.506 . . . . 0.0 112.05 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -80.3 16.16 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.494 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.72 -31.1 41.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.036 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.99 95.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.987 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -103.62 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -87.01 -37.04 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.153 0.501 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ARG . 51.6 m -159.92 163.69 34.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.923 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.24 130.99 50.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 p -123.8 130.79 53.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.7 127.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.252 0.549 . . . . 0.0 110.484 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 88.8 m -108.41 129.46 55.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.43 117.48 35.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.144 0.497 . . . . 0.0 110.508 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.5 m -102.29 -179.62 4.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.814 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 41' ' ' THR . 29.1 mm-40 -44.3 -66.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.502 0.721 . . . . 0.0 112.609 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -126.08 9.52 7.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 111.205 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -133.3 143.26 48.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.408 0.623 . . . . 0.0 111.411 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.92 128.31 48.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.809 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 45.7 t -104.29 123.46 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.157 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.3 mt-10 -95.2 129.13 42.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.446 0.641 . . . . 0.0 110.655 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.16 116.42 19.9 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.019 176.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.33 135.82 44.25 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.66 110.77 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.541 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 91.4 mtp -116.92 134.86 54.23 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.872 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.6 116.58 10.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.857 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -11.71 66.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.49 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 4.5 mmp_? -106.86 -59.41 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.183 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.84 -165.03 12.16 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.543 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -75.73 127.59 33.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.433 0.635 . . . . 0.0 110.523 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' THR . 79.4 t -115.91 121.84 68.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.158 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -88.58 122.43 32.03 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.844 0.354 . . . . 0.0 110.209 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 74.4 mt -91.13 164.85 23.54 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.554 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 11.7 Cg_endo -57.45 134.48 63.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.589 2.193 . . . . 0.0 111.655 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 46' ' ' VAL . 55.9 m-85 -58.86 132.14 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.346 -174.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.584 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 7.1 mmt -98.94 119.89 38.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 133.55 41.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.431 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -130.24 159.41 36.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 110.912 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 80' ' ' LEU . 50.1 mttm -122.82 158.2 30.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.614 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.59 112.86 38.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.131 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 78' ' ' GLN . 16.4 mt -83.05 -54.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.594 0.711 . . . . 0.0 109.702 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -142.36 150.74 41.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.585 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 71' ' ' THR . 60.9 tt0 -150.28 132.55 15.47 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.612 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 74' ' ' SER . 17.4 t -93.72 -21.24 19.46 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.492 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 26.6 m 75.15 -35.4 0.28 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.782 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.83 -7.0 22.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.694 ' HA3' HH11 ' A' ' 92' ' ' ARG . . . -158.87 -51.76 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.145 -1.502 . . . . 0.0 114.219 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 70' ' ' SER . 2.8 p -118.73 143.03 47.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.261 0.553 . . . . 0.0 112.466 -173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 69' ' ' GLN . 22.4 mt -136.64 137.6 47.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.432 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -118.91 124.58 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 30.2 pt -126.82 155.2 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.384 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.629 ' HB2' HD11 ' A' ' 67' ' ' ILE . 36.1 tt0 -124.45 146.93 48.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 21.1 m-85 -86.35 152.99 22.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.726 0.298 . . . . 0.0 110.487 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 65' ' ' LYS . 98.1 mt -114.26 163.72 14.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.31 -152.27 21.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.503 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.34 -8.57 12.87 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.965 2.444 . . . . 0.0 112.665 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 49.0 m-85 -104.75 18.67 21.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.858 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 2.2 p90 -55.71 169.63 0.49 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -176.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.858 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 9.28 -0.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 1 C-N-CA 128.734 6.289 . . . . 0.0 121.418 -150.983 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 87' ' ' LYS . 2.7 tm? -73.66 146.3 44.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 86' ' ' LEU . 65.9 pttt -144.17 173.1 12.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.644 0.735 . . . . 0.0 112.793 -167.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 m -132.69 159.42 39.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.029 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.3 m -130.26 142.82 50.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.5 mt -121.74 124.73 44.91 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 46.5 mmtm -114.59 170.03 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.694 HH11 ' HA3' ' A' ' 73' ' ' GLY . 27.7 ptt-85 -92.71 145.02 24.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.425 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -104.75 138.69 14.29 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.78 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.11 -35.91 76.28 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.091 0.556 . . . . 0.0 112.077 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -95.89 24.74 5.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.312 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.24 42.24 24.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.383 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.425 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 18.0 p -121.0 173.94 6.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.649 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 tp -120.39 131.33 54.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 63.8 mt -99.12 112.98 32.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.736 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 10.0 t90 -99.98 115.56 29.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.381 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 26.0 mt-10 -97.67 129.64 44.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -152.8 124.26 7.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.317 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 67.26 -7.46 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.44 0.463 . . . . 0.0 112.172 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.45 9.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.773 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.54 136.97 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.568 0.223 . . . . 0.0 110.413 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 76.1 mtt180 -100.41 116.32 32.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.898 0.38 . . . . 0.0 110.424 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -119.41 141.28 49.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.183 0.516 . . . . 0.0 111.332 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -94.41 122.69 37.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.952 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 100' ' ' TRP . 66.1 mtp -102.55 133.44 47.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.38 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -97.77 143.87 27.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.714 0.292 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -88.44 123.9 33.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.27 0.557 . . . . 0.0 110.992 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -79.02 155.84 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.461 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.357 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.675 0.274 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.5 Cg_exo -68.1 125.51 13.13 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.947 2.431 . . . . 0.0 111.161 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -67.49 -19.65 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -90.38 -13.06 35.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.349 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 18.0 t80 -78.61 134.0 37.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.86 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.93 -155.43 21.24 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.057 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.6 m -121.16 131.44 54.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.823 0.344 . . . . 0.0 110.35 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.541 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 74.0 m95 -116.26 141.41 48.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.1 t70 -106.11 133.49 50.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.052 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 51.5 mt-10 -94.87 71.46 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.652 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.21 41.6 3.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.832 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -167.32 147.79 5.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 74.74 144.71 0.11 Allowed Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.163 0.914 . . . . 0.0 111.464 -178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 6.2 Cg_exo -79.77 160.81 24.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.122 2.548 . . . . 0.0 112.986 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.95 8.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -38.35 128.11 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 124.261 3.308 . . . . 0.0 113.602 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -64.65 -13.24 53.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.96 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.12 -33.75 76.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.16 -10.0 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.852 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -81.71 132.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -94.87 -25.76 16.46 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.818 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 4.4 m 175.67 -178.95 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.23 0.956 . . . . 0.0 108.679 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.95 167.42 18.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.995 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 22' ' ' ASP . 15.9 p -117.89 137.23 52.94 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.6 p -112.09 124.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.377 0.608 . . . . 0.0 111.098 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 82.1 m -106.31 125.85 51.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.722 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.52 118.77 37.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 110.813 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.2 m -89.72 179.84 5.92 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 41' ' ' THR . 0.3 OUTLIER -47.37 -46.65 25.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.642 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -148.42 27.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.362 0.601 . . . . 0.0 110.539 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.82 159.53 41.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.347 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 64' ' ' TYR . 92.3 t -117.82 129.87 73.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.447 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 97.2 t -111.38 123.93 67.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -100.61 137.28 39.23 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.277 0.56 . . . . 0.0 111.514 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -123.27 117.4 25.19 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.214 172.117 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.57 133.44 43.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 56' ' ' GLU . 36.0 t -96.6 113.51 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.871 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 ttt -133.78 141.77 47.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.694 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.43 132.64 48.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.187 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.3 -14.61 61.97 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.281 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.41 -56.71 2.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 110.191 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.07 -143.52 15.74 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.358 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.9 mt-10 -96.33 115.61 27.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.46 0.648 . . . . 0.0 110.43 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.5 t -104.57 126.89 59.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.289 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.4 mt-30 -83.76 130.54 34.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.851 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 93.9 mt -93.73 160.15 33.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.757 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.7 Cg_endo -61.91 121.82 10.06 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.539 2.159 . . . . 0.0 111.545 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -45.9 128.79 9.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.216 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.5 mmm -110.48 129.67 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.518 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.33 148.51 29.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.746 0.307 . . . . 0.0 110.674 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CD1' HG23 ' A' ' 45' ' ' VAL . 28.7 p90 -144.28 164.91 29.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.05 155.63 36.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 109.992 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 77' ' ' ILE . 95.6 t -101.72 112.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.734 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.0 mt -73.83 -51.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.431 0.634 . . . . 0.0 109.629 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.08 146.26 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.48 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -149.07 136.88 20.52 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.264 0.554 . . . . 0.0 110.894 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t -107.38 149.08 28.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.557 171.708 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -61.35 -32.96 72.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.281 0.562 . . . . 0.0 109.678 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -157.51 91.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.802 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.81 -94.61 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.231 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.446 ' OG ' ' HG2' ' A' ' 91' ' ' LYS . 65.4 m -136.66 157.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -110.07 118.84 37.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.419 HG22 HG22 ' A' ' 66' ' ' VAL . 33.8 pt -126.29 158.14 36.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.779 -174.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 67' ' ' ILE . 8.8 tt0 -135.99 127.81 29.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.429 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 67.3 m-85 -85.17 129.34 34.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 84' ' ' TYR . 69.7 mt -86.53 162.22 18.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.921 0.391 . . . . 0.0 110.576 -176.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.4 -152.21 17.4 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.426 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.57 -18.71 65.05 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.803 2.335 . . . . 0.0 112.485 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -111.41 31.63 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.489 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 2.5 p90 -90.62 -1.14 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -169.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 94.6 Cg_endo -92.01 -3.49 4.01 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 CA-C-N 121.719 1.65 . . . . 0.0 112.764 166.665 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.79 134.27 50.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.197 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -113.72 174.27 6.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.24 0.543 . . . . 0.0 112.104 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -143.7 165.89 26.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.507 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -134.14 142.87 47.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 111.267 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.56 135.17 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.83 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 66.0 mttm -132.41 162.6 30.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.763 0.316 . . . . 0.0 110.324 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 92' ' ' ARG . 15.8 ptt-85 -84.67 144.92 28.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.31 152.46 20.65 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.09 -10.85 60.23 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -141.69 77.48 1.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.727 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.39 48.09 21.74 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.886 0.741 . . . . 0.0 113.535 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.5 169.77 16.98 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.748 -0.266 . . . . 0.0 110.942 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -124.07 135.26 53.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 82.1 mt -102.78 117.34 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.79 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.0 t90 -109.9 113.73 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -108.97 134.88 51.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.349 0.595 . . . . 0.0 111.078 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.55 119.0 6.43 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.38 -68.12 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.067 0.854 . . . . 0.0 112.018 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.04 1.65 0.07 OUTLIER Glycine 0 C--N 1.316 -0.58 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.822 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -113.42 135.42 53.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.724 0.762 . . . . 0.0 110.355 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -102.46 115.57 30.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.374 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 21.5 mmtp -94.89 136.59 35.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.041 0.448 . . . . 0.0 110.858 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 m -109.12 113.69 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' A' ' 21' ' ' TRP . 64.3 mtp -110.76 144.92 38.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.494 -174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -95.33 153.36 17.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.203 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -90.13 142.63 27.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.7 mm -92.99 148.98 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.173 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.544 179.844 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.9 t . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.6 Cg_exo -74.91 84.35 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.503 2.135 . . . . 0.0 111.486 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.571 ' HE1' ' HA ' ' A' ' 71' ' ' THR . 44.2 p90 -65.36 -24.39 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.54 -176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -82.35 -19.52 39.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -80.09 138.57 36.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.983 0.421 . . . . 0.0 110.764 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.54 -153.42 20.43 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.133 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -119.68 128.43 53.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 63.0 m95 -121.67 139.69 53.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.638 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 112' ' ' ILE . 9.9 t0 -107.94 135.6 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 55.7 mt-10 -54.12 -45.5 71.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.87 22.03 25.48 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.848 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -170.89 149.72 3.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 69.39 144.76 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.75 0.657 . . . . 0.0 111.479 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.7 Cg_exo -78.44 151.16 25.69 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.908 2.405 . . . . 0.0 112.582 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.45 -166.63 25.53 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.571 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.6 150.62 1.4 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.224 3.283 . . . . 0.0 113.949 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -72.31 -7.71 50.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.41 -12.41 51.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.962 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.84 41.98 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.866 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 t -105.12 133.28 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.58 -30.31 20.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.392 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 22.7 p -176.37 174.43 1.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.437 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.04 157.73 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.493 0.663 . . . . 0.0 111.0 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 1.5 p -117.39 129.51 55.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.662 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -112.54 129.41 68.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.225 0.536 . . . . 0.0 109.904 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 m -114.14 130.07 56.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.172 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.26 116.2 32.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.55 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -103.23 -178.28 3.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -47.96 -51.19 24.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -138.01 10.63 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.544 0.212 . . . . 0.0 111.389 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.55 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -138.76 149.1 44.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 111.785 -177.014 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' CD1' ' A' ' 64' ' ' TYR . 78.4 t -111.71 124.96 68.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.26 124.37 64.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.13 134.21 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.542 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 1.7 m -124.9 135.38 52.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.078 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.0 127.96 47.26 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -97.02 112.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.268 0.556 . . . . 0.0 110.702 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -119.21 107.18 13.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.905 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.96 117.1 5.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.77 -36.01 3.62 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -99.52 -62.3 1.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.697 0.76 . . . . 0.0 109.547 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 -164.42 24.21 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.052 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG3' HG22 ' A' ' 50' ' ' VAL . 11.2 mp0 -80.16 127.01 31.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 117.637 0.719 . . . . 0.0 110.177 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.54 121.54 63.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.604 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -80.36 130.52 35.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 111.622 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.7 mt -91.76 163.89 26.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.714 174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 73.6 Cg_exo -49.37 125.22 13.29 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.712 2.275 . . . . 0.0 112.114 176.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.74 137.57 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtm -108.09 121.99 45.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.33 148.15 41.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.566 ' CD1' HG23 ' A' ' 45' ' ' VAL . 9.9 p90 -146.85 151.43 37.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.33 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 158.94 29.79 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.69 112.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 78' ' ' GLN . 20.1 mt -76.83 -54.08 13.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.52 151.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.584 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -155.27 111.56 3.18 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.98 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.571 ' HA ' ' HE1' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -69.92 -11.0 60.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.105 174.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.24 -56.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.633 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.4 -47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.993 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 26.8 t -161.25 155.56 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.614 0.721 . . . . 0.0 112.721 -169.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.3 mt -126.21 137.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.342 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' HG2' HD12 ' A' ' 67' ' ' ILE . 37.7 tt0 -117.45 124.59 49.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 pt -129.98 157.47 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.402 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.647 ' OE1' ' HA ' ' A' ' 85' ' ' PRO . 23.2 tt0 -131.65 135.53 46.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.618 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -82.89 3.58 29.19 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -169.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.7 mt 52.29 -162.52 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.607 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.42 -151.86 42.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.816 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.22 -8.7 23.64 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.687 2.258 . . . . 0.0 111.579 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.88 15.24 22.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.447 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -65.7 178.07 0.62 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.647 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 11.2 Cg_exo 10.91 -1.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.274 1 C-N-CA 126.985 5.124 . . . . 0.0 120.263 -142.161 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.7 tp -78.12 103.83 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -103.9 172.08 7.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.379 0.609 . . . . 0.0 111.814 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 t -132.39 148.33 52.41 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.084 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.3 m -123.92 143.63 50.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.561 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 98' ' ' LEU . 85.8 mt -128.0 123.93 35.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.117 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 30.3 mtmm -123.67 160.32 27.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.709 0.29 . . . . 0.0 110.505 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -80.36 144.71 32.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.474 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -99.21 -175.53 31.64 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.465 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -91.43 -30.15 16.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.972 0.415 . . . . 0.0 111.935 -171.775 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -102.59 25.76 8.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.637 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.93 37.65 50.1 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.613 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' THR . . . . . 0.474 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 15.9 p -105.17 174.58 5.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.901 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 90' ' ' LEU . 29.8 tp -122.95 133.74 54.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 63.4 mt -96.96 110.25 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -98.34 113.21 25.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.867 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 11.9 mt-10 -110.85 132.01 54.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.73 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.451 ' NE2' ' HB2' ' A' ' 103' ' ' ASN . 23.2 tm0? -152.21 118.2 5.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.456 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.451 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 54.8 t30 63.97 24.04 13.49 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.657 0.742 . . . . 0.0 111.288 164.117 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.48 34.47 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.124 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -92.48 132.91 36.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.542 0.671 . . . . 0.0 111.346 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -103.58 116.36 32.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.919 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -127.08 117.8 23.15 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.4 m -93.16 114.15 26.58 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -112.28 159.73 18.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.116 -173.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -104.39 153.75 20.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.24 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -88.27 161.19 17.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 22' ' ' ASP . 21.7 mm -94.86 151.86 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.049 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.316 -0.856 0 CA-C-O 121.037 0.446 . . . . 0.0 109.817 -179.391 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.516 0.198 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 31.6 Cg_exo -58.98 122.25 11.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.889 2.392 . . . . 0.0 111.713 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -67.98 -14.91 63.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -98.99 -8.48 25.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.373 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 36.9 t80 -81.93 140.2 34.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.96 -171.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.1 -149.83 17.3 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.252 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 m -119.51 134.24 55.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.7 0.285 . . . . 0.0 110.254 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 82.3 m95 -126.08 142.64 51.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.606 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 112' ' ' ILE . 1.5 t70 -96.08 120.05 35.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.54 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.586 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 12.6 pt-20 -98.5 79.17 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.993 0.902 . . . . 0.0 109.795 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.83 -8.05 56.61 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.881 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.731 HH11 ' HB2' ' A' ' 26' ' ' ALA . 1.1 tmt_? -101.04 140.3 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.731 ' HB2' HH11 ' A' ' 25' ' ' ARG . . . 65.01 143.67 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.354 1.034 . . . . 0.0 111.274 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 74.1 Cg_endo -93.04 172.62 2.02 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.546 2.164 . . . . 0.0 112.242 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.9 -155.13 20.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.488 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HD2' HG21 ' A' ' 33' ' ' VAL . 10.3 Cg_endo -56.2 163.74 5.93 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.8 2.333 . . . . 0.0 112.804 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 m -74.72 2.52 9.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.566 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.84 -43.2 96.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.81 59.39 0.02 OUTLIER Glycine 0 CA--C 1.513 -0.065 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.56 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.609 HG21 ' HD2' ' A' ' 29' ' ' PRO . 8.3 t -100.24 134.61 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.887 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 8.7 mmpt? -81.71 -40.79 22.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -166.45 165.86 16.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.058 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.61 148.73 52.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.431 . . . . 0.0 111.266 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -133.5 131.49 39.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.155 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.85 139.56 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.925 0.393 . . . . 0.0 110.93 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.5 m -119.39 129.34 54.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.06 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -101.89 117.64 35.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.1 p -101.9 -177.35 3.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.184 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -45.03 -56.13 4.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.466 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.22 -4.13 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.719 -173.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.39 157.15 28.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.542 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.63 117.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 61' ' ' PHE . 33.3 t -108.56 124.21 64.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.78 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.76 136.48 42.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.654 0.74 . . . . 0.0 110.737 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.83 116.98 21.71 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.476 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -108.29 128.55 54.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.12 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.43 113.65 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.522 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.3 mtm -123.08 130.64 53.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.467 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.45 131.51 47.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.705 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.97 -29.44 11.24 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.284 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -122.57 -33.85 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 111.311 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.2 -151.24 19.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.564 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.09 133.45 46.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.228 0.537 . . . . 0.0 110.165 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.4 t -123.87 123.85 67.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.229 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -85.63 118.63 25.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.905 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.57 159.54 55.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 114.37 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.077 1.852 . . . . 0.0 110.62 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' HG22 ' A' ' 46' ' ' VAL . 32.5 p90 -69.9 146.69 51.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.534 -172.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.28 148.76 22.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.53 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.72 131.6 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -114.57 142.48 46.37 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.374 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -122.17 151.11 41.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.728 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.23 125.19 41.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.077 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.9 mt -96.26 -55.62 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -131.61 153.86 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.805 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.13 152.7 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 111.48 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 74' ' ' SER . 42.1 t -139.71 167.33 22.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -80.33 -38.8 29.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.34 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 6.4 p-10 -147.96 9.57 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.408 -172.335 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.19 -81.11 1.47 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.318 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 5.1 p -145.52 152.01 39.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 111.677 -174.486 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 22.4 mt -125.98 138.49 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.5 tt0 -117.54 127.38 53.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -125.66 157.08 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' A' ' 67' ' ' ILE . 8.3 tt0 -126.58 144.19 50.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -83.23 149.29 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.225 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -105.1 167.79 9.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.22 -152.1 21.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.23 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.04 -5.17 15.75 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.579 2.186 . . . . 0.0 111.795 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -98.6 15.58 24.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.724 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.757 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -63.0 -177.3 0.19 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.132 175.622 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.757 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 12.32 -0.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.252 1 C-N-CA 127.35 5.367 . . . . 0.0 120.561 -148.098 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.8 tp -85.31 121.26 27.78 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -120.65 168.48 11.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.386 0.612 . . . . 0.0 111.603 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.27 154.9 47.13 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.635 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 10.4 m -113.82 141.82 46.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.476 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 96.6 mt -124.14 124.78 43.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.287 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 33.3 mtmm -133.4 157.43 45.58 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.934 0.397 . . . . 0.0 110.467 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 24.1 ptt180 -66.16 147.26 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.058 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLY . . . . . 0.47 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -73.25 -170.23 18.38 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.159 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -86.96 -39.34 15.81 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.191 0.519 . . . . 0.0 110.013 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -148.64 102.2 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.925 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 53.82 44.92 70.8 Favored Glycine 0 C--N 1.333 0.385 0 O-C-N 123.349 0.406 . . . . 0.0 113.183 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.03 174.0 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.413 0.149 . . . . 0.0 111.149 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 tp -129.31 136.17 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG13 ' HA2' ' A' ' 93' ' ' GLY . 67.5 mt -111.55 110.59 32.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.877 0.37 . . . . 0.0 110.33 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.443 ' HE3' ' HE3' ' A' ' 109' ' ' MET . 10.0 t90 -105.14 113.07 26.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.786 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.614 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 70.2 mt-10 -96.49 130.3 43.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.423 0.63 . . . . 0.0 110.089 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' CD ' ' HB2' ' A' ' 103' ' ' ASN . 25.8 tm0? -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.684 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB2' ' CD ' ' A' ' 102' ' ' GLN . 5.8 t-20 67.75 9.89 7.4 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.409 0.443 . . . . 0.0 111.252 172.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.5 -10.85 53.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.255 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -108.62 143.5 37.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.854 -0.203 . . . . 0.0 110.547 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.614 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 24.6 ptt180 -99.4 126.26 45.26 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 1.5 mptm? -88.66 126.52 35.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.529 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 m -94.78 113.76 25.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.586 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 59.9 mtt -114.62 142.33 46.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 112.273 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.02 151.01 19.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.104 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -86.09 123.99 32.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 22' ' ' ASP . 37.3 mm -72.76 147.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.429 0.633 . . . . 0.0 111.518 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.656 -179.076 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 19.6 m . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.175 0.512 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.2 Cg_exo -63.44 104.17 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.985 2.457 . . . . 0.0 111.879 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.82 -15.17 63.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.382 -174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -101.85 6.79 41.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.01 125.99 44.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.158 0.504 . . . . 0.0 111.072 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.21 -168.95 24.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.236 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.1 m -102.07 131.44 48.54 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 109' ' ' MET . 62.6 m95 -116.09 137.14 52.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.816 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.592 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.9 t70 -99.79 127.01 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 112.185 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 35' ' ' SER . 44.4 mt-10 -101.64 78.04 1.8 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.997 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.11 -0.46 35.73 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.324 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 25' ' ' ARG . 6.9 tpp180 -114.9 144.11 44.08 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.65 146.83 0.12 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 0.0 111.179 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.54 171.91 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.497 2.132 . . . . 0.0 112.721 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.86 -155.18 25.03 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.887 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -38.38 145.54 0.16 Allowed 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 124.28 3.32 . . . . 0.0 113.665 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.21 -5.67 14.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -171.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.75 -36.09 81.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.09 53.61 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.597 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 49' ' ' GLU . 18.8 t -100.94 134.37 41.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -79.03 -39.68 33.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 38.5 m -159.77 166.17 30.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.085 -171.37 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.49 152.33 40.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 22' ' ' ASP . 12.9 p -131.87 127.04 35.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.33 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.89 136.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.106 0.479 . . . . 0.0 111.233 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 m -121.77 125.64 47.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.653 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.77 116.43 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.876 0.37 . . . . 0.0 110.375 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -104.58 170.13 8.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.92 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 41' ' ' THR . 32.5 tt0 -61.22 -45.86 92.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.877 0.37 . . . . 0.0 111.934 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.85 -9.2 23.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 3.7 pt-20 -156.74 148.08 22.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -166.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.7 t -101.77 118.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.843 170.002 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.34 124.46 55.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.7 0.286 . . . . 0.0 110.457 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.04 136.7 37.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.608 0.718 . . . . 0.0 111.518 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 2.3 m -128.47 131.4 48.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.526 171.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' HG11 ' A' ' 33' ' ' VAL . 32.9 mt-10 -120.53 135.93 54.93 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.522 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' A' ' 56' ' ' GLU . 45.8 t -96.41 113.6 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -119.74 126.88 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.384 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 106.88 6.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.325 0.583 . . . . 0.0 110.477 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.05 6.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.26 -60.01 1.65 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.921 0.867 . . . . 0.0 109.747 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.04 -166.32 14.04 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.003 -172.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.6 mp0 -71.89 127.15 31.66 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.502 0.668 . . . . 0.0 111.433 174.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.0 t -118.39 122.69 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.928 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 48' ' ' THR . 82.1 mt-30 -93.74 126.76 39.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.916 0.389 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.48 161.76 26.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.316 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 137.03 40.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.887 2.391 . . . . 0.0 112.059 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.615 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 44.2 p90 -72.09 152.49 42.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.8 mtp -111.87 140.45 46.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.663 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.96 28.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.502 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD1' HG23 ' A' ' 45' ' ' VAL . 7.7 p90 -147.28 166.52 26.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.812 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -128.19 159.3 35.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.55 126.3 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.123 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.2 mt -85.43 -51.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.1 m -145.03 161.31 39.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.462 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -148.97 132.99 17.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.08 0.466 . . . . 0.0 110.777 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' SER . 31.6 t -151.01 121.88 7.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -78.11 -15.74 58.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.527 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -104.27 -21.45 13.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.726 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 -67.06 0.47 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.838 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 47.3 t -177.52 157.09 1.23 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 0.0 110.993 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -116.85 132.71 65.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.212 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.498 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.0 tt0 -111.09 123.73 50.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 pt -124.96 157.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.032 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 36.1 tt0 -138.42 139.94 39.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 98.0 m-85 -88.17 153.97 20.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 0.0 110.896 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.4 mt -110.77 -176.82 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.029 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.54 -152.52 35.76 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.68 -16.91 51.59 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.396 2.064 . . . . 0.0 111.926 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -92.31 20.41 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.96 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 26.3 p90 -61.17 172.27 0.97 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.707 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 11.5 -0.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.084 1 C-N-CA 128.153 5.902 . . . . 0.0 121.065 -150.08 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.0 tp -69.22 104.21 2.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 119.556 1.071 . . . . 0.0 108.289 167.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 61.1 pttt -103.63 174.71 5.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.414 0.626 . . . . 0.0 111.94 -171.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 t -144.66 161.36 39.36 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.157 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -124.28 142.97 50.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.8 0.334 . . . . 0.0 110.578 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.48 122.72 38.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 53.4 mttp -118.83 160.58 21.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.2 0.524 . . . . 0.0 111.188 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -70.61 143.0 51.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.57 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.9 143.77 22.45 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.888 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.82 -44.5 73.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.908 -0.646 . . . . 0.0 111.172 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -128.51 81.34 2.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.81 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 55.3 55.1 30.06 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.711 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.52 175.24 10.09 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.832 -0.216 . . . . 0.0 111.112 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.57 135.26 54.52 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.576 HG23 ' HG3' ' A' ' 106' ' ' ARG . 82.7 mt -104.9 111.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.245 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 15.7 t90 -97.87 112.77 24.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.811 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 28.8 mt-10 -102.12 131.66 48.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -151.64 123.58 8.09 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.701 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.28 19.77 10.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.314 0.384 . . . . 0.0 111.827 173.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.07 -21.86 34.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.533 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 10.6 pt20 -92.61 145.65 24.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.013 0.406 . . . . 0.0 110.947 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HG3' HG23 ' A' ' 99' ' ' ILE . 15.6 ttm180 -94.04 117.98 30.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 28.1 mmtm -95.04 117.99 31.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.096 0.475 . . . . 0.0 109.809 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -100.13 114.59 28.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.615 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 21' ' ' TRP . 12.3 ptp -127.65 137.92 52.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.338 0.589 . . . . 0.0 111.729 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -101.05 146.43 27.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.582 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -80.52 127.73 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.158 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 22' ' ' ASP . 31.4 mm -73.57 145.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.535 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.311 -1.108 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 -176.447 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 10.1 t . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.247 0.546 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 37.9 Cg_exo -62.9 103.91 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.864 2.376 . . . . 0.0 111.949 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.78 -10.98 60.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.284 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 44.5 p90 -89.57 -6.62 56.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -71.35 138.99 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.136 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.42 -163.5 21.18 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.033 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.6 m -115.23 122.64 46.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.022 0.439 . . . . 0.0 110.432 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 50.1 m95 -116.3 133.64 55.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.139 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' CB ' HD11 ' A' ' 112' ' ' ILE . 11.7 t70 -109.68 132.43 54.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.952 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 109' ' ' MET . 6.2 mm-40 -74.04 -58.15 3.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.603 173.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.94 32.16 55.9 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 9.0 ttm180 -158.08 167.68 29.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -167.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . . . 67.43 165.36 0.12 Allowed Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.928 0.768 . . . . 0.0 112.211 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 134.5 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.355 2.037 . . . . 0.0 111.356 171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 -166.31 21.28 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.977 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -48.62 125.15 12.07 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.067 2.511 . . . . 0.0 111.868 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -80.1 -1.44 40.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.26 -33.92 74.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.559 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 146.57 37.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.977 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.63 138.91 28.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -86.58 -28.09 23.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.994 0.425 . . . . 0.0 111.108 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 p -177.31 167.47 2.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.981 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.43 144.23 49.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -117.87 133.58 55.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.111 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.03 136.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 111.161 -175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.6 m -123.02 130.94 53.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.555 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -100.61 120.61 40.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.097 0.475 . . . . 0.0 110.317 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -95.7 179.1 5.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.374 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 41' ' ' THR . 29.6 mt-10 -51.53 -38.68 55.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.306 0.642 . . . . 0.0 111.801 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -151.37 19.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 111.447 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -131.1 147.73 52.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 64' ' ' TYR . 66.5 t -101.84 118.51 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.464 HG22 ' CD1' ' A' ' 61' ' ' PHE . 70.6 t -108.21 124.42 64.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.34 137.5 52.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.342 0.591 . . . . 0.0 110.453 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.48 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.26 138.1 51.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.141 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -97.98 125.4 42.9 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 56' ' ' GLU . 48.6 t -90.11 110.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.512 ' SD ' ' HG3' ' A' ' 54' ' ' ARG . 43.0 ttm -112.07 135.21 53.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.151 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.77 113.35 3.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.934 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.57 -18.4 56.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.752 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 9.6 mmt180 -101.36 -74.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.816 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.41 -156.1 26.64 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 50' ' ' VAL . 44.8 mt-10 -92.92 120.69 33.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.415 0.626 . . . . 0.0 111.179 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -112.57 128.12 69.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.892 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HG2' HG23 ' A' ' 48' ' ' THR . 79.8 mt-30 -80.07 131.55 35.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.143 0.497 . . . . 0.0 111.601 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -87.86 163.7 36.98 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.494 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.25 123.58 12.27 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.648 2.232 . . . . 0.0 111.749 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 46' ' ' VAL . 17.8 m-85 -68.42 142.15 55.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.143 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.4 mtm -109.86 123.74 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.801 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.57 140.09 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD1' HG23 ' A' ' 45' ' ' VAL . 42.1 p90 -132.82 170.9 14.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.885 0.374 . . . . 0.0 110.63 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 80' ' ' LEU . 10.0 ptmm? -144.1 143.0 30.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.66 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -83.33 124.3 39.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.727 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 78' ' ' GLN . 11.5 mt -85.62 -54.41 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.595 0.712 . . . . 0.0 109.661 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 m -139.56 163.44 32.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.818 -174.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -144.51 149.27 35.65 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.5 t -125.33 121.02 32.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.6 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.89 -6.39 32.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 111.366 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.89 -48.17 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.571 ' HA3' ' HD3' ' A' ' 92' ' ' ARG . . . 146.33 46.49 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.64 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.6 m -147.27 151.97 37.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.224 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.49 138.44 48.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.231 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -110.46 126.8 54.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.934 0.397 . . . . 0.0 109.973 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.76 157.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.454 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.661 ' HB2' HD11 ' A' ' 67' ' ' ILE . 34.7 tt0 -132.34 144.85 50.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.614 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -92.86 156.98 16.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.02 0.438 . . . . 0.0 110.76 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 65' ' ' LYS . 83.1 mt -112.08 -177.08 3.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.415 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.85 -151.93 41.65 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.238 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.86 -5.27 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.551 2.168 . . . . 0.0 112.154 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -102.75 20.54 17.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.142 0.496 . . . . 0.0 109.805 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.959 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.1 p90 -58.47 170.81 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.298 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.959 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 1.2 Cg_exo 9.34 0.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.162 1 C-N-CA 128.711 6.274 . . . . 0.0 121.659 -152.699 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 84' ' ' TYR . 66.8 tp -66.57 109.81 2.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 119.986 1.266 . . . . 0.0 109.062 170.082 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.96 166.77 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 111.874 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 t -140.22 156.2 46.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.527 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -112.72 141.3 46.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.134 0.492 . . . . 0.0 110.89 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.93 126.75 49.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.805 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 94.0 mttt -124.95 154.96 40.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.945 0.402 . . . . 0.0 110.257 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.571 ' HD3' ' HA3' ' A' ' 73' ' ' GLY . 36.4 ptt-85 -79.42 144.26 34.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.051 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.7 26.54 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.14 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.12 134.36 38.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.021 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 71.89 -66.14 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.639 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.29 59.59 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.47 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 p -134.74 170.07 16.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.122 0.169 . . . . 0.0 110.581 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.3 tp -129.53 135.42 48.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.604 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 75.2 mt -105.65 126.26 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 17.7 t90 -117.3 115.75 25.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.079 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -110.99 134.87 52.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 111.432 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.68 121.35 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.937 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.85 9.74 5.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.635 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.95 -8.05 29.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.716 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.05 134.65 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -102.02 116.13 32.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.104 0.478 . . . . 0.0 111.237 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 2.0 mmpt? -98.55 139.49 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.547 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.9 m -121.74 112.24 18.15 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.572 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 52.2 mtm -116.8 141.4 48.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -173.507 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -98.63 151.77 20.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.539 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 57.1 ttp85 -83.5 127.4 33.69 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 22' ' ' ASP . 30.0 mm -85.4 144.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.47 0.652 . . . . 0.0 110.598 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.31 -1.12 0 CA-C-N 114.605 -1.18 . . . . 0.0 107.898 174.962 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 t . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.687 0.28 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 39.5 Cg_exo -61.42 109.37 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -68.45 -18.99 64.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.194 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -95.02 -10.18 31.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.795 0.331 . . . . 0.0 111.305 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 42.8 t80 -80.64 130.29 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 0.0 110.969 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.86 -164.24 25.51 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.263 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -105.39 130.69 53.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 98' ' ' LEU . 71.7 m95 -119.54 144.56 46.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.262 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.7 t70 -96.76 141.37 30.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 6.1 mm-40 -48.14 -49.97 30.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.12 -54.52 3.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.637 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -135.95 164.19 28.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.32 161.45 0.16 Allowed Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 124.039 0.837 . . . . 0.0 111.395 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.29 175.4 9.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.628 2.218 . . . . 0.0 112.154 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.21 -153.69 7.64 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.399 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.778 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 4.5 Cg_endo -47.68 148.62 5.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 124.355 3.37 . . . . 0.0 113.433 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.3 p -81.26 -2.17 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.923 -172.447 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.72 -1.04 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.251 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.62 35.23 29.36 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.897 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.778 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 24.6 t -76.4 133.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.767 ' HE3' ' HB3' ' A' ' 52' ' ' GLU . 49.5 mtmt -91.47 -13.58 31.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.813 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 18.5 m -148.7 157.51 43.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.877 0.37 . . . . 0.0 110.609 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -159.79 145.87 15.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.084 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 139.53 44.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.092 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.31 133.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 110.121 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -121.26 124.57 44.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.839 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -101.97 117.81 35.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.123 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -102.33 179.43 4.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.327 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 41' ' ' THR . 33.1 mt-10 -54.93 -42.92 72.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -128.21 -16.25 4.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.921 0.391 . . . . 0.0 111.808 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 6.9 pt-20 -125.76 142.17 51.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.166 0.508 . . . . 0.0 111.803 -173.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.61 125.56 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 61' ' ' PHE . 66.9 t -115.92 123.82 71.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 137.92 34.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 110.736 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.568 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -125.63 118.85 26.57 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.647 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -105.63 125.61 51.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.198 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.813 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 42.5 t -98.86 111.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.258 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -99.48 109.11 21.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.767 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 41.5 tt0 -65.39 106.63 1.43 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.045 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.95 -29.68 2.19 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.116 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' GLY . 17.0 ptp180 -125.01 -51.77 1.67 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.515 0.197 . . . . 0.0 111.04 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' ARG . . . 142.45 -156.36 26.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.017 -176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -79.8 146.34 32.33 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 111.818 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.21 122.05 59.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.412 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.0 mt-30 -95.68 131.5 41.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.806 0.336 . . . . 0.0 111.052 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.17 157.25 39.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.245 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.02 118.61 4.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.815 2.343 . . . . 0.0 111.577 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' A' ' 46' ' ' VAL . 52.6 p90 -60.44 145.35 48.55 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.214 0.53 . . . . 0.0 111.481 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.11 125.83 50.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.809 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.7 136.42 34.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -127.12 161.11 29.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.723 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -122.18 144.46 48.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.3 t -89.4 114.02 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.828 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 78' ' ' GLN . 10.1 mt -81.15 -56.69 5.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.741 0.781 . . . . 0.0 109.188 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -124.77 149.39 47.4 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.626 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -147.65 136.45 21.97 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.372 0.606 . . . . 0.0 111.774 -170.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 74' ' ' SER . 37.0 t -141.3 150.54 42.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.811 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -9.57 55.37 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -146.41 -27.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.73 -76.21 0.95 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.562 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.529 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 3.4 p -159.28 164.41 34.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 mt -132.92 135.53 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.43 131.72 55.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 pt -130.76 156.81 42.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.561 ' HB2' HD11 ' A' ' 67' ' ' ILE . 9.5 tt0 -124.98 131.74 53.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.658 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -85.62 152.96 22.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 111.034 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.72 -178.0 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.603 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.82 -152.27 34.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.175 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.59 -10.73 17.45 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.722 2.281 . . . . 0.0 112.589 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.59 25.96 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 1.011 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 34.9 p90 -55.24 166.51 0.86 Allowed Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.616 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 1.011 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 8.13 -0.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.031 1 C-N-CA 128.988 6.459 . . . . 0.0 121.487 -153.397 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' TYR . 35.4 tp -70.77 103.29 2.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 119.936 1.244 . . . . 0.0 107.928 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -98.45 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.415 0.626 . . . . 0.0 112.155 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -141.81 158.87 43.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.891 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.2 m -123.83 141.07 52.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.479 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.39 122.94 41.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.91 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 40.3 mtpt -137.96 149.45 46.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.533 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -90.2 147.08 23.78 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.16 -160.72 18.14 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.265 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.12 137.23 57.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 66.22 -157.96 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.924 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' HH11 ' A' ' 111' ' ' ARG . . . -90.5 57.18 3.47 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.561 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 42.1 p -121.13 148.88 43.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 20.9 tp -112.01 132.73 54.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -97.69 113.35 31.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -96.64 114.25 25.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.834 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.2 mt-10 -105.89 133.32 50.79 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.621 0.724 . . . . 0.0 110.405 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.55 133.21 15.78 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.775 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.99 -43.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.794 0.684 . . . . 0.0 111.38 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.26 -19.3 0.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -103.0 141.19 36.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.817 0.342 . . . . 0.0 110.99 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 15.3 ptp180 -101.33 138.51 38.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.496 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 17.0 mmtm -127.15 133.94 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.273 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 t -94.91 128.75 41.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.113 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 98' ' ' LEU . 22.1 ptt? -123.6 149.05 45.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.332 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.81 150.07 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.512 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HA3' ' A' ' 96' ' ' GLY . 12.8 ptt180 -85.03 154.81 21.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 22' ' ' ASP . 16.9 mm -96.86 150.57 4.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.995 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 47.4 Cg_exo -56.53 117.05 3.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.606 2.204 . . . . 0.0 112.152 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -63.78 -28.49 69.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.729 0.3 . . . . 0.0 111.52 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 12.2 p90 -85.27 -1.28 56.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.837 0.351 . . . . 0.0 111.313 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.676 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 55.3 t80 -75.49 125.64 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 109.999 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.98 -158.11 22.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.314 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 m -110.34 132.48 54.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.639 0.257 . . . . 0.0 110.8 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 61.5 m95 -123.15 137.8 54.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.552 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.59 ' HB2' HD11 ' A' ' 112' ' ' ILE . 17.0 t70 -103.73 128.16 51.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -95.25 75.84 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 39.72 2.33 Favored Glycine 0 C--N 1.317 -0.478 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.624 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -164.52 160.69 20.65 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 73.19 144.59 0.11 Allowed Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 124.022 0.826 . . . . 0.0 111.079 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 16.7 Cg_exo -67.45 140.66 53.2 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.836 2.357 . . . . 0.0 112.451 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.12 -167.84 43.02 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.432 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 32.9 Cg_exo -53.41 163.55 2.49 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.612 2.875 . . . . 0.0 113.376 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -71.37 -25.07 62.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.405 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.18 13.47 0.31 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.4 28.04 13.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 22.1 t -89.05 134.39 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -68.55 -44.31 74.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.542 0.686 . . . . 0.0 110.183 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.6 p -175.74 175.11 2.09 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.148 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.35 154.08 38.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.308 0.575 . . . . 0.0 111.332 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 22' ' ' ASP . 23.0 p -119.34 142.21 48.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.146 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.26 131.63 63.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.365 0.602 . . . . 0.0 110.615 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.2 m -116.71 120.03 37.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.127 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -101.4 117.01 34.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -101.72 -177.8 3.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -54.42 -45.37 72.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -126.58 -13.56 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -126.16 154.81 42.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 111.731 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.3 t -110.4 130.64 63.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.82 123.53 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.744 0.307 . . . . 0.0 110.176 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.85 137.74 34.48 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.426 0.631 . . . . 0.0 110.502 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -122.01 119.91 32.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.184 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -100.63 128.48 46.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.84 112.75 33.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.985 0.421 . . . . 0.0 109.876 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.7 ttp -116.63 138.17 51.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.72 126.1 22.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.818 0.699 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.39 -28.15 11.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.579 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HE ' ' HB3' ' A' ' 54' ' ' ARG . 9.4 mmm180 -92.81 -75.61 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.625 0.726 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.0 -145.35 16.84 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.025 -171.052 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.9 131.36 35.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.762 0.791 . . . . 0.0 111.261 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.32 120.64 64.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.975 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 48' ' ' THR . 78.7 mt-30 -92.58 126.69 37.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.81 158.46 47.65 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.495 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 132.34 28.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.92 2.414 . . . . 0.0 112.105 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -60.41 128.41 36.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.609 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -103.35 120.41 40.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.15 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.0 127.98 34.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.369 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.2 p90 -114.66 154.99 27.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.113 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.78 147.52 49.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.381 0.61 . . . . 0.0 110.331 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.8 114.67 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.679 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.8 mt -81.49 -53.96 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.5 m -133.17 153.26 51.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.301 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -148.64 145.27 27.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 145.7 50.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -71.86 -23.56 61.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -165.63 89.87 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.867 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.47 -84.92 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.078 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -146.89 156.09 42.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 9.1 mt -133.31 136.15 55.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.56 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.09 119.6 35.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.29 157.35 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 67' ' ' ILE . 29.5 tt0 -130.75 144.4 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -94.68 154.91 17.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.578 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.32 -177.38 3.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.26 -153.52 29.22 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.258 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.66 -16.03 52.26 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.514 2.143 . . . . 0.0 112.122 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.88 31.18 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.224 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.917 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 52.9 p90 -59.7 173.48 0.52 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.251 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 11.65 -0.84 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.128 1 C-N-CA 128.243 5.962 . . . . 0.0 121.415 -152.267 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.6 tp -68.47 104.27 1.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 119.575 1.08 . . . . 0.0 108.24 167.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -105.74 173.29 6.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 111.927 -172.145 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.8 t -139.54 158.42 44.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.204 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.4 m -119.61 142.87 48.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.826 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 97.7 mt -130.72 130.77 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.846 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -144.93 164.74 30.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.895 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -98.44 154.9 17.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.857 0.36 . . . . 0.0 110.034 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.08 -153.73 29.58 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.306 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -75.73 -46.76 29.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.565 0.698 . . . . 0.0 110.104 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -97.02 -160.46 0.8 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.79 51.28 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 p -117.05 141.32 48.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.781 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 28.9 tp -102.69 135.66 43.93 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.8 108.97 22.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -107.62 111.95 24.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 23.0 mt-10 -107.23 131.66 53.94 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.387 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -150.59 118.31 6.17 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.4 t30 69.63 -5.09 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.604 0.565 . . . . 0.0 112.229 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.13 -14.6 4.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.432 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -108.46 135.5 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.326 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -101.7 127.0 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.255 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 5.5 mtmt -117.98 124.82 49.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.665 0.269 . . . . 0.0 111.655 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 113.91 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 21.1 ptp -125.14 151.4 45.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.914 0.388 . . . . 0.0 110.965 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 m -100.17 156.07 17.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.143 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 41.9 ttt85 -87.45 141.42 28.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.927 0.394 . . . . 0.0 110.375 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 22' ' ' ASP . 30.6 mm -72.72 147.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 pm0 . . . . . 0 C--N 1.316 -0.853 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.8 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.601 0.715 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.3 Cg_exo -79.15 97.87 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.073 2.515 . . . . 0.0 110.831 172.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -63.17 -25.7 68.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.359 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -82.95 -18.32 40.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.666 0.27 . . . . 0.0 111.678 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -74.04 136.61 43.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.677 0.275 . . . . 0.0 110.709 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.15 -158.21 22.27 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.224 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.5 m -117.82 129.03 55.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.619 0.247 . . . . 0.0 110.605 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -113.7 141.36 47.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.182 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.677 ' HB2' HD11 ' A' ' 112' ' ' ILE . 20.1 t70 -109.02 134.98 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.778 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HB2' ' H ' ' A' ' 36' ' ' ALA . 33.8 mt-10 -96.1 40.8 1.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.602 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.06 78.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.319 -0.944 . . . . 0.0 110.945 172.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -91.66 142.82 27.2 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.71 155.49 0.14 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.594 1.184 . . . . 0.0 111.401 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.48 135.13 48.0 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.384 2.056 . . . . 0.0 111.862 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.78 -154.76 22.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.436 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 171.63 5.01 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.28 2.654 . . . . 0.0 113.037 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -129.66 -6.59 4.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.462 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.94 -41.2 70.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.692 0.758 . . . . 0.0 111.681 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.37 -37.01 0.3 Allowed Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 50' ' ' VAL . 17.8 t -67.34 134.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -111.26 -15.24 13.68 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.982 0.42 . . . . 0.0 110.786 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m -157.31 158.25 35.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.968 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.492 ' H ' ' HB2' ' A' ' 23' ' ' GLU . . . -136.12 164.73 27.37 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.193 0.521 . . . . 0.0 110.933 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 20.0 p -131.06 131.29 44.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.086 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.85 129.52 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.255 0.55 . . . . 0.0 110.702 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.6 m -114.53 125.65 54.03 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -101.4 117.14 34.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 p -101.75 -178.0 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.567 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -49.36 -52.82 25.77 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.478 0.486 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -134.87 9.23 3.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.228 0.537 . . . . 0.0 110.969 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 163.9 27.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.0 111.334 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.2 t -115.88 122.28 69.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.29 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.34 122.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.32 136.92 45.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.379 0.609 . . . . 0.0 110.817 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -125.9 130.72 51.86 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 178.537 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB3' HG11 ' A' ' 33' ' ' VAL . 43.3 mt-10 -110.33 136.53 49.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.246 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.5 t -94.34 111.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 115.39 25.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.44 113.89 7.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.606 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.12 -20.83 11.26 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -111.65 -61.06 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.815 0.817 . . . . 0.0 110.021 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.36 -158.83 22.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.287 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.24 131.08 36.96 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.376 0.608 . . . . 0.0 110.558 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' THR . 93.2 t -113.23 121.14 64.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.019 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -91.41 128.68 37.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.624 0.25 . . . . 0.0 110.926 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.9 mt -86.94 159.91 50.66 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 20.1 Cg_endo -62.74 132.05 35.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.063 1.842 . . . . 0.0 111.128 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -57.02 127.23 30.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.58 0.705 . . . . 0.0 111.191 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtm -104.19 130.05 51.95 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.6 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.83 132.09 41.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -124.39 146.74 48.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.549 ' HG2' HD11 ' A' ' 80' ' ' LEU . 73.5 mmtt -121.69 155.45 35.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.699 0.761 . . . . 0.0 110.663 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.5 115.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.522 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.2 mt -81.99 -54.0 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -136.39 153.11 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.77 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -148.25 150.9 34.52 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.9 t -143.57 139.09 29.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.617 0.246 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -68.98 -17.72 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.669 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.24 -44.92 86.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.413 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.59 30.54 0.22 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.802 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 p -135.0 131.25 36.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 mt -135.32 137.59 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.328 -177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -117.5 123.62 46.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.7 pt -132.59 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.154 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.585 ' HB2' HD11 ' A' ' 67' ' ' ILE . 7.0 tt0 -139.38 142.21 37.55 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -71.83 174.19 7.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.077 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 65' ' ' LYS . 76.5 mt -127.85 174.58 9.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.99 -152.76 31.8 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 -9.49 20.08 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.381 2.054 . . . . 0.0 111.952 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -102.34 20.5 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -95.43 2.64 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -172.925 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 77.1 Cg_endo -93.87 -4.58 2.76 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 CA-C-N 121.393 1.533 . . . . 0.0 112.368 162.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.85 112.02 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.679 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -99.81 170.26 8.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.56 . . . . 0.0 110.995 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -130.35 158.3 40.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.089 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.7 m -128.98 142.01 51.07 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.014 0.435 . . . . 0.0 111.069 -177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.8 mt -121.1 123.62 42.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.097 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.496 ' HE3' HG21 ' A' ' 89' ' ' THR . 93.3 mttt -132.0 155.37 48.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.107 0.479 . . . . 0.0 111.371 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -84.63 152.36 23.86 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.428 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.59 -156.79 32.36 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.344 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -83.34 -28.7 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -109.16 -165.15 0.99 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.266 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.88 54.01 4.64 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -117.34 154.61 30.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.611 0.243 . . . . 0.0 110.647 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 91' ' ' LYS . 61.5 tp -106.93 127.88 53.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.126 0.489 . . . . 0.0 110.749 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 66.7 mt -99.33 110.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.29 173.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -102.41 115.99 31.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 25.6 mt-10 -98.71 130.36 45.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.416 0.626 . . . . 0.0 110.119 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 1.2 tm0? -153.76 132.11 12.0 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 1.6 t-20 66.68 10.99 7.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.504 0.502 . . . . 0.0 111.865 172.126 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.93 1.77 55.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.964 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 58.7 mt-30 -96.0 136.76 36.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -99.13 114.03 26.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -119.98 137.92 53.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 0.0 111.882 -172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 t -119.92 124.48 46.11 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.613 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -125.73 160.66 29.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.21 0.529 . . . . 0.0 111.854 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.37 141.09 30.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.993 175.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -81.48 125.06 30.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mm -77.99 147.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--N 1.312 -1.055 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.333 -174.315 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.0 m . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 87.3 Cg_endo -97.97 133.18 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.036 2.491 . . . . 0.0 114.005 -167.741 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 54.4 p90 -105.9 -13.25 15.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.053 173.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 13.4 p90 -106.31 -0.27 24.48 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -80.48 26.38 0.38 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.88 -165.39 12.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.932 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.1 m -109.8 125.97 53.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 90.2 m95 -111.92 135.45 52.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.277 0.56 . . . . 0.0 111.394 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 112' ' ' ILE . 2.8 t70 -87.64 123.31 32.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.739 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.48 76.18 3.32 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.03 3.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.675 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -153.45 141.83 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.23 158.94 0.12 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 123.904 0.752 . . . . 0.0 112.206 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.04 177.67 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.971 2.447 . . . . 0.0 112.056 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.65 -162.67 11.71 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.41 157.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.446 3.431 . . . . 0.0 114.332 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -68.71 -18.66 64.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.901 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.89 -55.43 29.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.297 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.94 50.27 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.351 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -99.38 132.77 44.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 44.9 mtpt -111.62 -18.16 12.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.923 0.392 . . . . 0.0 110.878 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 19.0 m -155.38 167.05 31.65 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.239 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.33 150.21 49.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.855 0.359 . . . . 0.0 110.471 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 132.29 39.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.904 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -112.39 131.55 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.109 0.48 . . . . 0.0 110.648 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -113.45 125.25 54.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.145 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 98.8 m-85 -101.25 118.09 36.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.129 0.49 . . . . 0.0 109.684 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -179.09 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.385 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -50.58 -58.37 5.98 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.116 0.26 . . . . 0.0 111.53 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.53 -5.8 9.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 0.0 110.691 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -115.74 155.01 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.141 0.495 . . . . 0.0 111.307 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.2 118.14 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.64 124.66 60.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.71 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -95.28 133.59 39.01 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.679 0.752 . . . . 0.0 111.126 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 118.48 23.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.615 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -104.39 131.82 51.31 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.738 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 56' ' ' GLU . 47.4 t -86.8 112.42 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.745 0.784 . . . . 0.0 110.144 -174.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.615 ' HG2' HG22 ' A' ' 33' ' ' VAL . 66.8 mtt -113.29 120.02 39.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.34 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.88 129.63 43.06 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.011 0.434 . . . . 0.0 110.284 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.53 -20.38 48.66 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.278 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HG3' ' CB ' ' A' ' 51' ' ' MET . 7.1 mmt180 -107.01 -51.36 2.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.635 0.731 . . . . 0.0 109.553 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.48 -151.62 17.81 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.374 -172.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' HG22 ' A' ' 50' ' ' VAL . 45.4 mt-10 -81.68 121.64 26.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.241 0.521 . . . . 0.0 110.063 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -104.84 122.4 57.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.78 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -83.86 118.76 24.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 90.8 mt -95.44 163.63 21.07 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 88.4 Cg_exo -44.72 120.29 2.73 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.054 2.503 . . . . 0.0 112.773 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -71.84 141.44 49.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.104 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' MET . . . . . 0.445 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 24.7 mmt -103.88 149.81 24.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.49 141.42 28.54 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.47 162.31 29.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.126 0.488 . . . . 0.0 111.256 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -135.88 159.18 42.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.456 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.9 t -103.67 118.46 50.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.538 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.2 mt -85.91 -50.72 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -138.74 160.11 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.214 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -147.33 135.16 21.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.74 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 t -137.51 116.67 12.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -64.86 -20.94 66.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 0.0 109.949 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -42.76 78.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.826 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.36 35.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.347 -1.406 . . . . 0.0 115.004 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -154.58 140.85 18.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.652 0.726 . . . . 0.0 111.895 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 mt -130.05 137.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.9 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HG2' HD12 ' A' ' 67' ' ' ILE . 60.0 tt0 -110.3 123.42 49.78 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 158.35 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.615 ' HB2' HD11 ' A' ' 67' ' ' ILE . 9.6 tt0 -132.59 147.72 52.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.411 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 96.4 m-85 -99.17 157.43 16.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.173 0.511 . . . . 0.0 110.599 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 ' CE1' ' A' ' 84' ' ' TYR . 26.2 mt -112.22 179.51 3.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.073 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -150.43 41.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.921 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.09 -12.32 15.34 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.849 2.366 . . . . 0.0 112.833 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.19 20.49 18.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.377 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -66.23 -176.19 0.22 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.962 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 59.4 Cg_exo 2.98 -3.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.484 1 C-N-CA 126.613 4.876 . . . . 0.0 120.823 -138.232 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 84' ' ' TYR . 56.8 tp -72.3 116.71 13.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 120.116 1.325 . . . . 0.0 110.763 176.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.62 167.35 15.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.646 0.736 . . . . 0.0 111.883 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 t -150.58 145.08 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.334 169.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 141.57 51.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.886 0.374 . . . . 0.0 110.995 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.7 mt -115.86 124.03 49.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -129.7 165.88 20.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.119 0.485 . . . . 0.0 111.607 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -77.13 147.91 36.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.135 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.43 173.11 22.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.707 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.65 -2.43 48.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.72 28.49 5.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.535 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.07 49.15 42.62 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.138 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 p -130.98 173.79 10.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.809 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -119.06 134.0 55.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.76 116.74 41.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.124 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' TRP . . . . . 0.539 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 12.4 t90 -96.73 112.43 24.19 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.0 133.37 49.89 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -149.74 129.15 12.97 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.91 22.67 13.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.089 0.471 . . . . 0.0 110.85 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.26 -8.9 68.87 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.548 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -92.48 145.65 24.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.65 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -100.54 117.01 33.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.084 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -104.06 132.81 49.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.473 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 t -100.92 126.64 47.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.542 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 59.4 mtm -117.61 144.46 45.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 1.1 m -96.92 158.69 15.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.997 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.316 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 22' ' ' ASP . 24.1 mm -71.59 146.6 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--N 1.314 -0.969 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.43 -171.651 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.6 Cg_endo -83.58 123.73 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.199 2.599 . . . . 0.0 111.578 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -69.45 -9.36 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.12 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -113.24 -0.72 14.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.688 0.28 . . . . 0.0 111.619 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 58.2 t80 -97.99 126.64 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.141 0.496 . . . . 0.0 111.501 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -160.64 24.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.261 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' THR . . . . . 0.43 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 29.1 m -101.39 123.72 45.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.803 0.335 . . . . 0.0 110.403 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -104.85 139.63 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 111.851 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HB2' ' CD1' ' A' ' 112' ' ' ILE . 8.7 t70 -79.02 123.66 27.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.822 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 4.3 mm-40 -88.76 85.53 6.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.394 172.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -38.13 5.24 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.622 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -137.54 141.78 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 165.318 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -131.11 140.98 40.29 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.705 -171.708 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 27.6 Cg_endo -97.93 143.89 0.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.957 3.105 . . . . 0.0 111.293 168.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.49 -157.92 25.8 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.498 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 50.9 Cg_exo -49.05 161.62 0.53 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 125.006 3.804 . . . . 0.0 114.069 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.06 13.7 16.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.492 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.01 -28.1 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.87 59.55 0.59 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.45 133.31 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -96.03 -23.24 16.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 111.556 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -157.98 163.21 38.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -148.7 165.89 30.01 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 3.3 p -133.35 132.9 41.8 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.743 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 120.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.444 0.64 . . . . 0.0 109.596 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -108.93 126.11 52.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -100.66 117.64 35.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -100.16 173.61 6.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.347 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' HG22 ' A' ' 41' ' ' THR . 37.5 tt0 -50.38 -40.18 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -136.24 -0.59 2.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.099 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -126.05 151.66 46.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.942 -0.473 . . . . 0.0 111.759 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.84 118.89 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.85 124.06 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -98.07 139.15 34.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.315 0.578 . . . . 0.0 110.778 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -123.58 136.63 54.63 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.536 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 32.7 mt-10 -97.48 130.28 44.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.02 107.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' MET . . . . . 0.599 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -133.85 133.16 41.22 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.3 -169.243 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -80.38 88.8 5.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.091 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.65 -52.78 0.47 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.499 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 51' ' ' MET . 10.0 ptp180 -94.62 -33.11 13.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.52 -173.18 29.55 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.0 mp0 -67.33 117.22 9.03 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.774 0.797 . . . . 0.0 110.803 174.356 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -124.73 128.29 73.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.627 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 131.72 36.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.976 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.0 mt -89.86 162.25 36.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.735 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 76.5 Cg_exo -47.2 121.37 5.2 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.795 2.33 . . . . 0.0 112.307 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -70.62 141.16 51.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.295 0.569 . . . . 0.0 110.954 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -107.96 147.68 30.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.79 148.08 26.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.791 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -145.04 154.72 42.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.515 ' HG3' HD11 ' A' ' 80' ' ' LEU . 55.4 mtpt -128.46 156.19 43.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.41 124.22 49.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.843 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 78' ' ' GLN . 18.3 mt -87.49 -50.25 13.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -144.92 155.74 43.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.348 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.43 128.65 12.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.415 0.626 . . . . 0.0 111.108 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB3' ' H ' ' A' ' 74' ' ' SER . 38.4 t -136.56 147.14 46.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.3 p -80.85 -23.21 39.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.698 0.285 . . . . 0.0 111.593 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -143.16 -10.07 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.5 -83.22 1.06 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.337 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 70' ' ' SER . 4.1 p -164.37 153.67 13.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 122.84 0.456 . . . . 0.0 110.532 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 25.2 mt -114.09 138.01 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.2 tt0 -120.49 124.93 46.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.0 110.181 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -128.44 157.73 40.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.342 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 67' ' ' ILE . 57.3 tt0 -130.03 144.14 51.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -82.63 167.38 18.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.515 HD11 ' HG3' ' A' ' 65' ' ' LYS . 95.8 mt -129.22 166.48 19.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.334 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.53 -153.78 17.51 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.38 -21.9 46.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.038 1.825 . . . . 0.0 111.6 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -105.64 40.72 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.083 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' TYR . . . . . 0.477 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 45.8 p90 -78.15 -33.16 0.94 Allowed Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 85.9 Cg_endo -74.04 -3.6 14.05 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 CA-C-N 121.222 1.472 . . . . 0.0 113.068 -170.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 tp -88.1 124.83 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.156 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -111.66 168.97 9.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -138.29 153.45 49.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.63 -173.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -120.08 142.26 49.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.0 mt -125.95 124.41 40.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.74 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.564 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 85.9 mttt -130.52 163.35 27.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.039 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -86.79 143.67 27.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.72 -146.26 17.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.28 125.93 35.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.2 m120 65.06 -153.09 0.28 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.79 53.19 4.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.124 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 p -115.68 144.01 44.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 HD22 ' A' ' 90' ' ' LEU . 29.9 tp -109.57 133.68 52.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 70.9 mt -98.48 110.28 25.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 175.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -105.94 114.8 29.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 32.8 mt-10 -106.2 131.72 53.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.651 0.738 . . . . 0.0 110.321 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 1.2 tm0? -151.75 135.18 16.07 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.016 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.7 OUTLIER 65.09 9.12 5.25 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.796 0.331 . . . . 0.0 111.621 176.435 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.98 13.42 57.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.654 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 13.5 pt20 -120.93 149.0 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -96.07 125.85 40.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.325 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.589 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.1 mmpt? -111.71 139.75 46.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.544 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.3 m -105.25 114.66 28.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.722 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 64.2 mmm -101.85 133.15 47.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.62 142.87 33.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 111' ' ' ARG . 8.9 ttp180 -82.63 130.56 35.14 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.147 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.4 mm -62.83 144.58 14.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 121.422 0.63 . . . . 0.0 110.868 -171.602 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -135.33 164.55 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 0.0 111.333 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.7 ttp -106.98 116.03 31.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.72 110.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.983 0.421 . . . . 0.0 110.687 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -75.44 160.47 30.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.368 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.49 137.95 2.3 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -140.96 -59.35 0.5 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.527 0.164 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 64.08 -167.07 0.22 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.457 0.473 . . . . 0.0 110.548 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -143.65 150.14 38.31 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.98 123.28 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.163 0.506 . . . . 0.0 110.807 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 71.1 mmtt -81.35 -22.41 38.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.495 0.664 . . . . 0.0 109.225 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 pm0 -75.59 135.33 40.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.019 171.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.85 145.5 56.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.725 0.774 . . . . 0.0 111.627 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -144.7 80.66 11.46 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.007 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.96 115.72 4.38 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.378 2.052 . . . . 0.0 111.717 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.07 -14.94 63.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.121 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -94.4 -18.63 21.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.75 0.309 . . . . 0.0 111.417 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.28 139.84 39.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.765 0.317 . . . . 0.0 110.62 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.32 -152.62 21.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.307 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 m -126.8 128.25 46.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 55.5 m95 -118.51 143.75 46.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.849 0.357 . . . . 0.0 111.563 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' ILE . 19.4 t70 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.326 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.735 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 1.3 tp10 -106.53 36.44 2.62 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 123.39 1.567 . . . . 0.0 107.781 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.19 70.66 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.656 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -95.54 -168.0 1.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.156 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . -75.86 144.49 76.37 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 111.499 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' LYS . 10.0 Cg_exo -71.73 -178.93 3.36 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.414 2.742 . . . . 0.0 113.17 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.28 -151.46 5.56 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.495 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.16 -163.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.561 2.841 . . . . 0.0 112.588 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -52.81 -34.43 53.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.889 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 131' ' ' HIS . 10.1 m-20 -101.82 17.14 23.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.664 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 77.57 0.23 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 49' ' ' GLU . 99.0 t -54.76 144.67 5.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 123.554 0.742 . . . . 0.0 112.079 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 8.9 mtpm? -55.63 -40.68 72.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.398 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -154.69 163.39 40.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.802 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . . . -143.23 150.32 39.15 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.834 0.35 . . . . 0.0 110.573 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 p -134.0 140.56 46.79 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 21' ' ' TRP . 7.2 p -112.4 129.68 67.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 m -108.4 125.93 52.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.978 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -100.59 117.21 34.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.476 . . . . 0.0 110.076 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -102.35 -179.64 4.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.71 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 41' ' ' THR . 37.0 tt0 -44.33 -70.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.128 0.971 . . . . 0.0 113.057 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.21 9.84 8.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.226 0.536 . . . . 0.0 110.78 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.589 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 1.5 pm0 -133.69 150.61 51.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.358 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.51 133.89 56.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 61' ' ' PHE . 22.1 t -116.89 122.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.535 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.83 139.84 30.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.51 133.39 49.84 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.41 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.723 ' HB3' HG11 ' A' ' 33' ' ' VAL . 49.4 mt-10 -125.27 134.4 52.3 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 56' ' ' GLU . 21.3 t -91.11 108.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.336 0.588 . . . . 0.0 109.938 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 66.8 mtt -99.3 138.43 36.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 34.6 tt0 -64.53 115.21 4.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.781 0.324 . . . . 0.0 110.472 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.91 -13.69 63.43 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.433 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 0.1 OUTLIER -113.43 -37.51 4.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.352 0.596 . . . . 0.0 110.436 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.8 -159.83 29.5 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.2 mp0 -62.33 126.53 27.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.21 121.39 60.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.843 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -88.2 131.25 34.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.016 0.436 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD22 ' OE2' ' A' ' 129' ' ' GLU . 42.8 mt -88.0 165.04 31.38 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.493 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 51.6 Cg_exo -49.79 120.31 5.8 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.87 2.38 . . . . 0.0 111.499 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' HB3' HG22 ' A' ' 46' ' ' VAL . 11.0 p90 -64.3 134.14 54.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 111.653 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.5 mmm -102.07 129.91 48.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.48 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -77.13 148.94 35.73 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.338 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -140.14 153.83 46.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 80' ' ' LEU . 92.6 mttt -126.27 149.47 49.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.229 0.537 . . . . 0.0 110.362 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 77' ' ' ILE . 94.5 t -93.79 116.11 34.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.281 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 78' ' ' GLN . 21.6 mt -84.81 -52.45 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.428 0.632 . . . . 0.0 109.549 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -133.93 150.36 51.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.093 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -149.13 155.54 40.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.89 0.376 . . . . 0.0 111.019 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -125.02 158.81 32.79 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 t -67.9 -33.0 73.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -169.95 90.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.873 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.1 -78.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.703 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -139.86 155.77 47.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.088 0.47 . . . . 0.0 110.184 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 mt -135.11 137.19 50.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.669 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.64 121.67 42.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 75' ' ' ILE . 35.3 pt -132.92 151.43 34.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.313 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 67' ' ' ILE . 18.1 tt0 -124.54 136.73 54.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.391 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -79.91 170.1 16.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.727 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 88.5 mt -131.39 146.8 52.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . 0.439 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . 121.21 -153.71 16.6 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.95 -13.09 37.35 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.632 2.221 . . . . 0.0 112.601 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -125.83 46.32 2.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.993 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 32.9 p90 -84.5 -36.55 0.61 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -172.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 61.0 Cg_endo -75.32 -4.41 15.29 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 CA-C-N 121.097 1.427 . . . . 0.0 113.431 -170.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.26 109.52 21.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -86.95 166.47 15.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -131.38 163.16 28.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.996 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -121.25 141.74 50.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.036 0.446 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.7 mt -128.59 137.9 51.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.874 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 79.1 mttt -141.58 156.65 45.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -78.89 144.18 35.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.59 -171.4 15.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.891 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.44 155.63 29.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 71.81 -55.44 0.66 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.757 0.823 . . . . 0.0 111.049 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.08 40.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 110' ' ' THR . 28.5 p -108.11 171.9 7.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.14 0.495 . . . . 0.0 111.591 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 52.3 tp -118.61 132.67 56.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.323 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 73.0 mt -97.72 110.05 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CZ3' HG21 ' A' ' 38' ' ' VAL . 4.2 t90 -103.98 115.02 29.68 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.171 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 106' ' ' ARG . 35.5 mt-10 -112.39 131.54 55.49 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.884 0.85 . . . . 0.0 111.205 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -151.76 131.32 13.05 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.046 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.57 12.12 8.72 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.347 0.404 . . . . 0.0 111.13 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.89 70.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.274 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -92.61 135.18 34.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.792 0.33 . . . . 0.0 110.458 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 101' ' ' GLU . 22.5 ttt180 -102.31 116.81 33.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.488 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -118.09 128.36 54.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 111.571 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.3 m -95.01 119.21 33.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.104 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 20.7 mmt -107.19 135.26 49.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.61 146.74 24.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.877 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.533 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 26.6 ttp180 -93.27 128.91 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.931 0.396 . . . . 0.0 110.783 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.2 mm -84.39 150.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -94.15 99.32 11.62 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.505 0.669 . . . . 0.0 110.138 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 t -154.75 168.57 26.41 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.159 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 99.1 mttt 57.91 31.12 20.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.267 0.556 . . . . 0.0 110.716 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -77.32 46.45 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.88 25.64 6.73 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.214 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.89 130.09 22.18 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.035 0.445 . . . . 0.0 110.02 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -57.65 123.42 15.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.057 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 41.0 tt0 -129.29 110.61 12.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -82.93 147.14 28.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.256 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.48 160.58 31.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.977 176.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -110.39 148.6 31.67 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.82 118.33 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.238 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.0 m -138.8 128.45 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.063 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -98.33 105.38 17.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 109.779 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 t -109.55 128.93 55.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.417 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.2 99.13 10.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.528 ' OE2' HD22 ' A' ' 59' ' ' LEU . 7.6 pt-20 -144.11 159.14 43.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 112.385 -166.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -140.91 23.69 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.947 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -53.33 138.18 33.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.87 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -143.18 91.46 2.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.878 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -74.5 125.35 28.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -143.8 173.44 11.68 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.917 0.389 . . . . 0.0 111.266 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.901 176.504 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 120.871 0.367 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 pt -139.92 164.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.374 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.2 mtp -129.68 104.53 7.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.5 135.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.117 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 m -132.16 133.74 44.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.916 0.389 . . . . 0.0 110.708 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.39 -153.54 17.66 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.076 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m 62.98 19.77 11.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.789 0.435 . . . . 0.0 111.464 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.9 151.5 48.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.294 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 65.17 23.2 12.3 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.866 0.729 . . . . 0.0 111.51 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -90.58 121.92 32.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.54 122.49 40.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.59 0.234 . . . . 0.0 110.399 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.98 117.13 27.97 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -80.17 5.93 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 111.662 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -59.09 119.6 39.82 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.267 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.34 110.59 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.831 2.354 . . . . 0.0 112.424 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -62.71 -26.86 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.698 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 90' ' ' LEU . 21.8 p90 -88.44 -13.22 40.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.71 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -86.57 142.01 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.622 0.249 . . . . 0.0 110.387 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.79 -159.66 24.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.502 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 m -116.49 122.27 44.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 69.4 m95 -116.25 136.54 52.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.134 0.493 . . . . 0.0 111.543 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.582 ' HB2' HG12 ' A' ' 112' ' ' ILE . 26.3 t70 -110.26 151.51 27.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.219 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 56.3 mt-10 -63.05 -23.36 67.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.581 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.05 -59.05 0.38 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.262 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -170.27 170.86 7.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 75.42 148.75 0.12 Allowed Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.892 0.877 . . . . 0.0 111.655 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 60.8 Cg_endo -73.09 176.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 0.0 113.152 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -113.84 -152.74 10.85 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.324 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 3.2 Cg_endo -48.19 154.32 2.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.759 2.972 . . . . 0.0 113.471 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 t -69.08 -4.73 18.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.229 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.99 -22.78 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.58 22.07 1.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG21 ' HG2' ' A' ' 29' ' ' PRO . 20.1 t -89.16 132.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.0 110.187 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 58.6 mtmt -99.7 -14.96 18.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.107 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p 176.9 159.57 0.36 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.732 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -122.44 136.8 54.97 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.125 0.488 . . . . 0.0 110.331 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 p -118.39 130.74 56.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.664 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.78 134.51 55.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.298 0.571 . . . . 0.0 110.225 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 12.0 m -120.19 126.27 50.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.207 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -101.3 118.29 36.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.244 0.545 . . . . 0.0 110.206 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -96.77 175.86 6.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 41' ' ' THR . 23.1 tt0 -60.96 -35.63 77.29 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.84 -8.63 4.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.464 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 2.2 mp0 -126.68 153.51 45.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 112.219 -169.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.4 t -107.2 120.31 58.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.581 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 61' ' ' PHE . 52.2 t -107.06 125.06 63.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -112.01 127.3 55.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.058 0.456 . . . . 0.0 110.305 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.96 128.03 54.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.763 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 37.7 mt-10 -99.92 129.43 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 56' ' ' GLU . 44.8 t -90.24 110.11 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.9 ttm -122.56 145.2 48.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.89 135.07 57.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.839 0.352 . . . . 0.0 110.217 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.56 -56.65 1.97 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.288 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -95.7 -33.7 12.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.76 -149.39 19.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.952 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 45.1 mt-10 -72.92 115.25 12.0 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.6 t -108.75 122.52 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.408 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HG2' HG23 ' A' ' 48' ' ' THR . 85.7 mt-30 -85.86 119.17 25.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.495 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.1 154.67 67.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.73 122.98 8.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.992 2.461 . . . . 0.0 112.3 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' HB3' HG22 ' A' ' 46' ' ' VAL . 37.0 p90 -64.64 139.91 58.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtm -112.09 133.49 54.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.776 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.28 134.73 36.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.341 . . . . 0.0 110.68 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.454 ' CD1' HG23 ' A' ' 45' ' ' VAL . 37.1 p90 -130.98 157.12 43.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.089 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HE3' HD11 ' A' ' 80' ' ' LEU . 96.7 mttt -127.05 158.99 35.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.51 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.1 t -97.16 119.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.959 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 78' ' ' GLN . 17.7 mt -82.58 -56.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.404 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -127.68 153.83 46.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.501 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -148.28 148.02 29.99 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.178 -172.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -145.23 147.28 32.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.4 p -77.15 -26.81 53.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.469 . . . . 0.0 110.131 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.98 70.06 0.92 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.214 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.06 -88.75 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.882 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 t -152.43 157.78 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.175 0.512 . . . . 0.0 110.574 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.51 135.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.057 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -117.56 128.54 55.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 pt -124.39 157.06 32.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.26 0.553 . . . . 0.0 111.416 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.613 ' HB2' HD11 ' A' ' 67' ' ' ILE . 30.9 tt0 -134.41 144.63 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.102 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.86 151.1 20.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD11 ' HE3' ' A' ' 65' ' ' LYS . 94.8 mt -99.86 163.72 12.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.562 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -152.5 21.71 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.956 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.84 -6.68 13.07 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.368 2.045 . . . . 0.0 111.956 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.51 10.11 29.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.8 OUTLIER -61.28 170.17 1.82 Allowed Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.747 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 9.4 Cg_exo 9.42 -1.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.15 1 C-N-CA 128.173 5.915 . . . . 0.0 120.681 -148.344 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 84' ' ' TYR . 34.6 tp -74.3 103.84 4.84 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.117 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -113.33 173.47 6.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -138.52 149.29 45.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.524 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.3 m -122.18 143.35 49.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.94 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 17' ' ' TYR . 94.9 mt -121.65 131.8 54.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -134.57 155.88 49.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.636 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -74.13 144.65 44.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.025 0.44 . . . . 0.0 110.632 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 145.38 18.34 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -70.41 158.6 35.71 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.568 0.223 . . . . 0.0 110.797 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 67.83 12.86 9.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.345 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.72 56.11 2.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.791 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 p -130.58 173.0 11.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.774 -0.251 . . . . 0.0 110.795 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.9 tp -129.27 133.25 47.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 0.0 110.359 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.37 114.22 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -103.83 113.43 26.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.5 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 28.7 mt-10 -103.29 139.03 39.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.421 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -145.99 122.27 10.9 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.446 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 67.32 8.9 6.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.249 179.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.1 -14.77 25.98 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.649 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 32.5 mt-30 -93.33 133.39 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 30.6 ptt180 -102.41 124.33 47.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.4 0.619 . . . . 0.0 112.223 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -112.35 130.45 55.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 m -93.14 119.27 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 24.2 mmt -108.73 148.17 30.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.851 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -116.08 157.3 24.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.477 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 13.8 ttp180 -76.49 133.2 39.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mt -71.23 152.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 152.67 39.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.087 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.6 m -86.92 106.47 17.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -102.22 142.09 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.538 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -137.76 82.89 1.95 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.226 171.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.38 121.43 6.66 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.481 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -96.69 96.25 8.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -153.83 103.78 2.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.45 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.58 154.45 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -48.43 119.14 2.83 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.755 0.66 . . . . 0.0 112.389 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.45 134.13 46.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.479 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.24 114.09 23.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 0.0 111.527 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -141.38 107.91 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.9 p -98.7 103.09 15.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.862 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.86 147.29 24.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.239 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -59.08 138.1 57.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.1 mt -86.17 37.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 111.391 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -122.21 139.88 53.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.32 64.11 2.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.863 0.839 . . . . 0.0 110.658 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -81.2 105.54 12.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.192 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.0 p-80 -137.81 113.05 9.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.384 0.611 . . . . 0.0 111.169 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -135.66 131.8 36.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.752 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -131.76 167.33 19.71 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.7 m170 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.945 177.92 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.33 113.72 13.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.6 mtm -91.65 94.22 9.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.639 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.5 p -102.44 147.14 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.411 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -136.84 132.34 34.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.2 -165.65 34.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.782 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.8 p -170.57 143.21 2.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -122.72 142.19 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.261 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -116.11 89.49 3.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.022 0.439 . . . . 0.0 110.846 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -125.34 -169.53 2.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.444 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -80.07 149.39 30.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.154 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.03 136.89 58.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -92.72 -173.88 3.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 t -66.48 119.62 64.16 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.43 0.633 . . . . 0.0 110.119 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 2.4 Cg_endo -81.13 97.57 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.743 2.296 . . . . 0.0 112.271 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -77.84 -11.51 59.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 110.149 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -93.94 -4.31 50.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.121 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 83.4 t80 -75.63 135.74 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.648 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.95 -166.75 19.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.37 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 m -108.67 128.21 54.65 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 98' ' ' LEU . 61.6 m95 -111.1 146.74 36.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.292 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -108.98 139.24 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.199 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 7.2 mm-40 -45.43 -61.91 1.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.124 0.89 . . . . 0.0 112.251 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.17 21.34 59.35 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.252 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.17 -167.23 1.24 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.016 0.527 . . . . 0.0 110.989 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.22 146.99 59.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.34 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.08 152.61 36.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.245 2.63 . . . . 0.0 113.104 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -91.55 -153.91 30.13 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.545 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 6.1 Cg_endo -51.38 114.84 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.43 2.753 . . . . 0.0 112.415 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -82.19 70.45 9.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 123.143 1.449 . . . . 0.0 111.129 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -128.94 -63.34 0.97 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.269 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.94 -49.02 0.2 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.098 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 51' ' ' MET . 6.2 t -91.65 133.27 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -108.8 -19.33 13.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.148 0.499 . . . . 0.0 110.982 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 m -161.91 165.41 27.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.746 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -137.66 145.07 42.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.867 0.365 . . . . 0.0 110.838 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -122.77 132.25 54.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.43 129.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.225 0.536 . . . . 0.0 110.795 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.5 m -118.29 128.32 54.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.056 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.2 m -101.86 176.87 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.428 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 41' ' ' THR . 41.5 tt0 -50.47 -54.54 21.42 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.81 -21.28 9.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.457 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.56 156.88 42.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.342 0.591 . . . . 0.0 111.646 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.27 127.34 63.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.73 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.0 124.14 72.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -106.09 135.9 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.37 126.2 53.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.904 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -98.23 126.56 43.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 56' ' ' GLU . 45.8 t -86.3 111.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.382 0.61 . . . . 0.0 109.419 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.449 ' HG2' HG22 ' A' ' 33' ' ' VAL . 88.1 mtp -113.92 130.72 56.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.959 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.3 117.17 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.578 0.549 . . . . 0.0 111.026 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.09 -24.18 33.33 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.236 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 2.8 mmp_? -97.08 -58.09 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.715 0.769 . . . . 0.0 110.253 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.71 -152.0 17.26 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.611 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 50' ' ' VAL . 49.0 mt-10 -84.14 117.28 23.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.252 0.526 . . . . 0.0 110.101 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.0 t -105.47 123.86 60.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.9 126.79 31.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.32 159.39 64.82 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.043 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.84 141.93 34.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.036 2.491 . . . . 0.0 111.68 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -67.43 128.33 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.454 0.645 . . . . 0.0 111.062 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.0 mtm -103.89 119.49 39.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.932 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -74.41 134.85 42.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.472 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -127.52 147.41 50.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 0.0 110.489 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HD2' HD21 ' A' ' 80' ' ' LEU . 21.2 ptmt -122.9 159.08 28.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.17 122.59 54.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.052 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.1 mt -90.11 -48.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.502 0.667 . . . . 0.0 109.248 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 m -144.12 156.23 44.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.57 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.0 tt0 -149.43 130.56 14.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.363 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.2 t -173.24 160.67 4.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.804 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -84.95 -35.55 21.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.182 0.515 . . . . 0.0 109.992 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -100.27 -39.81 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.341 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.41 -3.04 88.52 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.683 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t 67.24 168.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.454 0.645 . . . . 0.0 111.374 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 26.7 mt -107.21 137.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.783 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.7 tt0 -122.83 128.54 50.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.409 HG13 ' HB3' ' A' ' 88' ' ' SER . 36.1 pt -122.3 158.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.506 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.641 ' CD ' ' HA ' ' A' ' 85' ' ' PRO . 33.0 tt0 -133.39 137.07 45.66 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 72.9 m-85 -80.42 150.45 29.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.457 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.569 HD21 ' HD2' ' A' ' 65' ' ' LYS . 97.2 mt -110.48 -173.09 2.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.892 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.75 -151.76 43.29 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.75 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 -17.03 39.38 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.212 1.942 . . . . 0.0 111.809 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.11 18.96 9.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.727 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 5.5 p90 -59.06 170.07 0.99 Allowed Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.249 0.343 . . . . 0.0 110.443 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 11.96 -0.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 1 C-N-CA 128.082 5.855 . . . . 0.0 121.405 -149.334 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.9 tp -66.97 115.98 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 119.631 1.105 . . . . 0.0 108.272 166.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 59.0 pttt -108.14 179.98 4.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.395 0.617 . . . . 0.0 112.31 -170.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB3' HG13 ' A' ' 77' ' ' ILE . 45.8 t -152.02 165.31 35.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.582 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.5 m -127.03 142.41 51.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.066 0.46 . . . . 0.0 111.215 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.9 mt -124.1 122.53 38.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.274 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 26.3 ttmt -133.35 158.49 42.87 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -173.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -89.42 153.17 21.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.17 0.509 . . . . 0.0 111.768 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.62 162.03 12.68 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.75 -10.39 53.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -130.47 51.12 2.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.765 0.317 . . . . 0.0 111.175 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.35 27.69 73.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.55 160.19 16.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.154 0.502 . . . . 0.0 112.071 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 19.6 tp -128.47 134.78 48.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 91' ' ' LYS . 72.8 mt -104.68 111.91 36.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.037 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.5 t90 -104.13 111.77 24.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.956 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 27.1 mt-10 -100.74 131.5 46.6 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.467 0.651 . . . . 0.0 110.369 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 16.9 tm0? -152.56 121.17 6.42 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.271 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 2.6 t-20 75.8 -53.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.95 0.781 . . . . 0.0 112.665 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.14 -25.07 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.207 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -120.19 152.76 37.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.857 0.829 . . . . 0.0 111.176 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 20.5 ptt180 -95.53 126.29 40.71 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 21.8 mmtp -88.25 127.21 35.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.911 0.386 . . . . 0.0 110.243 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.2 m -109.11 111.6 23.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -134.99 156.36 49.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.483 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 m -112.53 155.32 24.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.028 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.29 130.25 36.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.957 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.95 146.16 9.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.0 110.168 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -140.79 118.9 11.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.894 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -74.34 109.11 7.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.665 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 64.38 84.15 0.15 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.647 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -91.46 151.98 20.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.926 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.11 -133.82 4.62 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.883 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -130.02 155.18 46.55 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.202 0.525 . . . . 0.0 109.633 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.05 150.43 27.25 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.942 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.45 -82.18 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.405 -0.118 . . . . 0.0 111.025 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.4 tttt 69.06 131.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.91 0.756 . . . . 0.0 111.475 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.62 164.0 15.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.259 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -119.67 101.13 7.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.978 0.418 . . . . 0.0 110.716 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -91.71 101.9 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.8 p -141.46 160.3 40.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.486 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -146.58 146.26 30.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.113 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 m -127.51 110.14 12.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.667 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.49 97.97 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.067 0.461 . . . . 0.0 111.123 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.34 93.27 4.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -131.57 89.55 2.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -136.32 149.35 48.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.036 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -157.62 150.26 22.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.96 0.409 . . . . 0.0 110.986 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -153.58 105.21 2.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.63 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -82.48 89.43 6.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.555 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.9 t60 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.171 -0.919 . . . . 0.0 109.485 174.138 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.514 0.197 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.18 124.29 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -132.45 135.94 46.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.168 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.05 111.86 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.022 0.439 . . . . 0.0 111.023 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 p -153.32 144.85 23.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.828 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.1 -62.72 4.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.3 m -79.72 69.9 6.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.184 0.516 . . . . 0.0 109.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.17 78.95 1.76 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.697 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -92.39 11.64 25.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.11 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -81.82 100.77 9.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.161 0.505 . . . . 0.0 110.034 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.5 -27.76 64.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -70.27 103.31 2.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.774 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.12 175.84 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 m -63.33 118.15 40.84 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.086 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.7 Cg_exo -75.79 110.88 3.17 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.939 2.426 . . . . 0.0 111.305 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -63.68 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.058 -174.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -84.3 -13.22 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.779 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 17.2 t80 -78.5 138.16 38.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.67 -163.04 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.173 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 84.8 m -110.01 121.96 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.035 0.445 . . . . 0.0 110.511 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 80.8 m95 -106.41 144.41 33.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB2' HD11 ' A' ' 112' ' ' ILE . 22.6 t70 -104.34 120.34 40.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.51 48.44 1.55 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.783 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.49 47.13 2.65 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.568 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -162.5 144.24 10.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.92 164.16 0.13 Allowed Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 124.083 0.864 . . . . 0.0 111.328 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.56 135.54 49.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.681 2.254 . . . . 0.0 113.163 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.19 -154.12 8.69 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.525 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.49 124.49 9.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.617 2.878 . . . . 0.0 112.432 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -82.05 -7.86 59.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.786 -167.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.06 -32.58 62.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.093 0.473 . . . . 0.0 111.535 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.25 39.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.25 136.38 25.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.434 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.0 mmpt? -73.22 -41.01 64.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -161.69 160.4 28.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.162 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.99 135.4 54.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.9 p -117.29 125.91 51.86 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.95 127.72 75.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.2 m -105.82 124.69 49.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.49 118.84 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.36 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -100.38 179.56 4.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 167.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -68.52 -36.66 79.18 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.294 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -111.99 -11.67 13.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -135.01 145.81 48.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.491 0.662 . . . . 0.0 112.344 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' CD1' ' A' ' 64' ' ' TYR . 97.9 t -111.93 118.38 57.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.526 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.69 122.67 63.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.959 0.409 . . . . 0.0 109.977 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -107.26 133.02 52.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.808 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -124.31 134.27 53.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 30.1 mt-10 -100.22 125.24 46.36 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -88.01 110.1 20.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.21 121.64 43.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -170.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.88 115.94 4.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.52 10.14 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.098 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -111.44 -59.04 2.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.515 0.674 . . . . 0.0 109.972 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.93 -164.24 19.57 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.68 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.519 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.4 mp0 -69.65 126.64 30.34 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.589 0.709 . . . . 0.0 111.628 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.78 122.56 70.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.659 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 91.8 mt-30 -79.96 128.66 33.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.2 0.524 . . . . 0.0 111.993 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 75.6 mt -90.47 165.05 24.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.993 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.5 Cg_endo -57.54 130.47 39.1 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.724 2.283 . . . . 0.0 112.097 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -63.83 147.02 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.971 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -123.88 118.26 26.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.074 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.27 138.33 31.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.809 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.492 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.0 p90 -137.66 171.72 14.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.914 0.388 . . . . 0.0 110.388 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.702 ' HG3' HD11 ' A' ' 80' ' ' LEU . 80.7 mttt -130.01 154.44 47.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.266 0.555 . . . . 0.0 111.08 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.18 124.22 46.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.306 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.9 mt -88.55 -47.71 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 109.58 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -143.61 156.67 44.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.631 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 62.7 tt0 -149.2 150.92 33.41 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -140.36 145.08 36.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.987 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -73.64 -25.94 60.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.494 0.664 . . . . 0.0 109.506 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -152.35 76.31 1.15 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.582 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.39 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.392 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 m -150.7 154.17 36.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.134 0.492 . . . . 0.0 110.683 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 14.3 mt -118.52 137.62 51.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -117.42 121.68 41.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.83 156.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.672 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 67' ' ' ILE . 4.5 tt0 -130.26 138.35 50.47 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -80.05 -0.93 37.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -165.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 65' ' ' LYS . 97.6 mt 50.74 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.363 0.415 . . . . 0.0 111.586 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.79 -151.35 49.32 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.716 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.02 -11.1 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.767 2.311 . . . . 0.0 111.987 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.18 30.57 6.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.002 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 15.4 p90 -80.67 -15.71 0.23 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.181 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 87.3 Cg_endo -92.19 -3.82 3.83 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 CA-C-N 120.867 1.345 . . . . 0.0 112.929 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.47 113.73 25.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.0 0.428 . . . . 0.0 110.021 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 62.2 pttt -111.57 164.41 13.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 102' ' ' GLN . 21.8 t -134.01 155.67 49.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.812 -175.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.8 m -112.74 140.81 47.21 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.084 0.469 . . . . 0.0 110.508 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 98.3 mt -124.44 124.59 42.65 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.698 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 39.2 mtpt -135.53 155.19 50.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.2 ptt85 -86.72 161.09 18.6 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.38 39.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -90.69 -10.94 41.26 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -155.65 93.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 111.544 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.71 40.93 42.01 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.657 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.92 159.88 40.82 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.469 0.176 . . . . 0.0 110.859 -175.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -123.89 135.21 53.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 25.8 mm -103.84 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.585 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 7.5 t90 -108.46 113.78 27.1 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 31.9 mt-10 -106.19 129.29 54.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.263 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.467 ' HG3' ' HB2' ' A' ' 88' ' ' SER . 2.8 tt0 -153.35 134.08 13.79 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.115 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 9.4 m120 59.46 18.16 6.64 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.307 0.38 . . . . 0.0 111.834 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.01 -13.07 60.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.49 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 41.2 mt-30 -92.81 134.99 34.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.055 0.455 . . . . 0.0 111.133 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -101.44 115.8 31.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.09 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -111.16 141.01 45.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.598 0.237 . . . . 0.0 111.299 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -119.06 115.34 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.585 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -114.83 165.32 12.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.349 0.595 . . . . 0.0 111.553 -177.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -102.21 163.07 12.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.162 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 42.4 ttp180 -106.36 134.86 48.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.4 mm -81.87 155.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.668 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -75.77 84.49 2.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 110.564 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.9 m -78.82 92.92 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.061 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -101.7 7.2 42.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.261 0.553 . . . . 0.0 110.085 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.8 p -79.32 -10.14 59.74 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.287 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.01 -147.85 50.51 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.407 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -142.07 117.06 9.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.285 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.5 134.55 33.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.101 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -78.19 -67.95 0.68 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 59.08 17.84 5.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.586 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -151.95 172.95 15.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -105.78 179.34 4.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.377 . . . . 0.0 111.362 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -135.9 -165.6 1.73 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m 61.51 38.73 15.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.738 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -84.38 90.38 7.57 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.251 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.8 p -143.84 131.29 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.427 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.0 tp -140.42 142.65 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.571 ' HB3' ' HD2' ' A' ' 131' ' ' HIS . 48.4 mt-10 -117.84 146.56 43.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -141.2 73.25 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.256 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 129' ' ' GLU . 7.7 p80 -147.17 156.35 42.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.01 -10.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.5 t60 69.84 -80.1 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.351 0.66 . . . . 0.0 110.25 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -169.02 -51.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.937 0.495 . . . . 0.0 109.832 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.82 177.776 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.36 107.93 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.6 mtm 64.89 85.74 0.14 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.62 -24.7 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.1 m 64.73 -175.96 0.17 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.121 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.53 139.96 15.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.612 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.8 p -90.61 13.91 14.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.562 0.22 . . . . 0.0 111.024 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 7' ' ' CYS . 2.3 mp0 68.14 168.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.881 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 66.59 12.73 8.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -106.24 137.05 44.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.898 0.38 . . . . 0.0 110.985 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.42 69.02 7.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.83 -88.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 14' ' ' THR . 0.8 OUTLIER -173.6 178.2 2.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.737 -170.241 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 18.4 m 73.53 129.33 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.926 0.891 . . . . 0.0 113.328 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.93 122.24 11.28 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.919 2.413 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.34 -26.71 68.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -92.76 -10.43 37.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.055 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.5 -164.59 23.47 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.325 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.4 m -112.41 127.75 56.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.925 0.393 . . . . 0.0 110.145 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -117.42 151.41 37.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' HD11 ' A' ' 112' ' ' ILE . 13.8 t70 -89.52 130.92 35.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 4.2 mm-40 -52.85 -53.55 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.726 0.641 . . . . 0.0 112.376 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.04 35.17 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.51 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.5 tpp180 -99.41 149.33 23.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.58 79.07 21.73 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.3 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 25' ' ' ARG . 96.7 Cg_endo -99.91 -164.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.741 2.96 . . . . 0.0 110.927 174.149 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.35 173.79 33.08 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.912 171.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.1 132.51 16.79 Favored 'Trans proline' 0 C--N 1.324 -0.721 0 C-N-CA 122.989 2.459 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 p -86.03 6.74 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 t0 69.2 84.03 0.15 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.566 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.68 -38.02 2.07 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.63 138.54 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.676 0.274 . . . . 0.0 110.431 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HE3' ' HB2' ' A' ' 52' ' ' GLU . 95.8 mttt -91.17 -38.89 12.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.486 0.66 . . . . 0.0 110.201 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -167.75 171.8 9.74 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.65 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -135.55 164.5 27.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.079 0.466 . . . . 0.0 111.647 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 p -127.95 157.18 41.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.2 125.7 74.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.288 0.565 . . . . 0.0 111.02 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -108.33 122.4 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -101.14 117.67 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -101.61 176.32 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' H ' HG22 ' A' ' 41' ' ' THR . 44.7 mt-10 -62.56 -39.66 94.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.086 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.69 -3.35 5.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.849 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.99 157.5 45.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.224 0.535 . . . . 0.0 111.646 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.09 133.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.69 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.76 124.33 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.495 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HB2' HD12 ' A' ' 59' ' ' LEU . 17.8 mt-10 -98.79 137.41 37.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.264 0.554 . . . . 0.0 110.947 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.09 120.26 35.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.808 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.87 131.9 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.369 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 56' ' ' GLU . 39.9 t -89.48 113.6 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.297 0.57 . . . . 0.0 110.665 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.0 mtt -116.07 135.53 53.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.723 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 34.4 tt0 -70.66 128.91 37.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.99 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 -27.32 7.36 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.343 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -93.21 -62.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.665 0.745 . . . . 0.0 109.997 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.14 -155.26 19.78 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.299 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.3 mt-10 -87.71 129.09 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.374 0.607 . . . . 0.0 110.162 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.8 t -104.38 122.61 57.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.94 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.628 ' OE1' ' HA ' ' A' ' 119' ' ' GLU . 69.7 mt-30 -91.87 130.4 37.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.019 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 47' ' ' GLU . 94.8 mt -85.31 154.66 60.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -50.23 143.08 26.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.109 2.539 . . . . 0.0 112.524 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -59.87 119.02 6.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.7 mtm -109.79 121.78 46.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.218 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 149.36 39.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.531 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.21 159.91 36.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.84 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HD2' HD21 ' A' ' 80' ' ' LEU . 20.4 ptmt -121.69 144.31 48.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.029 0.442 . . . . 0.0 109.846 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.78 115.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.806 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.5 mt -93.6 -51.86 10.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.898 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -124.92 154.61 40.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.717 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -149.19 147.74 28.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -148.74 146.27 28.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.3 p -73.48 -24.19 60.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.375 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -161.29 78.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.91 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.87 -84.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.978 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 m -145.41 148.89 33.83 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.096 0.474 . . . . 0.0 110.644 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.23 132.35 66.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -114.76 124.17 51.09 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.72 149.21 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 32.4 tt0 -124.36 136.76 54.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 70.0 m-85 -77.11 157.45 31.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.281 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.572 HD21 ' HD2' ' A' ' 65' ' ' LYS . 90.6 mt -121.11 166.48 13.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.977 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.41 -152.19 17.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.977 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.69 -9.85 15.04 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -122.98 57.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 37.3 p90 -85.21 -27.68 0.39 Allowed Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.071 -171.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 10.3 Cg_endo -89.31 -3.57 5.95 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 CA-C-N 121.089 1.425 . . . . 0.0 112.701 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.9 tp -89.21 117.25 28.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 64.1 pttt -113.76 162.43 16.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.942 0.401 . . . . 0.0 110.955 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.77 160.26 34.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.9 m -115.7 139.24 50.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 98' ' ' LEU . 96.1 mt -124.1 124.33 42.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -132.33 152.86 51.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.496 . . . . 0.0 111.018 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -69.46 151.18 46.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.807 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.45 152.2 18.28 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.89 145.16 56.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.688 0.28 . . . . 0.0 111.259 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 66.47 20.48 10.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.553 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.47 4.21 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.072 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 p -117.16 173.8 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 90' ' ' LEU . 49.4 tp -127.7 135.94 50.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.251 0.548 . . . . 0.0 111.345 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.4 mt -108.8 111.06 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.5 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.78 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.2 t90 -105.41 117.97 35.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.322 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.4 mt-10 -102.48 132.75 48.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.528 0.68 . . . . 0.0 110.113 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -151.24 123.94 8.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.128 -173.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.6 m120 62.02 22.44 13.08 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.729 0.643 . . . . 0.0 111.26 179.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.39 -8.35 69.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.98 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -93.1 134.06 35.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.992 0.396 . . . . 0.0 110.064 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -101.18 127.66 47.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.103 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 5.0 mmpt? -127.51 139.58 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.169 0.509 . . . . 0.0 111.657 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 m -106.58 114.11 28.02 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.995 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.78 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 12.4 ptp -119.37 148.4 43.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.644 -172.146 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -98.15 152.78 18.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -84.67 123.89 30.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -74.13 154.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -72.28 90.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.128 0.49 . . . . 0.0 109.98 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 68.86 172.55 0.29 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.255 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -92.93 112.0 23.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.641 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.1 m -87.38 132.44 33.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.629 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 114.33 -161.07 12.85 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.048 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -151.08 124.59 8.97 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.628 ' HA ' ' OE1' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -74.42 112.99 11.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.223 0.535 . . . . 0.0 110.213 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -152.67 -71.5 0.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.371 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 61.21 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.999 0.812 . . . . 0.0 110.802 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -93.0 135.16 34.42 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.082 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 72.31 122.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.395 1.059 . . . . 0.0 111.832 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.7 123.14 20.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.7 m -112.58 98.11 7.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.768 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -108.7 72.17 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.566 . . . . 0.0 110.618 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -173.4 100.03 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.789 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.74 128.56 54.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -76.54 78.7 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.173 0.511 . . . . 0.0 110.215 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 29.3 p-80 -67.75 102.62 1.25 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -123.99 161.92 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.682 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -169.82 122.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.098 0.249 . . . . 0.0 110.35 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.56 103.9 1.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.974 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -112.53 119.81 39.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.394 -177.305 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.504 ' CE ' ' HB2' ' A' ' 132' ' ' HIS . 53.7 mtt . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.52 164.93 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.183 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -99.55 119.63 38.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.781 HG11 ' HA ' ' A' ' 127' ' ' SER . 7.2 p -71.68 140.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.899 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.5 m -64.5 113.18 3.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.84 166.55 22.59 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.355 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -70.21 96.32 1.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -159.81 156.71 27.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.153 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 19.9 tp60 -129.82 -95.96 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 29.8 tt0 165.22 120.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.622 0.769 . . . . 0.0 108.987 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -124.04 99.93 6.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.921 0.867 . . . . 0.0 110.88 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -141.92 8.95 1.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 14' ' ' THR . 9.0 tp10 -147.2 161.7 40.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 8.1 m 70.63 130.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 123.915 0.759 . . . . 0.0 112.29 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 39.2 Cg_exo -56.85 121.26 9.75 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.629 2.219 . . . . 0.0 111.684 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -69.86 -15.25 63.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.993 -172.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -98.15 -5.67 33.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 28.0 t80 -85.53 136.37 33.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 0.0 111.036 -171.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.18 -143.25 14.82 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.029 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m -127.88 126.39 41.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 87.2 m95 -117.92 138.81 51.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.139 0.495 . . . . 0.0 111.486 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 4.4 t70 -83.55 126.47 32.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.498 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 44.2 mt-10 -90.71 72.72 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.65 -15.94 60.86 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.257 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -100.45 142.75 31.49 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 70.71 145.24 0.11 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.562 1.164 . . . . 0.0 111.3 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 14.5 Cg_exo -69.69 148.78 66.28 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.702 2.268 . . . . 0.0 112.501 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.4 -160.9 36.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.048 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.552 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.9 Cg_endo -62.98 152.58 78.62 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.711 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 p -78.67 3.76 15.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.736 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.39 -11.22 60.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.287 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 111.69 47.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.718 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' HG2' ' A' ' 29' ' ' PRO . 17.1 t -105.84 135.12 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.672 0.272 . . . . 0.0 110.28 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.08 -42.44 47.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.624 . . . . 0.0 111.024 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -166.14 163.17 18.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.534 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.12 36.98 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.78 141.14 51.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.54 129.76 70.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.333 0.587 . . . . 0.0 110.578 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 35.1 m -111.95 119.48 38.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.305 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -102.17 121.19 41.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.799 0.333 . . . . 0.0 111.225 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 1.7 m -101.83 173.9 6.19 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 mp0 -53.04 -46.56 68.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -129.8 8.09 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 45.0 mt-10 -121.77 135.4 54.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.562 -175.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 64' ' ' TYR . 87.2 t -107.97 118.07 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 52.8 t -109.96 123.12 65.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 15.6 mt-10 -97.27 132.47 42.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.53 0.681 . . . . 0.0 111.066 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -127.85 118.25 23.33 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.1 177.023 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' OE2' ' HG3' ' A' ' 29' ' ' PRO . 27.6 mt-10 -109.0 126.66 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.302 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.88 111.65 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.247 0.546 . . . . 0.0 110.043 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 32' ' ' GLY . 39.1 ttm -118.92 125.95 50.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.515 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.03 127.17 30.5 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.012 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.6 -28.79 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.655 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -125.77 -34.73 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.178 0.513 . . . . 0.0 111.289 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.42 -140.73 15.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.251 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.63 138.56 50.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.23 0.538 . . . . 0.0 111.209 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 48' ' ' THR . 80.0 t -128.72 121.38 54.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.097 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -82.16 130.52 35.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 76.3 mt -95.84 159.69 31.82 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.651 171.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.08 117.39 3.85 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.79 2.327 . . . . 0.0 111.601 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -61.62 127.29 30.75 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.529 0.681 . . . . 0.0 111.475 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 42.5 ttm -95.2 144.36 25.87 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.556 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.97 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 110.471 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 45' ' ' VAL . 15.7 p90 -138.08 163.07 32.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.067 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.585 ' HE3' HG12 ' A' ' 67' ' ' ILE . 49.7 pttt -122.61 152.82 40.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.962 0.41 . . . . 0.0 110.117 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.63 112.95 37.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.032 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.585 HG12 ' HE3' ' A' ' 65' ' ' LYS . 11.5 mt -83.95 -53.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.287 0.565 . . . . 0.0 109.871 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 m -127.1 151.58 48.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.11 146.86 27.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -137.2 153.8 50.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.1 m -79.37 -30.02 42.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -152.76 80.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.131 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.32 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.671 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 p -148.68 154.71 40.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.173 0.511 . . . . 0.0 110.994 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 31.9 mt -128.35 130.99 69.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.001 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.81 124.13 51.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.32 157.68 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.765 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 47.4 tt0 -132.69 135.93 46.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -74.72 144.37 43.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 -179.7 3.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.759 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.67 -151.53 34.24 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.582 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 -10.15 21.35 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.718 2.278 . . . . 0.0 112.313 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -99.5 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.693 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.839 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 1.6 p90 -60.1 -179.31 0.17 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.371 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.839 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER 12.76 -0.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.258 1 C-N-CA 127.75 5.633 . . . . 0.0 121.343 -149.375 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' TYR . 63.0 tp -71.66 113.52 8.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 119.905 1.229 . . . . 0.0 109.759 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 94.7 mttt -91.44 170.82 9.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.418 0.628 . . . . 0.0 111.643 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -151.75 152.45 32.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.35 171.395 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.2 m -118.07 141.78 48.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.32 0.581 . . . . 0.0 111.31 -173.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 80.9 mt -121.12 124.65 45.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.641 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 51.9 mtpt -132.59 156.91 46.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 111.669 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -65.59 144.2 57.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.598 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.81 -168.53 25.3 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.926 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.7 -41.43 13.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.336 0.589 . . . . 0.0 111.674 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -102.84 18.37 21.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.191 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.66 26.36 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 p -106.0 175.67 5.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.341 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 90' ' ' LEU . 59.5 tp -105.55 128.4 53.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 34.0 mm -96.97 109.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 16.6 t90 -103.25 112.76 25.78 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.703 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.3 mt-10 -104.47 131.19 52.12 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.69 0.757 . . . . 0.0 109.853 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -151.15 120.29 6.74 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.314 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 61.56 23.2 13.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -8.79 70.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.748 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.2 142.23 27.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -93.68 115.76 28.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 71.3 mttt -106.33 115.56 30.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.444 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.0 m -92.93 118.05 30.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.599 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 10.3 mmt -99.42 139.09 35.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -95.12 143.51 26.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.107 0.479 . . . . 0.0 110.286 -177.931 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -79.24 128.94 33.94 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 22' ' ' ASP . 26.8 mm -75.99 142.85 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.337 0.589 . . . . 0.0 109.486 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -150.21 127.55 11.4 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 m 60.48 -159.17 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.651 0.594 . . . . 0.0 109.925 -174.081 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -100.07 22.28 11.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.01 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER 64.67 165.13 0.15 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.555 0.742 . . . . 0.0 111.463 -178.565 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.06 -112.5 2.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -138.23 108.47 6.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 111.459 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -133.46 125.65 29.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.578 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.25 121.17 15.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.053 0.454 . . . . 0.0 110.539 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -129.95 139.45 51.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.408 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.856 0.36 . . . . 0.0 111.332 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -95.51 107.34 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.408 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -100.04 95.81 7.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.942 0.401 . . . . 0.0 110.893 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.3 m -124.68 118.49 26.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -135.18 148.06 49.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' SER . . . . . 0.781 ' HA ' HG11 ' A' ' 4' ' ' VAL . 50.8 m -144.49 128.22 17.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.047 0.451 . . . . 0.0 111.771 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.64 141.15 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.626 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.85 123.45 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -139.94 100.32 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.408 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 33.8 m170 -78.45 178.7 7.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.216 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' HIS . . . . . 0.504 ' HB2' ' CE ' ' A' ' 1' ' ' MET . 12.5 t60 -105.12 125.85 51.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.768 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -90.15 -172.62 3.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.54 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 135' ' ' HIS . 24.4 m80 -76.46 73.55 3.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 134' ' ' HIS . 5.5 p80 . . . . . 0 C--O 1.243 0.721 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.75 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG2' HG12 ' A' ' 2' ' ' ILE . 21.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.458 HG12 ' HG2' ' A' ' 1' ' ' MET . 45.1 mm 65.78 82.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 O-C-N 123.622 0.576 . . . . 0.0 111.388 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.92 139.02 31.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.13 98.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.884 0.373 . . . . 0.0 110.57 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -76.76 109.28 10.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.778 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.39 167.94 30.48 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.789 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 42.8 t -119.3 82.34 1.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.165 0.507 . . . . 0.0 110.058 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.12 82.41 7.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.669 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.609 ' HG2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -93.73 67.78 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.957 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 49.8 tt0 -178.32 68.49 0.02 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -159.9 164.64 33.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -130.76 94.13 3.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.774 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -132.32 172.07 12.91 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 15.0 m -54.71 116.88 12.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 0.0 111.773 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.723 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.2 Cg_exo -67.45 104.13 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.816 2.344 . . . . 0.0 111.656 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 40.6 p90 -57.65 -34.27 69.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.987 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 50.1 p90 -78.93 -9.62 59.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 2.1 t80 -80.82 23.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.331 0.586 . . . . 0.0 111.364 -172.155 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.61 -177.78 18.49 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.095 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 m -99.23 116.86 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.45 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 50.6 m95 -114.05 132.32 56.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.465 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.28 129.99 45.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 36.6 mt-10 -62.25 -55.63 26.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.43 27.55 73.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.107 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.7 144.68 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.6 160.71 0.13 Allowed Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 124.388 1.055 . . . . 0.0 112.086 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.85 153.6 72.54 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.686 2.258 . . . . 0.0 111.516 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.03 -169.66 46.07 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.964 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 64.2 Cg_exo -50.66 162.89 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 124.466 3.444 . . . . 0.0 113.879 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 p -69.34 -9.42 53.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.884 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.59 -10.13 59.18 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.012 -0.43 . . . . 0.0 111.106 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.7 27.67 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.547 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.616 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 21.4 t -74.06 134.67 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.262 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -81.14 -32.67 33.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 m -158.73 160.34 36.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.506 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.01 137.01 46.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.142 0.496 . . . . 0.0 111.092 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 24.6 p -118.39 136.86 53.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.259 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.78 134.14 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.179 0.514 . . . . 0.0 110.671 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -123.3 128.31 49.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.701 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 97.0 m-85 -102.06 116.79 33.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.128 0.489 . . . . 0.0 110.546 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.524 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -103.04 -178.16 3.58 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.78 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -46.01 -64.2 0.8 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.17 10.29 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.772 0.796 . . . . 0.0 110.16 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.524 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -137.98 145.83 42.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.181 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' A' ' 64' ' ' TYR . 90.0 t -101.36 132.3 47.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.19 123.16 67.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.828 0.347 . . . . 0.0 110.159 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -103.78 138.31 40.56 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.435 0.636 . . . . 0.0 110.279 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.45 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -124.23 122.13 36.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.182 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.59 120.03 39.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.797 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 56' ' ' GLU . 33.2 t -87.98 112.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.6 127.57 55.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.16 132.12 49.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.67 0.606 . . . . 0.0 111.517 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.4 3.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.07 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -93.9 -63.96 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.14 -157.02 21.05 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.376 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.8 mp0 -74.98 129.61 37.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.38 0.61 . . . . 0.0 110.843 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.84 122.58 66.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.708 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -84.76 131.63 34.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.872 0.368 . . . . 0.0 111.917 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.69 164.89 30.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.543 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.83 152.33 36.1 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.876 2.384 . . . . 0.0 112.44 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.77 114.66 10.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 110.693 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.7 mtp -96.62 118.38 32.99 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.544 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -75.98 140.85 42.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.969 0.414 . . . . 0.0 111.66 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CD1' HG23 ' A' ' 45' ' ' VAL . 8.9 p90 -145.94 150.11 35.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -132.93 151.56 52.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.486 0.66 . . . . 0.0 111.243 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.87 128.94 38.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.846 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 36.7 mt -90.94 -52.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.177 175.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.6 m -138.48 156.95 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.196 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.609 ' HB3' ' HG2' ' A' ' 9' ' ' GLN . 34.9 tt0 -147.54 152.85 38.67 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -174.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.789 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 33.2 t -157.89 135.48 10.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 120.819 0.343 . . . . 0.0 111.156 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -11.94 59.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.1 -39.15 89.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.067 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.08 36.78 0.15 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.21 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 m -149.84 136.49 19.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 117.573 0.686 . . . . 0.0 110.736 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 18.6 mt -136.24 137.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.98 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -114.09 129.06 56.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 32.7 pt -131.45 157.43 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.858 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.896 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 6.2 tp-100 -124.28 147.05 48.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.272 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -96.48 151.05 19.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 63' ' ' ALA . 38.1 mt -107.74 156.13 19.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.154 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -154.42 21.75 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.24 -4.76 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.765 2.31 . . . . 0.0 112.618 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -97.67 11.45 37.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.988 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -65.35 176.71 0.79 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.948 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.988 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 20.0 Cg_exo 5.06 -1.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 1 C-N-CA 128.425 6.084 . . . . 0.0 121.872 -148.478 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' TYR . 51.2 tp -90.19 102.94 15.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 120.299 1.409 . . . . 0.0 108.057 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 20.4 pttp -115.39 178.66 4.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 0.0 112.352 -166.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.425 ' CB ' ' HE1' ' A' ' 100' ' ' TRP . 2.6 m -133.27 165.6 24.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -123.86 142.16 51.38 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.443 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 93.7 mt -117.92 124.6 48.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.365 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -137.51 154.98 49.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.955 0.407 . . . . 0.0 110.991 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -65.12 143.72 57.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.253 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.01 132.97 10.14 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 42.3 mt-10 -68.59 158.43 34.0 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.899 -0.177 . . . . 0.0 110.568 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 83.3 m-20 75.51 -7.42 1.79 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.74 0.816 . . . . 0.0 110.784 -174.29 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.53 0.9 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.873 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.4 p -131.16 174.24 10.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.748 0.309 . . . . 0.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.82 133.18 54.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.884 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.16 110.2 30.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.231 0.539 . . . . 0.0 109.87 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.453 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.9 t90 -104.97 114.13 28.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.788 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.9 134.71 43.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.266 0.555 . . . . 0.0 109.687 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -148.79 111.77 4.87 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.748 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.59 31.71 20.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.82 0.819 . . . . 0.0 110.698 166.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.44 -17.17 55.85 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.941 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -92.04 136.29 33.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.968 0.384 . . . . 0.0 110.839 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 106' ' ' ARG . 23.2 ttt180 -99.94 114.97 28.6 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -109.7 136.25 49.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.595 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -120.93 114.13 21.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.856 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.453 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -118.22 151.49 37.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -109.36 151.72 26.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -87.92 135.74 33.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.298 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.78 147.58 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.616 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.39 152.4 21.93 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.557 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.2 m -77.0 76.23 3.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -112.25 63.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -79.23 102.56 8.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.266 -172.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.0 66.6 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -98.49 83.48 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.632 0.73 . . . . 0.0 110.845 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -132.79 160.82 35.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.681 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -74.61 103.0 4.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.07 138.84 32.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.18 159.45 16.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.89 132.22 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.016 0.436 . . . . 0.0 111.204 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -64.17 104.41 0.74 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.667 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 t -87.87 104.56 16.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.243 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 70.15 -74.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.792 0.682 . . . . 0.0 111.488 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.0 t -164.44 133.24 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -113.27 107.32 15.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 110.449 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.46 152.0 8.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.73 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -62.71 107.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.192 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -116.9 130.98 57.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.785 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -104.79 117.3 33.71 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -82.56 -5.83 58.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.442 -171.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.0 t60 . . . . . 0 C--O 1.241 0.658 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.086 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.5 mtp . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt 68.15 96.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 O-C-N 123.924 0.765 . . . . 0.0 111.4 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtp -131.4 120.57 23.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.094 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.27 143.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -102.42 0.64 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.613 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.97 64.84 3.64 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.6 m -85.03 151.5 24.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.313 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.97 -138.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.676 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 70.07 35.81 2.09 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.458 0.474 . . . . 0.0 111.274 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -64.09 122.76 17.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -83.34 -32.61 26.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.43 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.59 61.65 3.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.976 0.893 . . . . 0.0 109.961 -170.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' O ' ' HB ' ' A' ' 14' ' ' THR . 10.0 tp10 -131.72 172.54 12.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.027 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 14.7 m 72.71 124.33 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 123.147 0.579 . . . . 0.0 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 14' ' ' THR . 6.1 Cg_endo -49.45 120.13 5.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.725 2.95 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -69.53 -14.24 62.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.468 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -98.03 -11.54 22.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.498 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -86.05 135.71 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.93 -168.24 22.5 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.984 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.7 m -104.08 129.93 51.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -120.44 135.8 54.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.016 0.436 . . . . 0.0 111.039 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.74 139.09 31.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.027 174.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 37.5 mt-10 -50.31 -43.83 53.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.21 -56.81 2.8 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.187 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 -105.7 141.24 37.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 65.81 142.77 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.637 1.211 . . . . 0.0 112.054 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.1 Cg_exo -81.44 171.09 13.96 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.251 2.634 . . . . 0.0 112.571 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.91 -154.97 30.34 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.313 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' O ' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -61.89 -31.06 84.72 Favored 'Trans proline' 0 C--O 1.23 0.098 0 C-N-CA 123.315 2.676 . . . . 0.0 113.597 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 83.2 m 75.6 -21.14 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.748 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -51.13 -54.7 22.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.398 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.36 -43.07 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.002 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.35 134.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.72 -32.47 14.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 m -167.88 165.41 13.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.943 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -121.97 148.06 45.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.096 0.474 . . . . 0.0 111.055 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 p -118.11 139.48 51.18 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.54 137.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.162 0.506 . . . . 0.0 111.19 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -119.41 127.84 53.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.901 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -101.69 125.64 48.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 111.425 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -101.36 178.97 4.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.439 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 41' ' ' THR . 36.5 mt-10 -55.03 -42.1 72.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -141.29 19.55 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 110.821 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.8 mt-10 -129.06 145.16 51.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 62' ' ' MET . 92.5 t -117.14 121.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.07 124.02 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -111.8 128.78 56.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -111.62 125.18 53.67 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.485 177.227 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.19 128.08 45.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 56' ' ' GLU . 43.6 t -92.31 112.61 26.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 0.0 110.359 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -112.3 161.56 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.433 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.0 123.96 26.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 110.759 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 -10.93 44.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.592 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -98.71 -68.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 50' ' ' VAL . . . 125.66 -142.59 13.86 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.613 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HG2' HG22 ' A' ' 50' ' ' VAL . 53.1 mt-10 -95.65 120.61 36.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.291 0.567 . . . . 0.0 110.644 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' THR . 73.9 t -104.68 124.89 59.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.694 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -88.13 119.57 28.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.629 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.6 mt -81.09 163.64 54.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.806 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.4 Cg_endo -62.25 146.4 95.89 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.792 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -64.04 131.01 46.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 111.075 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 50.8 mtt -97.43 118.19 33.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.838 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.83 127.71 32.83 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 45' ' ' VAL . 45.6 p90 -129.18 171.81 12.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.959 0.409 . . . . 0.0 111.332 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HE3' HD21 ' A' ' 80' ' ' LEU . 99.0 mttt -120.71 159.73 24.77 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.253 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -103.72 120.97 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.781 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 78' ' ' GLN . 19.9 mt -87.55 -54.0 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.233 0.539 . . . . 0.0 109.813 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -136.46 153.19 51.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.144 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.74 124.39 11.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.455 0.645 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 74' ' ' SER . 35.5 t -108.85 -22.55 12.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.124 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 m 73.77 -38.71 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.851 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.53 -59.41 1.75 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.756 0.312 . . . . 0.0 111.435 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.64 -60.52 2.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.176 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.498 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 30.5 t -154.0 164.84 37.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.407 0.622 . . . . 0.0 111.598 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.55 136.4 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.456 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 67' ' ' ILE . 27.2 tt0 -115.09 131.01 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.739 0.304 . . . . 0.0 110.37 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.64 158.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.136 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.606 ' HB2' HD11 ' A' ' 67' ' ' ILE . 61.8 tt0 -131.84 140.85 49.26 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 58.4 m-85 -86.41 179.42 6.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD21 ' HE3' ' A' ' 65' ' ' LYS . 90.0 mt -134.87 -176.21 4.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.324 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.65 -152.98 30.98 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HG2' ' CE2' ' A' ' 83' ' ' TYR . 28.0 Cg_endo -65.44 -7.35 15.75 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.215 1.944 . . . . 0.0 112.047 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.529 ' CE2' ' HG2' ' A' ' 82' ' ' PRO . 24.8 m-85 -114.16 34.78 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.1 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 19.6 p90 -85.33 -27.35 0.38 Allowed Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 84.2 Cg_endo -83.32 -4.44 11.0 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.439 1.55 . . . . 0.0 112.922 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.88 133.22 44.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.333 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 22.9 pttp -111.49 168.72 9.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.117 0.484 . . . . 0.0 111.181 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 156.47 46.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.315 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -124.58 142.13 51.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.83 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 98' ' ' LEU . 97.6 mt -120.39 124.19 44.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.567 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 32.8 mtmm -124.26 161.56 25.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.39 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.39 144.91 33.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.011 0.434 . . . . 0.0 110.396 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.64 171.09 23.65 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.507 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.18 -19.9 60.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.097 -0.551 . . . . 0.0 111.944 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -121.41 29.66 7.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 -173.667 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.05 39.7 62.92 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -116.63 174.91 5.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.451 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 90' ' ' LEU . 39.1 tp -113.23 131.78 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.89 111.44 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.866 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -97.0 112.89 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.827 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -110.81 132.63 54.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -150.69 128.25 11.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.092 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.66 17.12 9.47 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.6 64.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.82 134.3 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' NH2' ' HE3' ' A' ' 91' ' ' LYS . 96.4 mtt180 -101.39 123.92 46.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 19.3 mmtp -106.99 125.7 51.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.953 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -97.66 113.2 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.38 155.46 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.856 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.11 150.42 20.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.835 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 3.0 ptt180 -95.78 139.82 31.46 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mm -95.87 155.48 3.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.864 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.22 85.3 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.902 0.858 . . . . 0.0 109.769 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -99.68 57.7 1.02 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.332 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.83 86.39 4.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.117 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 t -154.62 179.13 9.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.315 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.55 161.22 14.12 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -89.06 97.26 11.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 0.0 110.314 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.13 153.18 30.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.956 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -113.91 118.28 33.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.227 -172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -89.88 107.99 19.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.86 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.07 99.4 8.99 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.852 0.834 . . . . 0.0 109.917 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -159.26 153.9 24.42 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.194 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -133.63 76.76 1.68 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.38 112.3 20.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.511 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -113.17 103.88 11.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.977 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -90.83 82.02 5.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 0.0 110.356 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.97 93.46 6.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.912 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 1.5 mm-40 -97.49 116.74 30.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.402 0.62 . . . . 0.0 111.009 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -127.43 30.06 5.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.885 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -90.72 146.51 23.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.4 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -83.68 114.83 21.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.629 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -69.11 116.57 9.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.805 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -137.18 118.02 14.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.726 178.428 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.974 0.416 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.56 91.16 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.01 118.72 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.028 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.17 151.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.098 0.475 . . . . 0.0 111.333 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 p -146.59 151.0 36.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -154.78 7.52 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.581 -175.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 t -131.85 7.59 4.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.168 0.509 . . . . 0.0 110.307 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLN . . . . . 0.53 ' HB2' ' HA ' ' A' ' 121' ' ' LYS . 5.9 tp60 -96.92 -175.06 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 54.2 tt0 -120.93 115.6 23.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -76.76 91.39 3.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.845 ' HG3' ' HG2' ' A' ' 12' ' ' GLU . 17.2 ptpt -95.19 -43.05 8.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.565 -169.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.845 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 4.5 pt-20 -158.62 103.88 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.0 111.028 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -101.92 -179.35 3.98 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.095 -177.125 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.818 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 29.3 m -80.35 -58.9 0.55 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 16.1 Cg_exo -68.82 90.47 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.192 1.928 . . . . 0.0 112.169 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -75.7 -9.15 58.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.01 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -84.41 -11.68 55.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 15' ' ' PRO . 10.5 m-85 -72.68 151.08 42.43 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.71 -167.07 12.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.388 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.3 m -110.55 128.07 55.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 110.501 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.439 ' CZ3' ' HB3' ' A' ' 111' ' ' ARG . 64.1 m95 -113.36 128.6 56.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.0 t70 -88.21 120.69 29.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.16 76.1 2.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.348 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.23 40.4 2.47 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -128.04 144.49 51.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.43 156.75 0.16 Allowed Pre-proline 0 N--CA 1.465 0.311 0 O-C-N 124.213 0.946 . . . . 0.0 111.756 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.74 134.51 50.94 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.455 2.104 . . . . 0.0 111.857 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.9 -174.85 34.98 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.229 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.607 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 18.2 Cg_endo -59.76 128.4 26.78 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.159 2.573 . . . . 0.0 112.75 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -67.86 -10.38 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.347 0.594 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.88 -33.17 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.561 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.57 -27.96 0.54 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.221 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.607 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 5.8 t -82.59 133.35 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -91.48 -31.08 16.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.092 0.473 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 m -160.2 165.09 32.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.613 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.78 154.85 51.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.012 0.434 . . . . 0.0 111.292 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 22' ' ' ASP . 5.7 p -123.18 130.44 52.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.407 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.39 130.39 66.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.058 0.456 . . . . 0.0 110.572 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.2 m -114.78 127.09 55.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.774 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.83 117.64 35.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.17 0.51 . . . . 0.0 110.2 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -101.11 179.18 4.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.543 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' H ' HG22 ' A' ' 41' ' ' THR . 29.9 mt-10 -52.84 -64.13 0.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -119.18 14.49 13.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 111.698 -174.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.49 148.62 34.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.91 0.386 . . . . 0.0 111.019 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 64' ' ' TYR . 98.0 t -110.19 119.45 59.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.526 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.8 123.35 53.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.991 0.424 . . . . 0.0 110.426 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.22 137.24 38.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.368 0.604 . . . . 0.0 110.75 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.03 122.26 31.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.867 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -99.67 135.89 40.41 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.53 112.08 23.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.6 mmm -110.47 124.94 52.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.043 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.56 113.88 2.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.976 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 -26.83 23.15 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.4 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -96.23 -55.03 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.598 0.713 . . . . 0.0 109.813 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.19 -156.64 15.64 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.496 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.99 126.74 30.52 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.279 0.561 . . . . 0.0 110.564 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.88 122.59 68.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -81.81 128.45 34.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.2 mt -93.75 165.45 17.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.489 173.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.0 Cg_endo -58.45 128.4 28.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.297 1.998 . . . . 0.0 111.432 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -66.89 122.9 18.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.75 0.786 . . . . 0.0 111.231 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 40.2 ttm -80.39 127.87 32.9 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.18 135.76 41.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CD1' HG23 ' A' ' 45' ' ' VAL . 6.2 p90 -147.09 157.93 43.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -123.68 136.64 54.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.169 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 77' ' ' ILE . 78.9 t -75.7 122.94 30.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.882 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 78' ' ' GLN . 27.4 mt -83.9 -54.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.4 m -140.78 156.47 46.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.7 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -148.67 126.39 11.81 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.161 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -161.94 156.26 22.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.056 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 m -82.17 -26.87 33.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.125 0.488 . . . . 0.0 110.107 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.7 -29.89 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.76 0.81 89.23 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p 60.96 -178.54 0.11 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.97 1.308 . . . . 0.0 112.222 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 11.3 mt -108.13 130.59 60.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.134 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -126.38 128.49 47.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' VAL . 29.4 pt -131.01 155.86 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.996 0.426 . . . . 0.0 111.198 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.758 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 5.6 tp-100 -123.68 146.22 48.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.205 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 41.4 m-85 -98.45 151.05 21.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.873 0.368 . . . . 0.0 110.365 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.4 mt -113.82 164.51 13.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.7 -151.28 23.05 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.513 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.68 -6.91 11.54 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.974 2.449 . . . . 0.0 112.627 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 13.07 30.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -60.45 174.22 0.53 Allowed Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.106 -173.697 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 44.5 Cg_exo 5.18 -0.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 128.847 6.365 . . . . 0.0 121.944 -148.432 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 84' ' ' TYR . 49.0 tp -78.12 103.04 7.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 120.086 1.312 . . . . 0.0 108.095 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 61.4 pttt -95.7 -176.8 3.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -166.38 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 77' ' ' ILE . 40.6 t -141.69 159.32 42.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.235 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.8 m -137.17 144.71 43.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.507 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 87.2 mt -126.59 124.65 40.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.546 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 98' ' ' LEU . 62.3 mttp -123.17 167.0 14.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -79.82 149.52 31.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.952 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' HA3' ' HB ' ' A' ' 97' ' ' THR . . . -116.24 137.66 13.85 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -41.41 74.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.32 25.78 2.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.453 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.04 39.02 13.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.27 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -107.63 171.91 7.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.362 -0.419 . . . . 0.0 109.886 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 91' ' ' LYS . 34.3 tp -128.8 131.08 47.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.78 112.81 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.446 ' HA ' HD23 ' A' ' 90' ' ' LEU . 20.7 t90 -96.54 112.65 24.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 36.3 mt-10 -104.64 130.04 52.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.458 0.647 . . . . 0.0 110.031 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 19.7 tm0? -153.78 134.74 13.87 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.798 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.9 OUTLIER 66.55 13.33 9.25 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.323 0.39 . . . . 0.0 111.525 173.739 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.28 71.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.073 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.31 142.69 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.554 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 58.7 mtt180 -99.51 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.168 0.508 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 29.7 mmmt -101.7 141.4 34.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.556 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 m -119.24 112.68 19.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HE3' HD23 ' A' ' 98' ' ' LEU . 23.6 ptt? -126.37 141.57 51.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.755 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.7 m -98.94 154.46 18.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.435 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 21' ' ' TRP . 20.3 ptt180 -88.11 157.72 18.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.054 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.7 mm -95.76 147.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.85 121.39 29.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.268 0.556 . . . . 0.0 111.435 -172.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 m -99.74 117.81 34.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.299 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -100.09 4.92 44.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.19 150.68 35.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.445 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.4 64.65 0.23 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 25.9 ttp-105 -97.1 84.8 3.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.973 0.416 . . . . 0.0 110.349 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -142.67 131.79 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.783 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 65.8 172.84 0.23 Allowed 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.922 0.764 . . . . 0.0 111.326 -174.051 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.53 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 46.2 tttp -173.37 130.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -118.97 -150.5 0.46 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 69.9 88.19 0.11 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.404 0.621 . . . . 0.0 111.251 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 118.13 11.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.319 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.6 m -153.58 109.01 3.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -121.03 18.32 11.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.395 0.617 . . . . 0.0 110.18 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m -91.79 101.02 13.62 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.4 tp -126.08 87.74 2.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.99 0.424 . . . . 0.0 110.15 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.69 131.03 44.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.304 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -175.42 117.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.964 0.411 . . . . 0.0 111.495 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -130.46 131.66 45.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.605 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -141.49 -80.79 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.14 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.1 m80 66.16 -60.91 0.3 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.685 0.616 . . . . 0.0 110.767 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.618 -0.705 . . . . 0.0 109.333 177.441 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.3 pt -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.588 0.709 . . . . 0.0 111.995 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -174.27 174.47 2.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.554 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 m -100.52 87.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 0.0 110.782 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 70' ' ' SER . 4.0 m -81.24 34.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.964 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.45 110.24 0.46 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.092 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' CYS . . . . . 0.593 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 41.8 t -143.46 131.68 21.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -75.83 -5.86 47.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 111.744 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.34 -18.5 24.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.717 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' A' ' 7' ' ' CYS . 55.5 mt-30 -70.33 -45.59 65.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.222 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 69.89 -70.26 0.15 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.04 0.837 . . . . 0.0 110.545 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 67.19 -71.43 0.1 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.737 0.648 . . . . 0.0 112.415 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 14' ' ' THR . 4.3 tp10 -154.9 173.63 16.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -174.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.401 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 11.2 t -75.91 136.83 69.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.069 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.2 124.63 14.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.277 2.651 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -64.78 -27.88 69.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.139 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -83.8 -6.45 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.249 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -71.75 137.11 47.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 109.996 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.03 -149.73 17.42 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.931 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.8 m -127.09 132.37 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.545 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -120.69 150.87 40.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.237 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 112' ' ' ILE . 7.0 t0 -107.23 127.85 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.13 -18.89 41.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.848 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 -56.02 1.07 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 40.0 ttm180 -170.44 149.8 3.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.29 155.86 50.12 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.732 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.23 134.35 33.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.609 2.206 . . . . 0.0 111.019 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.25 -153.22 7.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.667 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.21 138.68 72.29 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.059 2.506 . . . . 0.0 112.05 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -80.3 16.16 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.494 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.72 -31.1 41.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.036 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.99 95.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.987 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -103.62 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -87.01 -37.04 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.153 0.501 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ARG . 51.6 m -159.92 163.69 34.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.923 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.24 130.99 50.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 p -123.8 130.79 53.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.7 127.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.252 0.549 . . . . 0.0 110.484 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 88.8 m -108.41 129.46 55.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.43 117.48 35.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.144 0.497 . . . . 0.0 110.508 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.5 m -102.29 -179.62 4.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.814 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 41' ' ' THR . 29.1 mm-40 -44.3 -66.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.502 0.721 . . . . 0.0 112.609 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -126.08 9.52 7.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 111.205 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -133.3 143.26 48.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.408 0.623 . . . . 0.0 111.411 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.92 128.31 48.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.809 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 45.7 t -104.29 123.46 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.157 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.3 mt-10 -95.2 129.13 42.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.446 0.641 . . . . 0.0 110.655 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.16 116.42 19.9 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.019 176.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.33 135.82 44.25 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.66 110.77 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.541 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 91.4 mtp -116.92 134.86 54.23 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.872 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.6 116.58 10.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.857 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -11.71 66.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.49 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 4.5 mmp_? -106.86 -59.41 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.183 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.84 -165.03 12.16 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.543 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -75.73 127.59 33.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.433 0.635 . . . . 0.0 110.523 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' THR . 79.4 t -115.91 121.84 68.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.158 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 82.5 mt-30 -88.58 122.43 32.03 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.844 0.354 . . . . 0.0 110.209 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 74.4 mt -91.13 164.85 23.54 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.554 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 11.7 Cg_endo -57.45 134.48 63.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.589 2.193 . . . . 0.0 111.655 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 46' ' ' VAL . 55.9 m-85 -58.86 132.14 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.346 -174.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.584 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 7.1 mmt -98.94 119.89 38.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 133.55 41.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.431 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -130.24 159.41 36.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 110.912 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 80' ' ' LEU . 50.1 mttm -122.82 158.2 30.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.614 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.59 112.86 38.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.131 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 78' ' ' GLN . 16.4 mt -83.05 -54.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.594 0.711 . . . . 0.0 109.702 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -142.36 150.74 41.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.585 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 71' ' ' THR . 60.9 tt0 -150.28 132.55 15.47 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.612 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 74' ' ' SER . 17.4 t -93.72 -21.24 19.46 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.492 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 26.6 m 75.15 -35.4 0.28 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.782 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.83 -7.0 22.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.502 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.694 ' HA3' HH11 ' A' ' 92' ' ' ARG . . . -158.87 -51.76 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.145 -1.502 . . . . 0.0 114.219 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 70' ' ' SER . 2.8 p -118.73 143.03 47.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.261 0.553 . . . . 0.0 112.466 -173.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 69' ' ' GLN . 22.4 mt -136.64 137.6 47.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.432 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -118.91 124.58 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 30.2 pt -126.82 155.2 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.384 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.629 ' HB2' HD11 ' A' ' 67' ' ' ILE . 36.1 tt0 -124.45 146.93 48.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 21.1 m-85 -86.35 152.99 22.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.726 0.298 . . . . 0.0 110.487 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 65' ' ' LYS . 98.1 mt -114.26 163.72 14.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.31 -152.27 21.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.503 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.34 -8.57 12.87 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.965 2.444 . . . . 0.0 112.665 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 49.0 m-85 -104.75 18.67 21.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.858 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 2.2 p90 -55.71 169.63 0.49 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -176.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.858 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 9.28 -0.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 1 C-N-CA 128.734 6.289 . . . . 0.0 121.418 -150.983 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 87' ' ' LYS . 2.7 tm? -73.66 146.3 44.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 86' ' ' LEU . 65.9 pttt -144.17 173.1 12.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.644 0.735 . . . . 0.0 112.793 -167.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 m -132.69 159.42 39.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.029 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.3 m -130.26 142.82 50.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.5 mt -121.74 124.73 44.91 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 46.5 mmtm -114.59 170.03 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.694 HH11 ' HA3' ' A' ' 73' ' ' GLY . 27.7 ptt-85 -92.71 145.02 24.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -104.75 138.69 14.29 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.78 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.11 -35.91 76.28 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.091 0.556 . . . . 0.0 112.077 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -95.89 24.74 5.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.312 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.24 42.24 24.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.383 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.425 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 18.0 p -121.0 173.94 6.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.649 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 tp -120.39 131.33 54.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 63.8 mt -99.12 112.98 32.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.736 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 10.0 t90 -99.98 115.56 29.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.381 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 26.0 mt-10 -97.67 129.64 44.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -152.8 124.26 7.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.317 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 67.26 -7.46 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.44 0.463 . . . . 0.0 112.172 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.45 9.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.773 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.54 136.97 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.568 0.223 . . . . 0.0 110.413 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 76.1 mtt180 -100.41 116.32 32.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.898 0.38 . . . . 0.0 110.424 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -119.41 141.28 49.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.183 0.516 . . . . 0.0 111.332 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -94.41 122.69 37.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.952 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 100' ' ' TRP . 66.1 mtp -102.55 133.44 47.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.38 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -97.77 143.87 27.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.714 0.292 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -88.44 123.9 33.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.27 0.557 . . . . 0.0 110.992 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -79.02 155.84 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.461 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -68.65 93.65 0.53 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -98.4 105.52 17.67 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.558 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -122.53 138.9 54.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.3 p -75.24 125.01 28.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.321 0.581 . . . . 0.0 112.001 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -93.66 2.09 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -123.74 119.73 30.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.01 156.87 30.04 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.267 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 67.83 100.63 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.111 0.882 . . . . 0.0 109.874 -174.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 35.7 ttmt -125.04 141.15 52.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.847 -173.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.54 155.73 16.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.724 0.297 . . . . 0.0 110.608 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.33 -7.7 17.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.991 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.91 106.38 0.69 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.437 0.637 . . . . 0.0 110.827 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.3 p -140.14 154.55 47.02 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.797 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -134.01 123.4 24.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.006 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.2 m -88.2 115.34 25.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.65 -162.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 164.66 27.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -161.13 134.74 6.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -90.63 84.82 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -120.24 137.54 54.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -168.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -160.75 154.75 22.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.838 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -133.56 94.29 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.071 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.2 t60 . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.127 176.203 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.5 mtm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.972 0.415 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.92 103.23 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -115.72 121.99 44.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.1 143.08 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 m -142.74 88.67 2.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.66 103.33 0.39 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.61 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.8 m -100.31 151.7 21.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.261 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -110.22 61.76 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.313 0.577 . . . . 0.0 110.002 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 -98.18 8.18 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.278 0.561 . . . . 0.0 109.917 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.66 158.82 31.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.05 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -92.13 9.77 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.51 137.31 34.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.2 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.87 149.92 29.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.628 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -132.87 109.6 13.02 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.506 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.5 Cg_exo -68.1 125.51 13.13 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.947 2.431 . . . . 0.0 111.161 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -67.49 -19.65 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -90.38 -13.06 35.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.349 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 18.0 t80 -78.61 134.0 37.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.86 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.93 -155.43 21.24 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.057 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.6 m -121.16 131.44 54.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.823 0.344 . . . . 0.0 110.35 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.541 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 74.0 m95 -116.26 141.41 48.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.1 t70 -106.11 133.49 50.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.052 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 51.5 mt-10 -94.87 71.46 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.652 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.21 41.6 3.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.832 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -167.32 147.79 5.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 74.74 144.71 0.11 Allowed Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.163 0.914 . . . . 0.0 111.464 -178.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 6.2 Cg_exo -79.77 160.81 24.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.122 2.548 . . . . 0.0 112.986 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.95 8.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -38.35 128.11 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 124.261 3.308 . . . . 0.0 113.602 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -64.65 -13.24 53.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.96 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.12 -33.75 76.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.16 -10.0 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.852 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -81.71 132.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -94.87 -25.76 16.46 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.818 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 4.4 m 175.67 -178.95 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.23 0.956 . . . . 0.0 108.679 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.95 167.42 18.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.995 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 22' ' ' ASP . 15.9 p -117.89 137.23 52.94 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.6 p -112.09 124.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.377 0.608 . . . . 0.0 111.098 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 82.1 m -106.31 125.85 51.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.722 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.52 118.77 37.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 110.813 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.2 m -89.72 179.84 5.92 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 41' ' ' THR . 0.3 OUTLIER -47.37 -46.65 25.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.642 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -148.42 27.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.362 0.601 . . . . 0.0 110.539 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.82 159.53 41.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.347 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 64' ' ' TYR . 92.3 t -117.82 129.87 73.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.447 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 97.2 t -111.38 123.93 67.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -100.61 137.28 39.23 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.277 0.56 . . . . 0.0 111.514 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -123.27 117.4 25.19 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.214 172.117 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.57 133.44 43.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 56' ' ' GLU . 36.0 t -96.6 113.51 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.871 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 ttt -133.78 141.77 47.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.694 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.43 132.64 48.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.187 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.3 -14.61 61.97 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.281 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.41 -56.71 2.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 110.191 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.07 -143.52 15.74 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.358 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.9 mt-10 -96.33 115.61 27.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.46 0.648 . . . . 0.0 110.43 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.5 t -104.57 126.89 59.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.289 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.4 mt-30 -83.76 130.54 34.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.851 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 93.9 mt -93.73 160.15 33.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.757 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.7 Cg_endo -61.91 121.82 10.06 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.539 2.159 . . . . 0.0 111.545 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -45.9 128.79 9.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.216 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.5 mmm -110.48 129.67 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.518 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.33 148.51 29.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.746 0.307 . . . . 0.0 110.674 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CD1' HG23 ' A' ' 45' ' ' VAL . 28.7 p90 -144.28 164.91 29.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.05 155.63 36.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 109.992 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 77' ' ' ILE . 95.6 t -101.72 112.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.734 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.0 mt -73.83 -51.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.431 0.634 . . . . 0.0 109.629 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.08 146.26 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.48 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -149.07 136.88 20.52 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.264 0.554 . . . . 0.0 110.894 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t -107.38 149.08 28.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.557 171.708 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -61.35 -32.96 72.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.281 0.562 . . . . 0.0 109.678 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -157.51 91.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.802 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.81 -94.61 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.231 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.446 ' OG ' ' HG2' ' A' ' 91' ' ' LYS . 65.4 m -136.66 157.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -110.07 118.84 37.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.419 HG22 HG22 ' A' ' 66' ' ' VAL . 33.8 pt -126.29 158.14 36.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.779 -174.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 67' ' ' ILE . 8.8 tt0 -135.99 127.81 29.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.429 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 67.3 m-85 -85.17 129.34 34.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 84' ' ' TYR . 69.7 mt -86.53 162.22 18.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.921 0.391 . . . . 0.0 110.576 -176.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.4 -152.21 17.4 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.426 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.57 -18.71 65.05 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.803 2.335 . . . . 0.0 112.485 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -111.41 31.63 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.489 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 2.5 p90 -90.62 -1.14 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -169.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 94.6 Cg_endo -92.01 -3.49 4.01 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 CA-C-N 121.719 1.65 . . . . 0.0 112.764 166.665 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.3 tp -106.79 134.27 50.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.197 -177.42 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -113.72 174.27 6.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.24 0.543 . . . . 0.0 112.104 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -143.7 165.89 26.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.507 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -134.14 142.87 47.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 111.267 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.56 135.17 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.83 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 66.0 mttm -132.41 162.6 30.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.763 0.316 . . . . 0.0 110.324 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 92' ' ' ARG . 15.8 ptt-85 -84.67 144.92 28.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.31 152.46 20.65 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.09 -10.85 60.23 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -141.69 77.48 1.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.727 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.39 48.09 21.74 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.886 0.741 . . . . 0.0 113.535 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.5 169.77 16.98 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.748 -0.266 . . . . 0.0 110.942 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -124.07 135.26 53.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 82.1 mt -102.78 117.34 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.79 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.0 t90 -109.9 113.73 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -108.97 134.88 51.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.349 0.595 . . . . 0.0 111.078 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -150.55 119.0 6.43 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 68.38 -68.12 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.067 0.854 . . . . 0.0 112.018 176.723 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.04 1.65 0.07 OUTLIER Glycine 0 C--N 1.316 -0.58 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.822 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -113.42 135.42 53.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.724 0.762 . . . . 0.0 110.355 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -102.46 115.57 30.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.374 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 21.5 mmtp -94.89 136.59 35.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.041 0.448 . . . . 0.0 110.858 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 m -109.12 113.69 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' A' ' 21' ' ' TRP . 64.3 mtp -110.76 144.92 38.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.494 -174.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -95.33 153.36 17.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.203 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -90.13 142.63 27.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.7 mm -92.99 148.98 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.173 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -93.73 95.1 8.94 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.544 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.8 m -145.87 115.64 7.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.92 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -85.5 24.5 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.57 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -104.98 147.31 27.93 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.43 170.2 40.23 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 36.4 ttp-105 64.91 19.6 11.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.997 0.903 . . . . 0.0 110.046 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -91.24 104.66 17.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.97 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.87 135.74 35.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.799 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -148.46 94.36 2.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.269 0.557 . . . . 0.0 110.045 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.67 124.32 38.63 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.779 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.31 80.06 1.51 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.156 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 124' ' ' LYS . 13.7 ptpt -75.88 84.24 2.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.059 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.8 p -78.18 177.04 8.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.39 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -137.32 38.74 2.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.775 0.798 . . . . 0.0 109.878 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.3 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 pp -109.15 30.75 6.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -80.19 116.8 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.719 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -150.29 140.23 21.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.778 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -132.29 164.59 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.736 0.303 . . . . 0.0 110.484 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -94.04 139.79 30.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -132.93 111.92 11.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.336 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -76.39 165.37 24.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.302 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.5 p80 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.848 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 2' ' ' ILE . 35.0 pt -83.0 110.22 17.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.731 0.777 . . . . 0.0 112.315 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.0 mtt -133.71 -49.37 0.83 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.099 169.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 t 52.55 58.2 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.757 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -83.89 71.45 10.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.4 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.19 123.02 16.77 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.08 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.0 m -60.84 -54.12 49.06 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.563 0.214 . . . . 0.0 110.498 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 70.02 132.92 0.03 OUTLIER 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.89 0.744 . . . . 0.0 111.684 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.84 96.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.099 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 22.1 tp60 -105.04 -64.88 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 10' ' ' GLN . 47.6 mttp -155.8 109.29 2.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.408 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.71 29.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.267 -168.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.32 97.98 2.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.028 0.442 . . . . 0.0 110.363 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.9 t -168.33 138.58 2.08 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.175 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.6 Cg_exo -74.91 84.35 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.503 2.135 . . . . 0.0 111.486 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.571 ' HE1' ' HA ' ' A' ' 71' ' ' THR . 44.2 p90 -65.36 -24.39 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.54 -176.241 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -82.35 -19.52 39.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -80.09 138.57 36.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.983 0.421 . . . . 0.0 110.764 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.54 -153.42 20.43 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.133 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -119.68 128.43 53.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.452 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 63.0 m95 -121.67 139.69 53.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.638 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 112' ' ' ILE . 9.9 t0 -107.94 135.6 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 55.7 mt-10 -54.12 -45.5 71.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.87 22.03 25.48 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.848 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -170.89 149.72 3.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 69.39 144.76 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.75 0.657 . . . . 0.0 111.479 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.7 Cg_exo -78.44 151.16 25.69 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.908 2.405 . . . . 0.0 112.582 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.45 -166.63 25.53 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.571 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.6 150.62 1.4 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.224 3.283 . . . . 0.0 113.949 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -72.31 -7.71 50.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.41 -12.41 51.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.962 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.84 41.98 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.866 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 t -105.12 133.28 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.58 -30.31 20.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.392 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 22.7 p -176.37 174.43 1.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.437 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.04 157.73 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.493 0.663 . . . . 0.0 111.0 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 1.5 p -117.39 129.51 55.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.662 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -112.54 129.41 68.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.225 0.536 . . . . 0.0 109.904 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 m -114.14 130.07 56.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.172 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.26 116.2 32.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.55 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -103.23 -178.28 3.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -47.96 -51.19 24.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -138.01 10.63 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.544 0.212 . . . . 0.0 111.389 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.55 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -138.76 149.1 44.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 111.785 -177.014 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' CD1' ' A' ' 64' ' ' TYR . 78.4 t -111.71 124.96 68.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.26 124.37 64.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.13 134.21 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.542 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 1.7 m -124.9 135.38 52.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.078 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.0 127.96 47.26 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -97.02 112.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.268 0.556 . . . . 0.0 110.702 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -119.21 107.18 13.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.905 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.96 117.1 5.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.77 -36.01 3.62 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -99.52 -62.3 1.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.697 0.76 . . . . 0.0 109.547 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 -164.42 24.21 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.052 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG3' HG22 ' A' ' 50' ' ' VAL . 11.2 mp0 -80.16 127.01 31.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 117.637 0.719 . . . . 0.0 110.177 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.54 121.54 63.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.604 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -80.36 130.52 35.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 111.622 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.7 mt -91.76 163.89 26.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.714 174.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 73.6 Cg_exo -49.37 125.22 13.29 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.712 2.275 . . . . 0.0 112.114 176.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.74 137.57 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtm -108.09 121.99 45.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.33 148.15 41.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.566 ' CD1' HG23 ' A' ' 45' ' ' VAL . 9.9 p90 -146.85 151.43 37.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.33 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 158.94 29.79 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.69 112.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 78' ' ' GLN . 20.1 mt -76.83 -54.08 13.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.52 151.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.584 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -155.27 111.56 3.18 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.98 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.571 ' HA ' ' HE1' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -69.92 -11.0 60.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.105 174.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.24 -56.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.633 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.4 -47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.993 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 26.8 t -161.25 155.56 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.614 0.721 . . . . 0.0 112.721 -169.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.3 mt -126.21 137.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.342 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' HG2' HD12 ' A' ' 67' ' ' ILE . 37.7 tt0 -117.45 124.59 49.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 pt -129.98 157.47 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.402 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.647 ' OE1' ' HA ' ' A' ' 85' ' ' PRO . 23.2 tt0 -131.65 135.53 46.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.618 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -82.89 3.58 29.19 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -169.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.7 mt 52.29 -162.52 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.607 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.42 -151.86 42.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.816 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.22 -8.7 23.64 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.687 2.258 . . . . 0.0 111.579 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.88 15.24 22.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.447 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -65.7 178.07 0.62 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.647 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 11.2 Cg_exo 10.91 -1.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.274 1 C-N-CA 126.985 5.124 . . . . 0.0 120.263 -142.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.7 tp -78.12 103.83 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -103.9 172.08 7.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.379 0.609 . . . . 0.0 111.814 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 t -132.39 148.33 52.41 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.084 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.3 m -123.92 143.63 50.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.561 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 98' ' ' LEU . 85.8 mt -128.0 123.93 35.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.117 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 30.3 mtmm -123.67 160.32 27.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.709 0.29 . . . . 0.0 110.505 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -80.36 144.71 32.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.474 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -99.21 -175.53 31.64 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.465 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -91.43 -30.15 16.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.972 0.415 . . . . 0.0 111.935 -171.775 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -102.59 25.76 8.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.637 179.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.93 37.65 50.1 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.613 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . 0.474 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 15.9 p -105.17 174.58 5.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.901 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 90' ' ' LEU . 29.8 tp -122.95 133.74 54.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 63.4 mt -96.96 110.25 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -98.34 113.21 25.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.867 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 11.9 mt-10 -110.85 132.01 54.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.73 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' NE2' ' HB2' ' A' ' 103' ' ' ASN . 23.2 tm0? -152.21 118.2 5.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.456 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.451 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 54.8 t30 63.97 24.04 13.49 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.657 0.742 . . . . 0.0 111.288 164.117 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.48 34.47 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.124 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -92.48 132.91 36.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.542 0.671 . . . . 0.0 111.346 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -103.58 116.36 32.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.919 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -127.08 117.8 23.15 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.4 m -93.16 114.15 26.58 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -112.28 159.73 18.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.116 -173.467 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -104.39 153.75 20.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.24 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -88.27 161.19 17.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 22' ' ' ASP . 21.7 mm -94.86 151.86 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.049 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.83 105.08 4.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.037 0.446 . . . . 0.0 109.817 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -141.97 132.36 25.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -134.52 73.94 1.51 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.308 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.4 m -153.93 128.49 9.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.024 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.55 68.46 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -115.19 28.1 8.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.423 0.63 . . . . 0.0 109.707 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -78.25 103.43 8.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.772 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -117.24 126.74 53.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.491 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -125.16 162.38 24.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.293 0.568 . . . . 0.0 112.2 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -87.98 146.97 25.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.667 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.24 145.52 43.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.185 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.8 mtpt -114.1 88.16 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -93.42 97.3 10.47 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -83.0 129.09 35.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.181 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.5 t -152.65 113.42 4.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.5 tp -104.07 98.18 8.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.18 172.22 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.043 -167.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 68.52 96.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.034 172.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.92 129.01 38.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -116.91 132.76 56.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.027 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -122.85 100.67 7.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.477 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -96.89 142.1 29.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.303 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.232 177.578 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.708 0.29 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 64.77 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.417 -174.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 tpt -88.54 -13.92 38.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.63 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.7 t 61.89 72.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.901 0.857 . . . . 0.0 108.788 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -80.38 106.38 12.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.065 -170.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.38 150.38 18.51 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -131.3 122.39 26.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.621 0.71 . . . . 0.0 111.327 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -108.98 -167.56 1.23 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 16.7 mm-40 56.5 48.57 16.47 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -53.51 111.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.845 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -72.81 130.46 40.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.83 127.99 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.089 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.05 161.88 35.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.467 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 m -71.93 124.7 91.26 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 31.6 Cg_exo -58.98 122.25 11.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.889 2.392 . . . . 0.0 111.713 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -67.98 -14.91 63.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -98.99 -8.48 25.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.373 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 36.9 t80 -81.93 140.2 34.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.96 -171.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.1 -149.83 17.3 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.252 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 m -119.51 134.24 55.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.7 0.285 . . . . 0.0 110.254 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 82.3 m95 -126.08 142.64 51.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.606 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 112' ' ' ILE . 1.5 t70 -96.08 120.05 35.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.54 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.586 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 12.6 pt-20 -98.5 79.17 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.993 0.902 . . . . 0.0 109.795 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.83 -8.05 56.61 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.881 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.731 HH11 ' HB2' ' A' ' 26' ' ' ALA . 1.1 tmt_? -101.04 140.3 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.731 ' HB2' HH11 ' A' ' 25' ' ' ARG . . . 65.01 143.67 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.354 1.034 . . . . 0.0 111.274 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 74.1 Cg_endo -93.04 172.62 2.02 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.546 2.164 . . . . 0.0 112.242 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.9 -155.13 20.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.488 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HD2' HG21 ' A' ' 33' ' ' VAL . 10.3 Cg_endo -56.2 163.74 5.93 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.8 2.333 . . . . 0.0 112.804 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 m -74.72 2.52 9.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.566 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.84 -43.2 96.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.81 59.39 0.02 OUTLIER Glycine 0 CA--C 1.513 -0.065 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.56 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.609 HG21 ' HD2' ' A' ' 29' ' ' PRO . 8.3 t -100.24 134.61 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -177.346 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.887 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 8.7 mmpt? -81.71 -40.79 22.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -166.45 165.86 16.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.058 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.61 148.73 52.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.431 . . . . 0.0 111.266 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -133.5 131.49 39.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.155 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.85 139.56 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.925 0.393 . . . . 0.0 110.93 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.5 m -119.39 129.34 54.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.06 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -101.89 117.64 35.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.1 p -101.9 -177.35 3.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.184 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -45.03 -56.13 4.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.466 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.22 -4.13 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.719 -173.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.39 157.15 28.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.542 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.63 117.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 61' ' ' PHE . 33.3 t -108.56 124.21 64.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.78 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.76 136.48 42.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.654 0.74 . . . . 0.0 110.737 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.83 116.98 21.71 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.476 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -108.29 128.55 54.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.12 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.43 113.65 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.522 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.3 mtm -123.08 130.64 53.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.467 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.45 131.51 47.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.705 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.97 -29.44 11.24 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.284 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -122.57 -33.85 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 111.311 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.2 -151.24 19.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.564 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.09 133.45 46.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.228 0.537 . . . . 0.0 110.165 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.4 t -123.87 123.85 67.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.229 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 80.1 mt-30 -85.63 118.63 25.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.905 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.57 159.54 55.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 114.37 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.077 1.852 . . . . 0.0 110.62 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' HG22 ' A' ' 46' ' ' VAL . 32.5 p90 -69.9 146.69 51.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.534 -172.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.28 148.76 22.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.53 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.72 131.6 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -114.57 142.48 46.37 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.374 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -122.17 151.11 41.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.728 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.23 125.19 41.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.077 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.9 mt -96.26 -55.62 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -131.61 153.86 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.805 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.13 152.7 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 111.48 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 74' ' ' SER . 42.1 t -139.71 167.33 22.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -80.33 -38.8 29.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.34 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 6.4 p-10 -147.96 9.57 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.408 -172.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.19 -81.11 1.47 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.318 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 5.1 p -145.52 152.01 39.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 111.677 -174.486 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 22.4 mt -125.98 138.49 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.5 tt0 -117.54 127.38 53.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -125.66 157.08 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' A' ' 67' ' ' ILE . 8.3 tt0 -126.58 144.19 50.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -83.23 149.29 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.225 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -105.1 167.79 9.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.22 -152.1 21.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.23 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.04 -5.17 15.75 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.579 2.186 . . . . 0.0 111.795 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -98.6 15.58 24.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.724 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.757 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -63.0 -177.3 0.19 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.132 175.622 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.757 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 12.32 -0.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.252 1 C-N-CA 127.35 5.367 . . . . 0.0 120.561 -148.098 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.8 tp -85.31 121.26 27.78 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -120.65 168.48 11.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.386 0.612 . . . . 0.0 111.603 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.27 154.9 47.13 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.635 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 10.4 m -113.82 141.82 46.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.476 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 96.6 mt -124.14 124.78 43.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.287 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 33.3 mtmm -133.4 157.43 45.58 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.934 0.397 . . . . 0.0 110.467 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 24.1 ptt180 -66.16 147.26 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.058 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLY . . . . . 0.47 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -73.25 -170.23 18.38 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.159 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -86.96 -39.34 15.81 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.191 0.519 . . . . 0.0 110.013 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -148.64 102.2 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.925 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 53.82 44.92 70.8 Favored Glycine 0 C--N 1.333 0.385 0 O-C-N 123.349 0.406 . . . . 0.0 113.183 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.03 174.0 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.413 0.149 . . . . 0.0 111.149 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 tp -129.31 136.17 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG13 ' HA2' ' A' ' 93' ' ' GLY . 67.5 mt -111.55 110.59 32.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.877 0.37 . . . . 0.0 110.33 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.443 ' HE3' ' HE3' ' A' ' 109' ' ' MET . 10.0 t90 -105.14 113.07 26.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.786 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.614 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 70.2 mt-10 -96.49 130.3 43.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.423 0.63 . . . . 0.0 110.089 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' CD ' ' HB2' ' A' ' 103' ' ' ASN . 25.8 tm0? -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.684 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB2' ' CD ' ' A' ' 102' ' ' GLN . 5.8 t-20 67.75 9.89 7.4 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.409 0.443 . . . . 0.0 111.252 172.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.5 -10.85 53.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.255 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -108.62 143.5 37.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.854 -0.203 . . . . 0.0 110.547 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.614 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 24.6 ptt180 -99.4 126.26 45.26 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 1.5 mptm? -88.66 126.52 35.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.529 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 m -94.78 113.76 25.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.586 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 59.9 mtt -114.62 142.33 46.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 112.273 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.02 151.01 19.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.104 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -86.09 123.99 32.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 22' ' ' ASP . 37.3 mm -72.76 147.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.429 0.633 . . . . 0.0 111.518 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -127.67 138.72 52.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.656 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.3 m 59.99 41.85 16.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.091 0.472 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -68.7 130.77 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.2 m -68.08 129.95 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -128.0 151.77 18.8 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.23 87.03 7.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 110.893 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 120' ' ' GLU . 10.2 tt0 64.76 -169.55 0.2 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.028 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 42.2 mt-10 67.92 101.46 0.05 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.363 0.601 . . . . 0.0 111.398 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -165.9 171.03 13.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.234 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.75 144.91 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.27 -63.96 1.01 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.383 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -157.65 94.36 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.545 0.688 . . . . 0.0 110.789 -177.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.0 m -87.87 52.21 2.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.559 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.62 162.01 41.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.695 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.7 t -152.71 113.83 4.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.48 99.62 11.34 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.879 0.371 . . . . 0.0 110.477 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -150.12 133.2 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.709 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -97.09 143.74 27.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 110.372 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -147.91 114.81 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -117.57 150.35 39.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -128.85 145.55 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.104 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 67.37 157.6 0.13 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.871 0.732 . . . . 0.0 111.103 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.836 172.368 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -97.42 154.15 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -130.59 129.54 42.89 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.2 p -132.13 128.5 59.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.03 0.443 . . . . 0.0 111.083 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.8 t -143.45 118.95 10.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.159 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.66 116.37 0.8 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.673 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 t -69.91 152.05 44.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.373 . . . . 0.0 110.474 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -82.43 103.95 12.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.591 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -77.24 96.06 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.945 0.403 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.16 127.43 32.32 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -85.49 112.88 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 0.0 111.244 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.2 -156.67 0.55 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' O ' ' HB ' ' A' ' 14' ' ' THR . 7.2 tt0 -143.63 -156.75 0.72 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.19 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 19.6 m 72.12 123.42 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 123.326 0.65 . . . . 0.0 112.165 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.2 Cg_exo -63.44 104.17 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.985 2.457 . . . . 0.0 111.879 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.82 -15.17 63.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.382 -174.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -101.85 6.79 41.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.01 125.99 44.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.158 0.504 . . . . 0.0 111.072 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.21 -168.95 24.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.236 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.1 m -102.07 131.44 48.54 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 109' ' ' MET . 62.6 m95 -116.09 137.14 52.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.816 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.592 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.9 t70 -99.79 127.01 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 112.185 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 35' ' ' SER . 44.4 mt-10 -101.64 78.04 1.8 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.997 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.11 -0.46 35.73 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.324 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 25' ' ' ARG . 6.9 tpp180 -114.9 144.11 44.08 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.65 146.83 0.12 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 0.0 111.179 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.54 171.91 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.497 2.132 . . . . 0.0 112.721 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.86 -155.18 25.03 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.887 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -38.38 145.54 0.16 Allowed 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 124.28 3.32 . . . . 0.0 113.665 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.21 -5.67 14.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -171.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.75 -36.09 81.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.09 53.61 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.597 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 49' ' ' GLU . 18.8 t -100.94 134.37 41.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -79.03 -39.68 33.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 38.5 m -159.77 166.17 30.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.085 -171.37 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.49 152.33 40.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 22' ' ' ASP . 12.9 p -131.87 127.04 35.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.33 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.89 136.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.106 0.479 . . . . 0.0 111.233 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 m -121.77 125.64 47.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.653 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.77 116.43 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.876 0.37 . . . . 0.0 110.375 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -104.58 170.13 8.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.92 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 41' ' ' THR . 32.5 tt0 -61.22 -45.86 92.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.877 0.37 . . . . 0.0 111.934 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.85 -9.2 23.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 3.7 pt-20 -156.74 148.08 22.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -166.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.7 t -101.77 118.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.843 170.002 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.34 124.46 55.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.7 0.286 . . . . 0.0 110.457 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.04 136.7 37.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.608 0.718 . . . . 0.0 111.518 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 2.3 m -128.47 131.4 48.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.526 171.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' HG11 ' A' ' 33' ' ' VAL . 32.9 mt-10 -120.53 135.93 54.93 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.522 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' A' ' 56' ' ' GLU . 45.8 t -96.41 113.6 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -119.74 126.88 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.384 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 106.88 6.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.325 0.583 . . . . 0.0 110.477 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.05 6.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.26 -60.01 1.65 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.921 0.867 . . . . 0.0 109.747 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.04 -166.32 14.04 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.003 -172.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.6 mp0 -71.89 127.15 31.66 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.502 0.668 . . . . 0.0 111.433 174.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.0 t -118.39 122.69 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.928 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 48' ' ' THR . 82.1 mt-30 -93.74 126.76 39.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.916 0.389 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.48 161.76 26.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.316 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 137.03 40.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.887 2.391 . . . . 0.0 112.059 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.615 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 44.2 p90 -72.09 152.49 42.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.8 mtp -111.87 140.45 46.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.663 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.96 28.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.502 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD1' HG23 ' A' ' 45' ' ' VAL . 7.7 p90 -147.28 166.52 26.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.812 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -128.19 159.3 35.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.55 126.3 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.123 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.2 mt -85.43 -51.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.1 m -145.03 161.31 39.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.462 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -148.97 132.99 17.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.08 0.466 . . . . 0.0 110.777 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' SER . 31.6 t -151.01 121.88 7.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -78.11 -15.74 58.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.527 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -104.27 -21.45 13.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.726 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 -67.06 0.47 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.838 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 47.3 t -177.52 157.09 1.23 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 0.0 110.993 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -116.85 132.71 65.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.212 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.498 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.0 tt0 -111.09 123.73 50.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 pt -124.96 157.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.032 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 36.1 tt0 -138.42 139.94 39.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 98.0 m-85 -88.17 153.97 20.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 0.0 110.896 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.4 mt -110.77 -176.82 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.029 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.54 -152.52 35.76 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.68 -16.91 51.59 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.396 2.064 . . . . 0.0 111.926 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -92.31 20.41 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.96 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 26.3 p90 -61.17 172.27 0.97 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.707 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 11.5 -0.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.084 1 C-N-CA 128.153 5.902 . . . . 0.0 121.065 -150.08 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.0 tp -69.22 104.21 2.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 119.556 1.071 . . . . 0.0 108.289 167.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 61.1 pttt -103.63 174.71 5.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.414 0.626 . . . . 0.0 111.94 -171.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 t -144.66 161.36 39.36 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.157 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -124.28 142.97 50.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.8 0.334 . . . . 0.0 110.578 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.48 122.72 38.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 53.4 mttp -118.83 160.58 21.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.2 0.524 . . . . 0.0 111.188 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -70.61 143.0 51.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.57 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.9 143.77 22.45 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.888 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.82 -44.5 73.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.908 -0.646 . . . . 0.0 111.172 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 92.8 m-20 -128.51 81.34 2.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.81 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 55.3 55.1 30.06 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.711 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.52 175.24 10.09 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.832 -0.216 . . . . 0.0 111.112 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.57 135.26 54.52 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.576 HG23 ' HG3' ' A' ' 106' ' ' ARG . 82.7 mt -104.9 111.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.245 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 15.7 t90 -97.87 112.77 24.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.811 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 28.8 mt-10 -102.12 131.66 48.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -151.64 123.58 8.09 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.701 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.28 19.77 10.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.314 0.384 . . . . 0.0 111.827 173.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.07 -21.86 34.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.533 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 10.6 pt20 -92.61 145.65 24.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.013 0.406 . . . . 0.0 110.947 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HG3' HG23 ' A' ' 99' ' ' ILE . 15.6 ttm180 -94.04 117.98 30.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 28.1 mmtm -95.04 117.99 31.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.096 0.475 . . . . 0.0 109.809 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -100.13 114.59 28.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.615 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 21' ' ' TRP . 12.3 ptp -127.65 137.92 52.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.338 0.589 . . . . 0.0 111.729 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -101.05 146.43 27.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.582 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -80.52 127.73 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.158 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 22' ' ' ASP . 31.4 mm -73.57 145.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.535 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -121.32 111.71 17.68 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.3 m -91.91 93.14 8.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.136 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.23 19.61 19.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.231 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 t -139.66 152.26 46.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.562 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.04 -67.18 0.34 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 56.96 84.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.721 0.772 . . . . 0.0 111.448 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.0 OUTLIER -92.43 133.14 36.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.366 177.733 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -96.86 157.02 16.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.98 -177.48 4.51 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 9.2 t70 -91.02 149.28 21.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.9 102.98 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 122' ' ' ASP . 66.8 mmtt -120.16 124.89 46.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.527 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.5 t -130.36 150.7 51.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.666 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.03 107.18 10.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 110.768 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.0 t -113.45 103.85 11.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.875 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -106.18 99.99 9.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.364 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.13 157.72 22.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -102.18 115.26 30.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -67.94 123.62 21.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.263 0.554 . . . . 0.0 111.763 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -125.15 114.66 19.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.323 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -134.03 128.82 35.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.249 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -83.62 138.02 33.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.361 177.089 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.255 0.55 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.44 118.1 48.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.868 0.366 . . . . 0.0 110.528 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.73 124.61 43.68 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.3 t -85.01 -72.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.866 0.365 . . . . 0.0 111.245 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.6 p -136.86 111.58 8.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.1 76.04 2.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.916 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.0 m -76.95 103.16 6.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -109.01 134.89 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.14 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -101.27 116.12 32.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.937 ' HB2' HG21 ' A' ' 71' ' ' THR . 75.9 mm-40 -116.52 -74.68 0.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.044 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 11' ' ' LYS . 33.4 ttmt -169.75 163.88 9.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -60.91 114.8 3.27 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -105.81 166.98 10.09 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 10.1 t -55.03 120.63 30.64 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.247 0.546 . . . . 0.0 111.355 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 37.9 Cg_exo -62.9 103.91 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.864 2.376 . . . . 0.0 111.949 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.78 -10.98 60.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.284 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 44.5 p90 -89.57 -6.62 56.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -71.35 138.99 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.136 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.42 -163.5 21.18 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.033 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.6 m -115.23 122.64 46.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.022 0.439 . . . . 0.0 110.432 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 50.1 m95 -116.3 133.64 55.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.139 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' CB ' HD11 ' A' ' 112' ' ' ILE . 11.7 t70 -109.68 132.43 54.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.952 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 109' ' ' MET . 6.2 mm-40 -74.04 -58.15 3.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.603 173.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.94 32.16 55.9 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 9.0 ttm180 -158.08 167.68 29.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -167.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . . . 67.43 165.36 0.12 Allowed Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.928 0.768 . . . . 0.0 112.211 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 134.5 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.355 2.037 . . . . 0.0 111.356 171.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 -166.31 21.28 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.977 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -48.62 125.15 12.07 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.067 2.511 . . . . 0.0 111.868 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -80.1 -1.44 40.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.26 -33.92 74.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.559 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 146.57 37.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.977 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.63 138.91 28.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -86.58 -28.09 23.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.994 0.425 . . . . 0.0 111.108 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 p -177.31 167.47 2.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.981 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.43 144.23 49.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -117.87 133.58 55.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.111 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.03 136.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 111.161 -175.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.6 m -123.02 130.94 53.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.555 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -100.61 120.61 40.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.097 0.475 . . . . 0.0 110.317 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -95.7 179.1 5.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.374 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 41' ' ' THR . 29.6 mt-10 -51.53 -38.68 55.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.306 0.642 . . . . 0.0 111.801 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -151.37 19.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 111.447 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -131.1 147.73 52.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 64' ' ' TYR . 66.5 t -101.84 118.51 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.464 HG22 ' CD1' ' A' ' 61' ' ' PHE . 70.6 t -108.21 124.42 64.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.34 137.5 52.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.342 0.591 . . . . 0.0 110.453 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.48 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.26 138.1 51.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.141 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -97.98 125.4 42.9 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 56' ' ' GLU . 48.6 t -90.11 110.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.512 ' SD ' ' HG3' ' A' ' 54' ' ' ARG . 43.0 ttm -112.07 135.21 53.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.151 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.77 113.35 3.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.934 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.57 -18.4 56.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.752 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 9.6 mmt180 -101.36 -74.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.816 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.41 -156.1 26.64 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 50' ' ' VAL . 44.8 mt-10 -92.92 120.69 33.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.415 0.626 . . . . 0.0 111.179 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -112.57 128.12 69.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.892 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HG2' HG23 ' A' ' 48' ' ' THR . 79.8 mt-30 -80.07 131.55 35.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.143 0.497 . . . . 0.0 111.601 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -87.86 163.7 36.98 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.494 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.25 123.58 12.27 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.648 2.232 . . . . 0.0 111.749 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 46' ' ' VAL . 17.8 m-85 -68.42 142.15 55.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.143 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.4 mtm -109.86 123.74 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.801 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.57 140.09 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD1' HG23 ' A' ' 45' ' ' VAL . 42.1 p90 -132.82 170.9 14.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.885 0.374 . . . . 0.0 110.63 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 80' ' ' LEU . 10.0 ptmm? -144.1 143.0 30.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.66 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -83.33 124.3 39.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.727 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 78' ' ' GLN . 11.5 mt -85.62 -54.41 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.595 0.712 . . . . 0.0 109.661 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 m -139.56 163.44 32.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.818 -174.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 58.6 tt0 -144.51 149.27 35.65 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.5 t -125.33 121.02 32.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.6 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.937 HG21 ' HB2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -69.89 -6.39 32.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 111.366 177.139 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.89 -48.17 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.571 ' HA3' ' HD3' ' A' ' 92' ' ' ARG . . . 146.33 46.49 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.64 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.6 m -147.27 151.97 37.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.224 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.49 138.44 48.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.231 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -110.46 126.8 54.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.934 0.397 . . . . 0.0 109.973 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.76 157.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.454 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.661 ' HB2' HD11 ' A' ' 67' ' ' ILE . 34.7 tt0 -132.34 144.85 50.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.614 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -92.86 156.98 16.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.02 0.438 . . . . 0.0 110.76 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 65' ' ' LYS . 83.1 mt -112.08 -177.08 3.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.415 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.85 -151.93 41.65 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.238 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.86 -5.27 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.551 2.168 . . . . 0.0 112.154 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -102.75 20.54 17.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.142 0.496 . . . . 0.0 109.805 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.959 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.1 p90 -58.47 170.81 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.298 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.959 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 1.2 Cg_exo 9.34 0.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.162 1 C-N-CA 128.711 6.274 . . . . 0.0 121.659 -152.699 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 84' ' ' TYR . 66.8 tp -66.57 109.81 2.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 119.986 1.266 . . . . 0.0 109.062 170.082 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.96 166.77 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 111.874 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 t -140.22 156.2 46.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.527 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -112.72 141.3 46.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.134 0.492 . . . . 0.0 110.89 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.93 126.75 49.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.805 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 94.0 mttt -124.95 154.96 40.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.945 0.402 . . . . 0.0 110.257 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.571 ' HD3' ' HA3' ' A' ' 73' ' ' GLY . 36.4 ptt-85 -79.42 144.26 34.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.051 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.7 26.54 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.14 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.12 134.36 38.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.021 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 71.89 -66.14 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.639 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.29 59.59 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.47 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 p -134.74 170.07 16.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.122 0.169 . . . . 0.0 110.581 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.3 tp -129.53 135.42 48.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.604 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 75.2 mt -105.65 126.26 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 17.7 t90 -117.3 115.75 25.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.079 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -110.99 134.87 52.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 111.432 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.68 121.35 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.937 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.85 9.74 5.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.635 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.95 -8.05 29.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.716 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.05 134.65 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -102.02 116.13 32.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.104 0.478 . . . . 0.0 111.237 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 2.0 mmpt? -98.55 139.49 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.547 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.9 m -121.74 112.24 18.15 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.572 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 52.2 mtm -116.8 141.4 48.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -173.507 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -98.63 151.77 20.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.539 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 57.1 ttp85 -83.5 127.4 33.69 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 22' ' ' ASP . 30.0 mm -85.4 144.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.47 0.652 . . . . 0.0 110.598 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -131.27 110.66 11.26 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.605 -1.18 . . . . 0.0 107.898 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.9 p -114.02 122.42 46.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.654 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.55 36.44 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.965 0.888 . . . . 0.0 108.953 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.1 t -156.64 160.46 39.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.091 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.97 91.7 0.19 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.556 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.852 HH11 ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -119.45 109.2 15.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.83 99.56 0.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.852 ' HG2' HH11 ' A' ' 118' ' ' ARG . 37.4 mt-10 -103.3 94.12 5.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.079 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -87.59 133.65 33.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -172.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -113.18 141.67 46.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.468 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.08 103.63 14.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.11 0.481 . . . . 0.0 110.517 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -125.58 124.26 40.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.132 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.5 t -102.5 141.05 35.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.949 0.404 . . . . 0.0 110.842 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -101.02 85.93 2.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.0 m -91.18 75.65 6.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.081 0.467 . . . . 0.0 111.606 -173.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.1 134.09 29.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.729 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.8 136.08 34.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.309 0.576 . . . . 0.0 111.605 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -90.98 120.99 32.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.323 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -109.15 135.53 50.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.81 0.338 . . . . 0.0 110.37 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -68.88 103.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.956 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -116.32 97.12 5.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.435 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 170.37 -82.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.02 0.825 . . . . 0.0 109.566 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.337 178.204 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.483 0.183 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 mp -110.81 109.02 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 110.029 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.7 mtp -104.74 104.57 14.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.83 135.68 45.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.9 m -144.33 117.29 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.318 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.8 106.41 1.91 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.537 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.7 m -128.62 145.39 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.681 -0.305 . . . . 0.0 110.837 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.14 81.83 8.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -88.91 -39.33 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 10' ' ' GLN . 5.1 tp60 -141.38 131.22 24.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.793 0.33 . . . . 0.0 110.563 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -89.5 -33.31 16.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -75.5 127.01 32.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.924 -174.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.77 -171.55 3.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.887 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 t -82.46 140.17 44.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -177.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 39.5 Cg_exo -61.42 109.37 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -68.45 -18.99 64.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.194 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -95.02 -10.18 31.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.795 0.331 . . . . 0.0 111.305 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 42.8 t80 -80.64 130.29 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 0.0 110.969 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.86 -164.24 25.51 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.263 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -105.39 130.69 53.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 98' ' ' LEU . 71.7 m95 -119.54 144.56 46.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.262 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.7 t70 -96.76 141.37 30.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 6.1 mm-40 -48.14 -49.97 30.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.12 -54.52 3.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.637 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -135.95 164.19 28.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.32 161.45 0.16 Allowed Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 124.039 0.837 . . . . 0.0 111.395 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.29 175.4 9.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.628 2.218 . . . . 0.0 112.154 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.21 -153.69 7.64 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.399 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.778 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 4.5 Cg_endo -47.68 148.62 5.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 124.355 3.37 . . . . 0.0 113.433 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.3 p -81.26 -2.17 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.923 -172.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.72 -1.04 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.251 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.62 35.23 29.36 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.897 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.778 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 24.6 t -76.4 133.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.767 ' HE3' ' HB3' ' A' ' 52' ' ' GLU . 49.5 mtmt -91.47 -13.58 31.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.813 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 18.5 m -148.7 157.51 43.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.877 0.37 . . . . 0.0 110.609 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -159.79 145.87 15.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.084 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 139.53 44.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.092 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.31 133.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 110.121 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -121.26 124.57 44.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.839 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -101.97 117.81 35.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.123 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -102.33 179.43 4.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.327 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 41' ' ' THR . 33.1 mt-10 -54.93 -42.92 72.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -128.21 -16.25 4.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.921 0.391 . . . . 0.0 111.808 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 6.9 pt-20 -125.76 142.17 51.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.166 0.508 . . . . 0.0 111.803 -173.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.61 125.56 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 61' ' ' PHE . 66.9 t -115.92 123.82 71.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 137.92 34.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 110.736 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.568 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -125.63 118.85 26.57 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.647 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -105.63 125.61 51.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.198 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.813 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 42.5 t -98.86 111.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.258 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -99.48 109.11 21.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.767 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 41.5 tt0 -65.39 106.63 1.43 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.045 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.95 -29.68 2.19 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.116 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' GLY . 17.0 ptp180 -125.01 -51.77 1.67 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.515 0.197 . . . . 0.0 111.04 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' ARG . . . 142.45 -156.36 26.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.017 -176.01 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -79.8 146.34 32.33 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 111.818 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.21 122.05 59.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.412 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.0 mt-30 -95.68 131.5 41.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.806 0.336 . . . . 0.0 111.052 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.17 157.25 39.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.245 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.02 118.61 4.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.815 2.343 . . . . 0.0 111.577 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' A' ' 46' ' ' VAL . 52.6 p90 -60.44 145.35 48.55 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.214 0.53 . . . . 0.0 111.481 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.11 125.83 50.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.809 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.7 136.42 34.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -127.12 161.11 29.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.723 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -122.18 144.46 48.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.3 t -89.4 114.02 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.828 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 78' ' ' GLN . 10.1 mt -81.15 -56.69 5.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.741 0.781 . . . . 0.0 109.188 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -124.77 149.39 47.4 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.626 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -147.65 136.45 21.97 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.372 0.606 . . . . 0.0 111.774 -170.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 74' ' ' SER . 37.0 t -141.3 150.54 42.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.811 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -9.57 55.37 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -146.41 -27.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.73 -76.21 0.95 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.562 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.529 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 3.4 p -159.28 164.41 34.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 mt -132.92 135.53 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.43 131.72 55.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 pt -130.76 156.81 42.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.561 ' HB2' HD11 ' A' ' 67' ' ' ILE . 9.5 tt0 -124.98 131.74 53.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.658 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -85.62 152.96 22.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 111.034 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.72 -178.0 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.603 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.82 -152.27 34.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.175 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.59 -10.73 17.45 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.722 2.281 . . . . 0.0 112.589 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.59 25.96 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 1.011 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 34.9 p90 -55.24 166.51 0.86 Allowed Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.616 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 1.011 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 8.13 -0.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.031 1 C-N-CA 128.988 6.459 . . . . 0.0 121.487 -153.397 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.459 ' N ' ' O ' ' A' ' 84' ' ' TYR . 35.4 tp -70.77 103.29 2.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 119.936 1.244 . . . . 0.0 107.928 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -98.45 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.415 0.626 . . . . 0.0 112.155 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -141.81 158.87 43.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.891 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.2 m -123.83 141.07 52.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.479 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.39 122.94 41.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.91 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 40.3 mtpt -137.96 149.45 46.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.533 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -90.2 147.08 23.78 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.16 -160.72 18.14 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.265 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.12 137.23 57.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 66.22 -157.96 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.924 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' HH11 ' A' ' 111' ' ' ARG . . . -90.5 57.18 3.47 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.561 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 42.1 p -121.13 148.88 43.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 20.9 tp -112.01 132.73 54.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -97.69 113.35 31.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -96.64 114.25 25.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.834 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.2 mt-10 -105.89 133.32 50.79 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.621 0.724 . . . . 0.0 110.405 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -150.55 133.21 15.78 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.775 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.99 -43.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.794 0.684 . . . . 0.0 111.38 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.26 -19.3 0.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -103.0 141.19 36.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.817 0.342 . . . . 0.0 110.99 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 15.3 ptp180 -101.33 138.51 38.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.496 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 17.0 mmtm -127.15 133.94 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.273 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 t -94.91 128.75 41.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.113 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 98' ' ' LEU . 22.1 ptt? -123.6 149.05 45.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.332 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.81 150.07 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.512 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HA3' ' A' ' 96' ' ' GLY . 12.8 ptt180 -85.03 154.81 21.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 22' ' ' ASP . 16.9 mm -96.86 150.57 4.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.37 83.42 7.34 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.0 m -83.04 133.29 35.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.468 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.26 88.99 3.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.343 0.592 . . . . 0.0 110.015 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.1 m -151.98 135.67 16.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.396 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.33 -38.11 0.78 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.675 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -93.48 93.08 7.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.613 0.72 . . . . 0.0 109.743 177.336 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -146.52 120.69 9.5 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.026 -0.421 . . . . 0.0 112.045 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 72.1 149.33 0.09 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.138 0.899 . . . . 0.0 113.034 165.015 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -132.34 139.64 48.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.035 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -121.21 134.2 55.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.67 11.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.436 0.636 . . . . 0.0 111.364 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -116.41 111.1 19.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.15 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.0 p -146.22 134.02 21.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.36 . . . . 0.0 111.581 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -144.61 131.78 20.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.463 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.4 p -145.12 105.97 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.508 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.1 tp -168.41 125.1 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.243 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.84 179.32 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -147.12 154.48 41.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.621 0.248 . . . . 0.0 111.258 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -130.3 140.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.536 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.11 111.61 5.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.639 0.733 . . . . 0.0 110.718 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -85.09 123.58 30.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.62 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -70.41 120.02 15.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.994 0.426 . . . . 0.0 110.311 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.807 179.516 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.662 0.268 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.74 148.45 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.3 mtp -77.44 93.02 4.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.021 0.439 . . . . 0.0 110.848 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.69 111.8 37.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.618 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 m -81.31 106.71 13.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.539 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.89 167.87 32.25 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m -80.68 87.92 5.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -131.96 117.24 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.421 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.64 128.31 16.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.701 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 55.3 tt0 -85.0 111.15 19.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.148 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.15 -78.18 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.741 0.651 . . . . 0.0 111.261 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -172.1 143.44 1.53 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -104.62 -170.19 1.73 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.205 0.526 . . . . 0.0 111.22 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t -86.86 151.81 52.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.281 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 47.4 Cg_exo -56.53 117.05 3.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.606 2.204 . . . . 0.0 112.152 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -63.78 -28.49 69.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.729 0.3 . . . . 0.0 111.52 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 12.2 p90 -85.27 -1.28 56.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.837 0.351 . . . . 0.0 111.313 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.676 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 55.3 t80 -75.49 125.64 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 109.999 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.98 -158.11 22.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.314 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 m -110.34 132.48 54.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.639 0.257 . . . . 0.0 110.8 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 61.5 m95 -123.15 137.8 54.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.552 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.59 ' HB2' HD11 ' A' ' 112' ' ' ILE . 17.0 t70 -103.73 128.16 51.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -95.25 75.84 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 39.72 2.33 Favored Glycine 0 C--N 1.317 -0.478 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.624 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -164.52 160.69 20.65 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 73.19 144.59 0.11 Allowed Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 124.022 0.826 . . . . 0.0 111.079 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 16.7 Cg_exo -67.45 140.66 53.2 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.836 2.357 . . . . 0.0 112.451 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.12 -167.84 43.02 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.432 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 32.9 Cg_exo -53.41 163.55 2.49 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.612 2.875 . . . . 0.0 113.376 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -71.37 -25.07 62.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.405 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.18 13.47 0.31 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.4 28.04 13.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 22.1 t -89.05 134.39 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -68.55 -44.31 74.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.542 0.686 . . . . 0.0 110.183 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.6 p -175.74 175.11 2.09 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.148 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.35 154.08 38.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.308 0.575 . . . . 0.0 111.332 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 22' ' ' ASP . 23.0 p -119.34 142.21 48.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.146 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.26 131.63 63.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.365 0.602 . . . . 0.0 110.615 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.2 m -116.71 120.03 37.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.127 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -101.4 117.01 34.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -101.72 -177.8 3.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -54.42 -45.37 72.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -126.58 -13.56 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -126.16 154.81 42.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 111.731 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.3 t -110.4 130.64 63.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.82 123.53 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.744 0.307 . . . . 0.0 110.176 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.85 137.74 34.48 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.426 0.631 . . . . 0.0 110.502 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -122.01 119.91 32.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.184 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -100.63 128.48 46.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.84 112.75 33.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.985 0.421 . . . . 0.0 109.876 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.7 ttp -116.63 138.17 51.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.72 126.1 22.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.818 0.699 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.39 -28.15 11.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.579 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HE ' ' HB3' ' A' ' 54' ' ' ARG . 9.4 mmm180 -92.81 -75.61 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.625 0.726 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.0 -145.35 16.84 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.025 -171.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.9 131.36 35.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.762 0.791 . . . . 0.0 111.261 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.32 120.64 64.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.975 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 48' ' ' THR . 78.7 mt-30 -92.58 126.69 37.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.81 158.46 47.65 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.495 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 132.34 28.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.92 2.414 . . . . 0.0 112.105 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -60.41 128.41 36.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.609 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -103.35 120.41 40.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.15 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.0 127.98 34.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.369 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.2 p90 -114.66 154.99 27.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.113 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.78 147.52 49.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.381 0.61 . . . . 0.0 110.331 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.8 114.67 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.679 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.8 mt -81.49 -53.96 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.5 m -133.17 153.26 51.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.301 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 52.1 tt0 -148.64 145.27 27.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 145.7 50.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -71.86 -23.56 61.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -165.63 89.87 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.867 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.47 -84.92 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.078 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -146.89 156.09 42.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 9.1 mt -133.31 136.15 55.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.56 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.09 119.6 35.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.29 157.35 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.544 ' HB2' HD11 ' A' ' 67' ' ' ILE . 29.5 tt0 -130.75 144.4 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -94.68 154.91 17.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.578 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.32 -177.38 3.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.26 -153.52 29.22 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.258 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.66 -16.03 52.26 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.514 2.143 . . . . 0.0 112.122 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.88 31.18 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.224 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.917 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 52.9 p90 -59.7 173.48 0.52 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.251 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 11.65 -0.84 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.128 1 C-N-CA 128.243 5.962 . . . . 0.0 121.415 -152.267 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.6 tp -68.47 104.27 1.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 119.575 1.08 . . . . 0.0 108.24 167.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -105.74 173.29 6.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 111.927 -172.145 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.8 t -139.54 158.42 44.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.204 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.4 m -119.61 142.87 48.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.826 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 97.7 mt -130.72 130.77 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.846 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -144.93 164.74 30.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.895 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -98.44 154.9 17.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.857 0.36 . . . . 0.0 110.034 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.08 -153.73 29.58 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.306 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -75.73 -46.76 29.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.565 0.698 . . . . 0.0 110.104 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -97.02 -160.46 0.8 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.79 51.28 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 p -117.05 141.32 48.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.781 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 28.9 tp -102.69 135.66 43.93 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.8 108.97 22.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -107.62 111.95 24.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 23.0 mt-10 -107.23 131.66 53.94 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.387 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -150.59 118.31 6.17 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.4 t30 69.63 -5.09 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.604 0.565 . . . . 0.0 112.229 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.13 -14.6 4.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.432 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -108.46 135.5 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.326 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -101.7 127.0 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.255 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 5.5 mtmt -117.98 124.82 49.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.665 0.269 . . . . 0.0 111.655 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 113.91 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 21.1 ptp -125.14 151.4 45.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.914 0.388 . . . . 0.0 110.965 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 m -100.17 156.07 17.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.143 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 41.9 ttt85 -87.45 141.42 28.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.927 0.394 . . . . 0.0 110.375 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 22' ' ' ASP . 30.6 mm -72.72 147.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 pm0 -74.29 107.18 6.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 -175.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -100.12 16.54 23.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.059 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -137.55 19.48 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -175.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p -104.12 100.31 10.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.628 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.66 16.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.613 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 120' ' ' GLU . 43.4 ttt180 -157.94 153.65 26.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.4 pm0 -76.75 63.49 2.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 118' ' ' ARG . 74.7 mm-40 -66.99 149.33 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.349 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.99 104.74 16.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.368 0.604 . . . . 0.0 111.757 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.599 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 14.3 t70 -90.42 141.39 28.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.297 173.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.91 102.43 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' A' ' 122' ' ' ASP . 96.4 mttt -123.73 85.85 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.721 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.0 m -86.68 106.96 17.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.373 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -89.04 152.56 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -135.03 92.76 2.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.352 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.26 105.95 17.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.58 92.89 7.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.285 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.69 98.02 1.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.75 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -87.96 -42.15 12.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.435 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 68.06 104.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.198 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -70.34 134.02 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.472 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.9 121.41 42.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.621 0.248 . . . . 0.0 110.784 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.0 t60 . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 174.877 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -79.44 89.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.08 0.943 . . . . 0.0 111.198 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.789 ' HG2' HG23 ' A' ' 4' ' ' VAL . 46.1 ttm -156.91 132.94 9.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.189 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.789 HG23 ' HG2' ' A' ' 3' ' ' MET . 92.5 t 68.89 111.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 O-C-N 123.919 0.762 . . . . 0.0 112.216 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 m -87.66 -36.25 17.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.794 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.36 113.23 0.43 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.589 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.9 m -64.51 -34.57 78.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.697 0.248 . . . . 0.0 111.523 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.87 109.44 19.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 0.0 110.672 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -90.89 34.5 0.91 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.103 178.131 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -69.36 -32.76 72.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.256 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -103.02 118.78 37.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.88 88.5 2.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.803 0.335 . . . . 0.0 110.564 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -107.24 -1.0 22.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.526 0.679 . . . . 0.0 111.132 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.8 t -59.56 121.66 58.8 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.546 -172.154 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.3 Cg_exo -79.15 97.87 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.073 2.515 . . . . 0.0 110.831 172.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -63.17 -25.7 68.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.359 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -82.95 -18.32 40.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.666 0.27 . . . . 0.0 111.678 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -74.04 136.61 43.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.677 0.275 . . . . 0.0 110.709 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.15 -158.21 22.27 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.224 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.5 m -117.82 129.03 55.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.619 0.247 . . . . 0.0 110.605 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -113.7 141.36 47.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.182 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.677 ' HB2' HD11 ' A' ' 112' ' ' ILE . 20.1 t70 -109.02 134.98 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.778 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HB2' ' H ' ' A' ' 36' ' ' ALA . 33.8 mt-10 -96.1 40.8 1.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.602 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.06 78.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.319 -0.944 . . . . 0.0 110.945 172.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -91.66 142.82 27.2 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.71 155.49 0.14 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.594 1.184 . . . . 0.0 111.401 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.48 135.13 48.0 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.384 2.056 . . . . 0.0 111.862 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.78 -154.76 22.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.436 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 171.63 5.01 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.28 2.654 . . . . 0.0 113.037 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -129.66 -6.59 4.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.462 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.94 -41.2 70.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.692 0.758 . . . . 0.0 111.681 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.37 -37.01 0.3 Allowed Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 50' ' ' VAL . 17.8 t -67.34 134.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -111.26 -15.24 13.68 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.982 0.42 . . . . 0.0 110.786 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m -157.31 158.25 35.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.968 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.492 ' H ' ' HB2' ' A' ' 23' ' ' GLU . . . -136.12 164.73 27.37 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.193 0.521 . . . . 0.0 110.933 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 20.0 p -131.06 131.29 44.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.086 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.85 129.52 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.255 0.55 . . . . 0.0 110.702 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.6 m -114.53 125.65 54.03 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -101.4 117.14 34.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 p -101.75 -178.0 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.567 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -49.36 -52.82 25.77 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.478 0.486 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -134.87 9.23 3.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.228 0.537 . . . . 0.0 110.969 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 163.9 27.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.0 111.334 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.2 t -115.88 122.28 69.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.29 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.34 122.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.32 136.92 45.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.379 0.609 . . . . 0.0 110.817 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -125.9 130.72 51.86 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 178.537 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB3' HG11 ' A' ' 33' ' ' VAL . 43.3 mt-10 -110.33 136.53 49.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.246 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.5 t -94.34 111.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 115.39 25.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.44 113.89 7.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.606 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.12 -20.83 11.26 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -111.65 -61.06 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.815 0.817 . . . . 0.0 110.021 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.36 -158.83 22.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.287 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.24 131.08 36.96 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.376 0.608 . . . . 0.0 110.558 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' THR . 93.2 t -113.23 121.14 64.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.019 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -91.41 128.68 37.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.624 0.25 . . . . 0.0 110.926 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.9 mt -86.94 159.91 50.66 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 20.1 Cg_endo -62.74 132.05 35.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.063 1.842 . . . . 0.0 111.128 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -57.02 127.23 30.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.58 0.705 . . . . 0.0 111.191 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtm -104.19 130.05 51.95 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.6 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.83 132.09 41.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -124.39 146.74 48.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.549 ' HG2' HD11 ' A' ' 80' ' ' LEU . 73.5 mmtt -121.69 155.45 35.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.699 0.761 . . . . 0.0 110.663 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.5 115.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.522 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.2 mt -81.99 -54.0 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -136.39 153.11 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.77 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -148.25 150.9 34.52 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.9 t -143.57 139.09 29.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.617 0.246 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -68.98 -17.72 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.669 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.24 -44.92 86.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.413 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.59 30.54 0.22 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.802 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 p -135.0 131.25 36.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 mt -135.32 137.59 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.328 -177.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -117.5 123.62 46.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.7 pt -132.59 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.154 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.585 ' HB2' HD11 ' A' ' 67' ' ' ILE . 7.0 tt0 -139.38 142.21 37.55 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -71.83 174.19 7.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.077 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 65' ' ' LYS . 76.5 mt -127.85 174.58 9.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.99 -152.76 31.8 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 -9.49 20.08 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.381 2.054 . . . . 0.0 111.952 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -102.34 20.5 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -95.43 2.64 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -172.925 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 77.1 Cg_endo -93.87 -4.58 2.76 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 CA-C-N 121.393 1.533 . . . . 0.0 112.368 162.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.85 112.02 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.679 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -99.81 170.26 8.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.56 . . . . 0.0 110.995 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -130.35 158.3 40.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.089 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.7 m -128.98 142.01 51.07 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.014 0.435 . . . . 0.0 111.069 -177.505 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.8 mt -121.1 123.62 42.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.097 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.496 ' HE3' HG21 ' A' ' 89' ' ' THR . 93.3 mttt -132.0 155.37 48.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.107 0.479 . . . . 0.0 111.371 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -84.63 152.36 23.86 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.428 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.59 -156.79 32.36 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.344 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -83.34 -28.7 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -109.16 -165.15 0.99 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.266 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.88 54.01 4.64 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -117.34 154.61 30.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.611 0.243 . . . . 0.0 110.647 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 91' ' ' LYS . 61.5 tp -106.93 127.88 53.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.126 0.489 . . . . 0.0 110.749 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 66.7 mt -99.33 110.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.29 173.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -102.41 115.99 31.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 25.6 mt-10 -98.71 130.36 45.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.416 0.626 . . . . 0.0 110.119 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 1.2 tm0? -153.76 132.11 12.0 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 1.6 t-20 66.68 10.99 7.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.504 0.502 . . . . 0.0 111.865 172.126 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.93 1.77 55.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.964 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 58.7 mt-30 -96.0 136.76 36.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -99.13 114.03 26.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -119.98 137.92 53.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 0.0 111.882 -172.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 t -119.92 124.48 46.11 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.613 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -125.73 160.66 29.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.21 0.529 . . . . 0.0 111.854 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.37 141.09 30.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.993 175.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -81.48 125.06 30.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mm -77.99 147.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -100.74 125.74 47.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.333 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.1 m -106.11 101.44 10.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -91.71 113.96 26.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -103.65 155.27 18.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.426 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.08 130.61 2.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.939 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 84.33 1.32 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.65 87.53 2.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.845 0.355 . . . . 0.0 110.246 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 66.06 150.38 0.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.203 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -166.56 138.67 3.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.021 174.08 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.64 167.91 14.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -80.99 -74.42 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -112.98 113.16 25.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.781 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -140.65 102.71 4.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.114 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -82.96 -21.85 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.556 -176.239 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.4 t -75.95 74.37 2.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.405 0.621 . . . . 0.0 110.373 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.41 38.43 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.64 0.733 . . . . 0.0 109.365 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLU . . . . . 0.495 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 4.6 pt-20 -76.8 101.34 5.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.557 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -115.56 137.14 52.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.823 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -89.65 179.39 6.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.394 0.616 . . . . 0.0 111.727 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -144.2 153.03 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.166 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -150.37 122.46 8.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 0.0 110.806 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.39 117.94 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.276 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.881 176.295 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mm -86.96 85.63 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptm -88.44 -11.84 44.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.8 t 55.76 57.64 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.923 0.868 . . . . 0.0 110.225 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 m -152.56 100.07 2.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.305 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.06 -172.78 26.62 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.601 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.76 175.86 12.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 111.184 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -153.54 80.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 168.713 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -106.78 106.81 17.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.9 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.79 109.36 2.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.701 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -70.74 -25.56 62.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.583 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 37.49 21.31 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.242 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 tt0 -92.55 157.8 16.33 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.639 -1.619 . . . . 0.0 108.851 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.0 m -77.06 100.61 0.47 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 13' ' ' GLU . 87.3 Cg_endo -97.97 133.18 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.036 2.491 . . . . 0.0 114.005 -167.741 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 54.4 p90 -105.9 -13.25 15.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.053 173.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 13.4 p90 -106.31 -0.27 24.48 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -80.48 26.38 0.38 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.88 -165.39 12.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.932 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.572 ' OG1' ' HD2' ' A' ' 115' ' ' LYS . 22.1 m -109.8 125.97 53.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 90.2 m95 -111.92 135.45 52.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.277 0.56 . . . . 0.0 111.394 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 112' ' ' ILE . 2.8 t70 -87.64 123.31 32.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.739 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.48 76.18 3.32 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.03 3.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.675 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -153.45 141.83 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.23 158.94 0.12 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 123.904 0.752 . . . . 0.0 112.206 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.04 177.67 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.971 2.447 . . . . 0.0 112.056 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.65 -162.67 11.71 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.41 157.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.446 3.431 . . . . 0.0 114.332 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -68.71 -18.66 64.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.901 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.89 -55.43 29.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.297 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.94 50.27 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.351 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -99.38 132.77 44.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 44.9 mtpt -111.62 -18.16 12.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.923 0.392 . . . . 0.0 110.878 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 19.0 m -155.38 167.05 31.65 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.239 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.33 150.21 49.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.855 0.359 . . . . 0.0 110.471 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 132.29 39.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.904 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -112.39 131.55 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.109 0.48 . . . . 0.0 110.648 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -113.45 125.25 54.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.145 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 98.8 m-85 -101.25 118.09 36.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.129 0.49 . . . . 0.0 109.684 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -179.09 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.385 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -50.58 -58.37 5.98 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.116 0.26 . . . . 0.0 111.53 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.53 -5.8 9.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 0.0 110.691 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -115.74 155.01 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.141 0.495 . . . . 0.0 111.307 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.2 118.14 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.64 124.66 60.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.71 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -95.28 133.59 39.01 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.679 0.752 . . . . 0.0 111.126 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 118.48 23.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.615 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -104.39 131.82 51.31 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.738 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 56' ' ' GLU . 47.4 t -86.8 112.42 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.745 0.784 . . . . 0.0 110.144 -174.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.615 ' HG2' HG22 ' A' ' 33' ' ' VAL . 66.8 mtt -113.29 120.02 39.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.34 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.88 129.63 43.06 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.011 0.434 . . . . 0.0 110.284 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.53 -20.38 48.66 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.278 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HG3' ' CB ' ' A' ' 51' ' ' MET . 7.1 mmt180 -107.01 -51.36 2.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.635 0.731 . . . . 0.0 109.553 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.48 -151.62 17.81 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.374 -172.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' HG22 ' A' ' 50' ' ' VAL . 45.4 mt-10 -81.68 121.64 26.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.241 0.521 . . . . 0.0 110.063 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -104.84 122.4 57.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.78 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -83.86 118.76 24.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 90.8 mt -95.44 163.63 21.07 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 88.4 Cg_exo -44.72 120.29 2.73 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.054 2.503 . . . . 0.0 112.773 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -71.84 141.44 49.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.104 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' MET . . . . . 0.445 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 24.7 mmt -103.88 149.81 24.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.49 141.42 28.54 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.47 162.31 29.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.126 0.488 . . . . 0.0 111.256 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -135.88 159.18 42.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.456 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.9 t -103.67 118.46 50.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.538 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.2 mt -85.91 -50.72 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -138.74 160.11 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.214 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -147.33 135.16 21.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.74 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 t -137.51 116.67 12.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -64.86 -20.94 66.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 0.0 109.949 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -42.76 78.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.826 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.36 35.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.347 -1.406 . . . . 0.0 115.004 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -154.58 140.85 18.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.652 0.726 . . . . 0.0 111.895 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 mt -130.05 137.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.9 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HG2' HD12 ' A' ' 67' ' ' ILE . 60.0 tt0 -110.3 123.42 49.78 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 158.35 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.615 ' HB2' HD11 ' A' ' 67' ' ' ILE . 9.6 tt0 -132.59 147.72 52.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.411 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 96.4 m-85 -99.17 157.43 16.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.173 0.511 . . . . 0.0 110.599 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 ' CE1' ' A' ' 84' ' ' TYR . 26.2 mt -112.22 179.51 3.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.073 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -150.43 41.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.921 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.09 -12.32 15.34 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.849 2.366 . . . . 0.0 112.833 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.19 20.49 18.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.377 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -66.23 -176.19 0.22 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.538 ' HA ' ' OE1' ' A' ' 78' ' ' GLN . 59.4 Cg_exo 2.98 -3.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.484 1 C-N-CA 126.613 4.876 . . . . 0.0 120.823 -138.232 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 84' ' ' TYR . 56.8 tp -72.3 116.71 13.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 120.116 1.325 . . . . 0.0 110.763 176.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.62 167.35 15.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.646 0.736 . . . . 0.0 111.883 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 t -150.58 145.08 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.334 169.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 141.57 51.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.886 0.374 . . . . 0.0 110.995 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.7 mt -115.86 124.03 49.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -129.7 165.88 20.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.119 0.485 . . . . 0.0 111.607 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -77.13 147.91 36.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.135 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.43 173.11 22.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.707 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.65 -2.43 48.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.72 28.49 5.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.535 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.07 49.15 42.62 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.138 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 p -130.98 173.79 10.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.809 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -119.06 134.0 55.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.76 116.74 41.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.124 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' TRP . . . . . 0.539 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 12.4 t90 -96.73 112.43 24.19 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.0 133.37 49.89 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -149.74 129.15 12.97 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.91 22.67 13.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.089 0.471 . . . . 0.0 110.85 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.26 -8.9 68.87 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.548 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -92.48 145.65 24.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.65 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -100.54 117.01 33.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.084 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -104.06 132.81 49.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.473 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 t -100.92 126.64 47.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.542 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 59.4 mtm -117.61 144.46 45.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 1.1 m -96.92 158.69 15.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.997 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.316 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 22' ' ' ASP . 24.1 mm -71.59 146.6 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.13 85.59 5.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.43 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t 65.93 105.28 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.793 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.572 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 83.5 tttt -79.89 72.6 6.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 92.15 8.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.674 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 173.4 53.28 0.05 OUTLIER Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.604 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -98.55 98.92 10.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -160.58 84.53 0.7 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.479 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -134.18 123.26 24.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.223 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -72.13 134.79 45.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.26 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -82.66 130.31 35.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -161.49 104.55 1.25 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.746 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -136.94 130.93 32.31 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.518 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.2 t -104.5 179.68 4.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.372 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -145.13 121.0 10.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.744 0.307 . . . . 0.0 110.328 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 p -89.33 136.63 32.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.85 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 128' ' ' LEU . 2.4 pt? -150.35 127.75 11.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.903 0.383 . . . . 0.0 110.176 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.06 94.91 2.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.893 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.6 p80 -115.85 89.14 3.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.552 0.691 . . . . 0.0 110.832 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -134.55 129.57 35.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.816 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -129.68 147.73 51.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -103.35 137.7 41.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.809 0.338 . . . . 0.0 111.662 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 3.0 t-80 62.82 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.964 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' HIS . . . . . 0.421 ' H ' ' HB3' ' A' ' 134' ' ' HIS . 20.7 p-80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.099 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.749 0.309 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ILE . . . . . 0.8 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -94.35 173.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.291 177.402 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -89.87 109.66 20.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.152 0.501 . . . . 0.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.04 170.07 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.095 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 p -106.38 125.34 50.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.445 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.1 -17.48 69.5 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -80.12 75.76 6.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.675 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -138.89 129.45 25.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.674 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 57.96 38.19 26.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.5 0.667 . . . . 0.0 110.003 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 10' ' ' GLN . 8.0 pt20 -68.66 150.97 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.377 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -84.46 -3.39 58.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 111.004 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -128.14 118.66 23.8 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 8.9 mm-40 -68.59 146.49 53.02 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.257 0.551 . . . . 0.0 110.6 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -107.19 93.18 8.97 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.927 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 13' ' ' GLU . 2.6 Cg_endo -83.58 123.73 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.199 2.599 . . . . 0.0 111.578 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -69.45 -9.36 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.12 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -113.24 -0.72 14.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.688 0.28 . . . . 0.0 111.619 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 58.2 t80 -97.99 126.64 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.141 0.496 . . . . 0.0 111.501 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -160.64 24.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.261 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' THR . . . . . 0.43 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 29.1 m -101.39 123.72 45.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.803 0.335 . . . . 0.0 110.403 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -104.85 139.63 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 111.851 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HB2' ' CD1' ' A' ' 112' ' ' ILE . 8.7 t70 -79.02 123.66 27.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.822 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 4.3 mm-40 -88.76 85.53 6.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.394 172.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -38.13 5.24 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.622 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -137.54 141.78 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 165.318 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -131.11 140.98 40.29 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.705 -171.708 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 27.6 Cg_endo -97.93 143.89 0.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.957 3.105 . . . . 0.0 111.293 168.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.49 -157.92 25.8 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.498 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 50.9 Cg_exo -49.05 161.62 0.53 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 125.006 3.804 . . . . 0.0 114.069 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.06 13.7 16.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.492 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.01 -28.1 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.87 59.55 0.59 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.45 133.31 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -96.03 -23.24 16.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 111.556 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -157.98 163.21 38.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -148.7 165.89 30.01 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 3.3 p -133.35 132.9 41.8 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.743 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 120.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.444 0.64 . . . . 0.0 109.596 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -108.93 126.11 52.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -100.66 117.64 35.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -100.16 173.61 6.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.347 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' HG22 ' A' ' 41' ' ' THR . 37.5 tt0 -50.38 -40.18 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -136.24 -0.59 2.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.099 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -126.05 151.66 46.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.942 -0.473 . . . . 0.0 111.759 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.84 118.89 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.85 124.06 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -98.07 139.15 34.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.315 0.578 . . . . 0.0 110.778 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -123.58 136.63 54.63 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.536 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 32.7 mt-10 -97.48 130.28 44.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.02 107.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' MET . . . . . 0.599 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -133.85 133.16 41.22 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.3 -169.243 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -80.38 88.8 5.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.091 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.65 -52.78 0.47 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.499 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 51' ' ' MET . 10.0 ptp180 -94.62 -33.11 13.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.52 -173.18 29.55 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.0 mp0 -67.33 117.22 9.03 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.774 0.797 . . . . 0.0 110.803 174.356 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -124.73 128.29 73.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.627 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 131.72 36.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.976 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.0 mt -89.86 162.25 36.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.735 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 76.5 Cg_exo -47.2 121.37 5.2 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.795 2.33 . . . . 0.0 112.307 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -70.62 141.16 51.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.295 0.569 . . . . 0.0 110.954 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -107.96 147.68 30.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.79 148.08 26.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.791 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -145.04 154.72 42.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.515 ' HG3' HD11 ' A' ' 80' ' ' LEU . 55.4 mtpt -128.46 156.19 43.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.41 124.22 49.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.843 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 78' ' ' GLN . 18.3 mt -87.49 -50.25 13.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -144.92 155.74 43.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.348 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.43 128.65 12.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.415 0.626 . . . . 0.0 111.108 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB3' ' H ' ' A' ' 74' ' ' SER . 38.4 t -136.56 147.14 46.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.3 p -80.85 -23.21 39.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.698 0.285 . . . . 0.0 111.593 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -143.16 -10.07 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.5 -83.22 1.06 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.337 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 70' ' ' SER . 4.1 p -164.37 153.67 13.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 122.84 0.456 . . . . 0.0 110.532 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 25.2 mt -114.09 138.01 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.2 tt0 -120.49 124.93 46.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.0 110.181 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -128.44 157.73 40.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.342 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 67' ' ' ILE . 57.3 tt0 -130.03 144.14 51.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -82.63 167.38 18.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.515 HD11 ' HG3' ' A' ' 65' ' ' LYS . 95.8 mt -129.22 166.48 19.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.334 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.53 -153.78 17.51 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.38 -21.9 46.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.038 1.825 . . . . 0.0 111.6 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -105.64 40.72 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.083 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' TYR . . . . . 0.477 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 45.8 p90 -78.15 -33.16 0.94 Allowed Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 85.9 Cg_endo -74.04 -3.6 14.05 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 CA-C-N 121.222 1.472 . . . . 0.0 113.068 -170.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 tp -88.1 124.83 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.156 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -111.66 168.97 9.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -138.29 153.45 49.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.63 -173.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -120.08 142.26 49.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.0 mt -125.95 124.41 40.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.74 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.564 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 85.9 mttt -130.52 163.35 27.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.039 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -86.79 143.67 27.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.72 -146.26 17.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.28 125.93 35.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 30.2 m120 65.06 -153.09 0.28 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.79 53.19 4.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.124 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 p -115.68 144.01 44.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 HD22 ' A' ' 90' ' ' LEU . 29.9 tp -109.57 133.68 52.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 70.9 mt -98.48 110.28 25.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 175.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -105.94 114.8 29.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 32.8 mt-10 -106.2 131.72 53.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.651 0.738 . . . . 0.0 110.321 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 1.2 tm0? -151.75 135.18 16.07 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.016 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.7 OUTLIER 65.09 9.12 5.25 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.796 0.331 . . . . 0.0 111.621 176.435 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.98 13.42 57.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.654 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 13.5 pt20 -120.93 149.0 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -96.07 125.85 40.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.325 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.589 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.1 mmpt? -111.71 139.75 46.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.544 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.3 m -105.25 114.66 28.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.722 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 64.2 mmm -101.85 133.15 47.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.62 142.87 33.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 111' ' ' ARG . 8.9 ttp180 -82.63 130.56 35.14 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.147 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.4 mm -62.83 144.58 14.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -115.71 109.96 18.46 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.422 0.63 . . . . 0.0 110.868 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 t -171.26 107.04 0.25 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.607 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -88.23 128.02 35.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m 71.41 129.01 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.954 0.784 . . . . 0.0 109.575 -168.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.05 -102.88 0.5 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.612 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -125.35 155.17 40.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 -175.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.36 27.89 7.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.628 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.0 84.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.019 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.95 105.82 13.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.603 -172.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -169.04 132.99 1.4 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 175.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -150.99 130.87 13.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.084 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.48 92.13 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -70.91 95.97 1.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 110.758 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -77.87 112.94 15.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 p -121.48 126.17 48.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.4 tp -111.43 109.13 18.94 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.968 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -121.31 130.72 53.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -131.7 106.9 8.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -149.03 100.61 3.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -146.17 96.77 2.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.286 0.565 . . . . 0.0 110.593 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -95.75 116.05 28.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.282 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.4 p80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.274 177.514 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m . . . . . 0 N--CA 1.451 -0.377 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.96 115.72 4.38 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.378 2.052 . . . . 0.0 111.717 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.07 -14.94 63.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.121 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -94.4 -18.63 21.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.75 0.309 . . . . 0.0 111.417 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.28 139.84 39.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.765 0.317 . . . . 0.0 110.62 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.32 -152.62 21.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.307 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 m -126.8 128.25 46.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 55.5 m95 -118.51 143.75 46.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.849 0.357 . . . . 0.0 111.563 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' ILE . 19.4 t70 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.326 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.735 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 1.3 tp10 -106.53 36.44 2.62 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 123.39 1.567 . . . . 0.0 107.781 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.19 70.66 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.656 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -95.54 -168.0 1.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.156 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . -75.86 144.49 76.37 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 111.499 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' LYS . 10.0 Cg_exo -71.73 -178.93 3.36 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.414 2.742 . . . . 0.0 113.17 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.28 -151.46 5.56 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.495 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.16 -163.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.561 2.841 . . . . 0.0 112.588 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -52.81 -34.43 53.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.889 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -101.82 17.14 23.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.664 -179.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 77.57 0.23 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 49' ' ' GLU . 99.0 t -54.76 144.67 5.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 123.554 0.742 . . . . 0.0 112.079 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 8.9 mtpm? -55.63 -40.68 72.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.398 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -154.69 163.39 40.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.802 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . . . -143.23 150.32 39.15 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.834 0.35 . . . . 0.0 110.573 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 p -134.0 140.56 46.79 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 21' ' ' TRP . 7.2 p -112.4 129.68 67.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 m -108.4 125.93 52.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.978 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -100.59 117.21 34.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.476 . . . . 0.0 110.076 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -102.35 -179.64 4.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.71 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 41' ' ' THR . 37.0 tt0 -44.33 -70.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.128 0.971 . . . . 0.0 113.057 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.21 9.84 8.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.226 0.536 . . . . 0.0 110.78 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.589 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 1.5 pm0 -133.69 150.61 51.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.358 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.51 133.89 56.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 61' ' ' PHE . 22.1 t -116.89 122.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.535 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.83 139.84 30.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.51 133.39 49.84 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.41 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.723 ' HB3' HG11 ' A' ' 33' ' ' VAL . 49.4 mt-10 -125.27 134.4 52.3 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 56' ' ' GLU . 21.3 t -91.11 108.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.336 0.588 . . . . 0.0 109.938 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 66.8 mtt -99.3 138.43 36.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 34.6 tt0 -64.53 115.21 4.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.781 0.324 . . . . 0.0 110.472 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.91 -13.69 63.43 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.433 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 0.1 OUTLIER -113.43 -37.51 4.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.352 0.596 . . . . 0.0 110.436 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.8 -159.83 29.5 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.2 mp0 -62.33 126.53 27.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.21 121.39 60.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.843 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 7.7 mt-30 -88.2 131.25 34.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.016 0.436 . . . . 0.0 110.804 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.513 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 42.8 mt -88.0 165.04 31.38 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.493 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 51.6 Cg_exo -49.79 120.31 5.8 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.87 2.38 . . . . 0.0 111.499 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.567 ' HB3' HG22 ' A' ' 46' ' ' VAL . 11.0 p90 -64.3 134.14 54.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 111.653 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.5 mmm -102.07 129.91 48.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.48 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -77.13 148.94 35.73 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.338 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -140.14 153.83 46.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 80' ' ' LEU . 92.6 mttt -126.27 149.47 49.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.229 0.537 . . . . 0.0 110.362 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 77' ' ' ILE . 94.5 t -93.79 116.11 34.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.281 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 78' ' ' GLN . 21.6 mt -84.81 -52.45 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.428 0.632 . . . . 0.0 109.549 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -133.93 150.36 51.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.093 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.13 155.54 40.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.89 0.376 . . . . 0.0 111.019 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -125.02 158.81 32.79 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 t -67.9 -33.0 73.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -169.95 90.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.873 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.1 -78.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.703 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -139.86 155.77 47.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.088 0.47 . . . . 0.0 110.184 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 mt -135.11 137.19 50.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.669 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.64 121.67 42.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 75' ' ' ILE . 35.3 pt -132.92 151.43 34.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.313 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 67' ' ' ILE . 18.1 tt0 -124.54 136.73 54.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.391 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -79.91 170.1 16.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.727 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 88.5 mt -131.39 146.8 52.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . 0.439 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . 121.21 -153.71 16.6 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.95 -13.09 37.35 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.632 2.221 . . . . 0.0 112.601 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -125.83 46.32 2.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.993 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 32.9 p90 -84.5 -36.55 0.61 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 61.0 Cg_endo -75.32 -4.41 15.29 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 CA-C-N 121.097 1.427 . . . . 0.0 113.431 -170.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.26 109.52 21.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -86.95 166.47 15.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -131.38 163.16 28.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.996 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -121.25 141.74 50.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.036 0.446 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.7 mt -128.59 137.9 51.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.874 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 79.1 mttt -141.58 156.65 45.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -78.89 144.18 35.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.59 -171.4 15.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.891 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.44 155.63 29.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 71.81 -55.44 0.66 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.757 0.823 . . . . 0.0 111.049 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.08 40.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 110' ' ' THR . 28.5 p -108.11 171.9 7.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.14 0.495 . . . . 0.0 111.591 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 52.3 tp -118.61 132.67 56.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.323 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 73.0 mt -97.72 110.05 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CZ3' HG21 ' A' ' 38' ' ' VAL . 4.2 t90 -103.98 115.02 29.68 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.171 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 106' ' ' ARG . 35.5 mt-10 -112.39 131.54 55.49 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.884 0.85 . . . . 0.0 111.205 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -151.76 131.32 13.05 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.046 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.57 12.12 8.72 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.347 0.404 . . . . 0.0 111.13 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.89 70.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.274 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -92.61 135.18 34.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.792 0.33 . . . . 0.0 110.458 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 101' ' ' GLU . 22.5 ttt180 -102.31 116.81 33.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.488 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -118.09 128.36 54.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 111.571 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.3 m -95.01 119.21 33.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.104 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 20.7 mmt -107.19 135.26 49.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.61 146.74 24.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.533 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 26.6 ttp180 -93.27 128.91 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.931 0.396 . . . . 0.0 110.783 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.2 mm -84.39 150.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 . . . . . 0 C--N 1.317 -0.848 0 CA-C-O 121.505 0.669 . . . . 0.0 110.138 -179.1 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m . . . . . 0 N--CA 1.452 -0.37 0 N-CA-C 110.267 -0.272 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.34 110.59 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.831 2.354 . . . . 0.0 112.424 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -62.71 -26.86 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.698 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 90' ' ' LEU . 21.8 p90 -88.44 -13.22 40.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.71 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -86.57 142.01 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.622 0.249 . . . . 0.0 110.387 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.79 -159.66 24.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.502 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 m -116.49 122.27 44.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 69.4 m95 -116.25 136.54 52.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.134 0.493 . . . . 0.0 111.543 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.582 ' HB2' HG12 ' A' ' 112' ' ' ILE . 26.3 t70 -110.26 151.51 27.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.219 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 56.3 mt-10 -63.05 -23.36 67.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.581 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.05 -59.05 0.38 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.262 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -170.27 170.86 7.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 75.42 148.75 0.12 Allowed Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.892 0.877 . . . . 0.0 111.655 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 60.8 Cg_endo -73.09 176.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 0.0 113.152 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -113.84 -152.74 10.85 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.324 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 3.2 Cg_endo -48.19 154.32 2.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.759 2.972 . . . . 0.0 113.471 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 t -69.08 -4.73 18.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.229 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.99 -22.78 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.58 22.07 1.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.409 HG21 ' HG2' ' A' ' 29' ' ' PRO . 20.1 t -89.16 132.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.0 110.187 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 58.6 mtmt -99.7 -14.96 18.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.107 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p 176.9 159.57 0.36 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.732 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -122.44 136.8 54.97 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.125 0.488 . . . . 0.0 110.331 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 p -118.39 130.74 56.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.664 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.78 134.51 55.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.298 0.571 . . . . 0.0 110.225 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 12.0 m -120.19 126.27 50.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.207 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -101.3 118.29 36.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.244 0.545 . . . . 0.0 110.206 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -96.77 175.86 6.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 41' ' ' THR . 23.1 tt0 -60.96 -35.63 77.29 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.84 -8.63 4.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.464 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 2.2 mp0 -126.68 153.51 45.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 112.219 -169.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.454 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.4 t -107.2 120.31 58.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.581 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 61' ' ' PHE . 52.2 t -107.06 125.06 63.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -112.01 127.3 55.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.058 0.456 . . . . 0.0 110.305 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.96 128.03 54.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.763 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 37.7 mt-10 -99.92 129.43 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 56' ' ' GLU . 44.8 t -90.24 110.11 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.9 ttm -122.56 145.2 48.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.89 135.07 57.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.839 0.352 . . . . 0.0 110.217 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.56 -56.65 1.97 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.288 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -95.7 -33.7 12.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.76 -149.39 19.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.952 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 45.1 mt-10 -72.92 115.25 12.0 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.6 t -108.75 122.52 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.408 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HG2' HG23 ' A' ' 48' ' ' THR . 85.7 mt-30 -85.86 119.17 25.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.495 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.1 154.67 67.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.73 122.98 8.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.992 2.461 . . . . 0.0 112.3 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.557 ' HB3' HG22 ' A' ' 46' ' ' VAL . 37.0 p90 -64.64 139.91 58.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtm -112.09 133.49 54.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.776 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.28 134.73 36.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.341 . . . . 0.0 110.68 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.454 ' CD1' HG23 ' A' ' 45' ' ' VAL . 37.1 p90 -130.98 157.12 43.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.089 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HE3' HD11 ' A' ' 80' ' ' LEU . 96.7 mttt -127.05 158.99 35.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.51 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.1 t -97.16 119.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.959 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 78' ' ' GLN . 17.7 mt -82.58 -56.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.404 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -127.68 153.83 46.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.501 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -148.28 148.02 29.99 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.178 -172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -145.23 147.28 32.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.4 p -77.15 -26.81 53.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.469 . . . . 0.0 110.131 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.98 70.06 0.92 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.214 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.06 -88.75 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.882 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 t -152.43 157.78 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.175 0.512 . . . . 0.0 110.574 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.51 135.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.057 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -117.56 128.54 55.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 pt -124.39 157.06 32.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.26 0.553 . . . . 0.0 111.416 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.691 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 34.8 tt0 -134.41 144.63 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.102 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.86 151.1 20.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.587 HD11 ' HE3' ' A' ' 65' ' ' LYS . 94.8 mt -99.86 163.72 12.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.562 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -152.5 21.71 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.956 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.84 -6.68 13.07 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.368 2.045 . . . . 0.0 111.956 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.51 10.11 29.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.8 OUTLIER -61.28 170.17 1.82 Allowed Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.747 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 9.4 Cg_exo 9.42 -1.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.15 1 C-N-CA 128.173 5.915 . . . . 0.0 120.681 -148.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 84' ' ' TYR . 34.6 tp -74.3 103.84 4.84 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -113.33 173.47 6.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -138.52 149.29 45.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.524 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.3 m -122.18 143.35 49.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.94 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 17' ' ' TYR . 94.9 mt -121.65 131.8 54.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -134.57 155.88 49.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.636 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -74.13 144.65 44.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.025 0.44 . . . . 0.0 110.632 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 145.38 18.34 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -70.41 158.6 35.71 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.568 0.223 . . . . 0.0 110.797 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 67.83 12.86 9.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.345 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.72 56.11 2.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.791 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 p -130.58 173.0 11.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.774 -0.251 . . . . 0.0 110.795 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.9 tp -129.27 133.25 47.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 0.0 110.359 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.37 114.22 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -103.83 113.43 26.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.5 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 28.7 mt-10 -103.29 139.03 39.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.421 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -145.99 122.27 10.9 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.446 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.45 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER 67.32 8.9 6.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.249 179.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.1 -14.77 25.98 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.649 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 32.5 mt-30 -93.33 133.39 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 30.6 ptt180 -102.41 124.33 47.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.4 0.619 . . . . 0.0 112.223 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -112.35 130.45 55.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 m -93.14 119.27 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 24.2 mmt -108.73 148.17 30.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.851 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -116.08 157.3 24.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.477 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 13.8 ttp180 -76.49 133.2 39.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mt -71.23 152.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 . . . . . 0 C--N 1.321 -0.654 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.087 -178.711 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 t . . . . . 0 CA--C 1.534 0.327 0 CA-C-O 121.43 0.633 . . . . 0.0 110.119 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 2.4 Cg_endo -81.13 97.57 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.743 2.296 . . . . 0.0 112.271 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -77.84 -11.51 59.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 110.149 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -93.94 -4.31 50.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.121 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 83.4 t80 -75.63 135.74 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.648 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.95 -166.75 19.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.37 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 m -108.67 128.21 54.65 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 98' ' ' LEU . 61.6 m95 -111.1 146.74 36.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.292 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -108.98 139.24 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.199 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 7.2 mm-40 -45.43 -61.91 1.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.124 0.89 . . . . 0.0 112.251 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.17 21.34 59.35 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.252 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.17 -167.23 1.24 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.016 0.527 . . . . 0.0 110.989 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.22 146.99 59.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.34 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.08 152.61 36.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.245 2.63 . . . . 0.0 113.104 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -91.55 -153.91 30.13 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.545 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 6.1 Cg_endo -51.38 114.84 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.43 2.753 . . . . 0.0 112.415 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -82.19 70.45 9.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 123.143 1.449 . . . . 0.0 111.129 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -128.94 -63.34 0.97 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.269 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.94 -49.02 0.2 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.098 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 51' ' ' MET . 6.2 t -91.65 133.27 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -108.8 -19.33 13.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.148 0.499 . . . . 0.0 110.982 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 m -161.91 165.41 27.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.746 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -137.66 145.07 42.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.867 0.365 . . . . 0.0 110.838 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -122.77 132.25 54.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.43 129.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.225 0.536 . . . . 0.0 110.795 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.5 m -118.29 128.32 54.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.056 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.2 m -101.86 176.87 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.428 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 41' ' ' THR . 41.5 tt0 -50.47 -54.54 21.42 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.81 -21.28 9.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.457 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.56 156.88 42.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.342 0.591 . . . . 0.0 111.646 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.27 127.34 63.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.73 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.0 124.14 72.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -106.09 135.9 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.37 126.2 53.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.904 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -98.23 126.56 43.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 56' ' ' GLU . 45.8 t -86.3 111.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.382 0.61 . . . . 0.0 109.419 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.449 ' HG2' HG22 ' A' ' 33' ' ' VAL . 88.1 mtp -113.92 130.72 56.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.959 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.3 117.17 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.578 0.549 . . . . 0.0 111.026 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.09 -24.18 33.33 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.236 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 2.8 mmp_? -97.08 -58.09 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.715 0.769 . . . . 0.0 110.253 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.71 -152.0 17.26 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.611 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 50' ' ' VAL . 49.0 mt-10 -84.14 117.28 23.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.252 0.526 . . . . 0.0 110.101 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.0 t -105.47 123.86 60.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.9 126.79 31.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.32 159.39 64.82 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.043 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.84 141.93 34.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.036 2.491 . . . . 0.0 111.68 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -67.43 128.33 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.454 0.645 . . . . 0.0 111.062 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.0 mtm -103.89 119.49 39.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.932 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -74.41 134.85 42.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.472 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -127.52 147.41 50.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 0.0 110.489 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HD2' HD21 ' A' ' 80' ' ' LEU . 21.2 ptmt -122.9 159.08 28.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.17 122.59 54.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.052 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.1 mt -90.11 -48.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.502 0.667 . . . . 0.0 109.248 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 m -144.12 156.23 44.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.57 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -149.43 130.56 14.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.363 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.2 t -173.24 160.67 4.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.804 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -84.95 -35.55 21.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.182 0.515 . . . . 0.0 109.992 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -100.27 -39.81 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.341 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.41 -3.04 88.52 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.683 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t 67.24 168.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.454 0.645 . . . . 0.0 111.374 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 26.7 mt -107.21 137.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.783 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.7 tt0 -122.83 128.54 50.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.409 HG13 ' HB3' ' A' ' 88' ' ' SER . 36.1 pt -122.3 158.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.506 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.641 ' CD ' ' HA ' ' A' ' 85' ' ' PRO . 33.0 tt0 -133.39 137.07 45.66 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 72.9 m-85 -80.42 150.45 29.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.457 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.569 HD21 ' HD2' ' A' ' 65' ' ' LYS . 97.2 mt -110.48 -173.09 2.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.892 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.75 -151.76 43.29 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.75 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 -17.03 39.38 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.212 1.942 . . . . 0.0 111.809 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.11 18.96 9.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.727 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 5.5 p90 -59.06 170.07 0.99 Allowed Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.249 0.343 . . . . 0.0 110.443 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 11.96 -0.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 1 C-N-CA 128.082 5.855 . . . . 0.0 121.405 -149.334 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.9 tp -66.97 115.98 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 119.631 1.105 . . . . 0.0 108.272 166.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 59.0 pttt -108.14 179.98 4.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.395 0.617 . . . . 0.0 112.31 -170.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB3' HG13 ' A' ' 77' ' ' ILE . 45.8 t -152.02 165.31 35.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.582 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.5 m -127.03 142.41 51.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.066 0.46 . . . . 0.0 111.215 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.9 mt -124.1 122.53 38.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.274 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 26.3 ttmt -133.35 158.49 42.87 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -173.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -89.42 153.17 21.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.17 0.509 . . . . 0.0 111.768 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.62 162.03 12.68 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.75 -10.39 53.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -130.47 51.12 2.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.765 0.317 . . . . 0.0 111.175 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.35 27.69 73.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.55 160.19 16.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.154 0.502 . . . . 0.0 112.071 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 19.6 tp -128.47 134.78 48.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 91' ' ' LYS . 72.8 mt -104.68 111.91 36.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.037 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.5 t90 -104.13 111.77 24.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.956 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 27.1 mt-10 -100.74 131.5 46.6 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.467 0.651 . . . . 0.0 110.369 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 16.9 tm0? -152.56 121.17 6.42 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.271 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 2.6 t-20 75.8 -53.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.95 0.781 . . . . 0.0 112.665 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.14 -25.07 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.207 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -120.19 152.76 37.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.857 0.829 . . . . 0.0 111.176 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 20.5 ptt180 -95.53 126.29 40.71 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 21.8 mmtp -88.25 127.21 35.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.911 0.386 . . . . 0.0 110.243 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.2 m -109.11 111.6 23.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -134.99 156.36 49.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.483 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 m -112.53 155.32 24.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.028 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.29 130.25 36.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.957 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.95 146.16 9.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.0 110.168 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 . . . . . 0 C--N 1.315 -0.921 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.894 -179.689 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 m . . . . . 0 CA--C 1.533 0.309 0 N-CA-C 112.086 0.402 . . . . 0.0 112.086 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.7 Cg_exo -75.79 110.88 3.17 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.939 2.426 . . . . 0.0 111.305 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -63.68 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.058 -174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -84.3 -13.22 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.779 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 17.2 t80 -78.5 138.16 38.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.67 -163.04 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.173 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 84.8 m -110.01 121.96 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.035 0.445 . . . . 0.0 110.511 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 80.8 m95 -106.41 144.41 33.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB2' HD11 ' A' ' 112' ' ' ILE . 22.6 t70 -104.34 120.34 40.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.51 48.44 1.55 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.783 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.49 47.13 2.65 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.568 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -162.5 144.24 10.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.92 164.16 0.13 Allowed Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 124.083 0.864 . . . . 0.0 111.328 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.56 135.54 49.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.681 2.254 . . . . 0.0 113.163 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.19 -154.12 8.69 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.525 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.49 124.49 9.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.617 2.878 . . . . 0.0 112.432 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -82.05 -7.86 59.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.786 -167.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.06 -32.58 62.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.093 0.473 . . . . 0.0 111.535 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.25 39.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.25 136.38 25.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.434 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.0 mmpt? -73.22 -41.01 64.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -161.69 160.4 28.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.162 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.99 135.4 54.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.9 p -117.29 125.91 51.86 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.95 127.72 75.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.2 m -105.82 124.69 49.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.49 118.84 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.36 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -100.38 179.56 4.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 167.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -68.52 -36.66 79.18 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.294 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -111.99 -11.67 13.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -135.01 145.81 48.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.491 0.662 . . . . 0.0 112.344 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' CD1' ' A' ' 64' ' ' TYR . 97.9 t -111.93 118.38 57.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.526 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.69 122.67 63.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.959 0.409 . . . . 0.0 109.977 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -107.26 133.02 52.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.808 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -124.31 134.27 53.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 30.1 mt-10 -100.22 125.24 46.36 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -88.01 110.1 20.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.21 121.64 43.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -170.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.88 115.94 4.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.52 10.14 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.098 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -111.44 -59.04 2.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.515 0.674 . . . . 0.0 109.972 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.93 -164.24 19.57 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.68 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.519 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.4 mp0 -69.65 126.64 30.34 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.589 0.709 . . . . 0.0 111.628 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.78 122.56 70.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.659 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.96 128.66 33.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.2 0.524 . . . . 0.0 111.993 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 75.6 mt -90.47 165.05 24.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.993 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.5 Cg_endo -57.54 130.47 39.1 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.724 2.283 . . . . 0.0 112.097 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -63.83 147.02 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.971 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -123.88 118.26 26.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.074 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.27 138.33 31.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.809 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.492 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.0 p90 -137.66 171.72 14.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.914 0.388 . . . . 0.0 110.388 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.702 ' HG3' HD11 ' A' ' 80' ' ' LEU . 80.7 mttt -130.01 154.44 47.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.266 0.555 . . . . 0.0 111.08 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.18 124.22 46.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.306 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.9 mt -88.55 -47.71 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 109.58 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -143.61 156.67 44.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.631 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -149.2 150.92 33.41 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -140.36 145.08 36.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.987 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -73.64 -25.94 60.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.494 0.664 . . . . 0.0 109.506 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -152.35 76.31 1.15 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.582 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.39 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.392 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 m -150.7 154.17 36.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.134 0.492 . . . . 0.0 110.683 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 14.3 mt -118.52 137.62 51.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -117.42 121.68 41.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.83 156.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.672 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 67' ' ' ILE . 15.6 tt0 -130.26 138.35 50.47 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -80.05 -0.93 37.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -165.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 65' ' ' LYS . 97.6 mt 50.74 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.363 0.415 . . . . 0.0 111.586 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.79 -151.35 49.32 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.716 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.02 -11.1 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.767 2.311 . . . . 0.0 111.987 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.18 30.57 6.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.002 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.492 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 15.4 p90 -80.67 -15.71 0.23 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.181 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 87.3 Cg_endo -92.19 -3.82 3.83 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 CA-C-N 120.867 1.345 . . . . 0.0 112.929 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.47 113.73 25.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.0 0.428 . . . . 0.0 110.021 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 62.2 pttt -111.57 164.41 13.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 102' ' ' GLN . 21.8 t -134.01 155.67 49.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.812 -175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.8 m -112.74 140.81 47.21 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.084 0.469 . . . . 0.0 110.508 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 98.3 mt -124.44 124.59 42.65 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.698 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 39.2 mtpt -135.53 155.19 50.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.2 ptt85 -86.72 161.09 18.6 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.38 39.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -90.69 -10.94 41.26 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -155.65 93.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 111.544 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.71 40.93 42.01 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.657 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.92 159.88 40.82 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.469 0.176 . . . . 0.0 110.859 -175.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -123.89 135.21 53.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 25.8 mm -103.84 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.585 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 7.5 t90 -108.46 113.78 27.1 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 31.9 mt-10 -106.19 129.29 54.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.263 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.467 ' HG3' ' HB2' ' A' ' 88' ' ' SER . 7.0 tt0 -153.35 134.08 13.79 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.115 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 59.46 18.16 6.64 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.307 0.38 . . . . 0.0 111.834 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.01 -13.07 60.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.49 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 41.2 mt-30 -92.81 134.99 34.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.055 0.455 . . . . 0.0 111.133 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -101.44 115.8 31.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.09 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -111.16 141.01 45.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.598 0.237 . . . . 0.0 111.299 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -119.06 115.34 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.585 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -114.83 165.32 12.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.349 0.595 . . . . 0.0 111.553 -177.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -102.21 163.07 12.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.162 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 42.4 ttp180 -106.36 134.86 48.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.4 mm -81.87 155.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.668 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 . . . . . 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 110.564 -179.167 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 18.4 m . . . . . 0 CA--C 1.534 0.333 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.93 122.24 11.28 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.919 2.413 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.34 -26.71 68.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -92.76 -10.43 37.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.055 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.5 -164.59 23.47 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.325 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.4 m -112.41 127.75 56.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.925 0.393 . . . . 0.0 110.145 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -117.42 151.41 37.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' HD11 ' A' ' 112' ' ' ILE . 13.8 t70 -89.52 130.92 35.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 4.2 mm-40 -52.85 -53.55 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.726 0.641 . . . . 0.0 112.376 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.04 35.17 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.51 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.5 tpp180 -99.41 149.33 23.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.58 79.07 21.73 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.3 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 25' ' ' ARG . 96.7 Cg_endo -99.91 -164.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.741 2.96 . . . . 0.0 110.927 174.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.35 173.79 33.08 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.912 171.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.1 132.51 16.79 Favored 'Trans proline' 0 C--N 1.324 -0.721 0 C-N-CA 122.989 2.459 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 p -86.03 6.74 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 t0 69.2 84.03 0.15 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.566 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.68 -38.02 2.07 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.63 138.54 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.676 0.274 . . . . 0.0 110.431 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HE3' ' HB2' ' A' ' 52' ' ' GLU . 95.8 mttt -91.17 -38.89 12.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.486 0.66 . . . . 0.0 110.201 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -167.75 171.8 9.74 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.65 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -135.55 164.5 27.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.079 0.466 . . . . 0.0 111.647 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 p -127.95 157.18 41.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.2 125.7 74.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.288 0.565 . . . . 0.0 111.02 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -108.33 122.4 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -101.14 117.67 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -101.61 176.32 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.531 ' H ' HG22 ' A' ' 41' ' ' THR . 44.7 mt-10 -62.56 -39.66 94.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.69 -3.35 5.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.849 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.99 157.5 45.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.224 0.535 . . . . 0.0 111.646 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.09 133.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.69 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.76 124.33 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.495 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HB2' HD12 ' A' ' 59' ' ' LEU . 17.8 mt-10 -98.79 137.41 37.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.264 0.554 . . . . 0.0 110.947 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.09 120.26 35.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.808 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.87 131.9 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.369 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 56' ' ' GLU . 39.9 t -89.48 113.6 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.297 0.57 . . . . 0.0 110.665 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.0 mtt -116.07 135.53 53.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.723 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 34.4 tt0 -70.66 128.91 37.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.99 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 -27.32 7.36 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.343 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -93.21 -62.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.665 0.745 . . . . 0.0 109.997 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.14 -155.26 19.78 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.299 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.3 mt-10 -87.71 129.09 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.374 0.607 . . . . 0.0 110.162 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.8 t -104.38 122.61 57.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.94 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 69.7 mt-30 -91.87 130.4 37.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.019 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 47' ' ' GLU . 94.8 mt -85.31 154.66 60.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -50.23 143.08 26.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.109 2.539 . . . . 0.0 112.524 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -59.87 119.02 6.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.7 mtm -109.79 121.78 46.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.218 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 149.36 39.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.531 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.21 159.91 36.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.84 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HD2' HD21 ' A' ' 80' ' ' LEU . 20.4 ptmt -121.69 144.31 48.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.029 0.442 . . . . 0.0 109.846 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.78 115.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.806 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.5 mt -93.6 -51.86 10.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.898 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -124.92 154.61 40.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.717 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -149.19 147.74 28.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -148.74 146.27 28.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.3 p -73.48 -24.19 60.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.375 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -161.29 78.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.91 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.87 -84.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.978 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 m -145.41 148.89 33.83 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.096 0.474 . . . . 0.0 110.644 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.23 132.35 66.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -114.76 124.17 51.09 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.72 149.21 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 32.4 tt0 -124.36 136.76 54.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 70.0 m-85 -77.11 157.45 31.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.281 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.572 HD21 ' HD2' ' A' ' 65' ' ' LYS . 90.6 mt -121.11 166.48 13.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.977 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.41 -152.19 17.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.977 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.69 -9.85 15.04 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -122.98 57.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 37.3 p90 -85.21 -27.68 0.39 Allowed Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.071 -171.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 10.3 Cg_endo -89.31 -3.57 5.95 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 CA-C-N 121.089 1.425 . . . . 0.0 112.701 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.9 tp -89.21 117.25 28.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 64.1 pttt -113.76 162.43 16.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.942 0.401 . . . . 0.0 110.955 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.77 160.26 34.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.9 m -115.7 139.24 50.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 98' ' ' LEU . 96.1 mt -124.1 124.33 42.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -132.33 152.86 51.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.496 . . . . 0.0 111.018 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -69.46 151.18 46.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.807 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.45 152.2 18.28 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.89 145.16 56.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.688 0.28 . . . . 0.0 111.259 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 66.47 20.48 10.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.553 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.47 4.21 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.072 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 p -117.16 173.8 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 90' ' ' LEU . 49.4 tp -127.7 135.94 50.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.251 0.548 . . . . 0.0 111.345 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.4 mt -108.8 111.06 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.5 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.78 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.2 t90 -105.41 117.97 35.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.322 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.4 mt-10 -102.48 132.75 48.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.528 0.68 . . . . 0.0 110.113 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.447 ' CD ' HD22 ' A' ' 103' ' ' ASN . 1.4 tm0? -151.24 123.94 8.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.128 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.447 HD22 ' CD ' ' A' ' 102' ' ' GLN . 24.9 m-80 62.02 22.44 13.08 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.729 0.643 . . . . 0.0 111.26 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.39 -8.35 69.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.98 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -93.1 134.06 35.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.992 0.396 . . . . 0.0 110.064 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -101.18 127.66 47.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.103 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 5.0 mmpt? -127.51 139.58 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.169 0.509 . . . . 0.0 111.657 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 m -106.58 114.11 28.02 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.995 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.78 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 12.4 ptp -119.37 148.4 43.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.644 -172.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -98.15 152.78 18.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -84.67 123.89 30.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -74.13 154.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 . . . . . 0 C--N 1.326 -0.451 0 CA-C-O 121.128 0.49 . . . . 0.0 109.98 179.282 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.412 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.1 m . . . . . 0 CA--C 1.536 0.436 0 N-CA-C 112.29 0.478 . . . . 0.0 112.29 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 39.2 Cg_exo -56.85 121.26 9.75 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.629 2.219 . . . . 0.0 111.684 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -69.86 -15.25 63.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.993 -172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -98.15 -5.67 33.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 28.0 t80 -85.53 136.37 33.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 0.0 111.036 -171.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.18 -143.25 14.82 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.029 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m -127.88 126.39 41.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 87.2 m95 -117.92 138.81 51.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.139 0.495 . . . . 0.0 111.486 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 4.4 t70 -83.55 126.47 32.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.498 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.446 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 44.2 mt-10 -90.71 72.72 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.65 -15.94 60.86 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.257 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -100.45 142.75 31.49 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 70.71 145.24 0.11 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.562 1.164 . . . . 0.0 111.3 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 14.5 Cg_exo -69.69 148.78 66.28 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.702 2.268 . . . . 0.0 112.501 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.4 -160.9 36.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.048 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.552 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.9 Cg_endo -62.98 152.58 78.62 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.711 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 p -78.67 3.76 15.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.736 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.39 -11.22 60.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.287 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 111.69 47.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.718 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' HG2' ' A' ' 29' ' ' PRO . 17.1 t -105.84 135.12 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.672 0.272 . . . . 0.0 110.28 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.08 -42.44 47.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.624 . . . . 0.0 111.024 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -166.14 163.17 18.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.534 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.12 36.98 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.78 141.14 51.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.54 129.76 70.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.333 0.587 . . . . 0.0 110.578 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 35.1 m -111.95 119.48 38.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.305 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -102.17 121.19 41.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.799 0.333 . . . . 0.0 111.225 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 1.7 m -101.83 173.9 6.19 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.474 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 mp0 -53.04 -46.56 68.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -129.8 8.09 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 45.0 mt-10 -121.77 135.4 54.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.562 -175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 64' ' ' TYR . 87.2 t -107.97 118.07 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 52.8 t -109.96 123.12 65.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 15.6 mt-10 -97.27 132.47 42.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.53 0.681 . . . . 0.0 111.066 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -127.85 118.25 23.33 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.1 177.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' OE2' ' HG3' ' A' ' 29' ' ' PRO . 27.6 mt-10 -109.0 126.66 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.302 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.88 111.65 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.247 0.546 . . . . 0.0 110.043 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 32' ' ' GLY . 39.1 ttm -118.92 125.95 50.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.515 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.03 127.17 30.5 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.012 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.6 -28.79 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.655 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -125.77 -34.73 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.178 0.513 . . . . 0.0 111.289 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.42 -140.73 15.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.251 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.63 138.56 50.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.23 0.538 . . . . 0.0 111.209 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 48' ' ' THR . 80.0 t -128.72 121.38 54.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.097 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -82.16 130.52 35.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 76.3 mt -95.84 159.69 31.82 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.651 171.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.08 117.39 3.85 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.79 2.327 . . . . 0.0 111.601 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -61.62 127.29 30.75 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.529 0.681 . . . . 0.0 111.475 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 42.5 ttm -95.2 144.36 25.87 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.556 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.97 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 110.471 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 45' ' ' VAL . 15.7 p90 -138.08 163.07 32.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.067 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.585 ' HE3' HG12 ' A' ' 67' ' ' ILE . 49.7 pttt -122.61 152.82 40.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.962 0.41 . . . . 0.0 110.117 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.63 112.95 37.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.032 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.585 HG12 ' HE3' ' A' ' 65' ' ' LYS . 11.5 mt -83.95 -53.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.287 0.565 . . . . 0.0 109.871 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 m -127.1 151.58 48.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.11 146.86 27.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -137.2 153.8 50.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.1 m -79.37 -30.02 42.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -152.76 80.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.131 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.32 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.671 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 p -148.68 154.71 40.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.173 0.511 . . . . 0.0 110.994 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 31.9 mt -128.35 130.99 69.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.001 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.81 124.13 51.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.32 157.68 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.765 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 47.4 tt0 -132.69 135.93 46.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -74.72 144.37 43.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 -179.7 3.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.759 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.67 -151.53 34.24 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.582 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 -10.15 21.35 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.718 2.278 . . . . 0.0 112.313 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -99.5 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.693 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.839 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 1.6 p90 -60.1 -179.31 0.17 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.371 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.839 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER 12.76 -0.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.258 1 C-N-CA 127.75 5.633 . . . . 0.0 121.343 -149.375 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' TYR . 63.0 tp -71.66 113.52 8.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 119.905 1.229 . . . . 0.0 109.759 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 94.7 mttt -91.44 170.82 9.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.418 0.628 . . . . 0.0 111.643 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -151.75 152.45 32.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.35 171.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.2 m -118.07 141.78 48.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.32 0.581 . . . . 0.0 111.31 -173.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 80.9 mt -121.12 124.65 45.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.641 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 51.9 mtpt -132.59 156.91 46.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 111.669 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -65.59 144.2 57.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.598 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.81 -168.53 25.3 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.926 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.7 -41.43 13.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.336 0.589 . . . . 0.0 111.674 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.84 18.37 21.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.191 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.66 26.36 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 p -106.0 175.67 5.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.341 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 90' ' ' LEU . 59.5 tp -105.55 128.4 53.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 34.0 mm -96.97 109.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 16.6 t90 -103.25 112.76 25.78 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.703 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.3 mt-10 -104.47 131.19 52.12 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.69 0.757 . . . . 0.0 109.853 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -151.15 120.29 6.74 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.314 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 61.56 23.2 13.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -8.79 70.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.748 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.2 142.23 27.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -93.68 115.76 28.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 71.3 mttt -106.33 115.56 30.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.444 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.0 m -92.93 118.05 30.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.599 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 10.3 mmt -99.42 139.09 35.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -95.12 143.51 26.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.107 0.479 . . . . 0.0 110.286 -177.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -79.24 128.94 33.94 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 22' ' ' ASP . 26.8 mm -75.99 142.85 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.337 0.589 . . . . 0.0 109.486 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 . . . . . 0 C--N 1.308 -1.199 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.059 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 15.0 m . . . . . 0 CA--C 1.532 0.274 0 CA-C-O 120.828 0.347 . . . . 0.0 111.773 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.723 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.2 Cg_exo -67.45 104.13 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.816 2.344 . . . . 0.0 111.656 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.45 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 40.6 p90 -57.65 -34.27 69.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.987 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 50.1 p90 -78.93 -9.62 59.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 2.1 t80 -80.82 23.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.331 0.586 . . . . 0.0 111.364 -172.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.61 -177.78 18.49 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.095 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 m -99.23 116.86 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.45 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 50.6 m95 -114.05 132.32 56.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.465 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.28 129.99 45.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 36.6 mt-10 -62.25 -55.63 26.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.43 27.55 73.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.107 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.7 144.68 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.6 160.71 0.13 Allowed Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 124.388 1.055 . . . . 0.0 112.086 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.85 153.6 72.54 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.686 2.258 . . . . 0.0 111.516 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.03 -169.66 46.07 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.964 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 64.2 Cg_exo -50.66 162.89 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 124.466 3.444 . . . . 0.0 113.879 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 p -69.34 -9.42 53.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.59 -10.13 59.18 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.012 -0.43 . . . . 0.0 111.106 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.7 27.67 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.547 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.616 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 21.4 t -74.06 134.67 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.262 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -81.14 -32.67 33.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 m -158.73 160.34 36.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.506 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.01 137.01 46.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.142 0.496 . . . . 0.0 111.092 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 24.6 p -118.39 136.86 53.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.259 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.78 134.14 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.179 0.514 . . . . 0.0 110.671 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -123.3 128.31 49.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.701 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 97.0 m-85 -102.06 116.79 33.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.128 0.489 . . . . 0.0 110.546 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.524 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -103.04 -178.16 3.58 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.78 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -46.01 -64.2 0.8 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.17 10.29 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.772 0.796 . . . . 0.0 110.16 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.524 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -137.98 145.83 42.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.181 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' A' ' 64' ' ' TYR . 90.0 t -101.36 132.3 47.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.19 123.16 67.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.828 0.347 . . . . 0.0 110.159 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -103.78 138.31 40.56 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.435 0.636 . . . . 0.0 110.279 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.45 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -124.23 122.13 36.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.182 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.59 120.03 39.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.797 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 56' ' ' GLU . 33.2 t -87.98 112.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.6 127.57 55.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.16 132.12 49.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.67 0.606 . . . . 0.0 111.517 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.4 3.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.07 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -93.9 -63.96 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.14 -157.02 21.05 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.376 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.8 mp0 -74.98 129.61 37.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.38 0.61 . . . . 0.0 110.843 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.84 122.58 66.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.708 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -84.76 131.63 34.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.872 0.368 . . . . 0.0 111.917 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.69 164.89 30.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.543 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.83 152.33 36.1 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.876 2.384 . . . . 0.0 112.44 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.77 114.66 10.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 110.693 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.7 mtp -96.62 118.38 32.99 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.544 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -75.98 140.85 42.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.969 0.414 . . . . 0.0 111.66 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CD1' HG23 ' A' ' 45' ' ' VAL . 8.9 p90 -145.94 150.11 35.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -132.93 151.56 52.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.486 0.66 . . . . 0.0 111.243 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.87 128.94 38.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.846 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 36.7 mt -90.94 -52.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.177 175.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.6 m -138.48 156.95 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.196 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.9 tt0 -147.54 152.85 38.67 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -174.131 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.2 t -157.89 135.48 10.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 120.819 0.343 . . . . 0.0 111.156 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -11.94 59.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.1 -39.15 89.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.067 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.08 36.78 0.15 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.21 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 m -149.84 136.49 19.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 117.573 0.686 . . . . 0.0 110.736 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 18.6 mt -136.24 137.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.98 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -114.09 129.06 56.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 32.7 pt -131.45 157.43 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.858 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.896 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 6.2 tp-100 -124.28 147.05 48.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -96.48 151.05 19.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 63' ' ' ALA . 38.1 mt -107.74 156.13 19.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.154 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -154.42 21.75 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.24 -4.76 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.765 2.31 . . . . 0.0 112.618 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -97.67 11.45 37.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.988 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -65.35 176.71 0.79 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.948 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.988 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 20.0 Cg_exo 5.06 -1.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 1 C-N-CA 128.425 6.084 . . . . 0.0 121.872 -148.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' TYR . 51.2 tp -90.19 102.94 15.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 120.299 1.409 . . . . 0.0 108.057 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 20.4 pttp -115.39 178.66 4.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 0.0 112.352 -166.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.425 ' CB ' ' HE1' ' A' ' 100' ' ' TRP . 2.6 m -133.27 165.6 24.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -123.86 142.16 51.38 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.443 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 93.7 mt -117.92 124.6 48.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.365 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -137.51 154.98 49.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.955 0.407 . . . . 0.0 110.991 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -65.12 143.72 57.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.253 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.01 132.97 10.14 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 42.3 mt-10 -68.59 158.43 34.0 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.899 -0.177 . . . . 0.0 110.568 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 12.9 m120 75.51 -7.42 1.79 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.74 0.816 . . . . 0.0 110.784 -174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.53 0.9 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.873 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.4 p -131.16 174.24 10.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.748 0.309 . . . . 0.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.82 133.18 54.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.884 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.16 110.2 30.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.231 0.539 . . . . 0.0 109.87 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.453 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.9 t90 -104.97 114.13 28.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.788 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.9 134.71 43.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.266 0.555 . . . . 0.0 109.687 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -148.79 111.77 4.87 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.748 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.59 31.71 20.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.82 0.819 . . . . 0.0 110.698 166.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.44 -17.17 55.85 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.941 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -92.04 136.29 33.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.968 0.384 . . . . 0.0 110.839 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 106' ' ' ARG . 23.2 ttt180 -99.94 114.97 28.6 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -109.7 136.25 49.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.595 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -120.93 114.13 21.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.856 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.453 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -118.22 151.49 37.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -109.36 151.72 26.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -87.92 135.74 33.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.298 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.78 147.58 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.616 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 . . . . . 0 C--N 1.318 -0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.557 -174.774 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HD2' ' A' ' 15' ' ' PRO . 14.7 m . . . . . 0 N--CA 1.45 -0.449 0 CA-C-O 121.231 0.538 . . . . 0.0 111.856 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 14' ' ' THR . 6.1 Cg_endo -49.45 120.13 5.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.725 2.95 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -69.53 -14.24 62.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.468 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -98.03 -11.54 22.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.498 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -86.05 135.71 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.93 -168.24 22.5 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.984 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.7 m -104.08 129.93 51.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -120.44 135.8 54.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.016 0.436 . . . . 0.0 111.039 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.74 139.09 31.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.027 174.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 37.5 mt-10 -50.31 -43.83 53.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.21 -56.81 2.8 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.187 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 -105.7 141.24 37.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 65.81 142.77 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.637 1.211 . . . . 0.0 112.054 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.1 Cg_exo -81.44 171.09 13.96 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.251 2.634 . . . . 0.0 112.571 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.91 -154.97 30.34 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.313 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.51 ' O ' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -61.89 -31.06 84.72 Favored 'Trans proline' 0 C--O 1.23 0.098 0 C-N-CA 123.315 2.676 . . . . 0.0 113.597 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 83.2 m 75.6 -21.14 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.748 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -51.13 -54.7 22.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.398 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.36 -43.07 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.002 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.35 134.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.72 -32.47 14.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 m -167.88 165.41 13.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.943 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -121.97 148.06 45.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.096 0.474 . . . . 0.0 111.055 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 p -118.11 139.48 51.18 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.54 137.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.162 0.506 . . . . 0.0 111.19 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -119.41 127.84 53.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.901 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -101.69 125.64 48.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 111.425 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -101.36 178.97 4.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 41' ' ' THR . 36.5 mt-10 -55.03 -42.1 72.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -141.29 19.55 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 110.821 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.8 mt-10 -129.06 145.16 51.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 62' ' ' MET . 92.5 t -117.14 121.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.07 124.02 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -111.8 128.78 56.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -111.62 125.18 53.67 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.485 177.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.19 128.08 45.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 56' ' ' GLU . 43.6 t -92.31 112.61 26.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 0.0 110.359 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -112.3 161.56 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.433 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.0 123.96 26.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 110.759 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 -10.93 44.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.592 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -98.71 -68.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 50' ' ' VAL . . . 125.66 -142.59 13.86 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.613 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HG2' HG22 ' A' ' 50' ' ' VAL . 53.1 mt-10 -95.65 120.61 36.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.291 0.567 . . . . 0.0 110.644 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' THR . 73.9 t -104.68 124.89 59.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.694 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -88.13 119.57 28.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.629 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.6 mt -81.09 163.64 54.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.806 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.4 Cg_endo -62.25 146.4 95.89 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.792 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -64.04 131.01 46.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 111.075 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 50.8 mtt -97.43 118.19 33.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.838 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.83 127.71 32.83 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 45' ' ' VAL . 45.6 p90 -129.18 171.81 12.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.959 0.409 . . . . 0.0 111.332 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HE3' HD21 ' A' ' 80' ' ' LEU . 99.0 mttt -120.71 159.73 24.77 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.253 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -103.72 120.97 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.781 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 78' ' ' GLN . 19.9 mt -87.55 -54.0 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.233 0.539 . . . . 0.0 109.813 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -136.46 153.19 51.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.144 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.74 124.39 11.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.455 0.645 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 74' ' ' SER . 35.5 t -108.85 -22.55 12.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.124 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 m 73.77 -38.71 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.851 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.53 -59.41 1.75 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.756 0.312 . . . . 0.0 111.435 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.64 -60.52 2.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.176 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.498 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 30.5 t -154.0 164.84 37.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.407 0.622 . . . . 0.0 111.598 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.55 136.4 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.456 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 67' ' ' ILE . 27.2 tt0 -115.09 131.01 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.739 0.304 . . . . 0.0 110.37 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.64 158.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.136 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.606 ' HB2' HD11 ' A' ' 67' ' ' ILE . 61.8 tt0 -131.84 140.85 49.26 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 58.4 m-85 -86.41 179.42 6.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.568 HD21 ' HE3' ' A' ' 65' ' ' LYS . 90.0 mt -134.87 -176.21 4.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.324 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.65 -152.98 30.98 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HG2' ' CE2' ' A' ' 83' ' ' TYR . 28.0 Cg_endo -65.44 -7.35 15.75 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.215 1.944 . . . . 0.0 112.047 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.529 ' CE2' ' HG2' ' A' ' 82' ' ' PRO . 24.8 m-85 -114.16 34.78 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.1 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 19.6 p90 -85.33 -27.35 0.38 Allowed Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 84.2 Cg_endo -83.32 -4.44 11.0 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.439 1.55 . . . . 0.0 112.922 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.88 133.22 44.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.333 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 22.9 pttp -111.49 168.72 9.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.117 0.484 . . . . 0.0 111.181 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 156.47 46.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.315 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -124.58 142.13 51.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.83 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 98' ' ' LEU . 97.6 mt -120.39 124.19 44.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.567 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 32.8 mtmm -124.26 161.56 25.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.39 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.39 144.91 33.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.011 0.434 . . . . 0.0 110.396 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.64 171.09 23.65 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.507 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.18 -19.9 60.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.097 -0.551 . . . . 0.0 111.944 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -121.41 29.66 7.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 -173.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.05 39.7 62.92 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -116.63 174.91 5.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.451 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 90' ' ' LEU . 39.1 tp -113.23 131.78 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.89 111.44 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.866 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -97.0 112.89 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.827 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -110.81 132.63 54.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -150.69 128.25 11.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.092 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.66 17.12 9.47 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.6 64.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.82 134.3 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.435 ' NH2' ' HE3' ' A' ' 91' ' ' LYS . 96.4 mtt180 -101.39 123.92 46.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 19.3 mmtp -106.99 125.7 51.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.953 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -97.66 113.2 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.38 155.46 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.856 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.11 150.42 20.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.835 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 3.0 ptt180 -95.78 139.82 31.46 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mm -95.87 155.48 3.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.864 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--N 1.323 -0.573 0 CA-C-O 121.902 0.858 . . . . 0.0 109.769 177.811 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.818 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 29.3 m . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.217 0.451 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 16.1 Cg_exo -68.82 90.47 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.192 1.928 . . . . 0.0 112.169 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -75.7 -9.15 58.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.01 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -84.41 -11.68 55.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 15' ' ' PRO . 10.5 m-85 -72.68 151.08 42.43 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.71 -167.07 12.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.388 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.3 m -110.55 128.07 55.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 110.501 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.439 ' CZ3' ' HB3' ' A' ' 111' ' ' ARG . 64.1 m95 -113.36 128.6 56.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.0 t70 -88.21 120.69 29.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.16 76.1 2.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.348 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.23 40.4 2.47 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -128.04 144.49 51.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.43 156.75 0.16 Allowed Pre-proline 0 N--CA 1.465 0.311 0 O-C-N 124.213 0.946 . . . . 0.0 111.756 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.74 134.51 50.94 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.455 2.104 . . . . 0.0 111.857 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.9 -174.85 34.98 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.229 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.607 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 18.2 Cg_endo -59.76 128.4 26.78 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.159 2.573 . . . . 0.0 112.75 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -67.86 -10.38 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.347 0.594 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.88 -33.17 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.561 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.57 -27.96 0.54 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.221 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.607 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 5.8 t -82.59 133.35 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -91.48 -31.08 16.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.092 0.473 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 m -160.2 165.09 32.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.613 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.78 154.85 51.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.012 0.434 . . . . 0.0 111.292 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 22' ' ' ASP . 5.7 p -123.18 130.44 52.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.407 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.39 130.39 66.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.058 0.456 . . . . 0.0 110.572 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.2 m -114.78 127.09 55.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.774 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.83 117.64 35.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.17 0.51 . . . . 0.0 110.2 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -101.11 179.18 4.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.543 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.506 ' H ' HG22 ' A' ' 41' ' ' THR . 29.9 mt-10 -52.84 -64.13 0.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -119.18 14.49 13.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 111.698 -174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.49 148.62 34.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.91 0.386 . . . . 0.0 111.019 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 64' ' ' TYR . 98.0 t -110.19 119.45 59.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.526 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.8 123.35 53.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.991 0.424 . . . . 0.0 110.426 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.22 137.24 38.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.368 0.604 . . . . 0.0 110.75 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.03 122.26 31.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.867 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -99.67 135.89 40.41 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.53 112.08 23.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.6 mmm -110.47 124.94 52.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.043 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.56 113.88 2.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.976 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 -26.83 23.15 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.4 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -96.23 -55.03 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.598 0.713 . . . . 0.0 109.813 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.19 -156.64 15.64 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.496 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.99 126.74 30.52 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.279 0.561 . . . . 0.0 110.564 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.88 122.59 68.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -81.81 128.45 34.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.2 mt -93.75 165.45 17.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.489 173.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.0 Cg_endo -58.45 128.4 28.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.297 1.998 . . . . 0.0 111.432 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -66.89 122.9 18.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.75 0.786 . . . . 0.0 111.231 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 40.2 ttm -80.39 127.87 32.9 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.18 135.76 41.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CD1' HG23 ' A' ' 45' ' ' VAL . 6.2 p90 -147.09 157.93 43.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -123.68 136.64 54.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.169 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 77' ' ' ILE . 78.9 t -75.7 122.94 30.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.882 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 78' ' ' GLN . 27.4 mt -83.9 -54.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.4 m -140.78 156.47 46.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.7 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.67 126.39 11.81 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.161 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -161.94 156.26 22.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.056 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 m -82.17 -26.87 33.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.125 0.488 . . . . 0.0 110.107 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.7 -29.89 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.76 0.81 89.23 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p 60.96 -178.54 0.11 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.97 1.308 . . . . 0.0 112.222 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 11.3 mt -108.13 130.59 60.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.134 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -126.38 128.49 47.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' VAL . 29.4 pt -131.01 155.86 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.996 0.426 . . . . 0.0 111.198 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.758 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 5.6 tp-100 -123.68 146.22 48.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.205 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 41.4 m-85 -98.45 151.05 21.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.873 0.368 . . . . 0.0 110.365 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.4 mt -113.82 164.51 13.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.7 -151.28 23.05 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.513 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.68 -6.91 11.54 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.974 2.449 . . . . 0.0 112.627 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 13.07 30.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -60.45 174.22 0.53 Allowed Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.106 -173.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 44.5 Cg_exo 5.18 -0.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 128.847 6.365 . . . . 0.0 121.944 -148.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 84' ' ' TYR . 49.0 tp -78.12 103.04 7.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 120.086 1.312 . . . . 0.0 108.095 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 61.4 pttt -95.7 -176.8 3.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -166.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 77' ' ' ILE . 40.6 t -141.69 159.32 42.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.235 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.8 m -137.17 144.71 43.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.507 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 87.2 mt -126.59 124.65 40.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.546 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 98' ' ' LEU . 62.3 mttp -123.17 167.0 14.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -79.82 149.52 31.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.952 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.518 ' HA3' ' HB ' ' A' ' 97' ' ' THR . . . -116.24 137.66 13.85 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -41.41 74.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.32 25.78 2.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.453 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.04 39.02 13.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.27 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -107.63 171.91 7.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.362 -0.419 . . . . 0.0 109.886 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 91' ' ' LYS . 34.3 tp -128.8 131.08 47.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.78 112.81 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.446 ' HA ' HD23 ' A' ' 90' ' ' LEU . 20.7 t90 -96.54 112.65 24.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 36.3 mt-10 -104.64 130.04 52.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.458 0.647 . . . . 0.0 110.031 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 19.7 tm0? -153.78 134.74 13.87 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.798 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.9 OUTLIER 66.55 13.33 9.25 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.323 0.39 . . . . 0.0 111.525 173.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.28 71.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.073 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.31 142.69 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.554 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 58.7 mtt180 -99.51 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.168 0.508 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 29.7 mmmt -101.7 141.4 34.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.556 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 m -119.24 112.68 19.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HE3' HD23 ' A' ' 98' ' ' LEU . 23.6 ptt? -126.37 141.57 51.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.755 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.7 m -98.94 154.46 18.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.435 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 21' ' ' TRP . 20.3 ptt180 -88.11 157.72 18.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.054 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.7 mm -95.76 147.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 . . . . . 0 C--N 1.312 -1.036 0 CA-C-O 121.268 0.556 . . . . 0.0 111.435 -172.114 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 CA--C 1.535 0.402 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.2 124.63 14.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.277 2.651 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -64.78 -27.88 69.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.139 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -83.8 -6.45 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.249 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -71.75 137.11 47.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 109.996 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.03 -149.73 17.42 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.931 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.8 m -127.09 132.37 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.545 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -120.69 150.87 40.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.237 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 112' ' ' ILE . 7.0 t0 -107.23 127.85 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.13 -18.89 41.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.848 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 -56.02 1.07 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 40.0 ttm180 -170.44 149.8 3.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.29 155.86 50.12 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.732 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.23 134.35 33.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.609 2.206 . . . . 0.0 111.019 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.25 -153.22 7.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.667 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.21 138.68 72.29 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.059 2.506 . . . . 0.0 112.05 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -80.3 16.16 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.494 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.72 -31.1 41.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.036 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.99 95.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.987 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -103.62 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -87.01 -37.04 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.153 0.501 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ARG . 51.6 m -159.92 163.69 34.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.923 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.24 130.99 50.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 p -123.8 130.79 53.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.7 127.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.252 0.549 . . . . 0.0 110.484 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 88.8 m -108.41 129.46 55.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.43 117.48 35.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.144 0.497 . . . . 0.0 110.508 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.5 m -102.29 -179.62 4.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.814 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 41' ' ' THR . 29.1 mm-40 -44.3 -66.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.502 0.721 . . . . 0.0 112.609 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -126.08 9.52 7.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 111.205 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -133.3 143.26 48.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.408 0.623 . . . . 0.0 111.411 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.92 128.31 48.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.809 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 45.7 t -104.29 123.46 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.157 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.3 mt-10 -95.2 129.13 42.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.446 0.641 . . . . 0.0 110.655 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.16 116.42 19.9 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.019 176.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.33 135.82 44.25 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.66 110.77 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.541 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 91.4 mtp -116.92 134.86 54.23 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.872 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.6 116.58 10.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.857 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -11.71 66.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.49 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 4.5 mmp_? -106.86 -59.41 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.183 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.84 -165.03 12.16 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.543 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -75.73 127.59 33.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.433 0.635 . . . . 0.0 110.523 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' THR . 79.4 t -115.91 121.84 68.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.158 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.58 122.43 32.03 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.844 0.354 . . . . 0.0 110.209 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 74.4 mt -91.13 164.85 23.54 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.554 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 11.7 Cg_endo -57.45 134.48 63.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.589 2.193 . . . . 0.0 111.655 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 46' ' ' VAL . 55.9 m-85 -58.86 132.14 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.346 -174.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.584 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 7.1 mmt -98.94 119.89 38.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 133.55 41.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.431 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -130.24 159.41 36.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 110.912 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 80' ' ' LEU . 50.1 mttm -122.82 158.2 30.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.614 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.59 112.86 38.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.131 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 78' ' ' GLN . 16.4 mt -83.05 -54.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.594 0.711 . . . . 0.0 109.702 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -142.36 150.74 41.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.585 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 71' ' ' THR . 8.9 tt0 -150.28 132.55 15.47 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.612 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 74' ' ' SER . 17.4 t -93.72 -21.24 19.46 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.492 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 26.6 m 75.15 -35.4 0.28 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.782 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.83 -7.0 22.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.694 ' HA3' HH11 ' A' ' 92' ' ' ARG . . . -158.87 -51.76 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.145 -1.502 . . . . 0.0 114.219 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 70' ' ' SER . 2.8 p -118.73 143.03 47.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.261 0.553 . . . . 0.0 112.466 -173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 69' ' ' GLN . 22.4 mt -136.64 137.6 47.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.432 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -118.91 124.58 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 30.2 pt -126.82 155.2 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.384 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.629 ' HB2' HD11 ' A' ' 67' ' ' ILE . 36.1 tt0 -124.45 146.93 48.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 21.1 m-85 -86.35 152.99 22.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.726 0.298 . . . . 0.0 110.487 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 65' ' ' LYS . 98.1 mt -114.26 163.72 14.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.31 -152.27 21.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.503 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.34 -8.57 12.87 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.965 2.444 . . . . 0.0 112.665 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 49.0 m-85 -104.75 18.67 21.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.858 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 2.2 p90 -55.71 169.63 0.49 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -176.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.858 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 9.28 -0.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 1 C-N-CA 128.734 6.289 . . . . 0.0 121.418 -150.983 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 87' ' ' LYS . 2.7 tm? -73.66 146.3 44.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 86' ' ' LEU . 65.9 pttt -144.17 173.1 12.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.644 0.735 . . . . 0.0 112.793 -167.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 m -132.69 159.42 39.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.029 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.3 m -130.26 142.82 50.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.5 mt -121.74 124.73 44.91 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 46.5 mmtm -114.59 170.03 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.694 HH11 ' HA3' ' A' ' 73' ' ' GLY . 27.7 ptt-85 -92.71 145.02 24.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.425 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -104.75 138.69 14.29 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.78 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.11 -35.91 76.28 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.091 0.556 . . . . 0.0 112.077 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -95.89 24.74 5.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.312 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.24 42.24 24.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.383 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.425 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 18.0 p -121.0 173.94 6.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.649 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 tp -120.39 131.33 54.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 63.8 mt -99.12 112.98 32.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.736 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 10.0 t90 -99.98 115.56 29.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.381 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 26.0 mt-10 -97.67 129.64 44.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -152.8 124.26 7.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.317 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 67.26 -7.46 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.44 0.463 . . . . 0.0 112.172 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.45 9.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.773 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.54 136.97 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.568 0.223 . . . . 0.0 110.413 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 76.1 mtt180 -100.41 116.32 32.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.898 0.38 . . . . 0.0 110.424 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -119.41 141.28 49.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.183 0.516 . . . . 0.0 111.332 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -94.41 122.69 37.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.952 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 100' ' ' TRP . 66.1 mtp -102.55 133.44 47.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.38 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -97.77 143.87 27.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.714 0.292 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -88.44 123.9 33.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.27 0.557 . . . . 0.0 110.992 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -79.02 155.84 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.461 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 . . . . . 0 C--N 1.323 -0.559 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.357 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m . . . . . 0 N--CA 1.452 -0.361 0 CA-C-O 120.675 0.274 . . . . 0.0 111.506 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.5 Cg_exo -68.1 125.51 13.13 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.947 2.431 . . . . 0.0 111.161 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -67.49 -19.65 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -90.38 -13.06 35.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.349 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 18.0 t80 -78.61 134.0 37.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.86 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.93 -155.43 21.24 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.057 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.6 m -121.16 131.44 54.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.823 0.344 . . . . 0.0 110.35 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.541 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 74.0 m95 -116.26 141.41 48.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.1 t70 -106.11 133.49 50.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.052 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 51.5 mt-10 -94.87 71.46 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.652 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.21 41.6 3.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.832 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -167.32 147.79 5.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 74.74 144.71 0.11 Allowed Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.163 0.914 . . . . 0.0 111.464 -178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 6.2 Cg_exo -79.77 160.81 24.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.122 2.548 . . . . 0.0 112.986 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.95 8.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -38.35 128.11 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 124.261 3.308 . . . . 0.0 113.602 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -64.65 -13.24 53.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.96 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.12 -33.75 76.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.16 -10.0 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.852 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -81.71 132.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -94.87 -25.76 16.46 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.818 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 4.4 m 175.67 -178.95 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.23 0.956 . . . . 0.0 108.679 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.95 167.42 18.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.995 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 22' ' ' ASP . 15.9 p -117.89 137.23 52.94 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.6 p -112.09 124.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.377 0.608 . . . . 0.0 111.098 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 82.1 m -106.31 125.85 51.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.722 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.52 118.77 37.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 110.813 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.2 m -89.72 179.84 5.92 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 41' ' ' THR . 0.3 OUTLIER -47.37 -46.65 25.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -148.42 27.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.362 0.601 . . . . 0.0 110.539 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.82 159.53 41.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.347 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 64' ' ' TYR . 92.3 t -117.82 129.87 73.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.447 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 97.2 t -111.38 123.93 67.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -100.61 137.28 39.23 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.277 0.56 . . . . 0.0 111.514 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -123.27 117.4 25.19 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.214 172.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.57 133.44 43.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 56' ' ' GLU . 36.0 t -96.6 113.51 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.871 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 ttt -133.78 141.77 47.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.694 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.43 132.64 48.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.187 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.3 -14.61 61.97 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.281 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.41 -56.71 2.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 110.191 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.07 -143.52 15.74 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.358 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.9 mt-10 -96.33 115.61 27.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.46 0.648 . . . . 0.0 110.43 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.5 t -104.57 126.89 59.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.289 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.4 mt-30 -83.76 130.54 34.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.851 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 93.9 mt -93.73 160.15 33.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.757 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.7 Cg_endo -61.91 121.82 10.06 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.539 2.159 . . . . 0.0 111.545 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -45.9 128.79 9.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.216 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.5 mmm -110.48 129.67 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.518 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.33 148.51 29.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.746 0.307 . . . . 0.0 110.674 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CD1' HG23 ' A' ' 45' ' ' VAL . 28.7 p90 -144.28 164.91 29.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.05 155.63 36.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 109.992 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 77' ' ' ILE . 95.6 t -101.72 112.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.734 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.0 mt -73.83 -51.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.431 0.634 . . . . 0.0 109.629 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.08 146.26 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.48 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -149.07 136.88 20.52 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.264 0.554 . . . . 0.0 110.894 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t -107.38 149.08 28.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.557 171.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -61.35 -32.96 72.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.281 0.562 . . . . 0.0 109.678 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -157.51 91.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.802 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.81 -94.61 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.231 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.446 ' OG ' ' HG2' ' A' ' 91' ' ' LYS . 65.4 m -136.66 157.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -110.07 118.84 37.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.419 HG22 HG22 ' A' ' 66' ' ' VAL . 33.8 pt -126.29 158.14 36.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.779 -174.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 67' ' ' ILE . 45.8 tt0 -135.99 127.81 29.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.429 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 67.3 m-85 -85.17 129.34 34.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 84' ' ' TYR . 69.7 mt -86.53 162.22 18.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.921 0.391 . . . . 0.0 110.576 -176.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.4 -152.21 17.4 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.426 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.57 -18.71 65.05 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.803 2.335 . . . . 0.0 112.485 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -111.41 31.63 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.489 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 2.5 p90 -90.62 -1.14 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -169.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 94.6 Cg_endo -92.01 -3.49 4.01 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 CA-C-N 121.719 1.65 . . . . 0.0 112.764 166.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.424 HD21 HE22 ' A' ' 102' ' ' GLN . 25.3 tp -106.79 134.27 50.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.197 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -113.72 174.27 6.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.24 0.543 . . . . 0.0 112.104 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -143.7 165.89 26.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.507 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -134.14 142.87 47.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 111.267 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.56 135.17 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.83 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 66.0 mttm -132.41 162.6 30.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.763 0.316 . . . . 0.0 110.324 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 92' ' ' ARG . 15.8 ptt-85 -84.67 144.92 28.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.31 152.46 20.65 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.09 -10.85 60.23 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.69 77.48 1.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.727 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.39 48.09 21.74 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.886 0.741 . . . . 0.0 113.535 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.5 169.77 16.98 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.748 -0.266 . . . . 0.0 110.942 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -124.07 135.26 53.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 82.1 mt -102.78 117.34 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.79 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.0 t90 -109.9 113.73 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -108.97 134.88 51.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.349 0.595 . . . . 0.0 111.078 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.424 HE22 HD21 ' A' ' 86' ' ' LEU . 14.3 tm0? -150.55 119.0 6.43 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 68.38 -68.12 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.067 0.854 . . . . 0.0 112.018 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.04 1.65 0.07 OUTLIER Glycine 0 C--N 1.316 -0.58 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.822 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -113.42 135.42 53.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.724 0.762 . . . . 0.0 110.355 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -102.46 115.57 30.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.374 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 21.5 mmtp -94.89 136.59 35.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.041 0.448 . . . . 0.0 110.858 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 m -109.12 113.69 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' A' ' 21' ' ' TRP . 64.3 mtp -110.76 144.92 38.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.494 -174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -95.33 153.36 17.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.203 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -90.13 142.63 27.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.7 mm -92.99 148.98 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.173 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 . . . . . 0 C--N 1.316 -0.878 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.544 179.844 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.9 t . . . . . 0 N--CA 1.445 -0.715 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.6 Cg_exo -74.91 84.35 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.503 2.135 . . . . 0.0 111.486 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.571 ' HE1' ' HA ' ' A' ' 71' ' ' THR . 44.2 p90 -65.36 -24.39 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.54 -176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -82.35 -19.52 39.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -80.09 138.57 36.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.983 0.421 . . . . 0.0 110.764 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.54 -153.42 20.43 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.133 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -119.68 128.43 53.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.452 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 63.0 m95 -121.67 139.69 53.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.638 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 112' ' ' ILE . 9.9 t0 -107.94 135.6 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 55.7 mt-10 -54.12 -45.5 71.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.87 22.03 25.48 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.848 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -170.89 149.72 3.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 69.39 144.76 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.75 0.657 . . . . 0.0 111.479 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.7 Cg_exo -78.44 151.16 25.69 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.908 2.405 . . . . 0.0 112.582 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.45 -166.63 25.53 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.571 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.6 150.62 1.4 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.224 3.283 . . . . 0.0 113.949 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -72.31 -7.71 50.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.41 -12.41 51.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.962 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.84 41.98 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.866 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 t -105.12 133.28 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.58 -30.31 20.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.392 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 22.7 p -176.37 174.43 1.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.437 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.04 157.73 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.493 0.663 . . . . 0.0 111.0 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 1.5 p -117.39 129.51 55.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.662 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -112.54 129.41 68.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.225 0.536 . . . . 0.0 109.904 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 m -114.14 130.07 56.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.172 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.26 116.2 32.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.55 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -103.23 -178.28 3.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -47.96 -51.19 24.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -138.01 10.63 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.544 0.212 . . . . 0.0 111.389 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.55 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -138.76 149.1 44.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 111.785 -177.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' CD1' ' A' ' 64' ' ' TYR . 78.4 t -111.71 124.96 68.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.26 124.37 64.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.13 134.21 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.542 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 1.7 m -124.9 135.38 52.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.078 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.0 127.96 47.26 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -97.02 112.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.268 0.556 . . . . 0.0 110.702 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -119.21 107.18 13.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.905 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.96 117.1 5.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.77 -36.01 3.62 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -99.52 -62.3 1.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.697 0.76 . . . . 0.0 109.547 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 -164.42 24.21 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.052 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG3' HG22 ' A' ' 50' ' ' VAL . 11.2 mp0 -80.16 127.01 31.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 117.637 0.719 . . . . 0.0 110.177 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.54 121.54 63.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.604 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -80.36 130.52 35.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 111.622 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.7 mt -91.76 163.89 26.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.714 174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 73.6 Cg_exo -49.37 125.22 13.29 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.712 2.275 . . . . 0.0 112.114 176.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.74 137.57 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtm -108.09 121.99 45.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.33 148.15 41.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.566 ' CD1' HG23 ' A' ' 45' ' ' VAL . 9.9 p90 -146.85 151.43 37.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.33 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 158.94 29.79 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.69 112.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 78' ' ' GLN . 20.1 mt -76.83 -54.08 13.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.52 151.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.584 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -155.27 111.56 3.18 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.98 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.571 ' HA ' ' HE1' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -69.92 -11.0 60.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.105 174.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.24 -56.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.633 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.4 -47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.993 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 26.8 t -161.25 155.56 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.614 0.721 . . . . 0.0 112.721 -169.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.3 mt -126.21 137.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.342 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.539 ' HG2' HD12 ' A' ' 67' ' ' ILE . 37.7 tt0 -117.45 124.59 49.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 pt -129.98 157.47 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.402 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.797 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 32.9 tt0 -131.65 135.53 46.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.618 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -82.89 3.58 29.19 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -169.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.7 mt 52.29 -162.52 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.607 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.42 -151.86 42.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.816 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.22 -8.7 23.64 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.687 2.258 . . . . 0.0 111.579 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.88 15.24 22.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.447 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -65.7 178.07 0.62 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.797 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 11.2 Cg_exo 10.91 -1.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.274 1 C-N-CA 126.985 5.124 . . . . 0.0 120.263 -142.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.7 tp -78.12 103.83 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -103.9 172.08 7.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.379 0.609 . . . . 0.0 111.814 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 t -132.39 148.33 52.41 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.084 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.3 m -123.92 143.63 50.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.561 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 98' ' ' LEU . 85.8 mt -128.0 123.93 35.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.117 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 30.3 mtmm -123.67 160.32 27.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.709 0.29 . . . . 0.0 110.505 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -80.36 144.71 32.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.474 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -99.21 -175.53 31.64 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.465 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -91.43 -30.15 16.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.972 0.415 . . . . 0.0 111.935 -171.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . 0.486 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 48.5 m-80 -102.59 25.76 8.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.637 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.93 37.65 50.1 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.613 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . 0.474 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 15.9 p -105.17 174.58 5.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.901 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 90' ' ' LEU . 29.8 tp -122.95 133.74 54.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 63.4 mt -96.96 110.25 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -98.34 113.21 25.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.867 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 11.9 mt-10 -110.85 132.01 54.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.73 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.451 ' NE2' ' HB2' ' A' ' 103' ' ' ASN . 23.2 tm0? -152.21 118.2 5.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.456 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.451 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 54.8 t30 63.97 24.04 13.49 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.657 0.742 . . . . 0.0 111.288 164.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.48 34.47 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.124 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -92.48 132.91 36.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.542 0.671 . . . . 0.0 111.346 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -103.58 116.36 32.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.919 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -127.08 117.8 23.15 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.4 m -93.16 114.15 26.58 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -112.28 159.73 18.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.116 -173.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -104.39 153.75 20.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.24 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -88.27 161.19 17.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 22' ' ' ASP . 21.7 mm -94.86 151.86 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.049 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--N 1.316 -0.856 0 CA-C-O 121.037 0.446 . . . . 0.0 109.817 -179.391 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 m . . . . . 0 N--CA 1.451 -0.403 0 CA-C-O 120.516 0.198 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 31.6 Cg_exo -58.98 122.25 11.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.889 2.392 . . . . 0.0 111.713 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -67.98 -14.91 63.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -98.99 -8.48 25.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.373 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 36.9 t80 -81.93 140.2 34.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.96 -171.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.1 -149.83 17.3 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.252 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 m -119.51 134.24 55.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.7 0.285 . . . . 0.0 110.254 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 82.3 m95 -126.08 142.64 51.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.606 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 112' ' ' ILE . 1.5 t70 -96.08 120.05 35.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.54 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.586 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 12.6 pt-20 -98.5 79.17 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.993 0.902 . . . . 0.0 109.795 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.83 -8.05 56.61 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.881 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.731 HH11 ' HB2' ' A' ' 26' ' ' ALA . 1.1 tmt_? -101.04 140.3 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.731 ' HB2' HH11 ' A' ' 25' ' ' ARG . . . 65.01 143.67 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.354 1.034 . . . . 0.0 111.274 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 74.1 Cg_endo -93.04 172.62 2.02 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.546 2.164 . . . . 0.0 112.242 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.9 -155.13 20.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.488 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HD2' HG21 ' A' ' 33' ' ' VAL . 10.3 Cg_endo -56.2 163.74 5.93 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.8 2.333 . . . . 0.0 112.804 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 m -74.72 2.52 9.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.566 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.84 -43.2 96.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.81 59.39 0.02 OUTLIER Glycine 0 CA--C 1.513 -0.065 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.56 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.609 HG21 ' HD2' ' A' ' 29' ' ' PRO . 8.3 t -100.24 134.61 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.887 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 8.7 mmpt? -81.71 -40.79 22.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -166.45 165.86 16.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.058 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.61 148.73 52.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.431 . . . . 0.0 111.266 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -133.5 131.49 39.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.155 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.85 139.56 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.925 0.393 . . . . 0.0 110.93 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.5 m -119.39 129.34 54.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.06 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -101.89 117.64 35.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.1 p -101.9 -177.35 3.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.184 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -45.03 -56.13 4.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.466 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.22 -4.13 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.719 -173.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.39 157.15 28.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.542 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.63 117.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 61' ' ' PHE . 33.3 t -108.56 124.21 64.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.78 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.76 136.48 42.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.654 0.74 . . . . 0.0 110.737 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.83 116.98 21.71 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.476 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -108.29 128.55 54.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.12 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.43 113.65 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.522 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.3 mtm -123.08 130.64 53.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.467 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.45 131.51 47.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.705 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.97 -29.44 11.24 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.284 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -122.57 -33.85 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 111.311 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.2 -151.24 19.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.564 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.09 133.45 46.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.228 0.537 . . . . 0.0 110.165 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.4 t -123.87 123.85 67.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.229 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -85.63 118.63 25.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.905 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.57 159.54 55.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 114.37 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.077 1.852 . . . . 0.0 110.62 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' HG22 ' A' ' 46' ' ' VAL . 32.5 p90 -69.9 146.69 51.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.534 -172.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.28 148.76 22.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.53 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.72 131.6 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -114.57 142.48 46.37 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.374 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -122.17 151.11 41.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.728 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.23 125.19 41.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.077 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.9 mt -96.26 -55.62 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -131.61 153.86 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.805 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.13 152.7 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 111.48 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 74' ' ' SER . 42.1 t -139.71 167.33 22.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -80.33 -38.8 29.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.34 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 6.4 p-10 -147.96 9.57 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.408 -172.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.19 -81.11 1.47 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.318 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 5.1 p -145.52 152.01 39.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 111.677 -174.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 22.4 mt -125.98 138.49 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.5 tt0 -117.54 127.38 53.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -125.66 157.08 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' A' ' 67' ' ' ILE . 44.1 tt0 -126.58 144.19 50.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -83.23 149.29 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.225 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -105.1 167.79 9.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.22 -152.1 21.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.23 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.04 -5.17 15.75 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.579 2.186 . . . . 0.0 111.795 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -98.6 15.58 24.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.724 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.757 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -63.0 -177.3 0.19 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.132 175.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.757 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 12.32 -0.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.252 1 C-N-CA 127.35 5.367 . . . . 0.0 120.561 -148.098 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.8 tp -85.31 121.26 27.78 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -120.65 168.48 11.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.386 0.612 . . . . 0.0 111.603 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.27 154.9 47.13 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.635 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 10.4 m -113.82 141.82 46.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.476 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 96.6 mt -124.14 124.78 43.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.287 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 33.3 mtmm -133.4 157.43 45.58 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.934 0.397 . . . . 0.0 110.467 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 24.1 ptt180 -66.16 147.26 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.058 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . 0.47 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -73.25 -170.23 18.38 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.159 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -86.96 -39.34 15.81 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.191 0.519 . . . . 0.0 110.013 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -148.64 102.2 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.925 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 53.82 44.92 70.8 Favored Glycine 0 C--N 1.333 0.385 0 O-C-N 123.349 0.406 . . . . 0.0 113.183 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.03 174.0 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.413 0.149 . . . . 0.0 111.149 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 tp -129.31 136.17 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.47 HG13 ' HA2' ' A' ' 93' ' ' GLY . 67.5 mt -111.55 110.59 32.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.877 0.37 . . . . 0.0 110.33 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.443 ' HE3' ' HE3' ' A' ' 109' ' ' MET . 10.0 t90 -105.14 113.07 26.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.786 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.614 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 70.2 mt-10 -96.49 130.3 43.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.423 0.63 . . . . 0.0 110.089 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.479 ' CD ' ' HB2' ' A' ' 103' ' ' ASN . 25.8 tm0? -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.684 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB2' ' CD ' ' A' ' 102' ' ' GLN . 5.8 t-20 67.75 9.89 7.4 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.409 0.443 . . . . 0.0 111.252 172.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.5 -10.85 53.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.255 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -108.62 143.5 37.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.854 -0.203 . . . . 0.0 110.547 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.614 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 24.6 ptt180 -99.4 126.26 45.26 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 1.5 mptm? -88.66 126.52 35.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.529 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 m -94.78 113.76 25.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.586 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 59.9 mtt -114.62 142.33 46.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 112.273 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.02 151.01 19.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.104 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -86.09 123.99 32.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 22' ' ' ASP . 37.3 mm -72.76 147.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.429 0.633 . . . . 0.0 111.518 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.32 -0.684 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.656 -179.076 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.415 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 19.6 m . . . . . 0 N--CA 1.451 -0.386 0 CA-C-O 121.175 0.512 . . . . 0.0 112.165 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.2 Cg_exo -63.44 104.17 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.985 2.457 . . . . 0.0 111.879 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.82 -15.17 63.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.382 -174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -101.85 6.79 41.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.01 125.99 44.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.158 0.504 . . . . 0.0 111.072 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.21 -168.95 24.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.236 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.1 m -102.07 131.44 48.54 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 109' ' ' MET . 62.6 m95 -116.09 137.14 52.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.816 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.592 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.9 t70 -99.79 127.01 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 112.185 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 35' ' ' SER . 44.4 mt-10 -101.64 78.04 1.8 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.997 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.11 -0.46 35.73 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.324 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 25' ' ' ARG . 6.9 tpp180 -114.9 144.11 44.08 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.65 146.83 0.12 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 0.0 111.179 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.54 171.91 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.497 2.132 . . . . 0.0 112.721 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.86 -155.18 25.03 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.887 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -38.38 145.54 0.16 Allowed 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 124.28 3.32 . . . . 0.0 113.665 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.21 -5.67 14.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -171.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.75 -36.09 81.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.09 53.61 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.597 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 49' ' ' GLU . 18.8 t -100.94 134.37 41.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -79.03 -39.68 33.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 38.5 m -159.77 166.17 30.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.085 -171.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.49 152.33 40.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 22' ' ' ASP . 12.9 p -131.87 127.04 35.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.33 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.89 136.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.106 0.479 . . . . 0.0 111.233 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 m -121.77 125.64 47.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.653 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.77 116.43 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.876 0.37 . . . . 0.0 110.375 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -104.58 170.13 8.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 41' ' ' THR . 32.5 tt0 -61.22 -45.86 92.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.877 0.37 . . . . 0.0 111.934 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.85 -9.2 23.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 3.7 pt-20 -156.74 148.08 22.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -166.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.508 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.7 t -101.77 118.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.843 170.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.34 124.46 55.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.7 0.286 . . . . 0.0 110.457 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.04 136.7 37.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.608 0.718 . . . . 0.0 111.518 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 2.3 m -128.47 131.4 48.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.526 171.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' HG11 ' A' ' 33' ' ' VAL . 32.9 mt-10 -120.53 135.93 54.93 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.522 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' A' ' 56' ' ' GLU . 45.8 t -96.41 113.6 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -119.74 126.88 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.384 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 106.88 6.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.325 0.583 . . . . 0.0 110.477 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.05 6.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.26 -60.01 1.65 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.921 0.867 . . . . 0.0 109.747 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.04 -166.32 14.04 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.003 -172.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.6 mp0 -71.89 127.15 31.66 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.502 0.668 . . . . 0.0 111.433 174.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.0 t -118.39 122.69 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.928 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 48' ' ' THR . 82.1 mt-30 -93.74 126.76 39.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.916 0.389 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.48 161.76 26.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.316 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 137.03 40.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.887 2.391 . . . . 0.0 112.059 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.615 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 44.2 p90 -72.09 152.49 42.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.8 mtp -111.87 140.45 46.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.663 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.96 28.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.502 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD1' HG23 ' A' ' 45' ' ' VAL . 7.7 p90 -147.28 166.52 26.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.812 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -128.19 159.3 35.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.55 126.3 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.123 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.2 mt -85.43 -51.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.1 m -145.03 161.31 39.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.462 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -148.97 132.99 17.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.08 0.466 . . . . 0.0 110.777 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' SER . 31.6 t -151.01 121.88 7.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -78.11 -15.74 58.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.527 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -104.27 -21.45 13.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.726 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 -67.06 0.47 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.838 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 47.3 t -177.52 157.09 1.23 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 0.0 110.993 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -116.85 132.71 65.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.212 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.498 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.0 tt0 -111.09 123.73 50.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 pt -124.96 157.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.032 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 36.1 tt0 -138.42 139.94 39.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 98.0 m-85 -88.17 153.97 20.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 0.0 110.896 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.4 mt -110.77 -176.82 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.029 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.54 -152.52 35.76 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.68 -16.91 51.59 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.396 2.064 . . . . 0.0 111.926 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -92.31 20.41 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.96 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 26.3 p90 -61.17 172.27 0.97 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.707 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 11.5 -0.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.084 1 C-N-CA 128.153 5.902 . . . . 0.0 121.065 -150.08 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.0 tp -69.22 104.21 2.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 119.556 1.071 . . . . 0.0 108.289 167.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 61.1 pttt -103.63 174.71 5.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.414 0.626 . . . . 0.0 111.94 -171.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 t -144.66 161.36 39.36 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.157 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -124.28 142.97 50.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.8 0.334 . . . . 0.0 110.578 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.48 122.72 38.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 53.4 mttp -118.83 160.58 21.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.2 0.524 . . . . 0.0 111.188 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -70.61 143.0 51.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.57 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.9 143.77 22.45 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.888 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.82 -44.5 73.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.908 -0.646 . . . . 0.0 111.172 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.51 81.34 2.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.81 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 55.3 55.1 30.06 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.711 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.52 175.24 10.09 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.832 -0.216 . . . . 0.0 111.112 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.57 135.26 54.52 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.576 HG23 ' HG3' ' A' ' 106' ' ' ARG . 82.7 mt -104.9 111.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.245 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 15.7 t90 -97.87 112.77 24.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.811 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 28.8 mt-10 -102.12 131.66 48.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -151.64 123.58 8.09 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.701 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.28 19.77 10.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.314 0.384 . . . . 0.0 111.827 173.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.07 -21.86 34.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.533 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 10.6 pt20 -92.61 145.65 24.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.013 0.406 . . . . 0.0 110.947 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HG3' HG23 ' A' ' 99' ' ' ILE . 15.6 ttm180 -94.04 117.98 30.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 28.1 mmtm -95.04 117.99 31.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.096 0.475 . . . . 0.0 109.809 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -100.13 114.59 28.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.615 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 21' ' ' TRP . 12.3 ptp -127.65 137.92 52.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.338 0.589 . . . . 0.0 111.729 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -101.05 146.43 27.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.582 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -80.52 127.73 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.158 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 22' ' ' ASP . 31.4 mm -73.57 145.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.535 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.311 -1.108 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 -176.447 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 10.1 t . . . . . 0 CA--C 1.536 0.409 0 CA-C-O 121.247 0.546 . . . . 0.0 111.355 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 37.9 Cg_exo -62.9 103.91 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.864 2.376 . . . . 0.0 111.949 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.78 -10.98 60.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.284 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 44.5 p90 -89.57 -6.62 56.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -71.35 138.99 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.136 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.42 -163.5 21.18 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.033 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.6 m -115.23 122.64 46.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.022 0.439 . . . . 0.0 110.432 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 50.1 m95 -116.3 133.64 55.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.139 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.581 ' CB ' HD11 ' A' ' 112' ' ' ILE . 11.7 t70 -109.68 132.43 54.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.952 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 109' ' ' MET . 6.2 mm-40 -74.04 -58.15 3.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.603 173.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.94 32.16 55.9 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 9.0 ttm180 -158.08 167.68 29.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -167.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . . . 67.43 165.36 0.12 Allowed Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.928 0.768 . . . . 0.0 112.211 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 134.5 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.355 2.037 . . . . 0.0 111.356 171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 -166.31 21.28 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.977 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -48.62 125.15 12.07 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.067 2.511 . . . . 0.0 111.868 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -80.1 -1.44 40.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.26 -33.92 74.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.559 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 146.57 37.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.977 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.63 138.91 28.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -86.58 -28.09 23.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.994 0.425 . . . . 0.0 111.108 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 p -177.31 167.47 2.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.981 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.43 144.23 49.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -117.87 133.58 55.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.111 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.03 136.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 111.161 -175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.6 m -123.02 130.94 53.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.555 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -100.61 120.61 40.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.097 0.475 . . . . 0.0 110.317 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -95.7 179.1 5.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.374 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 41' ' ' THR . 29.6 mt-10 -51.53 -38.68 55.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.306 0.642 . . . . 0.0 111.801 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -151.37 19.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 111.447 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -131.1 147.73 52.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 64' ' ' TYR . 66.5 t -101.84 118.51 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.464 HG22 ' CD1' ' A' ' 61' ' ' PHE . 70.6 t -108.21 124.42 64.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.34 137.5 52.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.342 0.591 . . . . 0.0 110.453 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.48 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.26 138.1 51.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.141 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -97.98 125.4 42.9 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 56' ' ' GLU . 48.6 t -90.11 110.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.512 ' SD ' ' HG3' ' A' ' 54' ' ' ARG . 43.0 ttm -112.07 135.21 53.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.151 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.77 113.35 3.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.934 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.57 -18.4 56.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.752 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 9.6 mmt180 -101.36 -74.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.816 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.41 -156.1 26.64 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 50' ' ' VAL . 44.8 mt-10 -92.92 120.69 33.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.415 0.626 . . . . 0.0 111.179 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -112.57 128.12 69.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.892 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HG2' HG23 ' A' ' 48' ' ' THR . 79.8 mt-30 -80.07 131.55 35.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.143 0.497 . . . . 0.0 111.601 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -87.86 163.7 36.98 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.494 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.25 123.58 12.27 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.648 2.232 . . . . 0.0 111.749 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 46' ' ' VAL . 17.8 m-85 -68.42 142.15 55.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.143 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.4 mtm -109.86 123.74 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.801 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.57 140.09 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD1' HG23 ' A' ' 45' ' ' VAL . 42.1 p90 -132.82 170.9 14.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.885 0.374 . . . . 0.0 110.63 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 80' ' ' LEU . 10.0 ptmm? -144.1 143.0 30.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.66 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -83.33 124.3 39.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.727 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 78' ' ' GLN . 11.5 mt -85.62 -54.41 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.595 0.712 . . . . 0.0 109.661 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 m -139.56 163.44 32.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.818 -174.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -144.51 149.27 35.65 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.5 t -125.33 121.02 32.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.6 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -69.89 -6.39 32.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 111.366 177.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.89 -48.17 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.571 ' HA3' ' HD3' ' A' ' 92' ' ' ARG . . . 146.33 46.49 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.64 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.6 m -147.27 151.97 37.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.224 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.49 138.44 48.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.231 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -110.46 126.8 54.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.934 0.397 . . . . 0.0 109.973 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.76 157.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.454 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.661 ' HB2' HD11 ' A' ' 67' ' ' ILE . 34.7 tt0 -132.34 144.85 50.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.614 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -92.86 156.98 16.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.02 0.438 . . . . 0.0 110.76 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 65' ' ' LYS . 83.1 mt -112.08 -177.08 3.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.415 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.85 -151.93 41.65 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.238 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.86 -5.27 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.551 2.168 . . . . 0.0 112.154 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -102.75 20.54 17.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.142 0.496 . . . . 0.0 109.805 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.959 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.1 p90 -58.47 170.81 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.298 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.959 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 1.2 Cg_exo 9.34 0.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.162 1 C-N-CA 128.711 6.274 . . . . 0.0 121.659 -152.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 84' ' ' TYR . 66.8 tp -66.57 109.81 2.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 119.986 1.266 . . . . 0.0 109.062 170.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.96 166.77 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 111.874 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 t -140.22 156.2 46.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.527 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -112.72 141.3 46.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.134 0.492 . . . . 0.0 110.89 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.93 126.75 49.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.805 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 94.0 mttt -124.95 154.96 40.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.945 0.402 . . . . 0.0 110.257 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.571 ' HD3' ' HA3' ' A' ' 73' ' ' GLY . 36.4 ptt-85 -79.42 144.26 34.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.051 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.7 26.54 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.14 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.12 134.36 38.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.021 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 71.89 -66.14 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.639 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.29 59.59 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.47 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 p -134.74 170.07 16.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.122 0.169 . . . . 0.0 110.581 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.3 tp -129.53 135.42 48.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.604 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 75.2 mt -105.65 126.26 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 17.7 t90 -117.3 115.75 25.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.079 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -110.99 134.87 52.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 111.432 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.68 121.35 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.937 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.85 9.74 5.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.635 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.95 -8.05 29.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.716 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.05 134.65 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -102.02 116.13 32.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.104 0.478 . . . . 0.0 111.237 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 2.0 mmpt? -98.55 139.49 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.547 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.9 m -121.74 112.24 18.15 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.572 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 52.2 mtm -116.8 141.4 48.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -173.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -98.63 151.77 20.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.539 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 57.1 ttp85 -83.5 127.4 33.69 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 22' ' ' ASP . 30.0 mm -85.4 144.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.47 0.652 . . . . 0.0 110.598 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 . . . . . 0 C--N 1.31 -1.12 0 CA-C-N 114.605 -1.18 . . . . 0.0 107.898 174.962 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 t . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.687 0.28 . . . . 0.0 110.799 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 39.5 Cg_exo -61.42 109.37 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -68.45 -18.99 64.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.194 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -95.02 -10.18 31.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.795 0.331 . . . . 0.0 111.305 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 42.8 t80 -80.64 130.29 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 0.0 110.969 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.86 -164.24 25.51 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.263 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -105.39 130.69 53.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 98' ' ' LEU . 71.7 m95 -119.54 144.56 46.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.262 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.7 t70 -96.76 141.37 30.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 6.1 mm-40 -48.14 -49.97 30.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.12 -54.52 3.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.637 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -135.95 164.19 28.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.32 161.45 0.16 Allowed Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 124.039 0.837 . . . . 0.0 111.395 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.29 175.4 9.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.628 2.218 . . . . 0.0 112.154 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.21 -153.69 7.64 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.399 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.778 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 4.5 Cg_endo -47.68 148.62 5.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 124.355 3.37 . . . . 0.0 113.433 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.3 p -81.26 -2.17 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.923 -172.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.72 -1.04 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.251 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.62 35.23 29.36 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.897 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.778 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 24.6 t -76.4 133.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.767 ' HE3' ' HB3' ' A' ' 52' ' ' GLU . 49.5 mtmt -91.47 -13.58 31.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.813 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 18.5 m -148.7 157.51 43.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.877 0.37 . . . . 0.0 110.609 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -159.79 145.87 15.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.084 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 139.53 44.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.092 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.31 133.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 110.121 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -121.26 124.57 44.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.839 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -101.97 117.81 35.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.123 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -102.33 179.43 4.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.327 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 41' ' ' THR . 33.1 mt-10 -54.93 -42.92 72.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -128.21 -16.25 4.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.921 0.391 . . . . 0.0 111.808 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 6.9 pt-20 -125.76 142.17 51.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.166 0.508 . . . . 0.0 111.803 -173.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.61 125.56 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 61' ' ' PHE . 66.9 t -115.92 123.82 71.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 137.92 34.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 110.736 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.568 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -125.63 118.85 26.57 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.647 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -105.63 125.61 51.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.198 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.813 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 42.5 t -98.86 111.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.258 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -99.48 109.11 21.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.767 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 41.5 tt0 -65.39 106.63 1.43 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.045 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.95 -29.68 2.19 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.116 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' GLY . 17.0 ptp180 -125.01 -51.77 1.67 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.515 0.197 . . . . 0.0 111.04 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' ARG . . . 142.45 -156.36 26.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.017 -176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -79.8 146.34 32.33 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 111.818 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.21 122.05 59.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.412 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.0 mt-30 -95.68 131.5 41.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.806 0.336 . . . . 0.0 111.052 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.17 157.25 39.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.245 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.02 118.61 4.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.815 2.343 . . . . 0.0 111.577 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' A' ' 46' ' ' VAL . 52.6 p90 -60.44 145.35 48.55 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.214 0.53 . . . . 0.0 111.481 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.11 125.83 50.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.809 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.7 136.42 34.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -127.12 161.11 29.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.723 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -122.18 144.46 48.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.3 t -89.4 114.02 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.828 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 78' ' ' GLN . 10.1 mt -81.15 -56.69 5.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.741 0.781 . . . . 0.0 109.188 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -124.77 149.39 47.4 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.626 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -147.65 136.45 21.97 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.372 0.606 . . . . 0.0 111.774 -170.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 74' ' ' SER . 37.0 t -141.3 150.54 42.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.811 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -9.57 55.37 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -146.41 -27.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.73 -76.21 0.95 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.562 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.529 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 3.4 p -159.28 164.41 34.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 mt -132.92 135.53 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.43 131.72 55.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 pt -130.76 156.81 42.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.561 ' HB2' HD11 ' A' ' 67' ' ' ILE . 53.1 tt0 -124.98 131.74 53.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.658 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -85.62 152.96 22.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 111.034 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.72 -178.0 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.603 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.82 -152.27 34.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.175 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.59 -10.73 17.45 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.722 2.281 . . . . 0.0 112.589 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.59 25.96 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 1.011 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 34.9 p90 -55.24 166.51 0.86 Allowed Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.616 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 1.011 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 8.13 -0.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.031 1 C-N-CA 128.988 6.459 . . . . 0.0 121.487 -153.397 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.872 ' HG ' HE22 ' A' ' 102' ' ' GLN . 35.4 tp -70.77 103.29 2.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 119.936 1.244 . . . . 0.0 107.928 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -98.45 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.415 0.626 . . . . 0.0 112.155 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -141.81 158.87 43.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.891 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.2 m -123.83 141.07 52.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.479 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.39 122.94 41.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.91 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 40.3 mtpt -137.96 149.45 46.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.533 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -90.2 147.08 23.78 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.16 -160.72 18.14 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.265 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.12 137.23 57.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 66.22 -157.96 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.924 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' HH11 ' A' ' 111' ' ' ARG . . . -90.5 57.18 3.47 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.561 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 42.1 p -121.13 148.88 43.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.454 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 20.9 tp -112.01 132.73 54.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -97.69 113.35 31.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -96.64 114.25 25.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.834 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.2 mt-10 -105.89 133.32 50.79 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.621 0.724 . . . . 0.0 110.405 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.872 HE22 ' HG ' ' A' ' 86' ' ' LEU . 5.7 tm0? -150.55 133.21 15.78 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.775 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.99 -43.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.794 0.684 . . . . 0.0 111.38 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.26 -19.3 0.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -103.0 141.19 36.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.817 0.342 . . . . 0.0 110.99 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 15.3 ptp180 -101.33 138.51 38.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.496 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 17.0 mmtm -127.15 133.94 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.273 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 t -94.91 128.75 41.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.113 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 98' ' ' LEU . 22.1 ptt? -123.6 149.05 45.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.332 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.81 150.07 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.512 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HA3' ' A' ' 96' ' ' GLY . 12.8 ptt180 -85.03 154.81 21.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 22' ' ' ASP . 16.9 mm -96.86 150.57 4.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 . . . . . 0 C--N 1.314 -0.935 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.995 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 47.4 Cg_exo -56.53 117.05 3.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.606 2.204 . . . . 0.0 112.152 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -63.78 -28.49 69.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.729 0.3 . . . . 0.0 111.52 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 12.2 p90 -85.27 -1.28 56.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.837 0.351 . . . . 0.0 111.313 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.676 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 55.3 t80 -75.49 125.64 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 109.999 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.98 -158.11 22.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.314 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 m -110.34 132.48 54.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.639 0.257 . . . . 0.0 110.8 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 61.5 m95 -123.15 137.8 54.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.552 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.59 ' HB2' HD11 ' A' ' 112' ' ' ILE . 17.0 t70 -103.73 128.16 51.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -95.25 75.84 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 39.72 2.33 Favored Glycine 0 C--N 1.317 -0.478 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.624 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -164.52 160.69 20.65 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 73.19 144.59 0.11 Allowed Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 124.022 0.826 . . . . 0.0 111.079 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 16.7 Cg_exo -67.45 140.66 53.2 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.836 2.357 . . . . 0.0 112.451 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.12 -167.84 43.02 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.432 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 32.9 Cg_exo -53.41 163.55 2.49 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.612 2.875 . . . . 0.0 113.376 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -71.37 -25.07 62.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.405 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.18 13.47 0.31 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.4 28.04 13.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 22.1 t -89.05 134.39 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -68.55 -44.31 74.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.542 0.686 . . . . 0.0 110.183 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.6 p -175.74 175.11 2.09 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.148 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.35 154.08 38.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.308 0.575 . . . . 0.0 111.332 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 22' ' ' ASP . 23.0 p -119.34 142.21 48.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.146 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.26 131.63 63.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.365 0.602 . . . . 0.0 110.615 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.2 m -116.71 120.03 37.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.127 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -101.4 117.01 34.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -101.72 -177.8 3.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -54.42 -45.37 72.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -126.58 -13.56 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -126.16 154.81 42.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 111.731 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.3 t -110.4 130.64 63.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.82 123.53 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.744 0.307 . . . . 0.0 110.176 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.85 137.74 34.48 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.426 0.631 . . . . 0.0 110.502 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -122.01 119.91 32.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.184 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -100.63 128.48 46.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.84 112.75 33.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.985 0.421 . . . . 0.0 109.876 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.7 ttp -116.63 138.17 51.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.72 126.1 22.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.818 0.699 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.39 -28.15 11.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.579 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HE ' ' HB3' ' A' ' 54' ' ' ARG . 9.4 mmm180 -92.81 -75.61 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.625 0.726 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.0 -145.35 16.84 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.025 -171.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.9 131.36 35.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.762 0.791 . . . . 0.0 111.261 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.32 120.64 64.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.975 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 48' ' ' THR . 78.7 mt-30 -92.58 126.69 37.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.81 158.46 47.65 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.495 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 132.34 28.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.92 2.414 . . . . 0.0 112.105 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -60.41 128.41 36.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.609 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -103.35 120.41 40.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.15 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.0 127.98 34.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.369 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.2 p90 -114.66 154.99 27.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.113 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.78 147.52 49.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.381 0.61 . . . . 0.0 110.331 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.8 114.67 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.679 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.8 mt -81.49 -53.96 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.5 m -133.17 153.26 51.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.301 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.64 145.27 27.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 145.7 50.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -71.86 -23.56 61.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -165.63 89.87 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.867 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.47 -84.92 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.078 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -146.89 156.09 42.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 9.1 mt -133.31 136.15 55.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.56 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.09 119.6 35.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.29 157.35 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.706 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 33.9 tt0 -130.75 144.4 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -94.68 154.91 17.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.578 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.32 -177.38 3.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.26 -153.52 29.22 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.258 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.66 -16.03 52.26 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.514 2.143 . . . . 0.0 112.122 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.88 31.18 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.224 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.917 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 52.9 p90 -59.7 173.48 0.52 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.251 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 11.65 -0.84 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.128 1 C-N-CA 128.243 5.962 . . . . 0.0 121.415 -152.267 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.6 tp -68.47 104.27 1.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 119.575 1.08 . . . . 0.0 108.24 167.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -105.74 173.29 6.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 111.927 -172.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.8 t -139.54 158.42 44.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.204 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.4 m -119.61 142.87 48.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.826 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 97.7 mt -130.72 130.77 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.846 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -144.93 164.74 30.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.895 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -98.44 154.9 17.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.857 0.36 . . . . 0.0 110.034 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.08 -153.73 29.58 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.306 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -75.73 -46.76 29.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.565 0.698 . . . . 0.0 110.104 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -97.02 -160.46 0.8 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.79 51.28 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 p -117.05 141.32 48.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.781 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 28.9 tp -102.69 135.66 43.93 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.8 108.97 22.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -107.62 111.95 24.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 23.0 mt-10 -107.23 131.66 53.94 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.387 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -150.59 118.31 6.17 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.4 t30 69.63 -5.09 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.604 0.565 . . . . 0.0 112.229 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.13 -14.6 4.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.432 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -108.46 135.5 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.326 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -101.7 127.0 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.255 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 5.5 mtmt -117.98 124.82 49.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.665 0.269 . . . . 0.0 111.655 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 113.91 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 21.1 ptp -125.14 151.4 45.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.914 0.388 . . . . 0.0 110.965 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 m -100.17 156.07 17.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.143 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 41.9 ttt85 -87.45 141.42 28.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.927 0.394 . . . . 0.0 110.375 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 22' ' ' ASP . 30.6 mm -72.72 147.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 pm0 . . . . . 0 C--N 1.316 -0.853 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 -175.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.8 t . . . . . 0 CA--C 1.536 0.428 0 CA-C-O 121.601 0.715 . . . . 0.0 112.546 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.3 Cg_exo -79.15 97.87 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.073 2.515 . . . . 0.0 110.831 172.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -63.17 -25.7 68.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.359 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -82.95 -18.32 40.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.666 0.27 . . . . 0.0 111.678 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -74.04 136.61 43.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.677 0.275 . . . . 0.0 110.709 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.15 -158.21 22.27 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.224 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.5 m -117.82 129.03 55.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.619 0.247 . . . . 0.0 110.605 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -113.7 141.36 47.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.182 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.677 ' HB2' HD11 ' A' ' 112' ' ' ILE . 20.1 t70 -109.02 134.98 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.778 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HB2' ' H ' ' A' ' 36' ' ' ALA . 33.8 mt-10 -96.1 40.8 1.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.602 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.06 78.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.319 -0.944 . . . . 0.0 110.945 172.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -91.66 142.82 27.2 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.71 155.49 0.14 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.594 1.184 . . . . 0.0 111.401 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.48 135.13 48.0 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.384 2.056 . . . . 0.0 111.862 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.78 -154.76 22.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.436 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 171.63 5.01 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.28 2.654 . . . . 0.0 113.037 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -129.66 -6.59 4.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.462 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.94 -41.2 70.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.692 0.758 . . . . 0.0 111.681 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.37 -37.01 0.3 Allowed Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 50' ' ' VAL . 17.8 t -67.34 134.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -111.26 -15.24 13.68 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.982 0.42 . . . . 0.0 110.786 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m -157.31 158.25 35.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.968 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.492 ' H ' ' HB2' ' A' ' 23' ' ' GLU . . . -136.12 164.73 27.37 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.193 0.521 . . . . 0.0 110.933 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 20.0 p -131.06 131.29 44.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.086 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.85 129.52 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.255 0.55 . . . . 0.0 110.702 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.6 m -114.53 125.65 54.03 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -101.4 117.14 34.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 p -101.75 -178.0 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.567 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -49.36 -52.82 25.77 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.478 0.486 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -134.87 9.23 3.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.228 0.537 . . . . 0.0 110.969 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 163.9 27.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.0 111.334 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.2 t -115.88 122.28 69.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.29 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.34 122.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.32 136.92 45.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.379 0.609 . . . . 0.0 110.817 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -125.9 130.72 51.86 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 178.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB3' HG11 ' A' ' 33' ' ' VAL . 43.3 mt-10 -110.33 136.53 49.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.246 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.5 t -94.34 111.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 115.39 25.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.44 113.89 7.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.606 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.12 -20.83 11.26 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -111.65 -61.06 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.815 0.817 . . . . 0.0 110.021 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.36 -158.83 22.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.287 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.24 131.08 36.96 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.376 0.608 . . . . 0.0 110.558 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' THR . 93.2 t -113.23 121.14 64.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.019 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -91.41 128.68 37.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.624 0.25 . . . . 0.0 110.926 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.9 mt -86.94 159.91 50.66 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 20.1 Cg_endo -62.74 132.05 35.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.063 1.842 . . . . 0.0 111.128 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -57.02 127.23 30.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.58 0.705 . . . . 0.0 111.191 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtm -104.19 130.05 51.95 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.6 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.83 132.09 41.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -124.39 146.74 48.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.549 ' HG2' HD11 ' A' ' 80' ' ' LEU . 73.5 mmtt -121.69 155.45 35.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.699 0.761 . . . . 0.0 110.663 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.5 115.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.522 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.2 mt -81.99 -54.0 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -136.39 153.11 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.77 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -148.25 150.9 34.52 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.9 t -143.57 139.09 29.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.617 0.246 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -68.98 -17.72 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.669 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.24 -44.92 86.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.413 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.59 30.54 0.22 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.802 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 p -135.0 131.25 36.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 mt -135.32 137.59 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.328 -177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -117.5 123.62 46.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.7 pt -132.59 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.154 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.585 ' HB2' HD11 ' A' ' 67' ' ' ILE . 34.0 tt0 -139.38 142.21 37.55 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -71.83 174.19 7.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.077 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 65' ' ' LYS . 76.5 mt -127.85 174.58 9.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.99 -152.76 31.8 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 -9.49 20.08 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.381 2.054 . . . . 0.0 111.952 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -102.34 20.5 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -95.43 2.64 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -172.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 77.1 Cg_endo -93.87 -4.58 2.76 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 CA-C-N 121.393 1.533 . . . . 0.0 112.368 162.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.85 112.02 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.679 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -99.81 170.26 8.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.56 . . . . 0.0 110.995 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -130.35 158.3 40.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.089 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.7 m -128.98 142.01 51.07 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.014 0.435 . . . . 0.0 111.069 -177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.8 mt -121.1 123.62 42.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.097 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.496 ' HE3' HG21 ' A' ' 89' ' ' THR . 93.3 mttt -132.0 155.37 48.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.107 0.479 . . . . 0.0 111.371 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -84.63 152.36 23.86 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.428 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.59 -156.79 32.36 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.344 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -83.34 -28.7 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -109.16 -165.15 0.99 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.266 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.88 54.01 4.64 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -117.34 154.61 30.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.611 0.243 . . . . 0.0 110.647 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 91' ' ' LYS . 61.5 tp -106.93 127.88 53.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.126 0.489 . . . . 0.0 110.749 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 66.7 mt -99.33 110.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.29 173.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -102.41 115.99 31.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 25.6 mt-10 -98.71 130.36 45.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.416 0.626 . . . . 0.0 110.119 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 1.2 tm0? -153.76 132.11 12.0 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 1.6 t-20 66.68 10.99 7.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.504 0.502 . . . . 0.0 111.865 172.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.93 1.77 55.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.964 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 58.7 mt-30 -96.0 136.76 36.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -99.13 114.03 26.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -119.98 137.92 53.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 0.0 111.882 -172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 t -119.92 124.48 46.11 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.613 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -125.73 160.66 29.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.21 0.529 . . . . 0.0 111.854 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.37 141.09 30.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.993 175.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -81.48 125.06 30.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mm -77.99 147.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--N 1.312 -1.055 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.333 -174.315 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.0 m . . . . . 0 CA--C 1.528 0.113 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 87.3 Cg_endo -97.97 133.18 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.036 2.491 . . . . 0.0 114.005 -167.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . 0.42 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 54.4 p90 -105.9 -13.25 15.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.053 173.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 13.4 p90 -106.31 -0.27 24.48 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -80.48 26.38 0.38 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.88 -165.39 12.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.932 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 22.1 m -109.8 125.97 53.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 90.2 m95 -111.92 135.45 52.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.277 0.56 . . . . 0.0 111.394 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 112' ' ' ILE . 2.8 t70 -87.64 123.31 32.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.739 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.48 76.18 3.32 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.03 3.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.675 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -153.45 141.83 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.23 158.94 0.12 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 123.904 0.752 . . . . 0.0 112.206 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.04 177.67 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.971 2.447 . . . . 0.0 112.056 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.65 -162.67 11.71 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.41 157.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.446 3.431 . . . . 0.0 114.332 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -68.71 -18.66 64.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.901 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.89 -55.43 29.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.297 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.94 50.27 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.351 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -99.38 132.77 44.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 44.9 mtpt -111.62 -18.16 12.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.923 0.392 . . . . 0.0 110.878 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 19.0 m -155.38 167.05 31.65 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.239 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.33 150.21 49.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.855 0.359 . . . . 0.0 110.471 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 132.29 39.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.904 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -112.39 131.55 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.109 0.48 . . . . 0.0 110.648 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -113.45 125.25 54.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.145 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 98.8 m-85 -101.25 118.09 36.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.129 0.49 . . . . 0.0 109.684 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -179.09 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.385 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -50.58 -58.37 5.98 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.116 0.26 . . . . 0.0 111.53 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.53 -5.8 9.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 0.0 110.691 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -115.74 155.01 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.141 0.495 . . . . 0.0 111.307 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.2 118.14 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.64 124.66 60.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.71 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -95.28 133.59 39.01 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.679 0.752 . . . . 0.0 111.126 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 118.48 23.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.615 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -104.39 131.82 51.31 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.738 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 56' ' ' GLU . 47.4 t -86.8 112.42 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.745 0.784 . . . . 0.0 110.144 -174.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.615 ' HG2' HG22 ' A' ' 33' ' ' VAL . 66.8 mtt -113.29 120.02 39.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.34 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.88 129.63 43.06 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.011 0.434 . . . . 0.0 110.284 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.53 -20.38 48.66 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.278 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HG3' ' CB ' ' A' ' 51' ' ' MET . 7.1 mmt180 -107.01 -51.36 2.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.635 0.731 . . . . 0.0 109.553 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.48 -151.62 17.81 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.374 -172.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' HG22 ' A' ' 50' ' ' VAL . 45.4 mt-10 -81.68 121.64 26.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.241 0.521 . . . . 0.0 110.063 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -104.84 122.4 57.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.78 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -83.86 118.76 24.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 90.8 mt -95.44 163.63 21.07 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 88.4 Cg_exo -44.72 120.29 2.73 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.054 2.503 . . . . 0.0 112.773 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -71.84 141.44 49.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.104 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . 0.445 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 24.7 mmt -103.88 149.81 24.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.49 141.42 28.54 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.47 162.31 29.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.126 0.488 . . . . 0.0 111.256 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -135.88 159.18 42.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.456 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.9 t -103.67 118.46 50.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.538 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.2 mt -85.91 -50.72 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -138.74 160.11 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.214 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -147.33 135.16 21.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.74 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 t -137.51 116.67 12.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -64.86 -20.94 66.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 0.0 109.949 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -42.76 78.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.826 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.36 35.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.347 -1.406 . . . . 0.0 115.004 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -154.58 140.85 18.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.652 0.726 . . . . 0.0 111.895 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 mt -130.05 137.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.9 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HG2' HD12 ' A' ' 67' ' ' ILE . 60.0 tt0 -110.3 123.42 49.78 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 158.35 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.694 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 46.8 tt0 -132.59 147.72 52.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.411 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 96.4 m-85 -99.17 157.43 16.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.173 0.511 . . . . 0.0 110.599 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 ' CE1' ' A' ' 84' ' ' TYR . 26.2 mt -112.22 179.51 3.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.073 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -150.43 41.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.921 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.09 -12.32 15.34 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.849 2.366 . . . . 0.0 112.833 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.19 20.49 18.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.377 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -66.23 -176.19 0.22 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.694 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 59.4 Cg_exo 2.98 -3.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.484 1 C-N-CA 126.613 4.876 . . . . 0.0 120.823 -138.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 84' ' ' TYR . 56.8 tp -72.3 116.71 13.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 120.116 1.325 . . . . 0.0 110.763 176.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.62 167.35 15.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.646 0.736 . . . . 0.0 111.883 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 t -150.58 145.08 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.334 169.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 141.57 51.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.886 0.374 . . . . 0.0 110.995 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.7 mt -115.86 124.03 49.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -129.7 165.88 20.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.119 0.485 . . . . 0.0 111.607 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -77.13 147.91 36.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.135 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.43 173.11 22.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.707 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.65 -2.43 48.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.72 28.49 5.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.535 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.07 49.15 42.62 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.138 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 p -130.98 173.79 10.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.809 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -119.06 134.0 55.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.76 116.74 41.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.124 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . 0.539 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 12.4 t90 -96.73 112.43 24.19 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.0 133.37 49.89 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -149.74 129.15 12.97 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.91 22.67 13.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.089 0.471 . . . . 0.0 110.85 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.26 -8.9 68.87 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.548 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -92.48 145.65 24.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.65 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -100.54 117.01 33.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.084 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -104.06 132.81 49.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.473 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 t -100.92 126.64 47.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.542 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 59.4 mtm -117.61 144.46 45.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 1.1 m -96.92 158.69 15.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.997 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.316 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 22' ' ' ASP . 24.1 mm -71.59 146.6 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 . . . . . 0 C--N 1.314 -0.969 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.43 -171.651 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m . . . . . 0 N--CA 1.453 -0.278 0 N-CA-C 109.927 -0.397 . . . . 0.0 109.927 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.477 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.6 Cg_endo -83.58 123.73 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.199 2.599 . . . . 0.0 111.578 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -69.45 -9.36 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.12 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -113.24 -0.72 14.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.688 0.28 . . . . 0.0 111.619 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 58.2 t80 -97.99 126.64 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.141 0.496 . . . . 0.0 111.501 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -160.64 24.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.261 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' THR . . . . . 0.43 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 29.1 m -101.39 123.72 45.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.803 0.335 . . . . 0.0 110.403 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -104.85 139.63 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 111.851 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HB2' ' CD1' ' A' ' 112' ' ' ILE . 8.7 t70 -79.02 123.66 27.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.822 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 4.3 mm-40 -88.76 85.53 6.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.394 172.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -38.13 5.24 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.622 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -137.54 141.78 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 165.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -131.11 140.98 40.29 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.705 -171.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 27.6 Cg_endo -97.93 143.89 0.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.957 3.105 . . . . 0.0 111.293 168.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.49 -157.92 25.8 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.498 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 50.9 Cg_exo -49.05 161.62 0.53 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 125.006 3.804 . . . . 0.0 114.069 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.06 13.7 16.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.492 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.01 -28.1 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.87 59.55 0.59 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.45 133.31 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -96.03 -23.24 16.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 111.556 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -157.98 163.21 38.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -148.7 165.89 30.01 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 3.3 p -133.35 132.9 41.8 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.743 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 120.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.444 0.64 . . . . 0.0 109.596 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -108.93 126.11 52.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -100.66 117.64 35.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -100.16 173.61 6.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.347 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' HG22 ' A' ' 41' ' ' THR . 37.5 tt0 -50.38 -40.18 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -136.24 -0.59 2.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.099 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -126.05 151.66 46.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.942 -0.473 . . . . 0.0 111.759 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.84 118.89 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.85 124.06 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -98.07 139.15 34.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.315 0.578 . . . . 0.0 110.778 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -123.58 136.63 54.63 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.536 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 32.7 mt-10 -97.48 130.28 44.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.02 107.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' MET . . . . . 0.599 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -133.85 133.16 41.22 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.3 -169.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -80.38 88.8 5.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.091 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.65 -52.78 0.47 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.499 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 51' ' ' MET . 10.0 ptp180 -94.62 -33.11 13.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.52 -173.18 29.55 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.0 mp0 -67.33 117.22 9.03 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.774 0.797 . . . . 0.0 110.803 174.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -124.73 128.29 73.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.627 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 131.72 36.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.976 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.0 mt -89.86 162.25 36.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.735 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 76.5 Cg_exo -47.2 121.37 5.2 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.795 2.33 . . . . 0.0 112.307 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -70.62 141.16 51.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.295 0.569 . . . . 0.0 110.954 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -107.96 147.68 30.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.79 148.08 26.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.791 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -145.04 154.72 42.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.515 ' HG3' HD11 ' A' ' 80' ' ' LEU . 55.4 mtpt -128.46 156.19 43.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.41 124.22 49.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.843 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 78' ' ' GLN . 18.3 mt -87.49 -50.25 13.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -144.92 155.74 43.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.348 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.43 128.65 12.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.415 0.626 . . . . 0.0 111.108 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB3' ' H ' ' A' ' 74' ' ' SER . 38.4 t -136.56 147.14 46.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.3 p -80.85 -23.21 39.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.698 0.285 . . . . 0.0 111.593 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -143.16 -10.07 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.5 -83.22 1.06 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.337 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 70' ' ' SER . 4.1 p -164.37 153.67 13.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 122.84 0.456 . . . . 0.0 110.532 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 25.2 mt -114.09 138.01 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.2 tt0 -120.49 124.93 46.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.0 110.181 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -128.44 157.73 40.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.342 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 67' ' ' ILE . 57.3 tt0 -130.03 144.14 51.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -82.63 167.38 18.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.515 HD11 ' HG3' ' A' ' 65' ' ' LYS . 95.8 mt -129.22 166.48 19.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.334 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.53 -153.78 17.51 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.38 -21.9 46.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.038 1.825 . . . . 0.0 111.6 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -105.64 40.72 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.083 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' TYR . . . . . 0.477 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 45.8 p90 -78.15 -33.16 0.94 Allowed Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 85.9 Cg_endo -74.04 -3.6 14.05 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 CA-C-N 121.222 1.472 . . . . 0.0 113.068 -170.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 tp -88.1 124.83 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.156 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -111.66 168.97 9.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -138.29 153.45 49.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.63 -173.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -120.08 142.26 49.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.0 mt -125.95 124.41 40.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.74 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.564 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 85.9 mttt -130.52 163.35 27.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.039 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -86.79 143.67 27.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.72 -146.26 17.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.28 125.93 35.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.06 -153.09 0.28 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.79 53.19 4.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.124 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 p -115.68 144.01 44.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 HD22 ' A' ' 90' ' ' LEU . 29.9 tp -109.57 133.68 52.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 70.9 mt -98.48 110.28 25.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 175.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -105.94 114.8 29.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 32.8 mt-10 -106.2 131.72 53.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.651 0.738 . . . . 0.0 110.321 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 1.2 tm0? -151.75 135.18 16.07 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.016 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.7 OUTLIER 65.09 9.12 5.25 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.796 0.331 . . . . 0.0 111.621 176.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.98 13.42 57.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.654 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 3.5 pt20 -120.93 149.0 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -96.07 125.85 40.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.325 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.589 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.1 mmpt? -111.71 139.75 46.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.544 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.3 m -105.25 114.66 28.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.722 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 64.2 mmm -101.85 133.15 47.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.62 142.87 33.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 111' ' ' ARG . 8.9 ttp180 -82.63 130.56 35.14 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.147 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.4 mm -62.83 144.58 14.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 121.422 0.63 . . . . 0.0 110.868 -171.602 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.481 1.117 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.521 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -135.33 164.55 32.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.135 0.493 . . . . 0.0 111.333 -177.097 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 59.7 ttp -106.98 116.03 31.21 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 172.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 58.7 t -70.72 110.9 4.05 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 120.983 0.421 . . . . 0.0 110.687 -174.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 10.2 t -75.44 160.47 30.2 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.368 -178.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 164.49 137.95 2.3 Favored Glycine 0 N--CA 1.443 -0.835 0 N-CA-C 111.473 -0.651 . . . . 0.0 111.473 179.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.7 m -140.96 -59.35 0.5 Allowed 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.527 0.164 . . . . 0.0 110.655 -179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 64.08 -167.07 0.22 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 123.457 0.473 . . . . 0.0 110.548 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -143.65 150.14 38.31 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 174.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -86.98 123.28 31.91 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 121.163 0.506 . . . . 0.0 110.807 179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.417 ' HD3' ' HA ' ' A' ' 11' ' ' LYS . 71.1 mmtt -81.35 -22.41 38.46 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.495 0.664 . . . . 0.0 109.225 174.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.485 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 1.8 pm0 -75.59 135.33 40.54 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 115.011 -0.995 . . . . 0.0 109.019 171.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -64.85 145.5 56.18 Favored 'General case' 0 N--CA 1.438 -1.073 0 CA-C-O 121.725 0.774 . . . . 0.0 111.627 -176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 27.5 m -144.7 80.66 11.46 Favored Pre-proline 0 C--N 1.314 -0.974 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.007 175.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -70.96 115.72 4.38 Favored 'Trans proline' 0 N--CA 1.462 -0.33 0 C-N-CA 122.378 2.052 . . . . 0.0 111.717 177.178 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 38.9 p90 -67.07 -14.94 63.38 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.121 -174.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 14.2 p90 -94.4 -18.63 21.36 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.75 0.309 . . . . 0.0 111.417 -178.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 48.7 t80 -77.28 139.84 39.91 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.765 0.317 . . . . 0.0 110.62 -174.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.32 -152.62 21.22 Favored Glycine 0 N--CA 1.447 -0.588 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.307 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 13.4 m -126.8 128.25 46.28 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.365 -0.605 . . . . 0.0 109.365 178.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.654 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 55.5 m95 -118.51 143.75 46.52 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.849 0.357 . . . . 0.0 111.563 -173.399 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.784 ' HB2' HD11 ' A' ' 112' ' ' ILE . 19.4 t70 -90.89 120.27 31.77 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.749 -0.659 . . . . 0.0 112.326 -178.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.735 ' O ' ' HG3' ' A' ' 23' ' ' GLU . 1.3 tp10 -106.53 36.44 2.62 Favored 'General case' 0 N--CA 1.436 -1.135 0 CA-C-O 123.39 1.567 . . . . 0.0 107.781 171.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -76.19 70.66 2.09 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 114.573 -1.194 . . . . 0.0 112.656 -175.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 72.1 mtt180 -95.54 -168.0 1.71 Allowed 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.156 171.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . -75.86 144.49 76.37 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-O 120.943 0.401 . . . . 0.0 111.499 -176.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.527 ' HB3' ' HA ' ' A' ' 34' ' ' LYS . 10.0 Cg_exo -71.73 -178.93 3.36 Favored 'Trans proline' 0 C--O 1.237 0.436 0 C-N-CA 123.414 2.742 . . . . 0.0 113.17 -177.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -141.28 -151.46 5.56 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.495 -177.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -61.16 -163.0 0.03 OUTLIER 'Trans proline' 0 CA--C 1.536 0.601 0 C-N-CA 123.561 2.841 . . . . 0.0 112.588 175.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 38.0 p -52.81 -34.43 53.61 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 121.218 0.532 . . . . 0.0 111.889 -179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.618 ' HB3' ' HA ' ' A' ' 131' ' ' HIS . 10.1 m-20 -101.82 17.14 23.79 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.894 -0.593 . . . . 0.0 110.664 -179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -108.4 77.57 0.23 Allowed Glycine 0 N--CA 1.444 -0.776 0 N-CA-C 110.486 -1.045 . . . . 0.0 110.486 176.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.723 HG11 ' HB3' ' A' ' 49' ' ' GLU . 99.0 t -54.76 144.67 5.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 123.554 0.742 . . . . 0.0 112.079 -176.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.566 ' HD2' ' HB2' ' A' ' 52' ' ' GLU . 8.9 mtpm? -55.63 -40.68 72.49 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-N 115.348 -0.842 . . . . 0.0 112.398 -173.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -154.69 163.39 40.31 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.802 -177.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.474 ' HA ' ' HA ' ' A' ' 49' ' ' GLU . . . -143.23 150.32 39.15 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 120.834 0.35 . . . . 0.0 110.573 178.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.3 p -134.0 140.56 46.79 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 175.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.429 ' CG1' ' HB2' ' A' ' 21' ' ' TRP . 7.2 p -112.4 129.68 67.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 C-N-CA 120.293 -0.563 . . . . 0.0 110.757 -179.58 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 70.5 m -108.4 125.93 52.3 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.978 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 66.3 m-85 -100.59 117.21 34.26 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.101 0.476 . . . . 0.0 110.076 178.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.605 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -102.35 -179.64 4.04 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.124 -0.943 . . . . 0.0 109.71 -179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.605 ' H ' HG22 ' A' ' 41' ' ' THR . 37.0 tt0 -44.33 -70.19 0.11 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.128 0.971 . . . . 0.0 113.057 -178.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -125.21 9.84 8.02 Favored 'General case' 0 C--O 1.237 0.425 0 CA-C-O 121.226 0.536 . . . . 0.0 110.78 -177.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.589 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 1.5 pm0 -133.69 150.61 51.53 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.281 -0.872 . . . . 0.0 110.358 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 30.7 t -112.51 133.89 56.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.567 HG22 ' HB3' ' A' ' 61' ' ' PHE . 22.1 t -116.89 122.51 70.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.952 -0.299 . . . . 0.0 110.535 -179.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -94.83 139.84 30.73 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.335 0.588 . . . . 0.0 111.227 176.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -127.51 133.39 49.84 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 115.172 -0.922 . . . . 0.0 109.41 178.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.723 ' HB3' HG11 ' A' ' 33' ' ' VAL . 49.4 mt-10 -125.27 134.4 52.3 Favored 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 174.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.589 HG22 ' HG3' ' A' ' 56' ' ' GLU . 21.3 t -91.11 108.51 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.359 0 CA-C-O 121.336 0.588 . . . . 0.0 109.938 -176.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.455 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 66.8 mtt -99.3 138.43 36.41 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.29 -0.868 . . . . 0.0 110.118 -172.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.566 ' HB2' ' HD2' ' A' ' 34' ' ' LYS . 34.6 tt0 -64.53 115.21 4.94 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.781 0.324 . . . . 0.0 110.472 -179.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.91 -13.69 63.43 Favored Glycine 0 N--CA 1.448 -0.54 0 C-N-CA 121.037 -0.602 . . . . 0.0 112.433 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.455 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 0.1 OUTLIER -113.43 -37.51 4.64 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.352 0.596 . . . . 0.0 110.436 -178.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.8 -159.83 29.5 Favored Glycine 0 N--CA 1.451 -0.321 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.589 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.2 mp0 -62.33 126.53 27.66 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-O 121.574 0.702 . . . . 0.0 110.944 174.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.6 t -125.21 121.39 60.58 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 114.865 -1.061 . . . . 0.0 108.843 176.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.715 HE22 ' HB3' ' A' ' 122' ' ' ASP . 7.7 mt-30 -88.2 131.25 34.82 Favored 'General case' 0 N--CA 1.443 -0.818 0 CA-C-O 121.016 0.436 . . . . 0.0 110.804 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.528 HD22 ' OE2' ' A' ' 129' ' ' GLU . 42.8 mt -88.0 165.04 31.38 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.483 -0.78 . . . . 0.0 110.493 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 51.6 Cg_exo -49.79 120.31 5.8 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 122.87 2.38 . . . . 0.0 111.499 173.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.567 ' HB3' HG22 ' A' ' 46' ' ' VAL . 11.0 p90 -64.3 134.14 54.1 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.337 0.589 . . . . 0.0 111.653 -175.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.5 mmm -102.07 129.91 48.52 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.379 -0.828 . . . . 0.0 110.48 -179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.559 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -77.13 148.94 35.73 Favored 'General case' 0 C--N 1.324 -0.524 0 C-N-CA 120.944 -0.302 . . . . 0.0 110.338 179.158 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 28.3 p90 -140.14 153.83 46.8 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.62 0.248 . . . . 0.0 110.517 178.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.422 ' HE3' HD11 ' A' ' 80' ' ' LEU . 92.6 mttt -126.27 149.47 49.09 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.229 0.537 . . . . 0.0 110.362 172.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.401 ' HA ' HG22 ' A' ' 77' ' ' ILE . 94.5 t -93.79 116.11 34.23 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.281 -178.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.495 HD11 ' HB2' ' A' ' 78' ' ' GLN . 21.6 mt -84.81 -52.45 12.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.428 0.632 . . . . 0.0 109.549 178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -133.93 150.36 51.31 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.093 178.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -149.13 155.54 40.83 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-O 120.89 0.376 . . . . 0.0 111.019 -175.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 36.5 t -125.02 158.81 32.79 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 173.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 10.5 t -67.9 -33.0 73.86 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 176.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -169.95 90.45 0.18 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.873 174.611 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -171.1 -78.04 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.703 177.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 33.0 t -139.86 155.77 47.05 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.088 0.47 . . . . 0.0 110.184 178.238 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.491 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 60.2 mt -135.11 137.19 50.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.669 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -116.64 121.67 42.35 Favored 'General case' 0 C--N 1.321 -0.674 0 N-CA-C 109.307 -0.627 . . . . 0.0 109.307 177.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.444 HG23 HG22 ' A' ' 75' ' ' ILE . 35.3 pt -132.92 151.43 34.29 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.832 -0.622 . . . . 0.0 111.313 -174.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.495 ' HB2' HD11 ' A' ' 67' ' ' ILE . 18.1 tt0 -124.54 136.73 54.22 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.391 176.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.1 m-85 -79.91 170.1 16.96 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.727 -176.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.559 ' HB2' ' HB3' ' A' ' 63' ' ' ALA . 88.5 mt -131.39 146.8 52.43 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 173.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . 0.439 ' O ' ' HD1' ' A' ' 84' ' ' TYR . . . 121.21 -153.71 16.6 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -174.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -67.95 -13.09 37.35 Favored 'Trans proline' 0 CA--C 1.532 0.404 0 C-N-CA 122.632 2.221 . . . . 0.0 112.601 -179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 80.0 m-85 -125.83 46.32 2.43 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.243 -0.435 . . . . 0.0 109.993 -178.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.573 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 32.9 p90 -84.5 -36.55 0.61 Allowed Pre-proline 0 N--CA 1.448 -0.543 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -172.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.573 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 61.0 Cg_endo -75.32 -4.41 15.29 Favored 'Trans proline' 0 N--CA 1.446 -1.313 0 CA-C-N 121.097 1.427 . . . . 0.0 113.431 -170.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 41.3 tp -101.26 109.52 21.39 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 109.67 -0.493 . . . . 0.0 109.67 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 63.9 pttt -86.95 166.47 15.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 -178.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -131.38 163.16 28.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.996 -176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 3.6 m -121.25 141.74 50.59 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 121.036 0.446 . . . . 0.0 110.708 -179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.491 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.7 mt -128.59 137.9 51.94 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.874 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.52 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 79.1 mttt -141.58 156.65 45.68 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 179.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 26.1 ptt180 -78.89 144.18 35.17 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 109.816 -0.439 . . . . 0.0 109.816 176.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.59 -171.4 15.12 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.891 -176.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 80.5 mm-40 -78.44 155.63 29.81 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.583 -0.308 . . . . 0.0 110.873 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 71.81 -55.44 0.66 Allowed 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.757 0.823 . . . . 0.0 111.049 178.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 160.08 40.6 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 110.069 -1.212 . . . . 0.0 110.069 -178.485 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.517 HG22 ' HA ' ' A' ' 110' ' ' THR . 28.5 p -108.11 171.9 7.14 Favored 'General case' 0 N--CA 1.448 -0.535 0 CA-C-O 121.14 0.495 . . . . 0.0 111.591 -173.195 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.423 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 52.3 tp -118.61 132.67 56.19 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.323 177.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 73.0 mt -97.72 110.05 24.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 177.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.414 ' CZ3' HG21 ' A' ' 38' ' ' VAL . 4.2 t90 -103.98 115.02 29.68 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.456 -0.793 . . . . 0.0 109.171 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.413 ' HG2' ' HA ' ' A' ' 106' ' ' ARG . 35.5 mt-10 -112.39 131.54 55.49 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.884 0.85 . . . . 0.0 111.205 178.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -151.76 131.32 13.05 Favored 'General case' 0 C--N 1.309 -1.167 0 CA-C-N 114.105 -1.407 . . . . 0.0 109.046 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 67.57 12.12 8.72 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 123.347 0.404 . . . . 0.0 111.13 174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 93.56 -2.89 70.97 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 121.031 -0.604 . . . . 0.0 112.274 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 23.7 mm-40 -92.61 135.18 34.31 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 120.792 0.33 . . . . 0.0 110.458 177.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.413 ' HA ' ' HG2' ' A' ' 101' ' ' GLU . 22.5 ttt180 -102.31 116.81 33.41 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.488 -179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.7 mmmt -118.09 128.36 54.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.948 0.404 . . . . 0.0 111.571 -179.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 47.3 m -95.01 119.21 33.13 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.104 176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.654 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 20.7 mmt -107.19 135.26 49.02 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.85 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.517 ' HA ' HG22 ' A' ' 97' ' ' THR . 0.2 OUTLIER -96.61 146.74 24.56 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.811 -0.441 . . . . 0.0 109.811 176.877 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.533 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 26.6 ttp180 -93.27 128.91 39.46 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.931 0.396 . . . . 0.0 110.783 -177.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.784 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.2 mm -84.39 150.25 4.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.548 -0.751 . . . . 0.0 109.956 178.163 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -94.15 99.32 11.62 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-O 121.505 0.669 . . . . 0.0 110.138 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.7 t -154.75 168.57 26.41 Favored 'General case' 0 C--N 1.314 -0.963 0 CA-C-N 114.805 -1.089 . . . . 0.0 108.159 178.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.496 ' HE2' ' HB3' ' A' ' 120' ' ' GLU . 99.1 mttt 57.91 31.12 20.13 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 121.267 0.556 . . . . 0.0 110.716 -178.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.4 m -77.32 46.45 0.51 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.379 -0.828 . . . . 0.0 111.137 -177.069 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 104.88 25.64 6.73 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.214 -178.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.89 130.09 22.18 Favored 'General case' 0 N--CA 1.446 -0.671 0 CA-C-O 121.035 0.445 . . . . 0.0 110.02 -177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -57.65 123.42 15.55 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.057 177.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.496 ' HB3' ' HE2' ' A' ' 115' ' ' LYS . 41.0 tt0 -129.29 110.61 12.09 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 45.8 tttm -82.93 147.14 28.43 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.256 -176.312 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.715 ' HB3' HE22 ' A' ' 58' ' ' GLN . 1.3 m-20 -73.48 160.58 31.51 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.977 176.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.53 ' H ' ' NE2' ' A' ' 58' ' ' GLN . 7.4 tp10 -110.39 148.6 31.67 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 175.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -113.82 118.33 33.94 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.238 -177.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 46.0 m -138.8 128.45 24.74 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.063 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -98.33 105.38 17.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.061 0.458 . . . . 0.0 109.779 179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 44.2 t -109.55 128.93 55.55 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.417 -177.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 53.3 tp -85.2 99.13 10.89 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.389 -0.967 . . . . 0.0 108.389 172.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.528 ' OE2' HD22 ' A' ' 59' ' ' LEU . 7.6 pt-20 -144.11 159.14 43.14 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.292 0.568 . . . . 0.0 112.385 -166.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -140.91 23.69 2.23 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.259 -0.882 . . . . 0.0 108.947 173.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.618 ' HA ' ' HB3' ' A' ' 31' ' ' ASP . 0.5 OUTLIER -53.33 138.18 33.28 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 114.935 -1.03 . . . . 0.0 111.87 179.517 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -143.18 91.46 2.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.878 -179.255 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.1 p-80 -74.5 125.35 28.39 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 172.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 33.7 p80 -143.8 173.44 11.68 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 120.917 0.389 . . . . 0.0 111.266 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 . . . . . 0 C--O 1.249 1.072 0 CA-C-O 117.95 -1.024 . . . . 0.0 108.901 176.504 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.8 mtt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 120.871 0.367 . . . . 0.0 110.131 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 48.9 pt -139.92 164.59 23.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.374 178.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 90.2 mtp -129.68 104.53 7.48 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 175.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 7.1 p -63.5 135.97 26.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.117 179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.5 m -132.16 133.74 44.6 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.916 0.389 . . . . 0.0 110.708 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.39 -153.54 17.66 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.8 -0.714 . . . . 0.0 112.076 178.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 76.9 m 62.98 19.77 11.84 Favored 'General case' 0 N--CA 1.464 0.271 0 C-N-CA 122.789 0.435 . . . . 0.0 111.464 178.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -126.9 151.5 48.35 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.294 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 65.17 23.2 12.3 Favored 'General case' 0 N--CA 1.463 0.202 0 O-C-N 123.866 0.729 . . . . 0.0 111.51 -175.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.6 tt0 -90.58 121.92 32.94 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 176.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -120.54 122.49 40.71 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.59 0.234 . . . . 0.0 110.399 179.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -118.98 117.13 27.97 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 174.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -80.17 5.93 13.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.574 0.702 . . . . 0.0 111.662 -178.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 7.9 m -59.09 119.6 39.82 Favored Pre-proline 0 C--N 1.306 -1.313 0 CA-C-N 114.295 -1.32 . . . . 0.0 110.267 177.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -55.34 110.59 0.57 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.831 2.354 . . . . 0.0 112.424 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.1 p90 -62.71 -26.86 68.89 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.698 -176.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.509 ' HB2' HD13 ' A' ' 90' ' ' LEU . 21.8 p90 -88.44 -13.22 40.94 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.71 -175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 46.4 t80 -86.57 142.01 28.61 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.622 0.249 . . . . 0.0 110.387 -174.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 136.79 -159.66 24.62 Favored Glycine 0 N--CA 1.446 -0.657 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.502 177.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 3.1 m -116.49 122.27 44.24 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.622 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 69.4 m95 -116.25 136.54 52.92 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.134 0.493 . . . . 0.0 111.543 -172.807 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.582 ' HB2' HG12 ' A' ' 112' ' ' ILE . 26.3 t70 -110.26 151.51 27.28 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.219 176.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 56.3 mt-10 -63.05 -23.36 67.41 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.754 0.312 . . . . 0.0 111.581 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 112.05 -59.05 0.38 Allowed Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.262 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 66.6 ttt180 -170.27 170.86 7.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 -177.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 75.42 148.75 0.12 Allowed Pre-proline 0 N--CA 1.473 0.711 0 C-N-CA 123.892 0.877 . . . . 0.0 111.655 178.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.532 ' HA ' ' O ' ' A' ' 34' ' ' LYS . 60.8 Cg_endo -73.09 176.88 8.51 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.955 2.436 . . . . 0.0 113.152 -179.174 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -113.84 -152.74 10.85 Favored Glycine 0 N--CA 1.447 -0.579 0 CA-C-N 115.481 -0.781 . . . . 0.0 112.324 -177.013 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 3.2 Cg_endo -48.19 154.32 2.47 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 123.759 2.972 . . . . 0.0 113.471 178.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.3 t -69.08 -4.73 18.3 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.508 -0.769 . . . . 0.0 112.229 -174.338 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -57.99 -22.78 51.1 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.878 176.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 125.58 22.07 1.89 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.949 -0.643 . . . . 0.0 111.947 178.526 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.409 HG21 ' HG2' ' A' ' 29' ' ' PRO . 20.1 t -89.16 132.55 33.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-O 121.059 0.456 . . . . 0.0 110.187 -177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.532 ' O ' ' HA ' ' A' ' 27' ' ' PRO . 58.6 mtmt -99.7 -14.96 18.68 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.835 -0.62 . . . . 0.0 110.107 -179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.7 p 176.9 159.57 0.36 Allowed 'General case' 0 CA--C 1.515 -0.377 0 CA-C-N 114.718 -1.128 . . . . 0.0 109.732 175.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.518 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -122.44 136.8 54.97 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.125 0.488 . . . . 0.0 110.331 177.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 17.7 p -118.39 130.74 56.16 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 116.011 -0.541 . . . . 0.0 109.664 178.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -112.78 134.51 55.17 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.298 0.571 . . . . 0.0 110.225 -177.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.468 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 12.0 m -120.19 126.27 50.23 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.207 -178.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 81.9 m-85 -101.3 118.29 36.68 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.244 0.545 . . . . 0.0 110.206 179.717 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -96.77 175.86 6.21 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 179.113 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' H ' HG22 ' A' ' 41' ' ' THR . 23.1 tt0 -60.96 -35.63 77.29 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 111.682 0.253 . . . . 0.0 111.682 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -128.84 -8.63 4.97 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 121.036 -0.266 . . . . 0.0 111.464 -179.44 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.551 ' HB3' ' HB2' ' A' ' 61' ' ' PHE . 2.2 mp0 -126.68 153.51 45.32 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.225 0.536 . . . . 0.0 112.219 -169.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.454 HG23 ' CD1' ' A' ' 64' ' ' TYR . 89.4 t -107.2 120.31 58.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.581 171.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 61' ' ' PHE . 52.2 t -107.06 125.06 63.19 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 178.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 39.8 tt0 -112.01 127.3 55.84 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.058 0.456 . . . . 0.0 110.305 -179.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.414 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.96 128.03 54.41 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.763 -179.721 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 37.7 mt-10 -99.92 129.43 46.0 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 175.798 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.474 HG22 ' HG2' ' A' ' 56' ' ' GLU . 44.8 t -90.24 110.11 21.57 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 170.129 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 47.9 ttm -122.56 145.2 48.55 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.029 -173.556 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -62.89 135.07 57.12 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.839 0.352 . . . . 0.0 110.217 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.56 -56.65 1.97 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.288 179.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 18.1 ptt180 -95.7 -33.7 12.22 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -174.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 93.76 -149.39 19.41 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.638 -0.791 . . . . 0.0 111.952 178.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.513 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 45.1 mt-10 -72.92 115.25 12.0 Favored 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 121.391 0.615 . . . . 0.0 111.111 177.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 50.6 t -108.75 122.52 63.47 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 CA-C-N 115.001 -1.0 . . . . 0.0 109.408 175.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.414 ' HG2' HG23 ' A' ' 48' ' ' THR . 85.7 mt-30 -85.86 119.17 25.89 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.495 -177.765 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.1 154.67 67.21 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 115.925 -0.579 . . . . 0.0 110.329 177.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -48.73 122.98 8.85 Favored 'Trans proline' 0 C--O 1.234 0.281 0 C-N-CA 122.992 2.461 . . . . 0.0 112.3 177.586 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.557 ' HB3' HG22 ' A' ' 46' ' ' VAL . 37.0 p90 -64.64 139.91 58.81 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.075 -178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.4 mtm -112.09 133.49 54.22 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.782 -0.645 . . . . 0.0 110.776 -179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -79.28 134.73 36.63 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.815 0.341 . . . . 0.0 110.68 -179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.454 ' CD1' HG23 ' A' ' 45' ' ' VAL . 37.1 p90 -130.98 157.12 43.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.089 -178.29 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.587 ' HE3' HD11 ' A' ' 80' ' ' LEU . 96.7 mttt -127.05 158.99 35.5 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.51 174.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 95.1 t -97.16 119.94 45.85 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.952 0 CA-C-N 115.072 -0.967 . . . . 0.0 110.959 -177.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.613 HD11 ' HB2' ' A' ' 78' ' ' GLN . 17.7 mt -82.58 -56.36 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 121.744 0.783 . . . . 0.0 109.404 177.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.6 m -127.68 153.83 46.02 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.501 -178.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -148.28 148.02 29.99 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.178 -172.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.9 t -145.23 147.28 32.24 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 173.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 17.4 p -77.15 -26.81 53.44 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 121.084 0.469 . . . . 0.0 110.131 176.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 18.6 t0 -151.98 70.06 0.92 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.214 179.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -165.06 -88.75 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.833 0 CA-C-N 115.45 -0.795 . . . . 0.0 111.882 175.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 46.8 t -152.43 157.78 41.71 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.175 0.512 . . . . 0.0 110.574 -179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 12.5 mt -133.51 135.07 56.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.5 -0.773 . . . . 0.0 109.057 178.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -117.56 128.54 55.06 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 -178.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 38.7 pt -124.39 157.06 32.22 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-O 121.26 0.553 . . . . 0.0 111.416 -175.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.691 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 34.8 tt0 -134.41 144.63 48.28 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.458 -0.792 . . . . 0.0 110.102 -178.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -92.86 151.1 20.17 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 109.724 -0.472 . . . . 0.0 109.724 178.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.587 HD11 ' HE3' ' A' ' 65' ' ' LYS . 94.8 mt -99.86 163.72 12.33 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.562 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 91.08 -152.5 21.71 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.458 -0.877 . . . . 0.0 110.956 -175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -64.84 -6.68 13.07 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.368 2.045 . . . . 0.0 111.956 176.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.7 m-85 -91.51 10.11 29.21 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.251 177.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.717 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.8 OUTLIER -61.28 170.17 1.82 Allowed Pre-proline 0 CA--C 1.53 0.198 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.747 177.787 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.717 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 9.4 Cg_exo 9.42 -1.33 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.15 1 C-N-CA 128.173 5.915 . . . . 0.0 120.681 -148.344 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 84' ' ' TYR . 34.6 tp -74.3 103.84 4.84 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 167.117 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.4 pttt -113.33 173.47 6.39 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 112.894 0.702 . . . . 0.0 112.894 -167.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 9.2 t -138.52 149.29 45.21 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 114.632 -1.167 . . . . 0.0 109.524 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.494 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.3 m -122.18 143.35 49.62 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.899 0.38 . . . . 0.0 110.94 -174.548 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.509 HD13 ' HB2' ' A' ' 17' ' ' TYR . 94.9 mt -121.65 131.8 54.3 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.135 179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 85.0 mttt -134.57 155.88 49.67 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.636 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -74.13 144.65 44.8 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.025 0.44 . . . . 0.0 110.632 -178.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.39 145.38 18.34 Favored Glycine 0 N--CA 1.436 -1.313 0 N-CA-C 110.406 -1.078 . . . . 0.0 110.406 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.2 mm-40 -70.41 158.6 35.71 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-O 120.568 0.223 . . . . 0.0 110.797 -178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 67.83 12.86 9.02 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.63 -0.714 . . . . 0.0 111.345 -177.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 85.72 56.11 2.42 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.894 -0.67 . . . . 0.0 112.791 177.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.4 p -130.58 173.0 11.3 Favored 'General case' 0 C--N 1.325 -0.472 0 O-C-N 122.774 -0.251 . . . . 0.0 110.795 178.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 40.9 tp -129.27 133.25 47.41 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.821 0.343 . . . . 0.0 110.359 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.9 mt -98.37 114.22 35.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 22.9 t90 -103.83 113.43 26.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.5 -178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.509 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 28.7 mt-10 -103.29 139.03 39.27 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.421 177.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -145.99 122.27 10.9 Favored 'General case' 0 C--N 1.303 -1.427 0 CA-C-N 115.554 -0.748 . . . . 0.0 109.446 177.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.45 ' N ' HD22 ' A' ' 103' ' ' ASN . 0.9 OUTLIER 67.32 8.9 6.59 Favored 'General case' 0 N--CA 1.468 0.426 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.249 179.008 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.1 -14.77 25.98 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.649 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 32.5 mt-30 -93.33 133.39 36.62 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.509 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 30.6 ptt180 -102.41 124.33 47.79 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 121.4 0.619 . . . . 0.0 112.223 177.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 20.9 tptm -112.35 130.45 55.96 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.13 173.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.2 m -93.14 119.27 32.16 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.006 0.431 . . . . 0.0 110.535 -177.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.622 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 24.2 mmt -108.73 148.17 30.88 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.851 -177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -116.08 157.3 24.92 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.477 177.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.406 HH11 ' HD2' ' A' ' 111' ' ' ARG . 13.8 ttp180 -76.49 133.2 39.86 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 -178.377 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.582 HG12 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mt -71.23 152.04 8.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 177.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -63.96 152.67 39.36 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.087 -178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.6 m -86.92 106.47 17.81 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 177.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 53.9 mtpt -102.22 142.09 34.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.538 -174.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.8 m -137.76 82.89 1.95 Allowed 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.226 171.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.38 121.43 6.66 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.481 -178.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 42.6 ttm-85 -96.69 96.25 8.48 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.142 0.496 . . . . 0.0 110.296 -177.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 45.7 tt0 -153.83 103.78 2.63 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.45 178.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 -71.58 154.45 41.42 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.257 -177.155 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.7 ttpt -48.43 119.14 2.83 Favored 'General case' 0 N--CA 1.463 0.222 0 O-C-N 123.755 0.66 . . . . 0.0 112.389 -174.545 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -102.45 134.13 46.28 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.495 -0.775 . . . . 0.0 109.479 177.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -87.24 114.09 23.54 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.324 0.583 . . . . 0.0 111.527 -174.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 56.3 tptt -141.38 107.91 5.32 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.521 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 15.9 p -98.7 103.09 15.01 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.218 -0.447 . . . . 0.0 109.862 174.702 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -88.86 147.29 24.46 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.239 -177.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.1 m -59.08 138.1 57.68 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.744 179.152 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.1 mt -86.17 37.69 0.73 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.263 0.554 . . . . 0.0 111.391 -178.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -122.21 139.88 53.25 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 175.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -77.32 64.11 2.65 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.863 0.839 . . . . 0.0 110.658 176.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -81.2 105.54 12.48 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 114.626 -1.17 . . . . 0.0 109.192 176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 2.1 p80 -137.81 113.05 9.27 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.384 0.611 . . . . 0.0 111.169 -176.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 34.4 m-70 -135.66 131.8 36.18 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.752 175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 50.3 m80 -131.76 167.33 19.71 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 28.7 m170 . . . . . 0 C--O 1.245 0.841 0 CA-C-O 118.939 -0.553 . . . . 0.0 109.945 177.92 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.0 ttt . . . . . 0 N--CA 1.479 0.997 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 65.4 mt -74.33 113.72 13.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 74.6 mtm -91.65 94.22 9.29 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.639 -176.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 13.5 p -102.44 147.14 9.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.411 -179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.3 t -136.84 132.34 34.48 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 160.2 -165.65 34.91 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 121.133 -0.556 . . . . 0.0 111.782 -179.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 10.8 p -170.57 143.21 2.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.825 0.345 . . . . 0.0 110.446 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 79.7 mt-30 -122.72 142.19 50.97 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.261 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 90.2 mt-30 -116.11 89.49 3.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.022 0.439 . . . . 0.0 110.846 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -125.34 -169.53 2.01 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.444 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 54.0 mttp -80.07 149.39 30.68 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.154 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -63.03 136.89 58.07 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.434 177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -92.72 -173.88 3.47 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.49 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 14.7 t -66.48 119.62 64.16 Favored Pre-proline 0 C--N 1.325 -0.464 0 CA-C-O 121.43 0.633 . . . . 0.0 110.119 -177.62 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 2.4 Cg_endo -81.13 97.57 1.0 Allowed 'Trans proline' 0 N--CA 1.451 -0.989 0 C-N-CA 122.743 2.296 . . . . 0.0 112.271 -177.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 55.6 p90 -77.84 -11.51 59.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.092 0.472 . . . . 0.0 110.149 177.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 19.5 p90 -93.94 -4.31 50.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.121 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.483 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 83.4 t80 -75.63 135.74 40.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.648 -178.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.95 -166.75 19.63 Favored Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.86 -0.686 . . . . 0.0 112.37 177.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 31.1 m -108.67 128.21 54.65 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.403 ' CZ3' ' HB2' ' A' ' 98' ' ' LEU . 61.6 m95 -111.1 146.74 36.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.292 -178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -108.98 139.24 44.12 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.199 -179.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.494 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 7.2 mm-40 -45.43 -61.91 1.49 Allowed 'General case' 0 N--CA 1.465 0.295 0 O-C-N 124.124 0.89 . . . . 0.0 112.251 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 61.17 21.34 59.35 Favored Glycine 0 C--N 1.332 0.341 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.252 -170.153 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 18.9 mmt85 -116.17 -167.23 1.24 Allowed 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.016 0.527 . . . . 0.0 110.989 -174.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.22 146.99 59.55 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.34 177.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -56.08 152.61 36.46 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 123.245 2.63 . . . . 0.0 113.104 -179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.402 ' HA3' ' HD2' ' A' ' 29' ' ' PRO . . . -91.55 -153.91 30.13 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.763 -0.653 . . . . 0.0 112.545 -178.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.402 ' HD2' ' HA3' ' A' ' 28' ' ' GLY . 6.1 Cg_endo -51.38 114.84 1.73 Allowed 'Trans proline' 0 C--N 1.349 0.595 0 C-N-CA 123.43 2.753 . . . . 0.0 112.415 179.136 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.9 t -82.19 70.45 9.12 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 123.143 1.449 . . . . 0.0 111.129 -176.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -128.94 -63.34 0.97 Allowed 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 113.192 -1.822 . . . . 0.0 110.269 174.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -124.94 -49.02 0.2 Allowed Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.707 -0.759 . . . . 0.0 112.098 179.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG22 ' HG2' ' A' ' 51' ' ' MET . 6.2 t -91.65 133.27 33.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 N-CA-C 109.978 -0.379 . . . . 0.0 109.978 -179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 56.9 mtmt -108.8 -19.33 13.45 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 121.148 0.499 . . . . 0.0 110.982 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 36.8 m -161.91 165.41 27.64 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.746 -174.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -137.66 145.07 42.2 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.867 0.365 . . . . 0.0 110.838 -179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.5 p -122.77 132.25 54.14 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 10.4 p -112.43 129.85 67.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 CA-C-O 121.225 0.536 . . . . 0.0 110.795 -176.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.5 m -118.29 128.32 54.55 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.056 178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -100.22 117.98 35.57 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.549 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.2 m -101.86 176.87 5.07 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.464 -0.789 . . . . 0.0 109.428 -177.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.549 ' H ' HG22 ' A' ' 41' ' ' THR . 41.5 tt0 -50.47 -54.54 21.42 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.797 0.666 . . . . 0.0 112.797 -177.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -116.81 -21.28 9.09 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.963 0.411 . . . . 0.0 111.457 -173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -128.56 156.88 42.64 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.342 0.591 . . . . 0.0 111.646 -174.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.6 t -107.27 127.34 63.14 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.73 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 92.1 t -116.0 124.14 72.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -106.09 135.9 46.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 174.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.37 126.2 53.17 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-N 116.041 -0.527 . . . . 0.0 109.904 177.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -98.23 126.56 43.77 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 -178.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.532 HG22 ' HG2' ' A' ' 56' ' ' GLU . 45.8 t -86.3 111.53 21.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-O 121.382 0.61 . . . . 0.0 109.419 -179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.449 ' HG2' HG22 ' A' ' 33' ' ' VAL . 88.1 mtp -113.92 130.72 56.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 115.067 -0.969 . . . . 0.0 109.959 -175.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -62.3 117.17 5.75 Favored 'General case' 0 C--N 1.325 -0.479 0 O-C-N 123.578 0.549 . . . . 0.0 111.026 -175.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.09 -24.18 33.33 Favored Glycine 0 N--CA 1.451 -0.305 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.236 179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.4 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 2.8 mmp_? -97.08 -58.09 2.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.715 0.769 . . . . 0.0 110.253 -178.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.71 -152.0 17.26 Favored Glycine 0 N--CA 1.447 -0.595 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.611 -175.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.532 ' HG2' HG22 ' A' ' 50' ' ' VAL . 49.0 mt-10 -84.14 117.28 23.37 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-N 117.252 0.526 . . . . 0.0 110.101 174.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 81.0 t -105.47 123.86 60.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.82 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.141 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -78.9 126.79 31.16 Favored 'General case' 0 N--CA 1.447 -0.595 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.95 -176.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.9 mt -82.32 159.39 64.82 Favored Pre-proline 0 C--N 1.32 -0.701 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.043 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_exo -50.84 141.93 34.46 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 123.036 2.491 . . . . 0.0 111.68 174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.9 p90 -67.43 128.33 36.01 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.454 0.645 . . . . 0.0 111.062 -176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 61.0 mtm -103.89 119.49 39.03 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.932 179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.522 ' HB3' ' HB2' ' A' ' 80' ' ' LEU . . . -74.41 134.85 42.39 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.472 -178.308 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -127.52 147.41 50.32 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.015 0.436 . . . . 0.0 110.489 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.569 ' HD2' HD21 ' A' ' 80' ' ' LEU . 21.2 ptmt -122.9 159.08 28.97 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 109.123 -0.695 . . . . 0.0 109.123 173.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 76.3 t -102.17 122.59 54.63 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.052 -176.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.599 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.1 mt -90.11 -48.33 14.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.502 0.667 . . . . 0.0 109.248 176.713 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 10.6 m -144.12 156.23 44.26 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.57 178.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -149.43 130.56 14.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.363 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.2 t -173.24 160.67 4.09 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.804 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 5.1 t -84.95 -35.55 21.98 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.182 0.515 . . . . 0.0 109.992 174.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -100.27 -39.81 7.84 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.341 179.367 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.41 -3.04 88.52 Favored Glycine 0 N--CA 1.448 -0.506 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.683 178.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 32.9 t 67.24 168.54 0.25 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.454 0.645 . . . . 0.0 111.374 177.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 26.7 mt -107.21 137.09 39.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 109.783 177.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.7 tt0 -122.83 128.54 50.53 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 175.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.409 HG13 ' HB3' ' A' ' 88' ' ' SER . 36.1 pt -122.3 158.41 26.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.506 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.641 ' CD ' ' HA ' ' A' ' 85' ' ' PRO . 33.0 tt0 -133.39 137.07 45.66 Favored 'General case' 0 C--N 1.314 -0.954 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -179.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.519 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 72.9 m-85 -80.42 150.45 29.77 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.085 0.469 . . . . 0.0 110.457 -178.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.569 HD21 ' HD2' ' A' ' 65' ' ' LYS . 97.2 mt -110.48 -173.09 2.17 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 115.647 -0.706 . . . . 0.0 109.892 176.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.75 -151.76 43.29 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 119.766 -1.207 . . . . 0.0 110.75 -175.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.56 -17.03 39.38 Favored 'Trans proline' 0 CA--C 1.53 0.3 0 C-N-CA 122.212 1.942 . . . . 0.0 111.809 174.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 27.9 m-85 -94.11 18.96 9.86 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.638 -177.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.727 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 5.5 p90 -59.06 170.07 0.99 Allowed Pre-proline 0 CA--C 1.535 0.401 0 O-C-N 123.249 0.343 . . . . 0.0 110.443 -178.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.727 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 11.96 -0.53 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.1 1 C-N-CA 128.082 5.855 . . . . 0.0 121.405 -149.334 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.471 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.9 tp -66.97 115.98 7.3 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 119.631 1.105 . . . . 0.0 108.272 166.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 59.0 pttt -108.14 179.98 4.06 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.395 0.617 . . . . 0.0 112.31 -170.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB3' HG13 ' A' ' 77' ' ' ILE . 45.8 t -152.02 165.31 35.08 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.714 -1.13 . . . . 0.0 108.582 179.414 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.625 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.5 m -127.03 142.41 51.55 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.066 0.46 . . . . 0.0 111.215 -178.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.562 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.9 mt -124.1 122.53 38.11 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.274 177.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.59 ' HB3' ' HB ' ' A' ' 99' ' ' ILE . 26.3 ttmt -133.35 158.49 42.87 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.983 -0.377 . . . . 0.0 109.983 -173.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 21.6 ptt180 -89.42 153.17 21.05 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.17 0.509 . . . . 0.0 111.768 -174.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.62 162.03 12.68 Favored Glycine 0 N--CA 1.435 -1.367 0 N-CA-C 110.924 -0.871 . . . . 0.0 110.924 174.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -86.75 -10.39 53.74 Favored 'General case' 0 C--N 1.314 -0.963 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 38.8 m-80 -130.47 51.12 2.14 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.765 0.317 . . . . 0.0 111.175 -175.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 68.35 27.69 73.64 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 121.019 -0.61 . . . . 0.0 111.82 -179.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -108.55 160.19 16.11 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-O 121.154 0.502 . . . . 0.0 112.071 -175.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.403 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 19.6 tp -128.47 134.78 48.8 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 172.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.59 ' HB ' ' HB3' ' A' ' 91' ' ' LYS . 72.8 mt -104.68 111.91 36.16 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-O 120.961 0.41 . . . . 0.0 110.037 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.441 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.5 t90 -104.13 111.77 24.49 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.714 -0.676 . . . . 0.0 109.956 -178.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.625 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 27.1 mt-10 -100.74 131.5 46.6 Favored 'General case' 0 CA--C 1.508 -0.665 0 CA-C-O 121.467 0.651 . . . . 0.0 110.369 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.579 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 16.9 tm0? -152.56 121.17 6.42 Favored 'General case' 0 C--N 1.307 -1.243 0 CA-C-N 115.0 -1.0 . . . . 0.0 110.271 -179.106 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.579 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 2.6 t-20 75.8 -53.83 0.63 Allowed 'General case' 0 N--CA 1.466 0.33 0 O-C-N 123.95 0.781 . . . . 0.0 112.665 167.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -159.14 -25.07 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.154 -1.022 . . . . 0.0 114.207 -177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -120.19 152.76 37.23 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 117.857 0.829 . . . . 0.0 111.176 -173.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.426 ' O ' ' HG3' ' A' ' 106' ' ' ARG . 20.5 ptt180 -95.53 126.29 40.71 Favored 'General case' 0 N--CA 1.437 -1.077 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 172.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 99' ' ' ILE . 21.8 mmtp -88.25 127.21 35.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 120.911 0.386 . . . . 0.0 110.243 174.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.2 m -109.11 111.6 23.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 175.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.1 ptt? -134.99 156.36 49.16 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.483 -172.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 4.0 m -112.53 155.32 24.52 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.028 -179.083 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.9 ttp85 -78.29 130.25 36.0 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.957 -178.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mt -76.95 146.16 9.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.0 110.168 179.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -140.79 118.9 11.95 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.894 -179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.6 t -74.34 109.11 7.56 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.665 -175.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 60.2 tttm 64.38 84.15 0.15 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.362 -0.835 . . . . 0.0 111.647 176.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.9 m -91.46 151.98 20.56 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.672 -0.695 . . . . 0.0 109.926 177.619 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -120.11 -133.82 4.62 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.376 -0.916 . . . . 0.0 112.883 -178.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -130.02 155.18 46.55 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-O 121.202 0.525 . . . . 0.0 109.633 -176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -155.05 150.43 27.25 Favored 'General case' 0 C--N 1.309 -1.166 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.942 178.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -159.45 -82.18 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 121.405 -0.118 . . . . 0.0 111.025 -176.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 82.4 tttt 69.06 131.4 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.353 0 O-C-N 123.91 0.756 . . . . 0.0 111.475 -177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -88.62 164.0 15.56 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.259 176.207 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 18.7 tt0 -119.67 101.13 7.69 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.978 0.418 . . . . 0.0 110.716 178.154 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 4.2 tmtp? -91.71 101.9 14.51 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 176.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 80.8 p -141.46 160.3 40.43 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.486 -178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -146.58 146.26 30.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.113 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 22.7 m -127.51 110.14 12.43 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.667 -177.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.2 mt -114.49 97.97 6.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.067 0.461 . . . . 0.0 111.123 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.34 93.27 4.27 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 174.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -131.57 89.55 2.72 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.835 -173.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -136.32 149.35 48.36 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.036 179.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 45.4 p-80 -157.62 150.26 22.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.96 0.409 . . . . 0.0 110.986 -178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -153.58 105.21 2.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.63 175.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 56.7 t-80 -82.48 89.43 6.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.555 -173.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 13.9 t60 . . . . . 0 C--O 1.246 0.905 0 CA-C-O 118.171 -0.919 . . . . 0.0 109.485 174.138 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 mpt? . . . . . 0 N--CA 1.481 1.107 0 CA-C-O 120.514 0.197 . . . . 0.0 111.424 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.3 mp -82.18 124.29 39.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 20.9 ptt? -132.45 135.94 46.39 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.198 -0.456 . . . . 0.0 111.168 -175.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 44.7 t -101.05 111.86 32.1 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.022 0.439 . . . . 0.0 111.023 -177.051 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.4 p -153.32 144.85 23.29 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.828 178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 81.1 -62.72 4.42 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.744 -0.741 . . . . 0.0 111.388 -178.779 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 56.3 m -79.72 69.9 6.12 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.184 0.516 . . . . 0.0 109.813 176.059 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 43.3 mt-30 -125.17 78.95 1.76 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.697 -178.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 -92.39 11.64 25.38 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.483 -0.78 . . . . 0.0 111.11 -175.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 20.2 pt20 -81.82 100.77 9.76 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.161 0.505 . . . . 0.0 110.034 175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -70.5 -27.76 64.44 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.762 -0.654 . . . . 0.0 111.033 -178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -70.27 103.31 2.34 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.774 -177.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -145.12 175.84 9.95 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.422 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 11.8 m -63.33 118.15 40.84 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 116.116 -0.493 . . . . 0.0 112.086 -176.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.471 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 2.7 Cg_exo -75.79 110.88 3.17 Favored 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.939 2.426 . . . . 0.0 111.305 175.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 40.3 p90 -63.68 -30.76 71.82 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.044 -0.526 . . . . 0.0 112.058 -174.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -84.3 -13.22 53.07 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.779 -173.303 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.471 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 17.2 t80 -78.5 138.16 38.29 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.854 0.359 . . . . 0.0 110.748 -172.278 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 129.67 -163.04 22.82 Favored Glycine 0 N--CA 1.452 -0.269 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.173 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 84.8 m -110.01 121.96 46.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.035 0.445 . . . . 0.0 110.511 178.118 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.431 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 80.8 m95 -106.41 144.41 33.13 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.654 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.641 ' HB2' HD11 ' A' ' 112' ' ' ILE . 22.6 t70 -104.34 120.34 40.99 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.165 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -90.51 48.44 1.55 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.783 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -77.49 47.13 2.65 Favored Glycine 0 N--CA 1.452 -0.275 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.568 176.582 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 5.5 tpp180 -162.5 144.24 10.57 Favored 'General case' 0 C--N 1.318 -0.779 0 N-CA-C 108.223 -1.028 . . . . 0.0 108.223 -178.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.92 164.16 0.13 Allowed Pre-proline 0 CA--C 1.536 0.42 0 O-C-N 124.083 0.864 . . . . 0.0 111.328 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -63.56 135.54 49.81 Favored 'Trans proline' 0 C--N 1.347 0.479 0 C-N-CA 122.681 2.254 . . . . 0.0 113.163 178.548 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.19 -154.12 8.69 Favored Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.525 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -47.49 124.49 9.49 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 123.617 2.878 . . . . 0.0 112.432 178.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.6 t -82.05 -7.86 59.64 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.464 -0.789 . . . . 0.0 112.786 -167.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -55.06 -32.58 62.03 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.093 0.473 . . . . 0.0 111.535 179.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.25 39.93 0.2 Allowed Glycine 0 N--CA 1.448 -0.564 0 N-CA-C 110.911 -0.876 . . . . 0.0 110.911 -178.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 27.6 t -94.25 136.38 25.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 115.486 -0.357 . . . . 0.0 110.434 -174.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.671 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 9.0 mmpt? -73.22 -41.01 64.23 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.385 0.612 . . . . 0.0 110.694 -177.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 11.7 m -161.69 160.4 28.55 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.437 -0.801 . . . . 0.0 109.162 -177.189 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.99 135.4 54.46 Favored 'General case' 0 C--N 1.314 -0.977 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.9 p -117.29 125.91 51.86 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 177.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -118.95 127.72 75.79 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.851 -173.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 61.2 m -105.82 124.69 49.98 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.913 178.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -102.49 118.84 37.74 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.36 -177.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -100.38 179.56 4.42 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 167.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 24.5 tt0 -68.52 -36.66 79.18 Favored 'General case' 0 C--N 1.321 -0.657 0 C-N-CA 120.334 -0.546 . . . . 0.0 111.294 -173.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -111.99 -11.67 13.82 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 112.639 0.607 . . . . 0.0 112.639 -174.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -135.01 145.81 48.44 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 121.491 0.662 . . . . 0.0 112.344 -169.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG23 ' CD1' ' A' ' 64' ' ' TYR . 97.9 t -111.93 118.38 57.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.526 172.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 52.1 t -108.69 122.67 63.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.959 0.409 . . . . 0.0 109.977 176.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -107.26 133.02 52.44 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 116.126 -0.488 . . . . 0.0 109.808 -178.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.3 m -124.31 134.27 53.23 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.955 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.466 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 30.1 mt-10 -100.22 125.24 46.36 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 -178.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.519 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -88.01 110.1 20.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 174.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.21 121.64 43.56 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.531 -170.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -62.88 115.94 4.82 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.373 -177.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.07 -27.52 10.14 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.098 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 11.6 mtt180 -111.44 -59.04 2.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.515 0.674 . . . . 0.0 109.972 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 125.93 -164.24 19.57 Favored Glycine 0 N--CA 1.445 -0.72 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.68 -174.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.519 ' HG3' HG22 ' A' ' 50' ' ' VAL . 2.4 mp0 -69.65 126.64 30.34 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-O 121.589 0.709 . . . . 0.0 111.628 175.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.3 t -117.78 122.56 70.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 CA-C-N 114.577 -1.192 . . . . 0.0 109.659 177.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.7 mt-30 -79.96 128.66 33.73 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.2 0.524 . . . . 0.0 111.993 -177.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.588 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 75.6 mt -90.47 165.05 24.51 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 115.36 -0.836 . . . . 0.0 109.993 176.173 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.588 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.5 Cg_endo -57.54 130.47 39.1 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.724 2.283 . . . . 0.0 112.097 179.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -63.83 147.02 52.88 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.971 -178.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -123.88 118.26 26.69 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.074 177.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -88.27 138.33 31.53 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.809 -177.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.492 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.0 p90 -137.66 171.72 14.02 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.914 0.388 . . . . 0.0 110.388 -175.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.702 ' HG3' HD11 ' A' ' 80' ' ' LEU . 80.7 mttt -130.01 154.44 47.4 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.266 0.555 . . . . 0.0 111.08 173.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 97.3 t -94.18 124.22 46.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.894 0 CA-C-N 114.92 -1.036 . . . . 0.0 110.306 -179.143 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.57 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.9 mt -88.55 -47.71 15.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.496 0.665 . . . . 0.0 109.58 178.607 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 13.7 m -143.61 156.67 44.64 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.481 -0.782 . . . . 0.0 109.631 176.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -149.2 150.92 33.41 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.829 -175.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.4 t -140.36 145.08 36.68 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.283 -0.417 . . . . 0.0 109.987 174.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 3.9 m -73.64 -25.94 60.53 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.494 0.664 . . . . 0.0 109.506 174.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.1 t70 -152.35 76.31 1.15 Allowed 'General case' 0 N--CA 1.453 -0.317 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.582 178.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -172.39 -92.89 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.392 174.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 24.6 m -150.7 154.17 36.91 Favored 'General case' 0 N--CA 1.441 -0.904 0 CA-C-O 121.134 0.492 . . . . 0.0 110.683 178.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.624 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 14.3 mt -118.52 137.62 51.89 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 175.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -117.42 121.68 41.73 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 45.1 pt -129.83 156.77 42.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.672 -176.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.57 ' HB2' HD11 ' A' ' 67' ' ' ILE . 15.6 tt0 -130.26 138.35 50.47 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 178.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -80.05 -0.93 37.68 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 114.197 1.184 . . . . 0.0 114.197 -165.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.702 HD11 ' HG3' ' A' ' 65' ' ' LYS . 97.6 mt 50.74 -170.06 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.556 0 O-C-N 123.363 0.415 . . . . 0.0 111.586 -177.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 63.79 -151.35 49.32 Favored Glycine 0 C--O 1.226 -0.39 0 C-N-CA 120.1 -1.048 . . . . 0.0 111.716 176.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -60.02 -11.1 14.25 Favored 'Trans proline' 0 CA--C 1.534 0.476 0 C-N-CA 122.767 2.311 . . . . 0.0 111.987 174.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 92.5 m-85 -111.18 30.57 6.79 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.002 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.492 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 15.4 p90 -80.67 -15.71 0.23 Allowed Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-O 118.768 -0.634 . . . . 0.0 112.181 -174.006 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.492 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 87.3 Cg_endo -92.19 -3.82 3.83 Favored 'Trans proline' 0 N--CA 1.438 -1.767 0 CA-C-N 120.867 1.345 . . . . 0.0 112.929 165.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 61.2 tp -97.47 113.73 25.47 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.0 0.428 . . . . 0.0 110.021 179.487 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 62.2 pttt -111.57 164.41 13.03 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.185 0.517 . . . . 0.0 110.922 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 102' ' ' GLN . 21.8 t -134.01 155.67 49.56 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.812 -175.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.523 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.8 m -112.74 140.81 47.21 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-O 121.084 0.469 . . . . 0.0 110.508 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.624 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 98.3 mt -124.44 124.59 42.65 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.698 178.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 39.2 mtpt -135.53 155.19 50.9 Favored 'General case' 0 C--N 1.315 -0.918 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 33.2 ptt85 -86.72 161.09 18.6 Favored 'General case' 0 C--N 1.315 -0.897 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -93.94 -177.38 39.41 Favored Glycine 0 N--CA 1.437 -1.286 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 171.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -90.69 -10.94 41.26 Favored 'General case' 0 C--N 1.315 -0.932 0 CA-C-O 120.635 0.255 . . . . 0.0 111.126 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 5.2 p30 -155.65 93.25 1.46 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.926 0.393 . . . . 0.0 111.544 -177.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 50.71 40.93 42.01 Favored Glycine 0 C--N 1.333 0.396 0 CA-C-N 115.811 -0.631 . . . . 0.0 113.657 173.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -137.92 159.88 40.82 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 120.469 0.176 . . . . 0.0 110.859 -175.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.8 tp -123.89 135.21 53.57 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 25.8 mm -103.84 110.36 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.692 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 176.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.585 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 7.5 t90 -108.46 113.78 27.1 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 -179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.523 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 31.9 mt-10 -106.19 129.29 54.27 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.6 0.714 . . . . 0.0 110.263 177.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.467 ' HG3' ' HB2' ' A' ' 88' ' ' SER . 7.0 tt0 -153.35 134.08 13.79 Favored 'General case' 0 C--N 1.309 -1.178 0 CA-C-N 115.118 -0.946 . . . . 0.0 110.115 -177.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 30.0 m-80 59.46 18.16 6.64 Favored 'General case' 0 N--CA 1.472 0.627 0 O-C-N 123.307 0.38 . . . . 0.0 111.834 176.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.01 -13.07 60.65 Favored Glycine 0 N--CA 1.449 -0.439 0 C-N-CA 120.592 -0.813 . . . . 0.0 112.49 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.427 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 41.2 mt-30 -92.81 134.99 34.52 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.055 0.455 . . . . 0.0 111.133 -178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 3.1 tmt_? -101.44 115.8 31.33 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.282 -0.872 . . . . 0.0 110.09 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 35.9 ttmt -111.16 141.01 45.23 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.598 0.237 . . . . 0.0 111.299 179.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -119.06 115.34 24.1 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 173.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.585 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 1.0 OUTLIER -114.83 165.32 12.96 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.349 0.595 . . . . 0.0 111.553 -177.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 3.1 m -102.21 163.07 12.44 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.137 -0.938 . . . . 0.0 109.162 179.293 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.431 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 42.4 ttp180 -106.36 134.86 48.83 Favored 'General case' 0 C--N 1.325 -0.484 0 O-C-N 121.839 -0.538 . . . . 0.0 111.284 -177.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.641 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.4 mm -81.87 155.95 4.07 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.789 -0.641 . . . . 0.0 109.668 176.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -75.77 84.49 2.75 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.008 0.432 . . . . 0.0 110.564 -179.167 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 37.9 m -78.82 92.92 4.9 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.592 -0.731 . . . . 0.0 110.061 177.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 62.3 pttt -101.7 7.2 42.05 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.261 0.553 . . . . 0.0 110.085 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 16.8 p -79.32 -10.14 59.74 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.351 -0.84 . . . . 0.0 111.287 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 66.01 -147.85 50.51 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.264 -0.88 . . . . 0.0 112.407 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.9 tmm_? -142.07 117.06 9.95 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-N 115.626 -0.287 . . . . 0.0 110.285 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -87.5 134.55 33.59 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.101 175.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 7.9 mp0 -78.19 -67.95 0.68 Allowed 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.584 -0.525 . . . . 0.0 109.584 175.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt 59.08 17.84 5.87 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 115.705 -0.68 . . . . 0.0 112.586 175.342 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -151.95 172.95 15.45 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -105.78 179.34 4.3 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.891 0.377 . . . . 0.0 111.362 -174.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 55.1 mtpt -135.9 -165.6 1.73 Allowed 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 -179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 20.2 m 61.51 38.73 15.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.738 173.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 87.5 tttt -84.38 90.38 7.57 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.621 -0.432 . . . . 0.0 110.251 177.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.8 p -143.84 131.29 21.02 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.427 177.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 54.0 tp -140.42 142.65 35.41 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.603 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.571 ' HB3' ' HD2' ' A' ' 131' ' ' HIS . 48.4 mt-10 -117.84 146.56 43.78 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.873 0.368 . . . . 0.0 111.399 -177.315 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -141.2 73.25 1.41 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.256 172.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.571 ' HD2' ' HB3' ' A' ' 129' ' ' GLU . 7.7 p80 -147.17 156.35 42.9 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.047 0.451 . . . . 0.0 111.053 -177.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -157.01 -10.23 0.09 Allowed 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.911 177.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.5 t60 69.84 -80.1 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.269 0 C-N-CA 123.351 0.66 . . . . 0.0 110.25 -179.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 2.6 m170 -169.02 -51.26 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 122.937 0.495 . . . . 0.0 109.832 179.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.3 p-80 . . . . . 0 C--O 1.247 0.94 0 CA-C-O 118.67 -0.681 . . . . 0.0 109.82 177.776 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 89.9 mtp . . . . . 0 N--CA 1.481 1.114 0 N-CA-C 110.083 -0.34 . . . . 0.0 110.083 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 62.8 mt -105.36 107.93 23.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.659 -177.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 56.6 mtm 64.89 85.74 0.14 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.211 178.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.7 p -99.62 -24.7 4.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.036 -0.529 . . . . 0.0 109.653 177.824 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 28.1 m 64.73 -175.96 0.17 Allowed 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 115.448 -0.796 . . . . 0.0 112.121 174.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -89.53 139.96 15.4 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.696 -0.764 . . . . 0.0 111.612 176.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.404 ' O ' ' HB2' ' A' ' 8' ' ' GLN . 21.8 p -90.61 13.91 14.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.562 0.22 . . . . 0.0 111.024 -178.323 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.404 ' HB2' ' O ' ' A' ' 7' ' ' CYS . 2.3 mp0 68.14 168.11 0.26 Allowed 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.881 -176.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 66.59 12.73 8.95 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.383 177.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -106.24 137.05 44.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.898 0.38 . . . . 0.0 110.985 -175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -81.42 69.02 7.97 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.396 179.655 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -88.83 -88.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.227 0.455 . . . . 0.0 112.227 -171.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 14' ' ' THR . 0.8 OUTLIER -173.6 178.2 2.35 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 121.246 -0.182 . . . . 0.0 110.737 -170.241 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.459 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 18.4 m 73.53 129.33 0.03 OUTLIER Pre-proline 0 CA--C 1.534 0.333 0 C-N-CA 123.926 0.891 . . . . 0.0 113.328 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -58.93 122.24 11.28 Favored 'Trans proline' 0 C--N 1.35 0.617 0 C-N-CA 122.919 2.413 . . . . 0.0 111.864 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -63.34 -26.71 68.89 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -174.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 30.2 p90 -92.76 -10.43 37.03 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -174.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 85.6 t80 -71.44 132.15 44.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.954 0.407 . . . . 0.0 111.055 -175.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.5 -164.59 23.47 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.325 178.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 89.4 m -112.41 127.75 56.11 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.925 0.393 . . . . 0.0 110.145 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 30.7 m95 -117.42 151.41 37.1 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 -178.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HB2' HD11 ' A' ' 112' ' ' ILE . 13.8 t70 -89.52 130.92 35.78 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 178.231 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' ALA . 4.2 mm-40 -52.85 -53.55 47.23 Favored 'General case' 0 C--N 1.329 -0.307 0 O-C-N 123.726 0.641 . . . . 0.0 112.376 -176.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 59.04 35.17 82.58 Favored Glycine 0 N--CA 1.449 -0.453 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.51 -173.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.411 ' C ' ' HD3' ' A' ' 27' ' ' PRO . 6.5 tpp180 -99.41 149.33 23.29 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -176.684 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -119.58 79.07 21.73 Favored Pre-proline 0 C--N 1.313 -1.008 0 CA-C-N 116.07 -0.513 . . . . 0.0 111.3 177.078 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.411 ' HD3' ' C ' ' A' ' 25' ' ' ARG . 96.7 Cg_endo -99.91 -164.2 0.06 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.14 0 C-N-CA 123.741 2.96 . . . . 0.0 110.927 174.149 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.35 173.79 33.08 Favored Glycine 0 N--CA 1.433 -1.532 0 C-N-CA 120.055 -1.069 . . . . 0.0 110.912 171.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -74.1 132.51 16.79 Favored 'Trans proline' 0 C--N 1.324 -0.721 0 C-N-CA 122.989 2.459 . . . . 0.0 112.251 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.9 p -86.03 6.74 27.44 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.505 174.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 t0 69.2 84.03 0.15 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-N 114.72 -1.127 . . . . 0.0 110.566 -177.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 129.68 -38.02 2.07 Favored Glycine 0 N--CA 1.449 -0.485 0 CA-C-N 115.189 -0.914 . . . . 0.0 111.951 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -98.63 138.54 22.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 120.676 0.274 . . . . 0.0 110.431 -179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.723 ' HE3' ' HB2' ' A' ' 52' ' ' GLU . 95.8 mttt -91.17 -38.89 12.44 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.486 0.66 . . . . 0.0 110.201 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.6 m -167.75 171.8 9.74 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 114.639 -1.164 . . . . 0.0 108.65 -171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -135.55 164.5 27.68 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.079 0.466 . . . . 0.0 111.647 -176.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 35.8 p -127.95 157.18 41.28 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 172.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.3 p -121.2 125.7 74.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.288 0.565 . . . . 0.0 111.02 -179.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 87.0 m -108.33 122.4 46.91 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.112 178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -101.14 117.67 35.47 Favored 'General case' 0 C--N 1.325 -0.489 0 N-CA-C 109.673 -0.492 . . . . 0.0 109.673 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.531 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.1 m -101.61 176.32 5.27 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.531 ' H ' HG22 ' A' ' 41' ' ' THR . 44.7 mt-10 -62.56 -39.66 94.35 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -173.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -128.69 -3.35 5.33 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.849 -177.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -138.99 157.5 45.88 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.224 0.535 . . . . 0.0 111.646 -176.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.09 133.17 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.69 176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 49.6 t -122.76 124.33 70.28 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.471 -0.331 . . . . 0.0 110.495 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.458 ' HB2' HD12 ' A' ' 59' ' ' LEU . 17.8 mt-10 -98.79 137.41 37.42 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.264 0.554 . . . . 0.0 110.947 176.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -120.09 120.26 35.74 Favored 'General case' 0 C--N 1.312 -1.029 0 CA-C-N 115.066 -0.97 . . . . 0.0 110.808 -179.795 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -99.87 131.9 45.56 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.369 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.569 HG22 ' HG2' ' A' ' 56' ' ' GLU . 39.9 t -89.48 113.6 26.14 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.297 0.57 . . . . 0.0 110.665 -177.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.0 mtt -116.07 135.53 53.86 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 115.194 -0.912 . . . . 0.0 110.18 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.723 ' HB2' ' HE3' ' A' ' 34' ' ' LYS . 34.4 tt0 -70.66 128.91 37.72 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.903 0.382 . . . . 0.0 110.99 -176.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 88.8 -27.32 7.36 Favored Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 116.059 -0.519 . . . . 0.0 112.343 -179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 16.8 mmt180 -93.21 -62.74 1.32 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.665 0.745 . . . . 0.0 109.997 -179.482 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 127.14 -155.26 19.78 Favored Glycine 0 N--CA 1.447 -0.589 0 CA-C-N 114.51 -1.223 . . . . 0.0 110.299 -175.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.569 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.3 mt-10 -87.71 129.09 35.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.374 0.607 . . . . 0.0 110.162 175.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.8 t -104.38 122.61 57.51 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.821 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.94 -177.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.628 ' OE1' ' HA ' ' A' ' 119' ' ' GLU . 69.7 mt-30 -91.87 130.4 37.64 Favored 'General case' 0 N--CA 1.445 -0.717 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.019 -174.642 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.458 HD12 ' HB2' ' A' ' 47' ' ' GLU . 94.8 mt -85.31 154.66 60.0 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.269 174.601 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_exo -50.23 143.08 26.92 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 123.109 2.539 . . . . 0.0 112.524 178.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 48.3 m-85 -59.87 119.02 6.93 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.056 0.455 . . . . 0.0 110.592 -178.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 74.7 mtm -109.79 121.78 46.01 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.218 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.92 149.36 39.45 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.531 -175.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 47.1 p90 -131.21 159.91 36.38 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.84 176.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.572 ' HD2' HD21 ' A' ' 80' ' ' LEU . 20.4 ptmt -121.69 144.31 48.85 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.029 0.442 . . . . 0.0 109.846 178.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.3 t -93.78 115.4 32.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.806 -175.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 11.5 mt -93.6 -51.86 10.57 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.898 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.2 m -124.92 154.61 40.86 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 109.717 177.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -149.19 147.74 28.79 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-O 121.175 0.512 . . . . 0.0 111.452 -172.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.0 t -148.74 146.27 28.01 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 171.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 30.3 p -73.48 -24.19 60.17 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.04 0.448 . . . . 0.0 110.375 176.451 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -161.29 78.59 0.58 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.91 175.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.87 -84.82 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.978 177.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 16.7 m -145.41 148.89 33.83 Favored 'General case' 0 N--CA 1.439 -0.991 0 CA-C-O 121.096 0.474 . . . . 0.0 110.644 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 21.1 mt -129.23 132.35 66.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 N-CA-C 108.882 -0.784 . . . . 0.0 108.882 173.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -114.76 124.17 51.09 Favored 'General case' 0 C--N 1.318 -0.797 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -179.016 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.6 pt -133.72 149.21 30.61 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.757 -176.116 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.594 ' HA ' ' HA ' ' A' ' 87' ' ' LYS . 32.4 tt0 -124.36 136.76 54.34 Favored 'General case' 0 C--N 1.315 -0.9 0 N-CA-C 109.538 -0.542 . . . . 0.0 109.538 177.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 70.0 m-85 -77.11 157.45 31.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.281 -178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.572 HD21 ' HD2' ' A' ' 65' ' ' LYS . 90.6 mt -121.11 166.48 13.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.977 175.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 103.41 -152.19 17.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.501 -0.857 . . . . 0.0 110.977 -174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -61.69 -9.85 15.04 Favored 'Trans proline' 0 CA--C 1.532 0.424 0 C-N-CA 122.668 2.245 . . . . 0.0 112.381 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -122.98 57.57 1.12 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 177.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.457 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 37.3 p90 -85.21 -27.68 0.39 Allowed Pre-proline 0 N--CA 1.451 -0.416 0 CA-C-N 115.405 -0.816 . . . . 0.0 113.071 -171.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.457 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 10.3 Cg_endo -89.31 -3.57 5.95 Favored 'Trans proline' 0 N--CA 1.436 -1.861 0 CA-C-N 121.089 1.425 . . . . 0.0 112.701 177.509 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.9 tp -89.21 117.25 28.04 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.265 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.594 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 64.1 pttt -113.76 162.43 16.31 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.942 0.401 . . . . 0.0 110.955 177.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -130.77 160.26 34.88 Favored 'General case' 0 N--CA 1.442 -0.859 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.162 -179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.574 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 2.9 m -115.7 139.24 50.33 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.437 -179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.478 HD22 HD21 ' A' ' 98' ' ' LEU . 96.1 mt -124.1 124.33 42.28 Favored 'General case' 0 C--N 1.314 -0.938 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.4 mtpt -132.33 152.86 51.23 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.143 0.496 . . . . 0.0 111.018 -177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 39.2 ptt180 -69.46 151.18 46.38 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.388 -0.824 . . . . 0.0 111.807 -173.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -126.45 152.2 18.28 Favored Glycine 0 N--CA 1.436 -1.304 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 172.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -64.89 145.16 56.67 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.688 0.28 . . . . 0.0 111.259 -177.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.0 m-80 66.47 20.48 10.89 Favored 'General case' 0 N--CA 1.465 0.304 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.553 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 82.91 51.47 4.21 Favored Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.941 -0.647 . . . . 0.0 113.072 175.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 4.5 p -117.16 173.8 6.47 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.148 -0.316 . . . . 0.0 110.148 175.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.478 HD21 HD22 ' A' ' 90' ' ' LEU . 49.4 tp -127.7 135.94 50.87 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.251 0.548 . . . . 0.0 111.345 -176.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 65.4 mt -108.8 111.06 34.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.5 174.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.78 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.2 t90 -105.41 117.97 35.38 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.322 -177.611 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.574 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.4 mt-10 -102.48 132.75 48.31 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.528 0.68 . . . . 0.0 110.113 175.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.447 ' CD ' HD22 ' A' ' 103' ' ' ASN . 1.4 tm0? -151.24 123.94 8.53 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 114.861 -1.063 . . . . 0.0 110.128 -173.531 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.447 HD22 ' CD ' ' A' ' 102' ' ' GLN . 24.9 m-80 62.02 22.44 13.08 Favored 'General case' 0 N--CA 1.467 0.377 0 O-C-N 123.729 0.643 . . . . 0.0 111.26 179.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.39 -8.35 69.22 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.98 178.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 73.9 mt-30 -93.1 134.06 35.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.992 0.396 . . . . 0.0 110.064 178.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -101.18 127.66 47.65 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.103 176.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.584 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 5.0 mmpt? -127.51 139.58 52.7 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.169 0.509 . . . . 0.0 111.657 177.102 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.5 m -106.58 114.11 28.02 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.225 -0.898 . . . . 0.0 108.995 176.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.78 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 12.4 ptp -119.37 148.4 43.25 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 121.007 0.432 . . . . 0.0 111.644 -172.146 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.2 m -98.15 152.78 18.99 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.369 179.382 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -84.67 123.89 30.87 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.354 -178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.541 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -74.13 154.69 6.73 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.5 mp0 -72.28 90.3 1.25 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.128 0.49 . . . . 0.0 109.98 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 68.86 172.55 0.29 Allowed 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.756 -1.111 . . . . 0.0 111.255 -177.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.7 ptmm? -92.93 112.0 23.82 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.641 176.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 20.1 m -87.38 132.44 33.97 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.629 -177.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 114.33 -161.07 12.85 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.048 179.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 58.5 ttp180 -151.08 124.59 8.97 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.628 ' HA ' ' OE1' ' A' ' 58' ' ' GLN . 0.7 OUTLIER -74.42 112.99 11.13 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.223 0.535 . . . . 0.0 110.213 -179.912 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.4 tt0 -152.67 -71.5 0.15 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.704 -0.68 . . . . 0.0 110.371 -176.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 5.6 tmtt? 61.21 107.53 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.999 0.812 . . . . 0.0 110.802 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -93.0 135.16 34.42 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.719 -0.673 . . . . 0.0 111.082 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 25.0 tt0 72.31 122.94 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 O-C-N 124.395 1.059 . . . . 0.0 111.832 177.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 28.4 mtpp -68.7 123.14 20.11 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.701 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 24.7 m -112.58 98.11 7.03 Favored 'General case' 0 C--N 1.312 -1.04 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.768 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -108.7 72.17 0.81 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.29 0.566 . . . . 0.0 110.618 179.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.2 t -173.4 100.03 0.12 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.362 -0.835 . . . . 0.0 108.789 176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 6.3 mp -106.74 128.56 54.32 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.942 -174.742 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 59.6 mm-40 -76.54 78.7 3.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.173 0.511 . . . . 0.0 110.215 177.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 9.3 p80 -67.75 102.62 1.25 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.52 -178.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -123.99 161.92 24.49 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.333 -0.848 . . . . 0.0 109.682 177.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -169.82 122.04 0.7 Allowed 'General case' 0 C--N 1.329 -0.316 0 O-C-N 123.098 0.249 . . . . 0.0 110.35 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -158.56 103.9 1.78 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.974 178.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 79.4 t60 -112.53 119.81 39.46 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 175.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 2.1 t-160 . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.513 -0.756 . . . . 0.0 110.394 -177.305 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.504 ' CE ' ' HB2' ' A' ' 132' ' ' HIS . 53.7 mtt . . . . . 0 N--CA 1.477 0.9 0 CA-C-O 120.715 0.293 . . . . 0.0 110.424 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.52 164.93 21.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.183 175.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptt? -99.55 119.63 38.35 Favored 'General case' 0 C--N 1.321 -0.645 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 176.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.781 HG11 ' HA ' ' A' ' 127' ' ' SER . 7.2 p -71.68 140.64 17.83 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.767 -0.652 . . . . 0.0 110.899 -177.545 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 49.5 m -64.5 113.18 3.52 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.366 180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -97.84 166.55 22.59 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.743 -0.741 . . . . 0.0 111.355 176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 73.3 m -70.21 96.32 1.08 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.872 0.368 . . . . 0.0 110.823 -179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 -159.81 156.71 27.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.153 178.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.503 ' O ' ' HB2' ' A' ' 10' ' ' GLN . 19.9 tp60 -129.82 -95.96 0.38 Allowed 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 176.361 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.503 ' HB2' ' O ' ' A' ' 9' ' ' GLN . 29.8 tt0 165.22 120.0 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.622 0.769 . . . . 0.0 108.987 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 11' ' ' LYS . 0.0 OUTLIER -124.04 99.93 6.49 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.921 0.867 . . . . 0.0 110.88 179.632 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -141.92 8.95 1.92 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.18 178.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.499 ' O ' ' HB ' ' A' ' 14' ' ' THR . 9.0 tp10 -147.2 161.7 40.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.158 -173.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.499 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 8.1 m 70.63 130.89 0.04 OUTLIER Pre-proline 0 CA--C 1.536 0.436 0 O-C-N 123.915 0.759 . . . . 0.0 112.29 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.569 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 39.2 Cg_exo -56.85 121.26 9.75 Favored 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.629 2.219 . . . . 0.0 111.684 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.7 p90 -69.86 -15.25 63.06 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.993 -172.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 6.5 p90 -98.15 -5.67 33.06 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.755 0.312 . . . . 0.0 111.068 -178.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.569 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 28.0 t80 -85.53 136.37 33.44 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 120.954 0.407 . . . . 0.0 111.036 -171.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.18 -143.25 14.82 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.029 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 10.8 m -127.88 126.39 41.46 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 178.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.599 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 87.2 m95 -117.92 138.81 51.89 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.139 0.495 . . . . 0.0 111.486 -175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.491 ' HB3' ' HB ' ' A' ' 110' ' ' THR . 4.4 t70 -83.55 126.47 32.84 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.15 -0.932 . . . . 0.0 111.498 178.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.446 ' HA ' ' HE2' ' A' ' 109' ' ' MET . 44.2 mt-10 -90.71 72.72 6.71 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 173.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.65 -15.94 60.86 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.257 179.35 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 7.9 tpt180 -100.45 142.75 31.49 Favored 'General case' 0 N--CA 1.44 -0.943 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -178.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.424 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 70.71 145.24 0.11 Allowed Pre-proline 0 C--N 1.321 -0.634 0 O-C-N 124.562 1.164 . . . . 0.0 111.3 -178.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 14.5 Cg_exo -69.69 148.78 66.28 Favored 'Trans proline' 0 C--O 1.236 0.405 0 C-N-CA 122.702 2.268 . . . . 0.0 112.501 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -91.4 -160.9 36.76 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.851 -0.69 . . . . 0.0 112.048 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.552 ' HG2' HG21 ' A' ' 33' ' ' VAL . 17.9 Cg_endo -62.98 152.58 78.62 Favored 'Trans proline' 0 C--N 1.344 0.306 0 C-N-CA 122.676 2.251 . . . . 0.0 112.711 177.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.4 p -78.67 3.76 15.51 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.582 -0.736 . . . . 0.0 111.736 -178.237 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -71.39 -11.22 60.78 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.287 -178.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.448 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 111.69 47.94 0.71 Allowed Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.718 175.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.552 HG21 ' HG2' ' A' ' 29' ' ' PRO . 17.1 t -105.84 135.12 45.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-O 120.672 0.272 . . . . 0.0 110.28 -178.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mmtt -76.08 -42.44 47.39 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.411 0.624 . . . . 0.0 111.024 176.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.4 m -166.14 163.17 18.01 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.106 -0.952 . . . . 0.0 108.534 -176.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -126.53 158.12 36.98 Favored 'General case' 0 C--N 1.314 -0.95 0 C-N-CA 120.776 -0.37 . . . . 0.0 110.222 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.78 141.14 51.4 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 109.26 -0.644 . . . . 0.0 109.26 173.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.8 p -114.54 129.76 70.06 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.989 0 CA-C-O 121.333 0.587 . . . . 0.0 110.578 -176.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.585 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 35.1 m -111.95 119.48 38.64 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.606 -0.724 . . . . 0.0 110.305 -179.507 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 71.2 m-85 -102.17 121.19 41.75 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 120.799 0.333 . . . . 0.0 111.225 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.614 ' HB ' ' HB2' ' A' ' 44' ' ' GLU . 1.7 m -101.83 173.9 6.19 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 170.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.474 ' H ' HG22 ' A' ' 41' ' ' THR . 1.5 mp0 -53.04 -46.56 68.52 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -178.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -129.8 8.09 5.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.93 0.395 . . . . 0.0 111.151 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.614 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 45.0 mt-10 -121.77 135.4 54.93 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.953 0.406 . . . . 0.0 111.562 -175.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 64' ' ' TYR . 87.2 t -107.97 118.07 54.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 109.103 -0.703 . . . . 0.0 109.103 171.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.585 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 52.8 t -109.96 123.12 65.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 15.6 mt-10 -97.27 132.47 42.98 Favored 'General case' 0 CA--C 1.506 -0.712 0 CA-C-O 121.53 0.681 . . . . 0.0 111.066 178.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.443 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -127.85 118.25 23.33 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 114.35 -1.295 . . . . 0.0 110.1 177.023 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' OE2' ' HG3' ' A' ' 29' ' ' PRO . 27.6 mt-10 -109.0 126.66 53.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.302 -178.112 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 41.1 t -86.88 111.65 21.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.247 0.546 . . . . 0.0 110.043 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.448 ' HG3' ' O ' ' A' ' 32' ' ' GLY . 39.1 ttm -118.92 125.95 50.65 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.593 -0.73 . . . . 0.0 109.515 -179.244 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -65.03 127.17 30.5 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.012 -173.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.6 -28.79 9.16 Favored Glycine 0 N--CA 1.445 -0.706 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.655 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -125.77 -34.73 2.58 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.178 0.513 . . . . 0.0 111.289 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.42 -140.73 15.01 Favored Glycine 0 N--CA 1.447 -0.583 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.251 174.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -70.63 138.56 50.87 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.23 0.538 . . . . 0.0 111.209 178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.443 ' O ' ' HA ' ' A' ' 48' ' ' THR . 80.0 t -128.72 121.38 54.66 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.097 179.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 25.5 mt-30 -82.16 130.52 35.11 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 120.943 0.401 . . . . 0.0 111.245 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.529 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 76.3 mt -95.84 159.69 31.82 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.912 -0.585 . . . . 0.0 109.651 171.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -54.08 117.39 3.85 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.79 2.327 . . . . 0.0 111.601 176.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 30.7 p90 -61.62 127.29 30.75 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.529 0.681 . . . . 0.0 111.475 -174.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 42.5 ttm -95.2 144.36 25.87 Favored 'General case' 0 N--CA 1.428 -1.532 0 CA-C-N 114.898 -1.046 . . . . 0.0 110.556 -178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.97 141.16 28.84 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.781 0.324 . . . . 0.0 110.471 177.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.412 ' CD1' HG23 ' A' ' 45' ' ' VAL . 15.7 p90 -138.08 163.07 32.54 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.067 179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.585 ' HE3' HG12 ' A' ' 67' ' ' ILE . 49.7 pttt -122.61 152.82 40.07 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.962 0.41 . . . . 0.0 110.117 175.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.0 t -102.63 112.95 37.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.793 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.032 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.585 HG12 ' HE3' ' A' ' 65' ' ' LYS . 11.5 mt -83.95 -53.67 10.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 121.287 0.565 . . . . 0.0 109.871 -177.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 2.4 m -127.1 151.58 48.45 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.316 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.11 146.86 27.9 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.849 0.357 . . . . 0.0 110.732 -175.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 28.5 t -137.2 153.8 50.34 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 174.22 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 84.1 m -79.37 -30.02 42.37 Favored 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 173.709 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -152.76 80.44 1.22 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.992 -1.004 . . . . 0.0 110.131 177.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -174.32 -94.57 0.09 OUTLIER Glycine 0 N--CA 1.446 -0.699 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.671 177.622 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 8.5 p -148.68 154.71 40.03 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.173 0.511 . . . . 0.0 110.994 -179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 31.9 mt -128.35 130.99 69.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.001 177.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -110.81 124.13 51.42 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 178.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.5 pt -124.32 157.68 31.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.901 0 CA-C-N 115.512 -0.767 . . . . 0.0 109.979 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.765 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 47.4 tt0 -132.69 135.93 46.11 Favored 'General case' 0 C--N 1.316 -0.884 0 N-CA-C 109.699 -0.482 . . . . 0.0 109.699 -179.193 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -74.72 144.37 43.72 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.002 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 88.7 mt -114.02 -179.7 3.71 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-N 115.936 -0.574 . . . . 0.0 109.759 178.756 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.67 -151.53 34.24 Favored Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.534 -1.317 . . . . 0.0 110.582 -174.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -63.77 -10.15 21.35 Favored 'Trans proline' 0 CA--C 1.533 0.429 0 C-N-CA 122.718 2.278 . . . . 0.0 112.313 176.301 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -99.5 22.45 10.75 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.693 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.839 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 1.6 p90 -60.1 -179.31 0.17 Allowed Pre-proline 0 CA--C 1.544 0.739 0 CA-C-N 115.697 -0.683 . . . . 0.0 111.371 -178.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.839 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.5 OUTLIER 12.76 -0.85 0.0 OUTLIER 'Trans proline' 0 C--N 1.362 1.258 1 C-N-CA 127.75 5.633 . . . . 0.0 121.343 -149.375 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.478 ' H ' ' C ' ' A' ' 84' ' ' TYR . 63.0 tp -71.66 113.52 8.79 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 119.905 1.229 . . . . 0.0 109.759 172.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 94.7 mttt -91.44 170.82 9.65 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 121.418 0.628 . . . . 0.0 111.643 179.074 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 29.3 t -151.75 152.45 32.73 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 114.945 -1.025 . . . . 0.0 108.35 171.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.486 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.2 m -118.07 141.78 48.1 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.32 0.581 . . . . 0.0 111.31 -173.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 80.9 mt -121.12 124.65 45.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 115.029 -0.987 . . . . 0.0 108.641 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 51.9 mtpt -132.59 156.91 46.04 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-O 120.982 0.42 . . . . 0.0 111.669 -173.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 4.0 ptm180 -65.59 144.2 57.12 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.276 -0.874 . . . . 0.0 110.598 178.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -103.81 -168.53 25.3 Favored Glycine 0 N--CA 1.444 -0.809 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.926 -178.083 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -87.7 -41.43 13.36 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 121.336 0.589 . . . . 0.0 111.674 -175.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 -102.84 18.37 21.68 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.191 -176.045 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.92 33.66 26.36 Favored Glycine 0 N--CA 1.446 -0.673 0 N-CA-C 110.611 -0.996 . . . . 0.0 110.611 -171.665 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 13.4 p -106.0 175.67 5.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.127 -0.537 . . . . 0.0 110.341 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.552 HD21 HD22 ' A' ' 90' ' ' LEU . 59.5 tp -105.55 128.4 53.57 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.999 0.428 . . . . 0.0 110.605 -176.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.556 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 34.0 mm -96.97 109.42 23.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 173.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.465 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 16.6 t90 -103.25 112.76 25.78 Favored 'General case' 0 C--N 1.315 -0.917 0 CA-C-N 115.913 -0.585 . . . . 0.0 109.703 -176.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.486 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 34.3 mt-10 -104.47 131.19 52.12 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 121.69 0.757 . . . . 0.0 109.853 178.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.0 tm0? -151.15 120.29 6.74 Favored 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.735 -1.12 . . . . 0.0 110.314 -169.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 27.9 m-20 61.56 23.2 13.53 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-O 120.997 0.427 . . . . 0.0 111.692 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 95.02 -8.79 70.28 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.977 -0.63 . . . . 0.0 112.748 177.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -94.2 142.23 27.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 110.283 -0.266 . . . . 0.0 110.283 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -93.68 115.76 28.23 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.569 -0.53 . . . . 0.0 109.569 176.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 100' ' ' TRP . 71.3 mttt -106.33 115.56 30.43 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.444 -179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 85.0 m -92.93 118.05 30.73 Favored 'General case' 0 C--N 1.311 -1.097 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.599 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 10.3 mmt -99.42 139.09 35.58 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.022 -174.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.491 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 0.2 OUTLIER -95.12 143.51 26.5 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 121.107 0.479 . . . . 0.0 110.286 -177.931 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 34.7 ttm180 -79.24 128.94 33.94 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.483 HD11 ' HB2' ' A' ' 22' ' ' ASP . 26.8 mm -75.99 142.85 13.88 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.761 0 CA-C-O 121.337 0.589 . . . . 0.0 109.486 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -150.21 127.55 11.4 Favored 'General case' 0 C--N 1.308 -1.199 0 N-CA-C 107.946 -1.131 . . . . 0.0 107.946 -175.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 43.8 m 60.48 -159.17 0.32 Allowed 'General case' 0 C--N 1.327 -0.396 0 O-C-N 123.651 0.594 . . . . 0.0 109.925 -174.081 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.535 ' O ' HG22 ' A' ' 116' ' ' THR . 0.3 OUTLIER -100.07 22.28 11.54 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.731 -0.213 . . . . 0.0 111.01 179.169 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . 0.535 HG22 ' O ' ' A' ' 115' ' ' LYS . 0.5 OUTLIER 64.67 165.13 0.15 Allowed 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 123.555 0.742 . . . . 0.0 111.463 -178.565 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 113.06 -112.5 2.95 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.729 -0.748 . . . . 0.0 112.524 179.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 55.8 ttt180 -138.23 108.47 6.45 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.926 0.393 . . . . 0.0 111.459 -175.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 89.3 mt-10 -133.46 125.65 29.45 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.578 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 28.7 tt0 -68.25 121.17 15.66 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.053 0.454 . . . . 0.0 110.539 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -129.95 139.45 51.09 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.221 -0.899 . . . . 0.0 109.408 -175.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -126.37 138.58 53.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.856 0.36 . . . . 0.0 111.332 -174.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 40.0 mm-40 -95.51 107.34 19.5 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.408 178.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 59.8 tttp -100.04 95.81 7.1 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.942 0.401 . . . . 0.0 110.893 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.3 m -124.68 118.49 26.59 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.329 177.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.6 tttp -135.18 148.06 49.57 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . 0.781 ' HA ' HG11 ' A' ' 4' ' ' VAL . 50.8 m -144.49 128.22 17.23 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.047 0.451 . . . . 0.0 111.771 -177.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 4.2 pp -165.64 141.15 5.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.626 174.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -175.85 123.45 0.2 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 5.8 t60 -139.94 100.32 3.9 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 110.108 -0.331 . . . . 0.0 110.108 179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.408 ' HA ' ' SD ' ' A' ' 1' ' ' MET . 33.8 m170 -78.45 178.7 7.53 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.216 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . 0.504 ' HB2' ' CE ' ' A' ' 1' ' ' MET . 12.5 t60 -105.12 125.85 51.43 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.768 -178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 83.8 m-70 -90.15 -172.62 3.55 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.54 -177.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.418 ' O ' ' HB3' ' A' ' 135' ' ' HIS . 24.4 m80 -76.46 73.55 3.2 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.171 0.434 . . . . 0.0 112.171 -176.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.418 ' HB3' ' O ' ' A' ' 134' ' ' HIS . 5.5 p80 . . . . . 0 C--O 1.243 0.721 0 CA-C-N 115.202 -0.908 . . . . 0.0 108.75 169.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.458 ' HG2' HG12 ' A' ' 2' ' ' ILE . 21.0 ttt . . . . . 0 N--CA 1.48 1.032 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.458 HG12 ' HG2' ' A' ' 1' ' ' MET . 45.1 mm 65.78 82.42 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.232 0.142 0 O-C-N 123.622 0.576 . . . . 0.0 111.388 177.088 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 68.7 mtt -85.92 139.02 31.59 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.993 -0.743 . . . . 0.0 108.993 172.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.9 t -71.13 98.57 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 120.884 0.373 . . . . 0.0 110.57 -175.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 14.7 m -76.76 109.28 10.41 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.896 -0.593 . . . . 0.0 109.778 176.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -92.39 167.94 30.48 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.658 -177.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.789 ' HA ' ' HB2' ' A' ' 70' ' ' SER . 42.8 t -119.3 82.34 1.86 Allowed 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.165 0.507 . . . . 0.0 110.058 177.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 83.3 mt-30 -82.12 82.41 7.69 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.74 -0.664 . . . . 0.0 109.669 177.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.609 ' HG2' ' HB3' ' A' ' 69' ' ' GLN . 0.0 OUTLIER -93.73 67.78 3.89 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.132 -0.486 . . . . 0.0 109.957 -177.104 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -178.32 68.49 0.02 OUTLIER 'General case' 0 C--O 1.235 0.308 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.442 177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 25.4 mtpt -159.9 164.64 33.33 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.707 177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -130.76 94.13 3.56 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.774 174.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -132.32 172.07 12.91 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.947 -0.761 . . . . 0.0 108.947 179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.4 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 15.0 m -54.71 116.88 12.05 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-O 120.828 0.347 . . . . 0.0 111.773 -176.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.723 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.2 Cg_exo -67.45 104.13 0.88 Allowed 'Trans proline' 0 N--CA 1.461 -0.385 0 C-N-CA 122.816 2.344 . . . . 0.0 111.656 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 40.6 p90 -57.65 -34.27 69.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.987 -177.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 50.1 p90 -78.93 -9.62 59.56 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -174.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.723 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 2.1 t80 -80.82 23.79 0.52 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.331 0.586 . . . . 0.0 111.364 -172.155 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -115.61 -177.78 18.49 Favored Glycine 0 C--N 1.314 -0.664 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.095 -178.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 14.4 m -99.23 116.86 32.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 110.0 -0.37 . . . . 0.0 110.0 178.652 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.45 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 50.6 m95 -114.05 132.32 56.06 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.465 -175.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -99.28 129.99 45.54 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 169.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.413 ' HA ' ' HB3' ' A' ' 109' ' ' MET . 36.6 mt-10 -62.25 -55.63 26.52 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.859 0.362 . . . . 0.0 110.823 -178.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 66.43 27.55 73.17 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.107 -178.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.7 144.68 21.75 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 110.276 -0.268 . . . . 0.0 110.276 179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 66.6 160.71 0.13 Allowed Pre-proline 0 CA--C 1.536 0.41 0 O-C-N 124.388 1.055 . . . . 0.0 112.086 177.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -68.85 153.6 72.54 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.686 2.258 . . . . 0.0 111.516 173.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -87.03 -169.66 46.07 Favored Glycine 0 N--CA 1.441 -1.022 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.964 -177.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.616 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 64.2 Cg_exo -50.66 162.89 0.83 Allowed 'Trans proline' 0 CA--C 1.535 0.532 0 C-N-CA 124.466 3.444 . . . . 0.0 113.879 177.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.2 p -69.34 -9.42 53.27 Favored 'General case' 0 CA--C 1.535 0.372 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -170.884 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -75.59 -10.13 59.18 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 122.012 -0.43 . . . . 0.0 111.106 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 103.7 27.67 6.27 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.591 -0.814 . . . . 0.0 111.547 -179.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.616 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 21.4 t -74.06 134.67 29.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.32 -0.44 . . . . 0.0 110.262 -177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 13.5 mmmm -81.14 -32.67 33.61 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.938 -174.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 23.9 m -158.73 160.34 36.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.506 -178.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -133.01 137.01 46.35 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.142 0.496 . . . . 0.0 111.092 -175.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.45 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 24.6 p -118.39 136.86 53.5 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.259 177.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.0 p -117.78 134.14 62.34 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.179 0.514 . . . . 0.0 110.671 -177.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.3 m -123.3 128.31 49.76 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.701 177.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.559 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 97.0 m-85 -102.06 116.79 33.44 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.128 0.489 . . . . 0.0 110.546 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.524 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.0 OUTLIER -103.04 -178.16 3.58 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.78 178.613 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -46.01 -64.2 0.8 Allowed 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 113.05 0.759 . . . . 0.0 113.05 -175.21 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -128.17 10.29 6.32 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.772 0.796 . . . . 0.0 110.16 -173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.524 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 0.7 OUTLIER -137.98 145.83 42.42 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.181 -179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.511 HG23 ' CD1' ' A' ' 64' ' ' TYR . 90.0 t -101.36 132.3 47.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 173.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 46.6 t -112.19 123.16 67.66 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.662 0 CA-C-O 120.828 0.347 . . . . 0.0 110.159 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.1 mt-10 -103.78 138.31 40.56 Favored 'General case' 0 CA--C 1.508 -0.643 0 CA-C-O 121.435 0.636 . . . . 0.0 110.279 174.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.45 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -124.23 122.13 36.95 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.182 -179.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -100.59 120.03 39.42 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.797 -178.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.5 HG22 ' HG3' ' A' ' 56' ' ' GLU . 33.2 t -87.98 112.7 23.99 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.857 0 N-CA-C 110.016 -0.364 . . . . 0.0 110.016 -179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -115.6 127.57 55.32 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 -178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -56.16 132.12 49.58 Favored 'General case' 0 C--N 1.326 -0.439 0 O-C-N 123.67 0.606 . . . . 0.0 111.517 -177.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 97.38 -38.4 3.11 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.07 -179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -93.9 -63.96 1.14 Allowed 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.838 0.828 . . . . 0.0 110.11 -179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 128.14 -157.02 21.05 Favored Glycine 0 N--CA 1.443 -0.883 0 CA-C-N 114.232 -1.349 . . . . 0.0 110.376 -174.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.5 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.8 mp0 -74.98 129.61 37.94 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.38 0.61 . . . . 0.0 110.843 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 97.8 t -111.84 122.58 66.45 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 114.905 -1.043 . . . . 0.0 109.708 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 89.4 mt-30 -84.76 131.63 34.53 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-O 120.872 0.368 . . . . 0.0 111.917 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 75.7 mt -88.69 164.89 30.2 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.543 175.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -55.83 152.33 36.1 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.876 2.384 . . . . 0.0 112.44 175.731 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 80.7 m-85 -71.77 114.66 10.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.513 0.673 . . . . 0.0 110.693 -178.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.7 mtp -96.62 118.38 32.99 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 114.976 -1.011 . . . . 0.0 109.544 -179.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.499 ' HB1' HD12 ' A' ' 80' ' ' LEU . . . -75.98 140.85 42.23 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.969 0.414 . . . . 0.0 111.66 -175.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.511 ' CD1' HG23 ' A' ' 45' ' ' VAL . 8.9 p90 -145.94 150.11 35.44 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 177.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 48.5 mttp -132.93 151.56 52.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 121.486 0.66 . . . . 0.0 111.243 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.9 t -81.87 128.94 38.27 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 114.464 -1.244 . . . . 0.0 111.846 -172.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 36.7 mt -90.94 -52.56 10.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.177 175.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 12.6 m -138.48 156.95 47.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.196 177.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.609 ' HB3' ' HG2' ' A' ' 9' ' ' GLN . 34.9 tt0 -147.54 152.85 38.67 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 109.922 -0.399 . . . . 0.0 109.922 -174.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.789 ' HB2' ' HA ' ' A' ' 7' ' ' CYS . 33.2 t -157.89 135.48 10.46 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 120.819 0.343 . . . . 0.0 111.156 179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.49 -11.94 59.89 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.477 172.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.2 t70 -66.1 -39.15 89.75 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-N 115.876 -0.602 . . . . 0.0 110.067 176.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.08 36.78 0.15 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.072 -1.061 . . . . 0.0 114.21 173.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 15.8 m -149.84 136.49 19.25 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 117.573 0.686 . . . . 0.0 110.736 172.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.487 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 18.6 mt -136.24 137.5 48.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.98 179.506 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 24.1 tt0 -114.09 129.06 56.63 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.194 -0.669 . . . . 0.0 109.194 174.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.425 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 32.7 pt -131.45 157.43 43.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.653 -0.249 . . . . 0.0 110.858 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.896 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 6.2 tp-100 -124.28 147.05 48.39 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 175.272 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.6 m-85 -96.48 151.05 19.94 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.983 -179.122 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.499 HD12 ' HB1' ' A' ' 63' ' ' ALA . 38.1 mt -107.74 156.13 19.44 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.154 -179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 93.46 -154.42 21.75 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -174.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_exo -63.24 -4.76 6.92 Favored 'Trans proline' 0 CA--C 1.534 0.489 0 C-N-CA 122.765 2.31 . . . . 0.0 112.618 178.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.0 m-85 -97.67 11.45 37.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.847 -179.028 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.988 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -65.35 176.71 0.79 Allowed Pre-proline 0 CA--C 1.542 0.635 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.948 179.36 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.988 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 20.0 Cg_exo 5.06 -1.25 0.0 OUTLIER 'Trans proline' 0 CA--C 1.551 1.337 1 C-N-CA 128.425 6.084 . . . . 0.0 121.872 -148.478 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' N ' ' O ' ' A' ' 84' ' ' TYR . 51.2 tp -90.19 102.94 15.66 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 120.299 1.409 . . . . 0.0 108.057 168.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 20.4 pttp -115.39 178.66 4.21 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.399 0.618 . . . . 0.0 112.352 -166.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.425 ' CB ' ' HE1' ' A' ' 100' ' ' TRP . 2.6 m -133.27 165.6 24.44 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 114.923 -1.035 . . . . 0.0 111.096 -176.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 6.1 m -123.86 142.16 51.38 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.443 179.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.487 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 93.7 mt -117.92 124.6 48.65 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.365 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 43.6 mtpt -137.51 154.98 49.77 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.955 0.407 . . . . 0.0 110.991 -178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -65.12 143.72 57.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.562 -0.745 . . . . 0.0 111.253 -177.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -118.01 132.97 10.14 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 172.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' O ' ' HB2' ' A' ' 95' ' ' ASN . 42.3 mt-10 -68.59 158.43 34.0 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 122.899 -0.177 . . . . 0.0 110.568 -178.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.405 ' HB2' ' O ' ' A' ' 94' ' ' GLU . 12.9 m120 75.51 -7.42 1.79 Allowed 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 123.74 0.816 . . . . 0.0 110.784 -174.29 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 102.17 54.53 0.9 Allowed Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.873 -179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 14.4 p -131.16 174.24 10.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.748 0.309 . . . . 0.0 111.274 -179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 64.6 tp -121.82 133.18 54.89 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.884 177.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 62.0 mt -105.16 110.2 30.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-O 121.231 0.539 . . . . 0.0 109.87 175.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.453 ' HE3' ' HE1' ' A' ' 109' ' ' MET . 20.9 t90 -104.97 114.13 28.15 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.461 -0.79 . . . . 0.0 109.788 -178.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -100.9 134.71 43.48 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.266 0.555 . . . . 0.0 109.687 178.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 13.2 tm0? -148.79 111.77 4.87 Favored 'General case' 0 C--N 1.308 -1.224 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.748 -173.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 56.0 t30 60.59 31.71 20.27 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 121.82 0.819 . . . . 0.0 110.698 166.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 101.44 -17.17 55.85 Favored Glycine 0 N--CA 1.449 -0.468 0 CA-C-N 115.504 -0.771 . . . . 0.0 112.941 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -92.04 136.29 33.29 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.968 0.384 . . . . 0.0 110.839 -176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 106' ' ' ARG . 23.2 ttt180 -99.94 114.97 28.6 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 175.236 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -109.7 136.25 49.35 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.969 0.414 . . . . 0.0 110.595 178.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 18.4 m -120.93 114.13 21.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 116.064 -0.516 . . . . 0.0 109.856 177.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.453 ' HE1' ' HE3' ' A' ' 100' ' ' TRP . 0.1 OUTLIER -118.22 151.49 37.53 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 121.024 0.44 . . . . 0.0 111.183 -178.7 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -109.36 151.72 26.25 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.678 -0.692 . . . . 0.0 109.892 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -87.92 135.74 33.27 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.905 0.383 . . . . 0.0 110.298 -176.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 28.3 mm -74.78 147.58 8.47 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 CA-C-N 115.78 -0.645 . . . . 0.0 109.616 178.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.5 tp10 -88.39 152.4 21.93 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.557 -174.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 36.2 m -77.0 76.23 3.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.767 -174.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 67.9 mttm -112.25 63.99 0.63 Allowed 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 168.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 2.2 p -79.23 102.56 8.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.316 -0.857 . . . . 0.0 112.266 -172.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.0 66.6 3.91 Favored Glycine 0 N--CA 1.449 -0.474 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 174.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 2.4 ptp180 -98.49 83.48 3.02 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.632 0.73 . . . . 0.0 110.845 -177.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mp0 -132.79 160.82 35.76 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.218 -0.901 . . . . 0.0 108.681 176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -74.61 103.0 4.75 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 175.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -84.07 138.84 32.85 Favored 'General case' 0 C--N 1.317 -0.815 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.652 -178.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -91.18 159.45 16.07 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 171.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -67.89 132.22 46.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.016 0.436 . . . . 0.0 111.204 -175.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 57.2 pttt -64.17 104.41 0.74 Allowed 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.667 -175.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.3 t -87.87 104.56 16.71 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.015 -0.993 . . . . 0.0 110.243 177.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt 70.15 -74.58 0.08 Allowed 'General case' 0 N--CA 1.468 0.46 0 O-C-N 123.792 0.682 . . . . 0.0 111.488 178.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 27.0 t -164.44 133.24 3.6 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -177.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -113.27 107.32 15.73 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.855 0.36 . . . . 0.0 110.449 -174.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -166.46 152.0 8.31 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.828 -0.624 . . . . 0.0 109.473 175.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 20.7 m-70 -91.73 106.91 18.83 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -62.71 107.72 1.02 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.192 -175.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 38.7 p-80 -116.9 130.98 57.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.785 -172.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -104.79 117.3 33.71 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 177.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 14.1 t-160 -82.56 -5.83 58.99 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.905 0.383 . . . . 0.0 111.442 -171.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 38.0 t60 . . . . . 0 C--O 1.241 0.658 0 N-CA-C 108.968 -0.752 . . . . 0.0 108.968 177.086 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 92.5 mtp . . . . . 0 N--CA 1.479 1.022 0 N-CA-C 110.029 -0.359 . . . . 0.0 110.029 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 67.3 mt 68.15 96.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.464 0.253 0 O-C-N 123.924 0.765 . . . . 0.0 111.4 -179.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 70.2 mtp -131.4 120.57 23.25 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.094 176.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 34.5 m -103.27 143.4 15.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.401 -178.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 t -102.42 0.64 34.18 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 120.824 0.345 . . . . 0.0 110.613 179.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -78.97 64.84 3.64 Favored Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 37.6 m -85.03 151.5 24.12 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.844 0.354 . . . . 0.0 111.313 -174.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -104.97 -138.58 0.36 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.846 -0.616 . . . . 0.0 109.676 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 70.07 35.81 2.09 Favored 'General case' 0 N--CA 1.464 0.273 0 O-C-N 123.458 0.474 . . . . 0.0 111.274 174.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -64.09 122.76 17.33 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 174.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -83.34 -32.61 26.18 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.519 -0.764 . . . . 0.0 112.43 -169.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 53.59 61.65 3.01 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.976 0.893 . . . . 0.0 109.961 -170.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.548 ' O ' ' HB ' ' A' ' 14' ' ' THR . 10.0 tp10 -131.72 172.54 12.15 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.319 -1.309 . . . . 0.0 109.027 -175.072 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.548 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 14.7 m 72.71 124.33 0.03 OUTLIER Pre-proline 0 N--CA 1.45 -0.449 0 C-N-CA 123.147 0.579 . . . . 0.0 111.856 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 14' ' ' THR . 6.1 Cg_endo -49.45 120.13 5.4 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 123.725 2.95 . . . . 0.0 112.721 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.0 p90 -69.53 -14.24 62.75 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.468 -176.532 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -98.03 -11.54 22.88 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.498 -177.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 57.8 t80 -86.05 135.71 33.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.792 0.329 . . . . 0.0 110.895 -173.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.93 -168.24 22.5 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.984 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 30.7 m -104.08 129.93 51.77 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 177.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 64.9 m95 -120.44 135.8 54.94 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.016 0.436 . . . . 0.0 111.039 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -94.74 139.09 31.72 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.395 -0.82 . . . . 0.0 109.027 174.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 36' ' ' ALA . 37.5 mt-10 -50.31 -43.83 53.91 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 111.703 0.26 . . . . 0.0 111.703 -177.92 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 75.21 -56.81 2.8 Favored Glycine 0 N--CA 1.453 -0.224 0 C-N-CA 121.265 -0.493 . . . . 0.0 113.187 175.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 38.5 tpt85 -105.7 141.24 37.49 Favored 'General case' 0 N--CA 1.445 -0.72 0 N-CA-C 110.019 -0.363 . . . . 0.0 110.019 -176.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.626 ' HB3' ' HE2' ' A' ' 107' ' ' LYS . . . 65.81 142.77 0.08 OUTLIER Pre-proline 0 N--CA 1.468 0.449 0 O-C-N 124.637 1.211 . . . . 0.0 112.054 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.1 Cg_exo -81.44 171.09 13.96 Favored 'Trans proline' 0 N--CA 1.462 -0.344 0 C-N-CA 123.251 2.634 . . . . 0.0 112.571 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -89.91 -154.97 30.34 Favored Glycine 0 N--CA 1.446 -0.687 0 C-N-CA 120.942 -0.646 . . . . 0.0 112.313 177.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.51 ' O ' ' HB ' ' A' ' 30' ' ' THR . 18.8 Cg_endo -61.89 -31.06 84.72 Favored 'Trans proline' 0 C--O 1.23 0.098 0 C-N-CA 123.315 2.676 . . . . 0.0 113.597 -178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.51 ' HB ' ' O ' ' A' ' 29' ' ' PRO . 83.2 m 75.6 -21.14 0.32 Allowed 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.748 -177.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -51.13 -54.7 22.77 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.612 0.72 . . . . 0.0 110.398 176.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -147.36 -43.07 0.04 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 CA-C-N 114.997 -1.001 . . . . 0.0 111.002 176.33 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.9 t -77.35 134.03 29.44 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.3 mttt -92.72 -32.47 14.7 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.287 0.565 . . . . 0.0 110.301 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.1 m -167.88 165.41 13.87 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 114.954 -1.021 . . . . 0.0 108.943 -174.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.511 ' O ' ' HG3' ' A' ' 23' ' ' GLU . . . -121.97 148.06 45.26 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-O 121.096 0.474 . . . . 0.0 111.055 177.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 11.3 p -118.11 139.48 51.18 Favored 'General case' 0 C--N 1.319 -0.761 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 174.168 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 p -123.54 137.57 56.33 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-O 121.162 0.506 . . . . 0.0 111.19 -175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -119.41 127.84 53.49 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.248 -0.433 . . . . 0.0 109.901 176.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 90.7 m-85 -101.69 125.64 48.38 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.259 0.552 . . . . 0.0 111.425 -175.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.505 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.9 OUTLIER -101.36 178.97 4.5 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 174.439 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.505 ' H ' HG22 ' A' ' 41' ' ' THR . 36.5 mt-10 -55.03 -42.1 72.21 Favored 'General case' 0 CA--C 1.534 0.356 0 N-CA-C 112.2 0.445 . . . . 0.0 112.2 -175.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -141.29 19.55 2.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.974 0.416 . . . . 0.0 110.821 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.476 ' HB2' ' HB ' ' A' ' 41' ' ' THR . 29.8 mt-10 -129.06 145.16 51.34 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.173 -176.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.555 ' HB ' ' HB2' ' A' ' 62' ' ' MET . 92.5 t -117.14 121.17 67.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.495 175.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 91.1 t -108.07 124.02 64.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 174.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -111.8 128.78 56.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.465 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -111.62 125.18 53.67 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.485 177.227 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -99.19 128.08 45.26 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -178.587 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.556 HG22 ' HG2' ' A' ' 56' ' ' GLU . 43.6 t -92.31 112.61 26.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.138 0.494 . . . . 0.0 110.359 -178.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -112.3 161.56 16.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.363 -0.835 . . . . 0.0 110.433 -176.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -76.0 123.96 26.61 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.817 0.341 . . . . 0.0 110.759 -176.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 80.89 -10.93 44.21 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 121.06 -0.591 . . . . 0.0 112.592 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 17.8 mmt180 -98.71 -68.36 0.81 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.623 0.725 . . . . 0.0 110.395 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.454 ' O ' ' HA ' ' A' ' 50' ' ' VAL . . . 125.66 -142.59 13.86 Favored Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 114.778 -1.101 . . . . 0.0 110.613 -175.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.556 ' HG2' HG22 ' A' ' 50' ' ' VAL . 53.1 mt-10 -95.65 120.61 36.21 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-O 121.291 0.567 . . . . 0.0 110.644 177.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' O ' ' HA ' ' A' ' 48' ' ' THR . 73.9 t -104.68 124.89 59.56 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 CA-C-N 115.033 -0.985 . . . . 0.0 109.694 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 24.5 mt-30 -88.13 119.57 28.64 Favored 'General case' 0 N--CA 1.449 -0.51 0 CA-C-O 120.87 0.367 . . . . 0.0 111.629 -173.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.547 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.6 mt -81.09 163.64 54.31 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.806 173.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.547 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.4 Cg_endo -62.25 146.4 95.89 Favored 'Trans proline' 0 C--O 1.234 0.317 0 C-N-CA 122.246 1.964 . . . . 0.0 111.792 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.4 p90 -64.04 131.01 46.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.512 0.672 . . . . 0.0 111.075 -177.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.555 ' HB2' ' HB ' ' A' ' 45' ' ' VAL . 50.8 mtt -97.43 118.19 33.36 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.192 -0.913 . . . . 0.0 109.838 -179.732 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -80.83 127.71 32.83 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 179.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.493 ' CD1' HG23 ' A' ' 45' ' ' VAL . 45.6 p90 -129.18 171.81 12.06 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.959 0.409 . . . . 0.0 111.332 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HE3' HD21 ' A' ' 80' ' ' LEU . 99.0 mttt -120.71 159.73 24.77 Favored 'General case' 0 CA--C 1.512 -0.519 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.253 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.9 t -103.72 120.97 54.59 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-N 114.762 -1.108 . . . . 0.0 109.781 176.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.606 HD11 ' HB2' ' A' ' 78' ' ' GLN . 19.9 mt -87.55 -54.0 8.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.233 0.539 . . . . 0.0 109.813 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.2 m -136.46 153.19 51.13 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.144 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -147.74 124.39 11.12 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.455 0.645 . . . . 0.0 111.151 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.419 ' HB3' ' H ' ' A' ' 74' ' ' SER . 35.5 t -108.85 -22.55 12.15 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.167 -0.924 . . . . 0.0 110.124 177.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 25.5 m 73.77 -38.71 0.41 Allowed 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.851 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -98.53 -59.41 1.75 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.756 0.312 . . . . 0.0 111.435 -177.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -77.64 -60.52 2.78 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.707 -0.759 . . . . 0.0 113.176 -176.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.498 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 30.5 t -154.0 164.84 37.78 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.407 0.622 . . . . 0.0 111.598 -174.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 22.4 mt -133.55 136.4 54.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.792 -1.094 . . . . 0.0 108.456 172.03 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.457 ' HG2' HD12 ' A' ' 67' ' ' ILE . 27.2 tt0 -115.09 131.01 57.06 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.739 0.304 . . . . 0.0 110.37 -177.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 36.2 pt -131.64 158.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.136 -174.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.606 ' HB2' HD11 ' A' ' 67' ' ' ILE . 61.8 tt0 -131.84 140.85 49.26 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 177.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.414 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 58.4 m-85 -86.41 179.42 6.87 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.952 0.406 . . . . 0.0 110.996 -176.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.568 HD21 ' HE3' ' A' ' 65' ' ' LYS . 90.0 mt -134.87 -176.21 4.16 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.324 178.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 82.65 -152.98 30.98 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . 0.529 ' HG2' ' CE2' ' A' ' 83' ' ' TYR . 28.0 Cg_endo -65.44 -7.35 15.75 Favored 'Trans proline' 0 CA--C 1.53 0.322 0 C-N-CA 122.215 1.944 . . . . 0.0 112.047 175.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.529 ' CE2' ' HG2' ' A' ' 82' ' ' PRO . 24.8 m-85 -114.16 34.78 4.47 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.1 -178.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.569 ' CD1' ' HD3' ' A' ' 85' ' ' PRO . 19.6 p90 -85.33 -27.35 0.38 Allowed Pre-proline 0 N--CA 1.451 -0.404 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -170.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.569 ' HD3' ' CD1' ' A' ' 84' ' ' TYR . 84.2 Cg_endo -83.32 -4.44 11.0 Favored 'Trans proline' 0 N--CA 1.442 -1.505 0 CA-C-N 121.439 1.55 . . . . 0.0 112.922 -177.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 45.3 tp -99.88 133.22 44.57 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.333 -177.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 22.9 pttp -111.49 168.72 9.32 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.117 0.484 . . . . 0.0 111.181 -178.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 33.8 t -140.81 156.47 46.14 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.393 -0.822 . . . . 0.0 109.315 -177.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.7 m -124.58 142.13 51.58 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.942 0.401 . . . . 0.0 110.83 -177.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.495 ' HB3' HD11 ' A' ' 98' ' ' LEU . 97.6 mt -120.39 124.19 44.9 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.567 178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.498 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 32.8 mtmm -124.26 161.56 25.56 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.39 178.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 36.0 ptt180 -79.39 144.91 33.69 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.011 0.434 . . . . 0.0 110.396 177.687 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -99.64 171.09 23.65 Favored Glycine 0 N--CA 1.437 -1.277 0 CA-C-N 115.872 -0.604 . . . . 0.0 112.507 -177.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -74.18 -19.9 60.39 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.097 -0.551 . . . . 0.0 111.944 -172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 11.4 m120 -121.41 29.66 7.14 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.925 -173.667 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 71.05 39.7 62.92 Favored Glycine 0 N--CA 1.453 -0.206 0 N-CA-C 110.984 -0.847 . . . . 0.0 110.984 -175.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 24.8 p -116.63 174.91 5.82 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.023 -0.588 . . . . 0.0 110.451 -177.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.495 HD11 ' HB3' ' A' ' 90' ' ' LEU . 39.1 tp -113.23 131.78 55.77 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.875 0.369 . . . . 0.0 110.062 178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 30.5 mm -97.89 111.44 27.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 115.798 -0.637 . . . . 0.0 109.866 178.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 12.0 t90 -97.0 112.89 24.44 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.781 -0.645 . . . . 0.0 109.827 -177.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -110.81 132.63 54.04 Favored 'General case' 0 N--CA 1.444 -0.773 0 CA-C-O 120.91 0.386 . . . . 0.0 110.305 -177.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -150.69 128.25 11.5 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.092 -178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.6 m-20 62.66 17.12 9.47 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-O 121.227 0.537 . . . . 0.0 111.408 178.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 97.65 -9.6 64.37 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.587 179.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -92.82 134.3 35.21 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.881 -0.414 . . . . 0.0 109.881 179.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.435 ' NH2' ' HE3' ' A' ' 91' ' ' LYS . 96.4 mtt180 -101.39 123.92 46.23 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.864 -179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.626 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 19.3 mmtp -106.99 125.7 51.35 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.265 -0.425 . . . . 0.0 109.953 169.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 5.1 t -97.66 113.2 24.9 Favored 'General case' 0 C--N 1.316 -0.88 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 174.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.6 mtm -100.38 155.46 17.8 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.856 -169.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -96.11 150.42 20.52 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 115.411 -0.813 . . . . 0.0 108.835 175.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.413 ' O ' ' HG2' ' A' ' 111' ' ' ARG . 3.0 ptt180 -95.78 139.82 31.46 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.229 -0.656 . . . . 0.0 109.229 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . . . . . . . . . 25.6 mm -95.87 155.48 3.38 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.256 0 CA-C-N 115.457 -0.792 . . . . 0.0 108.864 176.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -70.22 85.3 0.56 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.902 0.858 . . . . 0.0 109.769 177.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 1.4 p -99.68 57.7 1.02 Allowed 'General case' 0 C--N 1.31 -1.142 0 CA-C-N 114.474 -1.239 . . . . 0.0 110.332 -176.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 85.9 tttt -78.83 86.39 4.75 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 114.972 -1.013 . . . . 0.0 110.117 -179.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 14.7 t -154.62 179.13 9.34 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.315 -178.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -106.55 161.22 14.12 Favored Glycine 0 N--CA 1.447 -0.588 0 N-CA-C 111.736 -0.546 . . . . 0.0 111.736 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 26.8 ttp180 -89.06 97.26 11.1 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.772 0.32 . . . . 0.0 110.314 -177.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 22.4 mt-10 -79.13 153.18 30.3 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.256 -0.429 . . . . 0.0 109.956 175.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -113.91 118.28 33.73 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.227 -172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.8 tttp -89.88 107.99 19.44 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.86 178.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -106.07 99.4 8.99 Favored 'General case' 0 CA--C 1.501 -0.911 0 CA-C-O 121.852 0.834 . . . . 0.0 109.917 172.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -159.26 153.9 24.42 Favored 'General case' 0 C--N 1.301 -1.5 0 CA-C-N 113.613 -1.631 . . . . 0.0 110.194 -177.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 23.0 ttmm -133.63 76.76 1.68 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 169.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -84.38 112.3 20.22 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.921 -1.036 . . . . 0.0 111.511 -175.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -113.17 103.88 11.79 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.977 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 25.3 m -90.83 82.02 5.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.104 0.478 . . . . 0.0 110.356 178.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 92.1 mt -80.97 93.46 6.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.641 -0.709 . . . . 0.0 110.912 -177.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.431 ' HA ' ' OE1' ' A' ' 129' ' ' GLU . 1.5 mm-40 -97.49 116.74 30.27 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.402 0.62 . . . . 0.0 111.009 178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -127.43 30.06 5.43 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.024 -0.989 . . . . 0.0 109.885 -179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 44.4 m80 -90.72 146.51 23.94 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.4 175.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 35.0 t-80 -83.68 114.83 21.84 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.482 -0.487 . . . . 0.0 110.629 -178.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 32.0 t-80 -69.11 116.57 9.71 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.805 179.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 49.4 t60 -137.18 118.02 14.15 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.035 177.358 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 . . . . . 0 C--O 1.246 0.887 0 CA-C-O 118.602 -0.713 . . . . 0.0 109.726 178.428 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.9 ttt . . . . . 0 N--CA 1.479 0.983 0 CA-C-O 120.974 0.416 . . . . 0.0 111.076 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 8.0 pt -138.56 91.16 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 172.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.01 118.72 10.2 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.028 -175.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 35.6 m -127.17 151.97 34.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.098 0.475 . . . . 0.0 111.333 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 p -146.59 151.0 36.59 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 174.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.7 -154.78 7.52 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 119.191 -1.48 . . . . 0.0 113.581 -175.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 35.8 t -131.85 7.59 4.4 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.168 0.509 . . . . 0.0 110.307 -176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . 0.53 ' HB2' ' HA ' ' A' ' 121' ' ' LYS . 5.9 tp60 -96.92 -175.06 3.15 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.607 -0.516 . . . . 0.0 109.607 179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.514 ' H ' ' HG3' ' A' ' 8' ' ' GLN . 54.2 tt0 -120.93 115.6 23.52 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.0 0.429 . . . . 0.0 111.087 -176.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.8 tp60 -76.76 91.39 3.49 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.466 -0.938 . . . . 0.0 108.466 171.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.845 ' HG3' ' HG2' ' A' ' 12' ' ' GLU . 17.2 ptpt -95.19 -43.05 8.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.565 -169.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.845 ' HG2' ' HG3' ' A' ' 11' ' ' LYS . 4.5 pt-20 -158.62 103.88 1.76 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.639 0.733 . . . . 0.0 111.028 -177.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -101.92 -179.35 3.98 Favored 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 115.074 -0.967 . . . . 0.0 111.095 -177.125 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.818 ' HB ' ' HD3' ' A' ' 15' ' ' PRO . 29.3 m -80.35 -58.9 0.55 Allowed Pre-proline 0 CA--C 1.538 0.501 0 CA-C-N 116.014 -0.539 . . . . 0.0 112.217 -178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.818 ' HD3' ' HB ' ' A' ' 14' ' ' THR . 16.1 Cg_exo -68.82 90.47 0.43 Allowed 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.192 1.928 . . . . 0.0 112.169 -179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -75.7 -9.15 58.34 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.01 -177.719 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 18.6 p90 -84.41 -11.68 55.81 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.899 0.333 . . . . 0.0 111.899 -175.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.495 ' CD2' ' HB2' ' A' ' 15' ' ' PRO . 10.5 m-85 -72.68 151.08 42.43 Favored 'General case' 0 N--CA 1.455 -0.203 0 CA-C-O 120.836 0.35 . . . . 0.0 110.9 178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 117.71 -167.07 12.71 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.81 -0.71 . . . . 0.0 112.388 178.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 54.3 m -110.55 128.07 55.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-O 120.929 0.395 . . . . 0.0 110.501 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.439 ' CZ3' ' HB3' ' A' ' 111' ' ' ARG . 64.1 m95 -113.36 128.6 56.51 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.402 -179.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.566 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.0 t70 -88.21 120.69 29.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.687 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 12.3 mm-40 -99.16 76.1 2.06 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.348 171.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.23 40.4 2.47 Favored Glycine 0 N--CA 1.448 -0.559 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.345 177.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -128.04 144.49 51.11 Favored 'General case' 0 N--CA 1.449 -0.522 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -178.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 71.43 156.75 0.16 Allowed Pre-proline 0 N--CA 1.465 0.311 0 O-C-N 124.213 0.946 . . . . 0.0 111.756 178.536 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -61.74 134.51 50.94 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.455 2.104 . . . . 0.0 111.857 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -96.9 -174.85 34.98 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.229 -179.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.607 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 18.2 Cg_endo -59.76 128.4 26.78 Favored 'Trans proline' 0 CA--C 1.528 0.193 0 C-N-CA 123.159 2.573 . . . . 0.0 112.75 -179.017 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.6 t -67.86 -10.38 52.56 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.347 0.594 . . . . 0.0 110.587 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -55.88 -33.17 64.34 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.156 -0.929 . . . . 0.0 111.561 178.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 156.57 -27.96 0.54 Allowed Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.1 -1.048 . . . . 0.0 113.221 178.656 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.607 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 5.8 t -82.59 133.35 29.32 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 N-CA-C 110.059 -0.349 . . . . 0.0 110.059 -178.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 43.2 mtmt -91.48 -31.08 16.11 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.092 0.473 . . . . 0.0 111.115 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.5 m -160.2 165.09 32.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.613 -174.042 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -134.78 154.85 51.43 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.012 0.434 . . . . 0.0 111.292 -177.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.548 HG22 ' HA ' ' A' ' 22' ' ' ASP . 5.7 p -123.18 130.44 52.76 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.791 -0.64 . . . . 0.0 109.407 174.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.1 p -112.39 130.39 66.22 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.891 0 CA-C-O 121.058 0.456 . . . . 0.0 110.572 -177.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 66.2 m -114.78 127.09 55.53 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.811 -0.632 . . . . 0.0 109.774 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -100.83 117.64 35.31 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-O 121.17 0.51 . . . . 0.0 110.2 -179.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.506 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.4 OUTLIER -101.11 179.18 4.45 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.194 -0.912 . . . . 0.0 108.543 176.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.506 ' H ' HG22 ' A' ' 41' ' ' THR . 29.9 mt-10 -52.84 -64.13 0.92 Allowed 'General case' 0 N--CA 1.449 -0.524 0 N-CA-C 112.06 0.393 . . . . 0.0 112.06 -176.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 -119.18 14.49 13.05 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.94 0.4 . . . . 0.0 111.698 -174.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -144.49 148.62 34.75 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.91 0.386 . . . . 0.0 111.019 -178.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.421 HG23 ' CD1' ' A' ' 64' ' ' TYR . 98.0 t -110.19 119.45 59.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.526 175.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 47.8 t -100.8 123.35 53.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.991 0.424 . . . . 0.0 110.426 -179.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -100.22 137.24 38.92 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 121.368 0.604 . . . . 0.0 110.75 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -128.03 122.26 31.76 Favored 'General case' 0 C--N 1.308 -1.214 0 CA-C-N 114.788 -1.096 . . . . 0.0 109.867 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -99.67 135.89 40.41 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 109.73 -0.47 . . . . 0.0 109.73 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.3 t -88.53 112.08 23.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 178.317 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 79.6 mmm -110.47 124.94 52.72 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.777 -0.647 . . . . 0.0 111.043 -176.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -61.56 113.88 2.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.408 -0.815 . . . . 0.0 110.976 -178.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 101.33 -26.83 23.15 Favored Glycine 0 C--N 1.33 0.23 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.4 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 15.6 mmt85 -96.23 -55.03 3.08 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.598 0.713 . . . . 0.0 109.813 -177.366 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 119.19 -156.64 15.64 Favored Glycine 0 N--CA 1.445 -0.764 0 CA-C-N 114.485 -1.234 . . . . 0.0 110.496 -176.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -71.99 126.74 30.52 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.279 0.561 . . . . 0.0 110.564 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.4 t -113.88 122.59 68.3 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.906 0 CA-C-N 115.182 -0.917 . . . . 0.0 110.148 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 22.4 mt-30 -81.81 128.45 34.03 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.089 0.471 . . . . 0.0 111.546 -177.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.562 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 89.2 mt -93.75 165.45 17.97 Favored Pre-proline 0 C--N 1.321 -0.661 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.489 173.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.562 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 13.0 Cg_endo -58.45 128.4 28.28 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 122.297 1.998 . . . . 0.0 111.432 178.192 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 18.0 p90 -66.89 122.9 18.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-O 121.75 0.786 . . . . 0.0 111.231 -176.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 40.2 ttm -80.39 127.87 32.9 Favored 'General case' 0 N--CA 1.429 -1.508 0 CA-C-N 114.888 -1.051 . . . . 0.0 110.655 -177.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -75.18 135.76 41.06 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 176.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.421 ' CD1' HG23 ' A' ' 45' ' ' VAL . 6.2 p90 -147.09 157.93 43.77 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 63.8 tttm -123.68 136.64 54.59 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.169 176.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.469 ' HA ' HG22 ' A' ' 77' ' ' ILE . 78.9 t -75.7 122.94 30.69 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.882 176.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 78' ' ' GLN . 27.4 mt -83.9 -54.44 8.97 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 176.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 5.4 m -140.78 156.47 46.16 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.7 -178.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -148.67 126.39 11.81 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.161 177.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 33.0 t -161.94 156.26 22.16 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.056 -177.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.5 m -82.17 -26.87 33.03 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.125 0.488 . . . . 0.0 110.107 177.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -118.7 -29.89 5.26 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.94 -179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -82.76 0.81 89.23 Favored Glycine 0 N--CA 1.453 -0.2 0 N-CA-C 111.422 -0.671 . . . . 0.0 111.422 173.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 83.7 p 60.96 -178.54 0.11 Allowed 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 124.97 1.308 . . . . 0.0 112.222 176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 11.3 mt -108.13 130.59 60.4 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.134 -177.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -126.38 128.49 47.12 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 179.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.469 HG22 ' HA ' ' A' ' 66' ' ' VAL . 29.4 pt -131.01 155.86 42.3 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.996 0.426 . . . . 0.0 111.198 -176.194 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.758 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 5.6 tp-100 -123.68 146.22 48.4 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.718 -0.674 . . . . 0.0 109.205 178.362 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.498 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 41.4 m-85 -98.45 151.05 21.0 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.873 0.368 . . . . 0.0 110.365 -177.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 40.4 mt -113.82 164.51 13.65 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.802 -0.636 . . . . 0.0 109.407 179.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 87.7 -151.28 23.05 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 119.682 -1.247 . . . . 0.0 111.513 -179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -63.68 -6.91 11.54 Favored 'Trans proline' 0 CA--C 1.536 0.583 0 C-N-CA 122.974 2.449 . . . . 0.0 112.627 178.543 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -105.7 13.07 30.29 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.302 -177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.3 OUTLIER -60.45 174.22 0.53 Allowed Pre-proline 0 CA--C 1.54 0.587 0 CA-C-N 115.623 -0.717 . . . . 0.0 112.106 -173.697 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 44.5 Cg_exo 5.18 -0.56 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.208 1 C-N-CA 128.847 6.365 . . . . 0.0 121.944 -148.432 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' H ' ' C ' ' A' ' 84' ' ' TYR . 49.0 tp -78.12 103.04 7.81 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 120.086 1.312 . . . . 0.0 108.095 168.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 77' ' ' ILE . 61.4 pttt -95.7 -176.8 3.85 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 112.702 0.63 . . . . 0.0 112.702 -166.38 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.42 ' HB3' HG13 ' A' ' 77' ' ' ILE . 40.6 t -141.69 159.32 42.47 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 115.087 -0.961 . . . . 0.0 110.235 -178.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.568 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.8 m -137.17 144.71 43.07 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.507 -178.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.582 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 87.2 mt -126.59 124.65 40.42 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.546 -179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.478 ' O ' HD12 ' A' ' 98' ' ' LEU . 62.3 mttp -123.17 167.0 14.26 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 179.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.8 mtt180 -79.82 149.52 31.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.952 -175.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.518 ' HA3' ' HB ' ' A' ' 97' ' ' THR . . . -116.24 137.66 13.85 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 173.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -55.89 -41.41 74.42 Favored 'General case' 0 C--N 1.321 -0.642 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -170.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 40.1 m-80 -92.32 25.78 2.82 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.453 -176.851 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 81.04 39.02 13.65 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.736 -0.745 . . . . 0.0 111.27 -178.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.518 ' HB ' ' HA3' ' A' ' 93' ' ' GLY . 1.0 OUTLIER -107.63 171.91 7.13 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.362 -0.419 . . . . 0.0 109.886 -176.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.478 HD12 ' O ' ' A' ' 91' ' ' LYS . 34.3 tp -128.8 131.08 47.75 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 175.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 67.5 mt -97.78 112.81 30.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.694 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.446 ' HA ' HD23 ' A' ' 90' ' ' LEU . 20.7 t90 -96.54 112.65 24.31 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.987 -176.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 36.3 mt-10 -104.64 130.04 52.7 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.458 0.647 . . . . 0.0 110.031 178.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.437 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 19.7 tm0? -153.78 134.74 13.87 Favored 'General case' 0 C--N 1.306 -1.31 0 CA-C-N 114.9 -1.046 . . . . 0.0 109.798 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.437 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.9 OUTLIER 66.55 13.33 9.25 Favored 'General case' 0 N--CA 1.468 0.439 0 O-C-N 123.323 0.39 . . . . 0.0 111.525 173.739 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 87.78 9.28 71.74 Favored Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.72 -0.753 . . . . 0.0 112.073 -176.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 30.9 mt-30 -111.31 142.69 43.21 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 110.245 -0.28 . . . . 0.0 110.245 177.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.554 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 58.7 mtt180 -99.51 117.11 33.18 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.168 0.508 . . . . 0.0 111.609 179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.428 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 29.7 mmmt -101.7 141.4 34.62 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.556 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.6 m -119.24 112.68 19.78 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.068 179.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HE3' HD23 ' A' ' 98' ' ' LEU . 23.6 ptt? -126.37 141.57 51.85 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.755 -175.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.7 m -98.94 154.46 18.04 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.435 -177.18 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.439 ' HB3' ' CZ3' ' A' ' 21' ' ' TRP . 20.3 ptt180 -88.11 157.72 18.77 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.054 -177.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.566 HD11 ' HB2' ' A' ' 22' ' ' ASP . 19.7 mm -95.76 147.46 5.96 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 108.707 -0.849 . . . . 0.0 108.707 174.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -86.85 121.39 29.27 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-O 121.268 0.556 . . . . 0.0 111.435 -172.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 23.1 m -99.74 117.81 34.88 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 115.443 -0.799 . . . . 0.0 109.299 174.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -100.09 4.92 44.89 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.162 0.506 . . . . 0.0 110.484 -178.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -147.19 150.68 35.38 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.353 -0.84 . . . . 0.0 110.445 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -164.4 64.65 0.23 Allowed Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.522 ' HA ' ' O ' ' A' ' 8' ' ' GLN . 25.9 ttp-105 -97.1 84.8 3.58 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.973 0.416 . . . . 0.0 110.349 -174.261 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -142.67 131.79 23.2 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.783 -178.712 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 16.2 mm-40 65.8 172.84 0.23 Allowed 'General case' 0 C--O 1.237 0.395 0 O-C-N 123.922 0.764 . . . . 0.0 111.326 -174.051 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.53 ' HA ' ' HB2' ' A' ' 8' ' ' GLN . 46.2 tttp -173.37 130.55 0.46 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.011 174.036 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -118.97 -150.5 0.46 Allowed 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 172.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.0 tt0 69.9 88.19 0.11 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 121.404 0.621 . . . . 0.0 111.251 173.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.03 118.13 11.25 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.319 176.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.6 m -153.58 109.01 3.21 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.45 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 53.6 tttm -121.03 18.32 11.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.395 0.617 . . . . 0.0 110.18 177.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 14.8 m -91.79 101.02 13.62 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 175.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 19.4 tp -126.08 87.74 2.73 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.99 0.424 . . . . 0.0 110.15 -178.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -68.69 131.03 44.51 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.304 -178.77 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 8.5 t-160 -175.42 117.72 0.16 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 178.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 32.6 m170 -100.02 152.41 20.24 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.964 0.411 . . . . 0.0 111.495 -173.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 58.3 m-70 -130.46 131.66 45.3 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.735 -0.666 . . . . 0.0 109.605 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -141.49 -80.79 0.24 Allowed 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.736 -0.211 . . . . 0.0 111.14 178.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.1 m80 66.16 -60.91 0.3 Allowed 'General case' 0 N--CA 1.471 0.613 0 O-C-N 123.685 0.616 . . . . 0.0 110.767 -172.373 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 23.2 t-80 . . . . . 0 C--O 1.245 0.817 0 CA-C-O 118.618 -0.705 . . . . 0.0 109.333 177.441 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 N--CA 1.484 1.259 0 N-CA-C 111.67 0.248 . . . . 0.0 111.67 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 17.3 pt -119.08 106.76 19.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.278 0 CA-C-O 121.588 0.709 . . . . 0.0 111.995 -176.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.0 ptt? -174.27 174.47 2.84 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.554 178.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.3 m -100.52 87.73 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-O 121.629 0.728 . . . . 0.0 110.782 177.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.443 ' HB2' ' HA ' ' A' ' 70' ' ' SER . 4.0 m -81.24 34.61 0.37 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.443 -0.798 . . . . 0.0 111.964 -174.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.45 110.24 0.46 Allowed Glycine 0 N--CA 1.448 -0.518 0 C-N-CA 120.543 -0.837 . . . . 0.0 113.092 -177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . 0.593 ' HB3' ' HG3' ' A' ' 10' ' ' GLN . 41.8 t -143.46 131.68 21.97 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 174.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -75.83 -5.86 47.93 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.139 0.495 . . . . 0.0 111.744 -175.214 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -91.34 -18.5 24.19 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.717 178.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.593 ' HG3' ' HB3' ' A' ' 7' ' ' CYS . 55.5 mt-30 -70.33 -45.59 65.87 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.222 -177.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 62.2 tttp 69.89 -70.26 0.15 Allowed 'General case' 0 N--CA 1.467 0.392 0 O-C-N 124.04 0.837 . . . . 0.0 110.545 -176.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 46.8 mm-40 67.19 -71.43 0.1 Allowed 'General case' 0 N--CA 1.466 0.325 0 O-C-N 123.737 0.648 . . . . 0.0 112.415 176.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.401 ' HG3' ' H ' ' A' ' 14' ' ' THR . 4.3 tp10 -154.9 173.63 16.25 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 -174.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.401 ' H ' ' HG3' ' A' ' 13' ' ' GLU . 11.2 t -75.91 136.83 69.76 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 175.069 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -51.2 124.63 14.44 Favored 'Trans proline' 0 C--N 1.349 0.573 0 C-N-CA 123.277 2.651 . . . . 0.0 112.966 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 51.4 p90 -64.78 -27.88 69.19 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 115.837 -0.62 . . . . 0.0 112.139 -176.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -83.8 -6.45 59.43 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.746 -0.206 . . . . 0.0 111.249 -175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 15.3 t80 -71.75 137.11 47.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.964 0.412 . . . . 0.0 109.996 -175.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 126.03 -149.73 17.42 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.861 -0.685 . . . . 0.0 111.931 -177.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 27.8 m -127.09 132.37 50.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.758 0.313 . . . . 0.0 110.545 -179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 51.6 m95 -120.69 150.87 40.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.237 -179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.585 ' HB2' HD11 ' A' ' 112' ' ' ILE . 7.0 t0 -107.23 127.85 53.9 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.838 178.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -82.13 -18.89 41.31 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.848 179.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 98.3 -56.02 1.07 Allowed Glycine 0 N--CA 1.447 -0.618 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 -173.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.496 ' HA ' ' HA ' ' A' ' 35' ' ' SER . 40.0 ttm180 -170.44 149.8 3.38 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -146.29 155.86 50.12 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.732 -178.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_exo -67.23 134.35 33.47 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.609 2.206 . . . . 0.0 111.019 173.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -165.25 -153.22 7.45 Favored Glycine 0 N--CA 1.447 -0.584 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.667 -175.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -54.21 138.68 72.29 Favored 'Trans proline' 0 C--O 1.235 0.333 0 C-N-CA 123.059 2.506 . . . . 0.0 112.05 178.044 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.1 p -80.3 16.16 1.37 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.922 -0.581 . . . . 0.0 112.494 -174.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.72 -31.1 41.1 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.036 176.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 128.99 95.42 0.8 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.74 -0.743 . . . . 0.0 112.987 178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.524 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -103.62 132.38 50.13 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 175.464 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 71.2 mmtt -87.01 -37.04 17.87 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.153 0.501 . . . . 0.0 110.829 -179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.496 ' HA ' ' HA ' ' A' ' 25' ' ' ARG . 51.6 m -159.92 163.69 34.06 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.092 -0.958 . . . . 0.0 109.923 -174.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -127.24 130.99 50.66 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.68 179.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 12.1 p -123.8 130.79 53.18 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.454 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 5.8 p -112.7 127.53 69.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.858 0 CA-C-O 121.252 0.549 . . . . 0.0 110.484 -178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.563 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 88.8 m -108.41 129.46 55.26 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.791 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -101.43 117.48 35.02 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.144 0.497 . . . . 0.0 110.508 -177.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.655 HG22 ' H ' ' A' ' 42' ' ' GLU . 2.5 m -102.29 -179.62 4.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.159 -0.928 . . . . 0.0 108.814 177.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.655 ' H ' HG22 ' A' ' 41' ' ' THR . 29.1 mm-40 -44.3 -66.45 0.39 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 123.502 0.721 . . . . 0.0 112.609 -177.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -126.08 9.52 7.44 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 120.775 0.322 . . . . 0.0 111.205 -176.467 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -133.3 143.26 48.92 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.408 0.623 . . . . 0.0 111.411 -177.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 88.4 t -96.92 128.31 48.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-N 115.287 -0.87 . . . . 0.0 109.809 176.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.563 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 45.7 t -104.29 123.46 58.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.157 178.15 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 59' ' ' LEU . 17.3 mt-10 -95.2 129.13 42.43 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-O 121.446 0.641 . . . . 0.0 110.655 175.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.422 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -128.16 116.42 19.9 Favored 'General case' 0 C--N 1.305 -1.326 0 CA-C-N 114.852 -1.067 . . . . 0.0 110.019 176.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -103.33 135.82 44.25 Favored 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.9 t -100.66 110.77 28.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.662 -0.866 . . . . 0.0 108.662 176.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.541 ' HB2' ' HB2' ' A' ' 54' ' ' ARG . 91.4 mtp -116.92 134.86 54.23 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.872 -172.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -69.6 116.58 10.16 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.857 -176.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 96.44 -11.71 66.79 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.648 -0.706 . . . . 0.0 111.49 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.541 ' HB2' ' HB2' ' A' ' 51' ' ' MET . 4.5 mmp_? -106.86 -59.41 1.81 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.476 0.655 . . . . 0.0 110.183 -179.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 115.84 -165.03 12.16 Favored Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 114.891 -1.05 . . . . 0.0 110.543 -174.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -75.73 127.59 33.36 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.433 0.635 . . . . 0.0 110.523 174.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.422 ' O ' ' HA ' ' A' ' 48' ' ' THR . 79.4 t -115.91 121.84 68.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 114.958 -1.019 . . . . 0.0 110.158 -179.432 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 19.8 mt-30 -88.58 122.43 32.03 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.844 0.354 . . . . 0.0 110.209 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.616 ' HB2' ' HB2' ' A' ' 47' ' ' GLU . 74.4 mt -91.13 164.85 23.54 Favored Pre-proline 0 C--N 1.317 -0.822 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.554 179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 11.7 Cg_endo -57.45 134.48 63.77 Favored 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.589 2.193 . . . . 0.0 111.655 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.431 ' CD2' HG22 ' A' ' 46' ' ' VAL . 55.9 m-85 -58.86 132.14 53.07 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.346 -174.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.584 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 7.1 mmt -98.94 119.89 38.47 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.419 178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.78 133.55 41.95 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.431 177.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 24.6 p90 -130.24 159.41 36.97 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-O 120.93 0.395 . . . . 0.0 110.912 179.09 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HD2' HD21 ' A' ' 80' ' ' LEU . 50.1 mttm -122.82 158.2 30.78 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.512 -0.767 . . . . 0.0 110.614 176.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 93.1 t -103.59 112.86 38.7 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.131 179.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.629 HD11 ' HB2' ' A' ' 78' ' ' GLN . 16.4 mt -83.05 -54.47 9.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.594 0.711 . . . . 0.0 109.702 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -142.36 150.74 41.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.148 -0.933 . . . . 0.0 109.585 -177.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . 0.492 ' HG2' ' N ' ' A' ' 71' ' ' THR . 8.9 tt0 -150.28 132.55 15.47 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.612 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.446 ' HB3' ' H ' ' A' ' 74' ' ' SER . 17.4 t -93.72 -21.24 19.46 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 172.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.492 ' N ' ' HG2' ' A' ' 69' ' ' GLN . 26.6 m 75.15 -35.4 0.28 Allowed 'General case' 0 CA--C 1.529 0.171 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.782 178.108 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -101.83 -7.0 22.9 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.168 0.433 . . . . 0.0 112.168 -174.502 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.694 ' HA3' HH11 ' A' ' 92' ' ' ARG . . . -158.87 -51.76 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 119.145 -1.502 . . . . 0.0 114.219 -178.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 70' ' ' SER . 2.8 p -118.73 143.03 47.14 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 121.261 0.553 . . . . 0.0 112.466 -173.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.467 HG12 ' HG3' ' A' ' 69' ' ' GLN . 22.4 mt -136.64 137.6 47.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.432 175.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -118.91 124.58 47.43 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.754 -0.462 . . . . 0.0 109.754 176.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.566 ' O ' ' HB2' ' A' ' 87' ' ' LYS . 30.2 pt -126.82 155.2 37.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.384 -174.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.629 ' HB2' HD11 ' A' ' 67' ' ' ILE . 36.1 tt0 -124.45 146.93 48.64 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.795 -177.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 83' ' ' TYR . 21.1 m-85 -86.35 152.99 22.28 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 120.726 0.298 . . . . 0.0 110.487 -179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.48 HD21 ' HD2' ' A' ' 65' ' ' LYS . 98.1 mt -114.26 163.72 14.88 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 92.31 -152.27 21.13 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 119.999 -1.096 . . . . 0.0 111.503 -176.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -62.34 -8.57 12.87 Favored 'Trans proline' 0 CA--C 1.534 0.5 0 C-N-CA 122.965 2.444 . . . . 0.0 112.665 177.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . 0.474 ' O ' ' HB2' ' A' ' 79' ' ' TYR . 49.0 m-85 -104.75 18.67 21.86 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.066 179.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.858 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 2.2 p90 -55.71 169.63 0.49 Allowed Pre-proline 0 CA--C 1.535 0.382 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.528 -176.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.858 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.4 OUTLIER 9.28 -0.9 0.0 OUTLIER 'Trans proline' 0 CA--C 1.544 1.003 1 C-N-CA 128.734 6.289 . . . . 0.0 121.418 -150.983 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.571 HD13 ' N ' ' A' ' 87' ' ' LYS . 2.7 tm? -73.66 146.3 44.65 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 167.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.571 ' N ' HD13 ' A' ' 86' ' ' LEU . 65.9 pttt -144.17 173.1 12.04 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 121.644 0.735 . . . . 0.0 112.793 -167.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.4 m -132.69 159.42 39.7 Favored 'General case' 0 N--CA 1.437 -1.109 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.029 176.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.556 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 3.3 m -130.26 142.82 50.53 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.818 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 91.5 mt -121.74 124.73 44.91 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.656 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.601 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 46.5 mmtm -114.59 170.03 8.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.982 -0.554 . . . . 0.0 109.644 173.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.694 HH11 ' HA3' ' A' ' 73' ' ' GLY . 27.7 ptt-85 -92.71 145.02 24.73 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.702 -178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.425 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -104.75 138.69 14.29 Favored Glycine 0 N--CA 1.439 -1.157 0 C-N-CA 121.045 -0.598 . . . . 0.0 111.78 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 -60.11 -35.91 76.28 Favored 'General case' 0 C--N 1.318 -0.797 0 C-N-CA 123.091 0.556 . . . . 0.0 112.077 -174.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 91.1 m-20 -95.89 24.74 5.2 Favored 'General case' 0 C--N 1.317 -0.833 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.312 -173.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 76.24 42.24 24.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.383 -177.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.425 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 18.0 p -121.0 173.94 6.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.573 -0.314 . . . . 0.0 110.649 -178.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 30.0 tp -120.39 131.33 54.76 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 176.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 63.8 mt -99.12 112.98 32.68 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.736 ' HB2' ' SD ' ' A' ' 109' ' ' MET . 10.0 t90 -99.98 115.56 29.99 Favored 'General case' 0 C--N 1.317 -0.804 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.381 -175.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.598 ' HG2' ' HG2' ' A' ' 106' ' ' ARG . 26.0 mt-10 -97.67 129.64 44.73 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 173.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 21.6 tm0? -152.8 124.26 7.7 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.165 -0.925 . . . . 0.0 110.317 -176.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 12.5 m-20 67.26 -7.46 0.52 Allowed 'General case' 0 N--CA 1.474 0.743 0 O-C-N 123.44 0.463 . . . . 0.0 112.172 177.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 122.31 -10.45 9.3 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 121.096 -0.573 . . . . 0.0 111.773 -176.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -92.54 136.97 32.76 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.568 0.223 . . . . 0.0 110.413 179.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.598 ' HG2' ' HG2' ' A' ' 101' ' ' GLU . 76.1 mtt180 -100.41 116.32 32.09 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 120.898 0.38 . . . . 0.0 110.424 175.711 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 27.9 mtpt -119.41 141.28 49.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.183 0.516 . . . . 0.0 111.332 -173.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.0 t -94.41 122.69 37.24 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.952 -178.223 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.736 ' SD ' ' HB2' ' A' ' 100' ' ' TRP . 66.1 mtp -102.55 133.44 47.53 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.38 178.638 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 26.9 p -97.77 143.87 27.96 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 120.714 0.292 . . . . 0.0 110.366 -179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 43.1 ttt180 -88.44 123.9 33.43 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.27 0.557 . . . . 0.0 110.992 -175.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 22' ' ' ASP . 27.5 mm -79.02 155.84 4.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.461 176.474 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 47.1 mp0 -68.65 93.65 0.53 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.157 -0.682 . . . . 0.0 109.157 176.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 8.5 t -98.4 105.52 17.67 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.417 -0.811 . . . . 0.0 110.558 -173.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 32.6 mmtp -122.53 138.9 54.42 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.579 -0.737 . . . . 0.0 109.541 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 40.3 p -75.24 125.01 28.07 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.321 0.581 . . . . 0.0 112.001 -174.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -99.77 -93.66 2.09 Favored Glycine 0 N--CA 1.447 -0.632 0 N-CA-C 110.683 -0.967 . . . . 0.0 110.683 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.47 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -123.74 119.73 30.62 Favored 'General case' 0 N--CA 1.436 -1.146 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 173.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -120.01 156.87 30.04 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.267 176.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 34.8 tt0 67.83 100.63 0.05 Allowed 'General case' 0 C--O 1.233 0.231 0 O-C-N 124.111 0.882 . . . . 0.0 109.874 -174.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.423 ' HB2' ' HE3' ' A' ' 121' ' ' LYS . 35.7 ttmt -125.04 141.15 52.31 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 114.904 -1.044 . . . . 0.0 109.847 -173.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -94.54 155.73 16.78 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.724 0.297 . . . . 0.0 110.608 -178.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -106.33 -7.7 17.59 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.991 -171.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -61.91 106.38 0.69 Allowed 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.437 0.637 . . . . 0.0 110.827 -173.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.3 p -140.14 154.55 47.02 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-N 115.214 -0.903 . . . . 0.0 110.797 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -134.01 123.4 24.5 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.006 178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 7.2 m -88.2 115.34 25.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.928 -178.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 9.6 mp -92.65 -162.75 0.96 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.937 -0.394 . . . . 0.0 109.937 176.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -135.37 164.66 27.25 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.488 -0.323 . . . . 0.0 110.577 179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -161.13 134.74 6.68 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.504 176.571 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 89.7 m-70 -90.63 84.82 5.95 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 5.0 t-80 -120.24 137.54 54.16 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.837 -0.62 . . . . 0.0 111.095 -168.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -160.75 154.75 22.78 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.616 -0.266 . . . . 0.0 110.838 176.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.1 m-70 -133.56 94.29 3.28 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.071 176.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 30.2 t60 . . . . . 0 C--O 1.25 1.089 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.127 176.203 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 72.5 mtm . . . . . 0 N--CA 1.478 0.948 0 CA-C-O 120.972 0.415 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 50.3 mm -96.92 103.23 14.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 174.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.8 mtp -115.72 121.99 44.16 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.139 -175.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.4 m -80.1 143.08 13.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.33 177.056 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.8 m -142.74 88.67 2.07 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-O 121.179 0.514 . . . . 0.0 110.662 179.189 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -138.66 103.33 0.39 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.61 179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 60.8 m -100.31 151.7 21.17 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.698 0.285 . . . . 0.0 110.261 179.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 53.1 tp60 -110.22 61.76 0.6 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.313 0.577 . . . . 0.0 110.002 -179.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 12.6 pm0 -98.18 8.18 45.18 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.278 0.561 . . . . 0.0 109.917 178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 50.5 mt-30 -67.66 158.82 31.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.05 -178.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 29.8 mmmt -92.13 9.77 32.12 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.005 178.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 44.7 mm-40 -82.51 137.31 34.66 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.6 -0.727 . . . . 0.0 112.2 -174.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -110.87 149.92 29.91 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.234 -0.894 . . . . 0.0 108.628 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 20.5 m -132.87 109.6 13.02 Favored Pre-proline 0 C--N 1.317 -0.827 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.506 -176.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.44 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 16.5 Cg_exo -68.1 125.51 13.13 Favored 'Trans proline' 0 C--N 1.344 0.297 0 C-N-CA 122.947 2.431 . . . . 0.0 111.161 174.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.2 p90 -67.49 -19.65 65.35 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -172.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 52.7 p90 -90.38 -13.06 35.79 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.68 0.276 . . . . 0.0 111.349 -177.406 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.44 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 18.0 t80 -78.61 134.0 37.23 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.86 -170.654 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.93 -155.43 21.24 Favored Glycine 0 N--CA 1.451 -0.335 0 CA-C-N 115.767 -0.651 . . . . 0.0 112.057 -179.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 38' ' ' VAL . 89.6 m -121.16 131.44 54.24 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.823 0.344 . . . . 0.0 110.35 178.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.541 ' HB2' ' HE1' ' A' ' 109' ' ' MET . 74.0 m95 -116.26 141.41 48.18 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.846 -177.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.611 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.1 t70 -106.11 133.49 50.74 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.052 -177.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.66 ' HB2' ' HB3' ' A' ' 35' ' ' SER . 51.5 mt-10 -94.87 71.46 3.45 Favored 'General case' 0 C--N 1.333 -0.123 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.652 173.645 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -85.21 41.6 3.08 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.832 -177.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 30.3 ttm180 -167.32 147.79 5.44 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 -178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.475 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 74.74 144.71 0.11 Allowed Pre-proline 0 N--CA 1.47 0.54 0 O-C-N 124.163 0.914 . . . . 0.0 111.464 -178.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 6.2 Cg_exo -79.77 160.81 24.62 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.122 2.548 . . . . 0.0 112.986 -178.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -125.77 -153.95 8.57 Favored Glycine 0 N--CA 1.448 -0.563 0 CA-C-N 115.681 -0.69 . . . . 0.0 112.097 -178.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_exo -38.35 128.11 1.05 Allowed 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 124.261 3.308 . . . . 0.0 113.602 175.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 t -64.65 -13.24 53.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.96 -175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -66.12 -33.75 76.5 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.1 -0.5 . . . . 0.0 112.217 -177.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.16 -10.0 0.85 Allowed Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 119.971 -1.109 . . . . 0.0 112.852 -176.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.9 t -81.71 132.18 32.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 174.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -94.87 -25.76 16.46 Favored 'General case' 0 C--N 1.317 -0.807 0 C-N-CA 120.803 -0.359 . . . . 0.0 110.818 -176.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.66 ' HB3' ' HB2' ' A' ' 23' ' ' GLU . 4.4 m 175.67 -178.95 0.13 Allowed 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.23 0.956 . . . . 0.0 108.679 -177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -129.95 167.42 18.24 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.175 0.512 . . . . 0.0 110.995 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.606 HG22 ' HA ' ' A' ' 22' ' ' ASP . 15.9 p -117.89 137.23 52.94 Favored 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 172.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.547 ' O ' ' HA ' ' A' ' 20' ' ' THR . 10.6 p -112.09 124.98 69.32 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.377 0.608 . . . . 0.0 111.098 -174.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.432 ' HB ' ' HB ' ' A' ' 46' ' ' VAL . 82.1 m -106.31 125.85 51.5 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.418 -0.81 . . . . 0.0 109.722 176.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -100.52 118.77 37.39 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.297 0.57 . . . . 0.0 110.813 -177.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.517 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.2 m -89.72 179.84 5.92 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 174.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.517 ' H ' HG22 ' A' ' 41' ' ' THR . 0.3 OUTLIER -47.37 -46.65 25.99 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -177.642 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -148.42 27.09 0.93 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.362 0.601 . . . . 0.0 110.539 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -137.82 159.53 41.75 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.347 -177.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG23 ' CD1' ' A' ' 64' ' ' TYR . 92.3 t -117.82 129.87 73.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.447 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.432 ' HB ' ' HB ' ' A' ' 39' ' ' THR . 97.2 t -111.38 123.93 67.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 172.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -100.61 137.28 39.23 Favored 'General case' 0 CA--C 1.508 -0.67 0 CA-C-O 121.277 0.56 . . . . 0.0 111.514 -179.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.473 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.1 OUTLIER -123.27 117.4 25.19 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.641 -1.163 . . . . 0.0 109.214 172.117 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 34.5 mt-10 -99.57 133.44 43.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.824 -0.436 . . . . 0.0 109.824 -175.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.56 HG22 ' HG2' ' A' ' 56' ' ' GLU . 36.0 t -96.6 113.51 31.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.871 -175.194 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 23.7 ttt -133.78 141.77 47.62 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.694 -178.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -67.43 132.64 48.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.187 179.226 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.3 -14.61 61.97 Favored Glycine 0 N--CA 1.449 -0.447 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.281 -178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -114.41 -56.71 2.36 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.691 0.758 . . . . 0.0 110.191 -178.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 106.07 -143.52 15.74 Favored Glycine 0 N--CA 1.445 -0.736 0 CA-C-N 114.777 -1.101 . . . . 0.0 110.358 -174.84 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.56 ' HG2' HG22 ' A' ' 50' ' ' VAL . 50.9 mt-10 -96.33 115.61 27.71 Favored 'General case' 0 N--CA 1.446 -0.631 0 CA-C-O 121.46 0.648 . . . . 0.0 110.43 173.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 48' ' ' THR . 71.5 t -104.57 126.89 59.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.095 0 CA-C-N 114.907 -1.042 . . . . 0.0 110.289 -179.327 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.457 ' HG2' HG23 ' A' ' 48' ' ' THR . 34.4 mt-30 -83.76 130.54 34.94 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.851 -177.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.53 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 93.9 mt -93.73 160.15 33.27 Favored Pre-proline 0 C--N 1.319 -0.734 0 CA-C-N 115.908 -0.587 . . . . 0.0 109.757 175.004 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.53 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 19.7 Cg_endo -61.91 121.82 10.06 Favored 'Trans proline' 0 C--O 1.236 0.377 0 C-N-CA 122.539 2.159 . . . . 0.0 111.545 -178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 22.7 p90 -45.9 128.79 9.24 Favored 'General case' 0 N--CA 1.463 0.209 0 CA-C-N 115.576 -0.738 . . . . 0.0 112.216 -176.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 89.5 mmm -110.48 129.67 55.73 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.257 -0.883 . . . . 0.0 110.518 -178.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.33 148.51 29.35 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.746 0.307 . . . . 0.0 110.674 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.479 ' CD1' HG23 ' A' ' 45' ' ' VAL . 28.7 p90 -144.28 164.91 29.38 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 177.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.05 155.63 36.49 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.274 0.559 . . . . 0.0 109.992 178.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.419 HG22 HG22 ' A' ' 77' ' ' ILE . 95.6 t -101.72 112.87 36.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.059 0 CA-C-N 115.266 -0.879 . . . . 0.0 109.734 179.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.0 mt -73.83 -51.71 23.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-O 121.431 0.634 . . . . 0.0 109.629 -179.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -139.08 146.26 40.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.48 179.9 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -149.07 136.88 20.52 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-O 121.264 0.554 . . . . 0.0 110.894 -179.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.3 t -107.38 149.08 28.28 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.121 -0.945 . . . . 0.0 108.557 171.708 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 14.2 p -61.35 -32.96 72.86 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.281 0.562 . . . . 0.0 109.678 173.14 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -157.51 91.09 1.13 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.802 175.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -170.81 -94.61 0.1 OUTLIER Glycine 0 N--CA 1.448 -0.55 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.231 175.074 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.446 ' OG ' ' HG2' ' A' ' 91' ' ' LYS . 65.4 m -136.66 157.81 45.9 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.9 mt -123.14 132.95 70.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 116.174 -0.466 . . . . 0.0 109.887 178.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -110.07 118.84 37.47 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.419 HG22 HG22 ' A' ' 66' ' ' VAL . 33.8 pt -126.29 158.14 36.27 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.099 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.779 -174.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.6 ' HB2' HD11 ' A' ' 67' ' ' ILE . 45.8 tt0 -135.99 127.81 29.27 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.854 -0.612 . . . . 0.0 109.429 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.679 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 67.3 m-85 -85.17 129.34 34.82 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.446 ' HA ' ' HB2' ' A' ' 84' ' ' TYR . 69.7 mt -86.53 162.22 18.16 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 120.921 0.391 . . . . 0.0 110.576 -176.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 110.4 -152.21 17.4 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.163 -1.018 . . . . 0.0 111.426 -173.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -62.57 -18.71 65.05 Favored 'Trans proline' 0 CA--C 1.527 0.172 0 C-N-CA 122.803 2.335 . . . . 0.0 112.485 179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 21.7 m-85 -111.41 31.63 5.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.489 -175.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.679 ' HA ' ' O ' ' A' ' 79' ' ' TYR . 2.5 p90 -90.62 -1.14 0.08 OUTLIER Pre-proline 0 N--CA 1.448 -0.554 0 N-CA-C 113.877 1.065 . . . . 0.0 113.877 -169.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 94.6 Cg_endo -92.01 -3.49 4.01 Favored 'Trans proline' 0 N--CA 1.441 -1.576 0 CA-C-N 121.719 1.65 . . . . 0.0 112.764 166.665 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.424 HD21 HE22 ' A' ' 102' ' ' GLN . 25.3 tp -106.79 134.27 50.19 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.197 -177.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 20.0 pttp -113.72 174.27 6.01 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.24 0.543 . . . . 0.0 112.104 -174.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 47.3 t -143.7 165.89 26.38 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.507 -179.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 5.0 m -134.14 142.87 47.63 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.172 0.51 . . . . 0.0 111.267 -177.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -122.56 135.17 54.57 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.83 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.586 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 66.0 mttm -132.41 162.6 30.71 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.763 0.316 . . . . 0.0 110.324 177.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 92' ' ' ARG . 15.8 ptt-85 -84.67 144.92 28.25 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.565 -178.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -94.31 152.46 20.65 Favored Glycine 0 N--CA 1.437 -1.24 0 N-CA-C 111.066 -0.814 . . . . 0.0 111.066 176.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -73.09 -10.85 60.23 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 112.204 0.446 . . . . 0.0 112.204 -175.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 53.8 m-80 -141.69 77.48 1.59 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.727 177.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 47.39 48.09 21.74 Favored Glycine 0 C--N 1.335 0.518 0 O-C-N 123.886 0.741 . . . . 0.0 113.535 176.149 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -135.5 169.77 16.98 Favored 'General case' 0 C--N 1.322 -0.59 0 O-C-N 122.748 -0.266 . . . . 0.0 110.942 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 36.2 tp -124.07 135.26 53.44 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 110.061 -0.348 . . . . 0.0 110.061 179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.586 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 82.1 mt -102.78 117.34 48.01 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.79 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.415 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 13.0 t90 -109.9 113.73 26.71 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.357 -177.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -108.97 134.88 51.03 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.349 0.595 . . . . 0.0 111.078 179.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.424 HE22 HD21 ' A' ' 86' ' ' LEU . 14.3 tm0? -150.55 119.0 6.43 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.222 179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 13.1 m-20 68.38 -68.12 0.18 Allowed 'General case' 0 N--CA 1.468 0.468 0 O-C-N 124.067 0.854 . . . . 0.0 112.018 176.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -161.04 1.65 0.07 OUTLIER Glycine 0 C--N 1.316 -0.58 0 CA-C-N 115.664 -0.698 . . . . 0.0 113.822 -177.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -113.42 135.42 53.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 117.724 0.762 . . . . 0.0 110.355 179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 43.6 ttm105 -102.46 115.57 30.85 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.374 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.415 ' HB2' ' HB3' ' A' ' 100' ' ' TRP . 21.5 mmtp -94.89 136.59 35.02 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.041 0.448 . . . . 0.0 110.858 177.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 25.6 m -109.12 113.69 26.76 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 173.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.541 ' HE1' ' HB2' ' A' ' 21' ' ' TRP . 64.3 mtp -110.76 144.92 38.98 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.494 -174.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -95.33 153.36 17.72 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.203 -178.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.0 ptt-85 -90.13 142.63 27.53 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -178.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.611 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.7 mm -92.99 148.98 4.37 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.173 177.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -93.73 95.1 8.94 Favored 'General case' 0 C--N 1.316 -0.878 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.544 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 67.8 m -145.87 115.64 7.29 Favored 'General case' 0 C--N 1.313 -0.981 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.92 -178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 40.3 pttt -85.5 24.5 1.18 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.57 178.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 8.8 m -104.98 147.31 27.93 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.388 -177.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -165.43 170.2 40.23 Favored Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.459 -1.056 . . . . 0.0 110.459 178.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.449 ' HG2' ' O ' ' A' ' 118' ' ' ARG . 36.4 ttp-105 64.91 19.6 11.89 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.997 0.903 . . . . 0.0 110.046 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -91.24 104.66 17.18 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.138 -0.937 . . . . 0.0 110.97 -178.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -80.87 135.74 35.97 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.799 177.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . 0.441 ' HE2' ' HB2' ' A' ' 121' ' ' LYS . 0.0 OUTLIER -148.46 94.36 2.28 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.269 0.557 . . . . 0.0 110.045 -179.297 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.67 124.32 38.63 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.779 -177.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -147.31 80.06 1.51 Allowed 'General case' 0 C--N 1.309 -1.157 0 CA-C-N 114.464 -1.244 . . . . 0.0 108.156 175.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.432 ' H ' ' HG2' ' A' ' 124' ' ' LYS . 13.7 ptpt -75.88 84.24 2.81 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.524 -0.762 . . . . 0.0 111.059 -176.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 53.8 p -78.18 177.04 8.69 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.39 174.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 35.1 tttt -137.32 38.74 2.49 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 121.775 0.798 . . . . 0.0 109.878 -179.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 49.3 m -87.47 113.91 23.6 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.305 -0.861 . . . . 0.0 110.114 175.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.7 pp -109.15 30.75 6.29 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.599 0.714 . . . . 0.0 109.56 177.142 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 11.8 mm-40 -80.19 116.8 20.49 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.719 -174.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.3 p-80 -150.29 140.23 21.92 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.778 178.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 33.2 m170 -132.29 164.59 26.07 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 120.736 0.303 . . . . 0.0 110.484 -179.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 47.0 m-70 -94.04 139.79 30.52 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.457 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -132.93 111.92 11.45 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.336 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 32.2 p-80 -76.39 165.37 24.93 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.302 -178.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 17.5 p80 . . . . . 0 C--O 1.246 0.871 0 CA-C-O 118.34 -0.838 . . . . 0.0 109.848 -179.895 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 55.3 ttp . . . . . 0 N--CA 1.478 0.941 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.431 ' O ' HG13 ' A' ' 2' ' ' ILE . 35.0 pt -83.0 110.22 17.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.731 0.777 . . . . 0.0 112.315 -174.461 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 61.0 mtt -133.71 -49.37 0.83 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.099 169.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 11.7 t 52.55 58.2 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 114.834 -1.075 . . . . 0.0 110.757 177.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.5 p -83.89 71.45 10.48 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.63 -0.714 . . . . 0.0 110.4 177.32 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -68.19 123.02 16.77 Favored Glycine 0 N--CA 1.446 -0.681 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.08 -179.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 63.0 m -60.84 -54.12 49.06 Favored 'General case' 0 C--N 1.326 -0.431 0 O-C-N 123.563 0.214 . . . . 0.0 110.498 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 70.02 132.92 0.03 OUTLIER 'General case' 0 C--O 1.234 0.284 0 O-C-N 123.89 0.744 . . . . 0.0 111.684 177.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -158.84 96.46 1.36 Allowed 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.099 176.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 11' ' ' LYS . 22.1 tp60 -105.04 -64.88 1.08 Allowed 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 175.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.478 ' HG3' ' O ' ' A' ' 10' ' ' GLN . 47.6 mttp -155.8 109.29 2.75 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.408 173.177 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -76.71 29.09 0.13 Allowed 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.205 -0.907 . . . . 0.0 113.267 -168.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -73.32 97.98 2.6 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-O 121.028 0.442 . . . . 0.0 110.363 176.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.456 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 3.9 t -168.33 138.58 2.08 Favored Pre-proline 0 C--N 1.307 -1.241 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.175 177.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.456 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.6 Cg_exo -74.91 84.35 1.66 Allowed 'Trans proline' 0 N--CA 1.458 -0.604 0 C-N-CA 122.503 2.135 . . . . 0.0 111.486 175.592 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.571 ' HE1' ' HA ' ' A' ' 71' ' ' THR . 44.2 p90 -65.36 -24.39 67.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.54 -176.241 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -82.35 -19.52 39.1 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.381 . . . . 0.0 111.098 -175.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -80.09 138.57 36.98 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.983 0.421 . . . . 0.0 110.764 -172.286 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 131.54 -153.42 20.43 Favored Glycine 0 N--CA 1.446 -0.688 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.133 179.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 4.7 m -119.68 128.43 53.81 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 110.345 -0.242 . . . . 0.0 110.345 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.452 ' HZ2' ' O ' ' A' ' 16' ' ' PHE . 63.0 m95 -121.67 139.69 53.24 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.547 -0.297 . . . . 0.0 110.638 -179.203 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' HB2' HD11 ' A' ' 112' ' ' ILE . 9.9 t0 -107.94 135.6 49.06 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 171.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.499 ' HB2' ' HB2' ' A' ' 35' ' ' SER . 55.7 mt-10 -54.12 -45.5 71.91 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.614 0.245 . . . . 0.0 110.393 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.87 22.03 25.48 Favored Glycine 0 C--N 1.334 0.472 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.848 -179.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 37.6 ttm180 -170.89 149.72 3.05 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -176.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.46 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 69.39 144.76 0.1 Allowed Pre-proline 0 N--CA 1.468 0.47 0 O-C-N 123.75 0.657 . . . . 0.0 111.479 -176.208 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 5.7 Cg_exo -78.44 151.16 25.69 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.908 2.405 . . . . 0.0 112.582 179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.45 -166.63 25.53 Favored Glycine 0 N--CA 1.445 -0.727 0 C-N-CA 121.201 -0.523 . . . . 0.0 112.571 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_exo -45.6 150.62 1.4 Allowed 'Trans proline' 0 CA--C 1.534 0.495 0 C-N-CA 124.224 3.283 . . . . 0.0 113.949 177.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 6.0 t -72.31 -7.71 50.96 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.337 -0.847 . . . . 0.0 111.742 -173.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -65.41 -12.41 51.98 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.962 179.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 116.84 41.98 0.69 Allowed Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.158 -0.544 . . . . 0.0 111.866 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.6 t -105.12 133.28 49.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 -177.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -87.58 -30.31 20.6 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.98 0.419 . . . . 0.0 110.392 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.499 ' HB2' ' HB2' ' A' ' 23' ' ' GLU . 22.7 p -176.37 174.43 1.96 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.983 -1.008 . . . . 0.0 108.437 179.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -120.04 157.73 28.3 Favored 'General case' 0 C--N 1.31 -1.125 0 CA-C-O 121.493 0.663 . . . . 0.0 111.0 -176.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.542 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 1.5 p -117.39 129.51 55.9 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 114.878 -1.055 . . . . 0.0 109.662 177.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 11.5 p -112.54 129.41 68.16 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.158 0 CA-C-O 121.225 0.536 . . . . 0.0 109.904 -177.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 9.8 m -114.14 130.07 56.6 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.172 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.26 116.2 32.26 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.55 ' HB ' ' OE2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -103.23 -178.28 3.62 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.249 -0.887 . . . . 0.0 110.12 -178.29 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -47.96 -51.19 24.66 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -138.01 10.63 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.544 0.212 . . . . 0.0 111.389 -178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.55 ' OE2' ' HB ' ' A' ' 41' ' ' THR . 1.0 OUTLIER -138.76 149.1 44.65 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.041 0.448 . . . . 0.0 111.785 -177.014 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.566 HG23 ' CD1' ' A' ' 64' ' ' TYR . 78.4 t -111.71 124.96 68.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.861 175.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 59.6 t -108.26 124.37 64.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 110.229 -0.285 . . . . 0.0 110.229 179.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.13 134.21 40.77 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.542 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 1.7 m -124.9 135.38 52.81 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.078 -176.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -101.0 127.96 47.26 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 -177.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.51 HG22 ' HG3' ' A' ' 56' ' ' GLU . 39.9 t -97.02 112.93 30.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 121.268 0.556 . . . . 0.0 110.702 -177.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 67.2 mtt -119.21 107.18 13.12 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.905 -178.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -61.96 117.1 5.5 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.022 0.439 . . . . 0.0 110.471 -179.741 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 119.77 -36.01 3.62 Favored Glycine 0 N--CA 1.446 -0.638 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -99.52 -62.3 1.26 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.697 0.76 . . . . 0.0 109.547 177.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 133.2 -164.42 24.21 Favored Glycine 0 N--CA 1.448 -0.522 0 CA-C-N 114.422 -1.263 . . . . 0.0 110.052 -176.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.51 ' HG3' HG22 ' A' ' 50' ' ' VAL . 11.2 mp0 -80.16 127.01 31.82 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 117.637 0.719 . . . . 0.0 110.177 171.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.5 t -110.54 121.54 63.49 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.604 178.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 41.7 mt-30 -80.36 130.52 35.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.864 0.364 . . . . 0.0 111.622 -176.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 88.7 mt -91.76 163.89 26.14 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.138 -0.483 . . . . 0.0 109.714 174.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 73.6 Cg_exo -49.37 125.22 13.29 Favored 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.712 2.275 . . . . 0.0 112.114 176.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 41.7 p90 -60.74 137.57 58.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.165 -178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 66.7 mtm -108.09 121.99 45.95 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.269 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.33 148.15 41.6 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 176.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.566 ' CD1' HG23 ' A' ' 45' ' ' VAL . 9.9 p90 -146.85 151.43 37.08 Favored 'General case' 0 C--N 1.319 -0.721 0 C-N-CA 120.726 -0.39 . . . . 0.0 110.33 -178.531 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.25 158.94 29.79 Favored 'General case' 0 C--N 1.317 -0.822 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 173.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.2 t -96.69 112.36 28.61 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.015 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.129 -175.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 78' ' ' GLN . 20.1 mt -76.83 -54.08 13.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 N-CA-C 108.983 -0.747 . . . . 0.0 108.983 178.517 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -133.52 151.05 51.68 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 114.872 -1.058 . . . . 0.0 108.584 178.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 35.7 tt0 -142.7 131.93 23.35 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-O 121.338 0.589 . . . . 0.0 111.081 -177.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.3 t -155.27 111.56 3.18 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.98 177.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.571 ' HA ' ' HE1' ' A' ' 16' ' ' PHE . 0.8 OUTLIER -69.92 -11.0 60.54 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.366 0.603 . . . . 0.0 110.105 174.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -73.24 -56.19 5.42 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.102 -0.954 . . . . 0.0 111.633 178.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -126.4 -47.61 0.2 Allowed Glycine 0 N--CA 1.443 -0.874 0 C-N-CA 119.856 -1.164 . . . . 0.0 113.993 -171.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.512 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 26.8 t -161.25 155.56 22.85 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.614 0.721 . . . . 0.0 112.721 -169.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 36.3 mt -126.21 137.6 57.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 114.787 -1.097 . . . . 0.0 109.342 177.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.539 ' HG2' HD12 ' A' ' 67' ' ' ILE . 37.7 tt0 -117.45 124.59 49.17 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 110.045 -0.354 . . . . 0.0 110.045 -178.307 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 31.9 pt -129.98 157.47 42.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.402 -174.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.797 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 32.9 tt0 -131.65 135.53 46.99 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.618 -178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -82.89 3.58 29.19 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 113.55 0.945 . . . . 0.0 113.55 -169.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 94.7 mt 52.29 -162.52 0.09 Allowed 'General case' 0 C--N 1.316 -0.88 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.607 179.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 61.42 -151.86 42.37 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.816 176.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -68.22 -8.7 23.64 Favored 'Trans proline' 0 N--CA 1.464 -0.216 0 C-N-CA 122.687 2.258 . . . . 0.0 111.579 174.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -96.88 15.24 22.72 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-N 115.311 -0.859 . . . . 0.0 110.447 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.574 ' CD2' ' HD2' ' A' ' 85' ' ' PRO . 0.1 OUTLIER -65.7 178.07 0.62 Allowed Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.69 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.797 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 11.2 Cg_exo 10.91 -1.48 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.274 1 C-N-CA 126.985 5.124 . . . . 0.0 120.263 -142.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.538 ' H ' ' C ' ' A' ' 84' ' ' TYR . 51.7 tp -78.12 103.83 8.31 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 165.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 60.7 pttt -103.9 172.08 7.0 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 121.379 0.609 . . . . 0.0 111.814 -171.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 36.4 t -132.39 148.33 52.41 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.084 177.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.3 m -123.92 143.63 50.26 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.561 -176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.443 ' HB3' HD11 ' A' ' 98' ' ' LEU . 85.8 mt -128.0 123.93 35.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.117 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 30.3 mtmm -123.67 160.32 27.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.709 0.29 . . . . 0.0 110.505 175.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 23.0 ptt180 -80.36 144.71 32.51 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 120.956 0.408 . . . . 0.0 110.91 -176.377 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.474 ' HA3' ' OG1' ' A' ' 97' ' ' THR . . . -99.21 -175.53 31.64 Favored Glycine 0 N--CA 1.445 -0.732 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.465 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.52 ' H ' ' CD ' ' A' ' 94' ' ' GLU . 0.0 OUTLIER -91.43 -30.15 16.65 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.972 0.415 . . . . 0.0 111.935 -171.775 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . 0.486 ' ND2' ' HG2' ' A' ' 94' ' ' GLU . 48.5 m-80 -102.59 25.76 8.74 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.637 179.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 73.93 37.65 50.1 Favored Glycine 0 N--CA 1.446 -0.648 0 C-N-CA 120.182 -1.009 . . . . 0.0 110.613 -173.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . 0.474 ' OG1' ' HA3' ' A' ' 93' ' ' GLY . 15.9 p -105.17 174.58 5.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.72 -0.74 . . . . 0.0 109.901 -177.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.443 HD11 ' HB3' ' A' ' 90' ' ' LEU . 29.8 tp -122.95 133.74 54.37 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.592 -0.521 . . . . 0.0 109.592 178.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.436 ' O ' ' HA ' ' A' ' 90' ' ' LEU . 63.4 mt -96.96 110.25 24.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.717 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 17.7 t90 -98.34 113.21 25.1 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.435 -0.802 . . . . 0.0 109.867 -176.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 11.9 mt-10 -110.85 132.01 54.57 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.73 179.07 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.451 ' NE2' ' HB2' ' A' ' 103' ' ' ASN . 23.2 tm0? -152.21 118.2 5.49 Favored 'General case' 0 C--N 1.307 -1.248 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.456 -178.311 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.451 ' HB2' ' NE2' ' A' ' 102' ' ' GLN . 54.8 t30 63.97 24.04 13.49 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.657 0.742 . . . . 0.0 111.288 164.117 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.22 -17.48 34.47 Favored Glycine 0 N--CA 1.443 -0.868 0 C-N-CA 120.539 -0.839 . . . . 0.0 113.124 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 72.3 mt-30 -92.48 132.91 36.41 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.542 0.671 . . . . 0.0 111.346 -177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 61.4 ttt-85 -103.58 116.36 32.22 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.919 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 17.5 mtmt -127.08 117.8 23.15 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 175.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.4 m -93.16 114.15 26.58 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 109.202 -0.666 . . . . 0.0 109.202 175.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 22.4 ptt? -112.28 159.73 18.35 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.116 -173.467 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.6 m -104.39 153.75 20.69 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.24 -176.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 12.3 ptt180 -88.27 161.19 17.31 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 -177.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' HB2' ' A' ' 22' ' ' ASP . 21.7 mm -94.86 151.86 3.75 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.136 0 CA-C-N 115.538 -0.755 . . . . 0.0 109.049 175.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -73.83 105.08 4.95 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.037 0.446 . . . . 0.0 109.817 -179.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 49.4 m -141.97 132.36 25.12 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.289 -0.869 . . . . 0.0 110.662 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.3 mmtm -134.52 73.94 1.51 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.308 172.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 18.4 m -153.93 128.49 9.29 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.024 -177.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 165.55 68.46 0.03 OUTLIER Glycine 0 N--CA 1.445 -0.704 0 N-CA-C 111.516 -0.634 . . . . 0.0 111.516 -179.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 69.5 ttt180 -115.19 28.1 8.93 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.423 0.63 . . . . 0.0 109.707 -178.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -78.25 103.43 8.19 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.772 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -117.24 126.74 53.24 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.491 179.164 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 63.5 pttt -125.16 162.38 24.76 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.293 0.568 . . . . 0.0 112.2 -172.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -87.98 146.97 25.25 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.667 177.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -137.24 145.52 43.68 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.456 -0.338 . . . . 0.0 110.185 -179.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 124' ' ' LYS . 45.8 mtpt -114.1 88.16 2.79 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 173.303 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.6 t -93.42 97.3 10.47 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -178.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -83.0 129.09 35.0 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-O 121.099 0.476 . . . . 0.0 110.181 -177.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 19.5 t -152.65 113.42 4.13 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.612 -178.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 38.5 tp -104.07 98.18 8.04 Favored 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 172.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.18 172.22 13.24 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.232 -0.44 . . . . 0.0 112.043 -167.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 53.0 t-80 68.52 96.67 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 CA-C-N 114.993 -1.003 . . . . 0.0 112.034 172.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.92 129.01 38.98 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 172.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 28.5 p-80 -116.91 132.76 56.62 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.95 0.405 . . . . 0.0 111.027 -175.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -122.85 100.67 7.02 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.477 176.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.1 t60 -96.89 142.1 29.28 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.303 -174.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 37.0 m80 . . . . . 0 C--O 1.246 0.873 0 CA-C-O 118.25 -0.881 . . . . 0.0 110.232 177.578 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 27.7 ttt . . . . . 0 N--CA 1.483 1.221 0 CA-C-O 120.708 0.29 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 49.7 mm 64.77 89.22 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.314 0 CA-C-O 121.541 0.686 . . . . 0.0 110.417 -174.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 16.0 tpt -88.54 -13.92 38.96 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.63 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 37.7 t 61.89 72.6 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.235 0.333 0 CA-C-O 121.901 0.857 . . . . 0.0 108.788 -173.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 16.7 m -80.38 106.38 12.35 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 114.894 -1.048 . . . . 0.0 112.065 -170.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.38 150.38 18.51 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 110.214 -1.154 . . . . 0.0 110.214 171.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 49.9 t -131.3 122.39 26.35 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 117.621 0.71 . . . . 0.0 111.327 -176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 81.0 mt-30 -108.98 -167.56 1.23 Allowed 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 172.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.416 ' HA ' ' OE1' ' A' ' 9' ' ' GLN . 16.7 mm-40 56.5 48.57 16.47 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 -171.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -53.51 111.35 0.7 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.594 -1.185 . . . . 0.0 111.845 -174.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 34.5 ttmt -72.81 130.46 40.51 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 175.183 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -61.83 127.99 34.05 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.031 -0.531 . . . . 0.0 112.089 -171.152 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -138.05 161.88 35.61 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.506 -0.77 . . . . 0.0 109.467 178.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.408 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 m -71.93 124.7 91.26 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.176 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 31.6 Cg_exo -58.98 122.25 11.3 Favored 'Trans proline' 0 C--N 1.346 0.413 0 C-N-CA 122.889 2.392 . . . . 0.0 111.713 177.066 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 39.4 p90 -67.98 -14.91 63.34 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -171.928 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -98.99 -8.48 25.34 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 120.835 -0.346 . . . . 0.0 111.373 -177.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.401 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 36.9 t80 -81.93 140.2 34.18 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.96 0.41 . . . . 0.0 110.96 -171.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 121.1 -149.83 17.3 Favored Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.252 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 39.8 m -119.51 134.24 55.31 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.7 0.285 . . . . 0.0 110.254 -178.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.474 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 82.3 m95 -126.08 142.64 51.44 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.606 -178.169 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HB2' HD11 ' A' ' 112' ' ' ILE . 1.5 t70 -96.08 120.05 35.67 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.54 177.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.586 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 12.6 pt-20 -98.5 79.17 2.46 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.993 0.902 . . . . 0.0 109.795 176.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -68.83 -8.05 56.61 Favored Glycine 0 N--CA 1.449 -0.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 112.881 177.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.731 HH11 ' HB2' ' A' ' 26' ' ' ALA . 1.1 tmt_? -101.04 140.3 35.53 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.731 ' HB2' HH11 ' A' ' 25' ' ' ARG . . . 65.01 143.67 0.08 OUTLIER Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.354 1.034 . . . . 0.0 111.274 -172.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 74.1 Cg_endo -93.04 172.62 2.02 Favored 'Trans proline' 0 N--CA 1.451 -1.004 0 C-N-CA 122.546 2.164 . . . . 0.0 112.242 177.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -83.9 -155.13 20.43 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.676 -0.773 . . . . 0.0 111.488 175.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HD2' HG21 ' A' ' 33' ' ' VAL . 10.3 Cg_endo -56.2 163.74 5.93 Favored 'Trans proline' 0 N--CA 1.462 -0.334 0 C-N-CA 122.8 2.333 . . . . 0.0 112.804 177.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.9 m -74.72 2.52 9.79 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.299 -0.864 . . . . 0.0 111.566 -178.166 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 15.2 t70 -63.84 -43.2 96.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 121.017 0.437 . . . . 0.0 110.508 -179.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.81 59.39 0.02 OUTLIER Glycine 0 CA--C 1.513 -0.065 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.56 178.134 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.609 HG21 ' HD2' ' A' ' 29' ' ' PRO . 8.3 t -100.24 134.61 39.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 120.754 0.311 . . . . 0.0 110.631 -177.346 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.887 ' HA ' ' HE2' ' A' ' 34' ' ' LYS . 8.7 mmpt? -81.71 -40.79 22.25 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.467 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.9 m -166.45 165.86 16.76 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.244 -0.889 . . . . 0.0 109.058 -175.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -131.61 148.73 52.63 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.004 0.431 . . . . 0.0 111.266 -178.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 5.9 p -133.5 131.49 39.9 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.155 177.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.3 p -112.85 139.56 37.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.642 0 CA-C-O 120.925 0.393 . . . . 0.0 110.93 -176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.5 m -119.39 129.34 54.76 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.06 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 96.4 m-85 -101.89 117.64 35.26 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 61.1 p -101.9 -177.35 3.39 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.184 178.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -45.03 -56.13 4.93 Favored 'General case' 0 CA--C 1.536 0.415 0 CA-C-N 116.002 -0.544 . . . . 0.0 112.466 -179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -127.22 -4.13 6.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.154 0.502 . . . . 0.0 111.719 -173.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -119.39 157.15 28.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.455 0.645 . . . . 0.0 111.542 -174.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 61.3 t -116.63 117.47 55.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 169.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.411 HG22 ' HB3' ' A' ' 61' ' ' PHE . 33.3 t -108.56 124.21 64.85 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-O 120.748 0.309 . . . . 0.0 110.78 -177.088 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -102.76 136.48 42.51 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.654 0.74 . . . . 0.0 110.737 176.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -126.83 116.98 21.71 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 114.479 -1.237 . . . . 0.0 109.476 176.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -108.29 128.55 54.84 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.12 -175.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 45.8 t -89.43 113.65 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.151 0.5 . . . . 0.0 110.522 -176.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 43.3 mtm -123.08 130.64 53.05 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.467 -178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -64.45 131.51 47.36 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.705 -176.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 105.97 -29.44 11.24 Favored Glycine 0 N--CA 1.446 -0.653 0 C-N-CA 120.883 -0.675 . . . . 0.0 112.284 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 -122.57 -33.85 3.35 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.852 0.358 . . . . 0.0 111.311 -177.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.2 -151.24 19.39 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.814 -0.708 . . . . 0.0 111.564 178.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 4.3 mp0 -71.09 133.45 46.27 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-O 121.228 0.537 . . . . 0.0 110.165 175.537 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 77.4 t -123.87 123.85 67.85 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 CA-C-N 115.558 -0.747 . . . . 0.0 110.229 -179.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 17.4 mt-30 -85.63 118.63 25.25 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.246 -0.434 . . . . 0.0 109.905 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.9 mt -85.57 159.54 55.36 Favored Pre-proline 0 C--N 1.314 -0.965 0 N-CA-C 109.423 -0.584 . . . . 0.0 109.423 175.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -51.32 114.37 1.52 Allowed 'Trans proline' 0 N--CA 1.459 -0.527 0 C-N-CA 122.077 1.852 . . . . 0.0 110.62 172.308 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.411 ' HB3' HG22 ' A' ' 46' ' ' VAL . 32.5 p90 -69.9 146.69 51.04 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.534 -172.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 22.7 mmt -96.28 148.76 22.41 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.53 -177.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -93.72 131.6 38.9 Favored 'General case' 0 C--N 1.317 -0.809 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 174.162 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 22.0 p90 -114.57 142.48 46.37 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.887 -0.325 . . . . 0.0 110.374 -178.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 49.6 mtpt -122.17 151.11 41.33 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.291 0.567 . . . . 0.0 110.728 173.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 86.1 t -88.23 125.19 41.61 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.988 -1.006 . . . . 0.0 111.077 -177.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.636 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.9 mt -96.26 -55.62 5.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 175.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.4 m -131.61 153.86 49.48 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.672 -1.149 . . . . 0.0 108.805 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.13 152.7 36.58 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.166 0.508 . . . . 0.0 111.48 -175.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 74' ' ' SER . 42.1 t -139.71 167.33 22.35 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 174.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 13.4 p -80.33 -38.8 29.88 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.935 0.398 . . . . 0.0 111.34 178.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . 0.438 ' O ' ' HD3' ' A' ' 92' ' ' ARG . 6.4 p-10 -147.96 9.57 0.89 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.933 -0.576 . . . . 0.0 112.408 -172.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -104.19 -81.11 1.47 Allowed Glycine 0 N--CA 1.443 -0.839 0 C-N-CA 120.297 -0.954 . . . . 0.0 112.318 179.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 5.1 p -145.52 152.01 39.07 Favored 'General case' 0 N--CA 1.443 -0.807 0 CA-C-O 121.276 0.56 . . . . 0.0 111.677 -174.486 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.421 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 22.4 mt -125.98 138.49 54.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 175.138 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.54 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.5 tt0 -117.54 127.38 53.93 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 109.797 -0.446 . . . . 0.0 109.797 178.537 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 40.1 pt -125.66 157.08 35.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.089 -175.238 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.636 ' HB2' HD11 ' A' ' 67' ' ' ILE . 44.1 tt0 -126.58 144.19 50.97 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.635 -0.711 . . . . 0.0 110.353 -178.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 30.3 m-85 -83.23 149.29 26.9 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.225 176.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 91.0 mt -105.1 167.79 9.49 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 172.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 90.22 -152.1 21.94 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 119.892 -1.147 . . . . 0.0 111.23 -176.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -70.04 -5.17 15.75 Favored 'Trans proline' 0 CA--C 1.529 0.269 0 C-N-CA 122.579 2.186 . . . . 0.0 111.795 178.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 48.9 m-85 -98.6 15.58 24.63 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.861 -0.608 . . . . 0.0 110.724 -179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.757 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 0.0 OUTLIER -63.0 -177.3 0.19 Allowed Pre-proline 0 CA--C 1.542 0.648 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.132 175.622 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.757 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 12.32 -0.79 0.0 OUTLIER 'Trans proline' 0 CA--C 1.549 1.252 1 C-N-CA 127.35 5.367 . . . . 0.0 120.561 -148.098 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.537 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.8 tp -85.31 121.26 27.78 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 166.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 22.9 pttp -120.65 168.48 11.35 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.386 0.612 . . . . 0.0 111.603 -173.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -130.27 154.9 47.13 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.296 -0.865 . . . . 0.0 110.635 -178.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.542 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 10.4 m -113.82 141.82 46.84 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.476 -178.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.421 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 96.6 mt -124.14 124.78 43.24 Favored 'General case' 0 C--N 1.308 -1.206 0 CA-C-N 115.17 -0.923 . . . . 0.0 109.287 178.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.556 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 33.3 mtmm -133.4 157.43 45.58 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.934 0.397 . . . . 0.0 110.467 176.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.438 ' HD3' ' O ' ' A' ' 72' ' ' ASP . 24.1 ptt180 -66.16 147.26 53.6 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.058 175.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . 0.47 ' HA2' HG13 ' A' ' 99' ' ' ILE . . . -73.25 -170.23 18.38 Favored Glycine 0 N--CA 1.44 -1.07 0 C-N-CA 120.37 -0.919 . . . . 0.0 112.159 178.917 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 -86.96 -39.34 15.81 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.191 0.519 . . . . 0.0 110.013 -178.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -148.64 102.2 3.28 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.94 -1.027 . . . . 0.0 109.925 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 53.82 44.92 70.8 Favored Glycine 0 C--N 1.333 0.385 0 O-C-N 123.349 0.406 . . . . 0.0 113.183 176.438 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -143.03 174.0 11.06 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.413 0.149 . . . . 0.0 111.149 -175.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 42.7 tp -129.31 136.17 49.69 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 176.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.47 HG13 ' HA2' ' A' ' 93' ' ' GLY . 67.5 mt -111.55 110.59 32.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-O 120.877 0.37 . . . . 0.0 110.33 179.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.443 ' HE3' ' HE3' ' A' ' 109' ' ' MET . 10.0 t90 -105.14 113.07 26.45 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.786 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.614 ' HG2' ' HB3' ' A' ' 106' ' ' ARG . 70.2 mt-10 -96.49 130.3 43.68 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.423 0.63 . . . . 0.0 110.089 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.479 ' CD ' ' HB2' ' A' ' 103' ' ' ASN . 25.8 tm0? -151.77 134.38 15.47 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 114.759 -1.11 . . . . 0.0 109.684 -174.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.479 ' HB2' ' CD ' ' A' ' 102' ' ' GLN . 5.8 t-20 67.75 9.89 7.4 Favored 'General case' 0 N--CA 1.467 0.398 0 O-C-N 123.409 0.443 . . . . 0.0 111.252 172.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 103.5 -10.85 53.91 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.255 -178.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 50.9 mt-30 -108.62 143.5 37.6 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 122.854 -0.203 . . . . 0.0 110.547 -178.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.614 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 24.6 ptt180 -99.4 126.26 45.26 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 121.078 0.466 . . . . 0.0 110.875 176.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 26' ' ' ALA . 1.5 mptm? -88.66 126.52 35.34 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.529 177.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 70.1 m -94.78 113.76 25.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 172.883 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.586 ' HE2' ' HB3' ' A' ' 23' ' ' GLU . 59.9 mtt -114.62 142.33 46.6 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.232 0.539 . . . . 0.0 112.273 -172.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.02 151.01 19.84 Favored 'General case' 0 N--CA 1.445 -0.679 0 CA-C-N 114.753 -1.112 . . . . 0.0 110.104 -179.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 39.2 ttt180 -86.09 123.99 32.01 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -179.574 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.459 HD11 ' HB2' ' A' ' 22' ' ' ASP . 37.3 mm -72.76 147.22 10.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-O 121.429 0.633 . . . . 0.0 111.518 -173.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -127.67 138.72 52.9 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 114.796 -1.093 . . . . 0.0 109.656 -179.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 74.3 m 59.99 41.85 16.87 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-O 121.091 0.472 . . . . 0.0 110.828 -178.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.5 pttp -68.7 130.77 43.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.659 179.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 7.2 m -68.08 129.95 41.48 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.114 -177.595 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -128.0 151.77 18.8 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 178.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -86.23 87.03 7.35 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.963 0.411 . . . . 0.0 110.893 -178.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.446 ' HG2' ' H ' ' A' ' 120' ' ' GLU . 10.2 tt0 64.76 -169.55 0.2 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.028 177.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.446 ' H ' ' HG2' ' A' ' 119' ' ' GLU . 42.2 mt-10 67.92 101.46 0.05 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.363 0.601 . . . . 0.0 111.398 176.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 17.8 ptpt -165.9 171.03 13.13 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.234 179.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -72.75 144.91 47.43 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 177.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -71.27 -63.96 1.01 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.383 -177.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.405 ' HB3' ' NZ ' ' A' ' 124' ' ' LYS . 0.2 OUTLIER -157.65 94.36 1.35 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.545 0.688 . . . . 0.0 110.789 -177.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.0 m -87.87 52.21 2.41 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.559 -178.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 65.0 pttt -150.62 162.01 41.49 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.695 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 12.7 t -152.71 113.83 4.2 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 174.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 7.2 mp -85.48 99.62 11.34 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.879 0.371 . . . . 0.0 110.477 -176.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -150.12 133.2 16.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.709 -179.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -97.09 143.74 27.63 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.897 0.379 . . . . 0.0 110.372 177.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -147.91 114.81 6.11 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.306 179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 6.0 p80 -117.57 150.35 39.13 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.372 -176.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 75.4 m-70 -128.85 145.55 51.17 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.104 -178.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 67.37 157.6 0.13 Allowed 'General case' 0 CA--C 1.534 0.364 0 O-C-N 123.871 0.732 . . . . 0.0 111.103 175.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 . . . . . 0 C--O 1.244 0.776 0 CA-C-O 118.499 -0.762 . . . . 0.0 109.836 172.368 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.1 ptt? . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 2.8 pp -97.42 154.15 3.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 177.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.8 ttt -130.59 129.54 42.89 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 -179.175 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 4.2 p -132.13 128.5 59.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.03 0.443 . . . . 0.0 111.083 -176.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 35.8 t -143.45 118.95 10.33 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.159 -179.769 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -148.66 116.37 0.8 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.836 -0.697 . . . . 0.0 111.673 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 48.5 t -69.91 152.05 44.94 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 120.882 0.373 . . . . 0.0 110.474 -178.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -82.43 103.95 12.36 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.591 -179.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 25.5 tp60 -77.24 96.06 4.47 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.945 0.403 . . . . 0.0 110.092 178.134 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -80.16 127.43 32.32 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 44.6 pttt -85.49 112.88 21.31 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.622 0.725 . . . . 0.0 111.244 -177.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.2 -156.67 0.55 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.189 -0.914 . . . . 0.0 109.957 -179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.549 ' O ' ' HB ' ' A' ' 14' ' ' THR . 7.2 tt0 -143.63 -156.75 0.72 Allowed 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 -177.19 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.549 ' HB ' ' O ' ' A' ' 13' ' ' GLU . 19.6 m 72.12 123.42 0.03 OUTLIER Pre-proline 0 N--CA 1.451 -0.386 0 C-N-CA 123.326 0.65 . . . . 0.0 112.165 -178.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 24.2 Cg_exo -63.44 104.17 0.42 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.985 2.457 . . . . 0.0 111.879 177.666 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 37.5 p90 -68.82 -15.17 63.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.662 -0.699 . . . . 0.0 112.382 -174.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 23.8 p90 -101.85 6.79 41.69 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 112.199 0.444 . . . . 0.0 112.199 -174.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 71.2 t80 -99.01 125.99 44.61 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.158 0.504 . . . . 0.0 111.072 -177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 140.21 -168.95 24.94 Favored Glycine 0 N--CA 1.448 -0.564 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.236 179.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 38.1 m -102.07 131.44 48.54 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.071 -0.344 . . . . 0.0 110.071 177.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.55 ' HB3' ' HB2' ' A' ' 109' ' ' MET . 62.6 m95 -116.09 137.14 52.39 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.816 -176.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.592 ' HB2' HD11 ' A' ' 112' ' ' ILE . 4.9 t70 -99.79 127.01 45.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.12 0.486 . . . . 0.0 112.185 179.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.405 ' O ' ' HB3' ' A' ' 35' ' ' SER . 44.4 mt-10 -101.64 78.04 1.8 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.505 -0.77 . . . . 0.0 108.997 172.218 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -71.11 -0.46 35.73 Favored Glycine 0 N--CA 1.453 -0.215 0 CA-C-N 115.862 -0.608 . . . . 0.0 113.324 -179.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 25' ' ' ARG . 6.9 tpp180 -114.9 144.11 44.08 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 108.891 -0.781 . . . . 0.0 108.891 178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.65 146.83 0.12 Allowed Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 124.541 1.151 . . . . 0.0 111.179 -175.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -84.54 171.91 9.52 Favored 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 122.497 2.132 . . . . 0.0 112.721 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -102.86 -155.18 25.03 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.887 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_exo -38.38 145.54 0.16 Allowed 'Trans proline' 0 C--O 1.238 0.498 0 C-N-CA 124.28 3.32 . . . . 0.0 113.665 174.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 5.0 t -67.21 -5.67 14.77 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.233 -0.894 . . . . 0.0 112.575 -171.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -62.75 -36.09 81.93 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.991 0.424 . . . . 0.0 110.265 175.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 137.09 53.61 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.577 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.597 178.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.48 HG11 ' HB3' ' A' ' 49' ' ' GLU . 18.8 t -100.94 134.37 41.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.842 -0.429 . . . . 0.0 109.842 178.436 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -79.03 -39.68 33.37 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.078 0.466 . . . . 0.0 111.678 -177.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.405 ' HB3' ' O ' ' A' ' 23' ' ' GLU . 38.5 m -159.77 166.17 30.97 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.085 -171.37 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.49 152.33 40.42 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.95 0.405 . . . . 0.0 110.824 -178.519 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.537 HG22 ' HA ' ' A' ' 22' ' ' ASP . 12.9 p -131.87 127.04 35.67 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.811 -0.631 . . . . 0.0 109.33 175.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.3 p -115.89 136.88 51.36 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.985 0 CA-C-O 121.106 0.479 . . . . 0.0 111.233 -173.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 47.1 m -121.77 125.64 47.0 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.653 175.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -100.77 116.43 32.64 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 120.876 0.37 . . . . 0.0 110.375 -177.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.564 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.8 OUTLIER -104.58 170.13 8.06 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 109.052 -0.722 . . . . 0.0 109.052 173.92 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.406 ' H ' HG22 ' A' ' 41' ' ' THR . 32.5 tt0 -61.22 -45.86 92.81 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.877 0.37 . . . . 0.0 111.934 -176.268 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -99.85 -9.2 23.17 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 111.912 0.338 . . . . 0.0 111.912 -173.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.615 ' HB2' ' HB2' ' A' ' 61' ' ' PHE . 3.7 pt-20 -156.74 148.08 22.28 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 113.123 0.786 . . . . 0.0 113.123 -166.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.508 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.7 t -101.77 118.75 49.03 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 115.385 -0.825 . . . . 0.0 108.843 170.002 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 57.7 t -101.34 124.46 55.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.7 0.286 . . . . 0.0 110.457 -179.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -97.04 136.7 37.22 Favored 'General case' 0 CA--C 1.509 -0.616 0 CA-C-O 121.608 0.718 . . . . 0.0 111.518 179.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.5 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 2.3 m -128.47 131.4 48.37 Favored 'General case' 0 C--N 1.309 -1.195 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.526 171.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.48 ' HB3' HG11 ' A' ' 33' ' ' VAL . 32.9 mt-10 -120.53 135.93 54.93 Favored 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 120.817 0.341 . . . . 0.0 110.522 -174.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.432 HG22 ' HG3' ' A' ' 56' ' ' GLU . 45.8 t -96.41 113.6 31.16 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.7 -177.185 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -119.74 126.88 52.13 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.672 -0.694 . . . . 0.0 109.384 -179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -75.13 106.88 6.87 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.325 0.583 . . . . 0.0 110.477 -174.046 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 124.17 -25.05 6.14 Favored Glycine 0 N--CA 1.445 -0.713 0 N-CA-C 110.968 -0.853 . . . . 0.0 110.968 -176.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 14.9 mmt180 -104.26 -60.01 1.65 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.921 0.867 . . . . 0.0 109.747 178.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 121.04 -166.32 14.04 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 113.995 -1.457 . . . . 0.0 110.003 -172.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.432 ' HG3' HG22 ' A' ' 50' ' ' VAL . 1.6 mp0 -71.89 127.15 31.66 Favored 'General case' 0 N--CA 1.443 -0.782 0 CA-C-O 121.502 0.668 . . . . 0.0 111.433 174.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 82.0 t -118.39 122.69 70.16 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.815 0 CA-C-N 114.73 -1.123 . . . . 0.0 109.928 179.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.463 ' HG2' HG23 ' A' ' 48' ' ' THR . 82.1 mt-30 -93.74 126.76 39.1 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.916 0.389 . . . . 0.0 111.289 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 77.5 mt -95.48 161.76 26.73 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.316 179.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -50.51 137.03 40.87 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 122.887 2.391 . . . . 0.0 112.059 175.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.615 ' HB2' ' HB2' ' A' ' 44' ' ' GLU . 44.2 p90 -72.09 152.49 42.33 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.315 0.579 . . . . 0.0 111.672 -174.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.8 mtp -111.87 140.45 46.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.663 177.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -84.71 143.96 28.84 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.667 -0.242 . . . . 0.0 110.502 177.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.508 ' CD1' HG23 ' A' ' 45' ' ' VAL . 7.7 p90 -147.28 166.52 26.82 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.914 0.388 . . . . 0.0 110.812 179.854 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 22.5 ptmt -128.19 159.3 35.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.191 178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 94.9 t -103.55 126.3 58.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.108 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.123 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.568 HD11 ' HB2' ' A' ' 78' ' ' GLN . 12.2 mt -85.43 -51.18 13.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 N-CA-C 109.267 -0.642 . . . . 0.0 109.267 179.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 49.1 m -145.03 161.31 39.72 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.462 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.5 tt0 -148.97 132.99 17.19 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 121.08 0.466 . . . . 0.0 110.777 -177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.412 ' HB3' ' H ' ' A' ' 74' ' ' SER . 31.6 t -151.01 121.88 7.59 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.385 -0.825 . . . . 0.0 109.511 178.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.4 p -78.11 -15.74 58.6 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.527 -178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -104.27 -21.45 13.52 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.802 -0.359 . . . . 0.0 111.726 -178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -113.83 -67.06 0.47 Allowed Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 120.255 -0.974 . . . . 0.0 112.838 -178.074 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.445 ' HB2' ' HG2' ' A' ' 91' ' ' LYS . 47.3 t -177.52 157.09 1.23 Allowed 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.242 0.544 . . . . 0.0 110.993 -171.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 31.8 mt -116.85 132.71 65.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.505 -0.77 . . . . 0.0 109.212 176.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.498 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.0 tt0 -111.09 123.73 50.78 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 41.0 pt -124.96 157.92 33.08 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.656 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.032 -176.103 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.659 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 36.1 tt0 -138.42 139.94 39.12 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.604 -179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.457 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 98.0 m-85 -88.17 153.97 20.81 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 120.971 0.415 . . . . 0.0 110.896 -177.516 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.4 mt -110.77 -176.82 3.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.029 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.54 -152.52 35.76 Favored Glycine 0 N--CA 1.447 -0.573 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 -174.136 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -61.68 -16.91 51.59 Favored 'Trans proline' 0 CA--C 1.531 0.369 0 C-N-CA 122.396 2.064 . . . . 0.0 111.926 176.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 87.2 m-85 -92.31 20.41 6.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.824 -0.626 . . . . 0.0 110.96 -178.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.883 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 26.3 p90 -61.17 172.27 0.97 Allowed Pre-proline 0 CA--C 1.534 0.349 0 CA-C-N 116.361 -0.382 . . . . 0.0 110.707 -179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.883 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 11.5 -0.3 0.0 OUTLIER 'Trans proline' 0 CA--C 1.546 1.084 1 C-N-CA 128.153 5.902 . . . . 0.0 121.065 -150.08 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 84' ' ' TYR . 62.0 tp -69.22 104.21 2.14 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 119.556 1.071 . . . . 0.0 108.289 167.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 78' ' ' GLN . 61.1 pttt -103.63 174.71 5.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.414 0.626 . . . . 0.0 111.94 -171.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 31.3 t -144.66 161.36 39.36 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.157 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.592 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -124.28 142.97 50.83 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-O 120.8 0.334 . . . . 0.0 110.578 -178.156 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -123.48 122.72 38.95 Favored 'General case' 0 C--N 1.318 -0.772 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.445 ' HG2' ' HB2' ' A' ' 74' ' ' SER . 53.4 mttp -118.83 160.58 21.66 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 121.2 0.524 . . . . 0.0 111.188 177.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.1 ptm180 -70.61 143.0 51.64 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 115.161 -0.927 . . . . 0.0 109.57 175.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -82.9 143.77 22.45 Favored Glycine 0 N--CA 1.432 -1.582 0 C-N-CA 120.977 -0.63 . . . . 0.0 111.888 -176.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 30.7 mt-10 -54.82 -44.5 73.89 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 114.908 -0.646 . . . . 0.0 111.172 -178.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -128.51 81.34 2.02 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.81 177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 55.3 55.1 30.06 Favored Glycine 0 C--N 1.334 0.443 0 CA-C-N 116.016 -0.538 . . . . 0.0 113.711 174.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -143.52 175.24 10.09 Favored 'General case' 0 C--N 1.321 -0.666 0 O-C-N 122.832 -0.216 . . . . 0.0 111.112 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 48.4 tp -118.57 135.26 54.52 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.798 -0.445 . . . . 0.0 109.798 171.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.576 HG23 ' HG3' ' A' ' 106' ' ' ARG . 82.7 mt -104.9 111.16 33.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.245 179.558 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.458 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 15.7 t90 -97.87 112.77 24.56 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.811 179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.592 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 28.8 mt-10 -102.12 131.66 48.47 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.622 0.725 . . . . 0.0 111.002 -179.142 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.506 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 0.4 OUTLIER -151.64 123.58 8.09 Favored 'General case' 0 C--N 1.305 -1.346 0 CA-C-N 114.502 -1.226 . . . . 0.0 109.701 177.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 61.28 19.77 10.44 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 123.314 0.384 . . . . 0.0 111.827 173.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.07 -21.86 34.72 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.811 -0.709 . . . . 0.0 113.533 176.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.506 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 10.6 pt20 -92.61 145.65 24.27 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 117.013 0.406 . . . . 0.0 110.947 -174.24 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.576 ' HG3' HG23 ' A' ' 99' ' ' ILE . 15.6 ttm180 -94.04 117.98 30.87 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.087 179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.473 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 28.1 mmtm -95.04 117.99 31.09 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.096 0.475 . . . . 0.0 109.809 169.279 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 86.6 m -100.13 114.59 28.07 Favored 'General case' 0 C--N 1.312 -1.041 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.615 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.55 ' HB2' ' HB3' ' A' ' 21' ' ' TRP . 12.3 ptp -127.65 137.92 52.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.338 0.589 . . . . 0.0 111.729 -173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.8 p -101.05 146.43 27.45 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.582 172.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.7 ttp180 -80.52 127.73 32.77 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.497 -0.481 . . . . 0.0 110.158 -177.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 22' ' ' ASP . 31.4 mm -73.57 145.21 11.82 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.535 178.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -121.32 111.71 17.68 Favored 'General case' 0 C--N 1.311 -1.108 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.617 -176.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.3 m -91.91 93.14 8.66 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.517 -0.765 . . . . 0.0 112.136 -171.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.3 mptm? -104.23 19.61 19.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.345 -0.843 . . . . 0.0 109.231 171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 6.3 t -139.66 152.26 46.6 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.026 -0.988 . . . . 0.0 109.562 -178.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -118.04 -67.18 0.34 Allowed Glycine 0 N--CA 1.445 -0.72 0 N-CA-C 110.856 -0.898 . . . . 0.0 110.856 177.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 55.2 ttp180 56.96 84.22 0.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.721 0.772 . . . . 0.0 111.448 177.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.437 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.0 OUTLIER -92.43 133.14 36.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.362 -0.836 . . . . 0.0 110.366 177.733 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 73.1 mm-40 -96.86 157.02 16.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.887 -178.182 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -92.98 -177.48 4.51 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 174.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.452 ' HB3' ' HE2' ' A' ' 124' ' ' LYS . 9.2 t70 -91.02 149.28 21.89 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 177.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -79.9 102.98 9.48 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.083 0.468 . . . . 0.0 109.997 -175.205 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.452 ' HE2' ' HB3' ' A' ' 122' ' ' ASP . 66.8 mmtt -120.16 124.89 46.85 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.527 -178.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 32.5 t -130.36 150.7 51.47 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 116.073 -0.512 . . . . 0.0 109.666 175.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 40.8 ttmt -125.03 107.18 10.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.947 0.403 . . . . 0.0 110.768 -178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 18.0 t -113.45 103.85 11.69 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.875 177.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 91.6 mt -106.18 99.99 9.55 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.364 -179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -83.13 157.72 22.68 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.923 -178.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 57.3 t-80 -102.18 115.26 30.18 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 169.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -67.94 123.62 21.09 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.263 0.554 . . . . 0.0 111.763 -175.736 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -125.15 114.66 19.3 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.323 175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 57.2 t-80 -134.03 128.82 35.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.581 -0.736 . . . . 0.0 109.249 -174.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 65.4 m170 -83.62 138.02 33.54 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.073 0.463 . . . . 0.0 111.101 -175.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 56.2 t-80 . . . . . 0 C--O 1.248 1.021 0 CA-C-O 118.465 -0.778 . . . . 0.0 109.361 177.089 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.3 ptp . . . . . 0 N--CA 1.481 1.114 0 CA-C-O 121.255 0.55 . . . . 0.0 110.304 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.7 mp -127.44 118.1 48.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-O 120.868 0.366 . . . . 0.0 110.528 -177.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -98.73 124.61 43.68 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 174.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.3 t -85.01 -72.1 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.866 0.365 . . . . 0.0 111.245 -175.289 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 21.6 p -136.86 111.58 8.75 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 120.952 0.406 . . . . 0.0 110.93 -175.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -83.1 76.04 2.3 Favored Glycine 0 N--CA 1.449 -0.475 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.916 178.225 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.0 m -76.95 103.16 6.73 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.034 0.445 . . . . 0.0 110.709 -179.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 57.1 tp60 -109.01 134.89 51.05 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.14 178.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -101.27 116.12 32.08 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 121.112 0.482 . . . . 0.0 111.524 -178.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.937 ' HB2' HG21 ' A' ' 71' ' ' THR . 75.9 mm-40 -116.52 -74.68 0.6 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.044 171.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . 0.446 ' HB2' ' HE3' ' A' ' 11' ' ' LYS . 33.4 ttmt -169.75 163.88 9.91 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -60.91 114.8 3.27 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.94 0.4 . . . . 0.0 111.4 -179.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -105.81 166.98 10.09 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 10.1 t -55.03 120.63 30.64 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-O 121.247 0.546 . . . . 0.0 111.355 -178.181 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.48 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 37.9 Cg_exo -62.9 103.91 0.36 Allowed 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 122.864 2.376 . . . . 0.0 111.949 179.188 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 41.8 p90 -70.78 -10.98 60.66 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.384 -0.825 . . . . 0.0 112.284 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.48 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 44.5 p90 -89.57 -6.62 56.14 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 111.851 0.315 . . . . 0.0 111.851 -174.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -71.35 138.99 49.67 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.018 0.437 . . . . 0.0 111.136 -179.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 127.42 -163.5 21.18 Favored Glycine 0 N--CA 1.449 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.033 -179.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 87.6 m -115.23 122.64 46.62 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.022 0.439 . . . . 0.0 110.432 179.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.453 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 50.1 m95 -116.3 133.64 55.79 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.139 -177.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.581 ' CB ' HD11 ' A' ' 112' ' ' ILE . 11.7 t70 -109.68 132.43 54.15 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.952 179.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.572 ' HG2' ' HG2' ' A' ' 109' ' ' MET . 6.2 mm-40 -74.04 -58.15 3.49 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.603 173.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 54.94 32.16 55.9 Favored Glycine 0 C--N 1.333 0.407 0 N-CA-C 110.485 -1.046 . . . . 0.0 110.485 -168.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . 0.474 ' HB3' ' OE1' ' A' ' 23' ' ' GLU . 9.0 ttm180 -158.08 167.68 29.19 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 108.505 -0.924 . . . . 0.0 108.505 -167.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.473 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . . . 67.43 165.36 0.12 Allowed Pre-proline 0 N--CA 1.466 0.367 0 O-C-N 123.928 0.768 . . . . 0.0 112.211 176.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -78.59 134.5 12.37 Favored 'Trans proline' 0 N--CA 1.457 -0.666 0 C-N-CA 122.355 2.037 . . . . 0.0 111.356 171.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -108.19 -166.31 21.28 Favored Glycine 0 N--CA 1.44 -1.056 0 C-N-CA 120.77 -0.729 . . . . 0.0 111.977 179.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -48.62 125.15 12.07 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 123.067 2.511 . . . . 0.0 111.868 175.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.5 t -80.1 -1.44 40.09 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.866 -173.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -61.26 -33.92 74.32 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.559 176.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 51' ' ' MET . . . 146.57 37.67 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 CA-C-N 115.646 -0.706 . . . . 0.0 111.977 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 51.3 t -105.63 138.91 28.59 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 -177.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 29.3 mtpp -86.58 -28.09 23.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.994 0.425 . . . . 0.0 111.108 -176.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.2 p -177.31 167.47 2.33 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.981 -178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -123.43 144.23 49.63 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.132 -177.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 25.1 p -117.87 133.58 55.79 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.111 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 14.8 p -113.03 136.31 49.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.3 0.571 . . . . 0.0 111.161 -175.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.6 m -123.02 130.94 53.44 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.555 175.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -100.61 120.61 40.3 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.097 0.475 . . . . 0.0 110.317 -177.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.548 HG22 ' H ' ' A' ' 42' ' ' GLU . 0.7 OUTLIER -95.7 179.1 5.24 Favored 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.395 -0.821 . . . . 0.0 109.374 -178.608 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.548 ' H ' HG22 ' A' ' 41' ' ' THR . 29.6 mt-10 -51.53 -38.68 55.36 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 123.306 0.642 . . . . 0.0 111.801 -175.751 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.2 p-10 -151.37 19.43 0.74 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.019 0.438 . . . . 0.0 111.447 176.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -131.1 147.73 52.65 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.151 -178.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.408 HG23 ' CD1' ' A' ' 64' ' ' TYR . 66.5 t -101.84 118.51 48.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 173.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.464 HG22 ' CD1' ' A' ' 61' ' ' PHE . 70.6 t -108.21 124.42 64.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.283 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -116.34 137.5 52.1 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.342 0.591 . . . . 0.0 110.453 177.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.48 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -117.26 138.1 51.95 Favored 'General case' 0 C--N 1.311 -1.097 0 CA-C-N 115.045 -0.979 . . . . 0.0 110.141 177.888 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 -97.98 125.4 42.9 Favored 'General case' 0 C--N 1.319 -0.75 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 177.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.536 HG22 ' HG2' ' A' ' 56' ' ' GLU . 48.6 t -90.11 110.32 21.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.798 0 N-CA-C 108.429 -0.952 . . . . 0.0 108.429 174.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.512 ' SD ' ' HG3' ' A' ' 54' ' ' ARG . 43.0 ttm -112.07 135.21 53.01 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.151 -173.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 28.4 tt0 -63.77 113.35 3.34 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.001 -0.999 . . . . 0.0 110.934 -175.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.57 -18.4 56.26 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.752 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.512 ' HG3' ' SD ' ' A' ' 51' ' ' MET . 9.6 mmt180 -101.36 -74.62 0.61 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.314 0.578 . . . . 0.0 110.816 -178.229 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 144.41 -156.1 26.64 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 -172.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.536 ' HG2' HG22 ' A' ' 50' ' ' VAL . 44.8 mt-10 -92.92 120.69 33.51 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.415 0.626 . . . . 0.0 111.179 176.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 73.8 t -112.57 128.12 69.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.014 -0.993 . . . . 0.0 109.892 178.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.48 ' HG2' HG23 ' A' ' 48' ' ' THR . 79.8 mt-30 -80.07 131.55 35.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.143 0.497 . . . . 0.0 111.601 -176.268 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.1 mt -87.86 163.7 36.98 Favored Pre-proline 0 C--N 1.323 -0.557 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.494 176.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_exo -51.25 123.58 12.27 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.648 2.232 . . . . 0.0 111.749 173.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.464 ' CD1' HG22 ' A' ' 46' ' ' VAL . 17.8 m-85 -68.42 142.15 55.47 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.143 -173.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 69.4 mtm -109.86 123.74 50.11 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.801 179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -81.57 140.09 34.68 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.408 ' CD1' HG23 ' A' ' 45' ' ' VAL . 42.1 p90 -132.82 170.9 14.62 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.885 0.374 . . . . 0.0 110.63 -178.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.519 ' HD2' HD21 ' A' ' 80' ' ' LEU . 10.0 ptmm? -144.1 143.0 30.94 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.617 -0.719 . . . . 0.0 109.66 175.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 78.0 t -83.33 124.3 39.46 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.727 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.661 HD11 ' HB2' ' A' ' 78' ' ' GLN . 11.5 mt -85.62 -54.41 8.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.595 0.712 . . . . 0.0 109.661 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 4.3 m -139.56 163.44 32.54 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.76 -1.109 . . . . 0.0 109.818 -174.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -144.51 149.27 35.65 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 42.5 t -125.33 121.02 32.74 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.6 176.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.937 HG21 ' HB2' ' A' ' 10' ' ' GLN . 0.7 OUTLIER -69.89 -6.39 32.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.074 0.464 . . . . 0.0 111.366 177.139 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -65.89 -48.17 72.38 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 170.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.571 ' HA3' ' HD3' ' A' ' 92' ' ' ARG . . . 146.33 46.49 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 120.447 -0.883 . . . . 0.0 112.64 176.264 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 52.6 m -147.27 151.97 37.52 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.769 0.319 . . . . 0.0 110.224 175.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.6 mt -135.49 138.44 48.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.231 -177.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -110.46 126.8 54.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.934 0.397 . . . . 0.0 109.973 178.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 44.3 pt -128.76 157.42 41.46 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 116.0 -0.546 . . . . 0.0 111.454 -174.649 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.661 ' HB2' HD11 ' A' ' 67' ' ' ILE . 34.7 tt0 -132.34 144.85 50.84 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.614 179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 84.0 m-85 -92.86 156.98 16.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.02 0.438 . . . . 0.0 110.76 -178.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD21 ' HD2' ' A' ' 65' ' ' LYS . 83.1 mt -112.08 -177.08 3.08 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.415 178.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 75.85 -151.93 41.65 Favored Glycine 0 N--CA 1.448 -0.501 0 C-N-CA 120.036 -1.078 . . . . 0.0 111.238 -177.811 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 27.1 Cg_endo -63.86 -5.27 8.71 Favored 'Trans proline' 0 CA--C 1.535 0.53 0 C-N-CA 122.551 2.168 . . . . 0.0 112.154 174.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -102.75 20.54 17.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.142 0.496 . . . . 0.0 109.805 179.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.959 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 18.1 p90 -58.47 170.81 0.7 Allowed Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 115.385 -0.825 . . . . 0.0 111.298 -177.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.959 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 1.2 Cg_exo 9.34 0.01 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.162 1 C-N-CA 128.711 6.274 . . . . 0.0 121.659 -152.699 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.433 ' H ' ' C ' ' A' ' 84' ' ' TYR . 66.8 tp -66.57 109.81 2.93 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 119.986 1.266 . . . . 0.0 109.062 170.082 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 59.2 pttt -101.96 166.77 10.46 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.236 0.541 . . . . 0.0 111.874 -174.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 34.8 t -140.22 156.2 46.6 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.337 -0.847 . . . . 0.0 109.527 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 1.3 m -112.72 141.3 46.68 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.134 0.492 . . . . 0.0 110.89 -177.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.8 mt -121.93 126.75 49.32 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.805 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.562 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 94.0 mttt -124.95 154.96 40.36 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.945 0.402 . . . . 0.0 110.257 179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.571 ' HD3' ' HA3' ' A' ' 73' ' ' GLY . 36.4 ptt-85 -79.42 144.26 34.26 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.051 178.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -100.9 175.7 26.54 Favored Glycine 0 N--CA 1.436 -1.344 0 C-N-CA 120.604 -0.807 . . . . 0.0 111.14 175.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -77.12 134.36 38.73 Favored 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 120.622 0.249 . . . . 0.0 111.021 -177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 43.2 m-80 71.89 -66.14 0.32 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.306 -0.861 . . . . 0.0 111.639 177.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -167.29 59.59 0.22 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.47 -178.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.1 p -134.74 170.07 16.38 Favored 'General case' 0 C--N 1.323 -0.556 0 C-N-CA 122.122 0.169 . . . . 0.0 110.581 179.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 39.3 tp -129.53 135.42 48.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.78 0.324 . . . . 0.0 110.604 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.562 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 75.2 mt -105.65 126.26 60.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.046 177.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.512 ' HB3' ' HB2' ' A' ' 107' ' ' LYS . 17.7 t90 -117.3 115.75 25.87 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.079 -177.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -110.99 134.87 52.26 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.394 0.616 . . . . 0.0 111.432 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -149.68 121.35 8.05 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.041 -0.981 . . . . 0.0 109.937 -179.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 64.85 9.74 5.57 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.635 176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.95 -8.05 29.4 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.621 -0.799 . . . . 0.0 112.716 179.468 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -92.05 134.65 34.63 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 110.158 -0.312 . . . . 0.0 110.158 179.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 37.5 ttm180 -102.02 116.13 32.04 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.104 0.478 . . . . 0.0 111.237 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.546 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 2.0 mmpt? -98.55 139.49 34.21 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.547 176.416 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 35.9 m -121.74 112.24 18.15 Favored 'General case' 0 C--N 1.316 -0.886 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.865 179.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.572 ' HG2' ' HG2' ' A' ' 23' ' ' GLU . 52.2 mtm -116.8 141.4 48.26 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.089 -173.507 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 1.3 m -98.63 151.77 20.34 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.539 177.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.435 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 57.1 ttp85 -83.5 127.4 33.69 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 -178.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.581 HD11 ' CB ' ' A' ' 22' ' ' ASP . 30.0 mm -85.4 144.83 8.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 121.47 0.652 . . . . 0.0 110.598 177.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -131.27 110.66 11.26 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 114.605 -1.18 . . . . 0.0 107.898 174.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 16.9 p -114.02 122.42 46.86 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 115.425 -0.807 . . . . 0.0 111.654 -171.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 25.2 mtpp -94.55 36.44 1.16 Allowed 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 121.965 0.888 . . . . 0.0 108.953 173.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 12.1 t -156.64 160.46 39.41 Favored 'General case' 0 N--CA 1.444 -0.765 0 CA-C-N 114.184 -1.371 . . . . 0.0 108.091 179.452 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 140.97 91.7 0.19 Allowed Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.493 -0.861 . . . . 0.0 111.556 -178.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.852 HH11 ' HG2' ' A' ' 120' ' ' GLU . 0.3 OUTLIER -119.45 109.2 15.46 Favored 'General case' 0 C--N 1.32 -0.684 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.104 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -62.83 99.56 0.16 Allowed 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.603 178.467 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.852 ' HG2' HH11 ' A' ' 118' ' ' ARG . 37.4 mt-10 -103.3 94.12 5.34 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 174.079 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 46.7 tttp -87.59 133.65 33.76 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.543 -172.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -113.18 141.67 46.68 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.866 -0.606 . . . . 0.0 109.468 178.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -85.08 103.63 14.26 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.11 0.481 . . . . 0.0 110.517 -176.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 54.5 tttp -125.58 124.26 40.86 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.132 -175.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 36.5 t -102.5 141.05 35.96 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.949 0.404 . . . . 0.0 110.842 -179.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -101.02 85.93 2.95 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 174.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.0 m -91.18 75.65 6.15 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.081 0.467 . . . . 0.0 111.606 -173.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 90.3 mt -141.1 134.09 29.17 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.729 176.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -93.8 136.08 34.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.309 0.576 . . . . 0.0 111.605 -179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 48.1 t-80 -90.98 120.99 32.43 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.323 175.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 13.9 p80 -109.15 135.53 50.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.81 0.338 . . . . 0.0 110.37 178.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 17.8 t60 -68.88 103.47 1.81 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.956 -179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 51.3 t-80 -116.32 97.12 5.86 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.526 -0.307 . . . . 0.0 111.435 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 170.37 -82.64 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.401 0 O-C-N 124.02 0.825 . . . . 0.0 109.566 173.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 52.7 t-80 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.448 -0.787 . . . . 0.0 109.337 178.204 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.2 ptm . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 120.483 0.183 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 4.3 mp -110.81 109.02 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 121.072 0.463 . . . . 0.0 110.029 177.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 87.7 mtp -104.74 104.57 14.39 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 176.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.83 135.68 45.64 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.561 -178.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 34.9 m -144.33 117.29 8.83 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.318 177.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -71.8 106.41 1.91 Allowed Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.668 -0.777 . . . . 0.0 111.537 176.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 61.7 m -128.62 145.39 51.16 Favored 'General case' 0 C--N 1.323 -0.554 0 O-C-N 122.681 -0.305 . . . . 0.0 110.837 -177.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 93.5 mt-30 -83.14 81.83 8.52 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -88.91 -39.33 13.86 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.097 -177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.423 ' HA ' ' OE1' ' A' ' 10' ' ' GLN . 5.1 tp60 -141.38 131.22 24.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.793 0.33 . . . . 0.0 110.563 -178.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 41.0 mtmt -89.5 -33.31 16.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.855 -0.612 . . . . 0.0 110.213 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -75.5 127.01 32.16 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.24 -0.891 . . . . 0.0 110.924 -174.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -84.77 -171.55 3.69 Favored 'General case' 0 N--CA 1.443 -0.785 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.887 -179.674 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.405 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 9.0 t -82.46 140.17 44.8 Favored Pre-proline 0 C--N 1.325 -0.498 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.799 -177.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 39.5 Cg_exo -61.42 109.37 0.73 Allowed 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 122.803 2.335 . . . . 0.0 111.873 178.001 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 53.3 p90 -68.45 -18.99 64.54 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.079 -0.51 . . . . 0.0 112.194 -174.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 13.4 p90 -95.02 -10.18 31.64 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.795 0.331 . . . . 0.0 111.305 -175.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.402 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 42.8 t80 -80.64 130.29 35.02 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 121.022 0.439 . . . . 0.0 110.969 -172.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 137.86 -164.24 25.51 Favored Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 115.523 -0.762 . . . . 0.0 112.263 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 17.4 m -105.39 130.69 53.44 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.802 0.334 . . . . 0.0 110.297 179.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.454 ' CH2' ' HB2' ' A' ' 98' ' ' LEU . 71.7 m95 -119.54 144.56 46.99 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.262 -179.049 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.664 ' HB2' HD11 ' A' ' 112' ' ' ILE . 15.7 t70 -96.76 141.37 30.06 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 175.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 36' ' ' ALA . 6.1 mm-40 -48.14 -49.97 30.42 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.157 0.503 . . . . 0.0 110.496 179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . 76.12 -54.52 3.11 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.608 -0.724 . . . . 0.0 113.637 176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 22.4 ttt180 -135.95 164.19 28.54 Favored 'General case' 0 N--CA 1.443 -0.786 0 N-CA-C 109.661 -0.496 . . . . 0.0 109.661 -172.296 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 72.32 161.45 0.16 Allowed Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 124.039 0.837 . . . . 0.0 111.395 178.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_exo -71.29 175.4 9.37 Favored 'Trans proline' 0 C--N 1.347 0.464 0 C-N-CA 122.628 2.218 . . . . 0.0 112.154 176.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -131.21 -153.69 7.64 Favored Glycine 0 N--CA 1.446 -0.666 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.399 -177.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.778 ' HG2' ' HB ' ' A' ' 33' ' ' VAL . 4.5 Cg_endo -47.68 148.62 5.68 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 124.355 3.37 . . . . 0.0 113.433 -178.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.3 p -81.26 -2.17 47.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.593 -0.731 . . . . 0.0 111.923 -172.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -79.72 -1.04 36.71 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.251 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 79.62 35.23 29.36 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.302 -0.951 . . . . 0.0 111.897 -178.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.778 ' HB ' ' HG2' ' A' ' 29' ' ' PRO . 24.6 t -76.4 133.06 31.84 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.065 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.767 ' HE3' ' HB3' ' A' ' 52' ' ' GLU . 49.5 mtmt -91.47 -13.58 31.98 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.971 0.73 . . . . 0.0 112.971 -170.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.813 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 18.5 m -148.7 157.51 43.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 120.877 0.37 . . . . 0.0 110.609 174.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.441 ' O ' ' HG2' ' A' ' 23' ' ' GLU . . . -159.79 145.87 15.89 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.084 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 7.5 p -135.07 139.53 44.82 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.092 175.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.7 p -111.31 133.98 55.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-O 121.297 0.57 . . . . 0.0 110.121 179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.7 m -121.26 124.57 44.96 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.839 -176.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 89.9 m-85 -101.97 117.81 35.61 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.123 179.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.513 ' HB ' ' HG2' ' A' ' 44' ' ' GLU . 0.2 OUTLIER -102.33 179.43 4.31 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.816 -0.629 . . . . 0.0 109.327 177.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.446 ' H ' HG22 ' A' ' 41' ' ' THR . 33.1 mt-10 -54.93 -42.92 72.86 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -176.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -128.21 -16.25 4.52 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.921 0.391 . . . . 0.0 111.808 -174.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.513 ' HG2' ' HB ' ' A' ' 41' ' ' THR . 6.9 pt-20 -125.76 142.17 51.64 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.166 0.508 . . . . 0.0 111.803 -173.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 48.9 t -102.61 125.56 56.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 172.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . 0.491 HG22 ' HB3' ' A' ' 61' ' ' PHE . 66.9 t -115.92 123.82 71.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-O 120.819 0.342 . . . . 0.0 110.499 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -96.07 137.92 34.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.131 0.491 . . . . 0.0 110.736 174.175 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.568 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.2 OUTLIER -125.63 118.85 26.57 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.647 177.814 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -105.63 125.61 51.18 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.198 -177.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.813 ' HB ' ' HB2' ' A' ' 35' ' ' SER . 42.5 t -98.86 111.06 27.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 120.956 0.408 . . . . 0.0 110.258 -176.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 2.0 tmm? -99.48 109.11 21.69 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 178.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.767 ' HB3' ' HE3' ' A' ' 34' ' ' LYS . 41.5 tt0 -65.39 106.63 1.43 Allowed 'General case' 0 C--N 1.312 -1.059 0 CA-C-N 115.15 -0.932 . . . . 0.0 110.045 -176.336 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 141.95 -29.68 2.19 Favored Glycine 0 N--CA 1.441 -0.969 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.116 -175.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.475 ' HG3' ' N ' ' A' ' 55' ' ' GLY . 17.0 ptp180 -125.01 -51.77 1.67 Allowed 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 120.515 0.197 . . . . 0.0 111.04 177.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' N ' ' HG3' ' A' ' 54' ' ' ARG . . . 142.45 -156.36 26.15 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 121.113 -0.565 . . . . 0.0 112.017 -176.01 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 26.3 mp0 -79.8 146.34 32.33 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 121.398 0.618 . . . . 0.0 111.818 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 75.2 t -127.21 122.05 59.02 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 115.065 -0.97 . . . . 0.0 109.412 174.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.568 ' HG2' HG23 ' A' ' 48' ' ' THR . 36.0 mt-30 -95.68 131.5 41.87 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 120.806 0.336 . . . . 0.0 111.052 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.9 mt -93.17 157.25 39.26 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.245 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -50.02 118.61 4.03 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 122.815 2.343 . . . . 0.0 111.577 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.491 ' HB3' HG22 ' A' ' 46' ' ' VAL . 52.6 p90 -60.44 145.35 48.55 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.214 0.53 . . . . 0.0 111.481 -175.217 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 71.0 mtm -103.11 125.83 50.01 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.809 178.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -83.7 136.42 34.19 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.045 176.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 51.1 p90 -127.12 161.11 29.23 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.84 0.352 . . . . 0.0 110.723 -179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -122.18 144.46 48.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.222 176.333 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 89.3 t -89.4 114.02 26.76 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.964 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.828 -176.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.561 HD11 ' HB2' ' A' ' 78' ' ' GLN . 10.1 mt -81.15 -56.69 5.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-O 121.741 0.781 . . . . 0.0 109.188 178.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.5 m -124.77 149.39 47.4 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 115.012 -0.995 . . . . 0.0 108.626 178.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.0 tt0 -147.65 136.45 21.97 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-O 121.372 0.606 . . . . 0.0 111.774 -170.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.462 ' HB3' ' H ' ' A' ' 74' ' ' SER . 37.0 t -141.3 150.54 42.66 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 114.896 -1.047 . . . . 0.0 108.811 175.147 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -86.93 -9.57 55.37 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 111.876 0.325 . . . . 0.0 111.876 -175.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -146.41 -27.46 0.42 Allowed 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 112.682 0.623 . . . . 0.0 112.682 -176.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.73 -76.21 0.95 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.16 -1.019 . . . . 0.0 112.562 -177.236 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.529 ' HB3' ' HG2' ' A' ' 91' ' ' LYS . 3.4 p -159.28 164.41 34.94 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.646 0.26 . . . . 0.0 110.728 -176.208 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.1 mt -132.92 135.53 56.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 177.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 42.0 tt0 -113.43 131.72 55.91 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 39.0 pt -130.76 156.81 42.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.216 0.531 . . . . 0.0 111.567 -173.53 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.561 ' HB2' HD11 ' A' ' 67' ' ' ILE . 53.1 tt0 -124.98 131.74 53.37 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.658 179.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 m-85 -85.62 152.96 22.71 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.179 0.514 . . . . 0.0 111.034 -178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.0 mt -117.72 -178.0 3.38 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.603 177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 79.82 -152.27 34.92 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 119.83 -1.176 . . . . 0.0 111.175 -177.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -61.59 -10.73 17.45 Favored 'Trans proline' 0 CA--C 1.532 0.378 0 C-N-CA 122.722 2.281 . . . . 0.0 112.589 178.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -109.59 25.96 11.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.266 0.555 . . . . 0.0 109.884 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 1.011 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 34.9 p90 -55.24 166.51 0.86 Allowed Pre-proline 0 C--N 1.332 -0.165 0 CA-C-N 114.982 -1.008 . . . . 0.0 111.616 -178.876 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 1.011 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.3 OUTLIER 8.13 -0.8 0.0 OUTLIER 'Trans proline' 0 CA--C 1.545 1.031 1 C-N-CA 128.988 6.459 . . . . 0.0 121.487 -153.397 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.872 ' HG ' HE22 ' A' ' 102' ' ' GLN . 35.4 tp -70.77 103.29 2.54 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 119.936 1.244 . . . . 0.0 107.928 171.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -98.45 173.04 7.15 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.415 0.626 . . . . 0.0 112.155 -167.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 39.9 t -141.81 158.87 43.28 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.1 -0.955 . . . . 0.0 109.891 -174.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.427 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.2 m -123.83 141.07 52.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.479 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 96.9 mt -120.39 122.94 41.84 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.91 178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.529 ' HG2' ' HB3' ' A' ' 74' ' ' SER . 40.3 mtpt -137.96 149.45 46.16 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.533 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 38.3 ptt85 -90.2 147.08 23.78 Favored 'General case' 0 C--N 1.312 -1.025 0 C-N-CA 120.656 -0.418 . . . . 0.0 110.102 179.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -110.16 -160.72 18.14 Favored Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.486 -0.864 . . . . 0.0 111.265 178.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -64.12 137.23 57.87 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 174.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 14.2 m120 66.22 -157.96 0.26 Allowed 'General case' 0 C--O 1.236 0.347 0 CA-C-N 116.21 -0.45 . . . . 0.0 109.924 -178.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.4 ' HA3' HH11 ' A' ' 111' ' ' ARG . . . -90.5 57.18 3.47 Favored Glycine 0 N--CA 1.446 -0.656 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.561 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 42.1 p -121.13 148.88 43.6 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.729 0.3 . . . . 0.0 110.694 178.026 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.454 ' HB2' ' CH2' ' A' ' 21' ' ' TRP . 20.9 tp -112.01 132.73 54.62 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 -179.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 66.0 mt -97.69 113.35 31.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.879 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 178.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 11.9 t90 -96.64 114.25 25.89 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.834 -176.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.427 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 26.2 mt-10 -105.89 133.32 50.79 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.621 0.724 . . . . 0.0 110.405 177.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.872 HE22 ' HG ' ' A' ' 86' ' ' LEU . 5.7 tm0? -150.55 133.21 15.78 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.775 -179.758 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 72.99 -43.16 0.55 Allowed 'General case' 0 N--CA 1.469 0.48 0 O-C-N 123.794 0.684 . . . . 0.0 111.38 178.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 164.26 -19.3 0.12 Allowed Glycine 0 N--CA 1.443 -0.847 0 CA-C-N 115.707 -0.679 . . . . 0.0 112.22 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -103.0 141.19 36.21 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.817 0.342 . . . . 0.0 110.99 -176.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . 0.423 ' HB3' ' HG2' ' A' ' 101' ' ' GLU . 15.3 ptp180 -101.33 138.51 38.25 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.793 -0.64 . . . . 0.0 111.496 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' HA ' ' HD3' ' A' ' 107' ' ' LYS . 17.0 mmtm -127.15 133.94 50.27 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.273 173.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 7.3 t -94.91 128.75 41.93 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.043 0.449 . . . . 0.0 110.113 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.421 ' CE ' HD23 ' A' ' 98' ' ' LEU . 22.1 ptt? -123.6 149.05 45.82 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.332 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -95.81 150.07 20.81 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.512 -174.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HA3' ' A' ' 96' ' ' GLY . 12.8 ptt180 -85.03 154.81 21.86 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.269 -177.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.664 HD11 ' HB2' ' A' ' 22' ' ' ASP . 16.9 mm -96.86 150.57 4.41 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.979 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 168.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 38.4 mm-40 -87.37 83.42 7.34 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -178.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 21.0 m -83.04 133.29 35.09 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.468 -178.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -77.26 88.99 3.69 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.343 0.592 . . . . 0.0 110.015 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 37.1 m -151.98 135.67 16.25 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.776 . . . . 0.0 109.396 -178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 152.33 -38.11 0.78 Allowed Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.675 -178.239 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.575 ' HD2' ' O ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -93.48 93.08 7.92 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 121.613 0.72 . . . . 0.0 109.743 177.336 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -146.52 120.69 9.5 Favored 'General case' 0 C--N 1.319 -0.755 0 O-C-N 122.026 -0.421 . . . . 0.0 112.045 -175.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 72.1 149.33 0.09 Allowed 'General case' 0 C--O 1.234 0.266 0 O-C-N 124.138 0.899 . . . . 0.0 113.034 165.015 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 44.3 pttt -132.34 139.64 48.23 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.035 174.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -121.21 134.2 55.19 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.068 -0.716 . . . . 0.0 109.068 174.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -113.02 103.67 11.62 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 121.436 0.636 . . . . 0.0 111.364 -171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 85.6 tttt -116.41 111.1 19.54 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.285 -0.871 . . . . 0.0 110.15 179.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 13.0 p -146.22 134.02 21.22 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.857 0.36 . . . . 0.0 111.581 -177.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 47.3 mttp -144.61 131.78 20.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.463 175.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 4.4 p -145.12 105.97 4.14 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.508 178.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 60.1 tp -168.41 125.1 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.243 -178.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -116.84 179.32 4.05 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.271 176.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 3.0 p-80 -147.12 154.48 41.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.621 0.248 . . . . 0.0 111.258 -174.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 40.4 m-70 -130.3 140.24 50.67 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.536 -178.314 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 23.1 p-80 -146.11 111.61 5.49 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 121.639 0.733 . . . . 0.0 110.718 172.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 20.9 t-80 -85.09 123.58 30.78 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.377 -0.828 . . . . 0.0 109.62 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.4 t-80 -70.41 120.02 15.45 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.994 0.426 . . . . 0.0 110.311 -177.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 75.3 m80 . . . . . 0 C--O 1.251 1.159 0 CA-C-O 118.254 -0.879 . . . . 0.0 109.807 179.516 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.2 ttt . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.662 0.268 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 10.2 tp -76.74 148.45 6.88 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 109.553 -0.536 . . . . 0.0 109.553 176.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 80.3 mtp -77.44 93.02 4.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.021 0.439 . . . . 0.0 110.848 179.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.9 p -113.69 111.8 37.59 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.618 175.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 33.2 m -81.31 106.71 13.5 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.539 -178.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -153.89 167.87 32.25 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.361 -0.696 . . . . 0.0 111.361 178.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 39.3 m -80.68 87.92 5.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.786 0.327 . . . . 0.0 110.751 -179.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 85.3 mt-30 -131.96 117.24 18.17 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.421 178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -145.64 128.31 16.18 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.701 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -85.0 111.15 19.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.148 179.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 86.1 tttt 70.15 -78.18 0.05 OUTLIER 'General case' 0 N--CA 1.463 0.186 0 O-C-N 123.741 0.651 . . . . 0.0 111.261 178.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -172.1 143.44 1.53 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 -176.357 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -104.62 -170.19 1.73 Allowed 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.205 0.526 . . . . 0.0 111.22 -178.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 4.8 t -86.86 151.81 52.82 Favored Pre-proline 0 C--N 1.321 -0.64 0 CA-C-N 115.455 -0.793 . . . . 0.0 109.281 177.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.676 ' HB2' ' HB2' ' A' ' 18' ' ' TYR . 47.4 Cg_exo -56.53 117.05 3.65 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.606 2.204 . . . . 0.0 112.152 178.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.7 p90 -63.78 -28.49 69.91 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.729 0.3 . . . . 0.0 111.52 -177.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.422 ' CE1' ' HB3' ' A' ' 15' ' ' PRO . 12.2 p90 -85.27 -1.28 56.77 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.837 0.351 . . . . 0.0 111.313 -178.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.676 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 55.3 t80 -75.49 125.64 29.42 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.92 0.391 . . . . 0.0 109.999 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 132.98 -158.11 22.96 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.314 -178.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 8.0 m -110.34 132.48 54.14 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.639 0.257 . . . . 0.0 110.8 -178.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.57 ' CZ3' ' HB2' ' A' ' 111' ' ' ARG . 61.5 m95 -123.15 137.8 54.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.552 -0.295 . . . . 0.0 110.552 179.708 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.59 ' HB2' HD11 ' A' ' 112' ' ' ILE . 17.0 t70 -103.73 128.16 51.12 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.745 179.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -95.25 75.84 3.41 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 175.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -80.37 39.72 2.33 Favored Glycine 0 C--N 1.317 -0.478 0 C-N-CA 121.043 -0.599 . . . . 0.0 113.624 -178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 25.1 ttp180 -164.52 160.69 20.65 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 177.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.419 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . . . 73.19 144.59 0.11 Allowed Pre-proline 0 N--CA 1.467 0.401 0 O-C-N 124.022 0.826 . . . . 0.0 111.079 -177.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 16.7 Cg_exo -67.45 140.66 53.2 Favored 'Trans proline' 0 C--O 1.236 0.385 0 C-N-CA 122.836 2.357 . . . . 0.0 112.451 -177.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -84.12 -167.84 43.02 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.993 -0.623 . . . . 0.0 112.432 179.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.712 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 32.9 Cg_exo -53.41 163.55 2.49 Favored 'Trans proline' 0 C--O 1.235 0.366 0 C-N-CA 123.612 2.875 . . . . 0.0 113.376 177.525 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 97.8 m -71.37 -25.07 62.22 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.405 -176.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -72.18 13.47 0.31 Allowed 'General case' 0 N--CA 1.467 0.425 0 N-CA-C 113.291 0.849 . . . . 0.0 113.291 -174.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.4 28.04 13.9 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.679 -0.772 . . . . 0.0 112.677 174.906 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.712 ' HB ' ' HD2' ' A' ' 29' ' ' PRO . 22.1 t -89.05 134.39 28.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 3.5 mmpt? -68.55 -44.31 74.77 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.542 0.686 . . . . 0.0 110.183 -178.66 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.6 p -175.74 175.11 2.09 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 114.494 -1.23 . . . . 0.0 109.148 -177.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -122.35 154.08 38.13 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.308 0.575 . . . . 0.0 111.332 -178.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.558 HG22 ' HA ' ' A' ' 22' ' ' ASP . 23.0 p -119.34 142.21 48.34 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.146 172.494 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 9.3 p -112.26 131.63 63.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 121.365 0.602 . . . . 0.0 110.615 -176.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 29.2 m -116.71 120.03 37.34 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.127 177.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -101.4 117.01 34.08 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 73.4 p -101.72 -177.8 3.53 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 20.4 tt0 -54.42 -45.37 72.97 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 112.341 0.497 . . . . 0.0 112.341 -173.575 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -126.58 -13.56 5.93 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.346 0.498 . . . . 0.0 112.346 -175.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -126.16 154.81 42.68 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.139 0.495 . . . . 0.0 111.731 -172.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.48 HG23 ' CD1' ' A' ' 64' ' ' TYR . 96.3 t -110.4 130.64 63.31 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 175.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 55.1 t -117.82 123.53 71.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.744 0.307 . . . . 0.0 110.176 178.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 13.6 mt-10 -95.85 137.74 34.48 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 121.426 0.631 . . . . 0.0 110.502 175.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.489 HG23 ' HG2' ' A' ' 58' ' ' GLN . 0.0 OUTLIER -122.01 119.91 32.83 Favored 'General case' 0 C--N 1.31 -1.139 0 CA-C-N 115.065 -0.97 . . . . 0.0 110.184 179.543 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -100.63 128.48 46.67 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 109.806 -0.442 . . . . 0.0 109.806 -179.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 44.2 t -99.84 112.75 33.19 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.789 0 CA-C-O 120.985 0.421 . . . . 0.0 109.876 178.037 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 29.7 ttp -116.63 138.17 51.63 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.738 -175.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -54.72 126.1 22.65 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 123.818 0.699 . . . . 0.0 111.594 -178.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.39 -28.15 11.77 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.579 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HE ' ' HB3' ' A' ' 54' ' ' ARG . 9.4 mmm180 -92.81 -75.61 0.49 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.625 0.726 . . . . 0.0 110.943 179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.0 -145.35 16.84 Favored Glycine 0 N--CA 1.444 -0.813 0 CA-C-N 114.373 -1.285 . . . . 0.0 110.025 -171.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -79.9 131.36 35.83 Favored 'General case' 0 N--CA 1.448 -0.572 0 CA-C-O 121.762 0.791 . . . . 0.0 111.261 177.085 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 94.9 t -118.32 120.64 64.99 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.547 -1.206 . . . . 0.0 108.975 175.144 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . 0.489 ' HG2' HG23 ' A' ' 48' ' ' THR . 78.7 mt-30 -92.58 126.69 37.78 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 120.877 0.37 . . . . 0.0 110.874 -177.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 92.8 mt -88.81 158.46 47.65 Favored Pre-proline 0 C--N 1.322 -0.606 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.495 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.26 132.34 28.48 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.92 2.414 . . . . 0.0 112.105 175.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 21.8 p90 -60.41 128.41 36.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.609 -178.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 82.6 mtp -103.35 120.41 40.74 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.15 177.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.0 127.98 34.32 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.369 -179.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.48 ' CD1' HG23 ' A' ' 45' ' ' VAL . 34.2 p90 -114.66 154.99 27.41 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.113 -179.516 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -126.78 147.52 49.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 121.381 0.61 . . . . 0.0 110.331 176.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 96.8 t -97.8 114.67 35.72 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.727 -1.124 . . . . 0.0 110.679 -176.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.544 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.8 mt -81.49 -53.96 11.04 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.331 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 6.5 m -133.17 153.26 51.69 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.205 -0.907 . . . . 0.0 109.301 178.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -148.64 145.27 27.68 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.878 -172.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.2 t -133.17 145.7 50.87 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 176.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 2.8 p -71.86 -23.56 61.54 Favored 'General case' 0 N--CA 1.45 -0.429 0 CA-C-O 121.087 0.47 . . . . 0.0 110.096 175.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -165.63 89.87 0.45 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-N 115.562 -0.745 . . . . 0.0 109.867 172.687 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -177.47 -84.92 0.06 OUTLIER Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.896 -0.668 . . . . 0.0 112.078 178.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -146.89 156.09 42.82 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.174 0.511 . . . . 0.0 110.419 -179.495 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.55 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 9.1 mt -133.31 136.15 55.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.56 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -118.09 119.6 35.25 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 42.5 pt -123.29 157.35 29.15 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.709 -176.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.706 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 33.9 tt0 -130.75 144.4 51.42 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.812 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 88.1 m-85 -94.68 154.91 17.1 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.892 0.377 . . . . 0.0 110.578 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.8 mt -108.32 -177.38 3.31 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.608 178.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 84.26 -153.52 29.22 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.258 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -63.66 -16.03 52.26 Favored 'Trans proline' 0 CA--C 1.529 0.233 0 C-N-CA 122.514 2.143 . . . . 0.0 112.122 177.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -99.88 31.18 3.36 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.225 0.536 . . . . 0.0 110.224 -178.924 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.917 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 52.9 p90 -59.7 173.48 0.52 Allowed Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.251 175.44 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.917 ' HD2' ' HB2' ' A' ' 84' ' ' TYR . 0.2 OUTLIER 11.65 -0.84 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.128 1 C-N-CA 128.243 5.962 . . . . 0.0 121.415 -152.267 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.472 ' H ' ' C ' ' A' ' 84' ' ' TYR . 61.6 tp -68.47 104.27 1.87 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 119.575 1.08 . . . . 0.0 108.24 167.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 62.6 pttt -105.74 173.29 6.37 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.075 0.464 . . . . 0.0 111.927 -172.145 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 12.8 t -139.54 158.42 44.16 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.359 -0.837 . . . . 0.0 110.204 -174.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.565 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.4 m -119.61 142.87 48.02 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.826 -177.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 97.7 mt -130.72 130.77 44.23 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.846 -178.461 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 34.0 mtmm -144.93 164.74 30.2 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.069 -0.514 . . . . 0.0 109.895 174.78 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 49.7 ptt85 -98.44 154.9 17.53 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.857 0.36 . . . . 0.0 110.034 173.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -97.08 -153.73 29.58 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.409 -0.9 . . . . 0.0 112.306 179.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.7 tt0 -75.73 -46.76 29.18 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.565 0.698 . . . . 0.0 110.104 178.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 34.5 m-80 -97.02 -160.46 0.8 Allowed 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.49 -1.232 . . . . 0.0 109.784 -179.429 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -76.79 51.28 3.07 Favored Glycine 0 N--CA 1.452 -0.273 0 N-CA-C 111.552 -0.619 . . . . 0.0 111.552 175.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 26.1 p -117.05 141.32 48.4 Favored 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 115.517 -0.342 . . . . 0.0 110.781 -178.025 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.487 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 28.9 tp -102.69 135.66 43.93 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 177.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 29.6 mm -97.8 108.97 22.67 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 16.2 t90 -107.62 111.95 24.43 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-O 121.093 0.473 . . . . 0.0 110.037 -178.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.565 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 23.0 mt-10 -107.23 131.66 53.94 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.725 -0.67 . . . . 0.0 109.387 176.515 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 9.7 tm0? -150.59 118.31 6.17 Favored 'General case' 0 C--N 1.306 -1.314 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.125 -174.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 55.4 t30 69.63 -5.09 1.24 Allowed 'General case' 0 CA--C 1.536 0.417 0 O-C-N 123.604 0.565 . . . . 0.0 112.229 165.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.13 -14.6 4.03 Favored Glycine 0 N--CA 1.443 -0.856 0 C-N-CA 120.818 -0.706 . . . . 0.0 112.432 -179.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -108.46 135.5 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 120.368 -0.533 . . . . 0.0 111.326 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 13.3 ttp180 -101.7 127.0 48.66 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.56 -0.745 . . . . 0.0 110.255 175.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.458 ' HB2' ' HE3' ' A' ' 107' ' ' LYS . 5.5 mtmt -117.98 124.82 49.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 120.665 0.269 . . . . 0.0 111.655 177.643 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 20.9 m -95.19 113.91 25.65 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 173.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.416 ' HB3' ' HE2' ' A' ' 109' ' ' MET . 21.1 ptp -125.14 151.4 45.81 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.914 0.388 . . . . 0.0 110.965 -175.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 2.5 m -100.17 156.07 17.4 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.143 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 21' ' ' TRP . 41.9 ttt85 -87.45 141.42 28.64 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.927 0.394 . . . . 0.0 110.375 -178.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 22' ' ' ASP . 30.6 mm -72.72 147.53 9.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 175.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.487 ' H ' ' CD ' ' A' ' 113' ' ' GLU . 1.9 pm0 -74.29 107.18 6.3 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.45 0.643 . . . . 0.0 110.746 -175.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 7.0 m -100.12 16.54 23.79 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.059 -177.548 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 20.4 ptmt -137.55 19.48 2.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.893 0.378 . . . . 0.0 111.13 -175.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 1.7 p -104.12 100.31 10.06 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.628 -178.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 120.88 -154.66 16.39 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.613 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.516 ' HD3' ' OE2' ' A' ' 120' ' ' GLU . 43.4 ttt180 -157.94 153.65 26.54 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . 0.448 ' H ' ' CD ' ' A' ' 119' ' ' GLU . 1.4 pm0 -76.75 63.49 2.18 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 121.262 0.553 . . . . 0.0 111.369 179.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . 0.516 ' OE2' ' HD3' ' A' ' 118' ' ' ARG . 74.7 mm-40 -66.99 149.33 50.78 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.349 172.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -94.99 104.74 16.62 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.368 0.604 . . . . 0.0 111.757 -175.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.599 ' HB3' ' HE3' ' A' ' 124' ' ' LYS . 14.3 t70 -90.42 141.39 28.79 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.297 173.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -66.91 102.43 0.97 Allowed 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.599 ' HE3' ' HB3' ' A' ' 122' ' ' ASP . 96.4 mttt -123.73 85.85 2.48 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.721 -178.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.0 m -86.68 106.96 17.99 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.373 174.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 20.9 ptmt -89.04 152.56 21.61 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.056 -174.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 35.7 t -135.03 92.76 2.91 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.352 178.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 61.0 tp -95.26 105.95 17.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.192 0.52 . . . . 0.0 110.989 -177.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 2.9 tm-20 -82.58 92.89 7.2 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 174.285 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 1.7 t60 -70.69 98.02 1.45 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.061 -0.518 . . . . 0.0 109.75 -176.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 3.4 t60 -87.96 -42.15 12.66 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.435 -173.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 41.2 t-80 68.06 104.63 0.05 Allowed 'General case' 0 N--CA 1.466 0.353 0 CA-C-N 115.636 -0.711 . . . . 0.0 112.198 176.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -70.34 134.02 47.51 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.472 172.733 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 60.6 t-80 -115.9 121.41 42.27 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.621 0.248 . . . . 0.0 110.784 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 82.0 t60 . . . . . 0 C--O 1.247 0.949 0 N-CA-C 109.595 -0.521 . . . . 0.0 109.595 174.877 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 110.405 -0.22 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 6.4 tp -79.44 89.29 1.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 122.08 0.943 . . . . 0.0 111.198 -178.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.789 ' HG2' HG23 ' A' ' 4' ' ' VAL . 46.1 ttm -156.91 132.94 9.63 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.189 179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.789 HG23 ' HG2' ' A' ' 3' ' ' MET . 92.5 t 68.89 111.6 0.04 OUTLIER 'Isoleucine or valine' 0 C--O 1.233 0.234 0 O-C-N 123.919 0.762 . . . . 0.0 112.216 176.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 46.9 m -87.66 -36.25 17.54 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.765 -0.652 . . . . 0.0 109.794 174.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -176.36 113.23 0.43 Allowed Glycine 0 N--CA 1.45 -0.417 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.589 177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 72.9 m -64.51 -34.57 78.53 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.697 0.248 . . . . 0.0 111.523 -177.307 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -110.87 109.44 19.62 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.245 0.545 . . . . 0.0 110.672 177.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . 0.424 ' H ' ' CD ' ' A' ' 9' ' ' GLN . 0.6 OUTLIER -90.89 34.5 0.91 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.103 178.131 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 26.4 tt0 -69.36 -32.76 72.03 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.256 179.677 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 8.6 mtpm? -103.02 118.78 37.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 174.201 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.88 88.5 2.95 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.803 0.335 . . . . 0.0 110.564 -175.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 25.3 mp0 -107.24 -1.0 22.23 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 121.526 0.679 . . . . 0.0 111.132 -179.1 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.469 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 8.8 t -59.56 121.66 58.8 Favored Pre-proline 0 C--N 1.303 -1.42 0 CA-C-N 114.331 -1.304 . . . . 0.0 112.546 -172.154 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.469 ' HD3' ' HA ' ' A' ' 14' ' ' THR . 6.3 Cg_exo -79.15 97.87 1.14 Allowed 'Trans proline' 0 N--CA 1.456 -0.682 0 C-N-CA 123.073 2.515 . . . . 0.0 110.831 172.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 46.5 p90 -63.17 -25.7 68.46 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.995 -0.548 . . . . 0.0 112.359 -173.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 33.7 p90 -82.95 -18.32 40.42 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.666 0.27 . . . . 0.0 111.678 -175.082 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -74.04 136.61 43.1 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 120.677 0.275 . . . . 0.0 110.709 -174.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 130.15 -158.21 22.27 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.224 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . . . . . . . . . 24.5 m -117.82 129.03 55.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.619 0.247 . . . . 0.0 110.605 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 80.9 m95 -113.7 141.36 47.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.182 179.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.677 ' HB2' HD11 ' A' ' 112' ' ' ILE . 20.1 t70 -109.02 134.98 50.94 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.778 -174.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.492 ' HB2' ' H ' ' A' ' 36' ' ' ALA . 33.8 mt-10 -96.1 40.8 1.11 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.602 178.882 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -73.04 -18.06 78.95 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.319 -0.944 . . . . 0.0 110.945 172.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 35.9 ttm180 -91.66 142.82 27.2 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.308 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 68.71 155.49 0.14 Allowed Pre-proline 0 C--N 1.325 -0.496 0 O-C-N 124.594 1.184 . . . . 0.0 111.401 -178.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_exo -63.48 135.13 48.0 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.384 2.056 . . . . 0.0 111.862 177.483 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -104.78 -154.76 22.77 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.96 -0.638 . . . . 0.0 112.436 -177.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -62.22 171.63 5.01 Favored 'Trans proline' 0 CA--C 1.531 0.325 0 C-N-CA 123.28 2.654 . . . . 0.0 113.037 178.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.6 t -129.66 -6.59 4.61 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.462 -177.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -54.94 -41.2 70.77 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.692 0.758 . . . . 0.0 111.681 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 164.37 -37.01 0.3 Allowed Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 108.506 -1.838 . . . . 0.0 108.506 -174.776 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.467 HG13 ' O ' ' A' ' 50' ' ' VAL . 17.8 t -67.34 134.36 30.24 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 164.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -111.26 -15.24 13.68 Favored 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 120.982 0.42 . . . . 0.0 110.786 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.5 m -157.31 158.25 35.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.928 -0.578 . . . . 0.0 109.968 -177.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.492 ' H ' ' HB2' ' A' ' 23' ' ' GLU . . . -136.12 164.73 27.37 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-O 121.193 0.521 . . . . 0.0 110.933 -176.532 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.411 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 20.0 p -131.06 131.29 44.15 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.086 175.321 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.2 p -111.85 129.52 67.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.84 0 CA-C-O 121.255 0.55 . . . . 0.0 110.702 -176.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 26.6 m -114.53 125.65 54.03 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.103 179.299 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -101.4 117.14 34.34 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 178.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 p -101.75 -178.0 3.59 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.639 -0.709 . . . . 0.0 110.567 178.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -49.36 -52.82 25.77 Favored 'General case' 0 CA--C 1.534 0.33 0 O-C-N 123.478 0.486 . . . . 0.0 112.303 -173.083 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -134.87 9.23 3.57 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.228 0.537 . . . . 0.0 110.969 -175.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -132.01 163.9 27.39 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.167 0.508 . . . . 0.0 111.334 -178.11 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 86.2 t -115.88 122.28 69.2 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.29 172.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 53.2 t -109.34 122.75 64.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 N-CA-C 109.754 -0.461 . . . . 0.0 109.754 177.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -106.32 136.92 45.2 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.379 0.609 . . . . 0.0 110.817 178.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.419 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 0.6 OUTLIER -125.9 130.72 51.86 Favored 'General case' 0 C--N 1.312 -1.063 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.956 178.537 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.458 ' HB3' HG11 ' A' ' 33' ' ' VAL . 43.3 mt-10 -110.33 136.53 49.36 Favored 'General case' 0 C--N 1.312 -1.048 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.246 -178.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.467 ' O ' HG13 ' A' ' 33' ' ' VAL . 47.5 t -94.34 111.78 25.9 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.839 -0.43 . . . . 0.0 109.839 178.312 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -116.7 115.39 25.56 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 -177.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 43.1 tt0 -69.44 113.89 7.17 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.606 -173.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 117.12 -20.83 11.26 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 110.848 -0.901 . . . . 0.0 110.848 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . . . . . . . . . 5.1 mmt180 -111.65 -61.06 1.76 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.815 0.817 . . . . 0.0 110.021 178.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 131.36 -158.83 22.91 Favored Glycine 0 N--CA 1.444 -0.77 0 CA-C-N 114.308 -1.314 . . . . 0.0 110.287 -176.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -78.24 131.08 36.96 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-O 121.376 0.608 . . . . 0.0 110.558 174.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' THR . 93.2 t -113.23 121.14 64.86 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.019 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -91.41 128.68 37.33 Favored 'General case' 0 N--CA 1.445 -0.695 0 CA-C-O 120.624 0.25 . . . . 0.0 110.926 179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.473 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.9 mt -86.94 159.91 50.66 Favored Pre-proline 0 C--N 1.319 -0.734 0 N-CA-C 109.404 -0.591 . . . . 0.0 109.404 173.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.473 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 20.1 Cg_endo -62.74 132.05 35.87 Favored 'Trans proline' 0 N--CA 1.464 -0.263 0 C-N-CA 122.063 1.842 . . . . 0.0 111.128 -179.849 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 40.5 p90 -57.02 127.23 30.88 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.58 0.705 . . . . 0.0 111.191 -175.464 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 67.8 mtm -104.19 130.05 51.95 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 115.403 -0.817 . . . . 0.0 110.6 -178.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -74.83 132.09 41.26 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.522 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 21.6 p90 -124.39 146.74 48.69 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.549 ' HG2' HD11 ' A' ' 80' ' ' LEU . 73.5 mmtt -121.69 155.45 35.16 Favored 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 121.699 0.761 . . . . 0.0 110.663 176.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.0 t -96.5 115.25 35.4 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.13 0 CA-C-N 114.176 -1.374 . . . . 0.0 110.522 -175.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.585 HD11 ' HB2' ' A' ' 78' ' ' GLN . 15.2 mt -81.99 -54.0 10.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 176.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 1.9 m -136.39 153.11 51.2 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.986 -1.007 . . . . 0.0 109.77 179.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 24.3 tt0 -148.25 150.9 34.52 Favored 'General case' 0 C--N 1.314 -0.945 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.626 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 35.9 t -143.57 139.09 29.54 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.617 0.246 . . . . 0.0 110.665 179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 7.2 p -68.98 -17.72 63.97 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.669 172.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -65.24 -44.92 86.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.291 -0.868 . . . . 0.0 111.413 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 138.59 30.54 0.22 Allowed Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.319 -0.943 . . . . 0.0 112.802 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.7 p -135.0 131.25 36.91 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.21 0.528 . . . . 0.0 110.717 175.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.568 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 33.3 mt -135.32 137.59 49.78 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.328 -177.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -117.5 123.62 46.77 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 177.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 27.7 pt -132.59 158.53 43.3 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.154 -176.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.585 ' HB2' HD11 ' A' ' 67' ' ' ILE . 34.0 tt0 -139.38 142.21 37.55 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 -179.086 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 90.1 m-85 -71.83 174.19 7.24 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.077 177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 65' ' ' LYS . 76.5 mt -127.85 174.58 9.03 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.762 176.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 81.99 -152.76 31.8 Favored Glycine 0 N--CA 1.442 -0.911 0 N-CA-C 110.42 -1.072 . . . . 0.0 110.42 -171.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -64.28 -9.49 20.08 Favored 'Trans proline' 0 CA--C 1.53 0.317 0 C-N-CA 122.381 2.054 . . . . 0.0 111.952 176.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 15.0 m-85 -102.34 20.5 16.77 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.477 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.526 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 0.9 OUTLIER -95.43 2.64 0.07 OUTLIER Pre-proline 0 N--CA 1.446 -0.668 0 N-CA-C 113.513 0.931 . . . . 0.0 113.513 -172.925 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.526 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 77.1 Cg_endo -93.87 -4.58 2.76 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 CA-C-N 121.393 1.533 . . . . 0.0 112.368 162.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 62.0 tp -100.85 112.02 24.35 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.727 -0.67 . . . . 0.0 109.679 177.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 65.6 pttt -99.81 170.26 8.66 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.277 0.56 . . . . 0.0 110.995 -179.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -130.35 158.3 40.2 Favored 'General case' 0 C--N 1.318 -0.764 0 CA-C-N 115.269 -0.878 . . . . 0.0 109.089 -178.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.573 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 4.7 m -128.98 142.01 51.07 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-O 121.014 0.435 . . . . 0.0 111.069 -177.505 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.568 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 94.8 mt -121.1 123.62 42.78 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.097 177.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.496 ' HE3' HG21 ' A' ' 89' ' ' THR . 93.3 mttt -132.0 155.37 48.12 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-O 121.107 0.479 . . . . 0.0 111.371 -177.095 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 5.3 ptt180 -84.63 152.36 23.86 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.405 -0.816 . . . . 0.0 109.428 174.593 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -89.59 -156.79 32.36 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.344 171.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 26.7 tt0 -83.34 -28.7 28.83 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 174.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 42.9 m-80 -109.16 -165.15 0.99 Allowed 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.309 -1.314 . . . . 0.0 109.266 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -80.88 54.01 4.64 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 120.887 -0.673 . . . . 0.0 112.492 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 25.5 p -117.34 154.61 30.97 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 120.611 0.243 . . . . 0.0 110.647 177.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.423 HD12 ' O ' ' A' ' 91' ' ' LYS . 61.5 tp -106.93 127.88 53.82 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.126 0.489 . . . . 0.0 110.749 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.43 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 66.7 mt -99.33 110.31 26.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.29 173.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 20.7 t90 -102.41 115.99 31.71 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 116.007 -0.542 . . . . 0.0 109.79 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.573 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 25.6 mt-10 -98.71 130.36 45.19 Favored 'General case' 0 CA--C 1.506 -0.722 0 CA-C-O 121.416 0.626 . . . . 0.0 110.119 175.172 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.513 ' OE1' ' HB2' ' A' ' 103' ' ' ASN . 1.2 tm0? -153.76 132.11 12.0 Favored 'General case' 0 C--N 1.304 -1.377 0 CA-C-N 114.631 -1.168 . . . . 0.0 110.133 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.513 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 1.6 t-20 66.68 10.99 7.9 Favored 'General case' 0 N--CA 1.47 0.535 0 O-C-N 123.504 0.502 . . . . 0.0 111.865 172.126 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 100.93 1.77 55.03 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.797 -0.716 . . . . 0.0 111.964 -178.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.404 ' O ' ' HA ' ' A' ' 101' ' ' GLU . 58.7 mt-30 -96.0 136.76 36.02 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 110.232 -0.284 . . . . 0.0 110.232 178.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 42.6 ttt180 -99.13 114.03 26.57 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 171.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 10.2 mmmm -119.98 137.92 53.79 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.337 0.589 . . . . 0.0 111.882 -172.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.6 t -119.92 124.48 46.11 Favored 'General case' 0 C--N 1.312 -1.064 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.613 174.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . . . . . . . . . 65.0 mtt -125.73 160.66 29.17 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.21 0.529 . . . . 0.0 111.854 -170.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -96.37 141.09 30.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.993 175.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -81.48 125.06 30.0 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.907 -177.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.677 HD11 ' HB2' ' A' ' 22' ' ' ASP . 22.6 mm -77.99 147.37 7.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 173.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -100.74 125.74 47.23 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.333 -174.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 15.1 m -106.11 101.44 10.93 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.67 -0.696 . . . . 0.0 110.427 -178.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -91.71 113.96 26.37 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.651 -0.5 . . . . 0.0 109.651 -177.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 4.6 m -103.65 155.27 18.69 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.426 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -170.08 130.61 2.05 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.772 -0.728 . . . . 0.0 111.939 178.182 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.25 84.33 1.32 Allowed 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 178.217 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -119.65 87.53 2.76 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 120.845 0.355 . . . . 0.0 110.246 -175.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 66.06 150.38 0.05 Allowed 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.203 178.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 86.9 tttt -166.56 138.67 3.63 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.657 -0.701 . . . . 0.0 110.021 174.08 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -68.64 167.91 14.19 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.776 177.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -80.99 -74.42 0.32 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.962 0.411 . . . . 0.0 111.472 -177.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -112.98 113.16 25.09 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.781 -175.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 67.0 m -140.65 102.71 4.37 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 115.415 -0.811 . . . . 0.0 109.114 169.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 5.1 tmtp? -82.96 -21.85 33.91 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.556 -176.239 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 23.4 t -75.95 74.37 2.85 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.405 0.621 . . . . 0.0 110.373 178.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 89.3 mt -104.41 38.43 1.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.64 0.733 . . . . 0.0 109.365 175.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . 0.495 ' H ' ' HG2' ' A' ' 129' ' ' GLU . 4.6 pt-20 -76.8 101.34 5.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 114.943 -1.026 . . . . 0.0 110.557 -179.06 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 30.9 t-80 -115.56 137.14 52.37 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.497 -0.774 . . . . 0.0 109.823 -176.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 19.6 m80 -89.65 179.39 6.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.394 0.616 . . . . 0.0 111.727 -178.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 8.3 p-80 -144.2 153.03 41.66 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.066 -0.97 . . . . 0.0 109.166 -179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 23.6 t-80 -150.37 122.46 8.27 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.753 0.311 . . . . 0.0 110.806 -174.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 58.8 t-80 -160.39 117.94 2.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.276 -179.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 55.4 t-80 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.881 176.295 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.484 1.261 0 CA-C-O 120.837 0.351 . . . . 0.0 110.574 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 42.3 mm -86.96 85.63 2.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.403 0.62 . . . . 0.0 109.732 -179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.5 ptm -88.44 -11.84 44.83 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.848 -178.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 20.8 t 55.76 57.64 0.3 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 CA-C-O 121.923 0.868 . . . . 0.0 110.225 -178.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 45.0 m -152.56 100.07 2.53 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.305 178.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -159.06 -172.78 26.62 Favored Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.601 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 5.9 p -159.76 175.86 12.64 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.679 0.276 . . . . 0.0 111.184 -177.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 35.5 mt-30 -153.54 80.83 1.17 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 108.377 -0.971 . . . . 0.0 108.377 168.713 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 56.2 tt0 -106.78 106.81 17.52 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.577 -0.738 . . . . 0.0 110.9 -174.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . . . . . . . . . 24.0 mp0 -66.79 109.36 2.86 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.701 173.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 32.9 mtmm -70.74 -25.56 62.98 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.583 -178.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 59.98 37.49 21.31 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-O 122.167 0.984 . . . . 0.0 109.242 -176.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.445 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 tt0 -92.55 157.8 16.33 Favored 'General case' 0 N--CA 1.445 -0.681 0 CA-C-N 113.639 -1.619 . . . . 0.0 108.851 -178.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 15' ' ' PRO . 20.0 m -77.06 100.61 0.47 Allowed Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 174.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 13' ' ' GLU . 87.3 Cg_endo -97.97 133.18 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.261 0 C-N-CA 123.036 2.491 . . . . 0.0 114.005 -167.741 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.42 ' O ' ' HZ2' ' A' ' 21' ' ' TRP . 54.4 p90 -105.9 -13.25 15.56 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.053 173.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.524 ' O ' ' HB2' ' A' ' 40' ' ' PHE . 13.4 p90 -106.31 -0.27 24.48 Favored 'General case' 0 CA--C 1.532 0.288 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.72 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 3.6 m-30 -80.48 26.38 0.38 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 112.451 0.537 . . . . 0.0 112.451 -176.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -120.88 -165.39 12.7 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.932 -174.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.572 ' OG1' ' HD2' ' A' ' 115' ' ' LYS . 22.1 m -109.8 125.97 53.29 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . 0.542 ' HB3' ' HB3' ' A' ' 109' ' ' MET . 90.2 m95 -111.92 135.45 52.53 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.277 0.56 . . . . 0.0 111.394 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.595 ' HB2' HD11 ' A' ' 112' ' ' ILE . 2.8 t70 -87.64 123.31 32.35 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.739 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -95.48 76.18 3.32 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 170.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -79.6 51.03 3.93 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.675 176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 6.7 tpt180 -153.45 141.83 20.65 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 -176.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . 64.23 158.94 0.12 Allowed Pre-proline 0 N--CA 1.47 0.573 0 O-C-N 123.904 0.752 . . . . 0.0 112.206 179.358 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -85.04 177.67 5.18 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.971 2.447 . . . . 0.0 112.056 174.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -121.65 -162.67 11.71 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.723 -0.751 . . . . 0.0 112.468 -179.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 99.3 Cg_exo -42.41 157.32 0.08 OUTLIER 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 124.446 3.431 . . . . 0.0 114.332 175.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -68.71 -18.66 64.28 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 114.701 -1.136 . . . . 0.0 113.901 -169.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -61.89 -55.43 29.73 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-O 121.026 0.441 . . . . 0.0 111.297 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 166.94 50.27 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.351 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.615 HG22 ' HG2' ' A' ' 51' ' ' MET . 5.1 t -99.38 132.77 44.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 34' ' ' LYS . 44.9 mtpt -111.62 -18.16 12.86 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-O 120.923 0.392 . . . . 0.0 110.878 -179.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 50' ' ' VAL . 19.0 m -155.38 167.05 31.65 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.239 -172.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -135.33 150.21 49.92 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.855 0.359 . . . . 0.0 110.471 175.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.6 p -134.1 132.29 39.75 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 116.182 -0.463 . . . . 0.0 109.904 173.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 8.1 p -112.39 131.55 63.59 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.109 0.48 . . . . 0.0 110.648 -178.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 27.6 m -113.45 125.25 54.02 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.145 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . 0.524 ' HB2' ' O ' ' A' ' 17' ' ' TYR . 98.8 m-85 -101.25 118.09 36.29 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 121.129 0.49 . . . . 0.0 109.684 177.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.65 -179.09 3.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.385 -177.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -50.58 -58.37 5.98 Favored 'General case' 0 C--N 1.33 -0.241 0 O-C-N 123.116 0.26 . . . . 0.0 111.53 -176.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -120.53 -5.8 9.77 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.349 0.595 . . . . 0.0 110.691 -178.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 3.8 mp0 -115.74 155.01 28.56 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.141 0.495 . . . . 0.0 111.307 -174.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 99.7 t -118.2 118.14 57.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 170.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 48.4 t -105.64 124.66 60.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.604 -0.271 . . . . 0.0 110.71 -176.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.8 mt-10 -95.28 133.59 39.01 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-O 121.679 0.752 . . . . 0.0 111.126 176.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -127.76 118.48 23.83 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-N 114.318 -1.31 . . . . 0.0 109.615 176.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -104.39 131.82 51.31 Favored 'General case' 0 C--N 1.313 -1.02 0 C-N-CA 120.165 -0.614 . . . . 0.0 109.738 178.429 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.463 HG22 ' HG2' ' A' ' 56' ' ' GLU . 47.4 t -86.8 112.42 22.97 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.745 0.784 . . . . 0.0 110.144 -174.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.615 ' HG2' HG22 ' A' ' 33' ' ' VAL . 66.8 mtt -113.29 120.02 39.73 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 114.633 -1.167 . . . . 0.0 109.34 -178.641 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -58.88 129.63 43.06 Favored 'General case' 0 N--CA 1.443 -0.784 0 CA-C-O 121.011 0.434 . . . . 0.0 110.284 -178.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 94.53 -20.38 48.66 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.625 -0.798 . . . . 0.0 112.278 -178.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.406 ' HG3' ' CB ' ' A' ' 51' ' ' MET . 7.1 mmt180 -107.01 -51.36 2.93 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.635 0.731 . . . . 0.0 109.553 178.124 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.48 -151.62 17.81 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 114.747 -1.115 . . . . 0.0 110.374 -172.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.463 ' HG2' HG22 ' A' ' 50' ' ' VAL . 45.4 mt-10 -81.68 121.64 26.62 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 117.241 0.521 . . . . 0.0 110.063 173.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 71.0 t -104.84 122.4 57.88 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.863 0 CA-C-N 115.618 -0.719 . . . . 0.0 109.78 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -83.86 118.76 24.18 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.103 0.478 . . . . 0.0 111.403 -176.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.495 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 90.8 mt -95.44 163.63 21.07 Favored Pre-proline 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 109.989 178.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 88.4 Cg_exo -44.72 120.29 2.73 Favored 'Trans proline' 0 C--N 1.348 0.513 0 C-N-CA 123.054 2.503 . . . . 0.0 112.773 178.467 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 45.0 p90 -71.84 141.44 49.61 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.104 -177.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . 0.445 ' CE ' ' HA ' ' A' ' 62' ' ' MET . 24.7 mmt -103.88 149.81 24.74 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.158 -177.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -92.49 141.42 28.54 Favored 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -130.47 162.31 29.48 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.126 0.488 . . . . 0.0 111.256 -177.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 21.9 ptmt -135.88 159.18 42.46 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.484 -0.78 . . . . 0.0 109.456 174.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 84.9 t -103.67 118.46 50.8 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.88 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.538 -175.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.615 HD11 ' HB2' ' A' ' 78' ' ' GLN . 14.2 mt -85.91 -50.72 14.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.301 0.572 . . . . 0.0 109.727 179.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 7.3 m -138.74 160.11 40.46 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.214 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -147.33 135.16 21.2 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.74 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 37.0 t -137.51 116.67 12.57 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.124 178.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 23.4 m -64.86 -20.94 66.69 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.098 0.475 . . . . 0.0 109.949 175.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -56.46 -42.76 78.71 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.826 176.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 151.36 35.65 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 119.347 -1.406 . . . . 0.0 115.004 173.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 5.2 p -154.58 140.85 18.59 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.652 0.726 . . . . 0.0 111.895 172.335 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 20.2 mt -130.05 137.35 56.71 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.771 0 CA-C-N 115.513 -0.767 . . . . 0.0 109.9 174.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.439 ' HG2' HD12 ' A' ' 67' ' ' ILE . 60.0 tt0 -110.3 123.42 49.78 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 34.0 pt -129.61 158.35 42.18 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-O 121.112 0.482 . . . . 0.0 110.925 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.694 ' NE2' ' HA ' ' A' ' 85' ' ' PRO . 46.8 tt0 -132.59 147.72 52.35 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.655 -0.702 . . . . 0.0 109.411 178.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 84' ' ' TYR . 96.4 m-85 -99.17 157.43 16.37 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.173 0.511 . . . . 0.0 110.599 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.443 HD23 ' CE1' ' A' ' 84' ' ' TYR . 26.2 mt -112.22 179.51 3.97 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.073 176.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 74.91 -150.43 41.09 Favored Glycine 0 N--CA 1.445 -0.71 0 C-N-CA 119.476 -1.345 . . . . 0.0 110.921 -177.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -59.09 -12.32 15.34 Favored 'Trans proline' 0 CA--C 1.532 0.421 0 C-N-CA 122.849 2.366 . . . . 0.0 112.833 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -104.19 20.49 18.23 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.377 179.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.534 ' C ' ' H ' ' A' ' 86' ' ' LEU . 0.4 OUTLIER -66.23 -176.19 0.22 Allowed Pre-proline 0 CA--C 1.55 0.953 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 175.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.694 ' HA ' ' NE2' ' A' ' 78' ' ' GLN . 59.4 Cg_exo 2.98 -3.09 0.0 OUTLIER 'Trans proline' 0 CA--C 1.554 1.484 1 C-N-CA 126.613 4.876 . . . . 0.0 120.823 -138.232 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.534 ' H ' ' C ' ' A' ' 84' ' ' TYR . 56.8 tp -72.3 116.71 13.05 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 120.116 1.325 . . . . 0.0 110.763 176.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.62 167.35 15.43 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.646 0.736 . . . . 0.0 111.883 177.553 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 30.0 t -150.58 145.08 25.69 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.334 169.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.25 141.57 51.36 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 120.886 0.374 . . . . 0.0 110.995 -176.199 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . . . . . . . . . 98.7 mt -115.86 124.03 49.64 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 176.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -129.7 165.88 20.96 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.119 0.485 . . . . 0.0 111.607 -176.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 19.3 ptt180 -77.13 147.91 36.29 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.557 -0.747 . . . . 0.0 111.135 -178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.43 173.11 22.73 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 121.021 -0.609 . . . . 0.0 111.707 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -95.65 -2.43 48.14 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 120.908 0.385 . . . . 0.0 111.259 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 15.3 m120 -129.72 28.49 5.12 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.535 -176.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 69.07 49.15 42.62 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.564 -0.827 . . . . 0.0 111.138 -174.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 8.2 p -130.98 173.79 10.64 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 115.512 -0.344 . . . . 0.0 110.809 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . . . . . . . . . 27.1 tp -119.06 134.0 55.47 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 177.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . . . . . . . . . 33.4 mm -97.76 116.74 41.11 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.124 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . 0.539 ' HB2' ' CE ' ' A' ' 109' ' ' MET . 12.4 t90 -96.73 112.43 24.19 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -105.0 133.37 49.89 Favored 'General case' 0 N--CA 1.439 -1.023 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -149.74 129.15 12.97 Favored 'General case' 0 C--N 1.313 -1.018 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 -179.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 7.4 m-20 62.91 22.67 13.57 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-O 121.089 0.471 . . . . 0.0 110.85 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 85.26 -8.9 68.87 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 121.006 -0.616 . . . . 0.0 112.548 -179.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -92.48 145.65 24.29 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.973 0.416 . . . . 0.0 110.65 -177.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -100.54 117.01 33.81 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.769 -0.65 . . . . 0.0 112.084 -171.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 13.6 mmtm -104.06 132.81 49.93 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.473 171.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 6.4 t -100.92 126.64 47.56 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 174.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.542 ' HB3' ' HB3' ' A' ' 21' ' ' TRP . 59.4 mtm -117.61 144.46 45.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.205 0.526 . . . . 0.0 111.937 -174.263 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.524 ' HB ' ' HB3' ' A' ' 22' ' ' ASP . 1.1 m -96.92 158.69 15.31 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.215 -0.902 . . . . 0.0 108.997 175.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 13.8 ttp180 -95.22 121.99 37.44 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.074 -0.65 . . . . 0.0 110.316 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.595 HD11 ' HB2' ' A' ' 22' ' ' ASP . 24.1 mm -71.59 146.6 11.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 176.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -92.13 85.59 5.53 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.112 -0.494 . . . . 0.0 111.43 -171.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 33.5 t 65.93 105.28 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.793 175.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.572 ' HD2' ' OG1' ' A' ' 20' ' ' THR . 83.5 tttt -79.89 72.6 6.64 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 175.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.24 92.15 8.34 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.674 -177.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . 173.4 53.28 0.05 OUTLIER Glycine 0 C--N 1.314 -0.682 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.604 -178.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 53.4 ttt180 -98.55 98.92 10.03 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -160.58 84.53 0.7 Allowed 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.479 178.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 12.4 mm-40 -134.18 123.26 24.05 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.425 -0.807 . . . . 0.0 109.223 174.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -72.13 134.79 45.95 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.26 -177.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -82.66 130.31 35.1 Favored 'General case' 0 C--N 1.321 -0.673 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 172.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -161.49 104.55 1.25 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.746 -176.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.1 pttm -136.94 130.93 32.31 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.518 -177.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.2 t -104.5 179.68 4.2 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.372 178.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 38.9 ttpt -145.13 121.0 10.61 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.744 0.307 . . . . 0.0 110.328 -177.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 48.4 p -89.33 136.63 32.91 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.191 -0.459 . . . . 0.0 109.85 177.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.403 HD23 ' N ' ' A' ' 128' ' ' LEU . 2.4 pt? -150.35 127.75 11.43 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 120.903 0.383 . . . . 0.0 110.176 -179.189 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -142.06 94.91 2.72 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.989 -0.55 . . . . 0.0 109.893 179.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 4.0 p-80 -115.85 89.14 3.03 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.552 0.691 . . . . 0.0 110.832 179.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 57.1 t-80 -134.55 129.57 35.24 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.816 178.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -129.68 147.73 51.5 Favored 'General case' 0 C--N 1.319 -0.748 0 N-CA-C 109.395 -0.594 . . . . 0.0 109.395 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -103.35 137.7 41.1 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.809 0.338 . . . . 0.0 111.662 -173.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . 0.421 ' HB3' ' H ' ' A' ' 135' ' ' HIS . 3.0 t-80 62.82 -90.13 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.184 -0.917 . . . . 0.0 110.964 176.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . 0.421 ' H ' ' HB3' ' A' ' 134' ' ' HIS . 20.7 p-80 . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.4 -0.809 . . . . 0.0 109.099 173.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.8 tpt . . . . . 0 N--CA 1.477 0.903 0 CA-C-O 120.749 0.309 . . . . 0.0 110.232 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . 0.8 ' H ' HD13 ' A' ' 2' ' ' ILE . 0.2 OUTLIER -94.35 173.57 0.9 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.291 177.402 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.9 ttt -89.87 109.66 20.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.152 0.501 . . . . 0.0 110.762 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 27.6 m -117.04 170.07 6.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.095 176.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 13.8 p -106.38 125.34 50.87 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.445 179.273 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -82.1 -17.48 69.5 Favored Glycine 0 N--CA 1.449 -0.497 0 N-CA-C 111.453 -0.659 . . . . 0.0 111.453 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' CYS . . . . . . . . . . . . . 1.6 p -80.12 75.76 6.88 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.227 0.537 . . . . 0.0 110.675 177.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLN . . . . . . . . . . . . . 27.7 tt0 -138.89 129.45 25.97 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.674 178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLN . . . . . . . . . . . . . 10.1 tp60 57.96 38.19 26.84 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.5 0.667 . . . . 0.0 110.003 178.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLN . . . . . 0.405 ' H ' ' HG2' ' A' ' 10' ' ' GLN . 2.5 pt20 -68.66 150.97 47.33 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.024 -0.989 . . . . 0.0 111.377 -176.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -84.46 -3.39 58.34 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.118 0.485 . . . . 0.0 111.004 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -128.14 118.66 23.8 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 174.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.559 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 8.9 mm-40 -68.59 146.49 53.02 Favored 'General case' 0 N--CA 1.437 -1.118 0 CA-C-O 121.257 0.551 . . . . 0.0 110.6 -179.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' THR . . . . . . . . . . . . . 32.9 m -107.19 93.18 8.97 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.927 176.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.559 ' HD3' ' O ' ' A' ' 13' ' ' GLU . 2.6 Cg_endo -83.58 123.73 3.41 Favored 'Trans proline' 0 N--CA 1.457 -0.642 0 C-N-CA 123.199 2.599 . . . . 0.0 111.578 179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.1 p90 -69.45 -9.36 53.32 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.136 -0.484 . . . . 0.0 112.12 -173.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -113.24 -0.72 14.51 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 120.688 0.28 . . . . 0.0 111.619 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.477 ' HB2' ' HB2' ' A' ' 15' ' ' PRO . 58.2 t80 -97.99 126.64 43.5 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.141 0.496 . . . . 0.0 111.501 -170.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 135.99 -160.64 24.68 Favored Glycine 0 N--CA 1.447 -0.576 0 CA-C-N 115.436 -0.802 . . . . 0.0 112.261 179.296 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' THR . . . . . 0.43 ' CG2' ' HB ' ' A' ' 37' ' ' THR . 29.1 m -101.39 123.72 45.92 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.803 0.335 . . . . 0.0 110.403 178.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' TRP . . . . . . . . . . . . . 97.2 m95 -104.85 139.63 39.33 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 121.267 0.556 . . . . 0.0 111.851 -176.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HB2' ' CD1' ' A' ' 112' ' ' ILE . 8.7 t70 -79.02 123.66 27.53 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.721 -1.127 . . . . 0.0 111.822 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . 0.53 ' HB3' ' HB2' ' A' ' 26' ' ' ALA . 4.3 mm-40 -88.76 85.53 6.79 Favored 'General case' 0 N--CA 1.444 -0.749 0 CA-C-N 114.873 -1.058 . . . . 0.0 109.394 172.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -44.54 -38.13 5.24 Favored Glycine 0 CA--C 1.52 0.389 0 CA-C-N 114.922 -1.035 . . . . 0.0 111.622 171.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ARG . . . . . . . . . . . . . 39.5 ttm180 -137.54 141.78 41.39 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 106.743 -1.577 . . . . 0.0 106.743 165.318 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.53 ' HB2' ' HB3' ' A' ' 23' ' ' GLU . . . -131.11 140.98 40.29 Favored Pre-proline 0 C--N 1.311 -1.106 0 C-N-CA 119.831 -0.747 . . . . 0.0 112.705 -171.708 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 26' ' ' ALA . 27.6 Cg_endo -97.93 143.89 0.62 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 C-N-CA 123.957 3.105 . . . . 0.0 111.293 168.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 174.49 -157.92 25.8 Favored Glycine 0 N--CA 1.435 -1.38 0 C-N-CA 119.421 -1.371 . . . . 0.0 113.498 178.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HG2' ' OE2' ' A' ' 49' ' ' GLU . 50.9 Cg_exo -49.05 161.62 0.53 Allowed 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 125.006 3.804 . . . . 0.0 114.069 178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 1.4 p -91.06 13.7 16.09 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.492 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -63.01 -28.1 69.87 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.35 -179.744 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 106.87 59.55 0.59 Allowed Glycine 0 N--CA 1.449 -0.462 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -176.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -94.45 133.31 35.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -96.03 -23.24 16.91 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-O 120.618 0.247 . . . . 0.0 111.556 -178.718 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.3 m -157.98 163.21 38.01 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 23' ' ' GLU . . . -148.7 165.89 30.01 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.468 ' OG1' ' HB ' ' A' ' 48' ' ' THR . 3.3 p -133.35 132.9 41.8 Favored 'General case' 0 C--N 1.313 -1.015 0 CA-C-N 115.829 -0.623 . . . . 0.0 109.743 176.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 7.6 p -111.2 120.86 62.73 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.852 0 CA-C-O 121.444 0.64 . . . . 0.0 109.596 179.852 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 52.5 m -108.93 126.11 52.73 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-N 115.544 -0.753 . . . . 0.0 110.3 -177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -100.66 117.64 35.18 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 176.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.519 HG22 ' H ' ' A' ' 42' ' ' GLU . 1.3 m -100.16 173.61 6.54 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.448 -0.796 . . . . 0.0 109.347 -177.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.519 ' H ' HG22 ' A' ' 41' ' ' THR . 37.5 tt0 -50.38 -40.18 48.87 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 112.038 0.385 . . . . 0.0 112.038 -177.329 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -136.24 -0.59 2.45 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 120.474 -0.49 . . . . 0.0 112.099 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 24.6 mp0 -126.05 151.66 46.84 Favored 'General case' 0 C--N 1.329 -0.325 0 O-C-N 121.942 -0.473 . . . . 0.0 111.759 -176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 93.0 t -106.84 118.89 55.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 169.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' VAL . . . . . . . . . . . . . 43.0 t -116.85 124.06 72.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 120.912 0.387 . . . . 0.0 111.027 -176.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -98.07 139.15 34.31 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-O 121.315 0.578 . . . . 0.0 110.778 175.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.468 ' HB ' ' OG1' ' A' ' 37' ' ' THR . 0.2 OUTLIER -123.58 136.63 54.63 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.536 177.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 56' ' ' GLU . 32.7 mt-10 -97.48 130.28 44.59 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 178.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . . . . . . . . . 48.1 t -99.02 107.27 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.924 0 N-CA-C 106.708 -1.589 . . . . 0.0 106.708 170.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' MET . . . . . 0.599 ' HB3' ' HG2' ' A' ' 54' ' ' ARG . 0.5 OUTLIER -133.85 133.16 41.22 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.3 -169.243 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -80.38 88.8 5.56 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.091 -175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 152.65 -52.78 0.47 Allowed Glycine 0 N--CA 1.443 -0.875 0 CA-C-N 115.588 -0.733 . . . . 0.0 111.499 -176.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ARG . . . . . 0.599 ' HG2' ' HB3' ' A' ' 51' ' ' MET . 10.0 ptp180 -94.62 -33.11 13.12 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.953 0.406 . . . . 0.0 110.671 178.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 96.52 -173.18 29.55 Favored Glycine 0 N--CA 1.447 -0.579 0 N-CA-C 110.484 -1.046 . . . . 0.0 110.484 -175.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.61 ' HA ' ' O ' ' A' ' 49' ' ' GLU . 60.0 mp0 -67.33 117.22 9.03 Favored 'General case' 0 N--CA 1.44 -0.927 0 CA-C-O 121.774 0.797 . . . . 0.0 110.803 174.356 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 83.4 t -124.73 128.29 73.27 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 CA-C-N 114.36 -1.291 . . . . 0.0 110.627 -177.246 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLN . . . . . . . . . . . . . 94.7 mt-30 -78.7 131.72 36.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.976 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.412 ' HB3' ' HD2' ' A' ' 60' ' ' PRO . 95.0 mt -89.86 162.25 36.24 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.735 175.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HD2' ' HB3' ' A' ' 59' ' ' LEU . 76.5 Cg_exo -47.2 121.37 5.2 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 122.795 2.33 . . . . 0.0 112.307 176.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 54.0 p90 -70.62 141.16 51.74 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.295 0.569 . . . . 0.0 110.954 -176.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' MET . . . . . . . . . . . . . 70.6 mtm -107.96 147.68 30.72 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.831 -179.22 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -85.79 148.08 26.01 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.791 175.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -145.04 154.72 42.81 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.036 0.446 . . . . 0.0 110.545 -179.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.515 ' HG3' HD11 ' A' ' 80' ' ' LEU . 55.4 mtpt -128.46 156.19 43.61 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.387 175.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 91.5 t -96.41 124.22 49.05 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.113 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.843 -176.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.608 HD11 ' HB2' ' A' ' 78' ' ' GLN . 18.3 mt -87.49 -50.25 13.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 177.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' SER . . . . . . . . . . . . . 15.3 m -144.92 155.74 43.6 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.348 177.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -149.43 128.65 12.84 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.415 0.626 . . . . 0.0 111.108 -175.694 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.482 ' HB3' ' H ' ' A' ' 74' ' ' SER . 38.4 t -136.56 147.14 46.86 Favored 'General case' 0 C--N 1.315 -0.913 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.223 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.3 p -80.85 -23.21 39.26 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.698 0.285 . . . . 0.0 111.593 -177.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -143.16 -10.07 0.76 Allowed 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 112.795 0.665 . . . . 0.0 112.795 -174.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.5 -83.22 1.06 Allowed Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 119.939 -1.124 . . . . 0.0 111.337 175.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.482 ' H ' ' HB3' ' A' ' 70' ' ' SER . 4.1 p -164.37 153.67 13.62 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 122.84 0.456 . . . . 0.0 110.532 177.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.584 ' HB ' ' HB2' ' A' ' 90' ' ' LEU . 25.2 mt -114.09 138.01 45.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 109.776 -0.453 . . . . 0.0 109.776 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.58 ' HG2' HD12 ' A' ' 67' ' ' ILE . 30.2 tt0 -120.49 124.93 46.61 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.888 0.375 . . . . 0.0 110.181 177.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 28.8 pt -128.44 157.73 40.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.342 -178.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.608 ' HB2' HD11 ' A' ' 67' ' ' ILE . 57.3 tt0 -130.03 144.14 51.18 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.528 -0.306 . . . . 0.0 110.176 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -82.63 167.38 18.32 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.52 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.515 HD11 ' HG3' ' A' ' 65' ' ' LYS . 95.8 mt -129.22 166.48 19.3 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.334 177.587 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 104.53 -153.78 17.51 Favored Glycine 0 N--CA 1.446 -0.649 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 -175.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PRO . . . . . . . . . . . . . 35.5 Cg_endo -67.38 -21.9 46.49 Favored 'Trans proline' 0 C--O 1.234 0.311 0 C-N-CA 122.038 1.825 . . . . 0.0 111.6 176.16 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' TYR . . . . . . . . . . . . . 57.4 m-85 -105.64 40.72 1.5 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.594 -0.73 . . . . 0.0 110.083 -178.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' TYR . . . . . 0.477 ' N ' ' CD ' ' A' ' 85' ' ' PRO . 45.8 p90 -78.15 -33.16 0.94 Allowed Pre-proline 0 N--CA 1.447 -0.616 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -173.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.477 ' CD ' ' N ' ' A' ' 84' ' ' TYR . 85.9 Cg_endo -74.04 -3.6 14.05 Favored 'Trans proline' 0 N--CA 1.446 -1.304 0 CA-C-N 121.222 1.472 . . . . 0.0 113.068 -170.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.7 tp -88.1 124.83 34.18 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.505 -0.316 . . . . 0.0 110.156 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LYS . . . . . . . . . . . . . 21.0 pttp -111.66 168.97 9.14 Favored 'General case' 0 C--N 1.327 -0.401 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.542 178.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.4 t -138.29 153.45 49.04 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.63 -173.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.578 ' HB ' ' HB2' ' A' ' 101' ' ' GLU . 1.9 m -120.08 142.26 49.04 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.63 -179.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.584 ' HB2' ' HB ' ' A' ' 75' ' ' ILE . 95.0 mt -125.95 124.41 40.72 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.74 179.058 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.564 ' HB2' ' HB ' ' A' ' 99' ' ' ILE . 85.9 mttt -130.52 163.35 27.23 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.039 178.576 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 18.7 mtt-85 -86.79 143.67 27.4 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-O 120.929 0.395 . . . . 0.0 110.743 171.305 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLY . . . . . . . . . . . . . . . -102.72 -146.26 17.15 Favored Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 110.799 -0.92 . . . . 0.0 110.799 173.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -89.28 125.93 35.3 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 175.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 65.06 -153.09 0.28 Allowed 'General case' 0 C--O 1.235 0.337 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 -175.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . -78.79 53.19 4.02 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 121.371 -0.443 . . . . 0.0 113.124 -177.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 39.2 p -115.68 144.01 44.55 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.888 0.375 . . . . 0.0 110.554 176.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LEU . . . . . 0.508 HD21 HD22 ' A' ' 90' ' ' LEU . 29.9 tp -109.57 133.68 52.82 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.196 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 91' ' ' LYS . 70.9 mt -98.48 110.28 25.64 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.845 0 N-CA-C 109.084 -0.709 . . . . 0.0 109.084 175.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' TRP . . . . . . . . . . . . . 21.8 t90 -105.94 114.8 29.16 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.926 -176.306 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.578 ' HB2' ' HB ' ' A' ' 89' ' ' THR . 32.8 mt-10 -106.2 131.72 53.12 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.651 0.738 . . . . 0.0 110.321 178.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLN . . . . . 0.518 ' O ' ' HG2' ' A' ' 105' ' ' GLN . 1.2 tm0? -151.75 135.18 16.07 Favored 'General case' 0 C--N 1.308 -1.213 0 CA-C-N 114.638 -1.165 . . . . 0.0 109.016 -176.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . 0.481 ' HB2' ' OE1' ' A' ' 102' ' ' GLN . 0.7 OUTLIER 65.09 9.12 5.25 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.796 0.331 . . . . 0.0 111.621 176.435 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 91.98 13.42 57.77 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 120.85 -0.69 . . . . 0.0 112.654 -179.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 102' ' ' GLN . 3.5 pt20 -120.93 149.0 43.3 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 176.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ARG . . . . . . . . . . . . . 30.4 ttm180 -96.07 125.85 40.89 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.325 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.589 ' HA ' ' HE2' ' A' ' 107' ' ' LYS . 3.1 mmpt? -111.71 139.75 46.91 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.544 173.423 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 24.3 m -105.25 114.66 28.98 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.722 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' MET . . . . . 0.42 ' HB2' ' HB3' ' A' ' 98' ' ' LEU . 64.2 mmm -101.85 133.15 47.07 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.86 -175.017 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -102.62 142.87 33.07 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 174.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 111' ' ' ARG . 8.9 ttp180 -82.63 130.56 35.14 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 119.813 -0.755 . . . . 0.0 110.147 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ILE . . . . . 0.507 ' CD1' ' HB2' ' A' ' 22' ' ' ASP . 20.4 mm -62.83 144.58 14.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 173.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 13.3 tp10 -115.71 109.96 18.46 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-O 121.422 0.63 . . . . 0.0 110.868 -171.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 9.1 t -171.26 107.04 0.25 Allowed 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 114.665 -1.152 . . . . 0.0 109.607 -178.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 48.5 mtpt -88.23 128.02 35.46 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 176.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' THR . . . . . . . . . . . . . 24.3 m 71.41 129.01 0.03 OUTLIER 'General case' 0 C--O 1.233 0.211 0 O-C-N 123.954 0.784 . . . . 0.0 109.575 -168.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLY . . . . . . . . . . . . . . . -83.05 -102.88 0.5 Allowed Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.612 -176.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.4 ptp85 -125.35 155.17 40.7 Favored 'General case' 0 N--CA 1.432 -1.372 0 CA-C-O 121.324 0.583 . . . . 0.0 109.599 -175.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -122.36 27.89 7.7 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.628 178.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -72.0 84.63 0.98 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.019 173.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LYS . . . . . . . . . . . . . 38.6 ttmt -114.95 105.82 13.42 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.603 -172.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -169.04 132.99 1.4 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.263 175.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -150.99 130.87 13.28 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.038 -0.528 . . . . 0.0 111.084 -176.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -130.48 92.13 3.21 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.75 -0.834 . . . . 0.0 108.75 170.184 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.5 m -70.91 95.97 1.23 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.045 0.45 . . . . 0.0 110.758 -178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt -77.87 112.94 15.27 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.133 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' SER . . . . . . . . . . . . . 57.8 p -121.48 126.17 48.62 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.79 0.329 . . . . 0.0 110.905 -178.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 43.4 tp -111.43 109.13 18.94 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 108.998 -0.742 . . . . 0.0 108.998 175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLU . . . . . . . . . . . . . 15.5 tp10 -97.6 114.8 26.8 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 116.233 -0.44 . . . . 0.0 109.968 -177.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' HIS . . . . . . . . . . . . . 26.4 t60 -121.31 130.72 53.79 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.388 -175.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 92.8 m-70 -131.7 106.9 8.44 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.838 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' HIS . . . . . . . . . . . . . 37.6 t-80 -149.03 100.61 3.08 Favored 'General case' 0 C--N 1.32 -0.704 0 N-CA-C 109.68 -0.489 . . . . 0.0 109.68 176.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' HIS . . . . . . . . . . . . . 71.0 t60 -146.17 96.77 2.84 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.286 0.565 . . . . 0.0 110.593 -177.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 -95.75 116.05 28.31 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.282 -179.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' HIS . . . . . . . . . . . . . 4.4 p80 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.337 -0.84 . . . . 0.0 110.274 177.514 . . . . . . . . 0 0 . 1 stop_ save_